id	sid	tid	token	lemma	pos
ihlr-28406	1	1	inventions	invention	NOUN
ihlr-28406	1	2	and	and	CCONJ
ihlr-28406	1	3	patents	patent	NOUN
ihlr-28406	1	4	for	for	ADP
ihlr-28406	1	5	treating	treat	VERB
ihlr-28406	1	6	thyroid	thyroid	NOUN
ihlr-28406	1	7	disease	disease	NOUN
ihlr-28406	1	8	inventions	invention	NOUN
ihlr-28406	1	9	and	and	CCONJ
ihlr-28406	1	10	patents	patent	NOUN
ihlr-28406	1	11	for	for	ADP
ihlr-28406	1	12	treating	treat	VERB
ihlr-28406	1	13	thyroid	thyroid	NOUN
ihlr-28406	1	14	disease	disease	NOUN
ihlr-28406	1	15	brizzia	brizzia	PROPN
ihlr-28406	1	16	munoz	munoz	PROPN
ihlr-28406	1	17	-	-	PUNCT
ihlr-28406	1	18	robles	robles	PROPN
ihlr-28406	1	19	and	and	CCONJ
ihlr-28406	1	20	brian	brian	PROPN
ihlr-28406	1	21	haney	haney	PROPN
ihlr-28406	1	22	*	*	PUNCT
ihlr-28406	1	23	2023	2023	NUM
ihlr-28406	1	24	abstract	abstract	NOUN
ihlr-28406	1	25	the	the	DET
ihlr-28406	1	26	thyroid	thyroid	NOUN
ihlr-28406	1	27	is	be	AUX
ihlr-28406	1	28	a	a	DET
ihlr-28406	1	29	bi	bi	ADJ
ihlr-28406	1	30	-	-	ADJ
ihlr-28406	1	31	lobed	lobed	ADJ
ihlr-28406	1	32	gland	gland	NOUN
ihlr-28406	1	33	located	locate	VERB
ihlr-28406	1	34	at	at	ADP
ihlr-28406	1	35	the	the	DET
ihlr-28406	1	36	base	base	NOUN
ihlr-28406	1	37	of	of	ADP
ihlr-28406	1	38	the	the	DET
ihlr-28406	1	39	neck	neck	NOUN
ihlr-28406	1	40	that	that	PRON
ihlr-28406	1	41	produces	produce	VERB
ihlr-28406	1	42	essential	essential	ADJ
ihlr-28406	1	43	hormones	hormone	NOUN
ihlr-28406	1	44	for	for	ADP
ihlr-28406	1	45	metabolic	metabolic	NOUN
ihlr-28406	1	46	control	control	NOUN
ihlr-28406	1	47	in	in	ADP
ihlr-28406	1	48	the	the	DET
ihlr-28406	1	49	human	human	ADJ
ihlr-28406	1	50	body	body	NOUN
ihlr-28406	1	51	.	.	PUNCT
ihlr-28406	2	1	affecting	affect	VERB
ihlr-28406	2	2	nearly	nearly	ADV
ihlr-28406	2	3	fifty	fifty	NUM
ihlr-28406	2	4	-	-	PUNCT
ihlr-28406	2	5	million	million	NUM
ihlr-28406	2	6	americans	americans	PROPN
ihlr-28406	2	7	,	,	PUNCT
ihlr-28406	2	8	thyroid	thyroid	NOUN
ihlr-28406	2	9	disease	disease	NOUN
ihlr-28406	2	10	has	have	AUX
ihlr-28406	2	11	become	become	VERB
ihlr-28406	2	12	a	a	DET
ihlr-28406	2	13	ubiquitous	ubiquitous	ADJ
ihlr-28406	2	14	cause	cause	NOUN
ihlr-28406	2	15	for	for	ADP
ihlr-28406	2	16	symptoms	symptom	NOUN
ihlr-28406	2	17	including	include	VERB
ihlr-28406	2	18	depression	depression	NOUN
ihlr-28406	2	19	,	,	PUNCT
ihlr-28406	2	20	anxiety	anxiety	NOUN
ihlr-28406	2	21	,	,	PUNCT
ihlr-28406	2	22	psychosis	psychosis	NOUN
ihlr-28406	2	23	,	,	PUNCT
ihlr-28406	2	24	and	and	CCONJ
ihlr-28406	2	25	heart	heart	NOUN
ihlr-28406	2	26	disease	disease	NOUN
ihlr-28406	2	27	.	.	PUNCT
ihlr-28406	3	1	yet	yet	ADV
ihlr-28406	3	2	,	,	PUNCT
ihlr-28406	3	3	while	while	SCONJ
ihlr-28406	3	4	the	the	DET
ihlr-28406	3	5	healthcare	healthcare	NOUN
ihlr-28406	3	6	law	law	NOUN
ihlr-28406	3	7	scholarship	scholarship	NOUN
ihlr-28406	3	8	is	be	AUX
ihlr-28406	3	9	visibly	visibly	ADV
ihlr-28406	3	10	scaling	scale	VERB
ihlr-28406	3	11	,	,	PUNCT
ihlr-28406	3	12	the	the	DET
ihlr-28406	3	13	research	research	NOUN
ihlr-28406	3	14	relating	relate	VERB
ihlr-28406	3	15	to	to	ADP
ihlr-28406	3	16	law	law	NOUN
ihlr-28406	3	17	,	,	PUNCT
ihlr-28406	3	18	innovation	innovation	NOUN
ihlr-28406	3	19	,	,	PUNCT
ihlr-28406	3	20	and	and	CCONJ
ihlr-28406	3	21	thyroid	thyroid	NOUN
ihlr-28406	3	22	disease	disease	NOUN
ihlr-28406	3	23	is	be	AUX
ihlr-28406	3	24	completely	completely	ADV
ihlr-28406	3	25	naked	naked	ADJ
ihlr-28406	3	26	.	.	PUNCT
ihlr-28406	4	1	this	this	DET
ihlr-28406	4	2	article	article	NOUN
ihlr-28406	4	3	provides	provide	VERB
ihlr-28406	4	4	an	an	DET
ihlr-28406	4	5	interdisciplinary	interdisciplinary	ADJ
ihlr-28406	4	6	introduction	introduction	NOUN
ihlr-28406	4	7	to	to	ADP
ihlr-28406	4	8	the	the	DET
ihlr-28406	4	9	thyroid	thyroid	NOUN
ihlr-28406	4	10	patent	patent	NOUN
ihlr-28406	4	11	dataset	dataset	NOUN
ihlr-28406	4	12	,	,	PUNCT
ihlr-28406	4	13	an	an	DET
ihlr-28406	4	14	evolving	evolve	VERB
ihlr-28406	4	15	mechanism	mechanism	NOUN
ihlr-28406	4	16	for	for	ADP
ihlr-28406	4	17	tracking	track	VERB
ihlr-28406	4	18	progress	progress	NOUN
ihlr-28406	4	19	in	in	ADP
ihlr-28406	4	20	treatments	treatment	NOUN
ihlr-28406	4	21	for	for	ADP
ihlr-28406	4	22	thyroid	thyroid	NOUN
ihlr-28406	4	23	disease	disease	NOUN
ihlr-28406	4	24	and	and	CCONJ
ihlr-28406	4	25	advances	advance	VERB
ihlr-28406	4	26	the	the	DET
ihlr-28406	4	27	literature	literature	NOUN
ihlr-28406	4	28	in	in	ADP
ihlr-28406	4	29	providing	provide	VERB
ihlr-28406	4	30	the	the	DET
ihlr-28406	4	31	first	first	ADJ
ihlr-28406	4	32	consolidated	consolidated	ADJ
ihlr-28406	4	33	review	review	NOUN
ihlr-28406	4	34	of	of	ADP
ihlr-28406	4	35	patents	patent	NOUN
ihlr-28406	4	36	for	for	ADP
ihlr-28406	4	37	a	a	DET
ihlr-28406	4	38	specific	specific	ADJ
ihlr-28406	4	39	disease	disease	NOUN
ihlr-28406	4	40	.	.	PUNCT
ihlr-28406	5	1	in	in	ADP
ihlr-28406	5	2	short	short	ADJ
ihlr-28406	5	3	,	,	PUNCT
ihlr-28406	5	4	this	this	DET
ihlr-28406	5	5	article	article	NOUN
ihlr-28406	5	6	explores	explore	VERB
ihlr-28406	5	7	the	the	DET
ihlr-28406	5	8	confluence	confluence	NOUN
ihlr-28406	5	9	of	of	ADP
ihlr-28406	5	10	thyroid	thyroid	NOUN
ihlr-28406	5	11	disease	disease	NOUN
ihlr-28406	5	12	,	,	PUNCT
ihlr-28406	5	13	patent	patent	NOUN
ihlr-28406	5	14	law	law	NOUN
ihlr-28406	5	15	,	,	PUNCT
ihlr-28406	5	16	and	and	CCONJ
ihlr-28406	5	17	innovation	innovation	NOUN
ihlr-28406	5	18	policy	policy	NOUN
ihlr-28406	5	19	to	to	PART
ihlr-28406	5	20	promote	promote	VERB
ihlr-28406	5	21	knowledge	knowledge	NOUN
ihlr-28406	5	22	in	in	ADP
ihlr-28406	5	23	human	human	ADJ
ihlr-28406	5	24	health	health	NOUN
ihlr-28406	5	25	relating	relate	VERB
ihlr-28406	5	26	to	to	ADP
ihlr-28406	5	27	the	the	DET
ihlr-28406	5	28	human	human	ADJ
ihlr-28406	5	29	thyroid	thyroid	NOUN
ihlr-28406	5	30	.	.	PUNCT
ihlr-28406	6	1	—	—	PUNCT
ihlr-28406	6	2	—	—	PUNCT
ihlr-28406	6	3	—	—	PUNCT
ihlr-28406	6	4	—	—	PUNCT
ihlr-28406	6	5	—	—	PUNCT
ihlr-28406	6	6	—	—	PUNCT
ihlr-28406	6	7	—	—	PUNCT
ihlr-28406	6	8	—	—	PUNCT
ihlr-28406	6	9	—	—	PUNCT
ihlr-28406	6	10	—	—	PUNCT
ihlr-28406	6	11	—	—	PUNCT
ihlr-28406	6	12	—	—	PUNCT
ihlr-28406	6	13	—	—	PUNCT
ihlr-28406	6	14	—	—	PUNCT
ihlr-28406	6	15	—	—	PUNCT
ihlr-28406	6	16	—	—	PUNCT
ihlr-28406	6	17	—	—	PUNCT
ihlr-28406	6	18	—	—	PUNCT
ihlr-28406	6	19	—	—	PUNCT
ihlr-28406	6	20	—	—	PUNCT
ihlr-28406	6	21	—	—	PUNCT
ihlr-28406	6	22	—	—	PUNCT
ihlr-28406	6	23	—	—	PUNCT
ihlr-28406	6	24	—	—	PUNCT
ihlr-28406	6	25	—	—	PUNCT
ihlr-28406	6	26	—	—	PUNCT
ihlr-28406	6	27	—	—	PUNCT
ihlr-28406	6	28	—	—	PUNCT
ihlr-28406	6	29	—	—	PUNCT
ihlr-28406	6	30	*	*	PUNCT
ihlr-28406	6	31	thank	thank	VERB
ihlr-28406	6	32	you	you	PRON
ihlr-28406	6	33	to	to	ADP
ihlr-28406	6	34	our	our	PRON
ihlr-28406	6	35	moms	mom	NOUN
ihlr-28406	6	36	,	,	PUNCT
ihlr-28406	6	37	mr	mr	PROPN
ihlr-28406	6	38	.	.	PROPN
ihlr-28406	6	39	munoz	munoz	PROPN
ihlr-28406	6	40	,	,	PUNCT
ihlr-28406	6	41	maria	maria	PROPN
ihlr-28406	6	42	,	,	PUNCT
ihlr-28406	6	43	christina	christina	PROPN
ihlr-28406	6	44	,	,	PUNCT
ihlr-28406	6	45	brad	brad	PROPN
ihlr-28406	6	46	,	,	PUNCT
ihlr-28406	6	47	nicolette	nicolette	PROPN
ihlr-28406	6	48	妹妹	妹妹	PROPN
ihlr-28406	6	49	,	,	PUNCT
ihlr-28406	6	50	broderick	broderick	PROPN
ihlr-28406	6	51	,	,	PUNCT
ihlr-28406	6	52	jon	jon	PROPN
ihlr-28406	6	53	j$	j$	PROPN
ihlr-28406	6	54	,	,	PUNCT
ihlr-28406	6	55	vince	vince	PROPN
ihlr-28406	6	56	,	,	PUNCT
ihlr-28406	6	57	zak	zak	PROPN
ihlr-28406	6	58	,	,	PUNCT
ihlr-28406	6	59	sawyer	sawyer	PROPN
ihlr-28406	6	60	,	,	PUNCT
ihlr-28406	6	61	jamie	jamie	PROPN
ihlr-28406	6	62	,	,	PUNCT
ihlr-28406	6	63	athena	athena	PROPN
ihlr-28406	6	64	,	,	PUNCT
ihlr-28406	6	65	riggs	riggs	PROPN
ihlr-28406	6	66	,	,	PUNCT
ihlr-28406	6	67	spearman	spearman	NOUN
ihlr-28406	6	68	,	,	PUNCT
ihlr-28406	6	69	dr	dr	PROPN
ihlr-28406	6	70	.	.	PROPN
ihlr-28406	6	71	blynn	blynn	PROPN
ihlr-28406	6	72	,	,	PUNCT
ihlr-28406	6	73	prairie	prairie	NOUN
ihlr-28406	6	74	,	,	PUNCT
ihlr-28406	6	75	dr	dr	PROPN
ihlr-28406	6	76	.	.	PROPN
ihlr-28406	6	77	josh	josh	PROPN
ihlr-28406	6	78	etzel	etzel	PROPN
ihlr-28406	6	79	,	,	PUNCT
ihlr-28406	6	80	nick	nick	PROPN
ihlr-28406	6	81	,	,	PUNCT
ihlr-28406	6	82	seth	seth	PROPN
ihlr-28406	6	83	,	,	PUNCT
ihlr-28406	6	84	nate	nate	PROPN
ihlr-28406	6	85	,	,	PUNCT
ihlr-28406	6	86	g	g	PROPN
ihlr-28406	6	87	,	,	PUNCT
ihlr-28406	6	88	mikey	mikey	PROPN
ihlr-28406	6	89	,	,	PUNCT
ihlr-28406	6	90	mr	mr	PROPN
ihlr-28406	6	91	.	.	PROPN
ihlr-28406	6	92	carr	carr	PROPN
ihlr-28406	6	93	,	,	PUNCT
ihlr-28406	6	94	mrs	mrs	PROPN
ihlr-28406	6	95	.	.	PROPN
ihlr-28406	6	96	carr	carr	PROPN
ihlr-28406	6	97	,	,	PUNCT
ihlr-28406	6	98	and	and	CCONJ
ihlr-28406	6	99	xi	xi	PROPN
ihlr-28406	6	100	liao	liao	PROPN
ihlr-28406	6	101	.	.	PUNCT
ihlr-28406	7	1	indiana	indiana	PROPN
ihlr-28406	7	2	health	health	PROPN
ihlr-28406	7	3	law	law	PROPN
ihlr-28406	7	4	review	review	NOUN
ihlr-28406	7	5	[	[	X
ihlr-28406	7	6	vol	vol	NOUN
ihlr-28406	7	7	.	.	PUNCT
ihlr-28406	8	1	21:277	21:277	NOUN
ihlr-28406	8	2	278	278	NUM
ihlr-28406	8	3	table	table	NOUN
ihlr-28406	8	4	of	of	ADP
ihlr-28406	8	5	contents	content	NOUN
ihlr-28406	8	6	introduction	introduction	NOUN
ihlr-28406	8	7	i.	i.	PROPN
ihlr-28406	8	8	thyroid	thyroid	PROPN
ihlr-28406	8	9	disease	disease	PROPN
ihlr-28406	8	10	a.	a.	PROPN
ihlr-28406	8	11	hypothyroidism	hypothyroidism	PROPN
ihlr-28406	8	12	b.	b.	PROPN
ihlr-28406	8	13	hyperthyroidism	hyperthyroidism	PROPN
ihlr-28406	8	14	c.	c.	PROPN
ihlr-28406	8	15	diagnostics	diagnostics	PROPN
ihlr-28406	8	16	ii	ii	PROPN
ihlr-28406	8	17	.	.	PUNCT
ihlr-28406	9	1	inventions	invention	NOUN
ihlr-28406	9	2	and	and	CCONJ
ihlr-28406	9	3	patents	patent	NOUN
ihlr-28406	9	4	a.	a.	NOUN
ihlr-28406	9	5	treatments	treatments	PROPN
ihlr-28406	9	6	b.	b.	PROPN
ihlr-28406	9	7	data	data	PROPN
ihlr-28406	9	8	c.	c.	PROPN
ihlr-28406	9	9	claims	claim	VERB
ihlr-28406	9	10	iii	iii	PROPN
ihlr-28406	9	11	.	.	PUNCT
ihlr-28406	10	1	clinical	clinical	ADJ
ihlr-28406	10	2	commercialization	commercialization	NOUN
ihlr-28406	10	3	a.	a.	NOUN
ihlr-28406	10	4	value	value	PROPN
ihlr-28406	10	5	b.	b.	PROPN
ihlr-28406	10	6	fda	fda	PROPN
ihlr-28406	10	7	trials	trials	PROPN
ihlr-28406	10	8	c.	c.	PROPN
ihlr-28406	10	9	innovation	innovation	PROPN
ihlr-28406	10	10	iv	iv	PROPN
ihlr-28406	10	11	.	.	PUNCT
ihlr-28406	10	12	conclusion	conclusion	NOUN
ihlr-28406	10	13	v.	v.	ADP
ihlr-28406	10	14	appendices	appendix	NOUN
ihlr-28406	10	15	appendix	appendix	VERB
ihlr-28406	10	16	a.	a.	NOUN
ihlr-28406	10	17	hypothalamic	hypothalamic	ADJ
ihlr-28406	10	18	-	-	PUNCT
ihlr-28406	10	19	pituitary	pituitary	ADJ
ihlr-28406	10	20	-	-	PUNCT
ihlr-28406	10	21	thyroid	thyroid	NOUN
ihlr-28406	10	22	axis	axis	NOUN
ihlr-28406	10	23	model	model	NOUN
ihlr-28406	10	24	appendix	appendix	PROPN
ihlr-28406	10	25	b.	b.	PROPN
ihlr-28406	10	26	hypothalamic	hypothalamic	ADJ
ihlr-28406	10	27	-	-	PUNCT
ihlr-28406	10	28	pituitary	pituitary	ADJ
ihlr-28406	10	29	-	-	PUNCT
ihlr-28406	10	30	thyroid	thyroid	NOUN
ihlr-28406	10	31	axis	axis	NOUN
ihlr-28406	10	32	description	description	NOUN
ihlr-28406	10	33	appendix	appendix	VERB
ihlr-28406	10	34	c.	c.	PROPN
ihlr-28406	10	35	levothyroxine	levothyroxine	PROPN
ihlr-28406	10	36	tablet	tablet	PROPN
ihlr-28406	10	37	information	information	NOUN
ihlr-28406	10	38	appendix	appendix	VERB
ihlr-28406	10	39	d.	d.	PROPN
ihlr-28406	10	40	symptoms	symptom	NOUN
ihlr-28406	10	41	for	for	ADP
ihlr-28406	10	42	thyroid	thyroid	NOUN
ihlr-28406	10	43	disease	disease	NOUN
ihlr-28406	10	44	introduction	introduction	NOUN
ihlr-28406	10	45	one	one	NUM
ihlr-28406	10	46	in	in	ADP
ihlr-28406	10	47	six	six	NUM
ihlr-28406	10	48	people	people	NOUN
ihlr-28406	10	49	have	have	VERB
ihlr-28406	10	50	thyroid	thyroid	NOUN
ihlr-28406	10	51	disease	disease	NOUN
ihlr-28406	10	52	in	in	ADP
ihlr-28406	10	53	their	their	PRON
ihlr-28406	10	54	lifetime	lifetime	NOUN
ihlr-28406	10	55	.	.	PUNCT
ihlr-28406	11	1	1	1	NUM
ihlr-28406	11	2	most	most	ADJ
ihlr-28406	11	3	people	people	NOUN
ihlr-28406	11	4	who	who	PRON
ihlr-28406	11	5	have	have	VERB
ihlr-28406	11	6	thyroid	thyroid	NOUN
ihlr-28406	11	7	disease	disease	NOUN
ihlr-28406	11	8	do	do	AUX
ihlr-28406	11	9	not	not	PART
ihlr-28406	11	10	know	know	VERB
ihlr-28406	11	11	because	because	SCONJ
ihlr-28406	11	12	symptoms	symptom	NOUN
ihlr-28406	11	13	are	be	AUX
ihlr-28406	11	14	not	not	PART
ihlr-28406	11	15	specific	specific	ADJ
ihlr-28406	11	16	,	,	PUNCT
ihlr-28406	11	17	and	and	CCONJ
ihlr-28406	11	18	it	it	PRON
ihlr-28406	11	19	is	be	AUX
ihlr-28406	11	20	difficult	difficult	ADJ
ihlr-28406	11	21	to	to	PART
ihlr-28406	11	22	isolate	isolate	VERB
ihlr-28406	11	23	in	in	ADP
ihlr-28406	11	24	diagnostics	diagnostic	NOUN
ihlr-28406	11	25	.	.	PUNCT
ihlr-28406	12	1	2	2	NUM
ihlr-28406	12	2	still	still	ADV
ihlr-28406	12	3	,	,	PUNCT
ihlr-28406	12	4	second	second	ADJ
ihlr-28406	12	5	only	only	ADV
ihlr-28406	12	6	to	to	ADP
ihlr-28406	12	7	diabetes	diabetes	NOUN
ihlr-28406	12	8	,	,	PUNCT
ihlr-28406	12	9	thyroid	thyroid	NOUN
ihlr-28406	12	10	diseases	disease	NOUN
ihlr-28406	12	11	are	be	AUX
ihlr-28406	12	12	the	the	DET
ihlr-28406	12	13	most	most	ADV
ihlr-28406	12	14	ubiquitous	ubiquitous	ADJ
ihlr-28406	12	15	endocrine	endocrine	NOUN
ihlr-28406	12	16	disorders	disorder	NOUN
ihlr-28406	12	17	worldwide	worldwide	ADV
ihlr-28406	12	18	.	.	PUNCT
ihlr-28406	13	1	3	3	NUM
ihlr-28406	13	2	although	although	SCONJ
ihlr-28406	13	3	thyroid	thyroid	NOUN
ihlr-28406	13	4	diseases	disease	NOUN
ihlr-28406	13	5	may	may	AUX
ihlr-28406	13	6	be	be	AUX
ihlr-28406	13	7	life	life	NOUN
ihlr-28406	13	8	lasting	last	VERB
ihlr-28406	13	9	and	and	CCONJ
ihlr-28406	13	10	terminal	terminal	NOUN
ihlr-28406	13	11	,	,	PUNCT
ihlr-28406	13	12	they	they	PRON
ihlr-28406	13	13	are	be	AUX
ihlr-28406	13	14	generally	generally	ADV
ihlr-28406	13	15	considered	consider	VERB
ihlr-28406	13	16	treatable	treatable	ADJ
ihlr-28406	13	17	.	.	PUNCT
ihlr-28406	14	1	4	4	NUM
ihlr-28406	14	2	the	the	DET
ihlr-28406	14	3	thyroid	thyroid	NOUN
ihlr-28406	14	4	is	be	AUX
ihlr-28406	14	5	a	a	DET
ihlr-28406	14	6	bi	bi	ADJ
ihlr-28406	14	7	-	-	ADJ
ihlr-28406	14	8	lobed	lobed	ADJ
ihlr-28406	14	9	gland	gland	NOUN
ihlr-28406	14	10	located	locate	VERB
ihlr-28406	14	11	at	at	ADP
ihlr-28406	14	12	the	the	DET
ihlr-28406	14	13	base	base	NOUN
ihlr-28406	14	14	of	of	ADP
ihlr-28406	14	15	the	the	DET
ihlr-28406	14	16	neck	neck	NOUN
ihlr-28406	14	17	in	in	ADP
ihlr-28406	14	18	front	front	NOUN
ihlr-28406	14	19	of	of	ADP
ihlr-28406	14	20	the	the	DET
ihlr-28406	14	21	windpipe	windpipe	NOUN
ihlr-28406	14	22	.	.	PUNCT
ihlr-28406	15	1	5	5	NUM
ihlr-28406	15	2	the	the	DET
ihlr-28406	15	3	thyroid	thyroid	NOUN
ihlr-28406	15	4	’s	’s	PART
ihlr-28406	15	5	functionality	functionality	NOUN
ihlr-28406	15	6	is	be	AUX
ihlr-28406	15	7	essentially	essentially	ADV
ihlr-28406	15	8	synthesizing	synthesize	VERB
ihlr-28406	15	9	thyroid	thyroid	NOUN
ihlr-28406	15	10	—	—	PUNCT
ihlr-28406	15	11	—	—	PUNCT
ihlr-28406	15	12	—	—	PUNCT
ihlr-28406	15	13	—	—	PUNCT
ihlr-28406	15	14	—	—	PUNCT
ihlr-28406	15	15	—	—	PUNCT
ihlr-28406	15	16	—	—	PUNCT
ihlr-28406	15	17	—	—	PUNCT
ihlr-28406	15	18	—	—	PUNCT
ihlr-28406	15	19	—	—	PUNCT
ihlr-28406	15	20	—	—	PUNCT
ihlr-28406	15	21	—	—	PUNCT
ihlr-28406	15	22	—	—	PUNCT
ihlr-28406	15	23	—	—	PUNCT
ihlr-28406	15	24	—	—	PUNCT
ihlr-28406	15	25	—	—	PUNCT
ihlr-28406	15	26	—	—	PUNCT
ihlr-28406	15	27	—	—	PUNCT
ihlr-28406	15	28	—	—	PUNCT
ihlr-28406	15	29	—	—	PUNCT
ihlr-28406	15	30	—	—	PUNCT
ihlr-28406	15	31	—	—	PUNCT
ihlr-28406	15	32	—	—	PUNCT
ihlr-28406	15	33	—	—	PUNCT
ihlr-28406	15	34	—	—	PUNCT
ihlr-28406	15	35	—	—	PUNCT
ihlr-28406	15	36	—	—	PUNCT
ihlr-28406	15	37	—	—	PUNCT
ihlr-28406	15	38	—	—	PUNCT
ihlr-28406	15	39	1	1	X
ihlr-28406	15	40	.	.	X
ihlr-28406	15	41	hypothyroidism	hypothyroidism	NOUN
ihlr-28406	15	42	,	,	PUNCT
ihlr-28406	15	43	american	american	PROPN
ihlr-28406	15	44	thyroid	thyroid	PROPN
ihlr-28406	15	45	association	association	PROPN
ihlr-28406	15	46	,	,	PUNCT
ihlr-28406	15	47	4	4	NUM
ihlr-28406	15	48	(	(	PUNCT
ihlr-28406	15	49	2013	2013	NUM
ihlr-28406	15	50	)	)	PUNCT
ihlr-28406	15	51	,	,	PUNCT
ihlr-28406	16	1	https://www.thyroid	https://www.thyroid	AUX
ihlr-28406	16	2	.	.	PUNCT
ihlr-28406	16	3	org	org	PROPN
ihlr-28406	16	4	/	/	SYM
ihlr-28406	16	5	wp	wp	PROPN
ihlr-28406	16	6	-	-	PUNCT
ihlr-28406	16	7	content	content	NOUN
ihlr-28406	16	8	/	/	SYM
ihlr-28406	16	9	uploads	upload	VERB
ihlr-28406	16	10	/	/	NOUN
ihlr-28406	16	11	patients	patient	NOUN
ihlr-28406	16	12	/	/	SYM
ihlr-28406	16	13	brochures	brochure	NOUN
ihlr-28406	16	14	/	/	SYM
ihlr-28406	16	15	hypothyroidism_web_booklet.pdf	hypothyroidism_web_booklet.pdf	NOUN
ihlr-28406	16	16	.	.	NOUN
ihlr-28406	16	17	2	2	X
ihlr-28406	16	18	.	.	X
ihlr-28406	16	19	gay	gay	PROPN
ihlr-28406	16	20	j.	j.	PROPN
ihlr-28406	16	21	canaris	canaris	PROPN
ihlr-28406	16	22	et	et	PROPN
ihlr-28406	16	23	al	al	PROPN
ihlr-28406	16	24	.	.	PROPN
ihlr-28406	16	25	,	,	PUNCT
ihlr-28406	16	26	the	the	DET
ihlr-28406	16	27	colorado	colorado	NOUN
ihlr-28406	16	28	thyroid	thyroid	PROPN
ihlr-28406	16	29	disease	disease	NOUN
ihlr-28406	16	30	prevalence	prevalence	NOUN
ihlr-28406	16	31	study	study	NOUN
ihlr-28406	16	32	,	,	PUNCT
ihlr-28406	16	33	160	160	NUM
ihlr-28406	16	34	archives	archive	NOUN
ihlr-28406	16	35	internal	internal	ADJ
ihlr-28406	16	36	med	med	ADJ
ihlr-28406	16	37	.	.	PUNCT
ihlr-28406	17	1	526	526	NUM
ihlr-28406	17	2	,	,	PUNCT
ihlr-28406	17	3	526	526	NUM
ihlr-28406	17	4	(	(	PUNCT
ihlr-28406	17	5	2000	2000	NUM
ihlr-28406	17	6	)	)	PUNCT
ihlr-28406	17	7	(	(	PUNCT
ihlr-28406	17	8	noting	note	VERB
ihlr-28406	17	9	that	that	SCONJ
ihlr-28406	17	10	abnormal	abnormal	ADJ
ihlr-28406	17	11	biochemical	biochemical	ADJ
ihlr-28406	17	12	thyroid	thyroid	NOUN
ihlr-28406	17	13	function	function	NOUN
ihlr-28406	17	14	reports	report	NOUN
ihlr-28406	17	15	substantiate	substantiate	VERB
ihlr-28406	17	16	substantial	substantial	ADJ
ihlr-28406	17	17	populations	population	NOUN
ihlr-28406	17	18	suffer	suffer	VERB
ihlr-28406	17	19	from	from	ADP
ihlr-28406	17	20	subclinical	subclinical	ADJ
ihlr-28406	17	21	conditions	condition	NOUN
ihlr-28406	17	22	)	)	PUNCT
ihlr-28406	17	23	.	.	PUNCT
ihlr-28406	18	1	3	3	X
ihlr-28406	18	2	.	.	X
ihlr-28406	18	3	c.c	c.c	PROPN
ihlr-28406	18	4	.	.	PROPN
ihlr-28406	18	5	heuck	heuck	VERB
ihlr-28406	18	6	et	et	PROPN
ihlr-28406	18	7	al	al	PROPN
ihlr-28406	18	8	.	.	PROPN
ihlr-28406	18	9	,	,	PUNCT
ihlr-28406	18	10	world	world	PROPN
ihlr-28406	18	11	health	health	NOUN
ihlr-28406	18	12	organization	organization	NOUN
ihlr-28406	18	13	,	,	PUNCT
ihlr-28406	18	14	diagnosis	diagnosis	NOUN
ihlr-28406	18	15	and	and	CCONJ
ihlr-28406	18	16	monitoring	monitoring	NOUN
ihlr-28406	18	17	of	of	ADP
ihlr-28406	18	18	diseases	disease	NOUN
ihlr-28406	18	19	of	of	ADP
ihlr-28406	18	20	the	the	DET
ihlr-28406	18	21	thyroid	thyroid	NOUN
ihlr-28406	18	22	8	8	NUM
ihlr-28406	18	23	(	(	PUNCT
ihlr-28406	18	24	2000	2000	NUM
ihlr-28406	18	25	)	)	PUNCT
ihlr-28406	18	26	,	,	PUNCT
ihlr-28406	18	27	https://apps.who.int/iris/handle/10665/66342	https://apps.who.int/iris/handle/10665/66342	ADP
ihlr-28406	18	28	[	[	X
ihlr-28406	18	29	https://perma	https://perma	X
ihlr-28406	18	30	.	.	PUNCT
ihlr-28406	18	31	cc/5j46	cc/5j46	PROPN
ihlr-28406	18	32	-	-	PUNCT
ihlr-28406	18	33	dcgg	dcgg	NOUN
ihlr-28406	18	34	]	]	X
ihlr-28406	18	35	.	.	PUNCT
ihlr-28406	19	1	4	4	X
ihlr-28406	19	2	.	.	X
ihlr-28406	20	1	i	i	PRON
ihlr-28406	20	2	d.	d.	PROPN
ihlr-28406	20	3	5	5	NUM
ihlr-28406	20	4	.	.	PUNCT
ihlr-28406	21	1	pharm	pharm	NOUN
ihlr-28406	21	2	.	.	PUNCT
ihlr-28406	22	1	compositions	composition	NOUN
ihlr-28406	22	2	to	to	ADP
ihlr-28406	22	3	tetrac	tetrac	NOUN
ihlr-28406	22	4	&	&	CCONJ
ihlr-28406	22	5	methods	method	NOUN
ihlr-28406	22	6	of	of	ADP
ihlr-28406	22	7	use	use	NOUN
ihlr-28406	22	8	thereof	thereof	ADV
ihlr-28406	22	9	,	,	PUNCT
ihlr-28406	22	10	u.s	u.s	PROPN
ihlr-28406	22	11	.	.	PROPN
ihlr-28406	22	12	patent	patent	NOUN
ihlr-28406	22	13	no	no	PROPN
ihlr-28406	22	14	.	.	PUNCT
ihlr-28406	22	15	6,740,680	6,740,680	NUM
ihlr-28406	22	16	(	(	PUNCT
ihlr-28406	22	17	issued	issue	VERB
ihlr-28406	22	18	may	may	PROPN
ihlr-28406	22	19	25	25	NUM
ihlr-28406	22	20	,	,	PUNCT
ihlr-28406	22	21	2004	2004	NUM
ihlr-28406	22	22	)	)	PUNCT
ihlr-28406	22	23	.	.	PUNCT
ihlr-28406	23	1	https://perma	https://perma	NOUN
ihlr-28406	23	2	https://apps.who.int/iris/handle/10665/66342	https://apps.who.int/iris/handle/10665/66342	PROPN
ihlr-28406	23	3	https://www.thyroid	https://www.thyroid	NOUN
ihlr-28406	23	4	2024	2024	NUM
ihlr-28406	23	5	]	]	PUNCT
ihlr-28406	23	6	inventions	invention	NOUN
ihlr-28406	23	7	and	and	CCONJ
ihlr-28406	23	8	patents	patent	NOUN
ihlr-28406	23	9	for	for	ADP
ihlr-28406	23	10	treating	treat	VERB
ihlr-28406	23	11	279	279	NUM
ihlr-28406	23	12	thyroid	thyroid	NOUN
ihlr-28406	23	13	disease	disease	NOUN
ihlr-28406	23	14	hormone.6	hormone.6	NOUN
ihlr-28406	23	15	in	in	ADP
ihlr-28406	23	16	other	other	ADJ
ihlr-28406	23	17	words	word	NOUN
ihlr-28406	23	18	,	,	PUNCT
ihlr-28406	23	19	the	the	DET
ihlr-28406	23	20	thyroid	thyroid	NOUN
ihlr-28406	23	21	produces	produce	VERB
ihlr-28406	23	22	hormones	hormone	NOUN
ihlr-28406	23	23	,	,	PUNCT
ihlr-28406	23	24	which	which	PRON
ihlr-28406	23	25	are	be	AUX
ihlr-28406	23	26	secreted	secrete	VERB
ihlr-28406	23	27	into	into	ADP
ihlr-28406	23	28	the	the	DET
ihlr-28406	23	29	blood	blood	NOUN
ihlr-28406	23	30	and	and	CCONJ
ihlr-28406	23	31	control	control	VERB
ihlr-28406	23	32	the	the	DET
ihlr-28406	23	33	body	body	NOUN
ihlr-28406	23	34	’s	’s	PART
ihlr-28406	23	35	metabolism	metabolism	NOUN
ihlr-28406	23	36	.	.	PUNCT
ihlr-28406	24	1	7	7	NUM
ihlr-28406	24	2	interestingly	interestingly	ADV
ihlr-28406	24	3	,	,	PUNCT
ihlr-28406	24	4	thyroid	thyroid	NOUN
ihlr-28406	24	5	hormone	hormone	NOUN
ihlr-28406	24	6	receptors	receptor	NOUN
ihlr-28406	24	7	are	be	AUX
ihlr-28406	24	8	located	locate	VERB
ihlr-28406	24	9	throughout	throughout	ADP
ihlr-28406	24	10	the	the	DET
ihlr-28406	24	11	brain	brain	NOUN
ihlr-28406	24	12	,	,	PUNCT
ihlr-28406	24	13	highlighting	highlight	VERB
ihlr-28406	24	14	their	their	PRON
ihlr-28406	24	15	importance	importance	NOUN
ihlr-28406	24	16	in	in	ADP
ihlr-28406	24	17	the	the	DET
ihlr-28406	24	18	central	central	ADJ
ihlr-28406	24	19	nervous	nervous	ADJ
ihlr-28406	24	20	system	system	NOUN
ihlr-28406	24	21	’s	’s	PART
ihlr-28406	24	22	development	development	NOUN
ihlr-28406	24	23	and	and	CCONJ
ihlr-28406	24	24	function.8	function.8	NOUN
ihlr-28406	24	25	this	this	DET
ihlr-28406	24	26	article	article	NOUN
ihlr-28406	24	27	proceeds	proceed	VERB
ihlr-28406	24	28	in	in	ADP
ihlr-28406	24	29	three	three	NUM
ihlr-28406	24	30	parts	part	NOUN
ihlr-28406	24	31	.	.	PUNCT
ihlr-28406	25	1	part	part	NOUN
ihlr-28406	25	2	i	i	PRON
ihlr-28406	25	3	explores	explore	VERB
ihlr-28406	25	4	thyroid	thyroid	NOUN
ihlr-28406	25	5	disease	disease	NOUN
ihlr-28406	25	6	,	,	PUNCT
ihlr-28406	25	7	including	include	VERB
ihlr-28406	25	8	diagnostics	diagnostic	NOUN
ihlr-28406	25	9	,	,	PUNCT
ihlr-28406	25	10	hypothyroidism	hypothyroidism	NOUN
ihlr-28406	25	11	,	,	PUNCT
ihlr-28406	25	12	and	and	CCONJ
ihlr-28406	25	13	hyperthyroidism	hyperthyroidism	NOUN
ihlr-28406	25	14	.	.	PUNCT
ihlr-28406	26	1	part	part	NOUN
ihlr-28406	26	2	ii	ii	PROPN
ihlr-28406	26	3	empirically	empirically	ADV
ihlr-28406	26	4	investigates	investigate	VERB
ihlr-28406	26	5	inventions	invention	NOUN
ihlr-28406	26	6	for	for	ADP
ihlr-28406	26	7	treatments	treatment	NOUN
ihlr-28406	26	8	to	to	PART
ihlr-28406	26	9	thyroid	thyroid	VERB
ihlr-28406	26	10	disease	disease	NOUN
ihlr-28406	26	11	through	through	ADP
ihlr-28406	26	12	the	the	DET
ihlr-28406	26	13	lens	lens	NOUN
ihlr-28406	26	14	of	of	ADP
ihlr-28406	26	15	the	the	DET
ihlr-28406	26	16	patent	patent	NOUN
ihlr-28406	26	17	system	system	NOUN
ihlr-28406	26	18	.	.	PUNCT
ihlr-28406	27	1	part	part	NOUN
ihlr-28406	27	2	iii	iii	NOUN
ihlr-28406	27	3	consolidates	consolidate	VERB
ihlr-28406	27	4	considerations	consideration	NOUN
ihlr-28406	27	5	for	for	ADP
ihlr-28406	27	6	commercialization	commercialization	NOUN
ihlr-28406	27	7	of	of	ADP
ihlr-28406	27	8	inventions	invention	NOUN
ihlr-28406	27	9	for	for	ADP
ihlr-28406	27	10	treating	treat	VERB
ihlr-28406	27	11	thyroid	thyroid	NOUN
ihlr-28406	27	12	disease	disease	NOUN
ihlr-28406	27	13	.	.	PUNCT
ihlr-28406	28	1	the	the	DET
ihlr-28406	28	2	purpose	purpose	NOUN
ihlr-28406	28	3	of	of	ADP
ihlr-28406	28	4	this	this	DET
ihlr-28406	28	5	article	article	NOUN
ihlr-28406	28	6	is	be	AUX
ihlr-28406	28	7	advancing	advance	VERB
ihlr-28406	28	8	the	the	DET
ihlr-28406	28	9	literature	literature	NOUN
ihlr-28406	28	10	and	and	CCONJ
ihlr-28406	28	11	human	human	ADJ
ihlr-28406	28	12	knowledge	knowledge	NOUN
ihlr-28406	28	13	in	in	ADP
ihlr-28406	28	14	thyroid	thyroid	NOUN
ihlr-28406	28	15	disease	disease	NOUN
ihlr-28406	28	16	,	,	PUNCT
ihlr-28406	28	17	intellectual	intellectual	ADJ
ihlr-28406	28	18	property	property	NOUN
ihlr-28406	28	19	,	,	PUNCT
ihlr-28406	28	20	and	and	CCONJ
ihlr-28406	28	21	invention	invention	VERB
ihlr-28406	28	22	commercialization	commercialization	NOUN
ihlr-28406	28	23	.	.	PUNCT
ihlr-28406	29	1	ii	ii	PROPN
ihlr-28406	29	2	.	.	PROPN
ihlr-28406	29	3	thyroid	thyroid	PROPN
ihlr-28406	29	4	disease	disease	NOUN
ihlr-28406	29	5	thyroid	thyroid	VERB
ihlr-28406	29	6	hormone	hormone	NOUN
ihlr-28406	29	7	synthesis	synthesis	NOUN
ihlr-28406	29	8	and	and	CCONJ
ihlr-28406	29	9	release	release	NOUN
ihlr-28406	29	10	is	be	AUX
ihlr-28406	29	11	a	a	DET
ihlr-28406	29	12	three	three	NUM
ihlr-28406	29	13	-	-	PUNCT
ihlr-28406	29	14	step	step	NOUN
ihlr-28406	29	15	process	process	NOUN
ihlr-28406	29	16	feedback	feedback	NOUN
ihlr-28406	29	17	loop	loop	NOUN
ihlr-28406	29	18	.	.	PUNCT
ihlr-28406	30	1	9	9	NUM
ihlr-28406	30	2	first	first	ADV
ihlr-28406	30	3	,	,	PUNCT
ihlr-28406	30	4	the	the	DET
ihlr-28406	30	5	hypothalamus	hypothalamus	NOUN
ihlr-28406	30	6	produces	produce	VERB
ihlr-28406	30	7	thyroid	thyroid	NOUN
ihlr-28406	30	8	releasing	release	VERB
ihlr-28406	30	9	hormone	hormone	NOUN
ihlr-28406	30	10	(	(	PUNCT
ihlr-28406	30	11	trh	trh	NOUN
ihlr-28406	30	12	)	)	PUNCT
ihlr-28406	30	13	,	,	PUNCT
ihlr-28406	30	14	10	10	NUM
ihlr-28406	30	15	stimulating	stimulate	VERB
ihlr-28406	30	16	the	the	DET
ihlr-28406	30	17	pituitary	pituitary	ADJ
ihlr-28406	30	18	gland	gland	NOUN
ihlr-28406	30	19	11	11	NUM
ihlr-28406	30	20	to	to	PART
ihlr-28406	30	21	release	release	VERB
ihlr-28406	30	22	thyroid	thyroid	NOUN
ihlr-28406	30	23	stimulating	stimulate	VERB
ihlr-28406	30	24	hormone	hormone	NOUN
ihlr-28406	30	25	(	(	PUNCT
ihlr-28406	30	26	tsh	tsh	NOUN
ihlr-28406	30	27	)	)	PUNCT
ihlr-28406	30	28	,	,	PUNCT
ihlr-28406	30	29	thyrotropin	thyrotropin	NOUN
ihlr-28406	30	30	,	,	PUNCT
ihlr-28406	30	31	12	12	NUM
ihlr-28406	30	32	which	which	PRON
ihlr-28406	30	33	in	in	ADP
ihlr-28406	30	34	turn	turn	NOUN
ihlr-28406	30	35	activates	activate	VERB
ihlr-28406	30	36	the	the	DET
ihlr-28406	30	37	thyroid	thyroid	NOUN
ihlr-28406	30	38	gland	gland	NOUN
ihlr-28406	30	39	.	.	PUNCT
ihlr-28406	31	1	second	second	ADJ
ihlr-28406	31	2	,	,	PUNCT
ihlr-28406	31	3	the	the	DET
ihlr-28406	31	4	thyroid	thyroid	NOUN
ihlr-28406	31	5	gland	gland	NOUN
ihlr-28406	31	6	excretes	excrete	VERB
ihlr-28406	31	7	two	two	NUM
ihlr-28406	31	8	thyroid	thyroid	NOUN
ihlr-28406	31	9	hormones	hormone	NOUN
ihlr-28406	31	10	:	:	PUNCT
ihlr-28406	31	11	thyroxine	thyroxine	NOUN
ihlr-28406	31	12	(	(	PUNCT
ihlr-28406	31	13	t4	t4	PROPN
ihlr-28406	31	14	)	)	PUNCT
ihlr-28406	31	15	and	and	CCONJ
ihlr-28406	31	16	triiodothyronine	triiodothyronine	NOUN
ihlr-28406	31	17	(	(	PUNCT
ihlr-28406	31	18	t3	t3	PROPN
ihlr-28406	31	19	)	)	PUNCT
ihlr-28406	31	20	to	to	ADP
ihlr-28406	31	21	the	the	DET
ihlr-28406	31	22	bloodstream	bloodstream	NOUN
ihlr-28406	31	23	.	.	PUNCT
ihlr-28406	32	1	13	13	NUM
ihlr-28406	32	2	third	third	NOUN
ihlr-28406	32	3	,	,	PUNCT
ihlr-28406	32	4	t4	t4	PROPN
ihlr-28406	32	5	converts	convert	VERB
ihlr-28406	32	6	to	to	ADP
ihlr-28406	32	7	t3	t3	VERB
ihlr-28406	32	8	through	through	ADP
ihlr-28406	32	9	deiodination	deiodination	NOUN
ihlr-28406	32	10	in	in	ADP
ihlr-28406	32	11	peripheral	peripheral	ADJ
ihlr-28406	32	12	—	—	PUNCT
ihlr-28406	32	13	—	—	PUNCT
ihlr-28406	32	14	—	—	PUNCT
ihlr-28406	32	15	—	—	PUNCT
ihlr-28406	32	16	—	—	PUNCT
ihlr-28406	32	17	—	—	PUNCT
ihlr-28406	32	18	—	—	PUNCT
ihlr-28406	32	19	—	—	PUNCT
ihlr-28406	32	20	—	—	PUNCT
ihlr-28406	32	21	—	—	PUNCT
ihlr-28406	32	22	—	—	PUNCT
ihlr-28406	32	23	—	—	PUNCT
ihlr-28406	32	24	—	—	PUNCT
ihlr-28406	32	25	—	—	PUNCT
ihlr-28406	32	26	—	—	PUNCT
ihlr-28406	32	27	—	—	PUNCT
ihlr-28406	32	28	—	—	PUNCT
ihlr-28406	32	29	—	—	PUNCT
ihlr-28406	32	30	—	—	PUNCT
ihlr-28406	32	31	—	—	PUNCT
ihlr-28406	32	32	—	—	PUNCT
ihlr-28406	32	33	—	—	PUNCT
ihlr-28406	32	34	—	—	PUNCT
ihlr-28406	32	35	—	—	PUNCT
ihlr-28406	32	36	—	—	PUNCT
ihlr-28406	32	37	—	—	PUNCT
ihlr-28406	32	38	—	—	PUNCT
ihlr-28406	32	39	—	—	PUNCT
ihlr-28406	32	40	—	—	PUNCT
ihlr-28406	32	41	6	6	X
ihlr-28406	32	42	.	.	X
ihlr-28406	32	43	see	see	VERB
ihlr-28406	32	44	appendix	appendix	PROPN
ihlr-28406	32	45	b.	b.	PROPN
ihlr-28406	32	46	hypothalamic	hypothalamic	ADJ
ihlr-28406	32	47	-	-	PUNCT
ihlr-28406	32	48	pituitary	pituitary	ADJ
ihlr-28406	32	49	-	-	PUNCT
ihlr-28406	32	50	thyroid	thyroid	NOUN
ihlr-28406	32	51	axis	axis	NOUN
ihlr-28406	32	52	model	model	NOUN
ihlr-28406	32	53	;	;	PUNCT
ihlr-28406	32	54	see	see	AUX
ihlr-28406	32	55	also	also	ADV
ihlr-28406	32	56	heuck	heuck	VERB
ihlr-28406	32	57	et	et	PROPN
ihlr-28406	32	58	al	al	PROPN
ihlr-28406	32	59	.	.	PROPN
ihlr-28406	33	1	supra	supra	PROPN
ihlr-28406	33	2	note	note	PROPN
ihlr-28406	33	3	3	3	NUM
ihlr-28406	33	4	,	,	PUNCT
ihlr-28406	33	5	at	at	ADP
ihlr-28406	33	6	8	8	NUM
ihlr-28406	33	7	;	;	PUNCT
ihlr-28406	33	8	see	see	VERB
ihlr-28406	33	9	also	also	ADV
ihlr-28406	33	10	elske	elske	ADJ
ihlr-28406	33	11	t.	t.	NOUN
ihlr-28406	33	12	massolt	massolt	NOUN
ihlr-28406	33	13	,	,	PUNCT
ihlr-28406	33	14	translational	translational	ADJ
ihlr-28406	33	15	studies	study	NOUN
ihlr-28406	33	16	toward	toward	ADP
ihlr-28406	33	17	understanding	understand	VERB
ihlr-28406	33	18	clinical	clinical	ADJ
ihlr-28406	33	19	effects	effect	NOUN
ihlr-28406	33	20	of	of	ADP
ihlr-28406	33	21	thyroid	thyroid	NOUN
ihlr-28406	33	22	hormone	hormone	NOUN
ihlr-28406	33	23	9	9	NUM
ihlr-28406	33	24	(	(	PUNCT
ihlr-28406	33	25	nov	nov	PROPN
ihlr-28406	33	26	.	.	PROPN
ihlr-28406	33	27	21	21	NUM
ihlr-28406	33	28	,	,	PUNCT
ihlr-28406	33	29	2017	2017	NUM
ihlr-28406	33	30	)	)	PUNCT
ihlr-28406	33	31	(	(	PUNCT
ihlr-28406	33	32	phd	phd	NOUN
ihlr-28406	33	33	thesis	thesis	NOUN
ihlr-28406	33	34	,	,	PUNCT
ihlr-28406	33	35	erasmus	erasmus	PROPN
ihlr-28406	33	36	university	university	PROPN
ihlr-28406	33	37	rotterdam	rotterdam	PROPN
ihlr-28406	33	38	)	)	PUNCT
ihlr-28406	33	39	,	,	PUNCT
ihlr-28406	33	40	https://repub.eur.nl/pub/102891/proefschriftmassoltvoorpedel.pdf	https://repub.eur.nl/pub/102891/proefschriftmassoltvoorpedel.pdf	PROPN
ihlr-28406	34	1	[	[	X
ihlr-28406	34	2	https://perma.cc/78xp-zk	https://perma.cc/78xp-zk	PROPN
ihlr-28406	34	3	rc	rc	PROPN
ihlr-28406	34	4	]	]	X
ihlr-28406	34	5	(	(	PUNCT
ihlr-28406	34	6	“	"	PUNCT
ihlr-28406	34	7	thyroid	thyroid	NOUN
ihlr-28406	34	8	hormone	hormone	NOUN
ihlr-28406	34	9	is	be	AUX
ihlr-28406	34	10	synthesized	synthesize	VERB
ihlr-28406	34	11	by	by	ADP
ihlr-28406	34	12	the	the	DET
ihlr-28406	34	13	thyroid	thyroid	NOUN
ihlr-28406	34	14	gland	gland	NOUN
ihlr-28406	34	15	,	,	PUNCT
ihlr-28406	34	16	which	which	PRON
ihlr-28406	34	17	is	be	AUX
ihlr-28406	34	18	located	locate	VERB
ihlr-28406	34	19	ventrocaudal	ventrocaudal	NOUN
ihlr-28406	34	20	of	of	ADP
ihlr-28406	34	21	the	the	DET
ihlr-28406	34	22	thyroid	thyroid	NOUN
ihlr-28406	34	23	cartilage	cartilage	NOUN
ihlr-28406	34	24	.	.	PUNCT
ihlr-28406	34	25	”	"	PUNCT
ihlr-28406	34	26	)	)	PUNCT
ihlr-28406	34	27	.	.	PUNCT
ihlr-28406	35	1	7	7	X
ihlr-28406	35	2	.	.	X
ihlr-28406	35	3	am	be	AUX
ihlr-28406	35	4	.	.	PUNCT
ihlr-28406	36	1	thyroid	thyroid	PROPN
ihlr-28406	36	2	ass’n	ass’n	NOUN
ihlr-28406	36	3	,	,	PUNCT
ihlr-28406	36	4	hypothyroidism	hypothyroidism	NOUN
ihlr-28406	36	5	4	4	NUM
ihlr-28406	36	6	(	(	PUNCT
ihlr-28406	36	7	2019	2019	NUM
ihlr-28406	36	8	)	)	PUNCT
ihlr-28406	36	9	,	,	PUNCT
ihlr-28406	36	10	https://www.thyroid.org/wpcontent/uploads/patients/brochures/hypothyroidism_web_booklet.pdf	https://www.thyroid.org/wpcontent/uploads/patients/brochures/hypothyroidism_web_booklet.pdf	PROPN
ihlr-28406	37	1	[	[	X
ihlr-28406	37	2	https://perma.cc/8ws9erca	https://perma.cc/8ws9erca	X
ihlr-28406	37	3	]	]	PUNCT
ihlr-28406	37	4	.	.	PUNCT
ihlr-28406	38	1	8	8	X
ihlr-28406	38	2	.	.	PUNCT
ihlr-28406	39	1	larry	larry	PROPN
ihlr-28406	39	2	squire	squire	PROPN
ihlr-28406	39	3	et	et	PROPN
ihlr-28406	39	4	al	al	PROPN
ihlr-28406	39	5	.	.	PROPN
ihlr-28406	39	6	,	,	PUNCT
ihlr-28406	39	7	fundamental	fundamental	ADJ
ihlr-28406	39	8	neuroscience	neuroscience	NOUN
ihlr-28406	39	9	910	910	NUM
ihlr-28406	39	10	(	(	PUNCT
ihlr-28406	39	11	3rd	3rd	ADJ
ihlr-28406	39	12	ed	ed	NOUN
ihlr-28406	39	13	.	.	PROPN
ihlr-28406	39	14	2008	2008	NUM
ihlr-28406	39	15	)	)	PUNCT
ihlr-28406	39	16	;	;	PUNCT
ihlr-28406	39	17	see	see	VERB
ihlr-28406	39	18	also	also	ADV
ihlr-28406	39	19	massolt	massolt	NOUN
ihlr-28406	39	20	,	,	PUNCT
ihlr-28406	39	21	supra	supra	ADJ
ihlr-28406	39	22	note	note	NOUN
ihlr-28406	39	23	6	6	NUM
ihlr-28406	39	24	,	,	PUNCT
ihlr-28406	39	25	at	at	ADP
ihlr-28406	39	26	10	10	NUM
ihlr-28406	39	27	(	(	PUNCT
ihlr-28406	39	28	“	"	PUNCT
ihlr-28406	39	29	thyroid	thyroid	NOUN
ihlr-28406	39	30	-	-	PUNCT
ihlr-28406	39	31	stimulating	stimulate	VERB
ihlr-28406	39	32	hormone	hormone	NOUN
ihlr-28406	39	33	production	production	NOUN
ihlr-28406	39	34	is	be	AUX
ihlr-28406	39	35	stimulated	stimulate	VERB
ihlr-28406	39	36	by	by	ADP
ihlr-28406	39	37	hypothalamic	hypothalamic	ADJ
ihlr-28406	39	38	thyrotropin	thyrotropin	NOUN
ihlr-28406	39	39	releasing	release	VERB
ihlr-28406	39	40	hormone	hormone	NOUN
ihlr-28406	39	41	.	.	PUNCT
ihlr-28406	39	42	”	"	PUNCT
ihlr-28406	39	43	)	)	PUNCT
ihlr-28406	39	44	.	.	PUNCT
ihlr-28406	40	1	9	9	X
ihlr-28406	40	2	.	.	X
ihlr-28406	40	3	massolt	massolt	NOUN
ihlr-28406	40	4	,	,	PUNCT
ihlr-28406	40	5	supra	supra	PROPN
ihlr-28406	40	6	note	note	NOUN
ihlr-28406	40	7	6	6	NUM
ihlr-28406	40	8	,	,	PUNCT
ihlr-28406	40	9	at	at	ADP
ihlr-28406	40	10	9	9	NUM
ihlr-28406	40	11	.	.	NOUN
ihlr-28406	40	12	10	10	NUM
ihlr-28406	40	13	.	.	PUNCT
ihlr-28406	41	1	squire	squire	VERB
ihlr-28406	41	2	et	et	PROPN
ihlr-28406	41	3	al	al	PROPN
ihlr-28406	41	4	.	.	PROPN
ihlr-28406	41	5	,	,	PUNCT
ihlr-28406	41	6	supra	supra	PROPN
ihlr-28406	41	7	note	note	PROPN
ihlr-28406	41	8	8	8	NUM
ihlr-28406	41	9	,	,	PUNCT
ihlr-28406	41	10	at	at	ADP
ihlr-28406	41	11	909	909	NUM
ihlr-28406	41	12	(	(	PUNCT
ihlr-28406	41	13	“	"	PUNCT
ihlr-28406	41	14	trh	trh	PROPN
ihlr-28406	41	15	neurons	neuron	NOUN
ihlr-28406	41	16	have	have	VERB
ihlr-28406	41	17	long	long	ADJ
ihlr-28406	41	18	axons	axon	NOUN
ihlr-28406	41	19	that	that	PRON
ihlr-28406	41	20	terminate	terminate	VERB
ihlr-28406	41	21	in	in	ADP
ihlr-28406	41	22	the	the	DET
ihlr-28406	41	23	[	[	X
ihlr-28406	41	24	median	median	ADJ
ihlr-28406	41	25	eminence	eminence	NOUN
ihlr-28406	41	26	’s	’s	PART
ihlr-28406	41	27	]	]	PUNCT
ihlr-28406	41	28	external	external	ADJ
ihlr-28406	41	29	zone	zone	NOUN
ihlr-28406	41	30	.	.	PUNCT
ihlr-28406	42	1	this	this	DET
ihlr-28406	42	2	region	region	NOUN
ihlr-28406	42	3	is	be	AUX
ihlr-28406	42	4	highly	highly	ADV
ihlr-28406	42	5	vascularized	vascularized	ADJ
ihlr-28406	42	6	by	by	ADP
ihlr-28406	42	7	the	the	DET
ihlr-28406	42	8	portal	portal	ADJ
ihlr-28406	42	9	capillary	capillary	ADJ
ihlr-28406	42	10	system	system	NOUN
ihlr-28406	42	11	,	,	PUNCT
ihlr-28406	42	12	which	which	PRON
ihlr-28406	42	13	transports	transport	VERB
ihlr-28406	42	14	trh	trh	NOUN
ihlr-28406	42	15	to	to	ADP
ihlr-28406	42	16	the	the	DET
ihlr-28406	42	17	anterior	anterior	ADJ
ihlr-28406	42	18	pituitary	pituitary	ADJ
ihlr-28406	42	19	gland	gland	NOUN
ihlr-28406	42	20	.	.	PUNCT
ihlr-28406	43	1	there	there	ADV
ihlr-28406	43	2	,	,	PUNCT
ihlr-28406	43	3	trh	trh	NOUN
ihlr-28406	43	4	targets	target	VERB
ihlr-28406	43	5	receptors	receptor	NOUN
ihlr-28406	43	6	on	on	ADP
ihlr-28406	43	7	thyrotropes	thyrotrope	NOUN
ihlr-28406	43	8	,	,	PUNCT
ihlr-28406	43	9	which	which	PRON
ihlr-28406	43	10	are	be	AUX
ihlr-28406	43	11	cells	cell	NOUN
ihlr-28406	43	12	that	that	PRON
ihlr-28406	43	13	,	,	PUNCT
ihlr-28406	43	14	when	when	SCONJ
ihlr-28406	43	15	stimulated	stimulate	VERB
ihlr-28406	43	16	,	,	PUNCT
ihlr-28406	43	17	produce	produce	VERB
ihlr-28406	43	18	the	the	DET
ihlr-28406	43	19	thyroid	thyroid	NOUN
ihlr-28406	43	20	-	-	PUNCT
ihlr-28406	43	21	stimulating	stimulate	VERB
ihlr-28406	43	22	hormone	hormone	NOUN
ihlr-28406	43	23	.	.	PUNCT
ihlr-28406	44	1	thyrotropes	thyrotrope	NOUN
ihlr-28406	44	2	constitute	constitute	VERB
ihlr-28406	44	3	approximately	approximately	ADV
ihlr-28406	44	4	10	10	NUM
ihlr-28406	44	5	%	%	NOUN
ihlr-28406	44	6	of	of	ADP
ihlr-28406	44	7	the	the	DET
ihlr-28406	44	8	cells	cell	NOUN
ihlr-28406	44	9	in	in	ADP
ihlr-28406	44	10	the	the	DET
ihlr-28406	44	11	anterior	anterior	ADJ
ihlr-28406	44	12	pituitary	pituitary	ADJ
ihlr-28406	44	13	gland	gland	NOUN
ihlr-28406	44	14	.	.	PUNCT
ihlr-28406	44	15	”	"	PUNCT
ihlr-28406	44	16	)	)	PUNCT
ihlr-28406	44	17	.	.	PUNCT
ihlr-28406	45	1	11	11	NUM
ihlr-28406	45	2	.	.	PUNCT
ihlr-28406	45	3	heuck	heuck	VERB
ihlr-28406	45	4	et	et	PROPN
ihlr-28406	45	5	al	al	PROPN
ihlr-28406	45	6	.	.	PROPN
ihlr-28406	45	7	,	,	PUNCT
ihlr-28406	45	8	supra	supra	PROPN
ihlr-28406	45	9	note	note	NOUN
ihlr-28406	45	10	3	3	NUM
ihlr-28406	45	11	,	,	PUNCT
ihlr-28406	45	12	at	at	ADP
ihlr-28406	45	13	5	5	NUM
ihlr-28406	45	14	(	(	PUNCT
ihlr-28406	45	15	thyroid	thyroid	NOUN
ihlr-28406	45	16	stimulating	stimulate	VERB
ihlr-28406	45	17	hormone	hormone	NOUN
ihlr-28406	45	18	is	be	AUX
ihlr-28406	45	19	a	a	DET
ihlr-28406	45	20	“	"	PUNCT
ihlr-28406	45	21	hormone	hormone	NOUN
ihlr-28406	45	22	produced	produce	VERB
ihlr-28406	45	23	by	by	ADP
ihlr-28406	45	24	the	the	DET
ihlr-28406	45	25	pituitary	pituitary	ADJ
ihlr-28406	45	26	gland	gland	NOUN
ihlr-28406	45	27	in	in	ADP
ihlr-28406	45	28	response	response	NOUN
ihlr-28406	45	29	to	to	ADP
ihlr-28406	45	30	signals	signal	NOUN
ihlr-28406	45	31	from	from	ADP
ihlr-28406	45	32	the	the	DET
ihlr-28406	45	33	hypothalamus	hypothalamus	NOUN
ihlr-28406	45	34	.	.	PUNCT
ihlr-28406	45	35	”	"	PUNCT
ihlr-28406	45	36	)	)	PUNCT
ihlr-28406	45	37	.	.	PUNCT
ihlr-28406	46	1	12	12	NUM
ihlr-28406	46	2	.	.	PUNCT
ihlr-28406	47	1	i	i	PRON
ihlr-28406	47	2	d.	d.	PROPN
ihlr-28406	47	3	(	(	PUNCT
ihlr-28406	47	4	thyrotrope	thyrotrope	NOUN
ihlr-28406	47	5	cells	cell	NOUN
ihlr-28406	47	6	in	in	ADP
ihlr-28406	47	7	the	the	DET
ihlr-28406	47	8	pituitary	pituitary	ADJ
ihlr-28406	47	9	gland	gland	NOUN
ihlr-28406	47	10	produce	produce	VERB
ihlr-28406	47	11	a	a	DET
ihlr-28406	47	12	glycoprotein	glycoprotein	ADJ
ihlr-28406	47	13	hormone	hormone	NOUN
ihlr-28406	47	14	called	call	VERB
ihlr-28406	47	15	thyrotropin	thyrotropin	PROPN
ihlr-28406	47	16	,	,	PUNCT
ihlr-28406	47	17	which	which	PRON
ihlr-28406	47	18	regulates	regulate	VERB
ihlr-28406	47	19	endocrine	endocrine	ADJ
ihlr-28406	47	20	function	function	NOUN
ihlr-28406	47	21	)	)	PUNCT
ihlr-28406	47	22	.	.	PUNCT
ihlr-28406	48	1	13	13	NUM
ihlr-28406	48	2	.	.	PUNCT
ihlr-28406	49	1	i	i	PRON
ihlr-28406	49	2	d.	d.	PROPN
ihlr-28406	49	3	at	at	ADP
ihlr-28406	49	4	8	8	NUM
ihlr-28406	49	5	.	.	PUNCT
ihlr-28406	50	1	https://perma.cc/8ws9	https://perma.cc/8ws9	PROPN
ihlr-28406	50	2	https://www.thyroid.org/wp	https://www.thyroid.org/wp	PROPN
ihlr-28406	50	3	https://perma.cc/78xp-zk	https://perma.cc/78xp-zk	NUM
ihlr-28406	50	4	https://repub.eur.nl/pub/102891/proefschriftmassoltvoorpedel.pdf	https://repub.eur.nl/pub/102891/proefschriftmassoltvoorpedel.pdf	PROPN
ihlr-28406	50	5	indiana	indiana	PROPN
ihlr-28406	50	6	health	health	PROPN
ihlr-28406	50	7	law	law	PROPN
ihlr-28406	50	8	review	review	NOUN
ihlr-28406	50	9	[	[	X
ihlr-28406	50	10	vol	vol	NOUN
ihlr-28406	50	11	.	.	PUNCT
ihlr-28406	51	1	21:277	21:277	NOUN
ihlr-28406	51	2	280	280	NUM
ihlr-28406	51	3	tissues	tissue	NOUN
ihlr-28406	51	4	.	.	PUNCT
ihlr-28406	52	1	14	14	NUM
ihlr-28406	52	2	this	this	DET
ihlr-28406	52	3	synthesis	synthesis	NOUN
ihlr-28406	52	4	is	be	AUX
ihlr-28406	52	5	critical	critical	ADJ
ihlr-28406	52	6	for	for	ADP
ihlr-28406	52	7	metabolic	metabolic	NOUN
ihlr-28406	52	8	control	control	NOUN
ihlr-28406	52	9	in	in	ADP
ihlr-28406	52	10	the	the	DET
ihlr-28406	52	11	human	human	ADJ
ihlr-28406	52	12	body	body	NOUN
ihlr-28406	52	13	.	.	PUNCT
ihlr-28406	53	1	15	15	NUM
ihlr-28406	53	2	thyroid	thyroid	NOUN
ihlr-28406	53	3	disease	disease	NOUN
ihlr-28406	53	4	control	control	NOUN
ihlr-28406	53	5	is	be	AUX
ihlr-28406	53	6	extremely	extremely	ADV
ihlr-28406	53	7	essential	essential	ADJ
ihlr-28406	53	8	,	,	PUNCT
ihlr-28406	53	9	and	and	CCONJ
ihlr-28406	53	10	abnormalities	abnormality	NOUN
ihlr-28406	53	11	can	can	AUX
ihlr-28406	53	12	have	have	VERB
ihlr-28406	53	13	catastrophic	catastrophic	ADJ
ihlr-28406	53	14	consequences	consequence	NOUN
ihlr-28406	53	15	.	.	PUNCT
ihlr-28406	54	1	16	16	NUM
ihlr-28406	54	2	thyroid	thyroid	NOUN
ihlr-28406	54	3	hormone	hormone	NOUN
ihlr-28406	54	4	imbalance	imbalance	NOUN
ihlr-28406	54	5	can	can	AUX
ihlr-28406	54	6	have	have	VERB
ihlr-28406	54	7	profound	profound	ADJ
ihlr-28406	54	8	effects	effect	NOUN
ihlr-28406	54	9	on	on	ADP
ihlr-28406	54	10	the	the	DET
ihlr-28406	54	11	central	central	ADJ
ihlr-28406	54	12	nervous	nervous	ADJ
ihlr-28406	54	13	system	system	NOUN
ihlr-28406	54	14	,	,	PUNCT
ihlr-28406	54	15	heart	heart	NOUN
ihlr-28406	54	16	,	,	PUNCT
ihlr-28406	54	17	and	and	CCONJ
ihlr-28406	54	18	brain	brain	NOUN
ihlr-28406	54	19	.	.	PUNCT
ihlr-28406	55	1	17	17	NUM
ihlr-28406	55	2	indeed	indeed	ADV
ihlr-28406	55	3	,	,	PUNCT
ihlr-28406	55	4	t3	t3	PROPN
ihlr-28406	55	5	and	and	CCONJ
ihlr-28406	55	6	t4	t4	PROPN
ihlr-28406	55	7	also	also	ADV
ihlr-28406	55	8	provide	provide	VERB
ihlr-28406	55	9	feedback	feedback	NOUN
ihlr-28406	55	10	to	to	ADP
ihlr-28406	55	11	the	the	DET
ihlr-28406	55	12	brain	brain	NOUN
ihlr-28406	55	13	and	and	CCONJ
ihlr-28406	55	14	anterior	anterior	ADJ
ihlr-28406	55	15	pituitary	pituitary	ADJ
ihlr-28406	55	16	gland	gland	NOUN
ihlr-28406	55	17	to	to	PART
ihlr-28406	55	18	regulate	regulate	VERB
ihlr-28406	55	19	trh	trh	NOUN
ihlr-28406	55	20	and	and	CCONJ
ihlr-28406	55	21	tsh.18	tsh.18	ADJ
ihlr-28406	55	22	subclinical	subclinical	ADJ
ihlr-28406	55	23	conditions	condition	NOUN
ihlr-28406	55	24	have	have	VERB
ihlr-28406	55	25	subtle	subtle	ADJ
ihlr-28406	55	26	manifestations	manifestation	NOUN
ihlr-28406	55	27	and	and	CCONJ
ihlr-28406	55	28	may	may	AUX
ihlr-28406	55	29	mimic	mimic	VERB
ihlr-28406	55	30	other	other	ADJ
ihlr-28406	55	31	diseases	disease	NOUN
ihlr-28406	55	32	,	,	PUNCT
ihlr-28406	55	33	19	19	NUM
ihlr-28406	55	34	and	and	CCONJ
ihlr-28406	55	35	,	,	PUNCT
ihlr-28406	55	36	among	among	ADP
ihlr-28406	55	37	patients	patient	NOUN
ihlr-28406	55	38	taking	take	VERB
ihlr-28406	55	39	thyroid	thyroid	NOUN
ihlr-28406	55	40	medication	medication	NOUN
ihlr-28406	55	41	,	,	PUNCT
ihlr-28406	55	42	only	only	ADV
ihlr-28406	55	43	60	60	NUM
ihlr-28406	55	44	%	%	NOUN
ihlr-28406	55	45	were	be	AUX
ihlr-28406	55	46	within	within	ADP
ihlr-28406	55	47	the	the	DET
ihlr-28406	55	48	normal	normal	ADJ
ihlr-28406	55	49	range	range	NOUN
ihlr-28406	55	50	of	of	ADP
ihlr-28406	55	51	tsh	tsh	NOUN
ihlr-28406	55	52	.	.	PROPN
ihlr-28406	55	53	20	20	NUM
ihlr-28406	55	54	in	in	ADP
ihlr-28406	55	55	short	short	ADJ
ihlr-28406	55	56	,	,	PUNCT
ihlr-28406	55	57	modest	modest	ADJ
ihlr-28406	55	58	tsh	tsh	NOUN
ihlr-28406	55	59	fluctuations	fluctuation	NOUN
ihlr-28406	55	60	corresponded	correspond	VERB
ihlr-28406	55	61	to	to	ADP
ihlr-28406	55	62	physiological	physiological	ADJ
ihlr-28406	55	63	changes	change	NOUN
ihlr-28406	55	64	affecting	affect	VERB
ihlr-28406	55	65	patient	patient	ADJ
ihlr-28406	55	66	health	health	NOUN
ihlr-28406	55	67	.	.	PUNCT
ihlr-28406	56	1	21	21	NUM
ihlr-28406	56	2	thyroid	thyroid	NOUN
ihlr-28406	56	3	dysfunction	dysfunction	NOUN
ihlr-28406	56	4	is	be	AUX
ihlr-28406	56	5	common	common	ADJ
ihlr-28406	56	6	,	,	PUNCT
ihlr-28406	56	7	often	often	ADV
ihlr-28406	56	8	undetected	undetecte	VERB
ihlr-28406	56	9	,	,	PUNCT
ihlr-28406	56	10	and	and	CCONJ
ihlr-28406	56	11	may	may	AUX
ihlr-28406	56	12	be	be	AUX
ihlr-28406	56	13	associated	associate	VERB
ihlr-28406	56	14	with	with	ADP
ihlr-28406	56	15	adverse	adverse	ADJ
ihlr-28406	56	16	health	health	NOUN
ihlr-28406	56	17	outcomes	outcome	NOUN
ihlr-28406	56	18	.	.	PUNCT
ihlr-28406	57	1	22	22	NUM
ihlr-28406	57	2	identifying	identify	VERB
ihlr-28406	57	3	thyroid	thyroid	NOUN
ihlr-28406	57	4	disease	disease	NOUN
ihlr-28406	57	5	is	be	AUX
ihlr-28406	57	6	challenging	challenge	VERB
ihlr-28406	57	7	because	because	SCONJ
ihlr-28406	57	8	symptoms	symptom	NOUN
ihlr-28406	57	9	often	often	ADV
ihlr-28406	57	10	develop	develop	VERB
ihlr-28406	57	11	so	so	ADV
ihlr-28406	57	12	subtly	subtly	ADV
ihlr-28406	57	13	that	that	SCONJ
ihlr-28406	57	14	they	they	PRON
ihlr-28406	57	15	go	go	VERB
ihlr-28406	57	16	unnoticed	unnoticed	ADJ
ihlr-28406	57	17	.	.	PUNCT
ihlr-28406	58	1	23	23	NUM
ihlr-28406	59	1	the	the	DET
ihlr-28406	59	2	difficulty	difficulty	NOUN
ihlr-28406	59	3	with	with	ADP
ihlr-28406	59	4	many	many	ADJ
ihlr-28406	59	5	studies	study	NOUN
ihlr-28406	59	6	lies	lie	VERB
ihlr-28406	59	7	in	in	ADP
ihlr-28406	59	8	the	the	DET
ihlr-28406	59	9	variable	variable	ADJ
ihlr-28406	59	10	disease	disease	NOUN
ihlr-28406	59	11	state	state	NOUN
ihlr-28406	59	12	definitions	definition	NOUN
ihlr-28406	59	13	,	,	PUNCT
ihlr-28406	59	14	where	where	SCONJ
ihlr-28406	59	15	poorly	poorly	ADV
ihlr-28406	59	16	defined	define	VERB
ihlr-28406	59	17	populations	population	NOUN
ihlr-28406	59	18	are	be	AUX
ihlr-28406	59	19	studied	study	VERB
ihlr-28406	59	20	with	with	ADP
ihlr-28406	59	21	limited	limited	ADJ
ihlr-28406	59	22	thyroid	thyroid	NOUN
ihlr-28406	59	23	functional	functional	ADJ
ihlr-28406	59	24	measures	measure	NOUN
ihlr-28406	59	25	.	.	PUNCT
ihlr-28406	60	1	24	24	NUM
ihlr-28406	60	2	additionally	additionally	ADV
ihlr-28406	60	3	,	,	PUNCT
ihlr-28406	60	4	studies	study	NOUN
ihlr-28406	60	5	from	from	ADP
ihlr-28406	60	6	various	various	ADJ
ihlr-28406	60	7	countries	country	NOUN
ihlr-28406	60	8	differ	differ	VERB
ihlr-28406	60	9	in	in	ADP
ihlr-28406	60	10	their	their	PRON
ihlr-28406	60	11	reported	report	VERB
ihlr-28406	60	12	estimates	estimate	NOUN
ihlr-28406	60	13	for	for	ADP
ihlr-28406	60	14	both	both	CCONJ
ihlr-28406	60	15	hypothyroidism	hypothyroidism	NOUN
ihlr-28406	60	16	and	and	CCONJ
ihlr-28406	60	17	hyperthyroidism	hyperthyroidism	NOUN
ihlr-28406	60	18	.	.	PUNCT
ihlr-28406	61	1	25	25	NUM
ihlr-28406	61	2	thyroxine	thyroxine	NOUN
ihlr-28406	61	3	(	(	PUNCT
ihlr-28406	61	4	t4	t4	PROPN
ihlr-28406	61	5	)	)	PUNCT
ihlr-28406	61	6	is	be	AUX
ihlr-28406	61	7	a	a	DET
ihlr-28406	61	8	hormone	hormone	NOUN
ihlr-28406	61	9	the	the	DET
ihlr-28406	61	10	thyroid	thyroid	NOUN
ihlr-28406	61	11	gland	gland	NOUN
ihlr-28406	61	12	secretes	secrete	NOUN
ihlr-28406	61	13	into	into	ADP
ihlr-28406	61	14	the	the	DET
ihlr-28406	61	15	bloodstream	bloodstream	NOUN
ihlr-28406	61	16	.	.	PUNCT
ihlr-28406	62	1	thyroxine	thyroxine	NOUN
ihlr-28406	62	2	plays	play	VERB
ihlr-28406	62	3	a	a	DET
ihlr-28406	62	4	crucial	crucial	ADJ
ihlr-28406	62	5	role	role	NOUN
ihlr-28406	62	6	in	in	ADP
ihlr-28406	62	7	heart	heart	NOUN
ihlr-28406	62	8	function	function	NOUN
ihlr-28406	62	9	,	,	PUNCT
ihlr-28406	62	10	metabolism	metabolism	NOUN
ihlr-28406	62	11	control	control	NOUN
ihlr-28406	62	12	,	,	PUNCT
ihlr-28406	62	13	brain	brain	NOUN
ihlr-28406	62	14	development	development	NOUN
ihlr-28406	62	15	,	,	PUNCT
ihlr-28406	62	16	bone	bone	NOUN
ihlr-28406	62	17	health	health	NOUN
ihlr-28406	62	18	,	,	PUNCT
ihlr-28406	62	19	and	and	CCONJ
ihlr-28406	62	20	muscle	muscle	NOUN
ihlr-28406	62	21	control	control	NOUN
ihlr-28406	62	22	.	.	PUNCT
ihlr-28406	63	1	26	26	NUM
ihlr-28406	63	2	distinctly	distinctly	ADV
ihlr-28406	64	1	,	,	PUNCT
ihlr-28406	64	2	thyroxine	thyroxine	PROPN
ihlr-28406	64	3	t4	t4	PROPN
ihlr-28406	64	4	contains	contain	VERB
ihlr-28406	64	5	four	four	NUM
ihlr-28406	64	6	iodine	iodine	NOUN
ihlr-28406	64	7	atoms	atom	NOUN
ihlr-28406	64	8	per	per	ADP
ihlr-28406	64	9	molecule	molecule	NOUN
ihlr-28406	64	10	.	.	PUNCT
ihlr-28406	65	1	27	27	NUM
ihlr-28406	65	2	—	—	PUNCT
ihlr-28406	65	3	—	—	PUNCT
ihlr-28406	65	4	—	—	PUNCT
ihlr-28406	65	5	—	—	PUNCT
ihlr-28406	65	6	—	—	PUNCT
ihlr-28406	65	7	—	—	PUNCT
ihlr-28406	65	8	—	—	PUNCT
ihlr-28406	65	9	—	—	PUNCT
ihlr-28406	65	10	—	—	PUNCT
ihlr-28406	65	11	—	—	PUNCT
ihlr-28406	65	12	—	—	PUNCT
ihlr-28406	65	13	—	—	PUNCT
ihlr-28406	65	14	—	—	PUNCT
ihlr-28406	65	15	—	—	PUNCT
ihlr-28406	65	16	—	—	PUNCT
ihlr-28406	65	17	—	—	PUNCT
ihlr-28406	65	18	—	—	PUNCT
ihlr-28406	65	19	—	—	PUNCT
ihlr-28406	65	20	—	—	PUNCT
ihlr-28406	65	21	—	—	PUNCT
ihlr-28406	65	22	—	—	PUNCT
ihlr-28406	65	23	—	—	PUNCT
ihlr-28406	65	24	—	—	PUNCT
ihlr-28406	65	25	—	—	PUNCT
ihlr-28406	65	26	—	—	PUNCT
ihlr-28406	65	27	—	—	PUNCT
ihlr-28406	65	28	—	—	PUNCT
ihlr-28406	65	29	—	—	PUNCT
ihlr-28406	65	30	—	—	PUNCT
ihlr-28406	65	31	14	14	NUM
ihlr-28406	65	32	.	.	PUNCT
ihlr-28406	66	1	i	i	PRON
ihlr-28406	66	2	d.	d.	PROPN
ihlr-28406	66	3	at	at	ADP
ihlr-28406	66	4	5	5	NUM
ihlr-28406	66	5	;	;	PUNCT
ihlr-28406	66	6	see	see	VERB
ihlr-28406	66	7	also	also	ADV
ihlr-28406	66	8	kerry	kerry	PROPN
ihlr-28406	66	9	richard	richard	PROPN
ihlr-28406	66	10	et	et	PROPN
ihlr-28406	66	11	al	al	PROPN
ihlr-28406	66	12	.	.	PROPN
ihlr-28406	66	13	,	,	PUNCT
ihlr-28406	66	14	sulfation	sulfation	NOUN
ihlr-28406	66	15	of	of	ADP
ihlr-28406	66	16	thyroid	thyroid	NOUN
ihlr-28406	66	17	hormone	hormone	NOUN
ihlr-28406	66	18	and	and	CCONJ
ihlr-28406	66	19	dopamine	dopamine	NOUN
ihlr-28406	66	20	during	during	ADP
ihlr-28406	66	21	human	human	ADJ
ihlr-28406	66	22	development	development	NOUN
ihlr-28406	66	23	:	:	PUNCT
ihlr-28406	66	24	ontogeny	ontogeny	NOUN
ihlr-28406	66	25	of	of	ADP
ihlr-28406	66	26	phenol	phenol	NOUN
ihlr-28406	66	27	sulfotransferases	sulfotransferase	NOUN
ihlr-28406	66	28	and	and	CCONJ
ihlr-28406	66	29	arylsulfatase	arylsulfatase	VERB
ihlr-28406	66	30	in	in	ADP
ihlr-28406	66	31	liver	liver	NOUN
ihlr-28406	66	32	,	,	PUNCT
ihlr-28406	66	33	lung	lung	NOUN
ihlr-28406	66	34	,	,	PUNCT
ihlr-28406	66	35	and	and	CCONJ
ihlr-28406	66	36	brain	brain	NOUN
ihlr-28406	66	37	,	,	PUNCT
ihlr-28406	66	38	86	86	NUM
ihlr-28406	66	39	j.	j.	PROPN
ihlr-28406	66	40	clinical	clinical	PROPN
ihlr-28406	66	41	endocrinology	endocrinology	PROPN
ihlr-28406	66	42	&	&	CCONJ
ihlr-28406	66	43	metabolism	metabolism	NOUN
ihlr-28406	66	44	2734	2734	NUM
ihlr-28406	66	45	,	,	PUNCT
ihlr-28406	66	46	2735	2735	NUM
ihlr-28406	66	47	(	(	PUNCT
ihlr-28406	66	48	2001	2001	NUM
ihlr-28406	66	49	)	)	PUNCT
ihlr-28406	66	50	.	.	PUNCT
ihlr-28406	67	1	15	15	X
ihlr-28406	67	2	.	.	X
ihlr-28406	67	3	see	see	VERB
ihlr-28406	67	4	appendix	appendix	NOUN
ihlr-28406	67	5	a.	a.	NOUN
ihlr-28406	67	6	hypothalamic	hypothalamic	ADJ
ihlr-28406	67	7	-	-	PUNCT
ihlr-28406	67	8	pituitary	pituitary	ADJ
ihlr-28406	67	9	-	-	PUNCT
ihlr-28406	67	10	thyroid	thyroid	NOUN
ihlr-28406	67	11	axis	axis	NOUN
ihlr-28406	67	12	model	model	NOUN
ihlr-28406	67	13	for	for	ADP
ihlr-28406	67	14	thyroid	thyroid	NOUN
ihlr-28406	67	15	control	control	PROPN
ihlr-28406	67	16	loop	loop	PROPN
ihlr-28406	67	17	.	.	PUNCT
ihlr-28406	68	1	16	16	NUM
ihlr-28406	68	2	.	.	PUNCT
ihlr-28406	69	1	squire	squire	PROPN
ihlr-28406	69	2	et	et	PROPN
ihlr-28406	69	3	al	al	PROPN
ihlr-28406	69	4	.	.	PROPN
ihlr-28406	69	5	,	,	PUNCT
ihlr-28406	69	6	supra	supra	PROPN
ihlr-28406	69	7	note	note	PROPN
ihlr-28406	69	8	8	8	NUM
ihlr-28406	69	9	,	,	PUNCT
ihlr-28406	69	10	at	at	ADP
ihlr-28406	69	11	910	910	NUM
ihlr-28406	69	12	(	(	PUNCT
ihlr-28406	69	13	the	the	DET
ihlr-28406	69	14	hypothalamic	hypothalamic	ADJ
ihlr-28406	69	15	hormone	hormone	NOUN
ihlr-28406	69	16	involved	involve	VERB
ihlr-28406	69	17	in	in	ADP
ihlr-28406	69	18	this	this	DET
ihlr-28406	69	19	function	function	NOUN
ihlr-28406	69	20	is	be	AUX
ihlr-28406	69	21	thyrotropin	thyrotropin	NOUN
ihlr-28406	69	22	-	-	PUNCT
ihlr-28406	69	23	releasing	release	VERB
ihlr-28406	69	24	hormone	hormone	NOUN
ihlr-28406	69	25	,	,	PUNCT
ihlr-28406	69	26	produced	produce	VERB
ihlr-28406	69	27	by	by	ADP
ihlr-28406	69	28	a	a	DET
ihlr-28406	69	29	group	group	NOUN
ihlr-28406	69	30	of	of	ADP
ihlr-28406	69	31	cells	cell	NOUN
ihlr-28406	69	32	in	in	ADP
ihlr-28406	69	33	a	a	DET
ihlr-28406	69	34	specific	specific	ADJ
ihlr-28406	69	35	nucleus	nucleus	NOUN
ihlr-28406	69	36	in	in	ADP
ihlr-28406	69	37	the	the	DET
ihlr-28406	69	38	hypothalamus	hypothalamus	NOUN
ihlr-28406	69	39	,	,	PUNCT
ihlr-28406	69	40	the	the	DET
ihlr-28406	69	41	paraventricular	paraventricular	ADJ
ihlr-28406	69	42	nucleus	nucleus	NOUN
ihlr-28406	69	43	)	)	PUNCT
ihlr-28406	69	44	.	.	PUNCT
ihlr-28406	70	1	17	17	NUM
ihlr-28406	70	2	.	.	PUNCT
ihlr-28406	71	1	i	i	PRON
ihlr-28406	71	2	d.	d.	PROPN
ihlr-28406	71	3	18	18	NUM
ihlr-28406	71	4	.	.	PUNCT
ihlr-28406	72	1	i	i	PRON
ihlr-28406	72	2	d.	d.	PROPN
ihlr-28406	72	3	at	at	ADP
ihlr-28406	72	4	909	909	NUM
ihlr-28406	72	5	;	;	PUNCT
ihlr-28406	72	6	see	see	AUX
ihlr-28406	72	7	also	also	ADV
ihlr-28406	72	8	substituted	substitute	VERB
ihlr-28406	72	9	anilide	anilide	ADJ
ihlr-28406	72	10	ligands	ligand	NOUN
ihlr-28406	72	11	for	for	ADP
ihlr-28406	72	12	the	the	DET
ihlr-28406	72	13	thyroid	thyroid	NOUN
ihlr-28406	72	14	receptor	receptor	NOUN
ihlr-28406	72	15	,	,	PUNCT
ihlr-28406	72	16	u.s	u.s	PROPN
ihlr-28406	72	17	.	.	PROPN
ihlr-28406	72	18	patent	patent	NOUN
ihlr-28406	72	19	no	no	PROPN
ihlr-28406	72	20	.	.	PUNCT
ihlr-28406	73	1	7,342,127	7,342,127	NUM
ihlr-28406	73	2	(	(	PUNCT
ihlr-28406	73	3	filed	file	VERB
ihlr-28406	73	4	mar	mar	PROPN
ihlr-28406	73	5	.	.	PROPN
ihlr-28406	73	6	11	11	NUM
ihlr-28406	73	7	,	,	PUNCT
ihlr-28406	73	8	2008	2008	NUM
ihlr-28406	73	9	)	)	PUNCT
ihlr-28406	73	10	(	(	PUNCT
ihlr-28406	73	11	thyroid	thyroid	NOUN
ihlr-28406	73	12	hormones	hormone	NOUN
ihlr-28406	73	13	are	be	AUX
ihlr-28406	73	14	currently	currently	ADV
ihlr-28406	73	15	used	use	VERB
ihlr-28406	73	16	primarily	primarily	ADV
ihlr-28406	73	17	as	as	ADP
ihlr-28406	73	18	replacement	replacement	NOUN
ihlr-28406	73	19	therapy	therapy	NOUN
ihlr-28406	73	20	for	for	ADP
ihlr-28406	73	21	patients	patient	NOUN
ihlr-28406	73	22	with	with	ADP
ihlr-28406	73	23	hypothyroidism	hypothyroidism	NOUN
ihlr-28406	73	24	)	)	PUNCT
ihlr-28406	73	25	.	.	PUNCT
ihlr-28406	74	1	19	19	NUM
ihlr-28406	74	2	.	.	PUNCT
ihlr-28406	74	3	heuck	heuck	VERB
ihlr-28406	74	4	et	et	PROPN
ihlr-28406	74	5	al	al	PROPN
ihlr-28406	74	6	.	.	PROPN
ihlr-28406	74	7	,	,	PUNCT
ihlr-28406	74	8	supra	supra	PROPN
ihlr-28406	74	9	note	note	NOUN
ihlr-28406	74	10	3	3	NUM
ihlr-28406	74	11	,	,	PUNCT
ihlr-28406	74	12	at	at	ADP
ihlr-28406	74	13	9	9	NUM
ihlr-28406	74	14	.	.	NOUN
ihlr-28406	74	15	20	20	NUM
ihlr-28406	74	16	.	.	PUNCT
ihlr-28406	75	1	canaris	canaris	PROPN
ihlr-28406	75	2	et	et	PROPN
ihlr-28406	75	3	al	al	PROPN
ihlr-28406	75	4	.	.	PROPN
ihlr-28406	75	5	,	,	PUNCT
ihlr-28406	75	6	supra	supra	PROPN
ihlr-28406	75	7	note	note	NOUN
ihlr-28406	75	8	2	2	NUM
ihlr-28406	75	9	,	,	PUNCT
ihlr-28406	75	10	at	at	ADP
ihlr-28406	75	11	526	526	NUM
ihlr-28406	75	12	.	.	PUNCT
ihlr-28406	76	1	21	21	NUM
ihlr-28406	76	2	.	.	PUNCT
ihlr-28406	77	1	i	i	PRON
ihlr-28406	77	2	d.	d.	PROPN
ihlr-28406	77	3	22	22	NUM
ihlr-28406	77	4	.	.	PUNCT
ihlr-28406	78	1	i	i	PRON
ihlr-28406	78	2	d.	d.	PROPN
ihlr-28406	78	3	23	23	NUM
ihlr-28406	78	4	.	.	PUNCT
ihlr-28406	79	1	i	i	PRON
ihlr-28406	79	2	d.	d.	PROPN
ihlr-28406	79	3	at	at	ADP
ihlr-28406	79	4	527	527	NUM
ihlr-28406	79	5	.	.	PUNCT
ihlr-28406	80	1	24	24	NUM
ihlr-28406	80	2	.	.	PUNCT
ihlr-28406	81	1	i	i	PRON
ihlr-28406	81	2	d.	d.	PROPN
ihlr-28406	81	3	at	at	ADP
ihlr-28406	81	4	526	526	NUM
ihlr-28406	81	5	;	;	PUNCT
ihlr-28406	81	6	see	see	VERB
ihlr-28406	81	7	also	also	ADV
ihlr-28406	81	8	massolt	massolt	NOUN
ihlr-28406	81	9	,	,	PUNCT
ihlr-28406	81	10	supra	supra	ADJ
ihlr-28406	81	11	note	note	NOUN
ihlr-28406	81	12	6	6	NUM
ihlr-28406	81	13	,	,	PUNCT
ihlr-28406	81	14	at	at	ADP
ihlr-28406	81	15	49	49	NUM
ihlr-28406	81	16	(	(	PUNCT
ihlr-28406	81	17	“	"	PUNCT
ihlr-28406	81	18	thyroid	thyroid	NOUN
ihlr-28406	81	19	peroxidase	peroxidase	NOUN
ihlr-28406	81	20	is	be	AUX
ihlr-28406	81	21	the	the	DET
ihlr-28406	81	22	major	major	ADJ
ihlr-28406	81	23	autoantigen	autoantigen	NOUN
ihlr-28406	81	24	and	and	CCONJ
ihlr-28406	81	25	tpo	tpo	PROPN
ihlr-28406	81	26	antibodies	antibodie	VERB
ihlr-28406	81	27	are	be	AUX
ihlr-28406	81	28	present	present	ADJ
ihlr-28406	81	29	in	in	ADP
ihlr-28406	81	30	almost	almost	ADV
ihlr-28406	81	31	all	all	PRON
ihlr-28406	81	32	patients	patient	NOUN
ihlr-28406	81	33	with	with	ADP
ihlr-28406	81	34	autoimmune	autoimmune	ADJ
ihlr-28406	81	35	hypothyroidism	hypothyroidism	NOUN
ihlr-28406	81	36	and	and	CCONJ
ihlr-28406	81	37	precede	precede	VERB
ihlr-28406	81	38	the	the	DET
ihlr-28406	81	39	clinical	clinical	ADJ
ihlr-28406	81	40	phase	phase	NOUN
ihlr-28406	81	41	of	of	ADP
ihlr-28406	81	42	autoimmune	autoimmune	ADJ
ihlr-28406	81	43	hypothyroidism	hypothyroidism	NOUN
ihlr-28406	81	44	by	by	ADP
ihlr-28406	81	45	many	many	ADJ
ihlr-28406	81	46	years	year	NOUN
ihlr-28406	81	47	.	.	PUNCT
ihlr-28406	81	48	”	"	PUNCT
ihlr-28406	81	49	)	)	PUNCT
ihlr-28406	81	50	.	.	PUNCT
ihlr-28406	82	1	25	25	NUM
ihlr-28406	82	2	.	.	PUNCT
ihlr-28406	82	3	canaris	canaris	PROPN
ihlr-28406	82	4	et	et	PROPN
ihlr-28406	82	5	al	al	PROPN
ihlr-28406	82	6	.	.	PROPN
ihlr-28406	82	7	,	,	PUNCT
ihlr-28406	82	8	supra	supra	PROPN
ihlr-28406	82	9	note	note	NOUN
ihlr-28406	82	10	2	2	NUM
ihlr-28406	82	11	,	,	PUNCT
ihlr-28406	82	12	at	at	ADP
ihlr-28406	82	13	526	526	NUM
ihlr-28406	82	14	.	.	PUNCT
ihlr-28406	83	1	26	26	NUM
ihlr-28406	83	2	.	.	PUNCT
ihlr-28406	84	1	michelle	michelle	PROPN
ihlr-28406	84	2	so	so	ADV
ihlr-28406	84	3	et	et	PROPN
ihlr-28406	84	4	al	al	PROPN
ihlr-28406	84	5	.	.	PROPN
ihlr-28406	84	6	,	,	PUNCT
ihlr-28406	84	7	hypothyroidism	hypothyroidism	NOUN
ihlr-28406	84	8	:	:	PUNCT
ihlr-28406	84	9	investigation	investigation	NOUN
ihlr-28406	84	10	and	and	CCONJ
ihlr-28406	84	11	management	management	NOUN
ihlr-28406	84	12	,	,	PUNCT
ihlr-28406	84	13	41	41	NUM
ihlr-28406	84	14	austl	austl	NOUN
ihlr-28406	84	15	.	.	PUNCT
ihlr-28406	85	1	fam	fam	PROPN
ihlr-28406	85	2	.	.	PUNCT
ihlr-28406	85	3	physician	physician	PROPN
ihlr-28406	85	4	556	556	NUM
ihlr-28406	85	5	,	,	PUNCT
ihlr-28406	85	6	559	559	NUM
ihlr-28406	85	7	(	(	PUNCT
ihlr-28406	85	8	2012	2012	NUM
ihlr-28406	85	9	)	)	PUNCT
ihlr-28406	85	10	.	.	PUNCT
ihlr-28406	86	1	27	27	NUM
ihlr-28406	86	2	.	.	PUNCT
ihlr-28406	86	3	heuck	heuck	VERB
ihlr-28406	86	4	et	et	PROPN
ihlr-28406	86	5	al	al	PROPN
ihlr-28406	86	6	.	.	PROPN
ihlr-28406	86	7	,	,	PUNCT
ihlr-28406	86	8	supra	supra	PROPN
ihlr-28406	86	9	note	note	NOUN
ihlr-28406	86	10	3	3	NUM
ihlr-28406	86	11	,	,	PUNCT
ihlr-28406	86	12	at	at	ADP
ihlr-28406	86	13	5	5	NUM
ihlr-28406	86	14	;	;	PUNCT
ihlr-28406	86	15	see	see	VERB
ihlr-28406	86	16	also	also	ADV
ihlr-28406	86	17	am	be	AUX
ihlr-28406	86	18	.	.	PUNCT
ihlr-28406	87	1	thyroid	thyroid	PROPN
ihlr-28406	87	2	ass’n	ass’n	NOUN
ihlr-28406	87	3	,	,	PUNCT
ihlr-28406	87	4	supra	supra	PROPN
ihlr-28406	87	5	note	note	NOUN
ihlr-28406	87	6	7	7	NUM
ihlr-28406	87	7	,	,	PUNCT
ihlr-28406	87	8	at	at	ADP
ihlr-28406	87	9	4	4	NUM
ihlr-28406	87	10	(	(	PUNCT
ihlr-28406	87	11	the	the	DET
ihlr-28406	87	12	main	main	ADJ
ihlr-28406	87	13	hormone	hormone	NOUN
ihlr-28406	87	14	made	make	VERB
ihlr-28406	87	15	by	by	ADP
ihlr-28406	87	16	the	the	DET
ihlr-28406	87	17	thyroid	thyroid	NOUN
ihlr-28406	87	18	is	be	AUX
ihlr-28406	87	19	thyroxine	thyroxine	NOUN
ihlr-28406	87	20	,	,	PUNCT
ihlr-28406	87	21	also	also	ADV
ihlr-28406	87	22	called	call	VERB
ihlr-28406	87	23	t4	t4	PROPN
ihlr-28406	87	24	because	because	SCONJ
ihlr-28406	87	25	it	it	PRON
ihlr-28406	87	26	contains	contain	VERB
ihlr-28406	87	27	four	four	NUM
ihlr-28406	87	28	iodine	iodine	NOUN
ihlr-28406	87	29	molecules	molecule	NOUN
ihlr-28406	87	30	)	)	PUNCT
ihlr-28406	87	31	.	.	PUNCT
ihlr-28406	88	1	2024	2024	NUM
ihlr-28406	88	2	]	]	PUNCT
ihlr-28406	88	3	inventions	invention	NOUN
ihlr-28406	88	4	and	and	CCONJ
ihlr-28406	88	5	patents	patent	NOUN
ihlr-28406	88	6	for	for	ADP
ihlr-28406	88	7	treating	treat	VERB
ihlr-28406	88	8	281	281	NUM
ihlr-28406	88	9	thyroid	thyroid	NOUN
ihlr-28406	88	10	disease	disease	NOUN
ihlr-28406	88	11	figure	figure	VERB
ihlr-28406	88	12	1	1	NUM
ihlr-28406	88	13	–	–	PUNCT
ihlr-28406	88	14	thyroxine	thyroxine	NOUN
ihlr-28406	88	15	molecule	molecule	NOUN
ihlr-28406	88	16	as	as	SCONJ
ihlr-28406	88	17	blood	blood	NOUN
ihlr-28406	88	18	flows	flow	VERB
ihlr-28406	88	19	through	through	ADP
ihlr-28406	88	20	the	the	DET
ihlr-28406	88	21	pituitary	pituitary	ADJ
ihlr-28406	88	22	gland	gland	NOUN
ihlr-28406	88	23	,	,	PUNCT
ihlr-28406	88	24	cells	cell	NOUN
ihlr-28406	88	25	measure	measure	VERB
ihlr-28406	88	26	t4	t4	PROPN
ihlr-28406	88	27	levels	level	NOUN
ihlr-28406	88	28	to	to	PART
ihlr-28406	88	29	determine	determine	VERB
ihlr-28406	88	30	set	set	NOUN
ihlr-28406	88	31	point	point	NOUN
ihlr-28406	88	32	accuracy	accuracy	NOUN
ihlr-28406	88	33	.	.	PUNCT
ihlr-28406	89	1	28	28	NUM
ihlr-28406	90	1	the	the	DET
ihlr-28406	90	2	pituitary	pituitary	ADJ
ihlr-28406	90	3	cells	cell	NOUN
ihlr-28406	90	4	communicate	communicate	VERB
ihlr-28406	90	5	with	with	ADP
ihlr-28406	90	6	the	the	DET
ihlr-28406	90	7	thyroid	thyroid	NOUN
ihlr-28406	90	8	through	through	ADP
ihlr-28406	90	9	tsh	tsh	ADJ
ihlr-28406	90	10	secretion	secretion	NOUN
ihlr-28406	90	11	.	.	PUNCT
ihlr-28406	91	1	29	29	NUM
ihlr-28406	91	2	when	when	SCONJ
ihlr-28406	91	3	t4	t4	PROPN
ihlr-28406	91	4	levels	level	NOUN
ihlr-28406	91	5	are	be	AUX
ihlr-28406	91	6	at	at	ADP
ihlr-28406	91	7	a	a	DET
ihlr-28406	91	8	set	set	VERB
ihlr-28406	91	9	point,30	point,30	NOUN
ihlr-28406	91	10	the	the	DET
ihlr-28406	91	11	pituitary	pituitary	ADJ
ihlr-28406	91	12	gland	gland	NOUN
ihlr-28406	91	13	sends	send	VERB
ihlr-28406	91	14	out	out	ADP
ihlr-28406	91	15	enough	enough	ADJ
ihlr-28406	91	16	tsh	tsh	NOUN
ihlr-28406	91	17	to	to	PART
ihlr-28406	91	18	tell	tell	VERB
ihlr-28406	91	19	the	the	DET
ihlr-28406	91	20	thyroid	thyroid	NOUN
ihlr-28406	91	21	to	to	PART
ihlr-28406	91	22	maintain	maintain	VERB
ihlr-28406	91	23	homeostasis	homeostasis	NOUN
ihlr-28406	91	24	.	.	PUNCT
ihlr-28406	92	1	31	31	NUM
ihlr-28406	93	1	if	if	SCONJ
ihlr-28406	93	2	the	the	DET
ihlr-28406	93	3	t4	t4	PROPN
ihlr-28406	93	4	levels	level	NOUN
ihlr-28406	93	5	get	get	VERB
ihlr-28406	93	6	low	low	ADJ
ihlr-28406	93	7	,	,	PUNCT
ihlr-28406	93	8	the	the	DET
ihlr-28406	93	9	pituitary	pituitary	ADJ
ihlr-28406	93	10	gland	gland	NOUN
ihlr-28406	93	11	releases	release	VERB
ihlr-28406	93	12	more	more	ADJ
ihlr-28406	93	13	tsh	tsh	NOUN
ihlr-28406	93	14	,	,	PUNCT
ihlr-28406	93	15	telling	tell	VERB
ihlr-28406	93	16	the	the	DET
ihlr-28406	93	17	thyroid	thyroid	NOUN
ihlr-28406	93	18	to	to	PART
ihlr-28406	93	19	make	make	VERB
ihlr-28406	93	20	more	more	ADJ
ihlr-28406	93	21	t4	t4	PROPN
ihlr-28406	93	22	.	.	PROPN
ihlr-28406	93	23	32	32	NUM
ihlr-28406	93	24	conversely	conversely	ADV
ihlr-28406	93	25	if	if	SCONJ
ihlr-28406	93	26	t4	t4	PROPN
ihlr-28406	93	27	are	be	AUX
ihlr-28406	93	28	high	high	ADJ
ihlr-28406	93	29	,	,	PUNCT
ihlr-28406	93	30	the	the	DET
ihlr-28406	93	31	pituitary	pituitary	ADJ
ihlr-28406	93	32	gland	gland	NOUN
ihlr-28406	93	33	releases	release	VERB
ihlr-28406	93	34	less	less	ADJ
ihlr-28406	93	35	tsh	tsh	NOUN
ihlr-28406	93	36	to	to	ADP
ihlr-28406	93	37	slow	slow	ADJ
ihlr-28406	93	38	production	production	NOUN
ihlr-28406	93	39	.	.	PUNCT
ihlr-28406	94	1	33	33	NUM
ihlr-28406	94	2	for	for	ADP
ihlr-28406	94	3	some	some	DET
ihlr-28406	94	4	patients	patient	NOUN
ihlr-28406	95	1	,	,	PUNCT
ihlr-28406	95	2	thyroxine	thyroxine	NOUN
ihlr-28406	95	3	replacement	replacement	NOUN
ihlr-28406	95	4	may	may	AUX
ihlr-28406	95	5	be	be	AUX
ihlr-28406	95	6	beneficial	beneficial	ADJ
ihlr-28406	95	7	where	where	SCONJ
ihlr-28406	95	8	tsh	tsh	NOUN
ihlr-28406	95	9	levels	level	NOUN
ihlr-28406	95	10	are	be	AUX
ihlr-28406	95	11	elevated	elevate	VERB
ihlr-28406	95	12	however	however	ADV
ihlr-28406	95	13	,	,	PUNCT
ihlr-28406	95	14	this	this	DET
ihlr-28406	95	15	option	option	NOUN
ihlr-28406	95	16	remains	remain	VERB
ihlr-28406	95	17	controversial	controversial	ADJ
ihlr-28406	95	18	.	.	PUNCT
ihlr-28406	96	1	34	34	NUM
ihlr-28406	96	2	indeed	indeed	ADV
ihlr-28406	96	3	,	,	PUNCT
ihlr-28406	96	4	t3	t3	PROPN
ihlr-28406	96	5	has	have	VERB
ihlr-28406	96	6	greater	great	ADJ
ihlr-28406	96	7	biological	biological	ADJ
ihlr-28406	96	8	activity	activity	NOUN
ihlr-28406	96	9	than	than	ADP
ihlr-28406	96	10	t4	t4	PROPN
ihlr-28406	96	11	comparatively.35	comparatively.35	PROPN
ihlr-28406	96	12	t4	t4	PROPN
ihlr-28406	96	13	converts	convert	NOUN
ihlr-28406	96	14	to	to	ADP
ihlr-28406	96	15	the	the	DET
ihlr-28406	96	16	active	active	ADJ
ihlr-28406	96	17	triiodothyronine	triiodothyronine	NOUN
ihlr-28406	96	18	(	(	PUNCT
ihlr-28406	96	19	t3	t3	NOUN
ihlr-28406	96	20	)	)	PUNCT
ihlr-28406	96	21	within	within	ADP
ihlr-28406	96	22	cells	cell	NOUN
ihlr-28406	96	23	and	and	CCONJ
ihlr-28406	96	24	peripheral	peripheral	ADJ
ihlr-28406	96	25	tissues	tissue	NOUN
ihlr-28406	96	26	by	by	ADP
ihlr-28406	96	27	deiodinases	deiodinase	NOUN
ihlr-28406	96	28	.	.	PUNCT
ihlr-28406	97	1	36	36	NUM
ihlr-28406	97	2	as	as	ADP
ihlr-28406	97	3	such	such	ADJ
ihlr-28406	97	4	,	,	PUNCT
ihlr-28406	97	5	in	in	ADP
ihlr-28406	97	6	contrast	contrast	NOUN
ihlr-28406	97	7	to	to	ADP
ihlr-28406	97	8	t4	t4	PROPN
ihlr-28406	97	9	,	,	PUNCT
ihlr-28406	97	10	the	the	DET
ihlr-28406	97	11	t3	t3	PROPN
ihlr-28406	97	12	molecule	molecule	NOUN
ihlr-28406	97	13	contains	contain	VERB
ihlr-28406	97	14	three	three	NUM
ihlr-28406	97	15	iodine	iodine	NOUN
ihlr-28406	97	16	atoms.37	atoms.37	NOUN
ihlr-28406	97	17	—	—	PUNCT
ihlr-28406	97	18	—	—	PUNCT
ihlr-28406	97	19	—	—	PUNCT
ihlr-28406	97	20	—	—	PUNCT
ihlr-28406	97	21	—	—	PUNCT
ihlr-28406	97	22	—	—	PUNCT
ihlr-28406	97	23	—	—	PUNCT
ihlr-28406	97	24	—	—	PUNCT
ihlr-28406	97	25	—	—	PUNCT
ihlr-28406	97	26	—	—	PUNCT
ihlr-28406	97	27	—	—	PUNCT
ihlr-28406	97	28	—	—	PUNCT
ihlr-28406	97	29	—	—	PUNCT
ihlr-28406	97	30	—	—	PUNCT
ihlr-28406	97	31	—	—	PUNCT
ihlr-28406	97	32	—	—	PUNCT
ihlr-28406	97	33	—	—	PUNCT
ihlr-28406	97	34	—	—	PUNCT
ihlr-28406	97	35	—	—	PUNCT
ihlr-28406	97	36	—	—	PUNCT
ihlr-28406	97	37	—	—	PUNCT
ihlr-28406	97	38	—	—	PUNCT
ihlr-28406	97	39	—	—	PUNCT
ihlr-28406	97	40	—	—	PUNCT
ihlr-28406	97	41	—	—	PUNCT
ihlr-28406	97	42	—	—	PUNCT
ihlr-28406	97	43	—	—	PUNCT
ihlr-28406	97	44	—	—	PUNCT
ihlr-28406	97	45	—	—	PUNCT
ihlr-28406	97	46	28	28	NUM
ihlr-28406	97	47	.	.	PUNCT
ihlr-28406	98	1	am	be	AUX
ihlr-28406	98	2	.	.	PUNCT
ihlr-28406	99	1	thyroid	thyroid	PROPN
ihlr-28406	99	2	ass’n	ass’n	NOUN
ihlr-28406	99	3	,	,	PUNCT
ihlr-28406	99	4	supra	supra	PROPN
ihlr-28406	99	5	note	note	NOUN
ihlr-28406	99	6	7	7	NUM
ihlr-28406	99	7	,	,	PUNCT
ihlr-28406	99	8	at	at	ADP
ihlr-28406	99	9	10	10	NUM
ihlr-28406	99	10	.	.	PUNCT
ihlr-28406	99	11	29	29	NUM
ihlr-28406	99	12	.	.	PUNCT
ihlr-28406	100	1	i	i	PRON
ihlr-28406	100	2	d.	d.	PROPN
ihlr-28406	100	3	30	30	NUM
ihlr-28406	100	4	.	.	PUNCT
ihlr-28406	101	1	see	see	VERB
ihlr-28406	101	2	am	be	AUX
ihlr-28406	101	3	.	.	PUNCT
ihlr-28406	102	1	thyroid	thyroid	PROPN
ihlr-28406	102	2	ass’n	ass’n	NOUN
ihlr-28406	102	3	,	,	PUNCT
ihlr-28406	102	4	supra	supra	PROPN
ihlr-28406	102	5	note	note	NOUN
ihlr-28406	102	6	7	7	NUM
ihlr-28406	102	7	,	,	PUNCT
ihlr-28406	102	8	at	at	ADP
ihlr-28406	102	9	8	8	NUM
ihlr-28406	102	10	(	(	PUNCT
ihlr-28406	102	11	a	a	DET
ihlr-28406	102	12	set	set	NOUN
ihlr-28406	102	13	point	point	NOUN
ihlr-28406	102	14	is	be	AUX
ihlr-28406	102	15	a	a	DET
ihlr-28406	102	16	predetermined	predetermine	VERB
ihlr-28406	102	17	hormone	hormone	NOUN
ihlr-28406	102	18	level	level	NOUN
ihlr-28406	102	19	)	)	PUNCT
ihlr-28406	102	20	.	.	PUNCT
ihlr-28406	103	1	31	31	NUM
ihlr-28406	103	2	.	.	PUNCT
ihlr-28406	104	1	i	i	PRON
ihlr-28406	104	2	d.	d.	PROPN
ihlr-28406	104	3	at	at	ADP
ihlr-28406	104	4	10	10	NUM
ihlr-28406	104	5	.	.	PUNCT
ihlr-28406	105	1	32	32	NUM
ihlr-28406	105	2	.	.	PUNCT
ihlr-28406	106	1	i	i	PRON
ihlr-28406	106	2	d.	d.	PROPN
ihlr-28406	106	3	33	33	NUM
ihlr-28406	106	4	.	.	PUNCT
ihlr-28406	107	1	so	so	ADV
ihlr-28406	107	2	et	et	PROPN
ihlr-28406	107	3	al	al	PROPN
ihlr-28406	107	4	.	.	PROPN
ihlr-28406	107	5	,	,	PUNCT
ihlr-28406	107	6	supra	supra	PROPN
ihlr-28406	107	7	note	note	PROPN
ihlr-28406	107	8	26	26	NUM
ihlr-28406	107	9	,	,	PUNCT
ihlr-28406	107	10	at	at	ADP
ihlr-28406	107	11	556	556	NUM
ihlr-28406	107	12	(	(	PUNCT
ihlr-28406	107	13	“	"	PUNCT
ihlr-28406	107	14	the	the	DET
ihlr-28406	107	15	significance	significance	NOUN
ihlr-28406	107	16	of	of	ADP
ihlr-28406	107	17	elevated	elevated	ADJ
ihlr-28406	107	18	tsh	tsh	NOUN
ihlr-28406	107	19	associated	associate	VERB
ihlr-28406	107	20	with	with	ADP
ihlr-28406	107	21	thyroid	thyroid	NOUN
ihlr-28406	107	22	hormones	hormone	NOUN
ihlr-28406	107	23	within	within	ADP
ihlr-28406	107	24	normal	normal	ADJ
ihlr-28406	107	25	range	range	NOUN
ihlr-28406	107	26	is	be	AUX
ihlr-28406	107	27	controversial	controversial	ADJ
ihlr-28406	107	28	;	;	PUNCT
ihlr-28406	107	29	thyroxine	thyroxine	NOUN
ihlr-28406	107	30	replacement	replacement	NOUN
ihlr-28406	107	31	may	may	AUX
ihlr-28406	107	32	be	be	AUX
ihlr-28406	107	33	beneficial	beneficial	ADJ
ihlr-28406	107	34	in	in	ADP
ihlr-28406	107	35	some	some	DET
ihlr-28406	107	36	cases	case	NOUN
ihlr-28406	107	37	.	.	PUNCT
ihlr-28406	107	38	”	"	PUNCT
ihlr-28406	107	39	)	)	PUNCT
ihlr-28406	107	40	.	.	PUNCT
ihlr-28406	108	1	34	34	NUM
ihlr-28406	108	2	.	.	PUNCT
ihlr-28406	109	1	i	i	PRON
ihlr-28406	109	2	d.	d.	PROPN
ihlr-28406	109	3	at	at	ADP
ihlr-28406	109	4	561	561	NUM
ihlr-28406	109	5	.	.	PUNCT
ihlr-28406	109	6	35	35	NUM
ihlr-28406	109	7	.	.	PUNCT
ihlr-28406	110	1	squire	squire	PROPN
ihlr-28406	110	2	et	et	PROPN
ihlr-28406	110	3	al	al	PROPN
ihlr-28406	110	4	.	.	PROPN
ihlr-28406	110	5	,	,	PUNCT
ihlr-28406	110	6	supra	supra	PROPN
ihlr-28406	110	7	note	note	PROPN
ihlr-28406	110	8	8	8	NUM
ihlr-28406	110	9	,	,	PUNCT
ihlr-28406	110	10	at	at	ADP
ihlr-28406	110	11	911	911	NUM
ihlr-28406	110	12	.	.	NOUN
ihlr-28406	110	13	36	36	NUM
ihlr-28406	110	14	.	.	PUNCT
ihlr-28406	110	15	heuck	heuck	VERB
ihlr-28406	110	16	et	et	PROPN
ihlr-28406	110	17	al	al	PROPN
ihlr-28406	110	18	.	.	PROPN
ihlr-28406	110	19	,	,	PUNCT
ihlr-28406	110	20	supra	supra	PROPN
ihlr-28406	110	21	note	note	NOUN
ihlr-28406	110	22	3	3	NUM
ihlr-28406	110	23	,	,	PUNCT
ihlr-28406	110	24	at	at	ADP
ihlr-28406	110	25	5	5	NUM
ihlr-28406	110	26	(	(	PUNCT
ihlr-28406	110	27	once	once	ADV
ihlr-28406	110	28	in	in	ADP
ihlr-28406	110	29	the	the	DET
ihlr-28406	110	30	bloodstream	bloodstream	NOUN
ihlr-28406	110	31	,	,	PUNCT
ihlr-28406	110	32	thyroxine	thyroxine	NOUN
ihlr-28406	110	33	travels	travel	VERB
ihlr-28406	110	34	to	to	ADP
ihlr-28406	110	35	the	the	DET
ihlr-28406	110	36	body	body	NOUN
ihlr-28406	110	37	’s	’s	PART
ihlr-28406	110	38	organs	organ	NOUN
ihlr-28406	110	39	,	,	PUNCT
ihlr-28406	110	40	where	where	SCONJ
ihlr-28406	110	41	it	it	PRON
ihlr-28406	110	42	is	be	AUX
ihlr-28406	110	43	converted	convert	VERB
ihlr-28406	110	44	to	to	ADP
ihlr-28406	110	45	an	an	DET
ihlr-28406	110	46	active	active	ADJ
ihlr-28406	110	47	form	form	NOUN
ihlr-28406	110	48	,	,	PUNCT
ihlr-28406	110	49	triiodothyronine	triiodothyronine	NOUN
ihlr-28406	110	50	t3	t3	PROPN
ihlr-28406	110	51	)	)	PUNCT
ihlr-28406	110	52	.	.	PUNCT
ihlr-28406	111	1	37	37	NUM
ihlr-28406	111	2	.	.	PUNCT
ihlr-28406	112	1	i	i	PRON
ihlr-28406	112	2	d.	d.	PROPN
ihlr-28406	112	3	indiana	indiana	PROPN
ihlr-28406	112	4	health	health	PROPN
ihlr-28406	112	5	law	law	PROPN
ihlr-28406	112	6	review	review	NOUN
ihlr-28406	112	7	[	[	X
ihlr-28406	112	8	vol	vol	NOUN
ihlr-28406	112	9	.	.	PUNCT
ihlr-28406	113	1	21:277	21:277	NOUN
ihlr-28406	113	2	282	282	NUM
ihlr-28406	113	3	figure	figure	NOUN
ihlr-28406	113	4	2	2	NUM
ihlr-28406	113	5	–	–	PUNCT
ihlr-28406	113	6	triiodothyronine	triiodothyronine	ADJ
ihlr-28406	113	7	molecule	molecule	NOUN
ihlr-28406	113	8	t3	t3	NOUN
ihlr-28406	113	9	is	be	AUX
ihlr-28406	113	10	the	the	DET
ihlr-28406	113	11	physiologically	physiologically	ADV
ihlr-28406	113	12	active	active	ADJ
ihlr-28406	113	13	thyroid	thyroid	NOUN
ihlr-28406	113	14	hormone	hormone	NOUN
ihlr-28406	113	15	.	.	PUNCT
ihlr-28406	114	1	38	38	NUM
ihlr-28406	114	2	it	it	PRON
ihlr-28406	114	3	controls	control	VERB
ihlr-28406	114	4	myocardium	myocardium	ADJ
ihlr-28406	114	5	properties	property	NOUN
ihlr-28406	114	6	,	,	PUNCT
ihlr-28406	114	7	heart	heart	NOUN
ihlr-28406	114	8	rate	rate	NOUN
ihlr-28406	114	9	,	,	PUNCT
ihlr-28406	114	10	and	and	CCONJ
ihlr-28406	114	11	vascular	vascular	ADJ
ihlr-28406	114	12	function	function	NOUN
ihlr-28406	114	13	.	.	PUNCT
ihlr-28406	115	1	39	39	NUM
ihlr-28406	115	2	in	in	ADP
ihlr-28406	115	3	fact	fact	NOUN
ihlr-28406	115	4	,	,	PUNCT
ihlr-28406	115	5	t3	t3	PROPN
ihlr-28406	115	6	affects	affect	VERB
ihlr-28406	115	7	almost	almost	ADV
ihlr-28406	115	8	every	every	PRON
ihlr-28406	115	9	process	process	NOUN
ihlr-28406	115	10	in	in	ADP
ihlr-28406	115	11	the	the	DET
ihlr-28406	115	12	body.40	body.40	NOUN
ihlr-28406	115	13	interestingly	interestingly	ADV
ihlr-28406	115	14	,	,	PUNCT
ihlr-28406	115	15	one	one	NUM
ihlr-28406	115	16	report	report	NOUN
ihlr-28406	115	17	suggests	suggest	VERB
ihlr-28406	115	18	the	the	DET
ihlr-28406	115	19	thyroid	thyroid	NOUN
ihlr-28406	115	20	gland	gland	NOUN
ihlr-28406	115	21	produces	produce	VERB
ihlr-28406	115	22	t3	t3	PROPN
ihlr-28406	115	23	directly.41	directly.41	PROPN
ihlr-28406	115	24	although	although	SCONJ
ihlr-28406	115	25	,	,	PUNCT
ihlr-28406	115	26	thyroid	thyroid	NOUN
ihlr-28406	115	27	disease	disease	NOUN
ihlr-28406	115	28	is	be	AUX
ihlr-28406	115	29	typically	typically	ADV
ihlr-28406	115	30	not	not	PART
ihlr-28406	115	31	treated	treat	VERB
ihlr-28406	115	32	with	with	ADP
ihlr-28406	115	33	t3	t3	PROPN
ihlr-28406	115	34	supplementation	supplementation	NOUN
ihlr-28406	115	35	.	.	PUNCT
ihlr-28406	116	1	however	however	ADV
ihlr-28406	116	2	,	,	PUNCT
ihlr-28406	116	3	some	some	DET
ihlr-28406	116	4	researchers	researcher	NOUN
ihlr-28406	116	5	speculate	speculate	VERB
ihlr-28406	116	6	a	a	DET
ihlr-28406	116	7	t4	t4	PROPN
ihlr-28406	116	8	and	and	CCONJ
ihlr-28406	116	9	t3	t3	PROPN
ihlr-28406	116	10	combination	combination	NOUN
ihlr-28406	116	11	might	might	AUX
ihlr-28406	116	12	be	be	AUX
ihlr-28406	116	13	better	well	ADJ
ihlr-28406	116	14	.	.	PUNCT
ihlr-28406	117	1	42	42	NUM
ihlr-28406	117	2	molecular	molecular	ADJ
ihlr-28406	117	3	structures	structure	NOUN
ihlr-28406	117	4	are	be	AUX
ihlr-28406	117	5	important	important	ADJ
ihlr-28406	117	6	because	because	SCONJ
ihlr-28406	117	7	clinical	clinical	ADJ
ihlr-28406	117	8	effects	effect	NOUN
ihlr-28406	117	9	resulting	result	VERB
ihlr-28406	117	10	from	from	ADP
ihlr-28406	117	11	thyroid	thyroid	NOUN
ihlr-28406	117	12	hormone	hormone	NOUN
ihlr-28406	117	13	imbalance	imbalance	NOUN
ihlr-28406	117	14	are	be	AUX
ihlr-28406	117	15	observable	observable	ADJ
ihlr-28406	117	16	at	at	ADP
ihlr-28406	117	17	the	the	DET
ihlr-28406	117	18	cellular	cellular	ADJ
ihlr-28406	117	19	level	level	NOUN
ihlr-28406	117	20	.	.	PUNCT
ihlr-28406	118	1	43	43	NUM
ihlr-28406	118	2	thyroid	thyroid	NOUN
ihlr-28406	118	3	diseases	disease	NOUN
ihlr-28406	118	4	are	be	AUX
ihlr-28406	118	5	influenced	influence	VERB
ihlr-28406	118	6	by	by	ADP
ihlr-28406	118	7	endocrine	endocrine	NOUN
ihlr-28406	118	8	physiology	physiology	NOUN
ihlr-28406	118	9	,	,	PUNCT
ihlr-28406	118	10	particularly	particularly	ADV
ihlr-28406	118	11	where	where	SCONJ
ihlr-28406	118	12	abnormal	abnormal	ADJ
ihlr-28406	118	13	thyroid	thyroid	NOUN
ihlr-28406	118	14	hormone	hormone	NOUN
ihlr-28406	118	15	concentrations	concentration	NOUN
ihlr-28406	118	16	affect	affect	VERB
ihlr-28406	118	17	organ	organ	NOUN
ihlr-28406	118	18	function	function	NOUN
ihlr-28406	118	19	resulting	result	VERB
ihlr-28406	118	20	in	in	ADP
ihlr-28406	118	21	clinical	clinical	ADJ
ihlr-28406	118	22	symptoms	symptom	NOUN
ihlr-28406	118	23	.	.	PUNCT
ihlr-28406	119	1	44	44	NUM
ihlr-28406	119	2	a.	a.	NOUN
ihlr-28406	119	3	hypothyroidism	hypothyroidism	NOUN
ihlr-28406	119	4	hypothyroidism	hypothyroidism	NOUN
ihlr-28406	119	5	is	be	AUX
ihlr-28406	119	6	a	a	DET
ihlr-28406	119	7	“	"	PUNCT
ihlr-28406	119	8	commonly	commonly	ADV
ihlr-28406	119	9	clinically	clinically	ADV
ihlr-28406	119	10	diagnosed	diagnose	VERB
ihlr-28406	119	11	condition	condition	NOUN
ihlr-28406	119	12	describing	describe	VERB
ihlr-28406	119	13	a	a	DET
ihlr-28406	119	14	thyroid	thyroid	NOUN
ihlr-28406	119	15	hormone	hormone	NOUN
ihlr-28406	119	16	deficiency	deficiency	NOUN
ihlr-28406	119	17	.	.	PUNCT
ihlr-28406	120	1	”45	”45	PROPN
ihlr-28406	120	2	if	if	SCONJ
ihlr-28406	120	3	left	leave	VERB
ihlr-28406	120	4	untreated	untreated	ADJ
ihlr-28406	120	5	,	,	PUNCT
ihlr-28406	120	6	hypothyroidism	hypothyroidism	NOUN
ihlr-28406	120	7	can	can	AUX
ihlr-28406	120	8	lead	lead	VERB
ihlr-28406	120	9	to	to	ADP
ihlr-28406	120	10	—	—	PUNCT
ihlr-28406	120	11	—	—	PUNCT
ihlr-28406	120	12	—	—	PUNCT
ihlr-28406	120	13	—	—	PUNCT
ihlr-28406	120	14	—	—	PUNCT
ihlr-28406	120	15	—	—	PUNCT
ihlr-28406	120	16	—	—	PUNCT
ihlr-28406	120	17	—	—	PUNCT
ihlr-28406	120	18	—	—	PUNCT
ihlr-28406	120	19	—	—	PUNCT
ihlr-28406	120	20	—	—	PUNCT
ihlr-28406	120	21	—	—	PUNCT
ihlr-28406	120	22	—	—	PUNCT
ihlr-28406	120	23	—	—	PUNCT
ihlr-28406	120	24	—	—	PUNCT
ihlr-28406	120	25	—	—	PUNCT
ihlr-28406	120	26	—	—	PUNCT
ihlr-28406	120	27	—	—	PUNCT
ihlr-28406	120	28	—	—	PUNCT
ihlr-28406	120	29	—	—	PUNCT
ihlr-28406	120	30	—	—	PUNCT
ihlr-28406	120	31	—	—	PUNCT
ihlr-28406	120	32	—	—	PUNCT
ihlr-28406	120	33	—	—	PUNCT
ihlr-28406	120	34	—	—	PUNCT
ihlr-28406	120	35	—	—	PUNCT
ihlr-28406	120	36	—	—	PUNCT
ihlr-28406	120	37	—	—	PUNCT
ihlr-28406	120	38	—	—	PUNCT
ihlr-28406	120	39	38	38	NUM
ihlr-28406	120	40	.	.	PUNCT
ihlr-28406	120	41	maynika	maynika	PROPN
ihlr-28406	120	42	rastogi	rastogi	PROPN
ihlr-28406	120	43	&	&	CCONJ
ihlr-28406	120	44	stephen	stephen	PROPN
ihlr-28406	120	45	lafranchi	lafranchi	PROPN
ihlr-28406	120	46	,	,	PUNCT
ihlr-28406	120	47	congenital	congenital	ADJ
ihlr-28406	120	48	hypothyroidism	hypothyroidism	NOUN
ihlr-28406	120	49	,	,	PUNCT
ihlr-28406	120	50	5	5	NUM
ihlr-28406	120	51	orphanet	orphanet	NOUN
ihlr-28406	120	52	j.	j.	PROPN
ihlr-28406	120	53	rare	rare	PROPN
ihlr-28406	120	54	diseases	disease	NOUN
ihlr-28406	120	55	1	1	NUM
ihlr-28406	120	56	,	,	PUNCT
ihlr-28406	120	57	12–13	12–13	NUM
ihlr-28406	120	58	(	(	PUNCT
ihlr-28406	120	59	2010	2010	NUM
ihlr-28406	120	60	)	)	PUNCT
ihlr-28406	120	61	,	,	PUNCT
ihlr-28406	120	62	https://doi.org/10.1186/1750-1172-5-17	https://doi.org/10.1186/1750-1172-5-17	VERB
ihlr-28406	121	1	[	[	X
ihlr-28406	121	2	https://perma.cc/z542hdel	https://perma.cc/z542hdel	X
ihlr-28406	121	3	]	]	X
ihlr-28406	121	4	(	(	PUNCT
ihlr-28406	121	5	although	although	SCONJ
ihlr-28406	121	6	t3	t3	PROPN
ihlr-28406	121	7	is	be	AUX
ihlr-28406	121	8	the	the	DET
ihlr-28406	121	9	biologically	biologically	ADV
ihlr-28406	121	10	active	active	ADJ
ihlr-28406	121	11	form	form	NOUN
ihlr-28406	121	12	of	of	ADP
ihlr-28406	121	13	the	the	DET
ihlr-28406	121	14	hormone	hormone	NOUN
ihlr-28406	121	15	,	,	PUNCT
ihlr-28406	121	16	most	most	ADJ
ihlr-28406	121	17	t3	t3	NOUN
ihlr-28406	121	18	in	in	ADP
ihlr-28406	121	19	the	the	DET
ihlr-28406	121	20	brain	brain	NOUN
ihlr-28406	121	21	is	be	AUX
ihlr-28406	121	22	formed	form	VERB
ihlr-28406	121	23	from	from	ADP
ihlr-28406	121	24	local	local	ADJ
ihlr-28406	121	25	deiodination	deiodination	NOUN
ihlr-28406	121	26	of	of	ADP
ihlr-28406	121	27	t4	t4	PROPN
ihlr-28406	121	28	;	;	PUNCT
ihlr-28406	121	29	thus	thus	ADV
ihlr-28406	121	30	,	,	PUNCT
ihlr-28406	121	31	t3	t3	PROPN
ihlr-28406	121	32	replacement	replacement	NOUN
ihlr-28406	121	33	is	be	AUX
ihlr-28406	121	34	not	not	PART
ihlr-28406	121	35	needed	need	VERB
ihlr-28406	121	36	for	for	ADP
ihlr-28406	121	37	normal	normal	ADJ
ihlr-28406	121	38	neurologic	neurologic	ADJ
ihlr-28406	121	39	functioning	functioning	NOUN
ihlr-28406	121	40	)	)	PUNCT
ihlr-28406	121	41	.	.	PUNCT
ihlr-28406	122	1	39	39	NUM
ihlr-28406	122	2	.	.	PUNCT
ihlr-28406	123	1	massolt	massolt	NOUN
ihlr-28406	123	2	,	,	PUNCT
ihlr-28406	123	3	supra	supra	PROPN
ihlr-28406	123	4	note	note	NOUN
ihlr-28406	123	5	6	6	NUM
ihlr-28406	123	6	,	,	PUNCT
ihlr-28406	123	7	at	at	ADP
ihlr-28406	123	8	33	33	NUM
ihlr-28406	123	9	.	.	NOUN
ihlr-28406	123	10	40	40	NUM
ihlr-28406	123	11	.	.	PUNCT
ihlr-28406	124	1	heuck	heuck	VERB
ihlr-28406	124	2	et	et	PROPN
ihlr-28406	124	3	al	al	PROPN
ihlr-28406	124	4	.	.	PROPN
ihlr-28406	124	5	,	,	PUNCT
ihlr-28406	124	6	supra	supra	PROPN
ihlr-28406	124	7	note	note	NOUN
ihlr-28406	124	8	3	3	NUM
ihlr-28406	124	9	,	,	PUNCT
ihlr-28406	124	10	at	at	ADP
ihlr-28406	124	11	5	5	NUM
ihlr-28406	124	12	.	.	NOUN
ihlr-28406	124	13	41	41	NUM
ihlr-28406	124	14	.	.	PUNCT
ihlr-28406	125	1	institute	institute	NOUN
ihlr-28406	125	2	for	for	ADP
ihlr-28406	125	3	quality	quality	NOUN
ihlr-28406	125	4	and	and	CCONJ
ihlr-28406	125	5	efficiency	efficiency	NOUN
ihlr-28406	125	6	in	in	ADP
ihlr-28406	125	7	health	health	NOUN
ihlr-28406	125	8	care	care	NOUN
ihlr-28406	125	9	,	,	PUNCT
ihlr-28406	125	10	how	how	SCONJ
ihlr-28406	125	11	does	do	AUX
ihlr-28406	125	12	the	the	DET
ihlr-28406	125	13	thyroid	thyroid	NOUN
ihlr-28406	125	14	gland	gland	NOUN
ihlr-28406	125	15	work	work	NOUN
ihlr-28406	125	16	?	?	PUNCT
ihlr-28406	125	17	,	,	PUNCT
ihlr-28406	125	18	nat’l	nat’l	PROPN
ihlr-28406	125	19	libr	libr	NOUN
ihlr-28406	125	20	.	.	PUNCT
ihlr-28406	126	1	of	of	ADP
ihlr-28406	126	2	med	med	PROPN
ihlr-28406	126	3	.	.	PUNCT
ihlr-28406	127	1	(	(	PUNCT
ihlr-28406	127	2	nov	nov	PROPN
ihlr-28406	127	3	.	.	PROPN
ihlr-28406	127	4	17	17	NUM
ihlr-28406	127	5	,	,	PUNCT
ihlr-28406	127	6	2010	2010	NUM
ihlr-28406	127	7	)	)	PUNCT
ihlr-28406	127	8	,	,	PUNCT
ihlr-28406	127	9	https://www.ncbi.nlm.nih.gov/books/nbk279388/	https://www.ncbi.nlm.nih.gov/books/nbk279388/	ADJ
ihlr-28406	127	10	[	[	X
ihlr-28406	127	11	https://perma.cc/42ss-k6r8	https://perma.cc/42ss-k6r8	X
ihlr-28406	127	12	]	]	X
ihlr-28406	127	13	(	(	PUNCT
ihlr-28406	127	14	they	they	PRON
ihlr-28406	127	15	are	be	AUX
ihlr-28406	127	16	made	make	VERB
ihlr-28406	127	17	in	in	ADP
ihlr-28406	127	18	what	what	PRON
ihlr-28406	127	19	are	be	AUX
ihlr-28406	127	20	known	know	VERB
ihlr-28406	127	21	as	as	ADP
ihlr-28406	127	22	the	the	DET
ihlr-28406	127	23	follicular	follicular	ADJ
ihlr-28406	127	24	epithelial	epithelial	ADJ
ihlr-28406	127	25	cells	cell	NOUN
ihlr-28406	127	26	of	of	ADP
ihlr-28406	127	27	the	the	DET
ihlr-28406	127	28	thyroid	thyroid	NOUN
ihlr-28406	127	29	)	)	PUNCT
ihlr-28406	127	30	.	.	PUNCT
ihlr-28406	128	1	42	42	NUM
ihlr-28406	128	2	.	.	PUNCT
ihlr-28406	128	3	am	be	AUX
ihlr-28406	128	4	.	.	PUNCT
ihlr-28406	129	1	thyroid	thyroid	PROPN
ihlr-28406	129	2	ass’n	ass’n	NOUN
ihlr-28406	129	3	,	,	PUNCT
ihlr-28406	129	4	supra	supra	PROPN
ihlr-28406	129	5	note	note	NOUN
ihlr-28406	129	6	7	7	NUM
ihlr-28406	129	7	,	,	PUNCT
ihlr-28406	129	8	at	at	ADP
ihlr-28406	129	9	17	17	NUM
ihlr-28406	129	10	.	.	PUNCT
ihlr-28406	129	11	43	43	NUM
ihlr-28406	129	12	.	.	PUNCT
ihlr-28406	130	1	massolt	massolt	NOUN
ihlr-28406	130	2	,	,	PUNCT
ihlr-28406	130	3	supra	supra	PROPN
ihlr-28406	130	4	note	note	NOUN
ihlr-28406	130	5	6	6	NUM
ihlr-28406	130	6	,	,	PUNCT
ihlr-28406	130	7	at	at	ADP
ihlr-28406	130	8	9	9	NUM
ihlr-28406	130	9	.	.	NUM
ihlr-28406	130	10	44	44	NUM
ihlr-28406	130	11	.	.	PUNCT
ihlr-28406	131	1	i	i	PRON
ihlr-28406	131	2	d.	d.	PROPN
ihlr-28406	131	3	45	45	NUM
ihlr-28406	131	4	.	.	PUNCT
ihlr-28406	131	5	chaker	chaker	PROPN
ihlr-28406	131	6	et	et	PROPN
ihlr-28406	131	7	al	al	PROPN
ihlr-28406	131	8	.	.	PROPN
ihlr-28406	131	9	,	,	PUNCT
ihlr-28406	131	10	hypothyroidism	hypothyroidism	NOUN
ihlr-28406	131	11	,	,	PUNCT
ihlr-28406	131	12	8	8	NUM
ihlr-28406	131	13	nature	nature	NOUN
ihlr-28406	131	14	rev	rev	VERB
ihlr-28406	131	15	.	.	PROPN
ihlr-28406	132	1	disease	disease	NOUN
ihlr-28406	132	2	primers	primer	NOUN
ihlr-28406	132	3	(	(	PUNCT
ihlr-28406	132	4	2022	2022	NUM
ihlr-28406	132	5	)	)	PUNCT
ihlr-28406	132	6	.	.	PUNCT
ihlr-28406	133	1	https://perma.cc/42ss-k6r8	https://perma.cc/42ss-k6r8	PROPN
ihlr-28406	133	2	https://www.ncbi.nlm.nih.gov/books/nbk279388	https://www.ncbi.nlm.nih.gov/books/nbk279388	X
ihlr-28406	133	3	https://perma.cc/z542	https://perma.cc/z542	PROPN
ihlr-28406	133	4	https://doi.org/10.1186/1750-1172-5-17	https://doi.org/10.1186/1750-1172-5-17	NOUN
ihlr-28406	133	5	2024	2024	NUM
ihlr-28406	133	6	]	]	PUNCT
ihlr-28406	133	7	inventions	invention	NOUN
ihlr-28406	133	8	and	and	CCONJ
ihlr-28406	133	9	patents	patent	NOUN
ihlr-28406	133	10	for	for	ADP
ihlr-28406	133	11	treating	treat	VERB
ihlr-28406	133	12	283	283	NUM
ihlr-28406	133	13	thyroid	thyroid	NOUN
ihlr-28406	133	14	disease	disease	NOUN
ihlr-28406	133	15	serious	serious	ADJ
ihlr-28406	133	16	adverse	adverse	ADJ
ihlr-28406	133	17	health	health	NOUN
ihlr-28406	133	18	effects	effect	NOUN
ihlr-28406	133	19	on	on	ADP
ihlr-28406	133	20	multiple	multiple	ADJ
ihlr-28406	133	21	organ	organ	NOUN
ihlr-28406	133	22	systems	system	NOUN
ihlr-28406	133	23	,	,	PUNCT
ihlr-28406	133	24	with	with	ADP
ihlr-28406	133	25	the	the	DET
ihlr-28406	133	26	cardiovascular	cardiovascular	ADJ
ihlr-28406	133	27	system	system	NOUN
ihlr-28406	133	28	as	as	ADP
ihlr-28406	133	29	the	the	DET
ihlr-28406	133	30	most	most	ADV
ihlr-28406	133	31	robustly	robustly	ADV
ihlr-28406	133	32	studied	study	VERB
ihlr-28406	133	33	target	target	NOUN
ihlr-28406	133	34	.	.	PUNCT
ihlr-28406	134	1	46	46	NUM
ihlr-28406	134	2	an	an	DET
ihlr-28406	134	3	estimated	estimate	VERB
ihlr-28406	134	4	2	2	NUM
ihlr-28406	134	5	-	-	SYM
ihlr-28406	134	6	3	3	NUM
ihlr-28406	134	7	%	%	NOUN
ihlr-28406	134	8	of	of	ADP
ihlr-28406	134	9	americans	americans	PROPN
ihlr-28406	134	10	have	have	VERB
ihlr-28406	134	11	clinical	clinical	ADJ
ihlr-28406	134	12	hypothyroidism	hypothyroidism	NOUN
ihlr-28406	134	13	and	and	CCONJ
ihlr-28406	134	14	10	10	NUM
ihlr-28406	134	15	-	-	SYM
ihlr-28406	134	16	15	15	NUM
ihlr-28406	134	17	%	%	NOUN
ihlr-28406	134	18	have	have	VERB
ihlr-28406	134	19	sub	sub	ADJ
ihlr-28406	134	20	-	-	ADJ
ihlr-28406	134	21	clinical	clinical	ADJ
ihlr-28406	134	22	hypothyroidism	hypothyroidism	NOUN
ihlr-28406	134	23	.	.	PUNCT
ihlr-28406	135	1	47	47	NUM
ihlr-28406	135	2	in	in	ADP
ihlr-28406	135	3	other	other	ADJ
ihlr-28406	135	4	words	word	NOUN
ihlr-28406	135	5	,	,	PUNCT
ihlr-28406	135	6	roughly	roughly	ADV
ihlr-28406	135	7	6,600,000	6,600,000	NUM
ihlr-28406	135	8	to	to	ADP
ihlr-28406	135	9	9,900,000	9,900,000	NUM
ihlr-28406	135	10	americans	americans	PROPN
ihlr-28406	135	11	have	have	VERB
ihlr-28406	135	12	severe	severe	ADJ
ihlr-28406	135	13	hypothyroidism	hypothyroidism	NOUN
ihlr-28406	135	14	,	,	PUNCT
ihlr-28406	135	15	while	while	SCONJ
ihlr-28406	135	16	33,000,000	33,000,000	NUM
ihlr-28406	135	17	to	to	ADP
ihlr-28406	135	18	49,500,000	49,500,000	NUM
ihlr-28406	135	19	americans	americans	PROPN
ihlr-28406	135	20	have	have	VERB
ihlr-28406	135	21	mild	mild	ADJ
ihlr-28406	135	22	hypothyroidism	hypothyroidism	NOUN
ihlr-28406	135	23	.	.	PUNCT
ihlr-28406	136	1	further	far	ADV
ihlr-28406	136	2	,	,	PUNCT
ihlr-28406	136	3	more	more	ADJ
ihlr-28406	136	4	than	than	ADP
ihlr-28406	136	5	half	half	NOUN
ihlr-28406	136	6	of	of	ADP
ihlr-28406	136	7	people	people	NOUN
ihlr-28406	136	8	with	with	ADP
ihlr-28406	136	9	hypothyroidism	hypothyroidism	NOUN
ihlr-28406	136	10	do	do	AUX
ihlr-28406	136	11	not	not	PART
ihlr-28406	136	12	know	know	VERB
ihlr-28406	136	13	they	they	PRON
ihlr-28406	136	14	have	have	VERB
ihlr-28406	136	15	it	it	PRON
ihlr-28406	136	16	.	.	PUNCT
ihlr-28406	137	1	48	48	NUM
ihlr-28406	137	2	approximately	approximately	ADV
ihlr-28406	137	3	10	10	NUM
ihlr-28406	137	4	-	-	SYM
ihlr-28406	137	5	15	15	NUM
ihlr-28406	137	6	%	%	NOUN
ihlr-28406	137	7	of	of	ADP
ihlr-28406	137	8	patients	patient	NOUN
ihlr-28406	137	9	with	with	ADP
ihlr-28406	137	10	hypothyroidism	hypothyroidism	NOUN
ihlr-28406	137	11	display	display	VERB
ihlr-28406	137	12	significant	significant	ADJ
ihlr-28406	137	13	psychological	psychological	ADJ
ihlr-28406	137	14	impairment	impairment	NOUN
ihlr-28406	137	15	.	.	PUNCT
ihlr-28406	138	1	49	49	NUM
ihlr-28406	138	2	there	there	PRON
ihlr-28406	138	3	are	be	VERB
ihlr-28406	138	4	several	several	ADJ
ihlr-28406	138	5	types	type	NOUN
ihlr-28406	138	6	of	of	ADP
ihlr-28406	138	7	hypothyroidism	hypothyroidism	NOUN
ihlr-28406	138	8	.	.	PUNCT
ihlr-28406	139	1	for	for	ADP
ihlr-28406	139	2	example	example	NOUN
ihlr-28406	139	3	,	,	PUNCT
ihlr-28406	139	4	congenital	congenital	ADJ
ihlr-28406	139	5	hypothyroidism	hypothyroidism	NOUN
ihlr-28406	139	6	(	(	PUNCT
ihlr-28406	139	7	ch	ch	NOUN
ihlr-28406	139	8	)	)	PUNCT
ihlr-28406	139	9	is	be	AUX
ihlr-28406	139	10	defined	define	VERB
ihlr-28406	139	11	as	as	SCONJ
ihlr-28406	139	12	thyroid	thyroid	NOUN
ihlr-28406	139	13	hormone	hormone	NOUN
ihlr-28406	139	14	deficiency	deficiency	NOUN
ihlr-28406	139	15	present	present	ADJ
ihlr-28406	139	16	at	at	ADP
ihlr-28406	139	17	birth.50	birth.50	NOUN
ihlr-28406	139	18	ch	ch	PROPN
ihlr-28406	139	19	describes	describe	VERB
ihlr-28406	139	20	an	an	DET
ihlr-28406	139	21	organism	organism	NOUN
ihlr-28406	139	22	with	with	ADP
ihlr-28406	139	23	insufficient	insufficient	ADJ
ihlr-28406	139	24	thyroid	thyroid	NOUN
ihlr-28406	139	25	hormone	hormone	NOUN
ihlr-28406	139	26	during	during	ADP
ihlr-28406	139	27	early	early	ADJ
ihlr-28406	139	28	neonatal	neonatal	ADJ
ihlr-28406	139	29	development	development	NOUN
ihlr-28406	139	30	.	.	PUNCT
ihlr-28406	140	1	51	51	NUM
ihlr-28406	140	2	thyroid	thyroid	NOUN
ihlr-28406	140	3	hormone	hormone	NOUN
ihlr-28406	140	4	deficiency	deficiency	NOUN
ihlr-28406	140	5	at	at	ADP
ihlr-28406	140	6	birth	birth	NOUN
ihlr-28406	140	7	is	be	AUX
ihlr-28406	140	8	mostly	mostly	ADV
ihlr-28406	140	9	caused	cause	VERB
ihlr-28406	140	10	by	by	ADP
ihlr-28406	140	11	a	a	DET
ihlr-28406	140	12	problem	problem	NOUN
ihlr-28406	140	13	with	with	ADP
ihlr-28406	140	14	the	the	DET
ihlr-28406	140	15	gland	gland	NOUN
ihlr-28406	140	16	’s	’s	PART
ihlr-28406	140	17	physical	physical	ADJ
ihlr-28406	140	18	development	development	NOUN
ihlr-28406	140	19	or	or	CCONJ
ihlr-28406	140	20	impaired	impaired	ADJ
ihlr-28406	140	21	thyroid	thyroid	NOUN
ihlr-28406	140	22	hormone	hormone	NOUN
ihlr-28406	140	23	biosynthesis	biosynthesis	NOUN
ihlr-28406	140	24	.	.	PUNCT
ihlr-28406	141	1	52	52	NUM
ihlr-28406	141	2	a	a	DET
ihlr-28406	141	3	second	second	ADJ
ihlr-28406	141	4	example	example	NOUN
ihlr-28406	141	5	is	be	AUX
ihlr-28406	141	6	autoimmune	autoimmune	ADJ
ihlr-28406	141	7	hypothyroidism	hypothyroidism	NOUN
ihlr-28406	141	8	,	,	PUNCT
ihlr-28406	141	9	which	which	PRON
ihlr-28406	141	10	is	be	AUX
ihlr-28406	141	11	characterized	characterize	VERB
ihlr-28406	141	12	by	by	ADP
ihlr-28406	141	13	elevated	elevate	VERB
ihlr-28406	141	14	serum	serum	NOUN
ihlr-28406	141	15	tsh	tsh	NOUN
ihlr-28406	141	16	with	with	ADP
ihlr-28406	141	17	reduced	reduce	VERB
ihlr-28406	141	18	free	free	ADJ
ihlr-28406	141	19	t4	t4	PROPN
ihlr-28406	141	20	levels	level	NOUN
ihlr-28406	141	21	,	,	PUNCT
ihlr-28406	141	22	serum	serum	NOUN
ihlr-28406	141	23	antibodies	antibody	NOUN
ihlr-28406	141	24	against	against	ADP
ihlr-28406	141	25	thyroid	thyroid	NOUN
ihlr-28406	141	26	antigens	antigen	NOUN
ihlr-28406	141	27	,	,	PUNCT
ihlr-28406	141	28	and	and	CCONJ
ihlr-28406	141	29	reduced	reduce	VERB
ihlr-28406	141	30	echogenicity	echogenicity	NOUN
ihlr-28406	141	31	in	in	ADP
ihlr-28406	141	32	the	the	DET
ihlr-28406	141	33	thyroid	thyroid	NOUN
ihlr-28406	141	34	sonogram	sonogram	NOUN
ihlr-28406	141	35	.	.	PUNCT
ihlr-28406	142	1	53	53	NUM
ihlr-28406	142	2	in	in	ADP
ihlr-28406	142	3	fact	fact	NOUN
ihlr-28406	142	4	,	,	PUNCT
ihlr-28406	142	5	thyroid	thyroid	NOUN
ihlr-28406	142	6	autoimmunity	autoimmunity	NOUN
ihlr-28406	142	7	is	be	AUX
ihlr-28406	142	8	one	one	NUM
ihlr-28406	142	9	of	of	ADP
ihlr-28406	142	10	the	the	DET
ihlr-28406	142	11	most	most	ADV
ihlr-28406	142	12	common	common	ADJ
ihlr-28406	142	13	causes	cause	NOUN
ihlr-28406	142	14	of	of	ADP
ihlr-28406	142	15	hypothyroidism	hypothyroidism	NOUN
ihlr-28406	142	16	,	,	PUNCT
ihlr-28406	142	17	hashimoto	hashimoto	NOUN
ihlr-28406	142	18	’s	’s	PART
ihlr-28406	142	19	disease	disease	NOUN
ihlr-28406	142	20	.	.	PUNCT
ihlr-28406	143	1	54	54	NUM
ihlr-28406	143	2	hashimoto	hashimoto	NOUN
ihlr-28406	143	3	thyroiditis	thyroiditis	NOUN
ihlr-28406	143	4	is	be	AUX
ihlr-28406	143	5	also	also	ADV
ihlr-28406	143	6	impacted	impact	VERB
ihlr-28406	143	7	by	by	ADP
ihlr-28406	143	8	environmental	environmental	ADJ
ihlr-28406	143	9	factors	factor	NOUN
ihlr-28406	143	10	including	include	VERB
ihlr-28406	143	11	vitamin	vitamin	NOUN
ihlr-28406	143	12	d	d	NOUN
ihlr-28406	143	13	and	and	CCONJ
ihlr-28406	143	14	selenium	selenium	NOUN
ihlr-28406	143	15	deficiency	deficiency	NOUN
ihlr-28406	143	16	,	,	PUNCT
ihlr-28406	143	17	and	and	CCONJ
ihlr-28406	143	18	moderate	moderate	ADJ
ihlr-28406	143	19	alcohol	alcohol	NOUN
ihlr-28406	143	20	intake.55	intake.55	NOUN
ihlr-28406	143	21	hypothyroidism	hypothyroidism	NOUN
ihlr-28406	143	22	,	,	PUNCT
ihlr-28406	143	23	has	have	VERB
ihlr-28406	143	24	several	several	ADJ
ihlr-28406	143	25	causes	cause	NOUN
ihlr-28406	143	26	.	.	PUNCT
ihlr-28406	144	1	56	56	NUM
ihlr-28406	144	2	for	for	ADP
ihlr-28406	144	3	example	example	NOUN
ihlr-28406	144	4	,	,	PUNCT
ihlr-28406	144	5	the	the	DET
ihlr-28406	144	6	thyroid	thyroid	NOUN
ihlr-28406	144	7	must	must	AUX
ihlr-28406	144	8	have	have	VERB
ihlr-28406	144	9	iodine	iodine	NOUN
ihlr-28406	144	10	to	to	PART
ihlr-28406	144	11	make	make	VERB
ihlr-28406	144	12	thyroid	thyroid	NOUN
ihlr-28406	144	13	hormone	hormone	NOUN
ihlr-28406	144	14	.	.	PUNCT
ihlr-28406	145	1	57	57	NUM
ihlr-28406	145	2	too	too	ADV
ihlr-28406	145	3	much	much	ADJ
ihlr-28406	145	4	iodine	iodine	NOUN
ihlr-28406	145	5	may	may	AUX
ihlr-28406	145	6	also	also	ADV
ihlr-28406	145	7	cause	cause	VERB
ihlr-28406	145	8	and	and	CCONJ
ihlr-28406	145	9	worsen	worsen	VERB
ihlr-28406	145	10	hypothyroidism	hypothyroidism	NOUN
ihlr-28406	145	11	.	.	PUNCT
ihlr-28406	146	1	58	58	NUM
ihlr-28406	146	2	in	in	ADP
ihlr-28406	146	3	the	the	DET
ihlr-28406	146	4	western	western	ADJ
ihlr-28406	146	5	world	world	NOUN
ihlr-28406	146	6	,	,	PUNCT
ihlr-28406	146	7	hypothyroidism	hypothyroidism	NOUN
ihlr-28406	146	8	is	be	AUX
ihlr-28406	146	9	most	most	ADV
ihlr-28406	146	10	caused	cause	VERB
ihlr-28406	146	11	by	by	ADP
ihlr-28406	146	12	autoimmune	autoimmune	ADJ
ihlr-28406	146	13	chronic	chronic	ADJ
ihlr-28406	146	14	lymphocytic	lymphocytic	ADJ
ihlr-28406	146	15	thyroiditis	thyroiditis	NOUN
ihlr-28406	146	16	.	.	PUNCT
ihlr-28406	147	1	59	59	NUM
ihlr-28406	147	2	however	however	ADV
ihlr-28406	147	3	,	,	PUNCT
ihlr-28406	147	4	worldwide	worldwide	ADV
ihlr-28406	147	5	,	,	PUNCT
ihlr-28406	147	6	iodine	iodine	NOUN
ihlr-28406	147	7	deficiency	deficiency	NOUN
ihlr-28406	147	8	is	be	AUX
ihlr-28406	147	9	the	the	DET
ihlr-28406	147	10	most	most	ADV
ihlr-28406	147	11	common	common	ADJ
ihlr-28406	147	12	cause	cause	NOUN
ihlr-28406	147	13	for	for	ADP
ihlr-28406	147	14	hypothyroidism	hypothyroidism	NOUN
ihlr-28406	147	15	,	,	PUNCT
ihlr-28406	147	16	although	although	SCONJ
ihlr-28406	147	17	it	it	PRON
ihlr-28406	147	18	is	be	AUX
ihlr-28406	147	19	a	a	DET
ihlr-28406	147	20	rare	rare	ADJ
ihlr-28406	147	21	cause	cause	NOUN
ihlr-28406	147	22	in	in	ADP
ihlr-28406	147	23	the	the	DET
ihlr-28406	147	24	united	united	ADJ
ihlr-28406	147	25	states.60	states.60	PROPN
ihlr-28406	147	26	hypothyroid	hypothyroid	ADJ
ihlr-28406	147	27	symptoms	symptom	NOUN
ihlr-28406	147	28	include	include	VERB
ihlr-28406	147	29	anxiety	anxiety	NOUN
ihlr-28406	147	30	,	,	PUNCT
ihlr-28406	147	31	physical	physical	ADJ
ihlr-28406	147	32	or	or	CCONJ
ihlr-28406	147	33	muscular	muscular	ADJ
ihlr-28406	147	34	weakness	weakness	NOUN
ihlr-28406	147	35	,	,	PUNCT
ihlr-28406	147	36	—	—	PUNCT
ihlr-28406	147	37	—	—	PUNCT
ihlr-28406	147	38	—	—	PUNCT
ihlr-28406	147	39	—	—	PUNCT
ihlr-28406	147	40	—	—	PUNCT
ihlr-28406	147	41	—	—	PUNCT
ihlr-28406	147	42	—	—	PUNCT
ihlr-28406	147	43	—	—	PUNCT
ihlr-28406	147	44	—	—	PUNCT
ihlr-28406	147	45	—	—	PUNCT
ihlr-28406	147	46	—	—	PUNCT
ihlr-28406	147	47	—	—	PUNCT
ihlr-28406	147	48	—	—	PUNCT
ihlr-28406	147	49	—	—	PUNCT
ihlr-28406	147	50	—	—	PUNCT
ihlr-28406	147	51	—	—	PUNCT
ihlr-28406	147	52	—	—	PUNCT
ihlr-28406	147	53	—	—	PUNCT
ihlr-28406	147	54	—	—	PUNCT
ihlr-28406	147	55	—	—	PUNCT
ihlr-28406	147	56	—	—	PUNCT
ihlr-28406	147	57	—	—	PUNCT
ihlr-28406	147	58	—	—	PUNCT
ihlr-28406	147	59	—	—	PUNCT
ihlr-28406	147	60	—	—	PUNCT
ihlr-28406	147	61	—	—	PUNCT
ihlr-28406	147	62	—	—	PUNCT
ihlr-28406	147	63	—	—	PUNCT
ihlr-28406	147	64	—	—	PUNCT
ihlr-28406	147	65	46	46	NUM
ihlr-28406	147	66	.	.	PUNCT
ihlr-28406	148	1	i	i	PRON
ihlr-28406	148	2	d.	d.	PROPN
ihlr-28406	148	3	47	47	NUM
ihlr-28406	148	4	.	.	PUNCT
ihlr-28406	149	1	am	be	AUX
ihlr-28406	149	2	.	.	PUNCT
ihlr-28406	150	1	thyroid	thyroid	PROPN
ihlr-28406	150	2	ass’n	ass’n	NOUN
ihlr-28406	150	3	,	,	PUNCT
ihlr-28406	150	4	supra	supra	PROPN
ihlr-28406	150	5	note	note	NOUN
ihlr-28406	150	6	7	7	NUM
ihlr-28406	150	7	,	,	PUNCT
ihlr-28406	150	8	at	at	ADP
ihlr-28406	150	9	4	4	NUM
ihlr-28406	150	10	.	.	NOUN
ihlr-28406	150	11	48	48	NUM
ihlr-28406	150	12	.	.	PUNCT
ihlr-28406	151	1	i	i	PRON
ihlr-28406	151	2	d.	d.	PROPN
ihlr-28406	151	3	49	49	NUM
ihlr-28406	151	4	.	.	PUNCT
ihlr-28406	152	1	massolt	massolt	NOUN
ihlr-28406	152	2	,	,	PUNCT
ihlr-28406	152	3	supra	supra	NOUN
ihlr-28406	152	4	note	note	NOUN
ihlr-28406	152	5	6	6	NUM
ihlr-28406	152	6	,	,	PUNCT
ihlr-28406	152	7	at	at	ADP
ihlr-28406	152	8	9	9	NUM
ihlr-28406	152	9	.	.	NOUN
ihlr-28406	152	10	50	50	NUM
ihlr-28406	152	11	.	.	PUNCT
ihlr-28406	153	1	rastogi	rastogi	PROPN
ihlr-28406	153	2	&	&	CCONJ
ihlr-28406	153	3	lafranchi	lafranchi	PROPN
ihlr-28406	153	4	,	,	PUNCT
ihlr-28406	153	5	supra	supra	PROPN
ihlr-28406	153	6	note	note	PROPN
ihlr-28406	153	7	38	38	NUM
ihlr-28406	153	8	,	,	PUNCT
ihlr-28406	153	9	at	at	ADP
ihlr-28406	153	10	1	1	NUM
ihlr-28406	153	11	.	.	PUNCT
ihlr-28406	153	12	51	51	NUM
ihlr-28406	153	13	.	.	PUNCT
ihlr-28406	154	1	squire	squire	VERB
ihlr-28406	154	2	et	et	PROPN
ihlr-28406	154	3	al	al	PROPN
ihlr-28406	154	4	.	.	PROPN
ihlr-28406	154	5	,	,	PUNCT
ihlr-28406	154	6	supra	supra	PROPN
ihlr-28406	154	7	note	note	PROPN
ihlr-28406	154	8	8	8	NUM
ihlr-28406	154	9	,	,	PUNCT
ihlr-28406	154	10	at	at	ADP
ihlr-28406	154	11	912	912	NUM
ihlr-28406	154	12	.	.	PUNCT
ihlr-28406	155	1	52	52	NUM
ihlr-28406	155	2	.	.	PUNCT
ihlr-28406	156	1	rastogi	rastogi	PROPN
ihlr-28406	156	2	&	&	CCONJ
ihlr-28406	156	3	lafranchi	lafranchi	PROPN
ihlr-28406	156	4	,	,	PUNCT
ihlr-28406	156	5	supra	supra	PROPN
ihlr-28406	156	6	note	note	PROPN
ihlr-28406	156	7	38	38	NUM
ihlr-28406	156	8	,	,	PUNCT
ihlr-28406	156	9	at	at	ADP
ihlr-28406	156	10	1	1	NUM
ihlr-28406	156	11	(	(	PUNCT
ihlr-28406	156	12	“	"	PUNCT
ihlr-28406	156	13	in	in	ADP
ihlr-28406	156	14	iodine	iodine	NOUN
ihlr-28406	156	15	sufficient	sufficient	ADJ
ihlr-28406	156	16	countries	country	NOUN
ihlr-28406	156	17	,	,	PUNCT
ihlr-28406	156	18	85	85	NUM
ihlr-28406	156	19	%	%	NOUN
ihlr-28406	156	20	of	of	ADP
ihlr-28406	156	21	congenital	congenital	ADJ
ihlr-28406	156	22	hypothyroidism	hypothyroidism	NOUN
ihlr-28406	156	23	is	be	AUX
ihlr-28406	156	24	due	due	ADJ
ihlr-28406	156	25	to	to	PART
ihlr-28406	156	26	thyroid	thyroid	VERB
ihlr-28406	156	27	dysgenesis	dysgenesis	NOUN
ihlr-28406	156	28	.	.	PUNCT
ihlr-28406	156	29	”	"	PUNCT
ihlr-28406	156	30	)	)	PUNCT
ihlr-28406	156	31	.	.	PUNCT
ihlr-28406	157	1	53	53	NUM
ihlr-28406	157	2	.	.	X
ihlr-28406	157	3	massolt	massolt	NOUN
ihlr-28406	157	4	,	,	PUNCT
ihlr-28406	157	5	supra	supra	PROPN
ihlr-28406	157	6	note	note	NOUN
ihlr-28406	157	7	6	6	NUM
ihlr-28406	157	8	,	,	PUNCT
ihlr-28406	157	9	at	at	ADP
ihlr-28406	157	10	49	49	NUM
ihlr-28406	157	11	.	.	PUNCT
ihlr-28406	158	1	54	54	NUM
ihlr-28406	158	2	.	.	PUNCT
ihlr-28406	159	1	i	i	PRON
ihlr-28406	159	2	d.	d.	PROPN
ihlr-28406	159	3	at	at	ADP
ihlr-28406	159	4	12	12	NUM
ihlr-28406	159	5	(	(	PUNCT
ihlr-28406	159	6	“	"	PUNCT
ihlr-28406	159	7	it	it	PRON
ihlr-28406	159	8	is	be	AUX
ihlr-28406	159	9	the	the	DET
ihlr-28406	159	10	most	most	ADV
ihlr-28406	159	11	common	common	ADJ
ihlr-28406	159	12	organ	organ	NOUN
ihlr-28406	159	13	-	-	PUNCT
ihlr-28406	159	14	specific	specific	ADJ
ihlr-28406	159	15	autoimmune	autoimmune	ADJ
ihlr-28406	159	16	disorder	disorder	NOUN
ihlr-28406	159	17	with	with	ADP
ihlr-28406	159	18	an	an	DET
ihlr-28406	159	19	estimated	estimate	VERB
ihlr-28406	159	20	prevalence	prevalence	NOUN
ihlr-28406	159	21	of	of	ADP
ihlr-28406	159	22	2	2	NUM
ihlr-28406	159	23	%	%	NOUN
ihlr-28406	159	24	,	,	PUNCT
ihlr-28406	159	25	with	with	ADP
ihlr-28406	159	26	a	a	DET
ihlr-28406	159	27	higher	high	ADJ
ihlr-28406	159	28	prevalence	prevalence	NOUN
ihlr-28406	159	29	in	in	ADP
ihlr-28406	159	30	women	woman	NOUN
ihlr-28406	159	31	and	and	CCONJ
ihlr-28406	159	32	depending	depend	VERB
ihlr-28406	159	33	on	on	ADP
ihlr-28406	159	34	iodine	iodine	NOUN
ihlr-28406	159	35	intake	intake	NOUN
ihlr-28406	159	36	.	.	PUNCT
ihlr-28406	159	37	”	"	PUNCT
ihlr-28406	159	38	)	)	PUNCT
ihlr-28406	159	39	.	.	PUNCT
ihlr-28406	160	1	55	55	NUM
ihlr-28406	160	2	.	.	PUNCT
ihlr-28406	160	3	chaker	chaker	PROPN
ihlr-28406	160	4	et	et	PROPN
ihlr-28406	160	5	al	al	PROPN
ihlr-28406	160	6	.	.	PROPN
ihlr-28406	160	7	,	,	PUNCT
ihlr-28406	160	8	supra	supra	PROPN
ihlr-28406	160	9	note	note	VERB
ihlr-28406	160	10	45	45	NUM
ihlr-28406	160	11	,	,	PUNCT
ihlr-28406	160	12	at	at	ADP
ihlr-28406	160	13	2	2	NUM
ihlr-28406	160	14	.	.	PUNCT
ihlr-28406	161	1	56.’680	56.’680	PROPN
ihlr-28406	161	2	patent	patent	NOUN
ihlr-28406	161	3	.	.	PUNCT
ihlr-28406	162	1	57	57	NUM
ihlr-28406	162	2	.	.	PUNCT
ihlr-28406	162	3	am	be	AUX
ihlr-28406	162	4	.	.	PUNCT
ihlr-28406	163	1	thyroid	thyroid	PROPN
ihlr-28406	163	2	ass’n	ass’n	NOUN
ihlr-28406	163	3	,	,	PUNCT
ihlr-28406	163	4	supra	supra	PROPN
ihlr-28406	163	5	note	note	NOUN
ihlr-28406	163	6	7	7	NUM
ihlr-28406	163	7	,	,	PUNCT
ihlr-28406	163	8	at	at	ADP
ihlr-28406	163	9	8	8	NUM
ihlr-28406	163	10	.	.	PUNCT
ihlr-28406	163	11	58	58	NUM
ihlr-28406	163	12	.	.	PUNCT
ihlr-28406	164	1	i	i	PRON
ihlr-28406	164	2	d.	d.	PROPN
ihlr-28406	164	3	59	59	NUM
ihlr-28406	164	4	.	.	PUNCT
ihlr-28406	165	1	so	so	ADV
ihlr-28406	165	2	et	et	PROPN
ihlr-28406	165	3	al	al	PROPN
ihlr-28406	165	4	.	.	PROPN
ihlr-28406	165	5	,	,	PUNCT
ihlr-28406	165	6	supra	supra	PROPN
ihlr-28406	165	7	note	note	PROPN
ihlr-28406	165	8	26	26	NUM
ihlr-28406	165	9	,	,	PUNCT
ihlr-28406	165	10	at	at	ADP
ihlr-28406	165	11	556	556	NUM
ihlr-28406	165	12	(	(	PUNCT
ihlr-28406	165	13	“	"	PUNCT
ihlr-28406	165	14	a	a	DET
ihlr-28406	165	15	thyroid	thyroid	NOUN
ihlr-28406	165	16	peroxidase	peroxidase	NOUN
ihlr-28406	165	17	antibody	antibody	NOUN
ihlr-28406	165	18	assay	assay	VERB
ihlr-28406	165	19	is	be	AUX
ihlr-28406	165	20	the	the	DET
ihlr-28406	165	21	only	only	ADJ
ihlr-28406	165	22	test	test	NOUN
ihlr-28406	165	23	required	require	VERB
ihlr-28406	165	24	to	to	PART
ihlr-28406	165	25	confirm	confirm	VERB
ihlr-28406	165	26	the	the	DET
ihlr-28406	165	27	diagnosis	diagnosis	NOUN
ihlr-28406	165	28	of	of	ADP
ihlr-28406	165	29	autoimmune	autoimmune	ADJ
ihlr-28406	165	30	thyroiditis	thyroiditis	NOUN
ihlr-28406	165	31	.	.	PUNCT
ihlr-28406	165	32	”	"	PUNCT
ihlr-28406	165	33	)	)	PUNCT
ihlr-28406	165	34	.	.	PUNCT
ihlr-28406	166	1	60	60	NUM
ihlr-28406	166	2	.	.	PUNCT
ihlr-28406	166	3	am	be	AUX
ihlr-28406	166	4	.	.	PUNCT
ihlr-28406	167	1	thyroid	thyroid	PROPN
ihlr-28406	167	2	ass’n	ass’n	NOUN
ihlr-28406	167	3	,	,	PUNCT
ihlr-28406	167	4	supra	supra	PROPN
ihlr-28406	167	5	note	note	NOUN
ihlr-28406	167	6	7	7	NUM
ihlr-28406	167	7	at	at	ADP
ihlr-28406	167	8	8	8	NUM
ihlr-28406	167	9	.	.	PUNCT
ihlr-28406	168	1	indiana	indiana	PROPN
ihlr-28406	168	2	health	health	PROPN
ihlr-28406	168	3	law	law	PROPN
ihlr-28406	168	4	review	review	NOUN
ihlr-28406	168	5	[	[	X
ihlr-28406	168	6	vol	vol	NOUN
ihlr-28406	168	7	.	.	PUNCT
ihlr-28406	169	1	21:277	21:277	NOUN
ihlr-28406	169	2	284	284	NUM
ihlr-28406	169	3	heart	heart	NOUN
ihlr-28406	169	4	disease	disease	NOUN
ihlr-28406	169	5	,	,	PUNCT
ihlr-28406	169	6	constipation	constipation	NOUN
ihlr-28406	169	7	,	,	PUNCT
ihlr-28406	169	8	depression	depression	NOUN
ihlr-28406	169	9	,	,	PUNCT
ihlr-28406	169	10	and	and	CCONJ
ihlr-28406	169	11	weight	weight	NOUN
ihlr-28406	169	12	gain	gain	NOUN
ihlr-28406	169	13	.	.	PUNCT
ihlr-28406	170	1	61	61	NUM
ihlr-28406	170	2	further	far	ADV
ihlr-28406	170	3	,	,	PUNCT
ihlr-28406	170	4	many	many	ADJ
ihlr-28406	170	5	patients	patient	NOUN
ihlr-28406	170	6	report	report	VERB
ihlr-28406	170	7	ongoing	ongoing	ADJ
ihlr-28406	170	8	symptoms	symptom	NOUN
ihlr-28406	170	9	such	such	ADJ
ihlr-28406	170	10	as	as	ADP
ihlr-28406	170	11	muscle	muscle	NOUN
ihlr-28406	170	12	aching	aching	NOUN
ihlr-28406	170	13	and	and	CCONJ
ihlr-28406	170	14	tiredness	tiredness	NOUN
ihlr-28406	170	15	.	.	PUNCT
ihlr-28406	171	1	62	62	NUM
ihlr-28406	171	2	additionally	additionally	ADV
ihlr-28406	171	3	,	,	PUNCT
ihlr-28406	171	4	hypothyroidism	hypothyroidism	NOUN
ihlr-28406	171	5	is	be	AUX
ihlr-28406	171	6	more	more	ADV
ihlr-28406	171	7	common	common	ADJ
ihlr-28406	171	8	in	in	ADP
ihlr-28406	171	9	biological	biological	ADJ
ihlr-28406	171	10	females	female	NOUN
ihlr-28406	171	11	than	than	ADP
ihlr-28406	171	12	biological	biological	ADJ
ihlr-28406	171	13	males	male	NOUN
ihlr-28406	171	14	,	,	PUNCT
ihlr-28406	171	15	and	and	CCONJ
ihlr-28406	171	16	more	more	ADV
ihlr-28406	171	17	common	common	ADJ
ihlr-28406	171	18	in	in	ADP
ihlr-28406	171	19	the	the	DET
ihlr-28406	171	20	elderly	elderly	ADJ
ihlr-28406	171	21	than	than	ADP
ihlr-28406	171	22	young	young	ADJ
ihlr-28406	171	23	.	.	PUNCT
ihlr-28406	172	1	63	63	NUM
ihlr-28406	172	2	in	in	ADP
ihlr-28406	172	3	fact	fact	NOUN
ihlr-28406	172	4	,	,	PUNCT
ihlr-28406	172	5	most	most	ADJ
ihlr-28406	172	6	disease	disease	NOUN
ihlr-28406	172	7	related	relate	VERB
ihlr-28406	172	8	deficiencies	deficiency	NOUN
ihlr-28406	172	9	can	can	AUX
ihlr-28406	172	10	be	be	AUX
ihlr-28406	172	11	mitigated	mitigate	VERB
ihlr-28406	172	12	by	by	ADP
ihlr-28406	172	13	newborn	newborn	ADJ
ihlr-28406	172	14	infant	infant	NOUN
ihlr-28406	172	15	screening	screening	NOUN
ihlr-28406	172	16	and	and	CCONJ
ihlr-28406	172	17	thyroid	thyroid	VERB
ihlr-28406	172	18	hormone	hormone	NOUN
ihlr-28406	172	19	replacement	replacement	NOUN
ihlr-28406	172	20	.	.	PUNCT
ihlr-28406	173	1	64	64	NUM
ihlr-28406	173	2	still	still	ADV
ihlr-28406	173	3	,	,	PUNCT
ihlr-28406	173	4	a	a	DET
ihlr-28406	173	5	completely	completely	ADV
ihlr-28406	173	6	unsupported	unsupported	ADJ
ihlr-28406	173	7	,	,	PUNCT
ihlr-28406	173	8	yet	yet	CCONJ
ihlr-28406	173	9	pervasive	pervasive	ADJ
ihlr-28406	173	10	claim	claim	NOUN
ihlr-28406	173	11	in	in	ADP
ihlr-28406	173	12	modern	modern	ADJ
ihlr-28406	173	13	medicine	medicine	NOUN
ihlr-28406	173	14	is	be	AUX
ihlr-28406	173	15	hypothyroidism	hypothyroidism	NOUN
ihlr-28406	173	16	can	can	AUX
ihlr-28406	173	17	not	not	PART
ihlr-28406	173	18	be	be	AUX
ihlr-28406	173	19	cured	cure	VERB
ihlr-28406	173	20	.	.	PUNCT
ihlr-28406	174	1	65	65	NUM
ihlr-28406	175	1	but	but	CCONJ
ihlr-28406	175	2	,	,	PUNCT
ihlr-28406	175	3	the	the	DET
ihlr-28406	175	4	truth	truth	NOUN
ihlr-28406	175	5	is	be	AUX
ihlr-28406	175	6	whether	whether	SCONJ
ihlr-28406	175	7	we	we	PRON
ihlr-28406	175	8	think	think	VERB
ihlr-28406	175	9	we	we	PRON
ihlr-28406	175	10	can	can	AUX
ihlr-28406	175	11	or	or	CCONJ
ihlr-28406	175	12	we	we	PRON
ihlr-28406	175	13	think	think	VERB
ihlr-28406	175	14	we	we	PRON
ihlr-28406	175	15	ca	can	AUX
ihlr-28406	175	16	n’t	not	PART
ihlr-28406	175	17	;	;	PUNCT
ihlr-28406	175	18	we	we	PRON
ihlr-28406	175	19	’re	’re	VERB
ihlr-28406	175	20	probably	probably	ADV
ihlr-28406	175	21	right	right	ADJ
ihlr-28406	175	22	.	.	PUNCT
ihlr-28406	176	1	b.	b.	PROPN
ihlr-28406	176	2	hyperthyroidism	hyperthyroidism	NOUN
ihlr-28406	176	3	hyperthyroidism	hyperthyroidism	NOUN
ihlr-28406	176	4	describes	describe	VERB
ihlr-28406	176	5	an	an	DET
ihlr-28406	176	6	excess	excess	ADJ
ihlr-28406	176	7	thyroid	thyroid	NOUN
ihlr-28406	176	8	hormone	hormone	NOUN
ihlr-28406	176	9	causing	cause	VERB
ihlr-28406	176	10	the	the	DET
ihlr-28406	176	11	pituitary	pituitary	ADJ
ihlr-28406	176	12	gland	gland	NOUN
ihlr-28406	176	13	to	to	PART
ihlr-28406	176	14	produce	produce	VERB
ihlr-28406	176	15	less	less	ADJ
ihlr-28406	176	16	tsh	tsh	NOUN
ihlr-28406	176	17	.	.	PROPN
ihlr-28406	176	18	66	66	NUM
ihlr-28406	176	19	tsh	tsh	NOUN
ihlr-28406	176	20	measurement	measurement	NOUN
ihlr-28406	176	21	is	be	AUX
ihlr-28406	176	22	the	the	DET
ihlr-28406	176	23	base	base	NOUN
ihlr-28406	176	24	for	for	ADP
ihlr-28406	176	25	the	the	DET
ihlr-28406	176	26	hyperthyroidism	hyperthyroidism	NOUN
ihlr-28406	176	27	diagnosis	diagnosis	NOUN
ihlr-28406	176	28	.	.	PUNCT
ihlr-28406	177	1	67	67	NUM
ihlr-28406	177	2	in	in	ADP
ihlr-28406	177	3	short	short	ADJ
ihlr-28406	177	4	,	,	PUNCT
ihlr-28406	177	5	low	low	ADJ
ihlr-28406	177	6	tsh	tsh	NOUN
ihlr-28406	177	7	and	and	CCONJ
ihlr-28406	177	8	high	high	ADJ
ihlr-28406	177	9	t3	t3	PROPN
ihlr-28406	177	10	and	and	CCONJ
ihlr-28406	177	11	t4	t4	PROPN
ihlr-28406	177	12	corresponds	correspond	VERB
ihlr-28406	177	13	to	to	ADP
ihlr-28406	177	14	hyperthyroidism	hyperthyroidism	NOUN
ihlr-28406	177	15	.	.	PUNCT
ihlr-28406	178	1	68	68	NUM
ihlr-28406	178	2	thyroid	thyroid	NOUN
ihlr-28406	178	3	gland	gland	NOUN
ihlr-28406	178	4	overactivity	overactivity	NOUN
ihlr-28406	178	5	has	have	VERB
ihlr-28406	178	6	several	several	ADJ
ihlr-28406	178	7	causes	cause	NOUN
ihlr-28406	178	8	.	.	PUNCT
ihlr-28406	179	1	69	69	NUM
ihlr-28406	179	2	hyperthyroidism	hyperthyroidism	NOUN
ihlr-28406	179	3	symptoms	symptom	NOUN
ihlr-28406	179	4	include	include	VERB
ihlr-28406	179	5	sweating	sweating	NOUN
ihlr-28406	179	6	,	,	PUNCT
ihlr-28406	179	7	heart	heart	NOUN
ihlr-28406	179	8	palpitations	palpitation	NOUN
ihlr-28406	179	9	,	,	PUNCT
ihlr-28406	179	10	and	and	CCONJ
ihlr-28406	179	11	weight	weight	NOUN
ihlr-28406	179	12	loss.70	loss.70	ADJ
ihlr-28406	179	13	additional	additional	ADJ
ihlr-28406	179	14	symptoms	symptom	NOUN
ihlr-28406	179	15	include	include	VERB
ihlr-28406	179	16	increased	increase	VERB
ihlr-28406	179	17	body	body	NOUN
ihlr-28406	179	18	temperature	temperature	NOUN
ihlr-28406	179	19	,	,	PUNCT
ihlr-28406	179	20	decreased	decrease	VERB
ihlr-28406	179	21	body	body	NOUN
ihlr-28406	179	22	weight	weight	NOUN
ihlr-28406	179	23	,	,	PUNCT
ihlr-28406	179	24	decreased	decrease	VERB
ihlr-28406	179	25	serum	serum	NOUN
ihlr-28406	179	26	cholesterol	cholesterol	PROPN
ihlr-28406	179	27	,	,	PUNCT
ihlr-28406	179	28	increased	increase	VERB
ihlr-28406	179	29	stroke	stroke	NOUN
ihlr-28406	179	30	volume	volume	NOUN
ihlr-28406	179	31	,	,	PUNCT
ihlr-28406	179	32	and	and	CCONJ
ihlr-28406	179	33	arrhythmia	arrhythmia	NOUN
ihlr-28406	179	34	.	.	PUNCT
ihlr-28406	180	1	71	71	NUM
ihlr-28406	180	2	excessive	excessive	ADJ
ihlr-28406	180	3	thyroid	thyroid	NOUN
ihlr-28406	180	4	hormone	hormone	NOUN
ihlr-28406	180	5	,	,	PUNCT
ihlr-28406	180	6	can	can	AUX
ihlr-28406	180	7	also	also	ADV
ihlr-28406	180	8	result	result	VERB
ihlr-28406	180	9	in	in	ADP
ihlr-28406	180	10	symptoms	symptom	NOUN
ihlr-28406	180	11	such	such	ADJ
ihlr-28406	180	12	as	as	ADP
ihlr-28406	180	13	tremor	tremor	NOUN
ihlr-28406	180	14	,	,	PUNCT
ihlr-28406	180	15	nervousness	nervousness	NOUN
ihlr-28406	180	16	,	,	PUNCT
ihlr-28406	180	17	insomnia	insomnia	NOUN
ihlr-28406	180	18	,	,	PUNCT
ihlr-28406	180	19	and	and	CCONJ
ihlr-28406	180	20	impairments	impairment	NOUN
ihlr-28406	180	21	in	in	ADP
ihlr-28406	180	22	memory	memory	NOUN
ihlr-28406	180	23	and	and	CCONJ
ihlr-28406	180	24	concentration.72	concentration.72	NOUN
ihlr-28406	180	25	hyperthyroidism	hyperthyroidism	NOUN
ihlr-28406	180	26	is	be	AUX
ihlr-28406	180	27	characterized	characterize	VERB
ihlr-28406	180	28	by	by	ADP
ihlr-28406	180	29	excessive	excessive	ADJ
ihlr-28406	180	30	secretion	secretion	NOUN
ihlr-28406	180	31	of	of	ADP
ihlr-28406	180	32	thyroid	thyroid	NOUN
ihlr-28406	180	33	hormones	hormone	NOUN
ihlr-28406	180	34	;	;	PUNCT
ihlr-28406	180	35	the	the	DET
ihlr-28406	180	36	most	most	ADV
ihlr-28406	180	37	common	common	ADJ
ihlr-28406	180	38	cause	cause	NOUN
ihlr-28406	180	39	is	be	AUX
ihlr-28406	180	40	the	the	DET
ihlr-28406	180	41	autoimmune	autoimmune	ADJ
ihlr-28406	180	42	disorder	disorder	NOUN
ihlr-28406	180	43	graves	grave	NOUN
ihlr-28406	180	44	’	'	PUNCT
ihlr-28406	180	45	disease	disease	NOUN
ihlr-28406	180	46	.	.	PUNCT
ihlr-28406	181	1	73	73	NUM
ihlr-28406	181	2	graves	grave	NOUN
ihlr-28406	181	3	’	’	PART
ihlr-28406	181	4	hyperthyroidism	hyperthyroidism	NOUN
ihlr-28406	181	5	is	be	AUX
ihlr-28406	181	6	a	a	DET
ihlr-28406	181	7	hypermetabolic	hypermetabolic	ADJ
ihlr-28406	181	8	state	state	NOUN
ihlr-28406	181	9	,	,	PUNCT
ihlr-28406	181	10	affecting	affect	VERB
ihlr-28406	181	11	virtually	virtually	ADV
ihlr-28406	181	12	every	every	PRON
ihlr-28406	181	13	tissue	tissue	NOUN
ihlr-28406	181	14	and	and	CCONJ
ihlr-28406	181	15	cell	cell	NOUN
ihlr-28406	181	16	in	in	ADP
ihlr-28406	181	17	the	the	DET
ihlr-28406	181	18	body	body	NOUN
ihlr-28406	181	19	and	and	CCONJ
ihlr-28406	181	20	leads	lead	VERB
ihlr-28406	181	21	to	to	ADP
ihlr-28406	181	22	cardiovascular	cardiovascular	ADJ
ihlr-28406	181	23	dysfunction	dysfunction	NOUN
ihlr-28406	181	24	and	and	CCONJ
ihlr-28406	181	25	death	death	NOUN
ihlr-28406	181	26	.	.	PUNCT
ihlr-28406	182	1	74	74	NUM
ihlr-28406	182	2	graves	grave	NOUN
ihlr-28406	182	3	’	’	PART
ihlr-28406	182	4	hyperthyroidism	hyperthyroidism	NOUN
ihlr-28406	182	5	is	be	AUX
ihlr-28406	182	6	treated	treat	VERB
ihlr-28406	182	7	by	by	ADP
ihlr-28406	182	8	surgical	surgical	ADJ
ihlr-28406	182	9	resection	resection	NOUN
ihlr-28406	182	10	,	,	PUNCT
ihlr-28406	182	11	75	75	NUM
ihlr-28406	182	12	therapeutic	therapeutic	ADJ
ihlr-28406	182	13	—	—	PUNCT
ihlr-28406	182	14	—	—	PUNCT
ihlr-28406	182	15	—	—	PUNCT
ihlr-28406	182	16	—	—	PUNCT
ihlr-28406	182	17	—	—	PUNCT
ihlr-28406	182	18	—	—	PUNCT
ihlr-28406	182	19	—	—	PUNCT
ihlr-28406	182	20	—	—	PUNCT
ihlr-28406	182	21	—	—	PUNCT
ihlr-28406	182	22	—	—	PUNCT
ihlr-28406	182	23	—	—	PUNCT
ihlr-28406	182	24	—	—	PUNCT
ihlr-28406	182	25	—	—	PUNCT
ihlr-28406	182	26	—	—	PUNCT
ihlr-28406	182	27	—	—	PUNCT
ihlr-28406	182	28	—	—	PUNCT
ihlr-28406	182	29	—	—	PUNCT
ihlr-28406	182	30	—	—	PUNCT
ihlr-28406	182	31	—	—	PUNCT
ihlr-28406	182	32	—	—	PUNCT
ihlr-28406	182	33	—	—	PUNCT
ihlr-28406	182	34	—	—	PUNCT
ihlr-28406	182	35	—	—	PUNCT
ihlr-28406	182	36	—	—	PUNCT
ihlr-28406	182	37	—	—	PUNCT
ihlr-28406	182	38	—	—	PUNCT
ihlr-28406	182	39	—	—	PUNCT
ihlr-28406	182	40	—	—	PUNCT
ihlr-28406	182	41	—	—	PUNCT
ihlr-28406	182	42	61	61	NUM
ihlr-28406	182	43	.	.	X
ihlr-28406	182	44	massolt	massolt	NOUN
ihlr-28406	182	45	,	,	PUNCT
ihlr-28406	182	46	supra	supra	PROPN
ihlr-28406	182	47	note	note	NOUN
ihlr-28406	182	48	6	6	NUM
ihlr-28406	182	49	,	,	PUNCT
ihlr-28406	182	50	at	at	ADP
ihlr-28406	182	51	123	123	NUM
ihlr-28406	182	52	.	.	PUNCT
ihlr-28406	183	1	62	62	NUM
ihlr-28406	183	2	.	.	PUNCT
ihlr-28406	184	1	i	i	PRON
ihlr-28406	184	2	d.	d.	PROPN
ihlr-28406	184	3	at	at	ADP
ihlr-28406	184	4	9	9	NUM
ihlr-28406	184	5	.	.	NUM
ihlr-28406	184	6	63	63	NUM
ihlr-28406	184	7	.	.	PUNCT
ihlr-28406	185	1	so	so	ADV
ihlr-28406	185	2	et	et	PROPN
ihlr-28406	185	3	al	al	PROPN
ihlr-28406	185	4	.	.	PROPN
ihlr-28406	185	5	,	,	PUNCT
ihlr-28406	185	6	supra	supra	PROPN
ihlr-28406	185	7	note	note	PROPN
ihlr-28406	185	8	26	26	NUM
ihlr-28406	185	9	,	,	PUNCT
ihlr-28406	185	10	at	at	ADP
ihlr-28406	185	11	556	556	NUM
ihlr-28406	185	12	(	(	PUNCT
ihlr-28406	185	13	“	"	PUNCT
ihlr-28406	185	14	unless	unless	SCONJ
ihlr-28406	185	15	contraindicated	contraindicate	VERB
ihlr-28406	185	16	,	,	PUNCT
ihlr-28406	185	17	iodine	iodine	NOUN
ihlr-28406	185	18	supplementation	supplementation	NOUN
ihlr-28406	185	19	should	should	AUX
ihlr-28406	185	20	be	be	AUX
ihlr-28406	185	21	prescribed	prescribe	VERB
ihlr-28406	185	22	routinely	routinely	ADV
ihlr-28406	185	23	in	in	ADP
ihlr-28406	185	24	women	woman	NOUN
ihlr-28406	185	25	planning	plan	VERB
ihlr-28406	185	26	a	a	DET
ihlr-28406	185	27	pregnancy	pregnancy	NOUN
ihlr-28406	185	28	.	.	PUNCT
ihlr-28406	185	29	”	"	PUNCT
ihlr-28406	185	30	)	)	PUNCT
ihlr-28406	185	31	.	.	PUNCT
ihlr-28406	186	1	64	64	NUM
ihlr-28406	186	2	.	.	PUNCT
ihlr-28406	187	1	i	i	PRON
ihlr-28406	187	2	d.	d.	PROPN
ihlr-28406	187	3	(	(	PUNCT
ihlr-28406	187	4	“	"	PUNCT
ihlr-28406	187	5	the	the	DET
ihlr-28406	187	6	initial	initial	ADJ
ihlr-28406	187	7	screening	screening	NOUN
ihlr-28406	187	8	for	for	ADP
ihlr-28406	187	9	suspected	suspect	VERB
ihlr-28406	187	10	hypothyroidism	hypothyroidism	NOUN
ihlr-28406	187	11	is	be	AUX
ihlr-28406	187	12	thyroid	thyroid	NOUN
ihlr-28406	187	13	stimulating	stimulate	VERB
ihlr-28406	187	14	hormone	hormone	NOUN
ihlr-28406	187	15	.	.	PUNCT
ihlr-28406	187	16	”	"	PUNCT
ihlr-28406	187	17	)	)	PUNCT
ihlr-28406	187	18	.	.	PUNCT
ihlr-28406	188	1	65	65	NUM
ihlr-28406	188	2	.	.	PUNCT
ihlr-28406	188	3	am	be	AUX
ihlr-28406	188	4	.	.	PUNCT
ihlr-28406	189	1	thyroid	thyroid	PROPN
ihlr-28406	189	2	ass’n	ass’n	NOUN
ihlr-28406	189	3	,	,	PUNCT
ihlr-28406	189	4	supra	supra	PROPN
ihlr-28406	189	5	note	note	NOUN
ihlr-28406	189	6	7	7	NUM
ihlr-28406	189	7	,	,	PUNCT
ihlr-28406	189	8	at	at	ADP
ihlr-28406	189	9	12	12	NUM
ihlr-28406	189	10	.	.	PUNCT
ihlr-28406	189	11	66	66	NUM
ihlr-28406	189	12	.	.	PUNCT
ihlr-28406	190	1	heuck	heuck	VERB
ihlr-28406	190	2	et	et	PROPN
ihlr-28406	190	3	al	al	PROPN
ihlr-28406	190	4	.	.	PROPN
ihlr-28406	190	5	,	,	PUNCT
ihlr-28406	190	6	supra	supra	PROPN
ihlr-28406	190	7	note	note	NOUN
ihlr-28406	190	8	3	3	NUM
ihlr-28406	190	9	,	,	PUNCT
ihlr-28406	190	10	at	at	ADP
ihlr-28406	190	11	5	5	NUM
ihlr-28406	190	12	.	.	SYM
ihlr-28406	190	13	67	67	NUM
ihlr-28406	190	14	.	.	PUNCT
ihlr-28406	191	1	i	i	PRON
ihlr-28406	191	2	d.	d.	PROPN
ihlr-28406	191	3	68	68	NUM
ihlr-28406	191	4	.	.	PUNCT
ihlr-28406	192	1	‘	'	PUNCT
ihlr-28406	192	2	680	680	NUM
ihlr-28406	192	3	patent	patent	NOUN
ihlr-28406	192	4	.	.	PUNCT
ihlr-28406	193	1	69	69	NUM
ihlr-28406	193	2	.	.	PUNCT
ihlr-28406	194	1	i	i	PRON
ihlr-28406	194	2	d.	d.	PROPN
ihlr-28406	194	3	70	70	NUM
ihlr-28406	194	4	.	.	PUNCT
ihlr-28406	194	5	massolt	massolt	NOUN
ihlr-28406	194	6	,	,	PUNCT
ihlr-28406	194	7	supra	supra	PROPN
ihlr-28406	194	8	note	note	NOUN
ihlr-28406	194	9	6	6	NUM
ihlr-28406	194	10	,	,	PUNCT
ihlr-28406	194	11	at	at	ADP
ihlr-28406	194	12	9	9	NUM
ihlr-28406	194	13	.	.	NOUN
ihlr-28406	194	14	71	71	NUM
ihlr-28406	194	15	.	.	PUNCT
ihlr-28406	194	16	thyroid	thyroid	NOUN
ihlr-28406	194	17	hormone	hormone	NOUN
ihlr-28406	194	18	receptor	receptor	NOUN
ihlr-28406	194	19	ligand	ligand	NOUN
ihlr-28406	194	20	,	,	PUNCT
ihlr-28406	194	21	medicinal	medicinal	ADJ
ihlr-28406	194	22	compositions	composition	NOUN
ihlr-28406	194	23	containing	contain	VERB
ihlr-28406	194	24	the	the	DET
ihlr-28406	194	25	same	same	ADJ
ihlr-28406	194	26	&	&	CCONJ
ihlr-28406	194	27	use	use	NOUN
ihlr-28406	194	28	thereof	thereof	ADV
ihlr-28406	194	29	,	,	PUNCT
ihlr-28406	194	30	u.s	u.s	PROPN
ihlr-28406	194	31	.	.	PROPN
ihlr-28406	194	32	patent	patent	NOUN
ihlr-28406	194	33	no	no	PROPN
ihlr-28406	194	34	.	.	PUNCT
ihlr-28406	195	1	7,230,031	7,230,031	NUM
ihlr-28406	195	2	(	(	PUNCT
ihlr-28406	195	3	issued	issue	VERB
ihlr-28406	195	4	june	june	PROPN
ihlr-28406	195	5	12	12	NUM
ihlr-28406	195	6	,	,	PUNCT
ihlr-28406	195	7	2007	2007	NUM
ihlr-28406	195	8	)	)	PUNCT
ihlr-28406	195	9	.	.	PUNCT
ihlr-28406	196	1	72	72	NUM
ihlr-28406	196	2	.	.	PUNCT
ihlr-28406	197	1	squire	squire	PROPN
ihlr-28406	197	2	et	et	PROPN
ihlr-28406	197	3	al	al	PROPN
ihlr-28406	197	4	.	.	PROPN
ihlr-28406	197	5	,	,	PUNCT
ihlr-28406	197	6	supra	supra	PROPN
ihlr-28406	197	7	note	note	PROPN
ihlr-28406	197	8	8	8	NUM
ihlr-28406	197	9	,	,	PUNCT
ihlr-28406	197	10	at	at	ADP
ihlr-28406	197	11	912	912	NUM
ihlr-28406	197	12	.	.	PUNCT
ihlr-28406	198	1	73	73	NUM
ihlr-28406	198	2	.	.	PUNCT
ihlr-28406	199	1	inverse	inverse	NOUN
ihlr-28406	199	2	agonists	agonist	NOUN
ihlr-28406	199	3	&	&	CCONJ
ihlr-28406	199	4	neutral	neutral	ADJ
ihlr-28406	199	5	antagonists	antagonist	NOUN
ihlr-28406	199	6	for	for	ADP
ihlr-28406	199	7	the	the	DET
ihlr-28406	199	8	tsh	tsh	NOUN
ihlr-28406	199	9	receptor	receptor	NOUN
ihlr-28406	199	10	,	,	PUNCT
ihlr-28406	199	11	u.s	u.s	PROPN
ihlr-28406	199	12	.	.	PROPN
ihlr-28406	199	13	patent	patent	NOUN
ihlr-28406	199	14	no	no	PROPN
ihlr-28406	199	15	.	.	PROPN
ihlr-28406	199	16	9,206,154	9,206,154	NUM
ihlr-28406	199	17	(	(	PUNCT
ihlr-28406	199	18	issued	issue	VERB
ihlr-28406	199	19	dec	dec	PROPN
ihlr-28406	199	20	.	.	PROPN
ihlr-28406	199	21	8	8	NUM
ihlr-28406	199	22	,	,	PUNCT
ihlr-28406	199	23	2015	2015	NUM
ihlr-28406	199	24	)	)	PUNCT
ihlr-28406	199	25	.	.	PUNCT
ihlr-28406	200	1	74	74	NUM
ihlr-28406	200	2	.	.	PUNCT
ihlr-28406	201	1	i	i	PRON
ihlr-28406	201	2	d.	d.	PROPN
ihlr-28406	201	3	(	(	PUNCT
ihlr-28406	201	4	graves	grave	NOUN
ihlr-28406	201	5	’	’	PART
ihlr-28406	201	6	hyperthyroid	hyperthyroid	NOUN
ihlr-28406	201	7	patients	patient	NOUN
ihlr-28406	201	8	as	as	SCONJ
ihlr-28406	201	9	diagnosed	diagnose	VERB
ihlr-28406	201	10	by	by	ADP
ihlr-28406	201	11	computerized	computerized	ADJ
ihlr-28406	201	12	tomographic	tomographic	ADJ
ihlr-28406	201	13	scan	scan	NOUN
ihlr-28406	201	14	)	)	PUNCT
ihlr-28406	201	15	.	.	PUNCT
ihlr-28406	202	1	75	75	NUM
ihlr-28406	202	2	.	.	PUNCT
ihlr-28406	202	3	am	be	AUX
ihlr-28406	202	4	.	.	PUNCT
ihlr-28406	203	1	thyroid	thyroid	PROPN
ihlr-28406	203	2	ass’n	ass’n	NOUN
ihlr-28406	203	3	,	,	PUNCT
ihlr-28406	203	4	supra	supra	PROPN
ihlr-28406	203	5	note	note	NOUN
ihlr-28406	203	6	7	7	NUM
ihlr-28406	203	7	,	,	PUNCT
ihlr-28406	203	8	at	at	ADP
ihlr-28406	203	9	7	7	NUM
ihlr-28406	203	10	(	(	PUNCT
ihlr-28406	203	11	“	"	PUNCT
ihlr-28406	203	12	some	some	DET
ihlr-28406	203	13	people	people	NOUN
ihlr-28406	203	14	with	with	ADP
ihlr-28406	203	15	thyroid	thyroid	NOUN
ihlr-28406	203	16	nodules	nodule	NOUN
ihlr-28406	203	17	,	,	PUNCT
ihlr-28406	203	18	thyroid	thyroid	NOUN
ihlr-28406	203	19	cancer	cancer	NOUN
ihlr-28406	203	20	,	,	PUNCT
ihlr-28406	203	21	or	or	CCONJ
ihlr-28406	203	22	graves	grave	NOUN
ihlr-28406	203	23	’	'	PUNCT
ihlr-28406	203	24	disease	disease	NOUN
ihlr-28406	203	25	need	need	VERB
ihlr-28406	203	26	to	to	PART
ihlr-28406	203	27	have	have	VERB
ihlr-28406	203	28	part	part	NOUN
ihlr-28406	203	29	or	or	CCONJ
ihlr-28406	203	30	the	the	DET
ihlr-28406	203	31	entire	entire	ADJ
ihlr-28406	203	32	thyroid	thyroid	NOUN
ihlr-28406	203	33	removed	remove	VERB
ihlr-28406	203	34	.	.	PUNCT
ihlr-28406	203	35	”	"	PUNCT
ihlr-28406	203	36	)	)	PUNCT
ihlr-28406	203	37	.	.	PUNCT
ihlr-28406	204	1	2024	2024	NUM
ihlr-28406	204	2	]	]	PUNCT
ihlr-28406	204	3	inventions	invention	NOUN
ihlr-28406	204	4	and	and	CCONJ
ihlr-28406	204	5	patents	patent	NOUN
ihlr-28406	204	6	for	for	ADP
ihlr-28406	204	7	treating	treat	VERB
ihlr-28406	204	8	285	285	NUM
ihlr-28406	204	9	thyroid	thyroid	NOUN
ihlr-28406	204	10	disease	disease	NOUN
ihlr-28406	204	11	doses	dose	NOUN
ihlr-28406	204	12	of	of	ADP
ihlr-28406	204	13	radioactive	radioactive	ADJ
ihlr-28406	204	14	iodine	iodine	NOUN
ihlr-28406	204	15	,	,	PUNCT
ihlr-28406	204	16	or	or	CCONJ
ihlr-28406	204	17	pharmacologically	pharmacologically	ADV
ihlr-28406	204	18	.	.	PUNCT
ihlr-28406	205	1	76	76	NUM
ihlr-28406	205	2	however	however	ADV
ihlr-28406	205	3	,	,	PUNCT
ihlr-28406	205	4	each	each	PRON
ihlr-28406	205	5	of	of	ADP
ihlr-28406	205	6	these	these	DET
ihlr-28406	205	7	treatment	treatment	NOUN
ihlr-28406	205	8	modalities	modality	NOUN
ihlr-28406	205	9	has	have	VERB
ihlr-28406	205	10	side	side	ADJ
ihlr-28406	205	11	effects	effect	NOUN
ihlr-28406	205	12	associated	associate	VERB
ihlr-28406	205	13	with	with	ADP
ihlr-28406	205	14	it	it	PRON
ihlr-28406	205	15	.	.	PUNCT
ihlr-28406	206	1	77	77	NUM
ihlr-28406	206	2	often	often	ADV
ihlr-28406	206	3	,	,	PUNCT
ihlr-28406	206	4	both	both	CCONJ
ihlr-28406	206	5	hypothyroidism	hypothyroidism	NOUN
ihlr-28406	206	6	and	and	CCONJ
ihlr-28406	206	7	hyperthyroidism	hyperthyroidism	NOUN
ihlr-28406	206	8	are	be	AUX
ihlr-28406	206	9	treatable	treatable	ADJ
ihlr-28406	206	10	with	with	ADP
ihlr-28406	206	11	lifelong	lifelong	ADJ
ihlr-28406	206	12	synthetic	synthetic	ADJ
ihlr-28406	206	13	thyroid	thyroid	NOUN
ihlr-28406	206	14	hormone	hormone	NOUN
ihlr-28406	206	15	replacement	replacement	NOUN
ihlr-28406	206	16	.	.	PUNCT
ihlr-28406	207	1	78	78	NUM
ihlr-28406	207	2	part	part	NOUN
ihlr-28406	207	3	ii	ii	PROPN
ihlr-28406	207	4	explores	explore	NOUN
ihlr-28406	207	5	thyroid	thyroid	VERB
ihlr-28406	207	6	disease	disease	NOUN
ihlr-28406	207	7	through	through	ADP
ihlr-28406	207	8	the	the	DET
ihlr-28406	207	9	patent	patent	NOUN
ihlr-28406	207	10	system	system	NOUN
ihlr-28406	207	11	and	and	CCONJ
ihlr-28406	207	12	the	the	DET
ihlr-28406	207	13	development	development	NOUN
ihlr-28406	207	14	of	of	ADP
ihlr-28406	207	15	legal	legal	ADJ
ihlr-28406	207	16	claims	claim	NOUN
ihlr-28406	207	17	to	to	ADP
ihlr-28406	207	18	new	new	ADJ
ihlr-28406	207	19	inventions	invention	NOUN
ihlr-28406	207	20	for	for	ADP
ihlr-28406	207	21	treating	treat	VERB
ihlr-28406	207	22	thyroid	thyroid	NOUN
ihlr-28406	207	23	disease	disease	NOUN
ihlr-28406	207	24	.	.	PUNCT
ihlr-28406	208	1	c.	c.	NOUN
ihlr-28406	208	2	diagnostics	diagnostic	NOUN
ihlr-28406	208	3	diagnostics	diagnostic	NOUN
ihlr-28406	208	4	refers	refer	VERB
ihlr-28406	208	5	to	to	ADP
ihlr-28406	208	6	the	the	DET
ihlr-28406	208	7	process	process	NOUN
ihlr-28406	208	8	by	by	SCONJ
ihlr-28406	208	9	which	which	DET
ihlr-28406	208	10	disease	disease	NOUN
ihlr-28406	208	11	is	be	AUX
ihlr-28406	208	12	identified	identify	VERB
ihlr-28406	208	13	.	.	PUNCT
ihlr-28406	209	1	for	for	ADP
ihlr-28406	209	2	patients	patient	NOUN
ihlr-28406	209	3	,	,	PUNCT
ihlr-28406	209	4	diagnosis	diagnosis	NOUN
ihlr-28406	209	5	of	of	ADP
ihlr-28406	209	6	thyroid	thyroid	NOUN
ihlr-28406	209	7	disease	disease	NOUN
ihlr-28406	209	8	is	be	AUX
ihlr-28406	209	9	often	often	ADV
ihlr-28406	209	10	conducted	conduct	VERB
ihlr-28406	209	11	through	through	ADP
ihlr-28406	209	12	a	a	DET
ihlr-28406	209	13	combination	combination	NOUN
ihlr-28406	209	14	of	of	ADP
ihlr-28406	209	15	patient	patient	ADJ
ihlr-28406	209	16	symptoms	symptom	NOUN
ihlr-28406	209	17	and	and	CCONJ
ihlr-28406	209	18	biochemical	biochemical	ADJ
ihlr-28406	209	19	testing	testing	NOUN
ihlr-28406	209	20	of	of	ADP
ihlr-28406	209	21	thyroid	thyroid	NOUN
ihlr-28406	209	22	function	function	NOUN
ihlr-28406	209	23	.	.	PUNCT
ihlr-28406	210	1	table	table	NOUN
ihlr-28406	210	2	1	1	NUM
ihlr-28406	210	3	there	there	PRON
ihlr-28406	210	4	are	be	VERB
ihlr-28406	210	5	two	two	NUM
ihlr-28406	210	6	primary	primary	ADJ
ihlr-28406	210	7	immunoassays	immunoassay	NOUN
ihlr-28406	210	8	used	use	VERB
ihlr-28406	210	9	to	to	PART
ihlr-28406	210	10	diagnose	diagnose	VERB
ihlr-28406	210	11	thyroid	thyroid	NOUN
ihlr-28406	210	12	dysfunction	dysfunction	NOUN
ihlr-28406	210	13	.	.	PUNCT
ihlr-28406	211	1	first	first	ADV
ihlr-28406	211	2	,	,	PUNCT
ihlr-28406	211	3	tsh	tsh	NOUN
ihlr-28406	211	4	levels	level	NOUN
ihlr-28406	211	5	are	be	AUX
ihlr-28406	211	6	measured	measure	VERB
ihlr-28406	211	7	.	.	PUNCT
ihlr-28406	212	1	if	if	SCONJ
ihlr-28406	212	2	levels	level	NOUN
ihlr-28406	212	3	do	do	AUX
ihlr-28406	212	4	not	not	PART
ihlr-28406	212	5	fall	fall	VERB
ihlr-28406	212	6	within	within	ADP
ihlr-28406	212	7	normal	normal	ADJ
ihlr-28406	212	8	range	range	NOUN
ihlr-28406	212	9	,	,	PUNCT
ihlr-28406	212	10	circulating	circulate	VERB
ihlr-28406	212	11	free	free	ADJ
ihlr-28406	212	12	forms	form	NOUN
ihlr-28406	212	13	of	of	ADP
ihlr-28406	212	14	t3	t3	PROPN
ihlr-28406	212	15	and	and	CCONJ
ihlr-28406	212	16	t4	t4	PROPN
ihlr-28406	212	17	in	in	ADP
ihlr-28406	212	18	patient	patient	ADJ
ihlr-28406	212	19	blood	blood	NOUN
ihlr-28406	212	20	are	be	AUX
ihlr-28406	212	21	measured	measure	VERB
ihlr-28406	212	22	.	.	PUNCT
ihlr-28406	213	1	tpoab	tpoab	PROPN
ihlr-28406	213	2	or	or	CCONJ
ihlr-28406	213	3	anti	anti	ADJ
ihlr-28406	213	4	-	-	ADJ
ihlr-28406	213	5	thyroglobulin	thyroglobulin	ADJ
ihlr-28406	213	6	antibodies	antibody	NOUN
ihlr-28406	213	7	are	be	AUX
ihlr-28406	213	8	also	also	ADV
ihlr-28406	213	9	markers	marker	NOUN
ihlr-28406	213	10	used	use	VERB
ihlr-28406	213	11	to	to	PART
ihlr-28406	213	12	detect	detect	VERB
ihlr-28406	213	13	thyroid	thyroid	NOUN
ihlr-28406	213	14	autoimmunity.79	autoimmunity.79	NOUN
ihlr-28406	213	15	table	table	NOUN
ihlr-28406	213	16	2	2	NUM
ihlr-28406	213	17	80	80	NUM
ihlr-28406	213	18	depending	depend	VERB
ihlr-28406	213	19	on	on	ADP
ihlr-28406	213	20	abnormalities	abnormality	NOUN
ihlr-28406	213	21	and	and	CCONJ
ihlr-28406	213	22	other	other	ADJ
ihlr-28406	213	23	symptoms	symptom	NOUN
ihlr-28406	213	24	,	,	PUNCT
ihlr-28406	213	25	patients	patient	NOUN
ihlr-28406	213	26	may	may	AUX
ihlr-28406	213	27	be	be	AUX
ihlr-28406	213	28	diagnosed	diagnose	VERB
ihlr-28406	213	29	with	with	ADP
ihlr-28406	213	30	a	a	DET
ihlr-28406	213	31	variety	variety	NOUN
ihlr-28406	213	32	of	of	ADP
ihlr-28406	213	33	thyroid	thyroid	NOUN
ihlr-28406	213	34	diseases	disease	NOUN
ihlr-28406	213	35	,	,	PUNCT
ihlr-28406	213	36	including	include	VERB
ihlr-28406	213	37	thyroid	thyroid	NOUN
ihlr-28406	213	38	cancer	cancer	NOUN
ihlr-28406	213	39	,	,	PUNCT
ihlr-28406	213	40	81	81	NUM
ihlr-28406	213	41	hypothyroidism	hypothyroidism	NOUN
ihlr-28406	213	42	,	,	PUNCT
ihlr-28406	213	43	and	and	CCONJ
ihlr-28406	213	44	hyperthyroidism	hyperthyroidism	NOUN
ihlr-28406	213	45	.	.	PUNCT
ihlr-28406	214	1	—	—	PUNCT
ihlr-28406	214	2	—	—	PUNCT
ihlr-28406	214	3	—	—	PUNCT
ihlr-28406	214	4	—	—	PUNCT
ihlr-28406	214	5	—	—	PUNCT
ihlr-28406	214	6	—	—	PUNCT
ihlr-28406	214	7	—	—	PUNCT
ihlr-28406	214	8	—	—	PUNCT
ihlr-28406	214	9	—	—	PUNCT
ihlr-28406	214	10	—	—	PUNCT
ihlr-28406	214	11	—	—	PUNCT
ihlr-28406	214	12	—	—	PUNCT
ihlr-28406	214	13	—	—	PUNCT
ihlr-28406	214	14	—	—	PUNCT
ihlr-28406	214	15	—	—	PUNCT
ihlr-28406	214	16	—	—	PUNCT
ihlr-28406	214	17	—	—	PUNCT
ihlr-28406	214	18	—	—	PUNCT
ihlr-28406	214	19	—	—	PUNCT
ihlr-28406	214	20	—	—	PUNCT
ihlr-28406	214	21	—	—	PUNCT
ihlr-28406	214	22	—	—	PUNCT
ihlr-28406	214	23	—	—	PUNCT
ihlr-28406	214	24	—	—	PUNCT
ihlr-28406	214	25	—	—	PUNCT
ihlr-28406	214	26	—	—	PUNCT
ihlr-28406	214	27	—	—	PUNCT
ihlr-28406	214	28	—	—	PUNCT
ihlr-28406	214	29	—	—	PUNCT
ihlr-28406	214	30	76	76	NUM
ihlr-28406	214	31	.	.	PUNCT
ihlr-28406	215	1	‘	'	PUNCT
ihlr-28406	215	2	154	154	NUM
ihlr-28406	215	3	patent	patent	NOUN
ihlr-28406	215	4	.	.	PUNCT
ihlr-28406	216	1	77	77	NUM
ihlr-28406	216	2	.	.	PUNCT
ihlr-28406	217	1	i	i	PRON
ihlr-28406	217	2	d.	d.	PROPN
ihlr-28406	217	3	78	78	NUM
ihlr-28406	217	4	.	.	PUNCT
ihlr-28406	218	1	‘	'	PUNCT
ihlr-28406	218	2	680	680	NUM
ihlr-28406	218	3	patent	patent	NOUN
ihlr-28406	218	4	.	.	PUNCT
ihlr-28406	219	1	79	79	NUM
ihlr-28406	219	2	.	.	PUNCT
ihlr-28406	220	1	see	see	VERB
ihlr-28406	220	2	chaker	chaker	PROPN
ihlr-28406	220	3	et	et	PROPN
ihlr-28406	220	4	al	al	PROPN
ihlr-28406	220	5	.	.	PROPN
ihlr-28406	220	6	,	,	PUNCT
ihlr-28406	220	7	supra	supra	PROPN
ihlr-28406	220	8	note	note	PROPN
ihlr-28406	220	9	45	45	NUM
ihlr-28406	220	10	;	;	PUNCT
ihlr-28406	220	11	see	see	VERB
ihlr-28406	220	12	also	also	ADV
ihlr-28406	220	13	nobuyuki	nobuyuki	PROPN
ihlr-28406	220	14	takasu	takasu	PROPN
ihlr-28406	220	15	&	&	CCONJ
ihlr-28406	220	16	jaeduk	jaeduk	PROPN
ihlr-28406	220	17	yoshimura	yoshimura	PROPN
ihlr-28406	220	18	noh	noh	PROPN
ihlr-28406	220	19	,	,	PUNCT
ihlr-28406	220	20	hashimoto	hashimoto	NOUN
ihlr-28406	220	21	’s	’s	PART
ihlr-28406	220	22	thyroiditis	thyroiditis	NOUN
ihlr-28406	220	23	:	:	PUNCT
ihlr-28406	220	24	tgab	tgab	NOUN
ihlr-28406	220	25	,	,	PUNCT
ihlr-28406	220	26	tpoab	tpoab	PROPN
ihlr-28406	220	27	,	,	PUNCT
ihlr-28406	220	28	trab	trab	NOUN
ihlr-28406	220	29	and	and	CCONJ
ihlr-28406	220	30	recovery	recovery	NOUN
ihlr-28406	220	31	from	from	ADP
ihlr-28406	220	32	hypothyroidism	hypothyroidism	NOUN
ihlr-28406	220	33	,	,	PUNCT
ihlr-28406	220	34	4	4	NUM
ihlr-28406	220	35	expert	expert	NOUN
ihlr-28406	220	36	rev	rev	VERB
ihlr-28406	220	37	.	.	PUNCT
ihlr-28406	221	1	clinical	clinical	ADJ
ihlr-28406	221	2	immunology	immunology	NOUN
ihlr-28406	221	3	221	221	NUM
ihlr-28406	221	4	(	(	PUNCT
ihlr-28406	221	5	2008	2008	NUM
ihlr-28406	221	6	)	)	PUNCT
ihlr-28406	221	7	.	.	PUNCT
ihlr-28406	222	1	80	80	NUM
ihlr-28406	222	2	.	.	PUNCT
ihlr-28406	223	1	see	see	VERB
ihlr-28406	223	2	appendix	appendix	ADJ
ihlr-28406	223	3	d.	d.	PROPN
ihlr-28406	223	4	symptoms	symptom	NOUN
ihlr-28406	223	5	for	for	ADP
ihlr-28406	223	6	thyroid	thyroid	NOUN
ihlr-28406	223	7	disease	disease	NOUN
ihlr-28406	223	8	.	.	PUNCT
ihlr-28406	224	1	81	81	NUM
ihlr-28406	224	2	.	.	PUNCT
ihlr-28406	225	1	the	the	DET
ihlr-28406	225	2	four	four	NUM
ihlr-28406	225	3	main	main	ADJ
ihlr-28406	225	4	kinds	kind	NOUN
ihlr-28406	225	5	of	of	ADP
ihlr-28406	225	6	thyroid	thyroid	NOUN
ihlr-28406	225	7	cancer	cancer	NOUN
ihlr-28406	225	8	are	be	AUX
ihlr-28406	225	9	papillary	papillary	ADJ
ihlr-28406	225	10	,	,	PUNCT
ihlr-28406	225	11	follicular	follicular	ADJ
ihlr-28406	225	12	,	,	PUNCT
ihlr-28406	225	13	medullary	medullary	ADJ
ihlr-28406	225	14	,	,	PUNCT
ihlr-28406	225	15	and	and	CCONJ
ihlr-28406	225	16	anaplastic	anaplastic	ADJ
ihlr-28406	225	17	.	.	PUNCT
ihlr-28406	226	1	however	however	ADV
ihlr-28406	226	2	,	,	PUNCT
ihlr-28406	226	3	thyroid	thyroid	NOUN
ihlr-28406	226	4	cancer	cancer	NOUN
ihlr-28406	226	5	is	be	AUX
ihlr-28406	226	6	relatively	relatively	ADV
ihlr-28406	226	7	far	far	ADV
ihlr-28406	226	8	rarer	rare	ADJ
ihlr-28406	226	9	than	than	ADP
ihlr-28406	226	10	hyperthyroidism	hyperthyroidism	NOUN
ihlr-28406	226	11	and	and	CCONJ
ihlr-28406	226	12	hypothyroidism	hypothyroidism	NOUN
ihlr-28406	226	13	.	.	PUNCT
ihlr-28406	227	1	indiana	indiana	PROPN
ihlr-28406	227	2	health	health	PROPN
ihlr-28406	227	3	law	law	PROPN
ihlr-28406	227	4	review	review	NOUN
ihlr-28406	227	5	[	[	X
ihlr-28406	227	6	vol	vol	NOUN
ihlr-28406	227	7	.	.	PUNCT
ihlr-28406	228	1	21:277	21:277	NOUN
ihlr-28406	228	2	286	286	NUM
ihlr-28406	228	3	iii	iii	NOUN
ihlr-28406	228	4	.	.	PUNCT
ihlr-28406	229	1	inventions	invention	NOUN
ihlr-28406	229	2	and	and	CCONJ
ihlr-28406	229	3	patents	patent	NOUN
ihlr-28406	229	4	a	a	DET
ihlr-28406	229	5	patent	patent	NOUN
ihlr-28406	229	6	is	be	AUX
ihlr-28406	229	7	a	a	DET
ihlr-28406	229	8	form	form	NOUN
ihlr-28406	229	9	of	of	ADP
ihlr-28406	229	10	legal	legal	ADJ
ihlr-28406	229	11	protection	protection	NOUN
ihlr-28406	229	12	for	for	ADP
ihlr-28406	229	13	new	new	ADJ
ihlr-28406	229	14	and	and	CCONJ
ihlr-28406	229	15	useful	useful	ADJ
ihlr-28406	229	16	technologies	technology	NOUN
ihlr-28406	229	17	.	.	PUNCT
ihlr-28406	230	1	82	82	NUM
ihlr-28406	231	1	it	it	PRON
ihlr-28406	231	2	provides	provide	VERB
ihlr-28406	231	3	the	the	DET
ihlr-28406	231	4	holder	holder	NOUN
ihlr-28406	231	5	the	the	DET
ihlr-28406	231	6	legal	legal	ADJ
ihlr-28406	231	7	right	right	NOUN
ihlr-28406	231	8	to	to	PART
ihlr-28406	231	9	prohibit	prohibit	VERB
ihlr-28406	231	10	others	other	NOUN
ihlr-28406	231	11	from	from	ADP
ihlr-28406	231	12	using	use	VERB
ihlr-28406	231	13	,	,	PUNCT
ihlr-28406	231	14	making	make	VERB
ihlr-28406	231	15	,	,	PUNCT
ihlr-28406	231	16	or	or	CCONJ
ihlr-28406	231	17	selling	sell	VERB
ihlr-28406	231	18	an	an	DET
ihlr-28406	231	19	invention.83	invention.83	PROPN
ihlr-28406	231	20	the	the	DET
ihlr-28406	231	21	united	united	PROPN
ihlr-28406	231	22	states	states	PROPN
ihlr-28406	231	23	patent	patent	NOUN
ihlr-28406	231	24	and	and	CCONJ
ihlr-28406	231	25	trademark	trademark	NOUN
ihlr-28406	231	26	office	office	NOUN
ihlr-28406	231	27	(	(	PUNCT
ihlr-28406	231	28	“	"	PUNCT
ihlr-28406	231	29	uspto	uspto	X
ihlr-28406	231	30	”	"	PUNCT
ihlr-28406	231	31	)	)	PUNCT
ihlr-28406	231	32	reviews	review	VERB
ihlr-28406	231	33	applications	application	NOUN
ihlr-28406	231	34	to	to	PART
ihlr-28406	231	35	determine	determine	VERB
ihlr-28406	231	36	whether	whether	SCONJ
ihlr-28406	231	37	a	a	DET
ihlr-28406	231	38	claimed	claim	VERB
ihlr-28406	231	39	invention	invention	NOUN
ihlr-28406	231	40	is	be	AUX
ihlr-28406	231	41	:	:	PUNCT
ihlr-28406	231	42	(	(	PUNCT
ihlr-28406	231	43	1	1	X
ihlr-28406	231	44	)	)	PUNCT
ihlr-28406	231	45	statutory	statutory	ADJ
ihlr-28406	231	46	subject	subject	NOUN
ihlr-28406	231	47	matter	matter	NOUN
ihlr-28406	231	48	;	;	PUNCT
ihlr-28406	231	49	(	(	PUNCT
ihlr-28406	231	50	2	2	X
ihlr-28406	231	51	)	)	PUNCT
ihlr-28406	231	52	useful	useful	ADJ
ihlr-28406	231	53	;	;	PUNCT
ihlr-28406	231	54	(	(	PUNCT
ihlr-28406	231	55	3	3	X
ihlr-28406	231	56	)	)	PUNCT
ihlr-28406	231	57	novel	novel	NOUN
ihlr-28406	231	58	;	;	PUNCT
ihlr-28406	231	59	(	(	PUNCT
ihlr-28406	231	60	4	4	X
ihlr-28406	231	61	)	)	PUNCT
ihlr-28406	231	62	would	would	AUX
ihlr-28406	231	63	not	not	PART
ihlr-28406	231	64	be	be	AUX
ihlr-28406	231	65	considered	consider	VERB
ihlr-28406	231	66	obvious	obvious	ADJ
ihlr-28406	231	67	by	by	ADP
ihlr-28406	231	68	a	a	DET
ihlr-28406	231	69	hypothetical	hypothetical	ADJ
ihlr-28406	231	70	person	person	NOUN
ihlr-28406	231	71	of	of	ADP
ihlr-28406	231	72	ordinary	ordinary	ADJ
ihlr-28406	231	73	skill	skill	NOUN
ihlr-28406	231	74	in	in	ADP
ihlr-28406	231	75	the	the	DET
ihlr-28406	231	76	field	field	NOUN
ihlr-28406	231	77	;	;	PUNCT
ihlr-28406	231	78	and	and	CCONJ
ihlr-28406	231	79	(	(	PUNCT
ihlr-28406	231	80	5	5	X
ihlr-28406	231	81	)	)	PUNCT
ihlr-28406	231	82	described	describe	VERB
ihlr-28406	231	83	well	well	ADV
ihlr-28406	231	84	enough	enough	ADV
ihlr-28406	231	85	that	that	SCONJ
ihlr-28406	231	86	those	those	PRON
ihlr-28406	231	87	in	in	ADP
ihlr-28406	231	88	the	the	DET
ihlr-28406	231	89	field	field	NOUN
ihlr-28406	231	90	can	can	AUX
ihlr-28406	231	91	make	make	VERB
ihlr-28406	231	92	and	and	CCONJ
ihlr-28406	231	93	use	use	VERB
ihlr-28406	231	94	the	the	DET
ihlr-28406	231	95	invention	invention	NOUN
ihlr-28406	231	96	.	.	PUNCT
ihlr-28406	232	1	84	84	NUM
ihlr-28406	232	2	notre	notre	PROPN
ihlr-28406	232	3	dame	dame	PROPN
ihlr-28406	232	4	law	law	NOUN
ihlr-28406	232	5	professor	professor	NOUN
ihlr-28406	232	6	stephen	stephen	PROPN
ihlr-28406	232	7	yelderman	yelderman	PROPN
ihlr-28406	232	8	argues	argue	VERB
ihlr-28406	232	9	the	the	DET
ihlr-28406	232	10	united	united	PROPN
ihlr-28406	232	11	states	states	PROPN
ihlr-28406	232	12	’	'	PUNCT
ihlr-28406	232	13	patent	patent	NOUN
ihlr-28406	232	14	system	system	NOUN
ihlr-28406	232	15	’s	’s	PART
ihlr-28406	232	16	central	central	ADJ
ihlr-28406	232	17	goal	goal	NOUN
ihlr-28406	232	18	is	be	AUX
ihlr-28406	232	19	to	to	PART
ihlr-28406	232	20	provide	provide	VERB
ihlr-28406	232	21	adequate	adequate	ADJ
ihlr-28406	232	22	incentive	incentive	NOUN
ihlr-28406	232	23	to	to	ADP
ihlr-28406	232	24	innovators	innovator	NOUN
ihlr-28406	232	25	to	to	PART
ihlr-28406	232	26	publish	publish	VERB
ihlr-28406	232	27	their	their	PRON
ihlr-28406	232	28	inventions	invention	NOUN
ihlr-28406	232	29	in	in	ADP
ihlr-28406	232	30	exchange	exchange	NOUN
ihlr-28406	232	31	for	for	ADP
ihlr-28406	232	32	rights	right	NOUN
ihlr-28406	232	33	.	.	PUNCT
ihlr-28406	233	1	85	85	NUM
ihlr-28406	233	2	however	however	ADV
ihlr-28406	233	3	,	,	PUNCT
ihlr-28406	233	4	practically	practically	ADV
ihlr-28406	233	5	speaking	speak	VERB
ihlr-28406	233	6	the	the	DET
ihlr-28406	233	7	united	united	PROPN
ihlr-28406	233	8	states	states	PROPN
ihlr-28406	233	9	patent	patent	NOUN
ihlr-28406	233	10	office	office	NOUN
ihlr-28406	233	11	has	have	AUX
ihlr-28406	233	12	largely	largely	ADV
ihlr-28406	233	13	abandoned	abandon	VERB
ihlr-28406	233	14	this	this	DET
ihlr-28406	233	15	goal	goal	NOUN
ihlr-28406	233	16	and	and	CCONJ
ihlr-28406	233	17	instead	instead	ADV
ihlr-28406	233	18	focuses	focus	VERB
ihlr-28406	233	19	on	on	ADP
ihlr-28406	233	20	stopping	stop	VERB
ihlr-28406	233	21	technical	technical	ADJ
ihlr-28406	233	22	progress	progress	NOUN
ihlr-28406	233	23	and	and	CCONJ
ihlr-28406	233	24	promoting	promote	VERB
ihlr-28406	233	25	stagnation	stagnation	NOUN
ihlr-28406	233	26	by	by	ADP
ihlr-28406	233	27	reviewing	review	VERB
ihlr-28406	233	28	applications	application	NOUN
ihlr-28406	233	29	from	from	ADP
ihlr-28406	233	30	large	large	ADJ
ihlr-28406	233	31	companies	company	NOUN
ihlr-28406	233	32	fast	fast	VERB
ihlr-28406	233	33	and	and	CCONJ
ihlr-28406	233	34	simply	simply	ADV
ihlr-28406	233	35	ignoring	ignore	VERB
ihlr-28406	233	36	inventions	invention	NOUN
ihlr-28406	233	37	filed	file	VERB
ihlr-28406	233	38	by	by	ADP
ihlr-28406	233	39	small	small	ADJ
ihlr-28406	233	40	businesses	business	NOUN
ihlr-28406	233	41	and	and	CCONJ
ihlr-28406	233	42	inventors	inventor	NOUN
ihlr-28406	233	43	for	for	ADP
ihlr-28406	233	44	many	many	ADJ
ihlr-28406	233	45	years	year	NOUN
ihlr-28406	233	46	despite	despite	SCONJ
ihlr-28406	233	47	being	be	AUX
ihlr-28406	233	48	grossly	grossly	ADV
ihlr-28406	233	49	overfunded	overfunde	VERB
ihlr-28406	233	50	and	and	CCONJ
ihlr-28406	233	51	overstaffed.86	overstaffed.86	NOUN
ihlr-28406	233	52	as	as	ADP
ihlr-28406	233	53	such	such	ADJ
ihlr-28406	233	54	,	,	PUNCT
ihlr-28406	233	55	in	in	ADP
ihlr-28406	233	56	conferring	confer	VERB
ihlr-28406	233	57	the	the	DET
ihlr-28406	233	58	exclusive	exclusive	ADJ
ihlr-28406	233	59	right	right	NOUN
ihlr-28406	233	60	to	to	ADP
ihlr-28406	233	61	discoveries	discovery	NOUN
ihlr-28406	233	62	to	to	ADP
ihlr-28406	233	63	its	its	PRON
ihlr-28406	233	64	inventors	inventor	NOUN
ihlr-28406	233	65	,	,	PUNCT
ihlr-28406	233	66	patents	patent	NOUN
ihlr-28406	233	67	confer	confer	VERB
ihlr-28406	233	68	a	a	DET
ihlr-28406	233	69	temporary	temporary	ADJ
ihlr-28406	233	70	monopoly	monopoly	NOUN
ihlr-28406	233	71	to	to	ADP
ihlr-28406	233	72	the	the	DET
ihlr-28406	233	73	holder	holder	NOUN
ihlr-28406	233	74	.	.	PUNCT
ihlr-28406	234	1	87	87	NUM
ihlr-28406	234	2	—	—	PUNCT
ihlr-28406	234	3	—	—	PUNCT
ihlr-28406	234	4	—	—	PUNCT
ihlr-28406	234	5	—	—	PUNCT
ihlr-28406	234	6	—	—	PUNCT
ihlr-28406	234	7	—	—	PUNCT
ihlr-28406	234	8	—	—	PUNCT
ihlr-28406	234	9	—	—	PUNCT
ihlr-28406	234	10	—	—	PUNCT
ihlr-28406	234	11	—	—	PUNCT
ihlr-28406	234	12	—	—	PUNCT
ihlr-28406	234	13	—	—	PUNCT
ihlr-28406	234	14	—	—	PUNCT
ihlr-28406	234	15	—	—	PUNCT
ihlr-28406	234	16	—	—	PUNCT
ihlr-28406	234	17	—	—	PUNCT
ihlr-28406	234	18	—	—	PUNCT
ihlr-28406	234	19	—	—	PUNCT
ihlr-28406	234	20	—	—	PUNCT
ihlr-28406	234	21	—	—	PUNCT
ihlr-28406	234	22	—	—	PUNCT
ihlr-28406	234	23	—	—	PUNCT
ihlr-28406	234	24	—	—	PUNCT
ihlr-28406	234	25	—	—	PUNCT
ihlr-28406	234	26	—	—	PUNCT
ihlr-28406	234	27	—	—	PUNCT
ihlr-28406	234	28	—	—	PUNCT
ihlr-28406	234	29	—	—	PUNCT
ihlr-28406	234	30	—	—	PUNCT
ihlr-28406	234	31	82	82	NUM
ihlr-28406	234	32	.	.	PUNCT
ihlr-28406	235	1	john	john	PROPN
ihlr-28406	235	2	palfrey	palfrey	PROPN
ihlr-28406	235	3	,	,	PUNCT
ihlr-28406	235	4	intellectual	intellectual	ADJ
ihlr-28406	235	5	property	property	NOUN
ihlr-28406	235	6	strategy	strategy	NOUN
ihlr-28406	235	7	55	55	NUM
ihlr-28406	235	8	(	(	PUNCT
ihlr-28406	235	9	mit	mit	PROPN
ihlr-28406	235	10	press	press	NOUN
ihlr-28406	235	11	2012	2012	NUM
ihlr-28406	235	12	)	)	PUNCT
ihlr-28406	235	13	.	.	PUNCT
ihlr-28406	236	1	83	83	NUM
ihlr-28406	236	2	.	.	PUNCT
ihlr-28406	236	3	stephen	stephen	PROPN
ihlr-28406	236	4	yelderman	yelderman	PROPN
ihlr-28406	236	5	,	,	PUNCT
ihlr-28406	236	6	the	the	DET
ihlr-28406	236	7	value	value	NOUN
ihlr-28406	236	8	of	of	ADP
ihlr-28406	236	9	accuracy	accuracy	NOUN
ihlr-28406	236	10	in	in	ADP
ihlr-28406	236	11	the	the	DET
ihlr-28406	236	12	patent	patent	NOUN
ihlr-28406	236	13	system	system	NOUN
ihlr-28406	236	14	,	,	PUNCT
ihlr-28406	236	15	84	84	NUM
ihlr-28406	236	16	u.	u.	NOUN
ihlr-28406	236	17	chi	chi	PROPN
ihlr-28406	236	18	.	.	PUNCT
ihlr-28406	237	1	l.	l.	PROPN
ihlr-28406	237	2	rev	rev	PROPN
ihlr-28406	237	3	.	.	PROPN
ihlr-28406	237	4	1217	1217	NUM
ihlr-28406	237	5	,	,	PUNCT
ihlr-28406	237	6	1270	1270	NUM
ihlr-28406	237	7	(	(	PUNCT
ihlr-28406	237	8	2017	2017	NUM
ihlr-28406	237	9	)	)	PUNCT
ihlr-28406	237	10	;	;	PUNCT
ihlr-28406	237	11	see	see	VERB
ihlr-28406	237	12	also	also	ADV
ihlr-28406	237	13	u.s	u.s	PROPN
ihlr-28406	237	14	.	.	PROPN
ihlr-28406	237	15	const	const	PROPN
ihlr-28406	237	16	.	.	PUNCT
ihlr-28406	237	17	art	art	NOUN
ihlr-28406	237	18	.	.	PUNCT
ihlr-28406	238	1	i	i	PRON
ihlr-28406	238	2	,	,	PUNCT
ihlr-28406	238	3	§	§	PROPN
ihlr-28406	238	4	8	8	NUM
ihlr-28406	238	5	,	,	PUNCT
ihlr-28406	238	6	cl	cl	NOUN
ihlr-28406	238	7	.	.	NOUN
ihlr-28406	238	8	8	8	NUM
ihlr-28406	238	9	(	(	PUNCT
ihlr-28406	238	10	providing	provide	VERB
ihlr-28406	238	11	the	the	DET
ihlr-28406	238	12	constitutional	constitutional	ADJ
ihlr-28406	238	13	basis	basis	NOUN
ihlr-28406	238	14	for	for	ADP
ihlr-28406	238	15	patents	patent	NOUN
ihlr-28406	238	16	,	,	PUNCT
ihlr-28406	238	17	“	"	PUNCT
ihlr-28406	238	18	[	[	X
ihlr-28406	238	19	t]he	t]he	ADJ
ihlr-28406	238	20	congress	congress	PROPN
ihlr-28406	238	21	shall	shall	AUX
ihlr-28406	238	22	have	have	VERB
ihlr-28406	238	23	the	the	DET
ihlr-28406	238	24	power	power	NOUN
ihlr-28406	238	25	…	…	PUNCT
ihlr-28406	238	26	to	to	PART
ihlr-28406	238	27	promote	promote	VERB
ihlr-28406	238	28	the	the	DET
ihlr-28406	238	29	progress	progress	NOUN
ihlr-28406	238	30	of	of	ADP
ihlr-28406	238	31	science	science	NOUN
ihlr-28406	238	32	and	and	CCONJ
ihlr-28406	238	33	useful	useful	ADJ
ihlr-28406	238	34	arts	art	NOUN
ihlr-28406	238	35	,	,	PUNCT
ihlr-28406	238	36	by	by	ADP
ihlr-28406	238	37	securing	secure	VERB
ihlr-28406	238	38	for	for	ADP
ihlr-28406	238	39	limited	limited	ADJ
ihlr-28406	238	40	times	time	NOUN
ihlr-28406	238	41	to	to	ADP
ihlr-28406	238	42	authors	author	NOUN
ihlr-28406	238	43	and	and	CCONJ
ihlr-28406	238	44	inventors	inventor	NOUN
ihlr-28406	238	45	the	the	DET
ihlr-28406	238	46	exclusive	exclusive	ADJ
ihlr-28406	238	47	right	right	NOUN
ihlr-28406	238	48	to	to	ADP
ihlr-28406	238	49	their	their	PRON
ihlr-28406	238	50	respective	respective	ADJ
ihlr-28406	238	51	writings	writing	NOUN
ihlr-28406	238	52	and	and	CCONJ
ihlr-28406	238	53	discoveries	discovery	NOUN
ihlr-28406	238	54	.	.	PUNCT
ihlr-28406	238	55	”	"	PUNCT
ihlr-28406	238	56	)	)	PUNCT
ihlr-28406	238	57	.	.	PUNCT
ihlr-28406	239	1	84	84	NUM
ihlr-28406	239	2	.	.	PUNCT
ihlr-28406	240	1	see	see	VERB
ihlr-28406	240	2	35	35	NUM
ihlr-28406	240	3	u.s.c	u.s.c	ADJ
ihlr-28406	240	4	.	.	PUNCT
ihlr-28406	241	1	§	§	PROPN
ihlr-28406	241	2	101	101	NUM
ihlr-28406	241	3	(	(	PUNCT
ihlr-28406	241	4	the	the	DET
ihlr-28406	241	5	first	first	ADJ
ihlr-28406	241	6	element	element	NOUN
ihlr-28406	241	7	of	of	ADP
ihlr-28406	241	8	the	the	DET
ihlr-28406	241	9	statutory	statutory	ADJ
ihlr-28406	241	10	requirements	requirement	NOUN
ihlr-28406	241	11	,	,	PUNCT
ihlr-28406	241	12	statutory	statutory	ADJ
ihlr-28406	241	13	subject	subject	NOUN
ihlr-28406	241	14	matter	matter	NOUN
ihlr-28406	241	15	,	,	PUNCT
ihlr-28406	241	16	includes	include	VERB
ihlr-28406	241	17	any	any	DET
ihlr-28406	241	18	new	new	ADJ
ihlr-28406	241	19	process	process	NOUN
ihlr-28406	241	20	,	,	PUNCT
ihlr-28406	241	21	machine	machine	NOUN
ihlr-28406	241	22	,	,	PUNCT
ihlr-28406	241	23	manufacture	manufacture	NOUN
ihlr-28406	241	24	,	,	PUNCT
ihlr-28406	241	25	or	or	CCONJ
ihlr-28406	241	26	composition	composition	NOUN
ihlr-28406	241	27	of	of	ADP
ihlr-28406	241	28	matter	matter	NOUN
ihlr-28406	241	29	,	,	PUNCT
ihlr-28406	241	30	or	or	CCONJ
ihlr-28406	241	31	any	any	DET
ihlr-28406	241	32	new	new	ADJ
ihlr-28406	241	33	and	and	CCONJ
ihlr-28406	241	34	useful	useful	ADJ
ihlr-28406	241	35	improvement	improvement	NOUN
ihlr-28406	241	36	thereof	thereof	ADV
ihlr-28406	241	37	)	)	PUNCT
ihlr-28406	241	38	;	;	PUNCT
ihlr-28406	241	39	see	see	VERB
ihlr-28406	241	40	also	also	ADV
ihlr-28406	241	41	35	35	NUM
ihlr-28406	241	42	u.s.c	u.s.c	ADJ
ihlr-28406	241	43	.	.	PUNCT
ihlr-28406	242	1	§	§	PROPN
ihlr-28406	242	2	112	112	NUM
ihlr-28406	242	3	.	.	PUNCT
ihlr-28406	242	4	85	85	NUM
ihlr-28406	242	5	.	.	PUNCT
ihlr-28406	243	1	in	in	ADP
ihlr-28406	243	2	other	other	ADJ
ihlr-28406	243	3	words	word	NOUN
ihlr-28406	243	4	,	,	PUNCT
ihlr-28406	243	5	the	the	DET
ihlr-28406	243	6	patent	patent	NOUN
ihlr-28406	243	7	statute	statute	NOUN
ihlr-28406	243	8	promotes	promote	VERB
ihlr-28406	243	9	technological	technological	ADJ
ihlr-28406	243	10	progress	progress	NOUN
ihlr-28406	243	11	through	through	ADP
ihlr-28406	243	12	the	the	DET
ihlr-28406	243	13	monopoly	monopoly	NOUN
ihlr-28406	243	14	it	it	PRON
ihlr-28406	243	15	offers	offer	VERB
ihlr-28406	243	16	for	for	ADP
ihlr-28406	243	17	the	the	DET
ihlr-28406	243	18	creation	creation	NOUN
ihlr-28406	243	19	and	and	CCONJ
ihlr-28406	243	20	disclosure	disclosure	NOUN
ihlr-28406	243	21	of	of	ADP
ihlr-28406	243	22	something	something	PRON
ihlr-28406	243	23	new	new	ADJ
ihlr-28406	243	24	.	.	PUNCT
ihlr-28406	244	1	see	see	VERB
ihlr-28406	244	2	yelderman	yelderman	NOUN
ihlr-28406	244	3	,	,	PUNCT
ihlr-28406	244	4	supra	supra	PROPN
ihlr-28406	244	5	note	note	PROPN
ihlr-28406	244	6	83	83	NUM
ihlr-28406	244	7	,	,	PUNCT
ihlr-28406	244	8	at	at	ADP
ihlr-28406	244	9	1263	1263	NUM
ihlr-28406	244	10	,	,	PUNCT
ihlr-28406	244	11	1670	1670	NUM
ihlr-28406	244	12	(	(	PUNCT
ihlr-28406	244	13	the	the	DET
ihlr-28406	244	14	system	system	NOUN
ihlr-28406	244	15	congress	congress	PROPN
ihlr-28406	244	16	created	create	VERB
ihlr-28406	244	17	provides	provide	VERB
ihlr-28406	244	18	a	a	DET
ihlr-28406	244	19	delicate	delicate	ADJ
ihlr-28406	244	20	balance	balance	NOUN
ihlr-28406	244	21	;	;	PUNCT
ihlr-28406	244	22	in	in	ADP
ihlr-28406	244	23	exchange	exchange	NOUN
ihlr-28406	244	24	for	for	ADP
ihlr-28406	244	25	monopoly	monopoly	NOUN
ihlr-28406	244	26	rights	right	NOUN
ihlr-28406	244	27	,	,	PUNCT
ihlr-28406	244	28	the	the	DET
ihlr-28406	244	29	innovator	innovator	NOUN
ihlr-28406	244	30	must	must	AUX
ihlr-28406	244	31	provide	provide	VERB
ihlr-28406	244	32	a	a	DET
ihlr-28406	244	33	description	description	NOUN
ihlr-28406	244	34	of	of	ADP
ihlr-28406	244	35	how	how	SCONJ
ihlr-28406	244	36	to	to	PART
ihlr-28406	244	37	make	make	VERB
ihlr-28406	244	38	and	and	CCONJ
ihlr-28406	244	39	use	use	VERB
ihlr-28406	244	40	the	the	DET
ihlr-28406	244	41	invention	invention	NOUN
ihlr-28406	244	42	)	)	PUNCT
ihlr-28406	244	43	;	;	PUNCT
ihlr-28406	244	44	see	see	VERB
ihlr-28406	244	45	also	also	ADV
ihlr-28406	244	46	max	max	PROPN
ihlr-28406	244	47	stul	stul	PROPN
ihlr-28406	244	48	oppenheimer	oppenheimer	PROPN
ihlr-28406	244	49	,	,	PUNCT
ihlr-28406	244	50	patents	patent	NOUN
ihlr-28406	244	51	101	101	NUM
ihlr-28406	244	52	:	:	PUNCT
ihlr-28406	244	53	patentable	patentable	ADJ
ihlr-28406	244	54	subject	subject	ADJ
ihlr-28406	244	55	matter	matter	NOUN
ihlr-28406	244	56	and	and	CCONJ
ihlr-28406	244	57	separation	separation	NOUN
ihlr-28406	244	58	of	of	ADP
ihlr-28406	244	59	powers	power	NOUN
ihlr-28406	244	60	,	,	PUNCT
ihlr-28406	244	61	15	15	NUM
ihlr-28406	244	62	vand	vand	NOUN
ihlr-28406	244	63	.	.	PUNCT
ihlr-28406	245	1	j.	j.	PROPN
ihlr-28406	245	2	ent	ent	PROPN
ihlr-28406	245	3	.	.	PROPN
ihlr-28406	245	4	&	&	CCONJ
ihlr-28406	245	5	tech	tech	PROPN
ihlr-28406	245	6	.	.	PUNCT
ihlr-28406	246	1	l.	l.	PROPN
ihlr-28406	246	2	1	1	NUM
ihlr-28406	246	3	,	,	PUNCT
ihlr-28406	246	4	8	8	NUM
ihlr-28406	246	5	(	(	PUNCT
ihlr-28406	246	6	2012	2012	NUM
ihlr-28406	246	7	)	)	PUNCT
ihlr-28406	246	8	.	.	PUNCT
ihlr-28406	247	1	86	86	NUM
ihlr-28406	247	2	.	.	PUNCT
ihlr-28406	248	1	budget	budget	NOUN
ihlr-28406	248	2	and	and	CCONJ
ihlr-28406	248	3	financial	financial	ADJ
ihlr-28406	248	4	information	information	NOUN
ihlr-28406	248	5	,	,	PUNCT
ihlr-28406	248	6	u.s	u.s	PROPN
ihlr-28406	248	7	.	.	PROPN
ihlr-28406	248	8	pat	pat	PROPN
ihlr-28406	248	9	.	.	PROPN
ihlr-28406	248	10	&	&	CCONJ
ihlr-28406	248	11	trademark	trademark	PROPN
ihlr-28406	248	12	off	off	ADP
ihlr-28406	248	13	.	.	PUNCT
ihlr-28406	249	1	(	(	PUNCT
ihlr-28406	249	2	2022	2022	NUM
ihlr-28406	249	3	)	)	PUNCT
ihlr-28406	249	4	,	,	PUNCT
ihlr-28406	249	5	https://www.uspto.gov/about-us/performance-and-planning/budget-and-financial-information	https://www.uspto.gov/about-us/performance-and-planning/budget-and-financial-information	NOUN
ihlr-28406	249	6	[	[	X
ihlr-28406	249	7	https://perma.cc/slz6-jg9a	https://perma.cc/slz6-jg9a	X
ihlr-28406	249	8	]	]	X
ihlr-28406	249	9	(	(	PUNCT
ihlr-28406	249	10	the	the	DET
ihlr-28406	249	11	uspto	uspto	PROPN
ihlr-28406	249	12	budget	budget	NOUN
ihlr-28406	249	13	will	will	AUX
ihlr-28406	249	14	increase	increase	VERB
ihlr-28406	249	15	to	to	ADP
ihlr-28406	249	16	$	$	SYM
ihlr-28406	249	17	4.25	4.25	NUM
ihlr-28406	249	18	billion	billion	NUM
ihlr-28406	249	19	in	in	ADP
ihlr-28406	249	20	2022	2022	NUM
ihlr-28406	249	21	and	and	CCONJ
ihlr-28406	249	22	patent	patent	NOUN
ihlr-28406	249	23	examiners	examiner	NOUN
ihlr-28406	249	24	make	make	AUX
ihlr-28406	249	25	commonly	commonly	ADV
ihlr-28406	249	26	make	make	VERB
ihlr-28406	249	27	between	between	ADP
ihlr-28406	249	28	$	$	SYM
ihlr-28406	249	29	100,000	100,000	NUM
ihlr-28406	249	30	and	and	CCONJ
ihlr-28406	249	31	$	$	SYM
ihlr-28406	249	32	200,000	200,000	NUM
ihlr-28406	249	33	per	per	ADP
ihlr-28406	249	34	year	year	NOUN
ihlr-28406	249	35	)	)	PUNCT
ihlr-28406	249	36	.	.	PUNCT
ihlr-28406	250	1	87	87	NUM
ihlr-28406	250	2	.	.	PUNCT
ihlr-28406	251	1	in	in	ADP
ihlr-28406	251	2	short	short	ADJ
ihlr-28406	251	3	,	,	PUNCT
ihlr-28406	251	4	a	a	DET
ihlr-28406	251	5	patent	patent	NOUN
ihlr-28406	251	6	awards	award	NOUN
ihlr-28406	251	7	the	the	DET
ihlr-28406	251	8	exclusive	exclusive	ADJ
ihlr-28406	251	9	rights	right	NOUN
ihlr-28406	251	10	to	to	PART
ihlr-28406	251	11	use	use	VERB
ihlr-28406	251	12	and	and	CCONJ
ihlr-28406	251	13	profit	profit	NOUN
ihlr-28406	251	14	from	from	ADP
ihlr-28406	251	15	an	an	DET
ihlr-28406	251	16	invention	invention	NOUN
ihlr-28406	251	17	to	to	ADP
ihlr-28406	251	18	the	the	DET
ihlr-28406	251	19	holder	holder	NOUN
ihlr-28406	251	20	,	,	PUNCT
ihlr-28406	251	21	backed	back	VERB
ihlr-28406	251	22	by	by	ADP
ihlr-28406	251	23	the	the	DET
ihlr-28406	251	24	government	government	NOUN
ihlr-28406	251	25	.	.	PUNCT
ihlr-28406	252	1	see	see	VERB
ihlr-28406	252	2	bryce	bryce	PROPN
ihlr-28406	252	3	c.	c.	PROPN
ihlr-28406	252	4	pilz	pilz	PROPN
ihlr-28406	252	5	,	,	PUNCT
ihlr-28406	252	6	student	student	NOUN
ihlr-28406	252	7	intellectual	intellectual	ADJ
ihlr-28406	252	8	property	property	NOUN
ihlr-28406	252	9	issues	issue	NOUN
ihlr-28406	252	10	on	on	ADP
ihlr-28406	252	11	the	the	DET
ihlr-28406	252	12	entrepreneurial	entrepreneurial	ADJ
ihlr-28406	252	13	campus	campus	NOUN
ihlr-28406	252	14	,	,	PUNCT
ihlr-28406	252	15	2	2	NUM
ihlr-28406	252	16	mich	mich	X
ihlr-28406	252	17	.	.	PUNCT
ihlr-28406	253	1	j.	j.	PROPN
ihlr-28406	253	2	private	private	PROPN
ihlr-28406	253	3	equity	equity	PROPN
ihlr-28406	253	4	&	&	CCONJ
ihlr-28406	253	5	venture	venture	PROPN
ihlr-28406	253	6	cap	cap	PROPN
ihlr-28406	253	7	.	.	PUNCT
ihlr-28406	254	1	l.	l.	PROPN
ihlr-28406	254	2	1	1	NUM
ihlr-28406	254	3	,	,	PUNCT
ihlr-28406	254	4	16	16	NUM
ihlr-28406	254	5	(	(	PUNCT
ihlr-28406	254	6	2012	2012	NUM
ihlr-28406	254	7	)	)	PUNCT
ihlr-28406	254	8	;	;	PUNCT
ihlr-28406	254	9	see	see	VERB
ihlr-28406	254	10	also	also	ADV
ihlr-28406	254	11	andrew	andrew	PROPN
ihlr-28406	254	12	beckerman	beckerman	PROPN
ihlr-28406	254	13	-	-	PUNCT
ihlr-28406	254	14	rodau	rodau	NOUN
ihlr-28406	254	15	,	,	PUNCT
ihlr-28406	254	16	the	the	DET
ihlr-28406	254	17	problem	problem	NOUN
ihlr-28406	254	18	with	with	ADP
ihlr-28406	254	19	intellectual	intellectual	ADJ
ihlr-28406	254	20	property	property	NOUN
ihlr-28406	254	21	rights	right	NOUN
ihlr-28406	254	22	:	:	PUNCT
ihlr-28406	254	23	subject	subject	ADJ
ihlr-28406	254	24	matter	matter	NOUN
ihlr-28406	254	25	expansion	expansion	NOUN
ihlr-28406	254	26	,	,	PUNCT
ihlr-28406	254	27	13	13	NUM
ihlr-28406	254	28	yale	yale	PROPN
ihlr-28406	254	29	j.	j.	PROPN
ihlr-28406	254	30	l.	l.	PROPN
ihlr-28406	254	31	&	&	CCONJ
ihlr-28406	254	32	tech	tech	PROPN
ihlr-28406	254	33	.	.	PUNCT
ihlr-28406	255	1	36	36	NUM
ihlr-28406	255	2	,	,	PUNCT
ihlr-28406	255	3	55	55	NUM
ihlr-28406	255	4	(	(	PUNCT
ihlr-28406	255	5	2010–2011	2010–2011	NUM
ihlr-28406	255	6	)	)	PUNCT
ihlr-28406	255	7	(	(	PUNCT
ihlr-28406	255	8	the	the	DET
ihlr-28406	255	9	uspto	uspto	PROPN
ihlr-28406	255	10	’s	’s	PART
ihlr-28406	255	11	granting	granting	NOUN
ihlr-28406	255	12	of	of	ADP
ihlr-28406	255	13	patent	patent	NOUN
ihlr-28406	255	14	rights	right	NOUN
ihlr-28406	255	15	provides	provide	VERB
ihlr-28406	255	16	typical	typical	ADJ
ihlr-28406	255	17	property	property	NOUN
ihlr-28406	255	18	rights	right	NOUN
ihlr-28406	255	19	,	,	PUNCT
ihlr-28406	255	20	including	include	VERB
ihlr-28406	255	21	the	the	DET
ihlr-28406	255	22	right	right	NOUN
ihlr-28406	255	23	of	of	ADP
ihlr-28406	255	24	the	the	DET
ihlr-28406	255	25	patent	patent	NOUN
ihlr-28406	255	26	owner	owner	NOUN
ihlr-28406	255	27	to	to	PART
ihlr-28406	255	28	exclude	exclude	VERB
ihlr-28406	255	29	others	other	NOUN
ihlr-28406	255	30	from	from	ADP
ihlr-28406	255	31	making	make	VERB
ihlr-28406	255	32	,	,	PUNCT
ihlr-28406	255	33	using	use	VERB
ihlr-28406	255	34	,	,	PUNCT
ihlr-28406	255	35	offering	offer	VERB
ihlr-28406	255	36	for	for	ADP
ihlr-28406	255	37	sale	sale	NOUN
ihlr-28406	255	38	,	,	PUNCT
ihlr-28406	255	39	or	or	CCONJ
ihlr-28406	255	40	selling	sell	VERB
ihlr-28406	255	41	the	the	DET
ihlr-28406	255	42	invention	invention	NOUN
ihlr-28406	255	43	throughout	throughout	ADP
ihlr-28406	255	44	the	the	DET
ihlr-28406	255	45	united	united	PROPN
ihlr-28406	255	46	states	states	PROPN
ihlr-28406	255	47	or	or	CCONJ
ihlr-28406	255	48	importing	import	VERB
ihlr-28406	255	49	the	the	DET
ihlr-28406	255	50	invention	invention	NOUN
ihlr-28406	255	51	into	into	ADP
ihlr-28406	255	52	the	the	DET
ihlr-28406	255	53	united	united	PROPN
ihlr-28406	255	54	states	states	PROPN
ihlr-28406	255	55	)	)	PUNCT
ihlr-28406	255	56	.	.	PUNCT
ihlr-28406	256	1	https://perma.cc/slz6-jg9a	https://perma.cc/slz6-jg9a	X
ihlr-28406	257	1	https://www.uspto.gov/about-us/performance-and-planning/budget-and-financial-information	https://www.uspto.gov/about-us/performance-and-planning/budget-and-financial-information	NUM
ihlr-28406	257	2	2024	2024	NUM
ihlr-28406	257	3	]	]	PUNCT
ihlr-28406	257	4	inventions	invention	NOUN
ihlr-28406	257	5	and	and	CCONJ
ihlr-28406	257	6	patents	patent	NOUN
ihlr-28406	257	7	for	for	ADP
ihlr-28406	257	8	treating	treat	VERB
ihlr-28406	257	9	287	287	NUM
ihlr-28406	257	10	thyroid	thyroid	NOUN
ihlr-28406	257	11	disease	disease	NOUN
ihlr-28406	257	12	a.	a.	NOUN
ihlr-28406	257	13	treatments	treatment	VERB
ihlr-28406	257	14	the	the	DET
ihlr-28406	257	15	treatment	treatment	NOUN
ihlr-28406	257	16	options	option	NOUN
ihlr-28406	257	17	available	available	ADJ
ihlr-28406	257	18	for	for	ADP
ihlr-28406	257	19	thyroid	thyroid	NOUN
ihlr-28406	257	20	disease	disease	NOUN
ihlr-28406	257	21	depend	depend	VERB
ihlr-28406	257	22	heavily	heavily	ADV
ihlr-28406	257	23	on	on	ADP
ihlr-28406	257	24	the	the	DET
ihlr-28406	257	25	nature	nature	NOUN
ihlr-28406	257	26	and	and	CCONJ
ihlr-28406	257	27	extent	extent	NOUN
ihlr-28406	257	28	to	to	PART
ihlr-28406	257	29	which	which	PRON
ihlr-28406	257	30	the	the	DET
ihlr-28406	257	31	body	body	NOUN
ihlr-28406	257	32	produces	produce	VERB
ihlr-28406	257	33	and	and	CCONJ
ihlr-28406	257	34	regulates	regulate	VERB
ihlr-28406	257	35	thyroid	thyroid	NOUN
ihlr-28406	257	36	hormone	hormone	NOUN
ihlr-28406	257	37	levels.88	levels.88	NOUN
ihlr-28406	257	38	for	for	ADP
ihlr-28406	257	39	example	example	NOUN
ihlr-28406	257	40	,	,	PUNCT
ihlr-28406	257	41	hypothyroidism	hypothyroidism	NOUN
ihlr-28406	257	42	is	be	AUX
ihlr-28406	257	43	usually	usually	ADV
ihlr-28406	257	44	treated	treat	VERB
ihlr-28406	257	45	by	by	ADP
ihlr-28406	257	46	replacing	replace	VERB
ihlr-28406	257	47	the	the	DET
ihlr-28406	257	48	hormone	hormone	NOUN
ihlr-28406	257	49	the	the	DET
ihlr-28406	257	50	thyroid	thyroid	NOUN
ihlr-28406	257	51	fails	fail	VERB
ihlr-28406	257	52	to	to	PART
ihlr-28406	257	53	produce	produce	VERB
ihlr-28406	257	54	with	with	ADP
ihlr-28406	257	55	synthetic	synthetic	ADJ
ihlr-28406	257	56	hormone	hormone	NOUN
ihlr-28406	257	57	.	.	PUNCT
ihlr-28406	258	1	89	89	NUM
ihlr-28406	258	2	by	by	ADP
ihlr-28406	258	3	contrast	contrast	NOUN
ihlr-28406	258	4	,	,	PUNCT
ihlr-28406	258	5	hyperthyroidism	hyperthyroidism	NOUN
ihlr-28406	258	6	may	may	AUX
ihlr-28406	258	7	be	be	AUX
ihlr-28406	258	8	treated	treat	VERB
ihlr-28406	258	9	by	by	ADP
ihlr-28406	258	10	surgically	surgically	ADV
ihlr-28406	258	11	destroying	destroy	VERB
ihlr-28406	258	12	part	part	NOUN
ihlr-28406	258	13	of	of	ADP
ihlr-28406	258	14	the	the	DET
ihlr-28406	258	15	thyroid	thyroid	NOUN
ihlr-28406	258	16	gland	gland	NOUN
ihlr-28406	258	17	.	.	PUNCT
ihlr-28406	259	1	90	90	NUM
ihlr-28406	259	2	in	in	ADP
ihlr-28406	259	3	all	all	DET
ihlr-28406	259	4	cases	case	NOUN
ihlr-28406	259	5	,	,	PUNCT
ihlr-28406	259	6	proper	proper	ADJ
ihlr-28406	259	7	treatment	treatment	NOUN
ihlr-28406	259	8	for	for	ADP
ihlr-28406	259	9	thyroid	thyroid	NOUN
ihlr-28406	259	10	disease	disease	NOUN
ihlr-28406	259	11	is	be	AUX
ihlr-28406	259	12	vital	vital	ADJ
ihlr-28406	259	13	to	to	AUX
ihlr-28406	259	14	patient	patient	VERB
ihlr-28406	259	15	health	health	NOUN
ihlr-28406	259	16	.	.	PUNCT
ihlr-28406	260	1	91	91	NUM
ihlr-28406	260	2	thyroid	thyroid	NOUN
ihlr-28406	260	3	hormone	hormone	NOUN
ihlr-28406	260	4	imbalance	imbalance	NOUN
ihlr-28406	260	5	can	can	AUX
ihlr-28406	260	6	have	have	VERB
ihlr-28406	260	7	deleterious	deleterious	ADJ
ihlr-28406	260	8	and	and	CCONJ
ihlr-28406	260	9	disastrous	disastrous	ADJ
ihlr-28406	260	10	consequences	consequence	NOUN
ihlr-28406	260	11	including	include	VERB
ihlr-28406	260	12	extreme	extreme	ADJ
ihlr-28406	260	13	anxiety	anxiety	NOUN
ihlr-28406	260	14	,	,	PUNCT
ihlr-28406	260	15	depression	depression	NOUN
ihlr-28406	260	16	,	,	PUNCT
ihlr-28406	260	17	and	and	CCONJ
ihlr-28406	260	18	fatigue	fatigue	NOUN
ihlr-28406	260	19	.	.	PUNCT
ihlr-28406	261	1	92	92	NUM
ihlr-28406	261	2	medication	medication	NOUN
ihlr-28406	261	3	options	option	NOUN
ihlr-28406	261	4	for	for	ADP
ihlr-28406	261	5	treating	treat	VERB
ihlr-28406	261	6	thyroid	thyroid	NOUN
ihlr-28406	261	7	disease	disease	NOUN
ihlr-28406	261	8	range	range	VERB
ihlr-28406	261	9	depending	depend	VERB
ihlr-28406	261	10	on	on	ADP
ihlr-28406	261	11	the	the	DET
ihlr-28406	261	12	clinical	clinical	ADJ
ihlr-28406	261	13	diagnosis	diagnosis	NOUN
ihlr-28406	261	14	and	and	CCONJ
ihlr-28406	261	15	individual	individual	ADJ
ihlr-28406	261	16	patient	patient	ADJ
ihlr-28406	261	17	response	response	NOUN
ihlr-28406	261	18	.	.	PUNCT
ihlr-28406	262	1	for	for	ADP
ihlr-28406	262	2	hypothyroidism	hypothyroidism	NOUN
ihlr-28406	262	3	,	,	PUNCT
ihlr-28406	262	4	physicians	physician	NOUN
ihlr-28406	262	5	often	often	ADV
ihlr-28406	262	6	prescribe	prescribe	VERB
ihlr-28406	262	7	synthetic	synthetic	ADJ
ihlr-28406	262	8	thyroxine	thyroxine	NOUN
ihlr-28406	262	9	.	.	PUNCT
ihlr-28406	263	1	93	93	NUM
ihlr-28406	263	2	synthetic	synthetic	ADJ
ihlr-28406	263	3	thyroxine	thyroxine	NOUN
ihlr-28406	263	4	pills	pill	NOUN
ihlr-28406	263	5	contain	contain	VERB
ihlr-28406	263	6	hormone	hormone	NOUN
ihlr-28406	263	7	like	like	ADP
ihlr-28406	263	8	the	the	DET
ihlr-28406	263	9	t4	t4	PROPN
ihlr-28406	263	10	,	,	PUNCT
ihlr-28406	263	11	which	which	PRON
ihlr-28406	263	12	a	a	DET
ihlr-28406	263	13	healthy	healthy	ADJ
ihlr-28406	263	14	thyroid	thyroid	NOUN
ihlr-28406	263	15	makes	make	VERB
ihlr-28406	263	16	naturally	naturally	ADV
ihlr-28406	263	17	.	.	PUNCT
ihlr-28406	264	1	94	94	NUM
ihlr-28406	264	2	in	in	ADP
ihlr-28406	264	3	other	other	ADJ
ihlr-28406	264	4	words	word	NOUN
ihlr-28406	264	5	,	,	PUNCT
ihlr-28406	264	6	synthetic	synthetic	ADJ
ihlr-28406	264	7	thyroxine	thyroxine	NOUN
ihlr-28406	264	8	replaces	replace	VERB
ihlr-28406	264	9	the	the	DET
ihlr-28406	264	10	hormone	hormone	NOUN
ihlr-28406	264	11	that	that	PRON
ihlr-28406	264	12	the	the	DET
ihlr-28406	264	13	thyroid	thyroid	NOUN
ihlr-28406	264	14	can	can	AUX
ihlr-28406	264	15	no	no	ADV
ihlr-28406	264	16	longer	long	ADV
ihlr-28406	264	17	make	make	VERB
ihlr-28406	264	18	.	.	PUNCT
ihlr-28406	265	1	95	95	NUM
ihlr-28406	265	2	oral	oral	ADJ
ihlr-28406	265	3	levothyroxine	levothyroxine	NOUN
ihlr-28406	265	4	(	(	PUNCT
ihlr-28406	265	5	lt4	lt4	PROPN
ihlr-28406	265	6	)	)	PUNCT
ihlr-28406	265	7	is	be	AUX
ihlr-28406	265	8	the	the	DET
ihlr-28406	265	9	standard	standard	ADJ
ihlr-28406	265	10	therapy	therapy	NOUN
ihlr-28406	265	11	for	for	ADP
ihlr-28406	265	12	patients	patient	NOUN
ihlr-28406	265	13	with	with	ADP
ihlr-28406	265	14	hypothyroidism	hypothyroidism	NOUN
ihlr-28406	265	15	.	.	PUNCT
ihlr-28406	266	1	96	96	NUM
ihlr-28406	267	1	both	both	PRON
ihlr-28406	267	2	brand	brand	NOUN
ihlr-28406	267	3	-	-	PUNCT
ihlr-28406	267	4	name	name	NOUN
ihlr-28406	267	5	and	and	CCONJ
ihlr-28406	267	6	generic	generic	ADJ
ihlr-28406	267	7	lt4	lt4	PROPN
ihlr-28406	267	8	tablets	tablet	NOUN
ihlr-28406	267	9	are	be	AUX
ihlr-28406	267	10	available	available	ADJ
ihlr-28406	267	11	.	.	PUNCT
ihlr-28406	268	1	97	97	NUM
ihlr-28406	268	2	—	—	PUNCT
ihlr-28406	268	3	—	—	PUNCT
ihlr-28406	268	4	—	—	PUNCT
ihlr-28406	268	5	—	—	PUNCT
ihlr-28406	268	6	—	—	PUNCT
ihlr-28406	268	7	—	—	PUNCT
ihlr-28406	268	8	—	—	PUNCT
ihlr-28406	268	9	—	—	PUNCT
ihlr-28406	268	10	—	—	PUNCT
ihlr-28406	268	11	—	—	PUNCT
ihlr-28406	268	12	—	—	PUNCT
ihlr-28406	268	13	—	—	PUNCT
ihlr-28406	268	14	—	—	PUNCT
ihlr-28406	268	15	—	—	PUNCT
ihlr-28406	268	16	—	—	PUNCT
ihlr-28406	268	17	—	—	PUNCT
ihlr-28406	268	18	—	—	PUNCT
ihlr-28406	268	19	—	—	PUNCT
ihlr-28406	268	20	—	—	PUNCT
ihlr-28406	268	21	—	—	PUNCT
ihlr-28406	268	22	—	—	PUNCT
ihlr-28406	268	23	—	—	PUNCT
ihlr-28406	268	24	—	—	PUNCT
ihlr-28406	268	25	—	—	PUNCT
ihlr-28406	268	26	—	—	PUNCT
ihlr-28406	268	27	—	—	PUNCT
ihlr-28406	268	28	—	—	PUNCT
ihlr-28406	268	29	—	—	PUNCT
ihlr-28406	268	30	—	—	PUNCT
ihlr-28406	268	31	88	88	NUM
ihlr-28406	268	32	.	.	PUNCT
ihlr-28406	268	33	levothyroxine	levothyroxine	PROPN
ihlr-28406	268	34	compositions	composition	NOUN
ihlr-28406	268	35	&	&	CCONJ
ihlr-28406	268	36	methods	method	NOUN
ihlr-28406	268	37	,	,	PUNCT
ihlr-28406	268	38	u.s	u.s	PROPN
ihlr-28406	268	39	.	.	PROPN
ihlr-28406	268	40	patent	patent	NOUN
ihlr-28406	268	41	no	no	PROPN
ihlr-28406	268	42	.	.	PUNCT
ihlr-28406	268	43	6,555,581	6,555,581	NUM
ihlr-28406	268	44	(	(	PUNCT
ihlr-28406	268	45	filed	file	VERB
ihlr-28406	268	46	feb	feb	PROPN
ihlr-28406	268	47	.	.	PROPN
ihlr-28406	268	48	15	15	NUM
ihlr-28406	268	49	,	,	PUNCT
ihlr-28406	268	50	2002	2002	NUM
ihlr-28406	268	51	)	)	PUNCT
ihlr-28406	268	52	(	(	PUNCT
ihlr-28406	268	53	“	"	PUNCT
ihlr-28406	268	54	thyroid	thyroid	VERB
ihlr-28406	268	55	hormone	hormone	NOUN
ihlr-28406	268	56	replacement	replacement	NOUN
ihlr-28406	268	57	therapy	therapy	NOUN
ihlr-28406	268	58	is	be	AUX
ihlr-28406	268	59	a	a	DET
ihlr-28406	268	60	chronic	chronic	NOUN
ihlr-28406	268	61	and	and	CCONJ
ihlr-28406	268	62	lifetime	lifetime	NOUN
ihlr-28406	268	63	endeavor	endeavor	NOUN
ihlr-28406	268	64	for	for	ADP
ihlr-28406	268	65	treatment	treatment	NOUN
ihlr-28406	268	66	.	.	PUNCT
ihlr-28406	269	1	thyroid	thyroid	NOUN
ihlr-28406	269	2	hormone	hormone	NOUN
ihlr-28406	269	3	dosage	dosage	NOUN
ihlr-28406	269	4	must	must	AUX
ihlr-28406	269	5	be	be	AUX
ihlr-28406	269	6	established	establish	VERB
ihlr-28406	269	7	for	for	ADP
ihlr-28406	269	8	each	each	DET
ihlr-28406	269	9	patient	patient	NOUN
ihlr-28406	269	10	individually	individually	ADV
ihlr-28406	269	11	.	.	PUNCT
ihlr-28406	269	12	”	"	PUNCT
ihlr-28406	269	13	)	)	PUNCT
ihlr-28406	269	14	.	.	PUNCT
ihlr-28406	270	1	89	89	NUM
ihlr-28406	270	2	.	.	PUNCT
ihlr-28406	270	3	am	be	AUX
ihlr-28406	270	4	.	.	PUNCT
ihlr-28406	271	1	thyroid	thyroid	PROPN
ihlr-28406	271	2	ass’n	ass’n	NOUN
ihlr-28406	271	3	,	,	PUNCT
ihlr-28406	271	4	supra	supra	PROPN
ihlr-28406	271	5	note	note	NOUN
ihlr-28406	271	6	7	7	NUM
ihlr-28406	271	7	,	,	PUNCT
ihlr-28406	271	8	at	at	ADP
ihlr-28406	271	9	12	12	NUM
ihlr-28406	271	10	;	;	PUNCT
ihlr-28406	271	11	see	see	AUX
ihlr-28406	271	12	also	also	ADV
ihlr-28406	271	13	squire	squire	VERB
ihlr-28406	271	14	et	et	PROPN
ihlr-28406	271	15	al	al	PROPN
ihlr-28406	271	16	.	.	PROPN
ihlr-28406	271	17	,	,	PUNCT
ihlr-28406	271	18	supra	supra	PROPN
ihlr-28406	271	19	note	note	PROPN
ihlr-28406	271	20	8	8	NUM
ihlr-28406	271	21	,	,	PUNCT
ihlr-28406	271	22	at	at	ADP
ihlr-28406	271	23	912	912	NUM
ihlr-28406	271	24	(	(	PUNCT
ihlr-28406	271	25	“	"	PUNCT
ihlr-28406	271	26	for	for	ADP
ihlr-28406	271	27	example	example	NOUN
ihlr-28406	271	28	,	,	PUNCT
ihlr-28406	271	29	hypothyroidism	hypothyroidism	NOUN
ihlr-28406	271	30	generally	generally	ADV
ihlr-28406	271	31	is	be	AUX
ihlr-28406	271	32	treated	treat	VERB
ihlr-28406	271	33	by	by	ADP
ihlr-28406	271	34	thyroid	thyroid	NOUN
ihlr-28406	271	35	hormone	hormone	NOUN
ihlr-28406	271	36	replacement	replacement	NOUN
ihlr-28406	271	37	.	.	PUNCT
ihlr-28406	271	38	”	"	PUNCT
ihlr-28406	271	39	)	)	PUNCT
ihlr-28406	271	40	.	.	PUNCT
ihlr-28406	272	1	90	90	NUM
ihlr-28406	272	2	.	.	PUNCT
ihlr-28406	273	1	‘	'	PUNCT
ihlr-28406	273	2	680	680	NUM
ihlr-28406	273	3	patent	patent	NOUN
ihlr-28406	273	4	.	.	PUNCT
ihlr-28406	274	1	91	91	NUM
ihlr-28406	274	2	.	.	PUNCT
ihlr-28406	275	1	‘	'	PUNCT
ihlr-28406	275	2	127	127	NUM
ihlr-28406	275	3	patent	patent	NOUN
ihlr-28406	275	4	(	(	PUNCT
ihlr-28406	275	5	“	"	PUNCT
ihlr-28406	275	6	in	in	ADP
ihlr-28406	275	7	hyperthyroidism	hyperthyroidism	NOUN
ihlr-28406	275	8	,	,	PUNCT
ihlr-28406	275	9	these	these	DET
ihlr-28406	275	10	hormones	hormone	NOUN
ihlr-28406	275	11	lead	lead	VERB
ihlr-28406	275	12	to	to	ADP
ihlr-28406	275	13	weight	weight	NOUN
ihlr-28406	275	14	loss	loss	NOUN
ihlr-28406	275	15	,	,	PUNCT
ihlr-28406	275	16	hypermetabolism	hypermetabolism	NOUN
ihlr-28406	275	17	,	,	PUNCT
ihlr-28406	275	18	lowering	lower	VERB
ihlr-28406	275	19	of	of	ADP
ihlr-28406	275	20	serum	serum	NOUN
ihlr-28406	275	21	ldl	ldl	NOUN
ihlr-28406	275	22	levels	level	NOUN
ihlr-28406	275	23	,	,	PUNCT
ihlr-28406	275	24	cardiac	cardiac	ADJ
ihlr-28406	275	25	arrhythmias	arrhythmia	NOUN
ihlr-28406	275	26	,	,	PUNCT
ihlr-28406	275	27	heart	heart	NOUN
ihlr-28406	275	28	failure	failure	NOUN
ihlr-28406	275	29	,	,	PUNCT
ihlr-28406	275	30	muscle	muscle	NOUN
ihlr-28406	275	31	weakness	weakness	NOUN
ihlr-28406	275	32	,	,	PUNCT
ihlr-28406	275	33	bone	bone	NOUN
ihlr-28406	275	34	loss	loss	NOUN
ihlr-28406	275	35	in	in	ADP
ihlr-28406	275	36	postmenopausal	postmenopausal	ADJ
ihlr-28406	275	37	women	woman	NOUN
ihlr-28406	275	38	,	,	PUNCT
ihlr-28406	275	39	and	and	CCONJ
ihlr-28406	275	40	anxiety	anxiety	NOUN
ihlr-28406	275	41	.	.	PUNCT
ihlr-28406	275	42	”	"	PUNCT
ihlr-28406	275	43	)	)	PUNCT
ihlr-28406	275	44	.	.	PUNCT
ihlr-28406	276	1	92	92	NUM
ihlr-28406	276	2	.	.	PUNCT
ihlr-28406	277	1	‘	'	PUNCT
ihlr-28406	277	2	581	581	NUM
ihlr-28406	277	3	patent	patent	NOUN
ihlr-28406	277	4	;	;	PUNCT
ihlr-28406	277	5	see	see	VERB
ihlr-28406	277	6	also	also	ADV
ihlr-28406	277	7	am	be	AUX
ihlr-28406	277	8	.	.	PUNCT
ihlr-28406	278	1	thyroid	thyroid	PROPN
ihlr-28406	278	2	ass’n	ass’n	NOUN
ihlr-28406	278	3	,	,	PUNCT
ihlr-28406	278	4	supra	supra	PROPN
ihlr-28406	278	5	note	note	NOUN
ihlr-28406	278	6	7	7	NUM
ihlr-28406	278	7	,	,	PUNCT
ihlr-28406	278	8	at	at	ADP
ihlr-28406	278	9	18	18	NUM
ihlr-28406	278	10	(	(	PUNCT
ihlr-28406	278	11	“	"	PUNCT
ihlr-28406	278	12	the	the	DET
ihlr-28406	278	13	most	most	ADV
ihlr-28406	278	14	common	common	ADJ
ihlr-28406	278	15	symptoms	symptom	NOUN
ihlr-28406	278	16	of	of	ADP
ihlr-28406	278	17	too	too	ADV
ihlr-28406	278	18	much	much	ADJ
ihlr-28406	278	19	thyroid	thyroid	NOUN
ihlr-28406	278	20	hormone	hormone	NOUN
ihlr-28406	278	21	are	be	AUX
ihlr-28406	278	22	fatigue	fatigue	NOUN
ihlr-28406	278	23	,	,	PUNCT
ihlr-28406	278	24	the	the	DET
ihlr-28406	278	25	inability	inability	NOUN
ihlr-28406	278	26	to	to	PART
ihlr-28406	278	27	sleep	sleep	VERB
ihlr-28406	278	28	,	,	PUNCT
ihlr-28406	278	29	greater	great	ADJ
ihlr-28406	278	30	appetite	appetite	NOUN
ihlr-28406	278	31	,	,	PUNCT
ihlr-28406	278	32	nervousness	nervousness	NOUN
ihlr-28406	278	33	,	,	PUNCT
ihlr-28406	278	34	shakiness	shakiness	NOUN
ihlr-28406	278	35	,	,	PUNCT
ihlr-28406	278	36	feeling	feel	VERB
ihlr-28406	278	37	hot	hot	ADJ
ihlr-28406	278	38	when	when	SCONJ
ihlr-28406	278	39	other	other	ADJ
ihlr-28406	278	40	people	people	NOUN
ihlr-28406	278	41	are	be	AUX
ihlr-28406	278	42	cold	cold	ADJ
ihlr-28406	278	43	,	,	PUNCT
ihlr-28406	278	44	muscle	muscle	NOUN
ihlr-28406	278	45	weakness	weakness	NOUN
ihlr-28406	278	46	,	,	PUNCT
ihlr-28406	278	47	shortness	shortness	NOUN
ihlr-28406	278	48	of	of	ADP
ihlr-28406	278	49	breath	breath	NOUN
ihlr-28406	278	50	,	,	PUNCT
ihlr-28406	278	51	and	and	CCONJ
ihlr-28406	278	52	a	a	DET
ihlr-28406	278	53	racing	racing	NOUN
ihlr-28406	278	54	,	,	PUNCT
ihlr-28406	278	55	skipping	skip	VERB
ihlr-28406	278	56	heart	heart	NOUN
ihlr-28406	278	57	.	.	PUNCT
ihlr-28406	278	58	”	"	PUNCT
ihlr-28406	278	59	)	)	PUNCT
ihlr-28406	278	60	.	.	PUNCT
ihlr-28406	279	1	93	93	NUM
ihlr-28406	279	2	.	.	PUNCT
ihlr-28406	280	1	storage	storage	NOUN
ihlr-28406	280	2	stable	stable	ADJ
ihlr-28406	280	3	thyroxine	thyroxine	NOUN
ihlr-28406	280	4	active	active	ADJ
ihlr-28406	280	5	drug	drug	NOUN
ihlr-28406	280	6	formulations	formulation	NOUN
ihlr-28406	280	7	&	&	CCONJ
ihlr-28406	280	8	methods	method	NOUN
ihlr-28406	280	9	for	for	ADP
ihlr-28406	280	10	their	their	PRON
ihlr-28406	280	11	production	production	NOUN
ihlr-28406	280	12	,	,	PUNCT
ihlr-28406	280	13	u.s	u.s	PROPN
ihlr-28406	280	14	.	.	PROPN
ihlr-28406	280	15	patent	patent	NOUN
ihlr-28406	280	16	no	no	PROPN
ihlr-28406	280	17	.	.	PROPN
ihlr-28406	280	18	6,936,274	6,936,274	NUM
ihlr-28406	280	19	(	(	PUNCT
ihlr-28406	280	20	filed	file	VERB
ihlr-28406	280	21	may	may	PROPN
ihlr-28406	280	22	22	22	NUM
ihlr-28406	280	23	,	,	PUNCT
ihlr-28406	280	24	2003	2003	NUM
ihlr-28406	280	25	)	)	PUNCT
ihlr-28406	280	26	.	.	PUNCT
ihlr-28406	281	1	94	94	NUM
ihlr-28406	281	2	.	.	PUNCT
ihlr-28406	281	3	am	be	AUX
ihlr-28406	281	4	.	.	PUNCT
ihlr-28406	282	1	thyroid	thyroid	PROPN
ihlr-28406	282	2	ass’n	ass’n	NOUN
ihlr-28406	282	3	,	,	PUNCT
ihlr-28406	282	4	supra	supra	PROPN
ihlr-28406	282	5	note	note	NOUN
ihlr-28406	282	6	7	7	NUM
ihlr-28406	282	7	,	,	PUNCT
ihlr-28406	282	8	at	at	ADP
ihlr-28406	282	9	12	12	NUM
ihlr-28406	282	10	.	.	PUNCT
ihlr-28406	282	11	95	95	NUM
ihlr-28406	282	12	.	.	PUNCT
ihlr-28406	283	1	i	i	PRON
ihlr-28406	283	2	d.	d.	PROPN
ihlr-28406	283	3	at	at	ADP
ihlr-28406	283	4	13	13	NUM
ihlr-28406	283	5	.	.	PUNCT
ihlr-28406	284	1	96	96	NUM
ihlr-28406	284	2	.	.	PUNCT
ihlr-28406	285	1	there	there	PRON
ihlr-28406	285	2	are	be	VERB
ihlr-28406	285	3	three	three	NUM
ihlr-28406	285	4	major	major	ADJ
ihlr-28406	285	5	problems	problem	NOUN
ihlr-28406	285	6	with	with	ADP
ihlr-28406	285	7	daily	daily	ADJ
ihlr-28406	285	8	oral	oral	ADJ
ihlr-28406	285	9	levothyroxine	levothyroxine	NOUN
ihlr-28406	285	10	for	for	ADP
ihlr-28406	285	11	treating	treat	VERB
ihlr-28406	285	12	hypothyroidism	hypothyroidism	NOUN
ihlr-28406	285	13	:	:	PUNCT
ihlr-28406	285	14	(	(	PUNCT
ihlr-28406	285	15	1	1	X
ihlr-28406	285	16	)	)	PUNCT
ihlr-28406	285	17	fluctuation	fluctuation	NOUN
ihlr-28406	285	18	in	in	ADP
ihlr-28406	285	19	ingestion	ingestion	NOUN
ihlr-28406	285	20	times	time	NOUN
ihlr-28406	285	21	and	and	CCONJ
ihlr-28406	285	22	surrounding	surround	VERB
ihlr-28406	285	23	dietary	dietary	ADJ
ihlr-28406	285	24	conditions	condition	NOUN
ihlr-28406	285	25	causes	cause	VERB
ihlr-28406	285	26	metabolic	metabolic	ADJ
ihlr-28406	285	27	imbalance	imbalance	NOUN
ihlr-28406	285	28	;	;	PUNCT
ihlr-28406	285	29	(	(	PUNCT
ihlr-28406	285	30	2	2	X
ihlr-28406	285	31	)	)	PUNCT
ihlr-28406	285	32	fluctuation	fluctuation	NOUN
ihlr-28406	285	33	in	in	ADP
ihlr-28406	285	34	patient	patient	NOUN
ihlr-28406	285	35	needs	need	NOUN
ihlr-28406	285	36	causes	cause	VERB
ihlr-28406	285	37	metabolic	metabolic	ADJ
ihlr-28406	285	38	imbalance	imbalance	NOUN
ihlr-28406	285	39	;	;	PUNCT
ihlr-28406	285	40	and	and	CCONJ
ihlr-28406	285	41	(	(	PUNCT
ihlr-28406	285	42	3	3	X
ihlr-28406	285	43	)	)	PUNCT
ihlr-28406	285	44	fluctuation	fluctuation	NOUN
ihlr-28406	285	45	in	in	ADP
ihlr-28406	285	46	brand	brand	NOUN
ihlr-28406	285	47	name	name	NOUN
ihlr-28406	285	48	may	may	AUX
ihlr-28406	285	49	cause	cause	VERB
ihlr-28406	285	50	metabolic	metabolic	ADJ
ihlr-28406	285	51	imbalance	imbalance	NOUN
ihlr-28406	285	52	.	.	PUNCT
ihlr-28406	286	1	the	the	DET
ihlr-28406	286	2	disclosed	disclose	VERB
ihlr-28406	286	3	invention	invention	NOUN
ihlr-28406	286	4	solves	solve	VERB
ihlr-28406	286	5	these	these	DET
ihlr-28406	286	6	three	three	NUM
ihlr-28406	286	7	problems	problem	NOUN
ihlr-28406	286	8	,	,	PUNCT
ihlr-28406	286	9	providing	provide	VERB
ihlr-28406	286	10	methods	method	NOUN
ihlr-28406	286	11	for	for	ADP
ihlr-28406	286	12	curing	cure	VERB
ihlr-28406	286	13	hypothyroidism	hypothyroidism	NOUN
ihlr-28406	286	14	with	with	ADP
ihlr-28406	286	15	automatic	automatic	ADJ
ihlr-28406	286	16	monitoring	monitoring	NOUN
ihlr-28406	286	17	and	and	CCONJ
ihlr-28406	286	18	corrective	corrective	ADJ
ihlr-28406	286	19	release	release	NOUN
ihlr-28406	286	20	to	to	PART
ihlr-28406	286	21	maintain	maintain	VERB
ihlr-28406	286	22	metabolic	metabolic	NOUN
ihlr-28406	286	23	homeostasis	homeostasis	NOUN
ihlr-28406	286	24	.	.	PUNCT
ihlr-28406	287	1	see	see	VERB
ihlr-28406	287	2	nienke	nienke	PROPN
ihlr-28406	287	3	bolk	bolk	PROPN
ihlr-28406	287	4	et	et	PROPN
ihlr-28406	287	5	al	al	PROPN
ihlr-28406	287	6	.	.	PROPN
ihlr-28406	287	7	,	,	PUNCT
ihlr-28406	287	8	effects	effect	NOUN
ihlr-28406	287	9	of	of	ADP
ihlr-28406	287	10	evening	evening	NOUN
ihlr-28406	287	11	vs	vs	ADP
ihlr-28406	287	12	morning	morning	NOUN
ihlr-28406	287	13	levothyroxine	levothyroxine	PROPN
ihlr-28406	287	14	intake	intake	NOUN
ihlr-28406	287	15	,	,	PUNCT
ihlr-28406	287	16	170	170	NUM
ihlr-28406	287	17	archives	archive	NOUN
ihlr-28406	287	18	internal	internal	ADJ
ihlr-28406	287	19	med	med	ADJ
ihlr-28406	287	20	.	.	PROPN
ihlr-28406	287	21	1	1	NUM
ihlr-28406	287	22	,	,	PUNCT
ihlr-28406	287	23	1	1	NUM
ihlr-28406	287	24	(	(	PUNCT
ihlr-28406	287	25	2010	2010	NUM
ihlr-28406	287	26	)	)	PUNCT
ihlr-28406	287	27	.	.	PUNCT
ihlr-28406	288	1	97	97	NUM
ihlr-28406	288	2	.	.	PUNCT
ihlr-28406	289	1	see	see	VERB
ihlr-28406	289	2	appendix	appendix	PROPN
ihlr-28406	289	3	c.	c.	PROPN
ihlr-28406	289	4	levothyroxine	levothyroxine	PROPN
ihlr-28406	289	5	tablet	tablet	PROPN
ihlr-28406	289	6	information	information	NOUN
ihlr-28406	289	7	;	;	PUNCT
ihlr-28406	289	8	see	see	VERB
ihlr-28406	289	9	also	also	ADV
ihlr-28406	289	10	am	be	AUX
ihlr-28406	289	11	.	.	PUNCT
ihlr-28406	290	1	thyroid	thyroid	PROPN
ihlr-28406	290	2	ass’n	ass’n	NOUN
ihlr-28406	290	3	,	,	PUNCT
ihlr-28406	290	4	supra	supra	PROPN
ihlr-28406	290	5	note	note	NOUN
ihlr-28406	290	6	7	7	NUM
ihlr-28406	290	7	,	,	PUNCT
ihlr-28406	290	8	at	at	ADP
ihlr-28406	290	9	11	11	NUM
ihlr-28406	290	10	(	(	PUNCT
ihlr-28406	290	11	in	in	ADP
ihlr-28406	290	12	the	the	DET
ihlr-28406	290	13	united	united	PROPN
ihlr-28406	290	14	states	states	PROPN
ihlr-28406	290	15	,	,	PUNCT
ihlr-28406	290	16	thyroxine	thyroxine	NOUN
ihlr-28406	290	17	pills	pill	NOUN
ihlr-28406	290	18	contain	contain	VERB
ihlr-28406	290	19	only	only	ADV
ihlr-28406	290	20	t4	t4	PROPN
ihlr-28406	290	21	.	.	PUNCT
ihlr-28406	291	1	however	however	ADV
ihlr-28406	291	2	,	,	PUNCT
ihlr-28406	291	3	some	some	DET
ihlr-28406	291	4	researchers	researcher	NOUN
ihlr-28406	291	5	speculate	speculate	VERB
ihlr-28406	291	6	whether	whether	SCONJ
ihlr-28406	291	7	a	a	DET
ihlr-28406	291	8	combination	combination	NOUN
ihlr-28406	291	9	of	of	ADP
ihlr-28406	291	10	t4	t4	PROPN
ihlr-28406	291	11	and	and	CCONJ
ihlr-28406	291	12	t3	t3	PROPN
ihlr-28406	291	13	might	might	AUX
ihlr-28406	291	14	be	be	AUX
ihlr-28406	291	15	better	well	ADJ
ihlr-28406	291	16	for	for	ADP
ihlr-28406	291	17	treating	treat	VERB
ihlr-28406	291	18	patients	patient	NOUN
ihlr-28406	291	19	.	.	PUNCT
ihlr-28406	292	1	while	while	SCONJ
ihlr-28406	292	2	there	there	PRON
ihlr-28406	292	3	have	have	AUX
ihlr-28406	292	4	been	be	AUX
ihlr-28406	292	5	some	some	DET
ihlr-28406	292	6	early	early	ADJ
ihlr-28406	292	7	studies	study	NOUN
ihlr-28406	292	8	,	,	PUNCT
ihlr-28406	292	9	the	the	DET
ihlr-28406	292	10	results	result	NOUN
ihlr-28406	292	11	have	have	AUX
ihlr-28406	292	12	not	not	PART
ihlr-28406	292	13	been	be	AUX
ihlr-28406	292	14	particularly	particularly	ADV
ihlr-28406	292	15	promising	promising	ADJ
ihlr-28406	292	16	.	.	PUNCT
ihlr-28406	292	17	)	)	PUNCT
ihlr-28406	292	18	.	.	PUNCT
ihlr-28406	293	1	indiana	indiana	PROPN
ihlr-28406	293	2	health	health	PROPN
ihlr-28406	293	3	law	law	PROPN
ihlr-28406	293	4	review	review	NOUN
ihlr-28406	293	5	[	[	X
ihlr-28406	293	6	vol	vol	NOUN
ihlr-28406	293	7	.	.	PUNCT
ihlr-28406	294	1	21:277	21:277	NOUN
ihlr-28406	294	2	288	288	NUM
ihlr-28406	294	3	figure	figure	NOUN
ihlr-28406	294	4	3	3	NUM
ihlr-28406	294	5	98	98	NUM
ihlr-28406	294	6	variations	variation	NOUN
ihlr-28406	294	7	in	in	ADP
ihlr-28406	294	8	hyperthyroidism	hyperthyroidism	NOUN
ihlr-28406	294	9	manifestations	manifestation	NOUN
ihlr-28406	294	10	and	and	CCONJ
ihlr-28406	294	11	corresponding	correspond	VERB
ihlr-28406	294	12	cardiovascular	cardiovascular	ADJ
ihlr-28406	294	13	concerns	concern	NOUN
ihlr-28406	294	14	limit	limit	VERB
ihlr-28406	294	15	treatment	treatment	NOUN
ihlr-28406	294	16	options	option	NOUN
ihlr-28406	294	17	for	for	ADP
ihlr-28406	294	18	hypothyroid	hypothyroid	ADJ
ihlr-28406	294	19	symptoms	symptom	NOUN
ihlr-28406	294	20	.	.	PUNCT
ihlr-28406	295	1	99	99	NUM
ihlr-28406	295	2	however	however	ADV
ihlr-28406	295	3	,	,	PUNCT
ihlr-28406	295	4	drug	drug	NOUN
ihlr-28406	295	5	therapy	therapy	NOUN
ihlr-28406	295	6	for	for	ADP
ihlr-28406	295	7	hyperthyroidism	hyperthyroidism	NOUN
ihlr-28406	295	8	typically	typically	ADV
ihlr-28406	295	9	involves	involve	VERB
ihlr-28406	295	10	antithyroid	antithyroid	ADJ
ihlr-28406	295	11	drugs	drug	NOUN
ihlr-28406	295	12	.	.	PUNCT
ihlr-28406	296	1	100	100	NUM
ihlr-28406	296	2	two	two	NUM
ihlr-28406	296	3	main	main	ADJ
ihlr-28406	296	4	antithyroid	antithyroid	NOUN
ihlr-28406	296	5	drugs	drug	NOUN
ihlr-28406	296	6	are	be	AUX
ihlr-28406	296	7	propylthiouracil	propylthiouracil	ADJ
ihlr-28406	296	8	and	and	CCONJ
ihlr-28406	296	9	methimazole	methimazole	NOUN
ihlr-28406	296	10	,	,	PUNCT
ihlr-28406	296	11	which	which	PRON
ihlr-28406	296	12	inhibit	inhibit	VERB
ihlr-28406	296	13	organic	organic	ADJ
ihlr-28406	296	14	iodine	iodine	NOUN
ihlr-28406	296	15	binding	bind	VERB
ihlr-28406	296	16	.	.	PUNCT
ihlr-28406	297	1	101	101	NUM
ihlr-28406	297	2	additionally	additionally	ADV
ihlr-28406	297	3	,	,	PUNCT
ihlr-28406	297	4	in	in	ADP
ihlr-28406	297	5	some	some	DET
ihlr-28406	297	6	cases	case	NOUN
ihlr-28406	297	7	treatment	treatment	NOUN
ihlr-28406	297	8	with	with	ADP
ihlr-28406	297	9	glucocorticoids102	glucocorticoids102	PROPN
ihlr-28406	297	10	has	have	AUX
ihlr-28406	297	11	shown	show	VERB
ihlr-28406	297	12	limited	limited	ADJ
ihlr-28406	297	13	effect	effect	NOUN
ihlr-28406	297	14	in	in	ADP
ihlr-28406	297	15	treating	treat	VERB
ihlr-28406	297	16	hyperthyroidism	hyperthyroidism	NOUN
ihlr-28406	297	17	.	.	PUNCT
ihlr-28406	298	1	103	103	NUM
ihlr-28406	298	2	yet	yet	ADV
ihlr-28406	298	3	,	,	PUNCT
ihlr-28406	298	4	key	key	ADJ
ihlr-28406	298	5	problems	problem	NOUN
ihlr-28406	298	6	persist	persist	VERB
ihlr-28406	298	7	.	.	PUNCT
ihlr-28406	299	1	for	for	ADP
ihlr-28406	299	2	example	example	NOUN
ihlr-28406	299	3	,	,	PUNCT
ihlr-28406	299	4	pharmacists	pharmacist	NOUN
ihlr-28406	299	5	often	often	ADV
ihlr-28406	299	6	switch	switch	VERB
ihlr-28406	299	7	between	between	ADP
ihlr-28406	299	8	lt4	lt4	PROPN
ihlr-28406	299	9	formulations	formulation	NOUN
ihlr-28406	299	10	which	which	PRON
ihlr-28406	299	11	have	have	AUX
ihlr-28406	299	12	been	be	AUX
ihlr-28406	299	13	determined	determine	VERB
ihlr-28406	299	14	bioequivalent	bioequivalent	NOUN
ihlr-28406	299	15	.	.	PUNCT
ihlr-28406	300	1	104	104	NUM
ihlr-28406	300	2	however	however	ADV
ihlr-28406	300	3	,	,	PUNCT
ihlr-28406	300	4	even	even	ADV
ihlr-28406	300	5	small	small	ADJ
ihlr-28406	300	6	differences	difference	NOUN
ihlr-28406	300	7	between	between	ADP
ihlr-28406	300	8	lt4	lt4	PROPN
ihlr-28406	300	9	formulations	formulation	NOUN
ihlr-28406	300	10	can	can	AUX
ihlr-28406	300	11	cause	cause	VERB
ihlr-28406	300	12	significant	significant	ADJ
ihlr-28406	300	13	changes	change	NOUN
ihlr-28406	300	14	in	in	ADP
ihlr-28406	300	15	tsh	tsh	ADJ
ihlr-28406	300	16	levels	level	NOUN
ihlr-28406	300	17	.	.	PUNCT
ihlr-28406	301	1	105	105	NUM
ihlr-28406	301	2	changes	change	NOUN
ihlr-28406	301	3	may	may	AUX
ihlr-28406	301	4	cause	cause	VERB
ihlr-28406	301	5	clinical	clinical	ADJ
ihlr-28406	301	6	symptoms	symptom	NOUN
ihlr-28406	301	7	,	,	PUNCT
ihlr-28406	301	8	some	some	PRON
ihlr-28406	301	9	of	of	ADP
ihlr-28406	301	10	which	which	PRON
ihlr-28406	301	11	can	can	AUX
ihlr-28406	301	12	be	be	AUX
ihlr-28406	301	13	caused	cause	VERB
ihlr-28406	301	14	by	by	ADP
ihlr-28406	301	15	inactive	inactive	ADJ
ihlr-28406	301	16	ingredients	ingredient	NOUN
ihlr-28406	301	17	.	.	PUNCT
ihlr-28406	302	1	106	106	NUM
ihlr-28406	302	2	as	as	ADP
ihlr-28406	302	3	such	such	ADJ
ihlr-28406	302	4	,	,	PUNCT
ihlr-28406	302	5	pharmaceutical	pharmaceutical	ADJ
ihlr-28406	302	6	swapping	swapping	NOUN
ihlr-28406	302	7	is	be	AUX
ihlr-28406	302	8	a	a	DET
ihlr-28406	302	9	particular	particular	ADJ
ihlr-28406	302	10	concern	concern	NOUN
ihlr-28406	302	11	in	in	ADP
ihlr-28406	302	12	vulnerable	vulnerable	ADJ
ihlr-28406	302	13	populations	population	NOUN
ihlr-28406	302	14	,	,	PUNCT
ihlr-28406	302	15	including	include	VERB
ihlr-28406	302	16	elderly	elderly	ADJ
ihlr-28406	302	17	,	,	PUNCT
ihlr-28406	302	18	pregnant	pregnant	ADJ
ihlr-28406	302	19	,	,	PUNCT
ihlr-28406	302	20	and	and	CCONJ
ihlr-28406	302	21	pediatric	pediatric	ADJ
ihlr-28406	302	22	patients	patient	NOUN
ihlr-28406	302	23	.	.	PUNCT
ihlr-28406	303	1	107	107	NUM
ihlr-28406	303	2	an	an	DET
ihlr-28406	303	3	important	important	ADJ
ihlr-28406	303	4	area	area	NOUN
ihlr-28406	303	5	for	for	ADP
ihlr-28406	303	6	improvement	improvement	NOUN
ihlr-28406	303	7	is	be	AUX
ihlr-28406	303	8	the	the	DET
ihlr-28406	303	9	development	development	NOUN
ihlr-28406	303	10	of	of	ADP
ihlr-28406	303	11	combination	combination	NOUN
ihlr-28406	303	12	therapy	therapy	NOUN
ihlr-28406	303	13	.	.	PUNCT
ihlr-28406	304	1	one	one	NUM
ihlr-28406	304	2	problem	problem	NOUN
ihlr-28406	304	3	with	with	ADP
ihlr-28406	304	4	current	current	ADJ
ihlr-28406	304	5	treatment	treatment	NOUN
ihlr-28406	304	6	options	option	NOUN
ihlr-28406	304	7	is	be	AUX
ihlr-28406	304	8	they	they	PRON
ihlr-28406	304	9	only	only	ADV
ihlr-28406	304	10	include	include	VERB
ihlr-28406	304	11	t4	t4	PROPN
ihlr-28406	304	12	.	.	PROPN
ihlr-28406	305	1	—	—	PUNCT
ihlr-28406	305	2	—	—	PUNCT
ihlr-28406	305	3	—	—	PUNCT
ihlr-28406	305	4	—	—	PUNCT
ihlr-28406	305	5	—	—	PUNCT
ihlr-28406	305	6	—	—	PUNCT
ihlr-28406	305	7	—	—	PUNCT
ihlr-28406	305	8	—	—	PUNCT
ihlr-28406	305	9	—	—	PUNCT
ihlr-28406	305	10	—	—	PUNCT
ihlr-28406	305	11	—	—	PUNCT
ihlr-28406	305	12	—	—	PUNCT
ihlr-28406	305	13	—	—	PUNCT
ihlr-28406	305	14	—	—	PUNCT
ihlr-28406	305	15	—	—	PUNCT
ihlr-28406	305	16	—	—	PUNCT
ihlr-28406	305	17	—	—	PUNCT
ihlr-28406	305	18	—	—	PUNCT
ihlr-28406	305	19	—	—	PUNCT
ihlr-28406	305	20	—	—	PUNCT
ihlr-28406	305	21	—	—	PUNCT
ihlr-28406	305	22	—	—	PUNCT
ihlr-28406	305	23	—	—	PUNCT
ihlr-28406	305	24	—	—	PUNCT
ihlr-28406	305	25	—	—	PUNCT
ihlr-28406	305	26	—	—	PUNCT
ihlr-28406	305	27	—	—	PUNCT
ihlr-28406	305	28	—	—	PUNCT
ihlr-28406	305	29	—	—	PUNCT
ihlr-28406	305	30	98	98	NUM
ihlr-28406	305	31	.	.	PUNCT
ihlr-28406	306	1	‘	'	PUNCT
ihlr-28406	306	2	581	581	NUM
ihlr-28406	306	3	patent	patent	NOUN
ihlr-28406	306	4	.	.	PUNCT
ihlr-28406	307	1	99	99	NUM
ihlr-28406	307	2	.	.	PUNCT
ihlr-28406	308	1	‘	'	PUNCT
ihlr-28406	308	2	127	127	NUM
ihlr-28406	308	3	patent	patent	NOUN
ihlr-28406	308	4	(	(	PUNCT
ihlr-28406	308	5	“	"	PUNCT
ihlr-28406	308	6	prior	prior	ADJ
ihlr-28406	308	7	attempts	attempt	NOUN
ihlr-28406	308	8	to	to	PART
ihlr-28406	308	9	utilize	utilize	VERB
ihlr-28406	308	10	thyroid	thyroid	NOUN
ihlr-28406	308	11	hormones	hormone	NOUN
ihlr-28406	308	12	pharmacologically	pharmacologically	ADV
ihlr-28406	308	13	to	to	PART
ihlr-28406	308	14	treat	treat	VERB
ihlr-28406	308	15	these	these	DET
ihlr-28406	308	16	disorders	disorder	NOUN
ihlr-28406	308	17	have	have	AUX
ihlr-28406	308	18	been	be	AUX
ihlr-28406	308	19	limited	limit	VERB
ihlr-28406	308	20	by	by	ADP
ihlr-28406	308	21	manifestations	manifestation	NOUN
ihlr-28406	308	22	of	of	ADP
ihlr-28406	308	23	hyperthyroidism	hyperthyroidism	NOUN
ihlr-28406	308	24	,	,	PUNCT
ihlr-28406	308	25	and	and	CCONJ
ihlr-28406	308	26	in	in	ADP
ihlr-28406	308	27	particular	particular	ADJ
ihlr-28406	308	28	by	by	ADP
ihlr-28406	308	29	cardiovascular	cardiovascular	ADJ
ihlr-28406	308	30	toxicity	toxicity	NOUN
ihlr-28406	308	31	.	.	PUNCT
ihlr-28406	308	32	”	"	PUNCT
ihlr-28406	308	33	)	)	PUNCT
ihlr-28406	308	34	.	.	PUNCT
ihlr-28406	309	1	100	100	NUM
ihlr-28406	309	2	.	.	PUNCT
ihlr-28406	309	3	method	method	NOUN
ihlr-28406	309	4	for	for	ADP
ihlr-28406	309	5	treating	treat	VERB
ihlr-28406	309	6	thyroid	thyroid	NOUN
ihlr-28406	309	7	disorders	disorder	NOUN
ihlr-28406	309	8	with	with	ADP
ihlr-28406	309	9	a	a	DET
ihlr-28406	309	10	botulinum	botulinum	ADJ
ihlr-28406	309	11	toxin	toxin	NOUN
ihlr-28406	309	12	,	,	PUNCT
ihlr-28406	309	13	u.s	u.s	PROPN
ihlr-28406	309	14	.	.	PROPN
ihlr-28406	309	15	patent	patent	NOUN
ihlr-28406	309	16	no	no	PROPN
ihlr-28406	309	17	.	.	PROPN
ihlr-28406	310	1	6,740,321	6,740,321	NUM
ihlr-28406	310	2	(	(	PUNCT
ihlr-28406	310	3	filed	file	VERB
ihlr-28406	310	4	nov	nov	PROPN
ihlr-28406	310	5	.	.	PROPN
ihlr-28406	310	6	2	2	NUM
ihlr-28406	310	7	,	,	PUNCT
ihlr-28406	310	8	2000	2000	NUM
ihlr-28406	310	9	)	)	PUNCT
ihlr-28406	310	10	.	.	PUNCT
ihlr-28406	311	1	101	101	NUM
ihlr-28406	311	2	.	.	PUNCT
ihlr-28406	312	1	‘	'	PUNCT
ihlr-28406	312	2	321	321	NUM
ihlr-28406	312	3	patent	patent	NOUN
ihlr-28406	312	4	.	.	PUNCT
ihlr-28406	313	1	102	102	NUM
ihlr-28406	313	2	.	.	PUNCT
ihlr-28406	314	1	glucocorticoids	glucocorticoid	NOUN
ihlr-28406	314	2	are	be	AUX
ihlr-28406	314	3	corticosteroids	corticosteroid	NOUN
ihlr-28406	314	4	,	,	PUNCT
ihlr-28406	314	5	a	a	DET
ihlr-28406	314	6	class	class	NOUN
ihlr-28406	314	7	of	of	ADP
ihlr-28406	314	8	steroid	steroid	NOUN
ihlr-28406	314	9	hormones	hormone	NOUN
ihlr-28406	314	10	.	.	PUNCT
ihlr-28406	315	1	glucocorticoids	glucocorticoid	NOUN
ihlr-28406	315	2	bind	bind	VERB
ihlr-28406	315	3	to	to	ADP
ihlr-28406	315	4	the	the	DET
ihlr-28406	315	5	glucocorticoid	glucocorticoid	ADJ
ihlr-28406	315	6	receptor	receptor	NOUN
ihlr-28406	315	7	in	in	ADP
ihlr-28406	315	8	cells	cell	NOUN
ihlr-28406	315	9	.	.	PUNCT
ihlr-28406	316	1	103	103	NUM
ihlr-28406	316	2	.	.	PUNCT
ihlr-28406	317	1	‘	'	PUNCT
ihlr-28406	317	2	154	154	NUM
ihlr-28406	317	3	patent	patent	NOUN
ihlr-28406	317	4	.	.	PUNCT
ihlr-28406	318	1	104	104	NUM
ihlr-28406	318	2	.	.	PUNCT
ihlr-28406	319	1	salvatore	salvatore	PROPN
ihlr-28406	319	2	benvenga	benvenga	PROPN
ihlr-28406	319	3	&	&	CCONJ
ihlr-28406	319	4	allan	allan	PROPN
ihlr-28406	319	5	carlé	carlé	PROPN
ihlr-28406	319	6	,	,	PUNCT
ihlr-28406	319	7	levothyroxine	levothyroxine	PROPN
ihlr-28406	319	8	formulations	formulation	NOUN
ihlr-28406	319	9	:	:	PUNCT
ihlr-28406	319	10	pharmacological	pharmacological	ADJ
ihlr-28406	319	11	and	and	CCONJ
ihlr-28406	319	12	clinical	clinical	ADJ
ihlr-28406	319	13	implications	implication	NOUN
ihlr-28406	319	14	of	of	ADP
ihlr-28406	319	15	generic	generic	ADJ
ihlr-28406	319	16	substitution	substitution	NOUN
ihlr-28406	319	17	,	,	PUNCT
ihlr-28406	319	18	36	36	NUM
ihlr-28406	319	19	advances	advance	NOUN
ihlr-28406	319	20	in	in	ADP
ihlr-28406	319	21	therapy	therapy	NOUN
ihlr-28406	319	22	59	59	NUM
ihlr-28406	319	23	,	,	PUNCT
ihlr-28406	319	24	59	59	NUM
ihlr-28406	319	25	(	(	PUNCT
ihlr-28406	319	26	2019	2019	NUM
ihlr-28406	319	27	)	)	PUNCT
ihlr-28406	319	28	.	.	PUNCT
ihlr-28406	320	1	(	(	PUNCT
ihlr-28406	320	2	“	"	PUNCT
ihlr-28406	320	3	in	in	ADP
ihlr-28406	320	4	the	the	DET
ihlr-28406	320	5	us	us	PROPN
ihlr-28406	320	6	,	,	PUNCT
ihlr-28406	320	7	the	the	DET
ihlr-28406	320	8	food	food	NOUN
ihlr-28406	320	9	and	and	CCONJ
ihlr-28406	320	10	drug	drug	PROPN
ihlr-28406	320	11	administration	administration	PROPN
ihlr-28406	320	12	(	(	PUNCT
ihlr-28406	320	13	fda	fda	PROPN
ihlr-28406	320	14	)	)	PUNCT
ihlr-28406	320	15	has	have	AUX
ihlr-28406	320	16	developed	develop	VERB
ihlr-28406	320	17	a	a	DET
ihlr-28406	320	18	protocol	protocol	NOUN
ihlr-28406	320	19	for	for	ADP
ihlr-28406	320	20	establishing	establish	VERB
ihlr-28406	320	21	bioequivalence	bioequivalence	NOUN
ihlr-28406	320	22	of	of	ADP
ihlr-28406	320	23	lt4	lt4	PROPN
ihlr-28406	320	24	formulations	formulation	NOUN
ihlr-28406	320	25	based	base	VERB
ihlr-28406	320	26	on	on	ADP
ihlr-28406	320	27	serum	serum	NOUN
ihlr-28406	320	28	thyroxine	thyroxine	NOUN
ihlr-28406	320	29	(	(	PUNCT
ihlr-28406	320	30	t4	t4	PROPN
ihlr-28406	320	31	)	)	PUNCT
ihlr-28406	320	32	levels	level	NOUN
ihlr-28406	320	33	after	after	ADP
ihlr-28406	320	34	a	a	DET
ihlr-28406	320	35	single	single	ADJ
ihlr-28406	320	36	oral	oral	ADJ
ihlr-28406	320	37	dose	dose	NOUN
ihlr-28406	320	38	administered	administer	VERB
ihlr-28406	320	39	to	to	ADP
ihlr-28406	320	40	healthy	healthy	ADJ
ihlr-28406	320	41	volunteers	volunteer	NOUN
ihlr-28406	320	42	.	.	PUNCT
ihlr-28406	320	43	”	"	PUNCT
ihlr-28406	320	44	)	)	PUNCT
ihlr-28406	320	45	.	.	PUNCT
ihlr-28406	321	1	see	see	VERB
ihlr-28406	321	2	also	also	ADV
ihlr-28406	321	3	am	be	AUX
ihlr-28406	321	4	.	.	PUNCT
ihlr-28406	322	1	thyroid	thyroid	PROPN
ihlr-28406	322	2	ass’n	ass’n	NOUN
ihlr-28406	322	3	,	,	PUNCT
ihlr-28406	322	4	supra	supra	PROPN
ihlr-28406	322	5	note	note	NOUN
ihlr-28406	322	6	7	7	NUM
ihlr-28406	322	7	,	,	PUNCT
ihlr-28406	322	8	at	at	ADP
ihlr-28406	322	9	12	12	NUM
ihlr-28406	322	10	.	.	PUNCT
ihlr-28406	323	1	(	(	PUNCT
ihlr-28406	323	2	“	"	PUNCT
ihlr-28406	323	3	this	this	PRON
ihlr-28406	323	4	is	be	AUX
ihlr-28406	323	5	because	because	SCONJ
ihlr-28406	323	6	generic	generic	ADJ
ihlr-28406	323	7	drugs	drug	NOUN
ihlr-28406	323	8	can	can	AUX
ihlr-28406	323	9	be	be	AUX
ihlr-28406	323	10	substituted	substitute	VERB
ihlr-28406	323	11	with	with	ADP
ihlr-28406	323	12	other	other	ADJ
ihlr-28406	323	13	generic	generic	ADJ
ihlr-28406	323	14	drugs	drug	NOUN
ihlr-28406	323	15	from	from	ADP
ihlr-28406	323	16	different	different	ADJ
ihlr-28406	323	17	manufacturers	manufacturer	NOUN
ihlr-28406	323	18	of	of	ADP
ihlr-28406	323	19	levothyroxine	levothyroxine	NOUN
ihlr-28406	323	20	each	each	DET
ihlr-28406	323	21	time	time	NOUN
ihlr-28406	323	22	you	you	PRON
ihlr-28406	323	23	get	get	VERB
ihlr-28406	323	24	your	your	PRON
ihlr-28406	323	25	prescriptions	prescription	NOUN
ihlr-28406	323	26	refilled	refill	VERB
ihlr-28406	323	27	.	.	PUNCT
ihlr-28406	323	28	”	"	PUNCT
ihlr-28406	324	1	)	)	PUNCT
ihlr-28406	324	2	105	105	NUM
ihlr-28406	324	3	.	.	PUNCT
ihlr-28406	324	4	benvenga	benvenga	PROPN
ihlr-28406	324	5	&	&	CCONJ
ihlr-28406	324	6	carlé	carlé	PROPN
ihlr-28406	324	7	,	,	PUNCT
ihlr-28406	324	8	supra	supra	PROPN
ihlr-28406	324	9	note	note	NOUN
ihlr-28406	324	10	104	104	NUM
ihlr-28406	324	11	.	.	PUNCT
ihlr-28406	324	12	106	106	NUM
ihlr-28406	324	13	.	.	PUNCT
ihlr-28406	325	1	see	see	VERB
ihlr-28406	325	2	appendix	appendix	PROPN
ihlr-28406	325	3	d.	d.	PROPN
ihlr-28406	325	4	see	see	VERB
ihlr-28406	325	5	also	also	ADV
ihlr-28406	325	6	benvenga	benvenga	PROPN
ihlr-28406	325	7	&	&	CCONJ
ihlr-28406	325	8	carlé	carlé	PROPN
ihlr-28406	325	9	,	,	PUNCT
ihlr-28406	325	10	supra	supra	PROPN
ihlr-28406	325	11	note	note	NOUN
ihlr-28406	325	12	104	104	NUM
ihlr-28406	325	13	.	.	PUNCT
ihlr-28406	326	1	(	(	PUNCT
ihlr-28406	326	2	patients	patient	NOUN
ihlr-28406	326	3	should	should	AUX
ihlr-28406	326	4	be	be	AUX
ihlr-28406	326	5	maintained	maintain	VERB
ihlr-28406	326	6	on	on	ADP
ihlr-28406	326	7	the	the	DET
ihlr-28406	326	8	same	same	ADJ
ihlr-28406	326	9	lt4	lt4	PROPN
ihlr-28406	326	10	preparation	preparation	NOUN
ihlr-28406	326	11	if	if	SCONJ
ihlr-28406	326	12	possible	possible	ADJ
ihlr-28406	326	13	.	.	PUNCT
ihlr-28406	327	1	if	if	SCONJ
ihlr-28406	327	2	the	the	DET
ihlr-28406	327	3	lt4	lt4	PROPN
ihlr-28406	327	4	preparation	preparation	NOUN
ihlr-28406	327	5	is	be	AUX
ihlr-28406	327	6	changed	change	VERB
ihlr-28406	327	7	,	,	PUNCT
ihlr-28406	327	8	tsh	tsh	NOUN
ihlr-28406	327	9	levels	level	NOUN
ihlr-28406	327	10	should	should	AUX
ihlr-28406	327	11	be	be	AUX
ihlr-28406	327	12	evaluated	evaluate	VERB
ihlr-28406	327	13	and	and	CCONJ
ihlr-28406	327	14	,	,	PUNCT
ihlr-28406	327	15	if	if	SCONJ
ihlr-28406	327	16	necessary	necessary	ADJ
ihlr-28406	327	17	,	,	PUNCT
ihlr-28406	327	18	the	the	DET
ihlr-28406	327	19	dose	dose	NOUN
ihlr-28406	327	20	of	of	ADP
ihlr-28406	327	21	lt4	lt4	PROPN
ihlr-28406	327	22	adjusted	adjust	VERB
ihlr-28406	327	23	.	.	PUNCT
ihlr-28406	327	24	)	)	PUNCT
ihlr-28406	328	1	107	107	NUM
ihlr-28406	328	2	.	.	PUNCT
ihlr-28406	329	1	benvenga	benvenga	PROPN
ihlr-28406	329	2	&	&	CCONJ
ihlr-28406	329	3	carlé	carlé	PROPN
ihlr-28406	329	4	,	,	PUNCT
ihlr-28406	329	5	supra	supra	PROPN
ihlr-28406	329	6	note	note	NOUN
ihlr-28406	329	7	104	104	NUM
ihlr-28406	329	8	.	.	PUNCT
ihlr-28406	329	9	2024	2024	NUM
ihlr-28406	329	10	]	]	PUNCT
ihlr-28406	329	11	inventions	invention	NOUN
ihlr-28406	329	12	and	and	CCONJ
ihlr-28406	329	13	patents	patent	NOUN
ihlr-28406	329	14	for	for	ADP
ihlr-28406	329	15	treating	treat	VERB
ihlr-28406	329	16	289	289	NUM
ihlr-28406	329	17	thyroid	thyroid	NOUN
ihlr-28406	329	18	disease	disease	NOUN
ihlr-28406	329	19	however	however	ADV
ihlr-28406	329	20	,	,	PUNCT
ihlr-28406	329	21	recent	recent	ADJ
ihlr-28406	329	22	research	research	NOUN
ihlr-28406	329	23	shows	show	VERB
ihlr-28406	329	24	that	that	SCONJ
ihlr-28406	329	25	the	the	DET
ihlr-28406	329	26	thyroid	thyroid	NOUN
ihlr-28406	329	27	produces	produce	VERB
ihlr-28406	329	28	both	both	CCONJ
ihlr-28406	329	29	t4	t4	PROPN
ihlr-28406	329	30	and	and	CCONJ
ihlr-28406	329	31	t3	t3	PROPN
ihlr-28406	329	32	.	.	PROPN
ihlr-28406	330	1	108	108	NUM
ihlr-28406	330	2	most	most	ADJ
ihlr-28406	330	3	of	of	ADP
ihlr-28406	330	4	the	the	DET
ihlr-28406	330	5	thyroid	thyroid	NOUN
ihlr-28406	330	6	hormone	hormone	NOUN
ihlr-28406	330	7	production	production	NOUN
ihlr-28406	330	8	is	be	AUX
ihlr-28406	330	9	t4	t4	PROPN
ihlr-28406	330	10	,	,	PUNCT
ihlr-28406	330	11	but	but	CCONJ
ihlr-28406	330	12	there	there	PRON
ihlr-28406	330	13	is	be	VERB
ihlr-28406	330	14	some	some	DET
ihlr-28406	330	15	t3	t3	NOUN
ihlr-28406	330	16	produced	produce	VERB
ihlr-28406	330	17	as	as	ADV
ihlr-28406	330	18	well	well	ADV
ihlr-28406	330	19	.	.	PUNCT
ihlr-28406	331	1	in	in	ADP
ihlr-28406	331	2	fact	fact	NOUN
ihlr-28406	331	3	,	,	PUNCT
ihlr-28406	331	4	treating	treat	VERB
ihlr-28406	331	5	patients	patient	NOUN
ihlr-28406	331	6	with	with	ADP
ihlr-28406	331	7	both	both	CCONJ
ihlr-28406	331	8	t4	t4	PROPN
ihlr-28406	331	9	and	and	CCONJ
ihlr-28406	331	10	t3	t3	PROPN
ihlr-28406	331	11	at	at	ADP
ihlr-28406	331	12	the	the	DET
ihlr-28406	331	13	right	right	ADJ
ihlr-28406	331	14	ratio	ratio	NOUN
ihlr-28406	331	15	would	would	AUX
ihlr-28406	331	16	help	help	VERB
ihlr-28406	331	17	with	with	ADP
ihlr-28406	331	18	treatment	treatment	NOUN
ihlr-28406	331	19	effectiveness	effectiveness	NOUN
ihlr-28406	331	20	.	.	PUNCT
ihlr-28406	332	1	for	for	ADP
ihlr-28406	332	2	example	example	NOUN
ihlr-28406	332	3	,	,	PUNCT
ihlr-28406	332	4	t3	t3	PROPN
ihlr-28406	332	5	supplementation	supplementation	NOUN
ihlr-28406	332	6	helps	help	VERB
ihlr-28406	332	7	with	with	ADP
ihlr-28406	332	8	depression.109	depression.109	PROPN
ihlr-28406	332	9	b.	b.	PROPN
ihlr-28406	332	10	data	data	PROPN
ihlr-28406	332	11	healthcare	healthcare	PROPN
ihlr-28406	332	12	will	will	AUX
ihlr-28406	332	13	be	be	AUX
ihlr-28406	332	14	the	the	DET
ihlr-28406	332	15	field	field	NOUN
ihlr-28406	332	16	having	have	VERB
ihlr-28406	332	17	the	the	DET
ihlr-28406	332	18	most	most	ADJ
ihlr-28406	332	19	impact	impact	NOUN
ihlr-28406	332	20	on	on	ADP
ihlr-28406	332	21	humanity	humanity	NOUN
ihlr-28406	332	22	’s	’s	PART
ihlr-28406	332	23	future	future	NOUN
ihlr-28406	332	24	and	and	CCONJ
ihlr-28406	332	25	as	as	ADP
ihlr-28406	332	26	such	such	ADJ
ihlr-28406	332	27	is	be	AUX
ihlr-28406	332	28	also	also	ADV
ihlr-28406	332	29	the	the	DET
ihlr-28406	332	30	ripest	ripe	ADJ
ihlr-28406	332	31	for	for	ADP
ihlr-28406	332	32	breakthrough	breakthrough	NOUN
ihlr-28406	332	33	innovation	innovation	NOUN
ihlr-28406	332	34	.	.	PUNCT
ihlr-28406	333	1	this	this	PRON
ihlr-28406	333	2	is	be	AUX
ihlr-28406	333	3	particularly	particularly	ADV
ihlr-28406	333	4	true	true	ADJ
ihlr-28406	333	5	for	for	ADP
ihlr-28406	333	6	the	the	DET
ihlr-28406	333	7	thyroid	thyroid	NOUN
ihlr-28406	333	8	,	,	PUNCT
ihlr-28406	333	9	which	which	PRON
ihlr-28406	333	10	is	be	AUX
ihlr-28406	333	11	often	often	ADV
ihlr-28406	333	12	ignored	ignore	VERB
ihlr-28406	333	13	as	as	ADP
ihlr-28406	333	14	part	part	NOUN
ihlr-28406	333	15	of	of	ADP
ihlr-28406	333	16	a	a	DET
ihlr-28406	333	17	larger	large	ADJ
ihlr-28406	333	18	field	field	NOUN
ihlr-28406	333	19	in	in	ADP
ihlr-28406	333	20	endocrinology	endocrinology	NOUN
ihlr-28406	333	21	.	.	PUNCT
ihlr-28406	334	1	the	the	DET
ihlr-28406	334	2	confluence	confluence	NOUN
ihlr-28406	334	3	of	of	ADP
ihlr-28406	334	4	healthcare	healthcare	NOUN
ihlr-28406	334	5	and	and	CCONJ
ihlr-28406	334	6	innovation	innovation	NOUN
ihlr-28406	334	7	is	be	AUX
ihlr-28406	334	8	well	well	ADV
ihlr-28406	334	9	presented	present	VERB
ihlr-28406	334	10	through	through	ADP
ihlr-28406	334	11	the	the	DET
ihlr-28406	334	12	patent	patent	NOUN
ihlr-28406	334	13	system	system	NOUN
ihlr-28406	334	14	.	.	PUNCT
ihlr-28406	335	1	any	any	DET
ihlr-28406	335	2	new	new	ADJ
ihlr-28406	335	3	and	and	CCONJ
ihlr-28406	335	4	useful	useful	ADJ
ihlr-28406	335	5	process	process	NOUN
ihlr-28406	335	6	or	or	CCONJ
ihlr-28406	335	7	machine	machine	NOUN
ihlr-28406	335	8	is	be	AUX
ihlr-28406	335	9	a	a	DET
ihlr-28406	335	10	patentable	patentable	ADJ
ihlr-28406	335	11	invention	invention	NOUN
ihlr-28406	335	12	.	.	PUNCT
ihlr-28406	336	1	110	110	NUM
ihlr-28406	336	2	this	this	DET
ihlr-28406	336	3	part	part	NOUN
ihlr-28406	336	4	explores	explore	VERB
ihlr-28406	336	5	inventions	invention	NOUN
ihlr-28406	336	6	and	and	CCONJ
ihlr-28406	336	7	patents	patent	NOUN
ihlr-28406	336	8	for	for	SCONJ
ihlr-28406	336	9	treatments	treatment	NOUN
ihlr-28406	336	10	to	to	PART
ihlr-28406	336	11	thyroid	thyroid	VERB
ihlr-28406	336	12	diseases	disease	NOUN
ihlr-28406	336	13	.	.	PUNCT
ihlr-28406	337	1	the	the	DET
ihlr-28406	337	2	thyroid	thyroid	NOUN
ihlr-28406	337	3	patent	patent	NOUN
ihlr-28406	337	4	dataset	dataset	NOUN
ihlr-28406	337	5	was	be	AUX
ihlr-28406	337	6	aggregated	aggregate	VERB
ihlr-28406	337	7	to	to	PART
ihlr-28406	337	8	contribute	contribute	VERB
ihlr-28406	337	9	the	the	DET
ihlr-28406	337	10	first	first	ADJ
ihlr-28406	337	11	empirical	empirical	ADJ
ihlr-28406	337	12	analysis	analysis	NOUN
ihlr-28406	337	13	for	for	ADP
ihlr-28406	337	14	patents	patent	NOUN
ihlr-28406	337	15	relating	relate	VERB
ihlr-28406	337	16	to	to	ADP
ihlr-28406	337	17	the	the	DET
ihlr-28406	337	18	thyroid	thyroid	NOUN
ihlr-28406	337	19	gland	gland	NOUN
ihlr-28406	337	20	’s	’s	PART
ihlr-28406	337	21	functionality	functionality	NOUN
ihlr-28406	337	22	in	in	ADP
ihlr-28406	337	23	the	the	DET
ihlr-28406	337	24	hypothalamic	hypothalamic	ADJ
ihlr-28406	337	25	-	-	PUNCT
ihlr-28406	337	26	pituitary	pituitary	ADJ
ihlr-28406	337	27	-	-	PUNCT
ihlr-28406	337	28	thyroid	thyroid	NOUN
ihlr-28406	337	29	axis	axis	NOUN
ihlr-28406	337	30	hormonal	hormonal	ADJ
ihlr-28406	337	31	control	control	NOUN
ihlr-28406	337	32	loop	loop	PROPN
ihlr-28406	337	33	.	.	PUNCT
ihlr-28406	338	1	the	the	DET
ihlr-28406	338	2	total	total	ADJ
ihlr-28406	338	3	thyroid	thyroid	NOUN
ihlr-28406	338	4	patent	patent	NOUN
ihlr-28406	338	5	dataset	dataset	NOUN
ihlr-28406	338	6	currently	currently	ADV
ihlr-28406	338	7	contains	contain	VERB
ihlr-28406	338	8	data	datum	NOUN
ihlr-28406	338	9	for	for	ADP
ihlr-28406	338	10	627	627	NUM
ihlr-28406	338	11	patents	patent	NOUN
ihlr-28406	338	12	,	,	PUNCT
ihlr-28406	338	13	and	and	CCONJ
ihlr-28406	338	14	is	be	AUX
ihlr-28406	338	15	an	an	DET
ihlr-28406	338	16	iteratively	iteratively	ADV
ihlr-28406	338	17	evolving	evolve	VERB
ihlr-28406	338	18	,	,	PUNCT
ihlr-28406	338	19	dynamic	dynamic	ADJ
ihlr-28406	338	20	software	software	NOUN
ihlr-28406	338	21	.	.	PUNCT
ihlr-28406	339	1	figure	figure	VERB
ihlr-28406	339	2	4	4	NUM
ihlr-28406	339	3	111	111	NUM
ihlr-28406	339	4	—	—	PUNCT
ihlr-28406	339	5	—	—	PUNCT
ihlr-28406	339	6	—	—	PUNCT
ihlr-28406	339	7	—	—	PUNCT
ihlr-28406	339	8	—	—	PUNCT
ihlr-28406	339	9	—	—	PUNCT
ihlr-28406	339	10	—	—	PUNCT
ihlr-28406	339	11	—	—	PUNCT
ihlr-28406	339	12	—	—	PUNCT
ihlr-28406	339	13	—	—	PUNCT
ihlr-28406	339	14	—	—	PUNCT
ihlr-28406	339	15	—	—	PUNCT
ihlr-28406	339	16	—	—	PUNCT
ihlr-28406	339	17	—	—	PUNCT
ihlr-28406	339	18	—	—	PUNCT
ihlr-28406	339	19	—	—	PUNCT
ihlr-28406	339	20	—	—	PUNCT
ihlr-28406	339	21	—	—	PUNCT
ihlr-28406	339	22	—	—	PUNCT
ihlr-28406	339	23	—	—	PUNCT
ihlr-28406	339	24	—	—	PUNCT
ihlr-28406	339	25	—	—	PUNCT
ihlr-28406	339	26	—	—	PUNCT
ihlr-28406	339	27	—	—	PUNCT
ihlr-28406	339	28	—	—	PUNCT
ihlr-28406	339	29	—	—	PUNCT
ihlr-28406	339	30	—	—	PUNCT
ihlr-28406	339	31	—	—	PUNCT
ihlr-28406	339	32	—	—	PUNCT
ihlr-28406	339	33	108	108	NUM
ihlr-28406	339	34	.	.	PUNCT
ihlr-28406	340	1	cristiane	cristiane	NOUN
ihlr-28406	340	2	gomes	gomes	PROPN
ihlr-28406	340	3	-	-	PUNCT
ihlr-28406	340	4	lima	lima	PROPN
ihlr-28406	340	5	et	et	PROPN
ihlr-28406	340	6	al	al	PROPN
ihlr-28406	340	7	.	.	PROPN
ihlr-28406	340	8	,	,	PUNCT
ihlr-28406	340	9	can	can	AUX
ihlr-28406	340	10	reverse	reverse	VERB
ihlr-28406	340	11	t3	t3	PROPN
ihlr-28406	340	12	assay	assay	PROPN
ihlr-28406	340	13	be	be	AUX
ihlr-28406	340	14	employed	employ	VERB
ihlr-28406	340	15	to	to	PART
ihlr-28406	340	16	guide	guide	VERB
ihlr-28406	340	17	t4	t4	PROPN
ihlr-28406	340	18	vs.	vs.	ADP
ihlr-28406	340	19	t4	t4	PROPN
ihlr-28406	340	20	/	/	SYM
ihlr-28406	340	21	t3	t3	PROPN
ihlr-28406	340	22	therapy	therapy	NOUN
ihlr-28406	340	23	in	in	ADP
ihlr-28406	340	24	hypothyroidism	hypothyroidism	NOUN
ihlr-28406	340	25	?	?	PUNCT
ihlr-28406	341	1	,	,	PUNCT
ihlr-28406	341	2	frontiers	frontier	NOUN
ihlr-28406	341	3	in	in	ADP
ihlr-28406	341	4	endocrinology	endocrinology	NOUN
ihlr-28406	341	5	(	(	PUNCT
ihlr-28406	341	6	dec	dec	PROPN
ihlr-28406	341	7	.	.	PROPN
ihlr-28406	341	8	11	11	NUM
ihlr-28406	341	9	,	,	PUNCT
ihlr-28406	341	10	2019	2019	NUM
ihlr-28406	341	11	)	)	PUNCT
ihlr-28406	341	12	,	,	PUNCT
ihlr-28406	341	13	https://doi.org/10	https://doi.org/10	PROPN
ihlr-28406	341	14	.	.	PUNCT
ihlr-28406	342	1	3389	3389	NUM
ihlr-28406	342	2	/	/	SYM
ihlr-28406	342	3	fendo.2019.00856	fendo.2019.00856	PROPN
ihlr-28406	342	4	[	[	X
ihlr-28406	342	5	https://perma.cc/mm7h-ge9e	https://perma.cc/mm7h-ge9e	X
ihlr-28406	342	6	]	]	X
ihlr-28406	342	7	.	.	PUNCT
ihlr-28406	343	1	(	(	PUNCT
ihlr-28406	343	2	“	"	PUNCT
ihlr-28406	343	3	in	in	ADP
ihlr-28406	343	4	humans	human	NOUN
ihlr-28406	343	5	,	,	PUNCT
ihlr-28406	343	6	a	a	DET
ihlr-28406	343	7	normal	normal	ADJ
ihlr-28406	343	8	thyroid	thyroid	NOUN
ihlr-28406	343	9	gland	gland	NOUN
ihlr-28406	343	10	produces	produce	VERB
ihlr-28406	343	11	~85	~85	PRON
ihlr-28406	343	12	mcg	mcg	NOUN
ihlr-28406	343	13	of	of	ADP
ihlr-28406	343	14	t4	t4	PROPN
ihlr-28406	343	15	and	and	CCONJ
ihlr-28406	343	16	6.5	6.5	NUM
ihlr-28406	343	17	mcg	mcg	NOUN
ihlr-28406	343	18	of	of	ADP
ihlr-28406	343	19	t3	t3	PROPN
ihlr-28406	343	20	daily	daily	PROPN
ihlr-28406	343	21	(	(	PUNCT
ihlr-28406	343	22	1	1	NUM
ihlr-28406	343	23	)	)	PUNCT
ihlr-28406	343	24	.	.	PUNCT
ihlr-28406	344	1	thus	thus	ADV
ihlr-28406	344	2	,	,	PUNCT
ihlr-28406	344	3	the	the	DET
ihlr-28406	344	4	ratio	ratio	NOUN
ihlr-28406	344	5	of	of	ADP
ihlr-28406	344	6	t4	t4	PROPN
ihlr-28406	344	7	:	:	PUNCT
ihlr-28406	344	8	t3	t3	PROPN
ihlr-28406	344	9	that	that	PRON
ihlr-28406	344	10	is	be	AUX
ihlr-28406	344	11	directly	directly	ADV
ihlr-28406	344	12	secreted	secrete	VERB
ihlr-28406	344	13	from	from	ADP
ihlr-28406	344	14	the	the	DET
ihlr-28406	344	15	thyroid	thyroid	NOUN
ihlr-28406	344	16	gland	gland	NOUN
ihlr-28406	344	17	is	be	AUX
ihlr-28406	344	18	around	around	ADV
ihlr-28406	344	19	13:1	13:1	NUM
ihlr-28406	344	20	.	.	PUNCT
ihlr-28406	344	21	”	"	PUNCT
ihlr-28406	344	22	)	)	PUNCT
ihlr-28406	344	23	109	109	NUM
ihlr-28406	344	24	.	.	PUNCT
ihlr-28406	344	25	kenneth	kenneth	PROPN
ihlr-28406	344	26	ain	ain	PROPN
ihlr-28406	344	27	&	&	CCONJ
ihlr-28406	344	28	m.	m.	PROPN
ihlr-28406	344	29	sara	sara	PROPN
ihlr-28406	344	30	rosenthal	rosenthal	PROPN
ihlr-28406	344	31	,	,	PUNCT
ihlr-28406	344	32	the	the	DET
ihlr-28406	344	33	complete	complete	ADJ
ihlr-28406	344	34	thyroid	thyroid	NOUN
ihlr-28406	344	35	book	book	NOUN
ihlr-28406	344	36	262	262	NUM
ihlr-28406	344	37	(	(	PUNCT
ihlr-28406	344	38	2011	2011	NUM
ihlr-28406	344	39	)	)	PUNCT
ihlr-28406	344	40	.	.	PUNCT
ihlr-28406	345	1	110	110	NUM
ihlr-28406	345	2	.	.	NOUN
ihlr-28406	345	3	35	35	NUM
ihlr-28406	345	4	u.s.c	u.s.c	NOUN
ihlr-28406	345	5	.	.	PUNCT
ihlr-28406	346	1	§	§	PROPN
ihlr-28406	346	2	101	101	NUM
ihlr-28406	346	3	.	.	NOUN
ihlr-28406	346	4	111	111	NUM
ihlr-28406	346	5	.	.	PUNCT
ihlr-28406	347	1	brian	brian	PROPN
ihlr-28406	347	2	s.	s.	PROPN
ihlr-28406	347	3	haney	haney	PROPN
ihlr-28406	347	4	,	,	PUNCT
ihlr-28406	347	5	thyroid	thyroid	NOUN
ihlr-28406	347	6	patents	patent	NOUN
ihlr-28406	347	7	(	(	PUNCT
ihlr-28406	347	8	2020	2020	NUM
ihlr-28406	347	9	)	)	PUNCT
ihlr-28406	347	10	.	.	PUNCT
ihlr-28406	348	1	(	(	PUNCT
ihlr-28406	348	2	the	the	DET
ihlr-28406	348	3	information	information	NOUN
ihlr-28406	348	4	contained	contain	VERB
ihlr-28406	348	5	in	in	ADP
ihlr-28406	348	6	this	this	DET
ihlr-28406	348	7	chart	chart	NOUN
ihlr-28406	348	8	was	be	AUX
ihlr-28406	348	9	prepared	prepare	VERB
ihlr-28406	348	10	by	by	ADP
ihlr-28406	348	11	the	the	DET
ihlr-28406	348	12	author	author	NOUN
ihlr-28406	348	13	with	with	ADP
ihlr-28406	348	14	information	information	NOUN
ihlr-28406	348	15	from	from	ADP
ihlr-28406	348	16	the	the	DET
ihlr-28406	348	17	united	united	PROPN
ihlr-28406	348	18	states	states	PROPN
ihlr-28406	348	19	patent	patent	PROPN
ihlr-28406	348	20	and	and	CCONJ
ihlr-28406	348	21	trademark	trademark	NOUN
ihlr-28406	348	22	office	office	NOUN
ihlr-28406	348	23	.	.	PUNCT
ihlr-28406	349	1	a	a	DET
ihlr-28406	349	2	copy	copy	NOUN
ihlr-28406	349	3	of	of	ADP
ihlr-28406	349	4	the	the	DET
ihlr-28406	349	5	data	data	NOUN
ihlr-28406	349	6	is	be	AUX
ihlr-28406	349	7	on	on	ADP
ihlr-28406	349	8	file	file	NOUN
ihlr-28406	349	9	with	with	ADP
ihlr-28406	349	10	the	the	DET
ihlr-28406	349	11	author	author	NOUN
ihlr-28406	349	12	.	.	PUNCT
ihlr-28406	349	13	)	)	PUNCT
ihlr-28406	350	1	https://perma.cc/mm7h-ge9e	https://perma.cc/mm7h-ge9e	PUNCT
ihlr-28406	351	1	https://doi.org/10	https://doi.org/10	PROPN
ihlr-28406	351	2	indiana	indiana	PROPN
ihlr-28406	351	3	health	health	PROPN
ihlr-28406	351	4	law	law	PROPN
ihlr-28406	351	5	review	review	NOUN
ihlr-28406	351	6	[	[	X
ihlr-28406	351	7	vol	vol	NOUN
ihlr-28406	351	8	.	.	PUNCT
ihlr-28406	352	1	21:277	21:277	NOUN
ihlr-28406	352	2	290	290	NUM
ihlr-28406	352	3	patents	patent	NOUN
ihlr-28406	352	4	with	with	ADP
ihlr-28406	352	5	claims	claim	NOUN
ihlr-28406	352	6	including	include	VERB
ihlr-28406	352	7	the	the	DET
ihlr-28406	352	8	two	two	NUM
ihlr-28406	352	9	major	major	ADJ
ihlr-28406	352	10	thyroid	thyroid	NOUN
ihlr-28406	352	11	diseases	disease	NOUN
ihlr-28406	352	12	,	,	PUNCT
ihlr-28406	352	13	hypothyroidism	hypothyroidism	NOUN
ihlr-28406	352	14	(	(	PUNCT
ihlr-28406	352	15	131	131	NUM
ihlr-28406	352	16	)	)	PUNCT
ihlr-28406	352	17	and	and	CCONJ
ihlr-28406	352	18	hyperthyroidism	hyperthyroidism	NOUN
ihlr-28406	352	19	(	(	PUNCT
ihlr-28406	352	20	123	123	NUM
ihlr-28406	352	21	)	)	PUNCT
ihlr-28406	352	22	are	be	AUX
ihlr-28406	352	23	included	include	VERB
ihlr-28406	352	24	in	in	ADP
ihlr-28406	352	25	the	the	DET
ihlr-28406	352	26	dataset	dataset	NOUN
ihlr-28406	352	27	because	because	SCONJ
ihlr-28406	352	28	they	they	PRON
ihlr-28406	352	29	are	be	AUX
ihlr-28406	352	30	problems	problem	NOUN
ihlr-28406	352	31	that	that	PRON
ihlr-28406	352	32	occur	occur	VERB
ihlr-28406	352	33	in	in	ADP
ihlr-28406	352	34	the	the	DET
ihlr-28406	352	35	thyroid	thyroid	NOUN
ihlr-28406	352	36	control	control	PROPN
ihlr-28406	352	37	loop	loop	PROPN
ihlr-28406	352	38	;	;	PUNCT
ihlr-28406	352	39	and	and	CCONJ
ihlr-28406	352	40	the	the	DET
ihlr-28406	352	41	aim	aim	NOUN
ihlr-28406	352	42	for	for	ADP
ihlr-28406	352	43	inventions	invention	NOUN
ihlr-28406	352	44	is	be	AUX
ihlr-28406	352	45	to	to	PART
ihlr-28406	352	46	solve	solve	VERB
ihlr-28406	352	47	these	these	DET
ihlr-28406	352	48	problems	problem	NOUN
ihlr-28406	352	49	.	.	PUNCT
ihlr-28406	353	1	further	far	ADV
ihlr-28406	353	2	,	,	PUNCT
ihlr-28406	353	3	patents	patent	NOUN
ihlr-28406	353	4	with	with	ADP
ihlr-28406	353	5	claims	claim	NOUN
ihlr-28406	353	6	including	include	VERB
ihlr-28406	353	7	the	the	DET
ihlr-28406	353	8	two	two	NUM
ihlr-28406	353	9	major	major	ADJ
ihlr-28406	353	10	thyroid	thyroid	NOUN
ihlr-28406	353	11	hormones	hormone	NOUN
ihlr-28406	353	12	,	,	PUNCT
ihlr-28406	353	13	thyroxine	thyroxine	NOUN
ihlr-28406	353	14	t4	t4	PROPN
ihlr-28406	353	15	(	(	PUNCT
ihlr-28406	353	16	256	256	NUM
ihlr-28406	353	17	)	)	PUNCT
ihlr-28406	353	18	and	and	CCONJ
ihlr-28406	353	19	triiodothyronine	triiodothyronine	VERB
ihlr-28406	353	20	t3	t3	PROPN
ihlr-28406	353	21	(	(	PUNCT
ihlr-28406	353	22	117	117	NUM
ihlr-28406	353	23	)	)	PUNCT
ihlr-28406	353	24	are	be	AUX
ihlr-28406	353	25	included	include	VERB
ihlr-28406	353	26	in	in	ADP
ihlr-28406	353	27	the	the	DET
ihlr-28406	353	28	dataset	dataset	NOUN
ihlr-28406	353	29	because	because	SCONJ
ihlr-28406	353	30	they	they	PRON
ihlr-28406	353	31	are	be	AUX
ihlr-28406	353	32	the	the	DET
ihlr-28406	353	33	effective	effective	ADJ
ihlr-28406	353	34	output	output	NOUN
ihlr-28406	353	35	for	for	ADP
ihlr-28406	353	36	the	the	DET
ihlr-28406	353	37	thyroid	thyroid	NOUN
ihlr-28406	353	38	control	control	PROPN
ihlr-28406	353	39	loop	loop	PROPN
ihlr-28406	353	40	.	.	PUNCT
ihlr-28406	354	1	the	the	DET
ihlr-28406	354	2	goal	goal	NOUN
ihlr-28406	354	3	for	for	ADP
ihlr-28406	354	4	the	the	DET
ihlr-28406	354	5	dataset	dataset	NOUN
ihlr-28406	354	6	is	be	AUX
ihlr-28406	354	7	to	to	PART
ihlr-28406	354	8	provide	provide	VERB
ihlr-28406	354	9	access	access	NOUN
ihlr-28406	354	10	to	to	ADP
ihlr-28406	354	11	key	key	ADJ
ihlr-28406	354	12	information	information	NOUN
ihlr-28406	354	13	relating	relate	VERB
ihlr-28406	354	14	to	to	ADP
ihlr-28406	354	15	treatments	treatment	NOUN
ihlr-28406	354	16	for	for	ADP
ihlr-28406	354	17	thyroid	thyroid	NOUN
ihlr-28406	354	18	disease	disease	NOUN
ihlr-28406	354	19	.	.	PUNCT
ihlr-28406	355	1	the	the	DET
ihlr-28406	355	2	dataset	dataset	NOUN
ihlr-28406	355	3	was	be	AUX
ihlr-28406	355	4	collected	collect	VERB
ihlr-28406	355	5	from	from	ADP
ihlr-28406	355	6	the	the	DET
ihlr-28406	355	7	uspto	uspto	PROPN
ihlr-28406	355	8	database	database	NOUN
ihlr-28406	355	9	through	through	ADP
ihlr-28406	355	10	structured	structured	ADJ
ihlr-28406	355	11	human	human	ADJ
ihlr-28406	355	12	techniques	technique	NOUN
ihlr-28406	355	13	in	in	ADP
ihlr-28406	355	14	compliance	compliance	NOUN
ihlr-28406	355	15	with	with	ADP
ihlr-28406	355	16	uspto	uspto	ADJ
ihlr-28406	355	17	policy	policy	NOUN
ihlr-28406	355	18	.	.	PUNCT
ihlr-28406	356	1	112	112	NUM
ihlr-28406	356	2	importantly	importantly	ADV
ihlr-28406	356	3	,	,	PUNCT
ihlr-28406	356	4	the	the	DET
ihlr-28406	356	5	uspto	uspto	NOUN
ihlr-28406	356	6	severely	severely	ADV
ihlr-28406	356	7	restricts	restrict	VERB
ihlr-28406	356	8	public	public	ADJ
ihlr-28406	356	9	access	access	NOUN
ihlr-28406	356	10	to	to	ADP
ihlr-28406	356	11	patent	patent	NOUN
ihlr-28406	356	12	data	datum	NOUN
ihlr-28406	356	13	,	,	PUNCT
ihlr-28406	356	14	which	which	PRON
ihlr-28406	356	15	as	as	ADP
ihlr-28406	356	16	a	a	DET
ihlr-28406	356	17	policy	policy	NOUN
ihlr-28406	356	18	must	must	AUX
ihlr-28406	356	19	end	end	VERB
ihlr-28406	356	20	.	.	PUNCT
ihlr-28406	357	1	113	113	NUM
ihlr-28406	357	2	the	the	DET
ihlr-28406	357	3	initial	initial	ADJ
ihlr-28406	357	4	terms	term	NOUN
ihlr-28406	357	5	were	be	AUX
ihlr-28406	357	6	selected	select	VERB
ihlr-28406	357	7	to	to	PART
ihlr-28406	357	8	pinpoint	pinpoint	VERB
ihlr-28406	357	9	patents	patent	NOUN
ihlr-28406	357	10	for	for	ADP
ihlr-28406	357	11	thyroid	thyroid	NOUN
ihlr-28406	357	12	disease	disease	NOUN
ihlr-28406	357	13	and	and	CCONJ
ihlr-28406	357	14	thyroid	thyroid	NOUN
ihlr-28406	357	15	hormone	hormone	NOUN
ihlr-28406	357	16	by	by	ADP
ihlr-28406	357	17	searching	search	VERB
ihlr-28406	357	18	the	the	DET
ihlr-28406	357	19	legal	legal	ADJ
ihlr-28406	357	20	claims	claim	NOUN
ihlr-28406	357	21	for	for	ADP
ihlr-28406	357	22	key	key	ADJ
ihlr-28406	357	23	terms	term	NOUN
ihlr-28406	357	24	.	.	PUNCT
ihlr-28406	358	1	the	the	DET
ihlr-28406	358	2	dataset	dataset	NOUN
ihlr-28406	358	3	is	be	AUX
ihlr-28406	358	4	currently	currently	ADV
ihlr-28406	358	5	limited	limit	VERB
ihlr-28406	358	6	to	to	ADP
ihlr-28406	358	7	patents	patent	NOUN
ihlr-28406	358	8	granted	grant	VERB
ihlr-28406	358	9	between	between	ADP
ihlr-28406	358	10	1999	1999	NUM
ihlr-28406	358	11	-	-	SYM
ihlr-28406	358	12	2019	2019	NUM
ihlr-28406	358	13	.	.	PUNCT
ihlr-28406	359	1	the	the	DET
ihlr-28406	359	2	thyroid	thyroid	NOUN
ihlr-28406	359	3	dataset	dataset	NOUN
ihlr-28406	359	4	is	be	AUX
ihlr-28406	359	5	stored	store	VERB
ihlr-28406	359	6	in	in	ADP
ihlr-28406	359	7	two	two	NUM
ihlr-28406	359	8	formats	format	NOUN
ihlr-28406	359	9	,	,	PUNCT
ihlr-28406	359	10	xls	xls	PROPN
ihlr-28406	359	11	and	and	CCONJ
ihlr-28406	359	12	csv	csv	VERB
ihlr-28406	359	13	,	,	PUNCT
ihlr-28406	359	14	for	for	ADP
ihlr-28406	359	15	processing	processing	NOUN
ihlr-28406	359	16	.	.	PUNCT
ihlr-28406	360	1	figure	figure	NOUN
ihlr-28406	360	2	5	5	NUM
ihlr-28406	360	3	depicts	depict	VERB
ihlr-28406	360	4	analysis	analysis	NOUN
ihlr-28406	360	5	for	for	ADP
ihlr-28406	360	6	claims	claim	NOUN
ihlr-28406	360	7	in	in	ADP
ihlr-28406	360	8	the	the	DET
ihlr-28406	360	9	thyroid	thyroid	NOUN
ihlr-28406	360	10	patent	patent	NOUN
ihlr-28406	360	11	dataset	dataset	NOUN
ihlr-28406	360	12	.	.	PUNCT
ihlr-28406	361	1	114	114	NUM
ihlr-28406	361	2	one	one	NUM
ihlr-28406	361	3	theory	theory	NOUN
ihlr-28406	361	4	is	be	AUX
ihlr-28406	361	5	valuable	valuable	ADJ
ihlr-28406	361	6	patents	patent	NOUN
ihlr-28406	361	7	contain	contain	VERB
ihlr-28406	361	8	more	more	ADJ
ihlr-28406	361	9	claims	claim	NOUN
ihlr-28406	361	10	than	than	ADP
ihlr-28406	361	11	ordinary	ordinary	ADJ
ihlr-28406	361	12	patents	patent	NOUN
ihlr-28406	361	13	.	.	PUNCT
ihlr-28406	362	1	115	115	NUM
ihlr-28406	363	1	the	the	DET
ihlr-28406	363	2	intuition	intuition	NOUN
ihlr-28406	363	3	behind	behind	ADP
ihlr-28406	363	4	this	this	DET
ihlr-28406	363	5	reasoning	reasoning	NOUN
ihlr-28406	363	6	is	be	AUX
ihlr-28406	363	7	consistent	consistent	ADJ
ihlr-28406	363	8	with	with	ADP
ihlr-28406	363	9	the	the	DET
ihlr-28406	363	10	uspto	uspto	PROPN
ihlr-28406	363	11	fee	fee	NOUN
ihlr-28406	363	12	structure	structure	NOUN
ihlr-28406	363	13	.	.	PUNCT
ihlr-28406	364	1	116	116	NUM
ihlr-28406	364	2	however	however	ADV
ihlr-28406	364	3	,	,	PUNCT
ihlr-28406	364	4	there	there	PRON
ihlr-28406	364	5	are	be	VERB
ihlr-28406	364	6	exceptions	exception	NOUN
ihlr-28406	364	7	to	to	ADP
ihlr-28406	364	8	this	this	DET
ihlr-28406	364	9	theory	theory	NOUN
ihlr-28406	364	10	,	,	PUNCT
ihlr-28406	364	11	where	where	SCONJ
ihlr-28406	364	12	patents	patent	NOUN
ihlr-28406	364	13	with	with	ADP
ihlr-28406	364	14	fewer	few	ADJ
ihlr-28406	364	15	claims	claim	NOUN
ihlr-28406	364	16	are	be	AUX
ihlr-28406	364	17	more	more	ADV
ihlr-28406	364	18	valuable	valuable	ADJ
ihlr-28406	364	19	.	.	PUNCT
ihlr-28406	365	1	—	—	PUNCT
ihlr-28406	365	2	—	—	PUNCT
ihlr-28406	365	3	—	—	PUNCT
ihlr-28406	365	4	—	—	PUNCT
ihlr-28406	365	5	—	—	PUNCT
ihlr-28406	365	6	—	—	PUNCT
ihlr-28406	365	7	—	—	PUNCT
ihlr-28406	365	8	—	—	PUNCT
ihlr-28406	365	9	—	—	PUNCT
ihlr-28406	365	10	—	—	PUNCT
ihlr-28406	365	11	—	—	PUNCT
ihlr-28406	365	12	—	—	PUNCT
ihlr-28406	365	13	—	—	PUNCT
ihlr-28406	365	14	—	—	PUNCT
ihlr-28406	365	15	—	—	PUNCT
ihlr-28406	365	16	—	—	PUNCT
ihlr-28406	365	17	—	—	PUNCT
ihlr-28406	365	18	—	—	PUNCT
ihlr-28406	365	19	—	—	PUNCT
ihlr-28406	365	20	—	—	PUNCT
ihlr-28406	365	21	—	—	PUNCT
ihlr-28406	365	22	—	—	PUNCT
ihlr-28406	365	23	—	—	PUNCT
ihlr-28406	365	24	—	—	PUNCT
ihlr-28406	365	25	—	—	PUNCT
ihlr-28406	365	26	—	—	PUNCT
ihlr-28406	365	27	—	—	PUNCT
ihlr-28406	365	28	—	—	PUNCT
ihlr-28406	365	29	—	—	PUNCT
ihlr-28406	365	30	112	112	NUM
ihlr-28406	365	31	.	.	PUNCT
ihlr-28406	365	32	uspto	uspto	NOUN
ihlr-28406	365	33	,	,	PUNCT
ihlr-28406	365	34	terms	term	NOUN
ihlr-28406	365	35	of	of	ADP
ihlr-28406	365	36	use	use	NOUN
ihlr-28406	365	37	for	for	ADP
ihlr-28406	365	38	uspto	uspto	ADJ
ihlr-28406	365	39	websites	website	NOUN
ihlr-28406	365	40	(	(	PUNCT
ihlr-28406	365	41	2020	2020	NUM
ihlr-28406	365	42	)	)	PUNCT
ihlr-28406	365	43	,	,	PUNCT
ihlr-28406	365	44	https://www.uspto.gov/terms-useuspto-websites	https://www.uspto.gov/terms-useuspto-websites	PROPN
ihlr-28406	366	1	[	[	X
ihlr-28406	366	2	https://perma.cc/us9n-v284	https://perma.cc/us9n-v284	NOUN
ihlr-28406	366	3	]	]	X
ihlr-28406	366	4	.	.	PUNCT
ihlr-28406	367	1	see	see	VERB
ihlr-28406	367	2	also	also	ADV
ihlr-28406	367	3	veronica	veronica	PROPN
ihlr-28406	367	4	root	root	NOUN
ihlr-28406	367	5	,	,	PUNCT
ihlr-28406	367	6	coordinating	coordinate	VERB
ihlr-28406	367	7	compliance	compliance	NOUN
ihlr-28406	367	8	incentives	incentive	NOUN
ihlr-28406	367	9	,	,	PUNCT
ihlr-28406	367	10	102	102	NUM
ihlr-28406	367	11	cornell	cornell	PROPN
ihlr-28406	367	12	l.	l.	PROPN
ihlr-28406	367	13	rev	rev	PROPN
ihlr-28406	367	14	.	.	PROPN
ihlr-28406	367	15	1003	1003	NUM
ihlr-28406	367	16	,	,	PUNCT
ihlr-28406	367	17	1029	1029	NUM
ihlr-28406	367	18	(	(	PUNCT
ihlr-28406	367	19	2017	2017	NUM
ihlr-28406	367	20	)	)	PUNCT
ihlr-28406	367	21	,	,	PUNCT
ihlr-28406	367	22	https://papers.ssrn.com/sol3/	https://papers.ssrn.com/sol3/	PUNCT
ihlr-28406	368	1	papers.cfm?abstract_id=2867048	papers.cfm?abstract_id=2867048	NOUN
ihlr-28406	369	1	[	[	X
ihlr-28406	369	2	https://perma.cc/tvw6-ph2	https://perma.cc/tvw6-ph2	NOUN
ihlr-28406	369	3	g	g	NOUN
ihlr-28406	369	4	]	]	PUNCT
ihlr-28406	369	5	.	.	PUNCT
ihlr-28406	370	1	(	(	PUNCT
ihlr-28406	370	2	“	"	PUNCT
ihlr-28406	370	3	governmental	governmental	ADJ
ihlr-28406	370	4	enforcement	enforcement	NOUN
ihlr-28406	370	5	agencies	agency	NOUN
ihlr-28406	370	6	and	and	CCONJ
ihlr-28406	370	7	actors	actor	NOUN
ihlr-28406	370	8	are	be	AUX
ihlr-28406	370	9	also	also	ADV
ihlr-28406	370	10	subject	subject	ADJ
ihlr-28406	370	11	to	to	ADP
ihlr-28406	370	12	the	the	DET
ihlr-28406	370	13	information	information	NOUN
ihlr-28406	370	14	and	and	CCONJ
ihlr-28406	370	15	coordination	coordination	NOUN
ihlr-28406	370	16	complexities	complexity	NOUN
ihlr-28406	370	17	that	that	PRON
ihlr-28406	370	18	confront	confront	VERB
ihlr-28406	370	19	many	many	ADJ
ihlr-28406	370	20	regulatory	regulatory	ADJ
ihlr-28406	370	21	agencies	agency	NOUN
ihlr-28406	370	22	within	within	ADP
ihlr-28406	370	23	the	the	DET
ihlr-28406	370	24	current	current	ADJ
ihlr-28406	370	25	administrative	administrative	ADJ
ihlr-28406	370	26	state	state	NOUN
ihlr-28406	370	27	.	.	PUNCT
ihlr-28406	371	1	importantly	importantly	ADV
ihlr-28406	371	2	,	,	PUNCT
ihlr-28406	371	3	these	these	DET
ihlr-28406	371	4	information	information	NOUN
ihlr-28406	371	5	and	and	CCONJ
ihlr-28406	371	6	coordination	coordination	NOUN
ihlr-28406	371	7	challenges	challenge	NOUN
ihlr-28406	371	8	may	may	AUX
ihlr-28406	371	9	lead	lead	VERB
ihlr-28406	371	10	to	to	ADP
ihlr-28406	371	11	a	a	DET
ihlr-28406	371	12	responsibility	responsibility	NOUN
ihlr-28406	371	13	vacuum	vacuum	NOUN
ihlr-28406	371	14	when	when	SCONJ
ihlr-28406	371	15	considering	consider	VERB
ihlr-28406	371	16	issues	issue	NOUN
ihlr-28406	371	17	of	of	ADP
ihlr-28406	371	18	corporate	corporate	ADJ
ihlr-28406	371	19	recidivists	recidivist	NOUN
ihlr-28406	371	20	.	.	PUNCT
ihlr-28406	371	21	”	"	PUNCT
ihlr-28406	371	22	)	)	PUNCT
ihlr-28406	371	23	.	.	PUNCT
ihlr-28406	372	1	113	113	NUM
ihlr-28406	372	2	.	.	PUNCT
ihlr-28406	373	1	i	i	PRON
ihlr-28406	373	2	d.	d.	PROPN
ihlr-28406	373	3	the	the	DET
ihlr-28406	373	4	uspto	uspto	PROPN
ihlr-28406	373	5	refuses	refuse	VERB
ihlr-28406	373	6	to	to	PART
ihlr-28406	373	7	allow	allow	VERB
ihlr-28406	373	8	inventors	inventor	NOUN
ihlr-28406	373	9	,	,	PUNCT
ihlr-28406	373	10	small	small	ADJ
ihlr-28406	373	11	business	business	NOUN
ihlr-28406	373	12	,	,	PUNCT
ihlr-28406	373	13	and	and	CCONJ
ihlr-28406	373	14	researchers	researcher	NOUN
ihlr-28406	373	15	access	access	VERB
ihlr-28406	373	16	to	to	ADP
ihlr-28406	373	17	key	key	ADJ
ihlr-28406	373	18	patent	patent	NOUN
ihlr-28406	373	19	data	datum	NOUN
ihlr-28406	373	20	necessary	necessary	ADJ
ihlr-28406	373	21	to	to	PART
ihlr-28406	373	22	promote	promote	VERB
ihlr-28406	373	23	technical	technical	ADJ
ihlr-28406	373	24	progress	progress	NOUN
ihlr-28406	373	25	and	and	CCONJ
ihlr-28406	373	26	innovation	innovation	NOUN
ihlr-28406	373	27	.	.	PUNCT
ihlr-28406	374	1	instead	instead	ADV
ihlr-28406	374	2	,	,	PUNCT
ihlr-28406	374	3	the	the	DET
ihlr-28406	374	4	uspto	uspto	PROPN
ihlr-28406	374	5	claims	claim	NOUN
ihlr-28406	374	6	to	to	PART
ihlr-28406	374	7	make	make	VERB
ihlr-28406	374	8	data	datum	NOUN
ihlr-28406	374	9	available	available	ADJ
ihlr-28406	374	10	to	to	ADP
ihlr-28406	374	11	the	the	DET
ihlr-28406	374	12	public	public	NOUN
ihlr-28406	374	13	through	through	ADP
ihlr-28406	374	14	a	a	DET
ihlr-28406	374	15	contract	contract	NOUN
ihlr-28406	374	16	with	with	ADP
ihlr-28406	374	17	reedtech	reedtech	NOUN
ihlr-28406	374	18	,	,	PUNCT
ihlr-28406	374	19	a	a	DET
ihlr-28406	374	20	lexis	lexis	NOUN
ihlr-28406	374	21	subsidiary	subsidiary	NOUN
ihlr-28406	374	22	.	.	PUNCT
ihlr-28406	375	1	however	however	ADV
ihlr-28406	375	2	,	,	PUNCT
ihlr-28406	375	3	the	the	DET
ihlr-28406	375	4	data	datum	NOUN
ihlr-28406	375	5	the	the	DET
ihlr-28406	375	6	uspto	uspto	NOUN
ihlr-28406	375	7	provides	provide	VERB
ihlr-28406	375	8	is	be	AUX
ihlr-28406	375	9	useless	useless	ADJ
ihlr-28406	375	10	for	for	ADP
ihlr-28406	375	11	inventors	inventor	NOUN
ihlr-28406	375	12	,	,	PUNCT
ihlr-28406	375	13	small	small	ADJ
ihlr-28406	375	14	businesses	business	NOUN
ihlr-28406	375	15	,	,	PUNCT
ihlr-28406	375	16	and	and	CCONJ
ihlr-28406	375	17	researchers	researcher	NOUN
ihlr-28406	375	18	because	because	SCONJ
ihlr-28406	375	19	it	it	PRON
ihlr-28406	375	20	is	be	AUX
ihlr-28406	375	21	stored	store	VERB
ihlr-28406	375	22	in	in	ADP
ihlr-28406	375	23	bulk	bulk	NOUN
ihlr-28406	375	24	.	.	PUNCT
ihlr-28406	376	1	as	as	ADP
ihlr-28406	376	2	a	a	DET
ihlr-28406	376	3	result	result	NOUN
ihlr-28406	376	4	,	,	PUNCT
ihlr-28406	376	5	processing	process	VERB
ihlr-28406	376	6	the	the	DET
ihlr-28406	376	7	data	datum	NOUN
ihlr-28406	376	8	requires	require	VERB
ihlr-28406	376	9	expensive	expensive	ADJ
ihlr-28406	376	10	industrial	industrial	ADJ
ihlr-28406	376	11	scale	scale	NOUN
ihlr-28406	376	12	computers	computer	NOUN
ihlr-28406	376	13	only	only	ADV
ihlr-28406	376	14	accessible	accessible	ADJ
ihlr-28406	376	15	to	to	ADP
ihlr-28406	376	16	large	large	ADJ
ihlr-28406	376	17	corporations	corporation	NOUN
ihlr-28406	376	18	.	.	PUNCT
ihlr-28406	377	1	this	this	DET
ihlr-28406	377	2	policy	policy	NOUN
ihlr-28406	377	3	could	could	AUX
ihlr-28406	377	4	easily	easily	ADV
ihlr-28406	377	5	be	be	AUX
ihlr-28406	377	6	fixed	fix	VERB
ihlr-28406	377	7	by	by	ADP
ihlr-28406	377	8	simply	simply	ADV
ihlr-28406	377	9	making	make	VERB
ihlr-28406	377	10	uspto	uspto	ADJ
ihlr-28406	377	11	data	datum	NOUN
ihlr-28406	377	12	available	available	ADJ
ihlr-28406	377	13	through	through	ADP
ihlr-28406	377	14	a	a	DET
ihlr-28406	377	15	cloud	cloud	ADJ
ihlr-28406	377	16	computing	computing	NOUN
ihlr-28406	377	17	model	model	NOUN
ihlr-28406	377	18	,	,	PUNCT
ihlr-28406	377	19	expanding	expand	VERB
ihlr-28406	377	20	bandwidth	bandwidth	ADJ
ihlr-28406	377	21	capability	capability	NOUN
ihlr-28406	377	22	,	,	PUNCT
ihlr-28406	377	23	and	and	CCONJ
ihlr-28406	377	24	saving	save	VERB
ihlr-28406	377	25	money	money	NOUN
ihlr-28406	377	26	.	.	PUNCT
ihlr-28406	378	1	yet	yet	ADV
ihlr-28406	378	2	,	,	PUNCT
ihlr-28406	378	3	resolution	resolution	NOUN
ihlr-28406	378	4	is	be	AUX
ihlr-28406	378	5	unlikely	unlikely	ADJ
ihlr-28406	378	6	because	because	SCONJ
ihlr-28406	378	7	the	the	DET
ihlr-28406	378	8	uspto	uspto	NOUN
ihlr-28406	378	9	’s	’s	PART
ihlr-28406	378	10	financial	financial	ADJ
ihlr-28406	378	11	incentives	incentive	NOUN
ihlr-28406	378	12	are	be	AUX
ihlr-28406	378	13	to	to	PART
ihlr-28406	378	14	exclude	exclude	VERB
ihlr-28406	378	15	non	non	ADJ
ihlr-28406	378	16	-	-	ADJ
ihlr-28406	378	17	corporate	corporate	ADJ
ihlr-28406	378	18	entities	entity	NOUN
ihlr-28406	378	19	from	from	ADP
ihlr-28406	378	20	the	the	DET
ihlr-28406	378	21	market	market	NOUN
ihlr-28406	378	22	.	.	PUNCT
ihlr-28406	379	1	114	114	NUM
ihlr-28406	379	2	.	.	PUNCT
ihlr-28406	379	3	alan	alan	PROPN
ihlr-28406	379	4	c.	c.	PROPN
ihlr-28406	379	5	marco	marco	PROPN
ihlr-28406	379	6	,	,	PUNCT
ihlr-28406	379	7	et	et	PROPN
ihlr-28406	379	8	al	al	PROPN
ihlr-28406	379	9	.	.	PROPN
ihlr-28406	379	10	,	,	PUNCT
ihlr-28406	379	11	patent	patent	NOUN
ihlr-28406	379	12	claims	claim	NOUN
ihlr-28406	379	13	and	and	CCONJ
ihlr-28406	379	14	patent	patent	NOUN
ihlr-28406	379	15	scope	scope	NOUN
ihlr-28406	379	16	,	,	PUNCT
ihlr-28406	379	17	u.s	u.s	PROPN
ihlr-28406	379	18	.	.	PROPN
ihlr-28406	379	19	patent	patent	NOUN
ihlr-28406	379	20	and	and	CCONJ
ihlr-28406	379	21	trademark	trademark	NOUN
ihlr-28406	379	22	office	office	NOUN
ihlr-28406	379	23	(	(	PUNCT
ihlr-28406	379	24	econ	econ	X
ihlr-28406	379	25	.	.	PUNCT
ihlr-28406	380	1	working	working	PROPN
ihlr-28406	380	2	paper	paper	NOUN
ihlr-28406	380	3	series	series	NOUN
ihlr-28406	380	4	,	,	PUNCT
ihlr-28406	380	5	9	9	NUM
ihlr-28406	380	6	,	,	PUNCT
ihlr-28406	380	7	oct	oct	PROPN
ihlr-28406	380	8	.	.	PROPN
ihlr-28406	380	9	2016	2016	NUM
ihlr-28406	380	10	)	)	PUNCT
ihlr-28406	380	11	,	,	PUNCT
ihlr-28406	380	12	https://papers.ssrn.com/sol3/papers	https://papers.ssrn.com/sol3/paper	NOUN
ihlr-28406	380	13	.	.	PUNCT
ihlr-28406	381	1	cfm?abstract_id=2844964	cfm?abstract_id=2844964	VERB
ihlr-28406	382	1	[	[	X
ihlr-28406	382	2	https://perma.cc/57l7-dpyb	https://perma.cc/57l7-dpyb	X
ihlr-28406	382	3	]	]	X
ihlr-28406	382	4	(	(	PUNCT
ihlr-28406	382	5	claims	claim	NOUN
ihlr-28406	382	6	represent	represent	VERB
ihlr-28406	382	7	the	the	DET
ihlr-28406	382	8	legal	legal	ADJ
ihlr-28406	382	9	bounds	bound	NOUN
ihlr-28406	382	10	of	of	ADP
ihlr-28406	382	11	the	the	DET
ihlr-28406	382	12	invention	invention	NOUN
ihlr-28406	382	13	)	)	PUNCT
ihlr-28406	382	14	.	.	PUNCT
ihlr-28406	383	1	115	115	NUM
ihlr-28406	383	2	.	.	PUNCT
ihlr-28406	384	1	john	john	PROPN
ihlr-28406	384	2	r.	r.	PROPN
ihlr-28406	384	3	allison	allison	PROPN
ihlr-28406	384	4	,	,	PUNCT
ihlr-28406	384	5	et	et	PROPN
ihlr-28406	384	6	al	al	PROPN
ihlr-28406	384	7	.	.	PROPN
ihlr-28406	384	8	,	,	PUNCT
ihlr-28406	384	9	valuable	valuable	ADJ
ihlr-28406	384	10	patents	patent	NOUN
ihlr-28406	384	11	,	,	PUNCT
ihlr-28406	385	1	92	92	NUM
ihlr-28406	385	2	geo	geo	PROPN
ihlr-28406	385	3	.	.	PUNCT
ihlr-28406	385	4	l.j	l.j	PROPN
ihlr-28406	385	5	.	.	PROPN
ihlr-28406	385	6	435	435	NUM
ihlr-28406	385	7	,	,	PUNCT
ihlr-28406	385	8	438	438	NUM
ihlr-28406	385	9	(	(	PUNCT
ihlr-28406	385	10	2004	2004	NUM
ihlr-28406	385	11	)	)	PUNCT
ihlr-28406	385	12	.	.	PUNCT
ihlr-28406	386	1	116	116	NUM
ihlr-28406	386	2	.	.	PUNCT
ihlr-28406	387	1	uspto	uspto	NOUN
ihlr-28406	387	2	,	,	PUNCT
ihlr-28406	387	3	uspto	uspto	PROPN
ihlr-28406	387	4	fee	fee	NOUN
ihlr-28406	387	5	schedule	schedule	NOUN
ihlr-28406	387	6	(	(	PUNCT
ihlr-28406	387	7	2022	2022	NUM
ihlr-28406	387	8	)	)	PUNCT
ihlr-28406	387	9	,	,	PUNCT
ihlr-28406	387	10	https://www.uspto.gov/learning-andresources/fees-and-payment/uspto-fee-schedule	https://www.uspto.gov/learning-andresources/fees-and-payment/uspto-fee-schedule	VERB
ihlr-28406	387	11	[	[	X
ihlr-28406	387	12	https://perma.cc/pt46-5gba	https://perma.cc/pt46-5gba	NOUN
ihlr-28406	387	13	]	]	PUNCT
ihlr-28406	387	14	.	.	PUNCT
ihlr-28406	388	1	see	see	VERB
ihlr-28406	388	2	also	also	ADV
ihlr-28406	388	3	leahysmith	leahysmith	PROPN
ihlr-28406	388	4	am	be	AUX
ihlr-28406	388	5	.	.	PUNCT
ihlr-28406	389	1	invents	invent	NOUN
ihlr-28406	389	2	act	act	PROPN
ihlr-28406	389	3	,	,	PUNCT
ihlr-28406	389	4	pub	pub	NOUN
ihlr-28406	389	5	.	.	PUNCT
ihlr-28406	390	1	l.	l.	PROPN
ihlr-28406	390	2	no	no	INTJ
ihlr-28406	390	3	.	.	PROPN
ihlr-28406	391	1	112	112	NUM
ihlr-28406	391	2	-	-	SYM
ihlr-28406	391	3	29	29	NUM
ihlr-28406	391	4	(	(	PUNCT
ihlr-28406	391	5	2011	2011	NUM
ihlr-28406	391	6	)	)	PUNCT
ihlr-28406	391	7	(	(	PUNCT
ihlr-28406	391	8	see	see	VERB
ihlr-28406	391	9	section	section	NOUN
ihlr-28406	391	10	11	11	NUM
ihlr-28406	391	11	fees	fee	NOUN
ihlr-28406	391	12	for	for	ADP
ihlr-28406	391	13	patent	patent	NOUN
ihlr-28406	391	14	services	service	NOUN
ihlr-28406	391	15	,	,	PUNCT
ihlr-28406	391	16	which	which	PRON
ihlr-28406	391	17	de	de	X
ihlr-28406	391	18	facto	facto	X
ihlr-28406	391	19	prevents	prevent	VERB
ihlr-28406	391	20	inventors	inventor	NOUN
ihlr-28406	391	21	living	live	VERB
ihlr-28406	391	22	in	in	ADP
ihlr-28406	391	23	poverty	poverty	NOUN
ihlr-28406	391	24	from	from	ADP
ihlr-28406	391	25	being	be	AUX
ihlr-28406	391	26	able	able	ADJ
ihlr-28406	391	27	to	to	PART
ihlr-28406	391	28	patent	patent	VERB
ihlr-28406	391	29	or	or	CCONJ
ihlr-28406	391	30	protect	protect	VERB
ihlr-28406	391	31	their	their	PRON
ihlr-28406	391	32	inventions	invention	NOUN
ihlr-28406	391	33	)	)	PUNCT
ihlr-28406	391	34	.	.	PUNCT
ihlr-28406	392	1	https://perma.cc/pt46-5gba	https://perma.cc/pt46-5gba	PROPN
ihlr-28406	392	2	https://www.uspto.gov/learning-and	https://www.uspto.gov/learning-and	NOUN
ihlr-28406	392	3	https://perma.cc/57l7-dpyb	https://perma.cc/57l7-dpyb	NOUN
ihlr-28406	392	4	https://papers.ssrn.com/sol3/papers	https://papers.ssrn.com/sol3/paper	NOUN
ihlr-28406	392	5	https://perma.cc/tvw6-ph2	https://perma.cc/tvw6-ph2	VERB
ihlr-28406	392	6	g	g	PROPN
ihlr-28406	392	7	https://papers.ssrn.com/sol3	https://papers.ssrn.com/sol3	PROPN
ihlr-28406	392	8	https://perma.cc/us9n-v284	https://perma.cc/us9n-v284	PROPN
ihlr-28406	392	9	https://www.uspto.gov/terms-use	https://www.uspto.gov/terms-use	NOUN
ihlr-28406	392	10	2024	2024	NUM
ihlr-28406	392	11	]	]	PUNCT
ihlr-28406	392	12	inventions	invention	NOUN
ihlr-28406	392	13	and	and	CCONJ
ihlr-28406	392	14	patents	patent	NOUN
ihlr-28406	392	15	for	for	ADP
ihlr-28406	392	16	treating	treat	VERB
ihlr-28406	392	17	291	291	NUM
ihlr-28406	392	18	thyroid	thyroid	NOUN
ihlr-28406	392	19	disease	disease	NOUN
ihlr-28406	392	20	figure	figure	VERB
ihlr-28406	392	21	5	5	NUM
ihlr-28406	392	22	117	117	NUM
ihlr-28406	392	23	owned	own	VERB
ihlr-28406	392	24	by	by	ADP
ihlr-28406	392	25	ilypsa	ilypsa	PROPN
ihlr-28406	392	26	,	,	PUNCT
ihlr-28406	392	27	inc	inc	PROPN
ihlr-28406	392	28	.	.	PROPN
ihlr-28406	392	29	,	,	PUNCT
ihlr-28406	392	30	u.s	u.s	PROPN
ihlr-28406	392	31	.	.	PROPN
ihlr-28406	392	32	patent	patent	NOUN
ihlr-28406	392	33	8,349,305	8,349,305	NUM
ihlr-28406	392	34	,	,	PUNCT
ihlr-28406	392	35	crosslinked	crosslinke	VERB
ihlr-28406	392	36	amine	amine	ADJ
ihlr-28406	392	37	polymers	polymer	NOUN
ihlr-28406	392	38	,	,	PUNCT
ihlr-28406	392	39	contained	contain	VERB
ihlr-28406	392	40	the	the	DET
ihlr-28406	392	41	maximum	maximum	ADJ
ihlr-28406	392	42	183	183	NUM
ihlr-28406	392	43	claims	claim	NOUN
ihlr-28406	392	44	.	.	PUNCT
ihlr-28406	393	1	118	118	NUM
ihlr-28406	393	2	the	the	DET
ihlr-28406	393	3	minimum	minimum	NOUN
ihlr-28406	393	4	was	be	AUX
ihlr-28406	393	5	shared	share	VERB
ihlr-28406	393	6	by	by	ADP
ihlr-28406	393	7	two	two	NUM
ihlr-28406	393	8	patents	patent	NOUN
ihlr-28406	393	9	,	,	PUNCT
ihlr-28406	393	10	u.s	u.s	PROPN
ihlr-28406	393	11	.	.	PROPN
ihlr-28406	393	12	patent	patent	NOUN
ihlr-28406	393	13	9,550,838	9,550,838	NUM
ihlr-28406	393	14	,	,	PUNCT
ihlr-28406	393	15	dock	dock	NOUN
ihlr-28406	393	16	-	-	PUNCT
ihlr-28406	393	17	and	and	CCONJ
ihlr-28406	393	18	-	-	PUNCT
ihlr-28406	393	19	lock	lock	NOUN
ihlr-28406	393	20	(	(	PUNCT
ihlr-28406	393	21	dnl	dnl	ADJ
ihlr-28406	393	22	)	)	PUNCT
ihlr-28406	393	23	complexes	complex	NOUN
ihlr-28406	393	24	for	for	ADP
ihlr-28406	393	25	therapeutic	therapeutic	ADJ
ihlr-28406	393	26	and	and	CCONJ
ihlr-28406	393	27	diagnostic	diagnostic	ADJ
ihlr-28406	393	28	use	use	NOUN
ihlr-28406	393	29	and	and	CCONJ
ihlr-28406	393	30	u.s	u.s	PROPN
ihlr-28406	393	31	.	.	PROPN
ihlr-28406	393	32	patent	patent	NOUN
ihlr-28406	393	33	9,085,510	9,085,510	NUM
ihlr-28406	393	34	,	,	PUNCT
ihlr-28406	393	35	preparation	preparation	NOUN
ihlr-28406	393	36	of	of	ADP
ihlr-28406	393	37	organic	organic	ADJ
ihlr-28406	393	38	compounds	compound	NOUN
ihlr-28406	393	39	for	for	ADP
ihlr-28406	393	40	enhanced	enhanced	ADJ
ihlr-28406	393	41	reactivity	reactivity	NOUN
ihlr-28406	393	42	,	,	PUNCT
ihlr-28406	393	43	each	each	PRON
ihlr-28406	393	44	containing	contain	VERB
ihlr-28406	393	45	one	one	NUM
ihlr-28406	393	46	claim	claim	NOUN
ihlr-28406	393	47	.	.	PUNCT
ihlr-28406	394	1	119	119	NUM
ihlr-28406	394	2	a	a	DET
ihlr-28406	394	3	second	second	ADJ
ihlr-28406	394	4	theory	theory	NOUN
ihlr-28406	394	5	is	be	AUX
ihlr-28406	394	6	valuable	valuable	ADJ
ihlr-28406	394	7	patents	patent	NOUN
ihlr-28406	394	8	tend	tend	VERB
ihlr-28406	394	9	to	to	PART
ihlr-28406	394	10	cite	cite	VERB
ihlr-28406	394	11	more	more	ADV
ihlr-28406	394	12	prior	prior	ADJ
ihlr-28406	394	13	art	art	NOUN
ihlr-28406	394	14	.	.	PUNCT
ihlr-28406	395	1	120	120	NUM
ihlr-28406	395	2	this	this	DET
ihlr-28406	395	3	reasoning	reasoning	NOUN
ihlr-28406	395	4	is	be	AUX
ihlr-28406	395	5	commensurate	commensurate	ADJ
ihlr-28406	395	6	with	with	ADP
ihlr-28406	395	7	time	time	NOUN
ihlr-28406	395	8	and	and	CCONJ
ihlr-28406	395	9	money	money	NOUN
ihlr-28406	395	10	spent	spend	VERB
ihlr-28406	395	11	on	on	ADP
ihlr-28406	395	12	patent	patent	NOUN
ihlr-28406	395	13	search	search	NOUN
ihlr-28406	395	14	,	,	PUNCT
ihlr-28406	395	15	research	research	NOUN
ihlr-28406	395	16	,	,	PUNCT
ihlr-28406	395	17	and	and	CCONJ
ihlr-28406	395	18	drafting	draft	VERB
ihlr-28406	395	19	–	–	PUNCT
ihlr-28406	395	20	each	each	PRON
ihlr-28406	395	21	of	of	ADP
ihlr-28406	395	22	which	which	PRON
ihlr-28406	395	23	positively	positively	ADV
ihlr-28406	395	24	corresponds	correspond	VERB
ihlr-28406	395	25	with	with	ADP
ihlr-28406	395	26	cost	cost	NOUN
ihlr-28406	395	27	.	.	PUNCT
ihlr-28406	396	1	figure	figure	VERB
ihlr-28406	396	2	6	6	NUM
ihlr-28406	396	3	models	model	NOUN
ihlr-28406	396	4	the	the	DET
ihlr-28406	396	5	prior	prior	ADJ
ihlr-28406	396	6	art	art	NOUN
ihlr-28406	396	7	citations	citation	NOUN
ihlr-28406	396	8	for	for	ADP
ihlr-28406	396	9	the	the	DET
ihlr-28406	396	10	thyroid	thyroid	NOUN
ihlr-28406	396	11	patent	patent	NOUN
ihlr-28406	396	12	dataset	dataset	NOUN
ihlr-28406	396	13	.	.	PUNCT
ihlr-28406	397	1	—	—	PUNCT
ihlr-28406	397	2	—	—	PUNCT
ihlr-28406	397	3	—	—	PUNCT
ihlr-28406	397	4	—	—	PUNCT
ihlr-28406	397	5	—	—	PUNCT
ihlr-28406	397	6	—	—	PUNCT
ihlr-28406	397	7	—	—	PUNCT
ihlr-28406	397	8	—	—	PUNCT
ihlr-28406	397	9	—	—	PUNCT
ihlr-28406	397	10	—	—	PUNCT
ihlr-28406	397	11	—	—	PUNCT
ihlr-28406	397	12	—	—	PUNCT
ihlr-28406	397	13	—	—	PUNCT
ihlr-28406	397	14	—	—	PUNCT
ihlr-28406	397	15	—	—	PUNCT
ihlr-28406	397	16	—	—	PUNCT
ihlr-28406	397	17	—	—	PUNCT
ihlr-28406	397	18	—	—	PUNCT
ihlr-28406	397	19	—	—	PUNCT
ihlr-28406	397	20	—	—	PUNCT
ihlr-28406	397	21	—	—	PUNCT
ihlr-28406	397	22	—	—	PUNCT
ihlr-28406	397	23	—	—	PUNCT
ihlr-28406	397	24	—	—	PUNCT
ihlr-28406	397	25	—	—	PUNCT
ihlr-28406	397	26	—	—	PUNCT
ihlr-28406	397	27	—	—	PUNCT
ihlr-28406	397	28	—	—	PUNCT
ihlr-28406	397	29	—	—	PUNCT
ihlr-28406	397	30	117	117	NUM
ihlr-28406	397	31	.	.	PUNCT
ihlr-28406	397	32	brian	brian	PROPN
ihlr-28406	397	33	s.	s.	PROPN
ihlr-28406	397	34	haney	haney	PROPN
ihlr-28406	397	35	,	,	PUNCT
ihlr-28406	397	36	thyroid	thyroid	NOUN
ihlr-28406	397	37	patents	patent	NOUN
ihlr-28406	397	38	(	(	PUNCT
ihlr-28406	397	39	2020	2020	NUM
ihlr-28406	397	40	)	)	PUNCT
ihlr-28406	397	41	.	.	PUNCT
ihlr-28406	398	1	(	(	PUNCT
ihlr-28406	398	2	the	the	DET
ihlr-28406	398	3	information	information	NOUN
ihlr-28406	398	4	contained	contain	VERB
ihlr-28406	398	5	in	in	ADP
ihlr-28406	398	6	this	this	DET
ihlr-28406	398	7	chart	chart	NOUN
ihlr-28406	398	8	was	be	AUX
ihlr-28406	398	9	prepared	prepare	VERB
ihlr-28406	398	10	by	by	ADP
ihlr-28406	398	11	the	the	DET
ihlr-28406	398	12	author	author	NOUN
ihlr-28406	398	13	with	with	ADP
ihlr-28406	398	14	information	information	NOUN
ihlr-28406	398	15	from	from	ADP
ihlr-28406	398	16	the	the	DET
ihlr-28406	398	17	united	united	PROPN
ihlr-28406	398	18	states	states	PROPN
ihlr-28406	398	19	patent	patent	PROPN
ihlr-28406	398	20	and	and	CCONJ
ihlr-28406	398	21	trademark	trademark	NOUN
ihlr-28406	398	22	office	office	NOUN
ihlr-28406	398	23	)	)	PUNCT
ihlr-28406	398	24	.	.	PUNCT
ihlr-28406	399	1	(	(	PUNCT
ihlr-28406	399	2	a	a	DET
ihlr-28406	399	3	copy	copy	NOUN
ihlr-28406	399	4	of	of	ADP
ihlr-28406	399	5	the	the	DET
ihlr-28406	399	6	data	data	NOUN
ihlr-28406	399	7	is	be	AUX
ihlr-28406	399	8	on	on	ADP
ihlr-28406	399	9	file	file	NOUN
ihlr-28406	399	10	with	with	ADP
ihlr-28406	399	11	the	the	DET
ihlr-28406	399	12	author	author	NOUN
ihlr-28406	399	13	)	)	PUNCT
ihlr-28406	399	14	.	.	PUNCT
ihlr-28406	400	1	118	118	NUM
ihlr-28406	400	2	.	.	PUNCT
ihlr-28406	401	1	crosslinked	crosslinke	VERB
ihlr-28406	401	2	amine	amine	ADJ
ihlr-28406	401	3	polymers	polymer	NOUN
ihlr-28406	401	4	,	,	PUNCT
ihlr-28406	401	5	u.s	u.s	PROPN
ihlr-28406	401	6	.	.	PROPN
ihlr-28406	401	7	patent	patent	NOUN
ihlr-28406	401	8	no	no	PROPN
ihlr-28406	401	9	.	.	PROPN
ihlr-28406	401	10	8,349,305	8,349,305	NUM
ihlr-28406	401	11	to	to	ADP
ihlr-28406	401	12	cheng	cheng	PROPN
ihlr-28406	401	13	,	,	PUNCT
ihlr-28406	401	14	et	et	PROPN
ihlr-28406	401	15	al	al	PROPN
ihlr-28406	401	16	.	.	PROPN
ihlr-28406	402	1	(	(	PUNCT
ihlr-28406	402	2	filed	file	VERB
ihlr-28406	402	3	jan	jan	PROPN
ihlr-28406	402	4	.	.	PROPN
ihlr-28406	402	5	8	8	NUM
ihlr-28406	402	6	,	,	PUNCT
ihlr-28406	402	7	2013	2013	NUM
ihlr-28406	402	8	)	)	PUNCT
ihlr-28406	402	9	.	.	PUNCT
ihlr-28406	403	1	119	119	NUM
ihlr-28406	403	2	.	.	PUNCT
ihlr-28406	404	1	dock	dock	NOUN
ihlr-28406	404	2	-	-	PUNCT
ihlr-28406	404	3	and	and	CCONJ
ihlr-28406	404	4	-	-	PUNCT
ihlr-28406	404	5	lock	lock	NOUN
ihlr-28406	404	6	(	(	PUNCT
ihlr-28406	404	7	dnl	dnl	ADJ
ihlr-28406	404	8	)	)	PUNCT
ihlr-28406	404	9	complexes	complex	NOUN
ihlr-28406	404	10	for	for	ADP
ihlr-28406	404	11	therapeutic	therapeutic	ADJ
ihlr-28406	404	12	and	and	CCONJ
ihlr-28406	404	13	diagnostic	diagnostic	ADJ
ihlr-28406	404	14	use	use	NOUN
ihlr-28406	404	15	,	,	PUNCT
ihlr-28406	404	16	u.s	u.s	PROPN
ihlr-28406	404	17	.	.	PROPN
ihlr-28406	404	18	patent	patent	NOUN
ihlr-28406	404	19	no	no	PROPN
ihlr-28406	404	20	.	.	PROPN
ihlr-28406	404	21	9,550,838	9,550,838	NUM
ihlr-28406	404	22	,	,	PUNCT
ihlr-28406	404	23	to	to	ADP
ihlr-28406	404	24	chang	chang	PROPN
ihlr-28406	404	25	,	,	PUNCT
ihlr-28406	404	26	et	et	PROPN
ihlr-28406	404	27	al	al	PROPN
ihlr-28406	404	28	.	.	PROPN
ihlr-28406	405	1	(	(	PUNCT
ihlr-28406	405	2	filed	file	VERB
ihlr-28406	405	3	jan	jan	PROPN
ihlr-28406	405	4	.	.	PROPN
ihlr-28406	405	5	24	24	NUM
ihlr-28406	405	6	,	,	PUNCT
ihlr-28406	405	7	2017	2017	NUM
ihlr-28406	405	8	)	)	PUNCT
ihlr-28406	405	9	.	.	PUNCT
ihlr-28406	406	1	see	see	VERB
ihlr-28406	406	2	also	also	ADV
ihlr-28406	406	3	preparation	preparation	NOUN
ihlr-28406	406	4	of	of	ADP
ihlr-28406	406	5	organic	organic	ADJ
ihlr-28406	406	6	compounds	compound	NOUN
ihlr-28406	406	7	for	for	ADP
ihlr-28406	406	8	enhanced	enhanced	ADJ
ihlr-28406	406	9	reactivity	reactivity	NOUN
ihlr-28406	406	10	,	,	PUNCT
ihlr-28406	406	11	u.s	u.s	PROPN
ihlr-28406	406	12	.	.	PROPN
ihlr-28406	406	13	patent	patent	NOUN
ihlr-28406	406	14	no	no	PROPN
ihlr-28406	406	15	.	.	PROPN
ihlr-28406	406	16	9,085,510	9,085,510	NUM
ihlr-28406	406	17	to	to	ADP
ihlr-28406	406	18	latham	latham	PROPN
ihlr-28406	406	19	(	(	PUNCT
ihlr-28406	406	20	filed	file	VERB
ihlr-28406	406	21	july	july	PROPN
ihlr-28406	406	22	21	21	NUM
ihlr-28406	406	23	,	,	PUNCT
ihlr-28406	406	24	2015	2015	NUM
ihlr-28406	406	25	)	)	PUNCT
ihlr-28406	406	26	.	.	PUNCT
ihlr-28406	407	1	120	120	NUM
ihlr-28406	407	2	.	.	PUNCT
ihlr-28406	408	1	allison	allison	PROPN
ihlr-28406	408	2	,	,	PUNCT
ihlr-28406	408	3	supra	supra	PROPN
ihlr-28406	408	4	note	note	NOUN
ihlr-28406	408	5	115	115	NUM
ihlr-28406	408	6	.	.	PUNCT
ihlr-28406	409	1	indiana	indiana	PROPN
ihlr-28406	409	2	health	health	PROPN
ihlr-28406	409	3	law	law	PROPN
ihlr-28406	409	4	review	review	NOUN
ihlr-28406	409	5	[	[	X
ihlr-28406	409	6	vol	vol	NOUN
ihlr-28406	409	7	.	.	PUNCT
ihlr-28406	410	1	21:277	21:277	NOUN
ihlr-28406	410	2	292	292	NUM
ihlr-28406	410	3	figure	figure	NOUN
ihlr-28406	410	4	6	6	NUM
ihlr-28406	410	5	121	121	NUM
ihlr-28406	410	6	yet	yet	ADV
ihlr-28406	410	7	,	,	PUNCT
ihlr-28406	410	8	a	a	DET
ihlr-28406	410	9	contrarian	contrarian	NOUN
ihlr-28406	410	10	may	may	AUX
ihlr-28406	410	11	argue	argue	VERB
ihlr-28406	410	12	fewer	few	ADJ
ihlr-28406	410	13	prior	prior	ADJ
ihlr-28406	410	14	art	art	NOUN
ihlr-28406	410	15	citations	citation	NOUN
ihlr-28406	410	16	are	be	AUX
ihlr-28406	410	17	more	more	ADV
ihlr-28406	410	18	valuable	valuable	ADJ
ihlr-28406	410	19	insofar	insofar	ADV
ihlr-28406	410	20	as	as	SCONJ
ihlr-28406	410	21	the	the	DET
ihlr-28406	410	22	invention	invention	NOUN
ihlr-28406	410	23	is	be	AUX
ihlr-28406	410	24	more	more	ADV
ihlr-28406	410	25	novel	novel	ADJ
ihlr-28406	410	26	.	.	PUNCT
ihlr-28406	411	1	the	the	DET
ihlr-28406	411	2	minimum	minimum	NOUN
ihlr-28406	411	3	in	in	ADP
ihlr-28406	411	4	the	the	DET
ihlr-28406	411	5	thyroid	thyroid	NOUN
ihlr-28406	411	6	patent	patent	NOUN
ihlr-28406	411	7	dataset	dataset	NOUN
ihlr-28406	411	8	,	,	PUNCT
ihlr-28406	411	9	owned	own	VERB
ihlr-28406	411	10	by	by	ADP
ihlr-28406	411	11	the	the	DET
ihlr-28406	411	12	johns	johns	PROPN
ihlr-28406	411	13	hopkins	hopkins	PROPN
ihlr-28406	411	14	university	university	PROPN
ihlr-28406	411	15	,	,	PUNCT
ihlr-28406	411	16	u.s	u.s	PROPN
ihlr-28406	411	17	.	.	PROPN
ihlr-28406	411	18	patent	patent	NOUN
ihlr-28406	411	19	no	no	PROPN
ihlr-28406	411	20	.	.	PROPN
ihlr-28406	411	21	9,039,994	9,039,994	NUM
ihlr-28406	411	22	,	,	PUNCT
ihlr-28406	411	23	biomarkers	biomarker	NOUN
ihlr-28406	411	24	for	for	ADP
ihlr-28406	411	25	myocardial	myocardial	ADJ
ihlr-28406	411	26	ischemia	ischemia	NOUN
ihlr-28406	411	27	,	,	PUNCT
ihlr-28406	411	28	cited	cite	VERB
ihlr-28406	411	29	no	no	DET
ihlr-28406	411	30	prior	prior	ADJ
ihlr-28406	411	31	art.122	art.122	NOUN
ihlr-28406	411	32	by	by	ADP
ihlr-28406	411	33	contrast	contrast	NOUN
ihlr-28406	411	34	,	,	PUNCT
ihlr-28406	411	35	the	the	DET
ihlr-28406	411	36	patent	patent	NOUN
ihlr-28406	411	37	with	with	ADP
ihlr-28406	411	38	maximum	maximum	ADJ
ihlr-28406	411	39	citation	citation	NOUN
ihlr-28406	411	40	count	count	NOUN
ihlr-28406	411	41	is	be	AUX
ihlr-28406	411	42	owned	own	VERB
ihlr-28406	411	43	by	by	ADP
ihlr-28406	411	44	sio2	sio2	PROPN
ihlr-28406	411	45	medical	medical	ADJ
ihlr-28406	411	46	products	product	NOUN
ihlr-28406	411	47	,	,	PUNCT
ihlr-28406	411	48	inc	inc	PROPN
ihlr-28406	411	49	.	.	PROPN
ihlr-28406	411	50	,	,	PUNCT
ihlr-28406	412	1	u.s	u.s	PROPN
ihlr-28406	412	2	.	.	PROPN
ihlr-28406	412	3	patent	patent	NOUN
ihlr-28406	412	4	no	no	PROPN
ihlr-28406	412	5	.	.	PROPN
ihlr-28406	413	1	9,662,450	9,662,450	NUM
ihlr-28406	413	2	,	,	PUNCT
ihlr-28406	413	3	plasma	plasma	NOUN
ihlr-28406	413	4	or	or	CCONJ
ihlr-28406	413	5	cvd	cvd	NOUN
ihlr-28406	413	6	pre	pre	NOUN
ihlr-28406	413	7	-	-	NOUN
ihlr-28406	413	8	treatment	treatment	NOUN
ihlr-28406	413	9	for	for	ADP
ihlr-28406	413	10	lubricated	lubricate	VERB
ihlr-28406	413	11	pharmaceutical	pharmaceutical	ADJ
ihlr-28406	413	12	package	package	NOUN
ihlr-28406	413	13	,	,	PUNCT
ihlr-28406	413	14	coating	coating	NOUN
ihlr-28406	413	15	process	process	NOUN
ihlr-28406	413	16	and	and	CCONJ
ihlr-28406	413	17	apparatus	apparatus	NOUN
ihlr-28406	413	18	,	,	PUNCT
ihlr-28406	413	19	which	which	PRON
ihlr-28406	413	20	cited	cite	VERB
ihlr-28406	413	21	1,445	1,445	NUM
ihlr-28406	413	22	prior	prior	ADV
ihlr-28406	413	23	art.123	art.123	NOUN
ihlr-28406	413	24	a	a	DET
ihlr-28406	413	25	third	third	ADJ
ihlr-28406	413	26	factor	factor	NOUN
ihlr-28406	413	27	which	which	PRON
ihlr-28406	413	28	may	may	AUX
ihlr-28406	413	29	be	be	AUX
ihlr-28406	413	30	considered	consider	VERB
ihlr-28406	413	31	is	be	AUX
ihlr-28406	413	32	a	a	DET
ihlr-28406	413	33	patent	patent	NOUN
ihlr-28406	413	34	’s	’s	PART
ihlr-28406	413	35	inventorship	inventorship	NOUN
ihlr-28406	413	36	.	.	PUNCT
ihlr-28406	414	1	a	a	DET
ihlr-28406	414	2	common	common	ADJ
ihlr-28406	414	3	argument	argument	NOUN
ihlr-28406	414	4	is	be	AUX
ihlr-28406	414	5	that	that	SCONJ
ihlr-28406	414	6	more	more	ADJ
ihlr-28406	414	7	inventors	inventor	NOUN
ihlr-28406	414	8	and	and	CCONJ
ihlr-28406	414	9	higher	high	ADJ
ihlr-28406	414	10	inventor	inventor	NOUN
ihlr-28406	414	11	prestige	prestige	NOUN
ihlr-28406	414	12	correspond	correspond	VERB
ihlr-28406	414	13	with	with	ADP
ihlr-28406	414	14	higher	high	ADJ
ihlr-28406	414	15	patent	patent	NOUN
ihlr-28406	414	16	quality	quality	NOUN
ihlr-28406	414	17	because	because	SCONJ
ihlr-28406	414	18	more	more	ADJ
ihlr-28406	414	19	intelligence	intelligence	NOUN
ihlr-28406	414	20	and	and	CCONJ
ihlr-28406	414	21	time	time	NOUN
ihlr-28406	414	22	were	be	AUX
ihlr-28406	414	23	committed	commit	VERB
ihlr-28406	414	24	to	to	ADP
ihlr-28406	414	25	the	the	DET
ihlr-28406	414	26	patent.124	patent.124	NOUN
ihlr-28406	414	27	—	—	PUNCT
ihlr-28406	414	28	—	—	PUNCT
ihlr-28406	414	29	—	—	PUNCT
ihlr-28406	414	30	—	—	PUNCT
ihlr-28406	414	31	—	—	PUNCT
ihlr-28406	414	32	—	—	PUNCT
ihlr-28406	414	33	—	—	PUNCT
ihlr-28406	414	34	—	—	PUNCT
ihlr-28406	414	35	—	—	PUNCT
ihlr-28406	414	36	—	—	PUNCT
ihlr-28406	414	37	—	—	PUNCT
ihlr-28406	414	38	—	—	PUNCT
ihlr-28406	414	39	—	—	PUNCT
ihlr-28406	414	40	—	—	PUNCT
ihlr-28406	414	41	—	—	PUNCT
ihlr-28406	414	42	—	—	PUNCT
ihlr-28406	414	43	—	—	PUNCT
ihlr-28406	414	44	—	—	PUNCT
ihlr-28406	414	45	—	—	PUNCT
ihlr-28406	414	46	—	—	PUNCT
ihlr-28406	414	47	—	—	PUNCT
ihlr-28406	414	48	—	—	PUNCT
ihlr-28406	414	49	—	—	PUNCT
ihlr-28406	414	50	—	—	PUNCT
ihlr-28406	414	51	—	—	PUNCT
ihlr-28406	414	52	—	—	PUNCT
ihlr-28406	414	53	—	—	PUNCT
ihlr-28406	414	54	—	—	PUNCT
ihlr-28406	414	55	—	—	PUNCT
ihlr-28406	414	56	121	121	NUM
ihlr-28406	414	57	.	.	PUNCT
ihlr-28406	415	1	haney	haney	PROPN
ihlr-28406	415	2	,	,	PUNCT
ihlr-28406	415	3	supra	supra	PROPN
ihlr-28406	415	4	note	note	NOUN
ihlr-28406	415	5	111	111	NUM
ihlr-28406	415	6	.	.	PUNCT
ihlr-28406	415	7	122	122	NUM
ihlr-28406	415	8	.	.	PUNCT
ihlr-28406	416	1	biomarkers	biomarker	NOUN
ihlr-28406	416	2	for	for	ADP
ihlr-28406	416	3	myocardial	myocardial	ADJ
ihlr-28406	416	4	ischemia	ischemia	NOUN
ihlr-28406	416	5	,	,	PUNCT
ihlr-28406	416	6	u.s	u.s	PROPN
ihlr-28406	416	7	.	.	PROPN
ihlr-28406	416	8	patent	patent	NOUN
ihlr-28406	416	9	no	no	PROPN
ihlr-28406	416	10	.	.	PROPN
ihlr-28406	416	11	9,039,994	9,039,994	NUM
ihlr-28406	416	12	to	to	ADP
ihlr-28406	416	13	van	van	PROPN
ihlr-28406	416	14	eyk	eyk	PROPN
ihlr-28406	416	15	,	,	PUNCT
ihlr-28406	416	16	et	et	PROPN
ihlr-28406	416	17	al	al	PROPN
ihlr-28406	416	18	.	.	PROPN
ihlr-28406	417	1	(	(	PUNCT
ihlr-28406	417	2	filed	file	VERB
ihlr-28406	417	3	may	may	PROPN
ihlr-28406	417	4	26	26	NUM
ihlr-28406	417	5	,	,	PUNCT
ihlr-28406	417	6	2015	2015	NUM
ihlr-28406	417	7	)	)	PUNCT
ihlr-28406	417	8	.	.	PUNCT
ihlr-28406	418	1	123	123	NUM
ihlr-28406	418	2	.	.	PUNCT
ihlr-28406	419	1	plasma	plasma	NOUN
ihlr-28406	419	2	or	or	CCONJ
ihlr-28406	419	3	cvd	cvd	PROPN
ihlr-28406	419	4	pre	pre	NOUN
ihlr-28406	419	5	-	-	NOUN
ihlr-28406	419	6	treatment	treatment	NOUN
ihlr-28406	419	7	for	for	ADP
ihlr-28406	419	8	lubricated	lubricate	VERB
ihlr-28406	419	9	pharmaceutical	pharmaceutical	ADJ
ihlr-28406	419	10	package	package	NOUN
ihlr-28406	419	11	,	,	PUNCT
ihlr-28406	419	12	coating	coating	NOUN
ihlr-28406	419	13	process	process	NOUN
ihlr-28406	419	14	,	,	PUNCT
ihlr-28406	419	15	and	and	CCONJ
ihlr-28406	419	16	apparatus	apparatus	NOUN
ihlr-28406	419	17	,	,	PUNCT
ihlr-28406	419	18	u.s	u.s	PROPN
ihlr-28406	419	19	.	.	PROPN
ihlr-28406	419	20	patent	patent	NOUN
ihlr-28406	419	21	no	no	PROPN
ihlr-28406	419	22	.	.	PROPN
ihlr-28406	419	23	9,662,450	9,662,450	NUM
ihlr-28406	419	24	to	to	ADP
ihlr-28406	419	25	jones	jones	PROPN
ihlr-28406	419	26	,	,	PUNCT
ihlr-28406	419	27	et	et	PROPN
ihlr-28406	419	28	al	al	PROPN
ihlr-28406	419	29	.	.	PROPN
ihlr-28406	420	1	(	(	PUNCT
ihlr-28406	420	2	filed	file	VERB
ihlr-28406	420	3	may	may	AUX
ihlr-28406	420	4	30	30	NUM
ihlr-28406	420	5	,	,	PUNCT
ihlr-28406	420	6	2017	2017	NUM
ihlr-28406	420	7	)	)	PUNCT
ihlr-28406	420	8	.	.	PUNCT
ihlr-28406	421	1	124	124	NUM
ihlr-28406	421	2	.	.	PUNCT
ihlr-28406	421	3	r.	r.	PROPN
ihlr-28406	421	4	polk	polk	PROPN
ihlr-28406	421	5	wagner	wagner	PROPN
ihlr-28406	421	6	,	,	PUNCT
ihlr-28406	421	7	understanding	understand	VERB
ihlr-28406	421	8	patent	patent	NOUN
ihlr-28406	421	9	-	-	PUNCT
ihlr-28406	421	10	quality	quality	NOUN
ihlr-28406	421	11	,	,	PUNCT
ihlr-28406	421	12	157	157	NUM
ihlr-28406	421	13	u.	u.	NOUN
ihlr-28406	421	14	pa	pa	PROPN
ihlr-28406	421	15	.	.	PROPN
ihlr-28406	421	16	l.	l.	PROPN
ihlr-28406	421	17	rev	rev	PROPN
ihlr-28406	421	18	.	.	PROPN
ihlr-28406	421	19	2135	2135	NUM
ihlr-28406	421	20	,	,	PUNCT
ihlr-28406	421	21	2138	2138	NUM
ihlr-28406	421	22	(	(	PUNCT
ihlr-28406	421	23	2009	2009	NUM
ihlr-28406	421	24	)	)	PUNCT
ihlr-28406	421	25	(	(	PUNCT
ihlr-28406	421	26	prestige	prestige	NOUN
ihlr-28406	421	27	and	and	CCONJ
ihlr-28406	421	28	time	time	NOUN
ihlr-28406	421	29	may	may	AUX
ihlr-28406	421	30	also	also	ADV
ihlr-28406	421	31	correlate	correlate	VERB
ihlr-28406	421	32	with	with	ADP
ihlr-28406	421	33	the	the	DET
ihlr-28406	421	34	capacity	capacity	NOUN
ihlr-28406	421	35	of	of	ADP
ihlr-28406	421	36	a	a	DET
ihlr-28406	421	37	granted	grant	VERB
ihlr-28406	421	38	patent	patent	NOUN
ihlr-28406	421	39	to	to	PART
ihlr-28406	421	40	meet	meet	VERB
ihlr-28406	421	41	the	the	DET
ihlr-28406	421	42	statutory	statutory	ADJ
ihlr-28406	421	43	standards	standard	NOUN
ihlr-28406	421	44	of	of	ADP
ihlr-28406	421	45	patentability	patentability	NOUN
ihlr-28406	421	46	–	–	PUNCT
ihlr-28406	421	47	most	most	ADV
ihlr-28406	421	48	importantly	importantly	ADV
ihlr-28406	421	49	,	,	PUNCT
ihlr-28406	421	50	to	to	PART
ihlr-28406	421	51	be	be	AUX
ihlr-28406	421	52	novel	novel	ADJ
ihlr-28406	421	53	,	,	PUNCT
ihlr-28406	421	54	non	non	ADJ
ihlr-28406	421	55	-	-	ADJ
ihlr-28406	421	56	obvious	obvious	ADJ
ihlr-28406	421	57	,	,	PUNCT
ihlr-28406	421	58	and	and	CCONJ
ihlr-28406	421	59	clearly	clearly	ADV
ihlr-28406	421	60	and	and	CCONJ
ihlr-28406	421	61	sufficiently	sufficiently	ADV
ihlr-28406	421	62	described	describe	VERB
ihlr-28406	421	63	.	.	PUNCT
ihlr-28406	421	64	)	)	PUNCT
ihlr-28406	421	65	.	.	PUNCT
ihlr-28406	422	1	see	see	VERB
ihlr-28406	422	2	also	also	ADV
ihlr-28406	422	3	heather	heather	PROPN
ihlr-28406	422	4	hamel	hamel	PROPN
ihlr-28406	422	5	,	,	PUNCT
ihlr-28406	422	6	valuing	value	VERB
ihlr-28406	422	7	the	the	DET
ihlr-28406	422	8	intangible	intangible	ADJ
ihlr-28406	422	9	:	:	PUNCT
ihlr-28406	422	10	mission	mission	NOUN
ihlr-28406	422	11	impossible	impossible	ADJ
ihlr-28406	422	12	?	?	PUNCT
ihlr-28406	423	1	an	an	DET
ihlr-28406	423	2	analysis	analysis	NOUN
ihlr-28406	423	3	of	of	ADP
ihlr-28406	423	4	the	the	DET
ihlr-28406	423	5	intellectual	intellectual	ADJ
ihlr-28406	423	6	property	property	NOUN
ihlr-28406	423	7	valuation	valuation	NOUN
ihlr-28406	423	8	process	process	NOUN
ihlr-28406	423	9	,	,	PUNCT
ihlr-28406	423	10	5	5	NUM
ihlr-28406	423	11	cybaris	cybaris	NOUN
ihlr-28406	423	12	an	an	DET
ihlr-28406	423	13	intell	intell	NOUN
ihlr-28406	423	14	.	.	PUNCT
ihlr-28406	424	1	prop	prop	PROPN
ihlr-28406	424	2	.	.	PUNCT
ihlr-28406	425	1	l.	l.	PROPN
ihlr-28406	425	2	rev	rev	PROPN
ihlr-28406	425	3	.	.	PROPN
ihlr-28406	425	4	183	183	NUM
ihlr-28406	425	5	,	,	PUNCT
ihlr-28406	425	6	187	187	NUM
ihlr-28406	425	7	(	(	PUNCT
ihlr-28406	425	8	2014	2014	NUM
ihlr-28406	425	9	)	)	PUNCT
ihlr-28406	425	10	.	.	PUNCT
ihlr-28406	426	1	2024	2024	NUM
ihlr-28406	426	2	]	]	PUNCT
ihlr-28406	426	3	inventions	invention	NOUN
ihlr-28406	426	4	and	and	CCONJ
ihlr-28406	426	5	patents	patent	NOUN
ihlr-28406	426	6	for	for	ADP
ihlr-28406	426	7	treating	treat	VERB
ihlr-28406	426	8	293	293	NUM
ihlr-28406	426	9	thyroid	thyroid	NOUN
ihlr-28406	426	10	disease	disease	NOUN
ihlr-28406	426	11	figure	figure	VERB
ihlr-28406	426	12	7	7	NUM
ihlr-28406	426	13	125	125	NUM
ihlr-28406	426	14	owned	own	VERB
ihlr-28406	426	15	by	by	ADP
ihlr-28406	426	16	otsuka	otsuka	PROPN
ihlr-28406	426	17	pharmaceutical	pharmaceutical	PROPN
ihlr-28406	426	18	co.	co.	PROPN
ihlr-28406	426	19	,	,	PUNCT
ihlr-28406	426	20	u.s	u.s	PROPN
ihlr-28406	426	21	.	.	PROPN
ihlr-28406	426	22	patent	patent	NOUN
ihlr-28406	426	23	8,420,623	8,420,623	NUM
ihlr-28406	426	24	,	,	PUNCT
ihlr-28406	426	25	n	n	CCONJ
ihlr-28406	426	26	,	,	PUNCT
ihlr-28406	426	27	nsubstituted	nsubstitute	VERB
ihlr-28406	426	28	3	3	NUM
ihlr-28406	426	29	-	-	PUNCT
ihlr-28406	426	30	aminopyrrolidine	aminopyrrolidine	NOUN
ihlr-28406	426	31	compounds	compound	VERB
ihlr-28406	426	32	useful	useful	ADJ
ihlr-28406	426	33	as	as	ADP
ihlr-28406	426	34	monoamines	monoamine	NOUN
ihlr-28406	426	35	reuptake	reuptake	NOUN
ihlr-28406	426	36	inhibitors	inhibitor	NOUN
ihlr-28406	426	37	,	,	PUNCT
ihlr-28406	426	38	listed	list	VERB
ihlr-28406	426	39	twenty	twenty	NUM
ihlr-28406	426	40	-	-	PUNCT
ihlr-28406	426	41	two	two	NUM
ihlr-28406	426	42	inventors	inventor	NOUN
ihlr-28406	426	43	.	.	PUNCT
ihlr-28406	427	1	126	126	NUM
ihlr-28406	427	2	however	however	ADV
ihlr-28406	427	3	,	,	PUNCT
ihlr-28406	427	4	one	one	NUM
ihlr-28406	427	5	counterargument	counterargument	NOUN
ihlr-28406	427	6	is	be	AUX
ihlr-28406	427	7	estimations	estimation	NOUN
ihlr-28406	427	8	based	base	VERB
ihlr-28406	427	9	on	on	ADP
ihlr-28406	427	10	inventorship	inventorship	NOUN
ihlr-28406	427	11	may	may	AUX
ihlr-28406	427	12	overlook	overlook	VERB
ihlr-28406	427	13	inventions	invention	NOUN
ihlr-28406	427	14	by	by	ADP
ihlr-28406	427	15	previously	previously	ADV
ihlr-28406	427	16	unknown	unknown	ADJ
ihlr-28406	427	17	inventors	inventor	NOUN
ihlr-28406	427	18	which	which	PRON
ihlr-28406	427	19	took	take	VERB
ihlr-28406	427	20	substantial	substantial	ADJ
ihlr-28406	427	21	time	time	NOUN
ihlr-28406	427	22	and	and	CCONJ
ihlr-28406	427	23	effort	effort	NOUN
ihlr-28406	427	24	.	.	PUNCT
ihlr-28406	428	1	in	in	ADP
ihlr-28406	428	2	other	other	ADJ
ihlr-28406	428	3	words	word	NOUN
ihlr-28406	428	4	,	,	PUNCT
ihlr-28406	428	5	similar	similar	ADJ
ihlr-28406	428	6	to	to	ADP
ihlr-28406	428	7	the	the	DET
ihlr-28406	428	8	way	way	NOUN
ihlr-28406	428	9	in	in	ADP
ihlr-28406	428	10	which	which	PRON
ihlr-28406	428	11	politicians	politician	NOUN
ihlr-28406	428	12	attack	attack	VERB
ihlr-28406	428	13	one	one	NOUN
ihlr-28406	428	14	another	another	DET
ihlr-28406	428	15	personally	personally	ADV
ihlr-28406	428	16	rather	rather	ADV
ihlr-28406	428	17	than	than	ADP
ihlr-28406	428	18	underlying	underlie	VERB
ihlr-28406	428	19	policies	policy	NOUN
ihlr-28406	428	20	and	and	CCONJ
ihlr-28406	428	21	ideas	idea	NOUN
ihlr-28406	428	22	,	,	PUNCT
ihlr-28406	428	23	patent	patent	NOUN
ihlr-28406	428	24	valuations	valuation	NOUN
ihlr-28406	428	25	based	base	VERB
ihlr-28406	428	26	on	on	ADP
ihlr-28406	428	27	inventorship	inventorship	NOUN
ihlr-28406	428	28	fall	fall	NOUN
ihlr-28406	428	29	victim	victim	NOUN
ihlr-28406	428	30	to	to	ADP
ihlr-28406	428	31	the	the	DET
ihlr-28406	428	32	ad	ad	NOUN
ihlr-28406	428	33	hominem	hominem	NOUN
ihlr-28406	428	34	fallacy.127	fallacy.127	PROPN
ihlr-28406	428	35	c.	c.	PROPN
ihlr-28406	428	36	claims	claim	VERB
ihlr-28406	428	37	claims	claim	NOUN
ihlr-28406	428	38	are	be	AUX
ihlr-28406	428	39	the	the	DET
ihlr-28406	428	40	most	most	ADV
ihlr-28406	428	41	important	important	ADJ
ihlr-28406	428	42	part	part	NOUN
ihlr-28406	428	43	of	of	ADP
ihlr-28406	428	44	a	a	DET
ihlr-28406	428	45	patent	patent	NOUN
ihlr-28406	428	46	because	because	SCONJ
ihlr-28406	428	47	they	they	PRON
ihlr-28406	428	48	declare	declare	VERB
ihlr-28406	428	49	the	the	DET
ihlr-28406	428	50	invention128	invention128	PROPN
ihlr-28406	428	51	because	because	SCONJ
ihlr-28406	428	52	claims	claim	NOUN
ihlr-28406	428	53	are	be	AUX
ihlr-28406	428	54	the	the	DET
ihlr-28406	428	55	only	only	ADJ
ihlr-28406	428	56	part	part	NOUN
ihlr-28406	428	57	of	of	ADP
ihlr-28406	428	58	the	the	DET
ihlr-28406	428	59	patent	patent	NOUN
ihlr-28406	428	60	that	that	PRON
ihlr-28406	428	61	can	can	AUX
ihlr-28406	428	62	be	be	AUX
ihlr-28406	428	63	infringed.129	infringed.129	PROPN
ihlr-28406	428	64	the	the	DET
ihlr-28406	428	65	uspto	uspto	PROPN
ihlr-28406	428	66	issues	issue	NOUN
ihlr-28406	428	67	patents	patent	NOUN
ihlr-28406	428	68	for	for	ADP
ihlr-28406	428	69	claims	claim	NOUN
ihlr-28406	428	70	it	it	PRON
ihlr-28406	428	71	determines	determine	VERB
ihlr-28406	428	72	satisfy	satisfy	VERB
ihlr-28406	428	73	the	the	DET
ihlr-28406	428	74	statutory	statutory	ADJ
ihlr-28406	428	75	requirements	requirement	NOUN
ihlr-28406	428	76	.	.	PUNCT
ihlr-28406	429	1	130	130	NUM
ihlr-28406	429	2	further	far	ADV
ihlr-28406	429	3	,	,	PUNCT
ihlr-28406	429	4	a	a	DET
ihlr-28406	429	5	challenge	challenge	NOUN
ihlr-28406	429	6	to	to	ADP
ihlr-28406	429	7	an	an	DET
ihlr-28406	429	8	issued	issue	VERB
ihlr-28406	429	9	patent	patent	NOUN
ihlr-28406	429	10	will	will	AUX
ihlr-28406	429	11	succeed	succeed	VERB
ihlr-28406	429	12	if	if	SCONJ
ihlr-28406	429	13	the	the	DET
ihlr-28406	429	14	challenger	challenger	NOUN
ihlr-28406	429	15	can	can	AUX
ihlr-28406	429	16	show	show	VERB
ihlr-28406	429	17	that	that	SCONJ
ihlr-28406	429	18	any	any	PRON
ihlr-28406	429	19	of	of	ADP
ihlr-28406	429	20	the	the	DET
ihlr-28406	429	21	requirements	requirement	NOUN
ihlr-28406	429	22	have	have	AUX
ihlr-28406	429	23	not	not	PART
ihlr-28406	429	24	been	be	AUX
ihlr-28406	429	25	met	meet	VERB
ihlr-28406	429	26	.	.	PUNCT
ihlr-28406	430	1	131	131	NUM
ihlr-28406	430	2	further	far	ADV
ihlr-28406	430	3	,	,	PUNCT
ihlr-28406	430	4	courts	court	NOUN
ihlr-28406	430	5	construe	construe	VERB
ihlr-28406	430	6	patent	patent	NOUN
ihlr-28406	430	7	claims	claim	NOUN
ihlr-28406	430	8	by	by	ADP
ihlr-28406	430	9	starting	start	VERB
ihlr-28406	430	10	with	with	ADP
ihlr-28406	430	11	the	the	DET
ihlr-28406	430	12	plain	plain	ADJ
ihlr-28406	430	13	meaning	meaning	NOUN
ihlr-28406	430	14	,	,	PUNCT
ihlr-28406	430	15	as	as	ADP
ihlr-28406	430	16	the	the	PRON
ihlr-28406	430	17	—	—	PUNCT
ihlr-28406	430	18	—	—	PUNCT
ihlr-28406	430	19	—	—	PUNCT
ihlr-28406	430	20	—	—	PUNCT
ihlr-28406	430	21	—	—	PUNCT
ihlr-28406	430	22	—	—	PUNCT
ihlr-28406	430	23	—	—	PUNCT
ihlr-28406	430	24	—	—	PUNCT
ihlr-28406	430	25	—	—	PUNCT
ihlr-28406	430	26	—	—	PUNCT
ihlr-28406	430	27	—	—	PUNCT
ihlr-28406	430	28	—	—	PUNCT
ihlr-28406	430	29	—	—	PUNCT
ihlr-28406	430	30	—	—	PUNCT
ihlr-28406	430	31	—	—	PUNCT
ihlr-28406	430	32	—	—	PUNCT
ihlr-28406	430	33	—	—	PUNCT
ihlr-28406	430	34	—	—	PUNCT
ihlr-28406	430	35	—	—	PUNCT
ihlr-28406	430	36	—	—	PUNCT
ihlr-28406	430	37	—	—	PUNCT
ihlr-28406	430	38	—	—	PUNCT
ihlr-28406	430	39	—	—	PUNCT
ihlr-28406	430	40	—	—	PUNCT
ihlr-28406	430	41	—	—	PUNCT
ihlr-28406	430	42	—	—	PUNCT
ihlr-28406	430	43	—	—	PUNCT
ihlr-28406	430	44	—	—	PUNCT
ihlr-28406	430	45	—	—	PUNCT
ihlr-28406	430	46	125	125	NUM
ihlr-28406	430	47	.	.	PUNCT
ihlr-28406	430	48	haney	haney	PROPN
ihlr-28406	430	49	,	,	PUNCT
ihlr-28406	430	50	supra	supra	PROPN
ihlr-28406	430	51	note	note	NOUN
ihlr-28406	430	52	111	111	NUM
ihlr-28406	430	53	.	.	PUNCT
ihlr-28406	430	54	126	126	NUM
ihlr-28406	430	55	.	.	PUNCT
ihlr-28406	431	1	n	n	CCONJ
ihlr-28406	431	2	,	,	PUNCT
ihlr-28406	431	3	n	n	CCONJ
ihlr-28406	431	4	-	-	PUNCT
ihlr-28406	431	5	substituted	substitute	VERB
ihlr-28406	431	6	3	3	NUM
ihlr-28406	431	7	-	-	PUNCT
ihlr-28406	431	8	aminopyrrolidine	aminopyrrolidine	NOUN
ihlr-28406	431	9	compounds	compound	VERB
ihlr-28406	431	10	useful	useful	ADJ
ihlr-28406	431	11	as	as	ADP
ihlr-28406	431	12	monoamines	monoamine	NOUN
ihlr-28406	431	13	reuptake	reuptake	NOUN
ihlr-28406	431	14	inhibitors	inhibitor	NOUN
ihlr-28406	431	15	,	,	PUNCT
ihlr-28406	431	16	u.s	u.s	PROPN
ihlr-28406	431	17	.	.	PROPN
ihlr-28406	431	18	patent	patent	NOUN
ihlr-28406	431	19	no	no	PROPN
ihlr-28406	432	1	.	.	PROPN
ihlr-28406	432	2	8,420,623	8,420,623	NUM
ihlr-28406	432	3	,	,	PUNCT
ihlr-28406	432	4	to	to	ADP
ihlr-28406	432	5	kurimura	kurimura	PROPN
ihlr-28406	432	6	,	,	PUNCT
ihlr-28406	432	7	et	et	PROPN
ihlr-28406	432	8	al	al	PROPN
ihlr-28406	432	9	.	.	PROPN
ihlr-28406	433	1	(	(	PUNCT
ihlr-28406	433	2	filed	file	VERB
ihlr-28406	433	3	april	april	PROPN
ihlr-28406	433	4	16	16	NUM
ihlr-28406	433	5	,	,	PUNCT
ihlr-28406	433	6	2013	2013	NUM
ihlr-28406	433	7	)	)	PUNCT
ihlr-28406	433	8	.	.	PUNCT
ihlr-28406	434	1	127	127	NUM
ihlr-28406	434	2	.	.	PUNCT
ihlr-28406	435	1	the	the	DET
ihlr-28406	435	2	ad	ad	NOUN
ihlr-28406	435	3	hominem	hominem	NOUN
ihlr-28406	435	4	fallacy	fallacy	NOUN
ihlr-28406	435	5	refers	refer	VERB
ihlr-28406	435	6	to	to	ADP
ihlr-28406	435	7	logical	logical	ADJ
ihlr-28406	435	8	arguments	argument	NOUN
ihlr-28406	435	9	relating	relate	VERB
ihlr-28406	435	10	to	to	ADP
ihlr-28406	435	11	a	a	DET
ihlr-28406	435	12	person	person	NOUN
ihlr-28406	435	13	,	,	PUNCT
ihlr-28406	435	14	rather	rather	ADV
ihlr-28406	435	15	than	than	ADP
ihlr-28406	435	16	the	the	DET
ihlr-28406	435	17	position	position	NOUN
ihlr-28406	435	18	they	they	PRON
ihlr-28406	435	19	are	be	AUX
ihlr-28406	435	20	maintaining	maintain	VERB
ihlr-28406	435	21	.	.	PUNCT
ihlr-28406	436	1	128	128	NUM
ihlr-28406	436	2	.	.	PUNCT
ihlr-28406	436	3	mark	mark	PROPN
ihlr-28406	436	4	a.	a.	PROPN
ihlr-28406	436	5	lemley	lemley	PROPN
ihlr-28406	436	6	,	,	PUNCT
ihlr-28406	436	7	the	the	DET
ihlr-28406	436	8	changing	change	VERB
ihlr-28406	436	9	meaning	meaning	NOUN
ihlr-28406	436	10	of	of	ADP
ihlr-28406	436	11	patent	patent	NOUN
ihlr-28406	436	12	claim	claim	NOUN
ihlr-28406	436	13	terms	term	NOUN
ihlr-28406	436	14	,	,	PUNCT
ihlr-28406	436	15	104	104	NUM
ihlr-28406	436	16	mich	mich	PROPN
ihlr-28406	436	17	.	.	PUNCT
ihlr-28406	437	1	l.	l.	PROPN
ihlr-28406	437	2	rev	rev	PROPN
ihlr-28406	437	3	.	.	PROPN
ihlr-28406	438	1	101	101	NUM
ihlr-28406	438	2	(	(	PUNCT
ihlr-28406	438	3	2005	2005	NUM
ihlr-28406	438	4	)	)	PUNCT
ihlr-28406	438	5	.	.	PUNCT
ihlr-28406	439	1	129	129	NUM
ihlr-28406	439	2	.	.	PUNCT
ihlr-28406	440	1	kevin	kevin	PROPN
ihlr-28406	440	2	f.	f.	PROPN
ihlr-28406	440	3	o’malley	o’malley	PROPN
ihlr-28406	440	4	,	,	PUNCT
ihlr-28406	440	5	et	et	PROPN
ihlr-28406	440	6	.	.	PUNCT
ihlr-28406	441	1	al	al	PROPN
ihlr-28406	441	2	.	.	PROPN
ihlr-28406	441	3	,	,	PUNCT
ihlr-28406	441	4	3a	3a	PROPN
ihlr-28406	441	5	fed	feed	VERB
ihlr-28406	441	6	.	.	PUNCT
ihlr-28406	442	1	jury	jury	PROPN
ihlr-28406	442	2	prac	prac	PROPN
ihlr-28406	442	3	.	.	PROPN
ihlr-28406	442	4	&	&	CCONJ
ihlr-28406	442	5	instr	instr	PROPN
ihlr-28406	442	6	.	.	PUNCT
ihlr-28406	443	1	§	§	PROPN
ihlr-28406	443	2	158:41	158:41	NUM
ihlr-28406	443	3	(	(	PUNCT
ihlr-28406	443	4	6th	6th	ADJ
ihlr-28406	443	5	ed	ed	NOUN
ihlr-28406	443	6	.	.	PROPN
ihlr-28406	443	7	2019	2019	NUM
ihlr-28406	443	8	)	)	PUNCT
ihlr-28406	443	9	.	.	PUNCT
ihlr-28406	444	1	130	130	NUM
ihlr-28406	444	2	.	.	PUNCT
ihlr-28406	445	1	max	max	PROPN
ihlr-28406	445	2	stul	stul	PROPN
ihlr-28406	445	3	oppenheimer	oppenheimer	PROPN
ihlr-28406	445	4	,	,	PUNCT
ihlr-28406	445	5	patents	patent	NOUN
ihlr-28406	445	6	101	101	NUM
ihlr-28406	445	7	:	:	PUNCT
ihlr-28406	445	8	patentable	patentable	ADJ
ihlr-28406	445	9	subject	subject	ADJ
ihlr-28406	445	10	matter	matter	NOUN
ihlr-28406	445	11	and	and	CCONJ
ihlr-28406	445	12	separation	separation	NOUN
ihlr-28406	445	13	of	of	ADP
ihlr-28406	445	14	powers	power	NOUN
ihlr-28406	445	15	,	,	PUNCT
ihlr-28406	445	16	15	15	NUM
ihlr-28406	445	17	vand	vand	NOUN
ihlr-28406	445	18	.	.	PUNCT
ihlr-28406	446	1	j.	j.	PROPN
ihlr-28406	446	2	ent	ent	PROPN
ihlr-28406	446	3	.	.	PROPN
ihlr-28406	446	4	&	&	CCONJ
ihlr-28406	446	5	tech	tech	PROPN
ihlr-28406	446	6	.	.	PUNCT
ihlr-28406	447	1	l.	l.	PROPN
ihlr-28406	447	2	1	1	NUM
ihlr-28406	447	3	,	,	PUNCT
ihlr-28406	447	4	4	4	NUM
ihlr-28406	447	5	(	(	PUNCT
ihlr-28406	447	6	2012	2012	NUM
ihlr-28406	447	7	)	)	PUNCT
ihlr-28406	447	8	.	.	PUNCT
ihlr-28406	448	1	131	131	X
ihlr-28406	448	2	.	.	PUNCT
ihlr-28406	449	1	i	i	PRON
ihlr-28406	449	2	d.	d.	PROPN
ihlr-28406	449	3	indiana	indiana	PROPN
ihlr-28406	449	4	health	health	PROPN
ihlr-28406	449	5	law	law	PROPN
ihlr-28406	449	6	review	review	NOUN
ihlr-28406	449	7	[	[	X
ihlr-28406	449	8	vol	vol	NOUN
ihlr-28406	449	9	.	.	PUNCT
ihlr-28406	450	1	21:277	21:277	NOUN
ihlr-28406	450	2	294	294	NUM
ihlr-28406	450	3	terms	term	NOUN
ihlr-28406	450	4	are	be	AUX
ihlr-28406	450	5	understood	understand	VERB
ihlr-28406	450	6	by	by	ADP
ihlr-28406	450	7	a	a	DET
ihlr-28406	450	8	person	person	NOUN
ihlr-28406	450	9	having	have	VERB
ihlr-28406	450	10	ordinary	ordinary	ADJ
ihlr-28406	450	11	skill	skill	NOUN
ihlr-28406	450	12	in	in	ADP
ihlr-28406	450	13	the	the	DET
ihlr-28406	450	14	art	art	NOUN
ihlr-28406	450	15	.	.	PUNCT
ihlr-28406	451	1	132	132	NUM
ihlr-28406	451	2	three	three	NUM
ihlr-28406	451	3	claim	claim	NOUN
ihlr-28406	451	4	drafting	draft	VERB
ihlr-28406	451	5	considerations	consideration	NOUN
ihlr-28406	451	6	crucial	crucial	ADJ
ihlr-28406	451	7	to	to	PART
ihlr-28406	451	8	thyroid	thyroid	VERB
ihlr-28406	451	9	patents	patent	NOUN
ihlr-28406	451	10	are	be	AUX
ihlr-28406	451	11	:	:	PUNCT
ihlr-28406	451	12	non	non	ADJ
ihlr-28406	451	13	-	-	ADJ
ihlr-28406	451	14	obviousness	obviousness	ADJ
ihlr-28406	451	15	,	,	PUNCT
ihlr-28406	451	16	novelty	novelty	NOUN
ihlr-28406	451	17	,	,	PUNCT
ihlr-28406	451	18	and	and	CCONJ
ihlr-28406	451	19	scope	scope	NOUN
ihlr-28406	451	20	.	.	PUNCT
ihlr-28406	452	1	the	the	DET
ihlr-28406	452	2	non	non	ADJ
ihlr-28406	452	3	-	-	ADJ
ihlr-28406	452	4	obviousness	obviousness	ADJ
ihlr-28406	452	5	doctrine	doctrine	NOUN
ihlr-28406	452	6	seeks	seek	VERB
ihlr-28406	452	7	to	to	PART
ihlr-28406	452	8	ensure	ensure	VERB
ihlr-28406	452	9	patents	patent	NOUN
ihlr-28406	452	10	are	be	AUX
ihlr-28406	452	11	granted	grant	VERB
ihlr-28406	452	12	only	only	ADV
ihlr-28406	452	13	for	for	ADP
ihlr-28406	452	14	technologically	technologically	ADV
ihlr-28406	452	15	significant	significant	ADJ
ihlr-28406	452	16	advances	advance	NOUN
ihlr-28406	452	17	to	to	PART
ihlr-28406	452	18	stimulate	stimulate	VERB
ihlr-28406	452	19	useful	useful	ADJ
ihlr-28406	452	20	innovation	innovation	NOUN
ihlr-28406	452	21	.	.	PUNCT
ihlr-28406	453	1	133	133	NUM
ihlr-28406	453	2	a	a	DET
ihlr-28406	453	3	patent	patent	NOUN
ihlr-28406	453	4	claim	claim	NOUN
ihlr-28406	453	5	is	be	AUX
ihlr-28406	453	6	invalid	invalid	ADJ
ihlr-28406	453	7	“	"	PUNCT
ihlr-28406	453	8	if	if	SCONJ
ihlr-28406	453	9	the	the	DET
ihlr-28406	453	10	differences	difference	NOUN
ihlr-28406	453	11	between	between	ADP
ihlr-28406	453	12	the	the	DET
ihlr-28406	453	13	claimed	claim	VERB
ihlr-28406	453	14	invention	invention	NOUN
ihlr-28406	453	15	and	and	CCONJ
ihlr-28406	453	16	the	the	DET
ihlr-28406	453	17	prior	prior	ADJ
ihlr-28406	453	18	art	art	NOUN
ihlr-28406	453	19	are	be	AUX
ihlr-28406	453	20	such	such	ADJ
ihlr-28406	453	21	that	that	SCONJ
ihlr-28406	453	22	the	the	DET
ihlr-28406	453	23	claimed	claim	VERB
ihlr-28406	453	24	invention	invention	NOUN
ihlr-28406	453	25	as	as	ADP
ihlr-28406	453	26	a	a	DET
ihlr-28406	453	27	whole	whole	NOUN
ihlr-28406	453	28	would	would	AUX
ihlr-28406	453	29	have	have	AUX
ihlr-28406	453	30	been	be	AUX
ihlr-28406	453	31	obvious	obvious	ADJ
ihlr-28406	453	32	.	.	PUNCT
ihlr-28406	453	33	.	.	PUNCT
ihlr-28406	454	1	.	.	PUNCT
ihlr-28406	455	1	to	to	ADP
ihlr-28406	455	2	a	a	DET
ihlr-28406	455	3	person	person	NOUN
ihlr-28406	455	4	having	have	VERB
ihlr-28406	455	5	ordinary	ordinary	ADJ
ihlr-28406	455	6	skill	skill	NOUN
ihlr-28406	455	7	in	in	ADP
ihlr-28406	455	8	the	the	DET
ihlr-28406	455	9	art	art	NOUN
ihlr-28406	455	10	.	.	PUNCT
ihlr-28406	455	11	”134	”134	PUNCT
ihlr-28406	455	12	nyu	nyu	PROPN
ihlr-28406	455	13	law	law	PROPN
ihlr-28406	455	14	professor	professor	NOUN
ihlr-28406	455	15	jeanne	jeanne	PROPN
ihlr-28406	455	16	fromer	fromer	PROPN
ihlr-28406	455	17	explains	explain	VERB
ihlr-28406	455	18	,	,	PUNCT
ihlr-28406	455	19	“	"	PUNCT
ihlr-28406	455	20	the	the	DET
ihlr-28406	455	21	non	non	ADJ
ihlr-28406	455	22	-	-	ADJ
ihlr-28406	455	23	obviousness	obviousness	ADJ
ihlr-28406	455	24	doctrine	doctrine	NOUN
ihlr-28406	455	25	seeks	seek	VERB
ihlr-28406	455	26	to	to	PART
ihlr-28406	455	27	ensure	ensure	VERB
ihlr-28406	455	28	that	that	SCONJ
ihlr-28406	455	29	patents	patent	NOUN
ihlr-28406	455	30	are	be	AUX
ihlr-28406	455	31	granted	grant	VERB
ihlr-28406	455	32	only	only	ADV
ihlr-28406	455	33	for	for	ADP
ihlr-28406	455	34	technologically	technologically	ADV
ihlr-28406	455	35	significant	significant	ADJ
ihlr-28406	455	36	advances	advance	NOUN
ihlr-28406	455	37	to	to	PART
ihlr-28406	455	38	foster	foster	VERB
ihlr-28406	455	39	the	the	DET
ihlr-28406	455	40	patent	patent	NOUN
ihlr-28406	455	41	system	system	NOUN
ihlr-28406	455	42	’s	’s	PART
ihlr-28406	455	43	goal	goal	NOUN
ihlr-28406	455	44	of	of	ADP
ihlr-28406	455	45	stimulating	stimulate	VERB
ihlr-28406	455	46	useful	useful	ADJ
ihlr-28406	455	47	innovation	innovation	NOUN
ihlr-28406	455	48	.	.	PUNCT
ihlr-28406	455	49	”135	”135	PUNCT
ihlr-28406	456	1	the	the	DET
ihlr-28406	456	2	statute	statute	NOUN
ihlr-28406	456	3	requires	require	VERB
ihlr-28406	456	4	that	that	SCONJ
ihlr-28406	456	5	obviousness	obviousness	NOUN
ihlr-28406	456	6	be	be	AUX
ihlr-28406	456	7	judged	judge	VERB
ihlr-28406	456	8	from	from	ADP
ihlr-28406	456	9	the	the	DET
ihlr-28406	456	10	perspective	perspective	NOUN
ihlr-28406	456	11	of	of	ADP
ihlr-28406	456	12	the	the	DET
ihlr-28406	456	13	person	person	NOUN
ihlr-28406	456	14	having	have	VERB
ihlr-28406	456	15	ordinary	ordinary	ADJ
ihlr-28406	456	16	skill	skill	NOUN
ihlr-28406	456	17	in	in	ADP
ihlr-28406	456	18	the	the	DET
ihlr-28406	456	19	art	art	NOUN
ihlr-28406	456	20	.	.	PUNCT
ihlr-28406	457	1	136	136	NUM
ihlr-28406	457	2	consider	consider	VERB
ihlr-28406	457	3	u.s	u.s	PROPN
ihlr-28406	457	4	.	.	PROPN
ihlr-28406	457	5	patent	patent	NOUN
ihlr-28406	457	6	no	no	PROPN
ihlr-28406	457	7	.	.	PUNCT
ihlr-28406	458	1	6,740,680	6,740,680	NUM
ihlr-28406	458	2	,	,	PUNCT
ihlr-28406	458	3	pharmaceutical	pharmaceutical	ADJ
ihlr-28406	458	4	compositions	composition	NOUN
ihlr-28406	458	5	to	to	ADP
ihlr-28406	458	6	tetrac	tetrac	NOUN
ihlr-28406	458	7	and	and	CCONJ
ihlr-28406	458	8	methods	method	NOUN
ihlr-28406	458	9	of	of	ADP
ihlr-28406	458	10	use	use	NOUN
ihlr-28406	458	11	thereof	thereof	ADV
ihlr-28406	458	12	,	,	PUNCT
ihlr-28406	458	13	which	which	PRON
ihlr-28406	458	14	claims	claim	VERB
ihlr-28406	458	15	:	:	PUNCT
ihlr-28406	458	16	1	1	X
ihlr-28406	458	17	.	.	X
ihlr-28406	458	18	a	a	DET
ihlr-28406	458	19	method	method	NOUN
ihlr-28406	458	20	for	for	ADP
ihlr-28406	458	21	suppressing	suppress	VERB
ihlr-28406	458	22	tsh	tsh	NOUN
ihlr-28406	458	23	secretion	secretion	NOUN
ihlr-28406	458	24	while	while	SCONJ
ihlr-28406	458	25	reducing	reduce	VERB
ihlr-28406	458	26	or	or	CCONJ
ihlr-28406	458	27	avoiding	avoid	VERB
ihlr-28406	458	28	the	the	DET
ihlr-28406	458	29	thyromimetic	thyromimetic	ADJ
ihlr-28406	458	30	stimulation	stimulation	NOUN
ihlr-28406	458	31	of	of	ADP
ihlr-28406	458	32	peripheral	peripheral	ADJ
ihlr-28406	458	33	tissues	tissue	NOUN
ihlr-28406	458	34	induced	induce	VERB
ihlr-28406	458	35	by	by	ADP
ihlr-28406	458	36	a	a	DET
ihlr-28406	458	37	dose	dose	NOUN
ihlr-28406	458	38	of	of	ADP
ihlr-28406	458	39	l	l	PROPN
ihlr-28406	458	40	-	-	NOUN
ihlr-28406	458	41	thyroxine	thyroxine	NOUN
ihlr-28406	458	42	which	which	PRON
ihlr-28406	458	43	produces	produce	VERB
ihlr-28406	458	44	an	an	DET
ihlr-28406	458	45	equivalent	equivalent	ADJ
ihlr-28406	458	46	tsh	tsh	ADJ
ihlr-28406	458	47	-	-	PUNCT
ihlr-28406	458	48	suppressive	suppressive	ADJ
ihlr-28406	458	49	effect	effect	NOUN
ihlr-28406	458	50	comprising	comprise	VERB
ihlr-28406	458	51	administration	administration	NOUN
ihlr-28406	458	52	of	of	ADP
ihlr-28406	458	53	a	a	DET
ihlr-28406	458	54	pharmaceutical	pharmaceutical	ADJ
ihlr-28406	458	55	composition	composition	NOUN
ihlr-28406	458	56	comprising	comprising	NOUN
ihlr-28406	458	57	tetrac	tetrac	NOUN
ihlr-28406	458	58	,	,	PUNCT
ihlr-28406	458	59	or	or	CCONJ
ihlr-28406	458	60	a	a	DET
ihlr-28406	458	61	pharmaceutically	pharmaceutically	ADV
ihlr-28406	458	62	acceptable	acceptable	ADJ
ihlr-28406	458	63	salt	salt	NOUN
ihlr-28406	458	64	thereof	thereof	ADV
ihlr-28406	458	65	,	,	PUNCT
ihlr-28406	458	66	admixed	admix	VERB
ihlr-28406	458	67	with	with	ADP
ihlr-28406	458	68	a	a	DET
ihlr-28406	458	69	pharmaceutically	pharmaceutically	ADV
ihlr-28406	458	70	acceptable	acceptable	ADJ
ihlr-28406	458	71	carrier	carrier	NOUN
ihlr-28406	458	72	.	.	PUNCT
ihlr-28406	459	1	137	137	NUM
ihlr-28406	459	2	here	here	ADV
ihlr-28406	459	3	,	,	PUNCT
ihlr-28406	459	4	the	the	DET
ihlr-28406	459	5	non	non	ADJ
ihlr-28406	459	6	-	-	ADJ
ihlr-28406	459	7	obvious	obvious	ADJ
ihlr-28406	459	8	advance	advance	NOUN
ihlr-28406	459	9	comprises	comprise	VERB
ihlr-28406	459	10	two	two	NUM
ihlr-28406	459	11	elements	element	NOUN
ihlr-28406	459	12	:	:	PUNCT
ihlr-28406	459	13	suppressing	suppress	VERB
ihlr-28406	459	14	tsh	tsh	NOUN
ihlr-28406	459	15	secretion	secretion	NOUN
ihlr-28406	459	16	and	and	CCONJ
ihlr-28406	459	17	a	a	DET
ihlr-28406	459	18	pharmaceutical	pharmaceutical	ADJ
ihlr-28406	459	19	composition	composition	NOUN
ihlr-28406	459	20	including	include	VERB
ihlr-28406	459	21	tetrac	tetrac	NOUN
ihlr-28406	459	22	138	138	NUM
ihlr-28406	459	23	and	and	CCONJ
ihlr-28406	459	24	other	other	ADJ
ihlr-28406	459	25	compounds	compound	NOUN
ihlr-28406	459	26	.	.	PUNCT
ihlr-28406	460	1	until	until	ADP
ihlr-28406	460	2	this	this	DET
ihlr-28406	460	3	patent	patent	NOUN
ihlr-28406	460	4	,	,	PUNCT
ihlr-28406	460	5	the	the	DET
ihlr-28406	460	6	state	state	NOUN
ihlr-28406	460	7	-	-	PUNCT
ihlr-28406	460	8	of	of	ADP
ihlr-28406	460	9	-	-	PUNCT
ihlr-28406	460	10	the	the	DET
ihlr-28406	460	11	-	-	PUNCT
ihlr-28406	460	12	art	art	NOUN
ihlr-28406	460	13	reflected	reflect	VERB
ihlr-28406	460	14	that	that	SCONJ
ihlr-28406	460	15	levothyroxine139	levothyroxine139	PROPN
ihlr-28406	460	16	was	be	AUX
ihlr-28406	460	17	considered	consider	VERB
ihlr-28406	460	18	the	the	DET
ihlr-28406	460	19	only	only	ADJ
ihlr-28406	460	20	pharmaceutical	pharmaceutical	ADJ
ihlr-28406	460	21	composition	composition	NOUN
ihlr-28406	460	22	capable	capable	ADJ
ihlr-28406	460	23	of	of	ADP
ihlr-28406	460	24	treating	treat	VERB
ihlr-28406	460	25	thyroid	thyroid	NOUN
ihlr-28406	460	26	disease	disease	NOUN
ihlr-28406	460	27	.	.	PUNCT
ihlr-28406	461	1	non	non	ADJ
ihlr-28406	461	2	-	-	ADJ
ihlr-28406	461	3	obviousness	obviousness	ADJ
ihlr-28406	461	4	is	be	AUX
ihlr-28406	461	5	a	a	DET
ihlr-28406	461	6	question	question	NOUN
ihlr-28406	461	7	of	of	ADP
ihlr-28406	461	8	law	law	NOUN
ihlr-28406	461	9	,	,	PUNCT
ihlr-28406	461	10	140	140	NUM
ihlr-28406	461	11	but	but	CCONJ
ihlr-28406	461	12	it	it	PRON
ihlr-28406	461	13	relies	rely	VERB
ihlr-28406	461	14	upon	upon	SCONJ
ihlr-28406	461	15	factual	factual	ADJ
ihlr-28406	461	16	inquiries	inquiry	NOUN
ihlr-28406	461	17	—	—	PUNCT
ihlr-28406	461	18	—	—	PUNCT
ihlr-28406	461	19	—	—	PUNCT
ihlr-28406	461	20	—	—	PUNCT
ihlr-28406	461	21	—	—	PUNCT
ihlr-28406	461	22	—	—	PUNCT
ihlr-28406	461	23	—	—	PUNCT
ihlr-28406	461	24	—	—	PUNCT
ihlr-28406	461	25	—	—	PUNCT
ihlr-28406	461	26	—	—	PUNCT
ihlr-28406	461	27	—	—	PUNCT
ihlr-28406	461	28	—	—	PUNCT
ihlr-28406	461	29	—	—	PUNCT
ihlr-28406	461	30	—	—	PUNCT
ihlr-28406	461	31	—	—	PUNCT
ihlr-28406	461	32	—	—	PUNCT
ihlr-28406	461	33	—	—	PUNCT
ihlr-28406	461	34	—	—	PUNCT
ihlr-28406	461	35	—	—	PUNCT
ihlr-28406	461	36	—	—	PUNCT
ihlr-28406	461	37	—	—	PUNCT
ihlr-28406	461	38	—	—	PUNCT
ihlr-28406	461	39	—	—	PUNCT
ihlr-28406	461	40	—	—	PUNCT
ihlr-28406	461	41	—	—	PUNCT
ihlr-28406	461	42	—	—	PUNCT
ihlr-28406	461	43	—	—	PUNCT
ihlr-28406	461	44	—	—	PUNCT
ihlr-28406	461	45	—	—	PUNCT
ihlr-28406	461	46	132	132	X
ihlr-28406	461	47	.	.	PUNCT
ihlr-28406	462	1	lemley	lemley	PROPN
ihlr-28406	462	2	,	,	PUNCT
ihlr-28406	462	3	supra	supra	PROPN
ihlr-28406	462	4	note	note	PROPN
ihlr-28406	462	5	128	128	NUM
ihlr-28406	462	6	,	,	PUNCT
ihlr-28406	462	7	at	at	ADP
ihlr-28406	462	8	102	102	NUM
ihlr-28406	462	9	.	.	PUNCT
ihlr-28406	463	1	133	133	NUM
ihlr-28406	463	2	.	.	PUNCT
ihlr-28406	464	1	jeanne	jeanne	PROPN
ihlr-28406	464	2	c.	c.	PROPN
ihlr-28406	464	3	fromer	fromer	PROPN
ihlr-28406	464	4	,	,	PUNCT
ihlr-28406	464	5	the	the	DET
ihlr-28406	464	6	layers	layer	NOUN
ihlr-28406	464	7	of	of	ADP
ihlr-28406	464	8	obviousness	obviousness	NOUN
ihlr-28406	464	9	in	in	ADP
ihlr-28406	464	10	patent	patent	NOUN
ihlr-28406	464	11	law	law	NOUN
ihlr-28406	464	12	,	,	PUNCT
ihlr-28406	464	13	22	22	NUM
ihlr-28406	464	14	harv	harv	NOUN
ihlr-28406	464	15	.	.	PUNCT
ihlr-28406	465	1	j.	j.	PROPN
ihlr-28406	465	2	of	of	ADP
ihlr-28406	465	3	l.	l.	PROPN
ihlr-28406	465	4	&	&	CCONJ
ihlr-28406	465	5	tech	tech	PROPN
ihlr-28406	465	6	.	.	PUNCT
ihlr-28406	466	1	75	75	NUM
ihlr-28406	466	2	(	(	PUNCT
ihlr-28406	466	3	2008	2008	NUM
ihlr-28406	466	4	)	)	PUNCT
ihlr-28406	466	5	.	.	PUNCT
ihlr-28406	467	1	(	(	PUNCT
ihlr-28406	467	2	“	"	PUNCT
ihlr-28406	467	3	the	the	DET
ihlr-28406	467	4	non	non	ADJ
ihlr-28406	467	5	-	-	ADJ
ihlr-28406	467	6	obviousness	obviousness	ADJ
ihlr-28406	467	7	doctrine	doctrine	NOUN
ihlr-28406	467	8	seeks	seek	VERB
ihlr-28406	467	9	to	to	PART
ihlr-28406	467	10	ensure	ensure	VERB
ihlr-28406	467	11	that	that	SCONJ
ihlr-28406	467	12	patents	patent	NOUN
ihlr-28406	467	13	are	be	AUX
ihlr-28406	467	14	granted	grant	VERB
ihlr-28406	467	15	only	only	ADV
ihlr-28406	467	16	for	for	ADP
ihlr-28406	467	17	technologically	technologically	ADV
ihlr-28406	467	18	significant	significant	ADJ
ihlr-28406	467	19	advances	advance	NOUN
ihlr-28406	467	20	to	to	PART
ihlr-28406	467	21	foster	foster	VERB
ihlr-28406	467	22	the	the	DET
ihlr-28406	467	23	patent	patent	NOUN
ihlr-28406	467	24	system	system	NOUN
ihlr-28406	467	25	’s	’s	PART
ihlr-28406	467	26	goal	goal	NOUN
ihlr-28406	467	27	of	of	ADP
ihlr-28406	467	28	stimulating	stimulate	VERB
ihlr-28406	467	29	useful	useful	ADJ
ihlr-28406	467	30	innovation	innovation	NOUN
ihlr-28406	467	31	.	.	PUNCT
ihlr-28406	467	32	”	"	PUNCT
ihlr-28406	467	33	)	)	PUNCT
ihlr-28406	467	34	.	.	PUNCT
ihlr-28406	468	1	134	134	NUM
ihlr-28406	468	2	.	.	NOUN
ihlr-28406	468	3	35	35	NUM
ihlr-28406	468	4	u.s.c	u.s.c	NOUN
ihlr-28406	468	5	.	.	PUNCT
ihlr-28406	469	1	§	§	PROPN
ihlr-28406	469	2	103	103	NUM
ihlr-28406	469	3	(	(	PUNCT
ihlr-28406	469	4	2013	2013	NUM
ihlr-28406	469	5	)	)	PUNCT
ihlr-28406	469	6	.	.	PUNCT
ihlr-28406	470	1	135	135	NUM
ihlr-28406	470	2	.	.	X
ihlr-28406	471	1	fromer	fromer	ADJ
ihlr-28406	471	2	,	,	PUNCT
ihlr-28406	471	3	supra	supra	PROPN
ihlr-28406	471	4	note	note	NOUN
ihlr-28406	471	5	133	133	NUM
ihlr-28406	471	6	.	.	PUNCT
ihlr-28406	471	7	136	136	NUM
ihlr-28406	471	8	.	.	PUNCT
ihlr-28406	472	1	endress	endress	PROPN
ihlr-28406	472	2	+	+	PROPN
ihlr-28406	472	3	hauser	hauser	PROPN
ihlr-28406	472	4	inc	inc	PROPN
ihlr-28406	472	5	.	.	PROPN
ihlr-28406	473	1	v.	v.	PROPN
ihlr-28406	473	2	hawk	hawk	PROPN
ihlr-28406	473	3	meas	mea	NOUN
ihlr-28406	473	4	.	.	PUNCT
ihlr-28406	474	1	sys	sys	PROPN
ihlr-28406	474	2	.	.	PUNCT
ihlr-28406	474	3	pty	pty	PROPN
ihlr-28406	474	4	.	.	PROPN
ihlr-28406	474	5	,	,	PUNCT
ihlr-28406	474	6	122	122	NUM
ihlr-28406	474	7	f.3d	f.3d	NUM
ihlr-28406	474	8	1040	1040	NUM
ihlr-28406	474	9	,	,	PUNCT
ihlr-28406	474	10	1042	1042	NUM
ihlr-28406	475	1	(	(	PUNCT
ihlr-28406	475	2	fed	fed	PROPN
ihlr-28406	475	3	.	.	PUNCT
ihlr-28406	475	4	cir	cir	PROPN
ihlr-28406	475	5	.	.	PROPN
ihlr-28406	475	6	1997	1997	NUM
ihlr-28406	475	7	)	)	PUNCT
ihlr-28406	476	1	(	(	PUNCT
ihlr-28406	476	2	analogizing	analogize	VERB
ihlr-28406	476	3	the	the	DET
ihlr-28406	476	4	person	person	NOUN
ihlr-28406	476	5	having	have	VERB
ihlr-28406	476	6	ordinary	ordinary	ADJ
ihlr-28406	476	7	skill	skill	NOUN
ihlr-28406	476	8	in	in	ADP
ihlr-28406	476	9	the	the	DET
ihlr-28406	476	10	art	art	NOUN
ihlr-28406	476	11	to	to	ADP
ihlr-28406	476	12	the	the	DET
ihlr-28406	476	13	reasonable	reasonable	ADJ
ihlr-28406	476	14	man	man	NOUN
ihlr-28406	476	15	in	in	ADP
ihlr-28406	476	16	criminal	criminal	ADJ
ihlr-28406	476	17	law	law	NOUN
ihlr-28406	476	18	)	)	PUNCT
ihlr-28406	476	19	.	.	PUNCT
ihlr-28406	477	1	see	see	VERB
ihlr-28406	477	2	also	also	ADV
ihlr-28406	477	3	dean	dean	PROPN
ihlr-28406	477	4	alderucci	alderucci	PROPN
ihlr-28406	477	5	,	,	PUNCT
ihlr-28406	477	6	the	the	DET
ihlr-28406	477	7	automation	automation	NOUN
ihlr-28406	477	8	of	of	ADP
ihlr-28406	477	9	legal	legal	ADJ
ihlr-28406	477	10	reasoning	reasoning	NOUN
ihlr-28406	477	11	:	:	PUNCT
ihlr-28406	477	12	customized	customize	VERB
ihlr-28406	477	13	ai	ai	VERB
ihlr-28406	477	14	techniques	technique	NOUN
ihlr-28406	477	15	for	for	ADP
ihlr-28406	477	16	the	the	DET
ihlr-28406	477	17	patent	patent	NOUN
ihlr-28406	477	18	field	field	NOUN
ihlr-28406	477	19	,	,	PUNCT
ihlr-28406	477	20	58	58	NUM
ihlr-28406	477	21	duq	duq	NOUN
ihlr-28406	477	22	.	.	PUNCT
ihlr-28406	478	1	l.r	l.r	PROPN
ihlr-28406	478	2	.	.	PROPN
ihlr-28406	478	3	50	50	NUM
ihlr-28406	478	4	(	(	PUNCT
ihlr-28406	478	5	2020	2020	NUM
ihlr-28406	478	6	)	)	PUNCT
ihlr-28406	478	7	.	.	PUNCT
ihlr-28406	479	1	137	137	NUM
ihlr-28406	479	2	.	.	PUNCT
ihlr-28406	480	1	pharmaceutical	pharmaceutical	ADJ
ihlr-28406	480	2	compositions	composition	NOUN
ihlr-28406	480	3	to	to	ADP
ihlr-28406	480	4	tetrac	tetrac	NOUN
ihlr-28406	480	5	and	and	CCONJ
ihlr-28406	480	6	methods	method	NOUN
ihlr-28406	480	7	of	of	ADP
ihlr-28406	480	8	use	use	NOUN
ihlr-28406	480	9	thereof	thereof	ADV
ihlr-28406	480	10	,	,	PUNCT
ihlr-28406	480	11	supra	supra	PROPN
ihlr-28406	480	12	note	note	NOUN
ihlr-28406	480	13	4	4	NUM
ihlr-28406	480	14	.	.	NUM
ihlr-28406	480	15	138	138	NUM
ihlr-28406	480	16	.	.	PUNCT
ihlr-28406	481	1	maria	maria	PROPN
ihlr-28406	481	2	e.	e.	PROPN
ihlr-28406	481	3	everts	everts	PROPN
ihlr-28406	481	4	et	et	PROPN
ihlr-28406	481	5	al	al	PROPN
ihlr-28406	481	6	.	.	PROPN
ihlr-28406	481	7	,	,	PUNCT
ihlr-28406	481	8	uptake	uptake	NOUN
ihlr-28406	481	9	of	of	ADP
ihlr-28406	481	10	3,3’,5,5’-tetraiodothyroacetic	3,3’,5,5’-tetraiodothyroacetic	ADJ
ihlr-28406	481	11	acid	acid	NOUN
ihlr-28406	481	12	and	and	CCONJ
ihlr-28406	481	13	3,3’,5’triiodothyronine	3,3’,5’triiodothyronine	NOUN
ihlr-28406	481	14	in	in	ADP
ihlr-28406	481	15	cultured	cultured	ADJ
ihlr-28406	481	16	rat	rat	NOUN
ihlr-28406	481	17	anterior	anterior	ADJ
ihlr-28406	481	18	pituitary	pituitary	ADJ
ihlr-28406	481	19	cells	cell	NOUN
ihlr-28406	481	20	and	and	CCONJ
ihlr-28406	481	21	their	their	PRON
ihlr-28406	481	22	effects	effect	NOUN
ihlr-28406	481	23	on	on	ADP
ihlr-28406	481	24	thyrotropin	thyrotropin	PROPN
ihlr-28406	481	25	secretion	secretion	NOUN
ihlr-28406	481	26	,	,	PUNCT
ihlr-28406	481	27	136	136	NUM
ihlr-28406	481	28	endocrinology	endocrinology	NOUN
ihlr-28406	481	29	4454	4454	NUM
ihlr-28406	481	30	(	(	PUNCT
ihlr-28406	481	31	1995	1995	NUM
ihlr-28406	481	32	)	)	PUNCT
ihlr-28406	481	33	.	.	PUNCT
ihlr-28406	482	1	139	139	NUM
ihlr-28406	482	2	.	.	PUNCT
ihlr-28406	482	3	levothyroxine	levothyroxine	PROPN
ihlr-28406	482	4	compositions	composition	NOUN
ihlr-28406	482	5	and	and	CCONJ
ihlr-28406	482	6	methods	method	NOUN
ihlr-28406	482	7	,	,	PUNCT
ihlr-28406	482	8	supra	supra	PROPN
ihlr-28406	482	9	note	note	NOUN
ihlr-28406	482	10	88	88	NUM
ihlr-28406	482	11	.	.	PUNCT
ihlr-28406	483	1	140.graham	140.graham	NUM
ihlr-28406	484	1	v.	v.	ADP
ihlr-28406	484	2	john	john	PROPN
ihlr-28406	484	3	deere	deere	PROPN
ihlr-28406	484	4	co.	co.	PROPN
ihlr-28406	484	5	,	,	PUNCT
ihlr-28406	484	6	383	383	NUM
ihlr-28406	484	7	u.s	u.s	PROPN
ihlr-28406	484	8	.	.	PROPN
ihlr-28406	484	9	1	1	NUM
ihlr-28406	484	10	,	,	PUNCT
ihlr-28406	484	11	17	17	NUM
ihlr-28406	484	12	-	-	SYM
ihlr-28406	484	13	18	18	NUM
ihlr-28406	484	14	(	(	PUNCT
ihlr-28406	484	15	1966	1966	NUM
ihlr-28406	484	16	)	)	PUNCT
ihlr-28406	484	17	.	.	PUNCT
ihlr-28406	485	1	2024	2024	NUM
ihlr-28406	485	2	]	]	PUNCT
ihlr-28406	485	3	inventions	invention	NOUN
ihlr-28406	485	4	and	and	CCONJ
ihlr-28406	485	5	patents	patent	NOUN
ihlr-28406	485	6	for	for	ADP
ihlr-28406	485	7	treating	treat	VERB
ihlr-28406	485	8	295	295	NUM
ihlr-28406	485	9	thyroid	thyroid	NOUN
ihlr-28406	485	10	disease	disease	NOUN
ihlr-28406	485	11	surrounding	surround	VERB
ihlr-28406	485	12	the	the	DET
ihlr-28406	485	13	differences	difference	NOUN
ihlr-28406	485	14	between	between	ADP
ihlr-28406	485	15	the	the	DET
ihlr-28406	485	16	prior	prior	ADJ
ihlr-28406	485	17	art	art	NOUN
ihlr-28406	485	18	and	and	CCONJ
ihlr-28406	485	19	the	the	DET
ihlr-28406	485	20	application	application	NOUN
ihlr-28406	485	21	’s	’s	PART
ihlr-28406	485	22	claims	claim	NOUN
ihlr-28406	485	23	.	.	PUNCT
ihlr-28406	486	1	141	141	NUM
ihlr-28406	486	2	the	the	DET
ihlr-28406	486	3	goal	goal	NOUN
ihlr-28406	486	4	for	for	ADP
ihlr-28406	486	5	the	the	DET
ihlr-28406	486	6	non	non	ADJ
ihlr-28406	486	7	-	-	ADJ
ihlr-28406	486	8	obviousness	obviousness	ADJ
ihlr-28406	486	9	requirement	requirement	NOUN
ihlr-28406	486	10	is	be	AUX
ihlr-28406	486	11	to	to	PART
ihlr-28406	486	12	limit	limit	VERB
ihlr-28406	486	13	patents	patent	NOUN
ihlr-28406	486	14	to	to	ADP
ihlr-28406	486	15	only	only	ADV
ihlr-28406	486	16	those	those	DET
ihlr-28406	486	17	inventions	invention	NOUN
ihlr-28406	486	18	representing	represent	VERB
ihlr-28406	486	19	a	a	DET
ihlr-28406	486	20	sufficiently	sufficiently	ADV
ihlr-28406	486	21	large	large	ADJ
ihlr-28406	486	22	advance	advance	NOUN
ihlr-28406	486	23	over	over	ADP
ihlr-28406	486	24	previously	previously	ADV
ihlr-28406	486	25	known	know	VERB
ihlr-28406	486	26	technology	technology	NOUN
ihlr-28406	486	27	.	.	PUNCT
ihlr-28406	487	1	142	142	NUM
ihlr-28406	487	2	to	to	ADP
ihlr-28406	487	3	one	one	NUM
ihlr-28406	487	4	skilled	skille	VERB
ihlr-28406	487	5	-	-	PUNCT
ihlr-28406	487	6	in	in	ADP
ihlr-28406	487	7	-	-	PUNCT
ihlr-28406	487	8	the	the	DET
ihlr-28406	487	9	-	-	PUNCT
ihlr-28406	487	10	art	art	NOUN
ihlr-28406	487	11	,	,	PUNCT
ihlr-28406	487	12	the	the	DET
ihlr-28406	487	13	degree	degree	NOUN
ihlr-28406	487	14	to	to	PART
ihlr-28406	487	15	which	which	PRON
ihlr-28406	487	16	an	an	DET
ihlr-28406	487	17	invention	invention	NOUN
ihlr-28406	487	18	advances	advance	VERB
ihlr-28406	487	19	the	the	DET
ihlr-28406	487	20	art	art	NOUN
ihlr-28406	487	21	may	may	AUX
ihlr-28406	487	22	be	be	AUX
ihlr-28406	487	23	entirely	entirely	ADV
ihlr-28406	487	24	subjective	subjective	ADJ
ihlr-28406	487	25	.	.	PUNCT
ihlr-28406	488	1	143	143	NUM
ihlr-28406	488	2	and	and	CCONJ
ihlr-28406	488	3	yet	yet	ADV
ihlr-28406	488	4	,	,	PUNCT
ihlr-28406	488	5	in	in	ADP
ihlr-28406	488	6	addition	addition	NOUN
ihlr-28406	488	7	to	to	ADP
ihlr-28406	488	8	nonobvious	nonobvious	ADJ
ihlr-28406	488	9	,	,	PUNCT
ihlr-28406	488	10	patentable	patentable	ADJ
ihlr-28406	488	11	claims	claim	NOUN
ihlr-28406	488	12	must	must	AUX
ihlr-28406	488	13	also	also	ADV
ihlr-28406	488	14	be	be	AUX
ihlr-28406	488	15	for	for	ADP
ihlr-28406	488	16	something	something	PRON
ihlr-28406	488	17	new	new	ADJ
ihlr-28406	488	18	.	.	PUNCT
ihlr-28406	489	1	a	a	DET
ihlr-28406	489	2	second	second	ADJ
ihlr-28406	489	3	component	component	NOUN
ihlr-28406	489	4	for	for	ADP
ihlr-28406	489	5	patent	patent	NOUN
ihlr-28406	489	6	claims	claim	NOUN
ihlr-28406	489	7	is	be	AUX
ihlr-28406	489	8	that	that	SCONJ
ihlr-28406	489	9	they	they	PRON
ihlr-28406	489	10	must	must	AUX
ihlr-28406	489	11	claim	claim	VERB
ihlr-28406	489	12	a	a	DET
ihlr-28406	489	13	novel	novel	ADJ
ihlr-28406	489	14	invention	invention	NOUN
ihlr-28406	489	15	.	.	PUNCT
ihlr-28406	490	1	144	144	NUM
ihlr-28406	490	2	in	in	ADP
ihlr-28406	490	3	fact	fact	NOUN
ihlr-28406	490	4	,	,	PUNCT
ihlr-28406	490	5	patents	patent	NOUN
ihlr-28406	490	6	are	be	AUX
ihlr-28406	490	7	validated	validate	VERB
ihlr-28406	490	8	technical	technical	ADJ
ihlr-28406	490	9	advancements	advancement	NOUN
ihlr-28406	490	10	for	for	ADP
ihlr-28406	490	11	new	new	ADJ
ihlr-28406	490	12	products	product	NOUN
ihlr-28406	490	13	and	and	CCONJ
ihlr-28406	490	14	innovation	innovation	NOUN
ihlr-28406	490	15	services	service	NOUN
ihlr-28406	490	16	.	.	PUNCT
ihlr-28406	491	1	145	145	NUM
ihlr-28406	491	2	the	the	DET
ihlr-28406	491	3	law	law	NOUN
ihlr-28406	491	4	requires	require	VERB
ihlr-28406	491	5	that	that	SCONJ
ihlr-28406	491	6	an	an	DET
ihlr-28406	491	7	invention	invention	NOUN
ihlr-28406	491	8	be	be	AUX
ihlr-28406	491	9	novel	novel	ADJ
ihlr-28406	491	10	,	,	PUNCT
ihlr-28406	491	11	or	or	CCONJ
ihlr-28406	491	12	new	new	ADJ
ihlr-28406	491	13	,	,	PUNCT
ihlr-28406	491	14	to	to	PART
ihlr-28406	491	15	be	be	AUX
ihlr-28406	491	16	granted	grant	VERB
ihlr-28406	491	17	a	a	DET
ihlr-28406	491	18	patent	patent	NOUN
ihlr-28406	491	19	.	.	PUNCT
ihlr-28406	492	1	146	146	NUM
ihlr-28406	492	2	consider	consider	VERB
ihlr-28406	492	3	u.s	u.s	PROPN
ihlr-28406	492	4	.	.	PROPN
ihlr-28406	492	5	patent	patent	NOUN
ihlr-28406	492	6	.	.	PUNCT
ihlr-28406	493	1	no	no	INTJ
ihlr-28406	493	2	.	.	NOUN
ihlr-28406	494	1	7,493,172	7,493,172	NUM
ihlr-28406	494	2	,	,	PUNCT
ihlr-28406	494	3	methods	method	NOUN
ihlr-28406	494	4	and	and	CCONJ
ihlr-28406	494	5	systems	system	NOUN
ihlr-28406	494	6	for	for	ADP
ihlr-28406	494	7	stimulating	stimulate	VERB
ihlr-28406	494	8	a	a	DET
ihlr-28406	494	9	nerve	nerve	NOUN
ihlr-28406	494	10	originating	originating	NOUN
ihlr-28406	494	11	in	in	ADP
ihlr-28406	494	12	an	an	DET
ihlr-28406	494	13	upper	upper	ADJ
ihlr-28406	494	14	cervical	cervical	ADJ
ihlr-28406	494	15	spine	spine	ADJ
ihlr-28406	494	16	area	area	NOUN
ihlr-28406	494	17	to	to	PART
ihlr-28406	494	18	treat	treat	VERB
ihlr-28406	494	19	a	a	DET
ihlr-28406	494	20	medical	medical	ADJ
ihlr-28406	494	21	condition	condition	NOUN
ihlr-28406	494	22	,	,	PUNCT
ihlr-28406	494	23	which	which	PRON
ihlr-28406	494	24	claims	claim	VERB
ihlr-28406	494	25	:	:	PUNCT
ihlr-28406	494	26	1	1	X
ihlr-28406	494	27	.	.	X
ihlr-28406	494	28	a	a	DET
ihlr-28406	494	29	method	method	NOUN
ihlr-28406	494	30	of	of	ADP
ihlr-28406	494	31	treating	treat	VERB
ihlr-28406	494	32	a	a	DET
ihlr-28406	494	33	medical	medical	ADJ
ihlr-28406	494	34	condition	condition	NOUN
ihlr-28406	494	35	of	of	ADP
ihlr-28406	494	36	a	a	DET
ihlr-28406	494	37	patient	patient	NOUN
ihlr-28406	494	38	,	,	PUNCT
ihlr-28406	494	39	said	say	VERB
ihlr-28406	494	40	method	method	NOUN
ihlr-28406	494	41	comprising	comprising	NOUN
ihlr-28406	494	42	:	:	PUNCT
ihlr-28406	494	43	applying	apply	VERB
ihlr-28406	494	44	at	at	ADV
ihlr-28406	494	45	least	least	ADV
ihlr-28406	494	46	one	one	NUM
ihlr-28406	494	47	stimulus	stimulus	NOUN
ihlr-28406	494	48	to	to	ADP
ihlr-28406	494	49	a	a	DET
ihlr-28406	494	50	target	target	NOUN
ihlr-28406	494	51	nerve	nerve	NOUN
ihlr-28406	494	52	within	within	ADP
ihlr-28406	494	53	a	a	DET
ihlr-28406	494	54	patient	patient	NOUN
ihlr-28406	494	55	with	with	ADP
ihlr-28406	494	56	an	an	DET
ihlr-28406	494	57	implanted	implant	VERB
ihlr-28406	494	58	system	system	NOUN
ihlr-28406	494	59	control	control	NOUN
ihlr-28406	494	60	unit	unit	NOUN
ihlr-28406	494	61	in	in	ADP
ihlr-28406	494	62	accordance	accordance	NOUN
ihlr-28406	494	63	with	with	ADP
ihlr-28406	494	64	one	one	NUM
ihlr-28406	494	65	or	or	CCONJ
ihlr-28406	494	66	more	more	ADJ
ihlr-28406	494	67	stimulation	stimulation	NOUN
ihlr-28406	494	68	parameters	parameter	NOUN
ihlr-28406	494	69	configured	configure	VERB
ihlr-28406	494	70	to	to	PART
ihlr-28406	494	71	treat	treat	VERB
ihlr-28406	494	72	said	say	VERB
ihlr-28406	494	73	medical	medical	ADJ
ihlr-28406	494	74	condition	condition	NOUN
ihlr-28406	494	75	;	;	PUNCT
ihlr-28406	494	76	wherein	wherein	SCONJ
ihlr-28406	494	77	said	say	VERB
ihlr-28406	494	78	target	target	NOUN
ihlr-28406	494	79	nerve	nerve	NOUN
ihlr-28406	494	80	comprises	comprise	VERB
ihlr-28406	494	81	a	a	DET
ihlr-28406	494	82	nerve	nerve	NOUN
ihlr-28406	494	83	originating	originating	NOUN
ihlr-28406	494	84	in	in	ADP
ihlr-28406	494	85	an	an	DET
ihlr-28406	494	86	upper	upper	ADJ
ihlr-28406	494	87	cervical	cervical	ADJ
ihlr-28406	494	88	spine	spine	ADJ
ihlr-28406	494	89	area	area	NOUN
ihlr-28406	494	90	of	of	ADP
ihlr-28406	494	91	said	say	VERB
ihlr-28406	494	92	patient	patient	ADJ
ihlr-28406	494	93	and	and	CCONJ
ihlr-28406	494	94	wherein	wherein	ADJ
ihlr-28406	494	95	said	say	VERB
ihlr-28406	494	96	medical	medical	ADJ
ihlr-28406	494	97	condition	condition	NOUN
ihlr-28406	494	98	comprises	comprise	VERB
ihlr-28406	494	99	at	at	ADV
ihlr-28406	494	100	least	least	ADV
ihlr-28406	494	101	one	one	NUM
ihlr-28406	494	102	or	or	CCONJ
ihlr-28406	494	103	more	more	ADJ
ihlr-28406	494	104	of	of	ADP
ihlr-28406	494	105	—	—	PUNCT
ihlr-28406	494	106	—	—	PUNCT
ihlr-28406	494	107	—	—	PUNCT
ihlr-28406	494	108	—	—	PUNCT
ihlr-28406	494	109	—	—	PUNCT
ihlr-28406	494	110	—	—	PUNCT
ihlr-28406	494	111	—	—	PUNCT
ihlr-28406	494	112	—	—	PUNCT
ihlr-28406	494	113	—	—	PUNCT
ihlr-28406	494	114	—	—	PUNCT
ihlr-28406	494	115	—	—	PUNCT
ihlr-28406	494	116	—	—	PUNCT
ihlr-28406	494	117	—	—	PUNCT
ihlr-28406	494	118	—	—	PUNCT
ihlr-28406	494	119	—	—	PUNCT
ihlr-28406	494	120	—	—	PUNCT
ihlr-28406	494	121	—	—	PUNCT
ihlr-28406	494	122	—	—	PUNCT
ihlr-28406	494	123	—	—	PUNCT
ihlr-28406	494	124	—	—	PUNCT
ihlr-28406	494	125	—	—	PUNCT
ihlr-28406	494	126	—	—	PUNCT
ihlr-28406	494	127	—	—	PUNCT
ihlr-28406	494	128	—	—	PUNCT
ihlr-28406	494	129	—	—	PUNCT
ihlr-28406	494	130	—	—	PUNCT
ihlr-28406	494	131	—	—	PUNCT
ihlr-28406	494	132	—	—	PUNCT
ihlr-28406	494	133	—	—	PUNCT
ihlr-28406	494	134	141	141	NUM
ihlr-28406	494	135	.	.	PUNCT
ihlr-28406	494	136	brian	brian	PROPN
ihlr-28406	494	137	s.	s.	PROPN
ihlr-28406	494	138	haney	haney	PROPN
ihlr-28406	494	139	,	,	PUNCT
ihlr-28406	494	140	patents	patent	NOUN
ihlr-28406	494	141	for	for	ADP
ihlr-28406	494	142	nlp	nlp	NOUN
ihlr-28406	494	143	software	software	NOUN
ihlr-28406	494	144	:	:	PUNCT
ihlr-28406	494	145	an	an	DET
ihlr-28406	494	146	empirical	empirical	ADJ
ihlr-28406	494	147	review	review	NOUN
ihlr-28406	494	148	,	,	PUNCT
ihlr-28406	494	149	18	18	NUM
ihlr-28406	494	150	iup	iup	VERB
ihlr-28406	494	151	j.	j.	PROPN
ihlr-28406	494	152	knowledge	knowledge	PROPN
ihlr-28406	494	153	mgmt	mgmt	PROPN
ihlr-28406	494	154	.	.	PUNCT
ihlr-28406	495	1	27	27	NUM
ihlr-28406	495	2	,	,	PUNCT
ihlr-28406	495	3	52	52	NUM
ihlr-28406	495	4	(	(	PUNCT
ihlr-28406	495	5	2020	2020	NUM
ihlr-28406	495	6	)	)	PUNCT
ihlr-28406	495	7	(	(	PUNCT
ihlr-28406	495	8	one	one	NUM
ihlr-28406	495	9	idea	idea	NOUN
ihlr-28406	495	10	is	be	AUX
ihlr-28406	495	11	to	to	PART
ihlr-28406	495	12	measure	measure	VERB
ihlr-28406	495	13	these	these	DET
ihlr-28406	495	14	factual	factual	ADJ
ihlr-28406	495	15	considerations	consideration	NOUN
ihlr-28406	495	16	objectively	objectively	ADV
ihlr-28406	495	17	to	to	PART
ihlr-28406	495	18	identify	identify	VERB
ihlr-28406	495	19	probabilistic	probabilistic	ADJ
ihlr-28406	495	20	correlation	correlation	NOUN
ihlr-28406	495	21	.	.	PUNCT
ihlr-28406	496	1	for	for	ADP
ihlr-28406	496	2	example	example	NOUN
ihlr-28406	496	3	,	,	PUNCT
ihlr-28406	496	4	the	the	DET
ihlr-28406	496	5	relationship	relationship	NOUN
ihlr-28406	496	6	between	between	ADP
ihlr-28406	496	7	the	the	DET
ihlr-28406	496	8	prior	prior	ADJ
ihlr-28406	496	9	art	art	NOUN
ihlr-28406	496	10	and	and	CCONJ
ihlr-28406	496	11	the	the	DET
ihlr-28406	496	12	patent	patent	NOUN
ihlr-28406	496	13	could	could	AUX
ihlr-28406	496	14	be	be	AUX
ihlr-28406	496	15	objectively	objectively	ADV
ihlr-28406	496	16	measured	measure	VERB
ihlr-28406	496	17	according	accord	VERB
ihlr-28406	496	18	to	to	ADP
ihlr-28406	496	19	the	the	DET
ihlr-28406	496	20	relative	relative	ADJ
ihlr-28406	496	21	syntactic	syntactic	ADJ
ihlr-28406	496	22	similarity	similarity	NOUN
ihlr-28406	496	23	between	between	ADP
ihlr-28406	496	24	the	the	DET
ihlr-28406	496	25	prior	prior	ADJ
ihlr-28406	496	26	art	art	NOUN
ihlr-28406	496	27	claims	claim	NOUN
ihlr-28406	496	28	and	and	CCONJ
ihlr-28406	496	29	patent	patent	NOUN
ihlr-28406	496	30	claims	claim	NOUN
ihlr-28406	496	31	)	)	PUNCT
ihlr-28406	496	32	.	.	PUNCT
ihlr-28406	497	1	142	142	NUM
ihlr-28406	497	2	.	.	PUNCT
ihlr-28406	498	1	sensonics	sensonic	NOUN
ihlr-28406	498	2	,	,	PUNCT
ihlr-28406	498	3	inc	inc	PROPN
ihlr-28406	498	4	.	.	PROPN
ihlr-28406	498	5	v.	v.	PROPN
ihlr-28406	498	6	aerosonic	aerosonic	PROPN
ihlr-28406	498	7	corp	corp	PROPN
ihlr-28406	498	8	.	.	PROPN
ihlr-28406	498	9	,	,	PUNCT
ihlr-28406	498	10	81	81	NUM
ihlr-28406	498	11	f.3d	f.3d	NUM
ihlr-28406	498	12	1566	1566	NUM
ihlr-28406	498	13	,	,	PUNCT
ihlr-28406	498	14	1570	1570	NUM
ihlr-28406	498	15	(	(	PUNCT
ihlr-28406	498	16	fed	fed	PROPN
ihlr-28406	498	17	.	.	PUNCT
ihlr-28406	498	18	cir	cir	PROPN
ihlr-28406	498	19	.	.	PUNCT
ihlr-28406	498	20	1996	1996	NUM
ihlr-28406	498	21	)	)	PUNCT
ihlr-28406	498	22	.	.	PUNCT
ihlr-28406	499	1	143	143	X
ihlr-28406	499	2	.	.	PUNCT
ihlr-28406	499	3	oliver	oliver	PROPN
ihlr-28406	499	4	wendell	wendell	PROPN
ihlr-28406	499	5	holmes	holmes	PROPN
ihlr-28406	499	6	,	,	PUNCT
ihlr-28406	499	7	jr	jr	PROPN
ihlr-28406	499	8	.	.	PROPN
ihlr-28406	499	9	,	,	PUNCT
ihlr-28406	499	10	the	the	DET
ihlr-28406	499	11	path	path	NOUN
ihlr-28406	499	12	of	of	ADP
ihlr-28406	499	13	the	the	DET
ihlr-28406	499	14	law	law	NOUN
ihlr-28406	499	15	,	,	PUNCT
ihlr-28406	499	16	10	10	NUM
ihlr-28406	499	17	harv	harv	NOUN
ihlr-28406	499	18	.	.	PUNCT
ihlr-28406	500	1	l.	l.	PROPN
ihlr-28406	500	2	rev	rev	PROPN
ihlr-28406	500	3	.	.	PROPN
ihlr-28406	500	4	457	457	NUM
ihlr-28406	500	5	,	,	PUNCT
ihlr-28406	500	6	465	465	NUM
ihlr-28406	500	7	(	(	PUNCT
ihlr-28406	500	8	1897	1897	NUM
ihlr-28406	500	9	)	)	PUNCT
ihlr-28406	500	10	(	(	PUNCT
ihlr-28406	500	11	one	one	PRON
ihlr-28406	500	12	can	can	AUX
ihlr-28406	500	13	give	give	VERB
ihlr-28406	500	14	any	any	DET
ihlr-28406	500	15	conclusion	conclusion	NOUN
ihlr-28406	500	16	a	a	DET
ihlr-28406	500	17	logical	logical	ADJ
ihlr-28406	500	18	form	form	NOUN
ihlr-28406	500	19	)	)	PUNCT
ihlr-28406	500	20	.	.	PUNCT
ihlr-28406	501	1	see	see	VERB
ihlr-28406	501	2	also	also	ADV
ihlr-28406	501	3	brian	brian	PROPN
ihlr-28406	501	4	s.	s.	PROPN
ihlr-28406	501	5	haney	haney	PROPN
ihlr-28406	501	6	,	,	PUNCT
ihlr-28406	501	7	applied	apply	VERB
ihlr-28406	501	8	natural	natural	ADJ
ihlr-28406	501	9	language	language	NOUN
ihlr-28406	501	10	processing	processing	NOUN
ihlr-28406	501	11	for	for	ADP
ihlr-28406	501	12	law	law	NOUN
ihlr-28406	501	13	practice	practice	NOUN
ihlr-28406	501	14	,	,	PUNCT
ihlr-28406	501	15	2020	2020	NUM
ihlr-28406	501	16	b.c	b.c	PROPN
ihlr-28406	501	17	.	.	PROPN
ihlr-28406	501	18	intell	intell	PROPN
ihlr-28406	501	19	.	.	PUNCT
ihlr-28406	502	1	prop	prop	PROPN
ihlr-28406	502	2	.	.	PUNCT
ihlr-28406	502	3	&	&	CCONJ
ihlr-28406	502	4	tech	tech	PROPN
ihlr-28406	502	5	.	.	PUNCT
ihlr-28406	503	1	f.	f.	PROPN
ihlr-28406	503	2	1	1	NUM
ihlr-28406	503	3	,	,	PUNCT
ihlr-28406	503	4	42	42	NUM
ihlr-28406	503	5	(	(	PUNCT
ihlr-28406	503	6	2020	2020	NUM
ihlr-28406	503	7	)	)	PUNCT
ihlr-28406	503	8	(	(	PUNCT
ihlr-28406	503	9	“	"	PUNCT
ihlr-28406	503	10	as	as	ADP
ihlr-28406	503	11	a	a	DET
ihlr-28406	503	12	result	result	NOUN
ihlr-28406	503	13	,	,	PUNCT
ihlr-28406	503	14	language	language	NOUN
ihlr-28406	503	15	is	be	AUX
ihlr-28406	503	16	often	often	ADV
ihlr-28406	503	17	peripheral	peripheral	ADJ
ihlr-28406	503	18	in	in	ADP
ihlr-28406	503	19	the	the	DET
ihlr-28406	503	20	practice	practice	NOUN
ihlr-28406	503	21	of	of	ADP
ihlr-28406	503	22	law	law	NOUN
ihlr-28406	503	23	”	"	PUNCT
ihlr-28406	503	24	)	)	PUNCT
ihlr-28406	503	25	.	.	PUNCT
ihlr-28406	504	1	144	144	NUM
ihlr-28406	504	2	.	.	PUNCT
ihlr-28406	504	3	sarah	sarah	PROPN
ihlr-28406	504	4	murphy	murphy	PROPN
ihlr-28406	504	5	,	,	PUNCT
ihlr-28406	504	6	heads	head	VERB
ihlr-28406	504	7	i	i	PRON
ihlr-28406	504	8	win	win	VERB
ihlr-28406	504	9	,	,	PUNCT
ihlr-28406	504	10	tails	tail	NOUN
ihlr-28406	504	11	you	you	PRON
ihlr-28406	504	12	lose	lose	VERB
ihlr-28406	504	13	:	:	PUNCT
ihlr-28406	504	14	the	the	DET
ihlr-28406	504	15	“	"	PUNCT
ihlr-28406	504	16	expense	expense	NOUN
ihlr-28406	504	17	”	"	PUNCT
ihlr-28406	504	18	of	of	ADP
ihlr-28406	504	19	a	a	DET
ihlr-28406	504	20	de	de	X
ihlr-28406	504	21	novo	novo	NOUN
ihlr-28406	504	22	review	review	NOUN
ihlr-28406	504	23	of	of	ADP
ihlr-28406	504	24	uspto	uspto	NOUN
ihlr-28406	504	25	decisions	decision	NOUN
ihlr-28406	504	26	,	,	PUNCT
ihlr-28406	504	27	60	60	NUM
ihlr-28406	504	28	b.c.l	b.c.l	NOUN
ihlr-28406	504	29	.	.	PUNCT
ihlr-28406	504	30	rev	rev	PROPN
ihlr-28406	504	31	.	.	PROPN
ihlr-28406	505	1	ii.-197	ii.-197	ADP
ihlr-28406	505	2	(	(	PUNCT
ihlr-28406	505	3	2019	2019	NUM
ihlr-28406	505	4	)	)	PUNCT
ihlr-28406	505	5	(	(	PUNCT
ihlr-28406	505	6	“	"	PUNCT
ihlr-28406	505	7	the	the	DET
ihlr-28406	505	8	united	united	PROPN
ihlr-28406	505	9	states	states	PROPN
ihlr-28406	505	10	patent	patent	PROPN
ihlr-28406	505	11	and	and	CCONJ
ihlr-28406	505	12	trademark	trademark	NOUN
ihlr-28406	505	13	office	office	NOUN
ihlr-28406	505	14	(	(	PUNCT
ihlr-28406	505	15	the	the	DET
ihlr-28406	505	16	“	"	PUNCT
ihlr-28406	505	17	uspto	uspto	NOUN
ihlr-28406	505	18	”	"	PUNCT
ihlr-28406	505	19	)	)	PUNCT
ihlr-28406	505	20	may	may	AUX
ihlr-28406	505	21	deny	deny	VERB
ihlr-28406	505	22	patent	patent	NOUN
ihlr-28406	505	23	applications	application	NOUN
ihlr-28406	505	24	and	and	CCONJ
ihlr-28406	505	25	trademark	trademark	NOUN
ihlr-28406	505	26	registrations	registration	NOUN
ihlr-28406	505	27	to	to	ADP
ihlr-28406	505	28	applicants	applicant	NOUN
ihlr-28406	505	29	who	who	PRON
ihlr-28406	505	30	do	do	AUX
ihlr-28406	505	31	not	not	PART
ihlr-28406	505	32	meet	meet	VERB
ihlr-28406	505	33	the	the	DET
ihlr-28406	505	34	necessary	necessary	ADJ
ihlr-28406	505	35	requirements	requirement	NOUN
ihlr-28406	505	36	.	.	PUNCT
ihlr-28406	505	37	”	"	PUNCT
ihlr-28406	505	38	)	)	PUNCT
ihlr-28406	505	39	.	.	PUNCT
ihlr-28406	506	1	145	145	NUM
ihlr-28406	506	2	.	.	PUNCT
ihlr-28406	506	3	m.	m.	PROPN
ihlr-28406	506	4	c.	c.	PROPN
ihlr-28406	506	5	guardo	guardo	PROPN
ihlr-28406	506	6	&	&	CCONJ
ihlr-28406	506	7	k.	k.	PROPN
ihlr-28406	506	8	r.	r.	PROPN
ihlr-28406	506	9	harrigan	harrigan	PROPN
ihlr-28406	506	10	,	,	PUNCT
ihlr-28406	506	11	shaping	shape	VERB
ihlr-28406	506	12	the	the	DET
ihlr-28406	506	13	path	path	NOUN
ihlr-28406	506	14	to	to	ADP
ihlr-28406	506	15	inventive	inventive	ADJ
ihlr-28406	506	16	activity	activity	NOUN
ihlr-28406	506	17	:	:	PUNCT
ihlr-28406	506	18	the	the	DET
ihlr-28406	506	19	role	role	NOUN
ihlr-28406	506	20	of	of	ADP
ihlr-28406	506	21	past	past	ADJ
ihlr-28406	506	22	experience	experience	NOUN
ihlr-28406	506	23	in	in	ADP
ihlr-28406	506	24	r&d	r&d	NOUN
ihlr-28406	506	25	alliances	alliance	NOUN
ihlr-28406	506	26	,	,	PUNCT
ihlr-28406	506	27	41	41	NUM
ihlr-28406	506	28	j.	j.	PROPN
ihlr-28406	506	29	technol	technol	PROPN
ihlr-28406	506	30	transf	transf	PROPN
ihlr-28406	506	31	.	.	PUNCT
ihlr-28406	507	1	250	250	NUM
ihlr-28406	507	2	,	,	PUNCT
ihlr-28406	507	3	258	258	NUM
ihlr-28406	507	4	,	,	PUNCT
ihlr-28406	507	5	(	(	PUNCT
ihlr-28406	507	6	2016	2016	NUM
ihlr-28406	507	7	)	)	PUNCT
ihlr-28406	507	8	(	(	PUNCT
ihlr-28406	507	9	“	"	PUNCT
ihlr-28406	507	10	not	not	PART
ihlr-28406	507	11	only	only	ADV
ihlr-28406	507	12	do	do	AUX
ihlr-28406	507	13	they	they	PRON
ihlr-28406	507	14	represent	represent	VERB
ihlr-28406	507	15	an	an	DET
ihlr-28406	507	16	externally	externally	ADV
ihlr-28406	507	17	validated	validate	VERB
ihlr-28406	507	18	measure	measure	NOUN
ihlr-28406	507	19	of	of	ADP
ihlr-28406	507	20	technological	technological	ADJ
ihlr-28406	507	21	novelty	novelty	NOUN
ihlr-28406	507	22	with	with	ADP
ihlr-28406	507	23	a	a	DET
ihlr-28406	507	24	clear	clear	ADJ
ihlr-28406	507	25	economic	economic	ADJ
ihlr-28406	507	26	significance	significance	NOUN
ihlr-28406	507	27	,	,	PUNCT
ihlr-28406	507	28	but	but	CCONJ
ihlr-28406	507	29	their	their	PRON
ihlr-28406	507	30	correlation	correlation	NOUN
ihlr-28406	507	31	with	with	ADP
ihlr-28406	507	32	other	other	ADJ
ihlr-28406	507	33	measures	measure	NOUN
ihlr-28406	507	34	of	of	ADP
ihlr-28406	507	35	technological	technological	ADJ
ihlr-28406	507	36	performance	performance	NOUN
ihlr-28406	507	37	,	,	PUNCT
ihlr-28406	507	38	such	such	ADJ
ihlr-28406	507	39	as	as	ADP
ihlr-28406	507	40	new	new	ADJ
ihlr-28406	507	41	products	product	NOUN
ihlr-28406	507	42	or	or	CCONJ
ihlr-28406	507	43	innovation	innovation	NOUN
ihlr-28406	507	44	counts	count	NOUN
ihlr-28406	507	45	,	,	PUNCT
ihlr-28406	507	46	has	have	AUX
ihlr-28406	507	47	been	be	AUX
ihlr-28406	507	48	vetted	vet	VERB
ihlr-28406	507	49	.	.	PUNCT
ihlr-28406	507	50	”	"	PUNCT
ihlr-28406	507	51	)	)	PUNCT
ihlr-28406	507	52	.	.	PUNCT
ihlr-28406	508	1	146	146	NUM
ihlr-28406	508	2	.	.	PUNCT
ihlr-28406	508	3	stefania	stefania	PROPN
ihlr-28406	508	4	fusco	fusco	PROPN
ihlr-28406	508	5	,	,	PUNCT
ihlr-28406	508	6	trips	trip	VERB
ihlr-28406	508	7	non	non	ADJ
ihlr-28406	508	8	-	-	ADJ
ihlr-28406	508	9	discrimination	discrimination	ADJ
ihlr-28406	508	10	principle	principle	NOUN
ihlr-28406	508	11	:	:	PUNCT
ihlr-28406	508	12	are	be	AUX
ihlr-28406	508	13	alice	alice	PROPN
ihlr-28406	508	14	and	and	CCONJ
ihlr-28406	508	15	bilski	bilski	VERB
ihlr-28406	508	16	really	really	ADV
ihlr-28406	508	17	the	the	DET
ihlr-28406	508	18	end	end	NOUN
ihlr-28406	508	19	of	of	ADP
ihlr-28406	508	20	npes	npe	NOUN
ihlr-28406	508	21	?	?	PUNCT
ihlr-28406	509	1	,	,	PUNCT
ihlr-28406	509	2	24	24	NUM
ihlr-28406	509	3	tex	tex	PROPN
ihlr-28406	509	4	.	.	PROPN
ihlr-28406	509	5	intell	intell	PROPN
ihlr-28406	509	6	.	.	PUNCT
ihlr-28406	510	1	prop	prop	PROPN
ihlr-28406	510	2	.	.	PUNCT
ihlr-28406	511	1	l.j	l.j	PROPN
ihlr-28406	511	2	.	.	PROPN
ihlr-28406	511	3	131	131	NUM
ihlr-28406	511	4	,	,	PUNCT
ihlr-28406	511	5	139	139	NUM
ihlr-28406	511	6	(	(	PUNCT
ihlr-28406	511	7	nov	nov	PROPN
ihlr-28406	511	8	.	.	PROPN
ihlr-28406	511	9	30	30	NUM
ihlr-28406	511	10	,	,	PUNCT
ihlr-28406	511	11	2016	2016	NUM
ihlr-28406	511	12	)	)	PUNCT
ihlr-28406	511	13	,	,	PUNCT
ihlr-28406	511	14	https://papers	https://papers	X
ihlr-28406	511	15	.	.	PUNCT
ihlr-28406	512	1	ssrn.com/sol3/papers.cfm?abstract_id=2653463	ssrn.com/sol3/papers.cfm?abstract_id=2653463	PROPN
ihlr-28406	512	2	[	[	X
ihlr-28406	512	3	https://perma.cc/b9hp-28qp	https://perma.cc/b9hp-28qp	NUM
ihlr-28406	512	4	]	]	X
ihlr-28406	512	5	(	(	PUNCT
ihlr-28406	512	6	“	"	PUNCT
ihlr-28406	512	7	the	the	DET
ihlr-28406	512	8	accusations	accusation	NOUN
ihlr-28406	512	9	were	be	AUX
ihlr-28406	512	10	primarily	primarily	ADV
ihlr-28406	512	11	directed	direct	VERB
ihlr-28406	512	12	at	at	ADP
ihlr-28406	512	13	the	the	DET
ihlr-28406	512	14	quality	quality	NOUN
ihlr-28406	512	15	of	of	ADP
ihlr-28406	512	16	business	business	NOUN
ihlr-28406	512	17	method	method	NOUN
ihlr-28406	512	18	patents	patent	NOUN
ihlr-28406	512	19	and	and	CCONJ
ihlr-28406	512	20	,	,	PUNCT
ihlr-28406	512	21	specifically	specifically	ADV
ihlr-28406	512	22	,	,	PUNCT
ihlr-28406	512	23	the	the	DET
ihlr-28406	512	24	lack	lack	NOUN
ihlr-28406	512	25	of	of	ADP
ihlr-28406	512	26	novelty	novelty	NOUN
ihlr-28406	512	27	in	in	ADP
ihlr-28406	512	28	their	their	PRON
ihlr-28406	512	29	inventions	invention	NOUN
ihlr-28406	512	30	.	.	PUNCT
ihlr-28406	512	31	”	"	PUNCT
ihlr-28406	512	32	)	)	PUNCT
ihlr-28406	512	33	.	.	PUNCT
ihlr-28406	513	1	see	see	AUX
ihlr-28406	513	2	also	also	ADV
ihlr-28406	513	3	mark	mark	VERB
ihlr-28406	513	4	a.lemley	a.lemley	PROPN
ihlr-28406	513	5	&	&	CCONJ
ihlr-28406	513	6	mark	mark	PROPN
ihlr-28406	513	7	p.	p.	PROPN
ihlr-28406	513	8	mckenna	mckenna	PROPN
ihlr-28406	513	9	,	,	PUNCT
ihlr-28406	513	10	scope	scope	NOUN
ihlr-28406	513	11	,	,	PUNCT
ihlr-28406	513	12	57	57	NUM
ihlr-28406	513	13	wm	wm	PROPN
ihlr-28406	513	14	.	.	PROPN
ihlr-28406	513	15	&	&	CCONJ
ihlr-28406	513	16	mary	mary	PROPN
ihlr-28406	513	17	l.	l.	PROPN
ihlr-28406	513	18	rev	rev	PROPN
ihlr-28406	513	19	2197	2197	NUM
ihlr-28406	513	20	,	,	PUNCT
ihlr-28406	513	21	2240	2240	NUM
ihlr-28406	513	22	(	(	PUNCT
ihlr-28406	513	23	2015	2015	NUM
ihlr-28406	513	24	)	)	PUNCT
ihlr-28406	513	25	(	(	PUNCT
ihlr-28406	513	26	accessed	access	VERB
ihlr-28406	513	27	at	at	ADP
ihlr-28406	513	28	https://papers.ssrn.com/sol3/	https://papers.ssrn.com/sol3/	X
ihlr-28406	513	29	papers.cfm?abstract_id=2660951[https://perma.cc/j2g3-uyhr	papers.cfm?abstract_id=2660951[https://perma.cc/j2g3-uyhr	PROPN
ihlr-28406	513	30	]	]	PUNCT
ihlr-28406	513	31	)	)	PUNCT
ihlr-28406	513	32	(	(	PUNCT
ihlr-28406	513	33	“	"	PUNCT
ihlr-28406	513	34	because	because	SCONJ
ihlr-28406	513	35	patent	patent	NOUN
ihlr-28406	513	36	law	law	NOUN
ihlr-28406	513	37	requires	require	VERB
ihlr-28406	513	38	that	that	SCONJ
ihlr-28406	513	39	an	an	DET
ihlr-28406	513	40	invention	invention	NOUN
ihlr-28406	513	41	be	be	AUX
ihlr-28406	513	42	novel	novel	ADJ
ihlr-28406	513	43	and	and	CCONJ
ihlr-28406	513	44	non	non	ADJ
ihlr-28406	513	45	-	-	ADJ
ihlr-28406	513	46	obvious	obvious	ADJ
ihlr-28406	513	47	,	,	PUNCT
ihlr-28406	513	48	it	it	PRON
ihlr-28406	513	49	should	should	AUX
ihlr-28406	513	50	be	be	AUX
ihlr-28406	513	51	clear	clear	ADJ
ihlr-28406	513	52	that	that	SCONJ
ihlr-28406	513	53	a	a	DET
ihlr-28406	513	54	patent	patent	NOUN
ihlr-28406	513	55	owner	owner	NOUN
ihlr-28406	513	56	is	be	AUX
ihlr-28406	513	57	not	not	PART
ihlr-28406	513	58	entitled	entitle	VERB
ihlr-28406	513	59	to	to	PART
ihlr-28406	513	60	sue	sue	VERB
ihlr-28406	513	61	someone	someone	PRON
ihlr-28406	513	62	for	for	ADP
ihlr-28406	513	63	using	use	VERB
ihlr-28406	513	64	technology	technology	NOUN
ihlr-28406	513	65	that	that	PRON
ihlr-28406	513	66	existed	exist	VERB
ihlr-28406	513	67	before	before	SCONJ
ihlr-28406	513	68	she	she	PRON
ihlr-28406	513	69	ever	ever	ADV
ihlr-28406	513	70	“	"	PUNCT
ihlr-28406	513	71	invented	invent	VERB
ihlr-28406	513	72	”	"	PUNCT
ihlr-28406	513	73	it	it	PRON
ihlr-28406	513	74	.	.	PUNCT
ihlr-28406	513	75	”	"	PUNCT
ihlr-28406	513	76	)	)	PUNCT
ihlr-28406	513	77	.	.	PUNCT
ihlr-28406	514	1	https://papers.ssrn.com/sol3	https://papers.ssrn.com/sol3	PROPN
ihlr-28406	514	2	https://perma.cc/b9hp-28qp	https://perma.cc/b9hp-28qp	PROPN
ihlr-28406	514	3	https://papers	https://papers	PROPN
ihlr-28406	514	4	indiana	indiana	PROPN
ihlr-28406	514	5	health	health	PROPN
ihlr-28406	514	6	law	law	PROPN
ihlr-28406	514	7	review	review	NOUN
ihlr-28406	515	1	[	[	X
ihlr-28406	515	2	vol	vol	NOUN
ihlr-28406	515	3	.	.	PUNCT
ihlr-28406	516	1	21:277	21:277	NOUN
ihlr-28406	516	2	296	296	NUM
ihlr-28406	516	3	an	an	DET
ihlr-28406	516	4	autoimmune	autoimmune	ADJ
ihlr-28406	516	5	disease	disease	NOUN
ihlr-28406	516	6	,	,	PUNCT
ihlr-28406	516	7	hyperthyroidism	hyperthyroidism	NOUN
ihlr-28406	516	8	,	,	PUNCT
ihlr-28406	516	9	and	and	CCONJ
ihlr-28406	516	10	hypothyroidism	hypothyroidism	NOUN
ihlr-28406	516	11	.	.	PUNCT
ihlr-28406	517	1	147	147	NUM
ihlr-28406	518	1	the	the	DET
ihlr-28406	518	2	claim	claim	NOUN
ihlr-28406	518	3	is	be	AUX
ihlr-28406	518	4	a	a	DET
ihlr-28406	518	5	method	method	NOUN
ihlr-28406	518	6	for	for	ADP
ihlr-28406	518	7	treating	treat	VERB
ihlr-28406	518	8	a	a	DET
ihlr-28406	518	9	medical	medical	ADJ
ihlr-28406	518	10	condition	condition	NOUN
ihlr-28406	518	11	,	,	PUNCT
ihlr-28406	518	12	wherein	wherein	SCONJ
ihlr-28406	518	13	the	the	DET
ihlr-28406	518	14	medical	medical	ADJ
ihlr-28406	518	15	condition	condition	NOUN
ihlr-28406	518	16	includes	include	VERB
ihlr-28406	518	17	an	an	DET
ihlr-28406	518	18	autoimmune	autoimmune	ADJ
ihlr-28406	518	19	or	or	CCONJ
ihlr-28406	518	20	thyroid	thyroid	NOUN
ihlr-28406	518	21	disease	disease	NOUN
ihlr-28406	518	22	.	.	PUNCT
ihlr-28406	519	1	the	the	DET
ihlr-28406	519	2	claim	claim	NOUN
ihlr-28406	519	3	’s	’s	PART
ihlr-28406	519	4	novelty	novelty	NOUN
ihlr-28406	519	5	is	be	AUX
ihlr-28406	519	6	in	in	ADP
ihlr-28406	519	7	the	the	DET
ihlr-28406	519	8	applying	apply	VERB
ihlr-28406	519	9	a	a	DET
ihlr-28406	519	10	stimulus	stimulus	NOUN
ihlr-28406	519	11	to	to	ADP
ihlr-28406	519	12	the	the	DET
ihlr-28406	519	13	nervous	nervous	ADJ
ihlr-28406	519	14	system	system	NOUN
ihlr-28406	519	15	according	accord	VERB
ihlr-28406	519	16	to	to	ADP
ihlr-28406	519	17	pre	pre	ADJ
ihlr-28406	519	18	-	-	ADJ
ihlr-28406	519	19	defined	define	VERB
ihlr-28406	519	20	parameters	parameter	NOUN
ihlr-28406	519	21	.	.	PUNCT
ihlr-28406	520	1	the	the	DET
ihlr-28406	520	2	invention	invention	NOUN
ihlr-28406	520	3	highlights	highlight	VERB
ihlr-28406	520	4	the	the	DET
ihlr-28406	520	5	critical	critical	ADJ
ihlr-28406	520	6	relationship	relationship	NOUN
ihlr-28406	520	7	between	between	ADP
ihlr-28406	520	8	the	the	DET
ihlr-28406	520	9	thyroid	thyroid	NOUN
ihlr-28406	520	10	and	and	CCONJ
ihlr-28406	520	11	nervous	nervous	ADJ
ihlr-28406	520	12	system	system	NOUN
ihlr-28406	520	13	.	.	PUNCT
ihlr-28406	521	1	148	148	NUM
ihlr-28406	521	2	yet	yet	ADV
ihlr-28406	521	3	,	,	PUNCT
ihlr-28406	521	4	novelty	novelty	NOUN
ihlr-28406	521	5	in	in	ADP
ihlr-28406	521	6	thyroid	thyroid	NOUN
ihlr-28406	521	7	technologies	technology	NOUN
ihlr-28406	521	8	and	and	CCONJ
ihlr-28406	521	9	treatments	treatment	NOUN
ihlr-28406	521	10	is	be	AUX
ihlr-28406	521	11	not	not	PART
ihlr-28406	521	12	a	a	DET
ihlr-28406	521	13	difficult	difficult	ADJ
ihlr-28406	521	14	task	task	NOUN
ihlr-28406	521	15	to	to	PART
ihlr-28406	521	16	achieve	achieve	VERB
ihlr-28406	521	17	due	due	ADP
ihlr-28406	521	18	to	to	ADP
ihlr-28406	521	19	the	the	DET
ihlr-28406	521	20	currently	currently	ADV
ihlr-28406	521	21	shallow	shallow	ADJ
ihlr-28406	521	22	limits	limit	NOUN
ihlr-28406	521	23	in	in	ADP
ihlr-28406	521	24	human	human	ADJ
ihlr-28406	521	25	knowledge	knowledge	NOUN
ihlr-28406	521	26	.	.	PUNCT
ihlr-28406	522	1	in	in	ADP
ihlr-28406	522	2	other	other	ADJ
ihlr-28406	522	3	words	word	NOUN
ihlr-28406	522	4	,	,	PUNCT
ihlr-28406	522	5	very	very	ADV
ihlr-28406	522	6	little	little	ADJ
ihlr-28406	522	7	is	be	AUX
ihlr-28406	522	8	known	know	VERB
ihlr-28406	522	9	about	about	ADP
ihlr-28406	522	10	the	the	DET
ihlr-28406	522	11	thyroid	thyroid	NOUN
ihlr-28406	522	12	,	,	PUNCT
ihlr-28406	522	13	providing	provide	VERB
ihlr-28406	522	14	opportunity	opportunity	NOUN
ihlr-28406	522	15	for	for	ADP
ihlr-28406	522	16	innovation	innovation	NOUN
ihlr-28406	522	17	.	.	PUNCT
ihlr-28406	523	1	the	the	DET
ihlr-28406	523	2	backdrop	backdrop	NOUN
ihlr-28406	523	3	against	against	ADP
ihlr-28406	523	4	which	which	PRON
ihlr-28406	523	5	something	something	PRON
ihlr-28406	523	6	is	be	AUX
ihlr-28406	523	7	new	new	ADJ
ihlr-28406	523	8	is	be	AUX
ihlr-28406	523	9	a	a	DET
ihlr-28406	523	10	critical	critical	ADJ
ihlr-28406	523	11	aspect	aspect	NOUN
ihlr-28406	523	12	for	for	ADP
ihlr-28406	523	13	the	the	DET
ihlr-28406	523	14	novelty	novelty	NOUN
ihlr-28406	523	15	requirement	requirement	NOUN
ihlr-28406	523	16	.	.	PUNCT
ihlr-28406	524	1	larissa	larissa	PROPN
ihlr-28406	524	2	bifano	bifano	PROPN
ihlr-28406	524	3	,	,	PUNCT
ihlr-28406	524	4	a	a	DET
ihlr-28406	524	5	partner	partner	NOUN
ihlr-28406	524	6	with	with	ADP
ihlr-28406	524	7	dla	dla	NOUN
ihlr-28406	524	8	piper	piper	NOUN
ihlr-28406	524	9	explains	explain	VERB
ihlr-28406	524	10	,	,	PUNCT
ihlr-28406	524	11	“	"	PUNCT
ihlr-28406	524	12	in	in	ADP
ihlr-28406	524	13	addition	addition	NOUN
ihlr-28406	524	14	to	to	ADP
ihlr-28406	524	15	the	the	DET
ihlr-28406	524	16	technical	technical	ADJ
ihlr-28406	524	17	details	detail	NOUN
ihlr-28406	524	18	,	,	PUNCT
ihlr-28406	524	19	establishing	establish	VERB
ihlr-28406	524	20	a	a	DET
ihlr-28406	524	21	narrative	narrative	NOUN
ihlr-28406	524	22	of	of	ADP
ihlr-28406	524	23	the	the	DET
ihlr-28406	524	24	inventive	inventive	ADJ
ihlr-28406	524	25	concept	concept	NOUN
ihlr-28406	524	26	can	can	AUX
ihlr-28406	524	27	greatly	greatly	ADV
ihlr-28406	524	28	help	help	VERB
ihlr-28406	524	29	practitioners	practitioner	NOUN
ihlr-28406	524	30	during	during	ADP
ihlr-28406	524	31	the	the	DET
ihlr-28406	524	32	prosecution	prosecution	NOUN
ihlr-28406	524	33	stage	stage	NOUN
ihlr-28406	524	34	.	.	PUNCT
ihlr-28406	524	35	”149	”149	PUNCT
ihlr-28406	525	1	professor	professor	PROPN
ihlr-28406	525	2	elona	elona	PROPN
ihlr-28406	525	3	marku	marku	PROPN
ihlr-28406	525	4	at	at	ADP
ihlr-28406	525	5	the	the	DET
ihlr-28406	525	6	university	university	NOUN
ihlr-28406	525	7	of	of	ADP
ihlr-28406	525	8	cagliari	cagliari	PROPN
ihlr-28406	525	9	in	in	ADP
ihlr-28406	525	10	italy	italy	PROPN
ihlr-28406	525	11	is	be	AUX
ihlr-28406	525	12	developing	develop	VERB
ihlr-28406	525	13	objective	objective	ADJ
ihlr-28406	525	14	measures	measure	NOUN
ihlr-28406	525	15	for	for	ADP
ihlr-28406	525	16	novelty	novelty	NOUN
ihlr-28406	525	17	.	.	PUNCT
ihlr-28406	526	1	in	in	ADP
ihlr-28406	526	2	fact	fact	NOUN
ihlr-28406	526	3	,	,	PUNCT
ihlr-28406	526	4	they	they	PRON
ihlr-28406	526	5	have	have	AUX
ihlr-28406	526	6	developed	develop	VERB
ihlr-28406	526	7	a	a	DET
ihlr-28406	526	8	quality	quality	NOUN
ihlr-28406	526	9	formalism	formalism	NOUN
ihlr-28406	526	10	for	for	ADP
ihlr-28406	526	11	measuring	measure	VERB
ihlr-28406	526	12	patent	patent	NOUN
ihlr-28406	526	13	originality	originality	NOUN
ihlr-28406	526	14	,	,	PUNCT
ihlr-28406	526	15	which	which	PRON
ihlr-28406	526	16	may	may	AUX
ihlr-28406	526	17	be	be	AUX
ihlr-28406	526	18	modified	modify	VERB
ihlr-28406	526	19	to	to	PART
ihlr-28406	526	20	measure	measure	VERB
ihlr-28406	526	21	novelty	novelty	NOUN
ihlr-28406	526	22	.	.	PUNCT
ihlr-28406	527	1	150	150	NUM
ihlr-28406	527	2	according	accord	VERB
ihlr-28406	527	3	to	to	ADP
ihlr-28406	527	4	professor	professor	PROPN
ihlr-28406	527	5	marku	marku	PROPN
ihlr-28406	527	6	,	,	PUNCT
ihlr-28406	527	7	the	the	DET
ihlr-28406	527	8	algorithmic	algorithmic	ADJ
ihlr-28406	527	9	measure	measure	NOUN
ihlr-28406	527	10	“	"	PUNCT
ihlr-28406	527	11	captures	capture	VERB
ihlr-28406	527	12	the	the	DET
ihlr-28406	527	13	breadth	breadth	NOUN
ihlr-28406	527	14	of	of	ADP
ihlr-28406	527	15	the	the	DET
ihlr-28406	527	16	technological	technological	ADJ
ihlr-28406	527	17	knowledge	knowledge	NOUN
ihlr-28406	527	18	bases	basis	NOUN
ihlr-28406	527	19	that	that	PRON
ihlr-28406	527	20	have	have	AUX
ihlr-28406	527	21	been	be	AUX
ihlr-28406	527	22	synthesized	synthesize	VERB
ihlr-28406	527	23	in	in	ADP
ihlr-28406	527	24	the	the	DET
ihlr-28406	527	25	focal	focal	ADJ
ihlr-28406	527	26	patent	patent	NOUN
ihlr-28406	527	27	and	and	CCONJ
ihlr-28406	527	28	captures	capture	VERB
ihlr-28406	527	29	the	the	DET
ihlr-28406	527	30	antecedent	antecedent	NOUN
ihlr-28406	527	31	technology	technology	NOUN
ihlr-28406	527	32	embodied	embody	VERB
ihlr-28406	527	33	in	in	ADP
ihlr-28406	527	34	each	each	DET
ihlr-28406	527	35	patent	patent	NOUN
ihlr-28406	527	36	.	.	PUNCT
ihlr-28406	527	37	”151	”151	PUNCT
ihlr-28406	528	1	the	the	DET
ihlr-28406	528	2	intuition	intuition	NOUN
ihlr-28406	528	3	is	be	AUX
ihlr-28406	528	4	that	that	SCONJ
ihlr-28406	528	5	synthesizing	synthesize	VERB
ihlr-28406	528	6	divergent	divergent	ADJ
ihlr-28406	528	7	ideas	idea	NOUN
ihlr-28406	528	8	is	be	AUX
ihlr-28406	528	9	a	a	DET
ihlr-28406	528	10	characteristic	characteristic	NOUN
ihlr-28406	528	11	for	for	ADP
ihlr-28406	528	12	original	original	ADJ
ihlr-28406	528	13	research.152	research.152	NOUN
ihlr-28406	528	14	a	a	DET
ihlr-28406	528	15	patent	patent	NOUN
ihlr-28406	528	16	’s	’s	PART
ihlr-28406	528	17	scope	scope	NOUN
ihlr-28406	528	18	depends	depend	VERB
ihlr-28406	528	19	on	on	ADP
ihlr-28406	528	20	the	the	DET
ihlr-28406	528	21	relevant	relevant	ADJ
ihlr-28406	528	22	patent	patent	NOUN
ihlr-28406	528	23	’s	’s	PART
ihlr-28406	528	24	defined	define	VERB
ihlr-28406	528	25	protectable	protectable	NOUN
ihlr-28406	528	26	—	—	PUNCT
ihlr-28406	528	27	—	—	PUNCT
ihlr-28406	528	28	—	—	PUNCT
ihlr-28406	528	29	—	—	PUNCT
ihlr-28406	528	30	—	—	PUNCT
ihlr-28406	528	31	—	—	PUNCT
ihlr-28406	528	32	—	—	PUNCT
ihlr-28406	528	33	—	—	PUNCT
ihlr-28406	528	34	—	—	PUNCT
ihlr-28406	528	35	—	—	PUNCT
ihlr-28406	528	36	—	—	PUNCT
ihlr-28406	528	37	—	—	PUNCT
ihlr-28406	528	38	—	—	PUNCT
ihlr-28406	528	39	—	—	PUNCT
ihlr-28406	528	40	—	—	PUNCT
ihlr-28406	528	41	—	—	PUNCT
ihlr-28406	528	42	—	—	PUNCT
ihlr-28406	528	43	—	—	PUNCT
ihlr-28406	528	44	—	—	PUNCT
ihlr-28406	528	45	—	—	PUNCT
ihlr-28406	528	46	—	—	PUNCT
ihlr-28406	528	47	—	—	PUNCT
ihlr-28406	528	48	—	—	PUNCT
ihlr-28406	528	49	—	—	PUNCT
ihlr-28406	528	50	—	—	PUNCT
ihlr-28406	528	51	—	—	PUNCT
ihlr-28406	528	52	—	—	PUNCT
ihlr-28406	528	53	—	—	PUNCT
ihlr-28406	528	54	—	—	PUNCT
ihlr-28406	528	55	147	147	NUM
ihlr-28406	528	56	.	.	PUNCT
ihlr-28406	529	1	whitehurst	whitehurst	PROPN
ihlr-28406	529	2	et	et	PROPN
ihlr-28406	529	3	al	al	PROPN
ihlr-28406	529	4	.	.	PROPN
ihlr-28406	529	5	,	,	PUNCT
ihlr-28406	529	6	methods	method	NOUN
ihlr-28406	529	7	and	and	CCONJ
ihlr-28406	529	8	systems	system	NOUN
ihlr-28406	529	9	for	for	ADP
ihlr-28406	529	10	stimulating	stimulate	VERB
ihlr-28406	529	11	a	a	DET
ihlr-28406	529	12	nerve	nerve	NOUN
ihlr-28406	529	13	originating	originating	NOUN
ihlr-28406	529	14	in	in	ADP
ihlr-28406	529	15	an	an	DET
ihlr-28406	529	16	upper	upper	ADJ
ihlr-28406	529	17	cervical	cervical	ADJ
ihlr-28406	529	18	spine	spine	ADJ
ihlr-28406	529	19	area	area	NOUN
ihlr-28406	529	20	to	to	PART
ihlr-28406	529	21	treat	treat	VERB
ihlr-28406	529	22	a	a	DET
ihlr-28406	529	23	medical	medical	ADJ
ihlr-28406	529	24	condition	condition	NOUN
ihlr-28406	529	25	,	,	PUNCT
ihlr-28406	529	26	u.s	u.s	PROPN
ihlr-28406	529	27	.	.	PROPN
ihlr-28406	529	28	patent	patent	NOUN
ihlr-28406	529	29	.	.	PUNCT
ihlr-28406	530	1	no	no	INTJ
ihlr-28406	530	2	.	.	NOUN
ihlr-28406	530	3	7,493,172	7,493,172	NUM
ihlr-28406	530	4	to	to	ADP
ihlr-28406	530	5	boston	boston	PROPN
ihlr-28406	530	6	scientific	scientific	PROPN
ihlr-28406	530	7	neuromodulation	neuromodulation	PROPN
ihlr-28406	530	8	corp	corp	PROPN
ihlr-28406	530	9	.	.	PROPN
ihlr-28406	530	10	(	(	PUNCT
ihlr-28406	530	11	issued	issue	VERB
ihlr-28406	530	12	feb	feb	PROPN
ihlr-28406	530	13	17	17	NUM
ihlr-28406	530	14	,	,	PUNCT
ihlr-28406	530	15	2009	2009	NUM
ihlr-28406	530	16	)	)	PUNCT
ihlr-28406	530	17	.	.	PUNCT
ihlr-28406	530	18	)	)	PUNCT
ihlr-28406	531	1	148	148	NUM
ihlr-28406	531	2	..	..	PUNCT
ihlr-28406	531	3	squire	squire	VERB
ihlr-28406	531	4	et	et	PROPN
ihlr-28406	531	5	al	al	PROPN
ihlr-28406	531	6	.	.	PROPN
ihlr-28406	531	7	,	,	PUNCT
ihlr-28406	531	8	supra	supra	PROPN
ihlr-28406	531	9	note	note	PROPN
ihlr-28406	531	10	8	8	NUM
ihlr-28406	531	11	,	,	PUNCT
ihlr-28406	531	12	at	at	ADP
ihlr-28406	531	13	910	910	NUM
ihlr-28406	531	14	.	.	PUNCT
ihlr-28406	532	1	(	(	PUNCT
ihlr-28406	532	2	“	"	PUNCT
ihlr-28406	532	3	thyroid	thyroid	NOUN
ihlr-28406	532	4	hormone	hormone	NOUN
ihlr-28406	532	5	receptors	receptor	NOUN
ihlr-28406	532	6	are	be	AUX
ihlr-28406	532	7	located	locate	VERB
ihlr-28406	532	8	throughout	throughout	ADP
ihlr-28406	532	9	the	the	DET
ihlr-28406	532	10	brain	brain	NOUN
ihlr-28406	532	11	,	,	PUNCT
ihlr-28406	532	12	highlighting	highlight	VERB
ihlr-28406	532	13	their	their	PRON
ihlr-28406	532	14	importance	importance	NOUN
ihlr-28406	532	15	in	in	ADP
ihlr-28406	532	16	central	central	ADJ
ihlr-28406	532	17	nervous	nervous	ADJ
ihlr-28406	532	18	system	system	NOUN
ihlr-28406	532	19	development	development	NOUN
ihlr-28406	532	20	and	and	CCONJ
ihlr-28406	532	21	function	function	NOUN
ihlr-28406	532	22	.	.	PUNCT
ihlr-28406	532	23	”	"	PUNCT
ihlr-28406	533	1	)	)	PUNCT
ihlr-28406	533	2	149	149	NUM
ihlr-28406	533	3	.	.	PUNCT
ihlr-28406	534	1	larissa	larissa	PROPN
ihlr-28406	534	2	bifano	bifano	PROPN
ihlr-28406	534	3	,	,	PUNCT
ihlr-28406	534	4	et	et	PROPN
ihlr-28406	534	5	al	al	PROPN
ihlr-28406	534	6	.	.	PROPN
ihlr-28406	534	7	,	,	PUNCT
ihlr-28406	534	8	protecting	protect	VERB
ihlr-28406	534	9	ai	ai	PROPN
ihlr-28406	534	10	technologies	technology	NOUN
ihlr-28406	534	11	through	through	ADP
ihlr-28406	534	12	patents	patent	NOUN
ihlr-28406	534	13	:	:	PUNCT
ihlr-28406	534	14	a	a	DET
ihlr-28406	534	15	us	us	PROPN
ihlr-28406	534	16	guide	guide	NOUN
ihlr-28406	534	17	,	,	PUNCT
ihlr-28406	534	18	3	3	NUM
ihlr-28406	534	19	dla	dla	NOUN
ihlr-28406	534	20	piper	piper	NOUN
ihlr-28406	534	21	(	(	PUNCT
ihlr-28406	534	22	2020	2020	NUM
ihlr-28406	534	23	)	)	PUNCT
ihlr-28406	534	24	,	,	PUNCT
ihlr-28406	534	25	https://www.dlapiper.com/en/us/insights/publications/2020/04/a-us-guideto-protecting-ai-based-inventions/	https://www.dlapiper.com/en/us/insights/publications/2020/04/a-us-guideto-protecting-ai-based-inventions/	NOUN
ihlr-28406	535	1	[	[	X
ihlr-28406	535	2	https://perma.cc/7jyx-e68	https://perma.cc/7jyx-e68	NOUN
ihlr-28406	535	3	g	g	NOUN
ihlr-28406	535	4	]	]	PUNCT
ihlr-28406	535	5	(	(	PUNCT
ihlr-28406	535	6	“	"	PUNCT
ihlr-28406	535	7	recent	recent	ADJ
ihlr-28406	535	8	case	case	NOUN
ihlr-28406	535	9	law	law	NOUN
ihlr-28406	535	10	and	and	CCONJ
ihlr-28406	535	11	us	us	PROPN
ihlr-28406	535	12	patent	patent	NOUN
ihlr-28406	535	13	office	office	NOUN
ihlr-28406	535	14	guidance	guidance	NOUN
ihlr-28406	535	15	have	have	AUX
ihlr-28406	535	16	focused	focus	VERB
ihlr-28406	535	17	on	on	ADP
ihlr-28406	535	18	identifying	identify	VERB
ihlr-28406	535	19	the	the	DET
ihlr-28406	535	20	technical	technical	ADJ
ihlr-28406	535	21	improvement	improvement	NOUN
ihlr-28406	535	22	that	that	PRON
ihlr-28406	535	23	results	result	VERB
ihlr-28406	535	24	from	from	ADP
ihlr-28406	535	25	the	the	DET
ihlr-28406	535	26	artificial	artificial	ADJ
ihlr-28406	535	27	intelligence	intelligence	NOUN
ihlr-28406	535	28	innovation	innovation	NOUN
ihlr-28406	535	29	.	.	PUNCT
ihlr-28406	535	30	”	"	PUNCT
ihlr-28406	535	31	)	)	PUNCT
ihlr-28406	535	32	.	.	PUNCT
ihlr-28406	536	1	150	150	NUM
ihlr-28406	536	2	.	.	PUNCT
ihlr-28406	537	1	elona	elona	PROPN
ihlr-28406	537	2	marku	marku	PROPN
ihlr-28406	537	3	et	et	PROPN
ihlr-28406	537	4	al	al	PROPN
ihlr-28406	537	5	.	.	PROPN
ihlr-28406	537	6	,	,	PUNCT
ihlr-28406	537	7	quantity	quantity	NOUN
ihlr-28406	537	8	at	at	ADP
ihlr-28406	537	9	expense	expense	NOUN
ihlr-28406	537	10	of	of	ADP
ihlr-28406	537	11	quality	quality	NOUN
ihlr-28406	537	12	?	?	PUNCT
ihlr-28406	538	1	measuring	measure	VERB
ihlr-28406	538	2	the	the	DET
ihlr-28406	538	3	effects	effect	NOUN
ihlr-28406	538	4	of	of	ADP
ihlr-28406	538	5	technological	technological	ADJ
ihlr-28406	538	6	m&a	m&a	PROPN
ihlr-28406	538	7	on	on	ADP
ihlr-28406	538	8	innovation	innovation	NOUN
ihlr-28406	538	9	performance	performance	NOUN
ihlr-28406	538	10	8	8	NUM
ihlr-28406	538	11	col	col	PROPN
ihlr-28406	538	12	.	.	PROPN
ihlr-28406	538	13	bus	bus	PROPN
ihlr-28406	538	14	.	.	PUNCT
ihlr-28406	539	1	sch	sch	INTJ
ihlr-28406	539	2	.	.	PUNCT
ihlr-28406	540	1	(	(	PUNCT
ihlr-28406	540	2	2015	2015	NUM
ihlr-28406	540	3	)	)	PUNCT
ihlr-28406	540	4	.	.	PUNCT
ihlr-28406	541	1	the	the	DET
ihlr-28406	541	2	originality	originality	NOUN
ihlr-28406	541	3	algorithm	algorithm	NOUN
ihlr-28406	541	4	may	may	AUX
ihlr-28406	541	5	be	be	AUX
ihlr-28406	541	6	modified	modify	VERB
ihlr-28406	541	7	as	as	SCONJ
ihlr-28406	541	8	follows	follow	VERB
ihlr-28406	541	9	to	to	PART
ihlr-28406	541	10	measure	measure	NOUN
ihlr-28406	541	11	novelty	novelty	NOUN
ihlr-28406	541	12	:	:	PUNCT
ihlr-28406	542	1	𝑁𝑜𝑣𝑒𝑙𝑡𝑦𝑖	𝑁𝑜𝑣𝑒𝑙𝑡𝑦𝑖	PROPN
ihlr-28406	542	2	=	=	PUNCT
ihlr-28406	542	3	1	1	NUM
ihlr-28406	542	4	−	−	NOUN
ihlr-28406	542	5	∑	∑	PUNCT
ihlr-28406	542	6	𝑆𝑖𝑗	𝑆𝑖𝑗	PROPN
ihlr-28406	542	7	2	2	NUM
ihlr-28406	542	8	𝑛𝑖	𝑛𝑖	PROPN
ihlr-28406	542	9	𝑗=1	𝑗=1	PROPN
ihlr-28406	542	10	where	where	SCONJ
ihlr-28406	542	11	𝑆𝑖𝑗	𝑆𝑖𝑗	PROPN
ihlr-28406	542	12	represents	represent	VERB
ihlr-28406	542	13	the	the	DET
ihlr-28406	542	14	backward	backward	ADJ
ihlr-28406	542	15	citations	citation	NOUN
ihlr-28406	542	16	of	of	ADP
ihlr-28406	542	17	patent	patent	NOUN
ihlr-28406	542	18	𝑖	𝑖	NOUN
ihlr-28406	542	19	that	that	PRON
ihlr-28406	542	20	have	have	VERB
ihlr-28406	542	21	class	class	NOUN
ihlr-28406	542	22	code	code	PROPN
ihlr-28406	542	23	𝑗	𝑗	PROPN
ihlr-28406	542	24	,	,	PUNCT
ihlr-28406	542	25	out	out	ADP
ihlr-28406	542	26	of	of	ADP
ihlr-28406	542	27	𝑛𝑖	𝑛𝑖	PROPN
ihlr-28406	542	28	different	different	ADJ
ihlr-28406	542	29	patent	patent	NOUN
ihlr-28406	542	30	technology	technology	NOUN
ihlr-28406	542	31	classes	class	NOUN
ihlr-28406	542	32	during	during	ADP
ihlr-28406	542	33	the	the	DET
ihlr-28406	542	34	four	four	NUM
ihlr-28406	542	35	-	-	PUNCT
ihlr-28406	542	36	year	year	NOUN
ihlr-28406	542	37	,	,	PUNCT
ihlr-28406	542	38	pre	pre	ADJ
ihlr-28406	542	39	-	-	NOUN
ihlr-28406	542	40	acquisition	acquisition	NOUN
ihlr-28406	542	41	and	and	CCONJ
ihlr-28406	542	42	postacquisition	postacquisition	NOUN
ihlr-28406	542	43	windows	window	NOUN
ihlr-28406	542	44	,	,	PUNCT
ihlr-28406	542	45	respectively	respectively	ADV
ihlr-28406	542	46	.	.	PUNCT
ihlr-28406	543	1	151	151	NUM
ihlr-28406	543	2	.	.	PUNCT
ihlr-28406	544	1	i	i	PRON
ihlr-28406	544	2	d.	d.	PROPN
ihlr-28406	544	3	152	152	NUM
ihlr-28406	544	4	.	.	PUNCT
ihlr-28406	545	1	guardo	guardo	PROPN
ihlr-28406	545	2	&	&	CCONJ
ihlr-28406	545	3	harrigan	harrigan	PROPN
ihlr-28406	545	4	,	,	PUNCT
ihlr-28406	545	5	supra	supra	PROPN
ihlr-28406	545	6	note	note	PROPN
ihlr-28406	545	7	145	145	NUM
ihlr-28406	545	8	.	.	PUNCT
ihlr-28406	546	1	https://perma.cc/7jyx-e68	https://perma.cc/7jyx-e68	NOUN
ihlr-28406	546	2	g	g	NOUN
ihlr-28406	546	3	https://www.dlapiper.com/en/us/insights/publications/2020/04/a-us-guide	https://www.dlapiper.com/en/us/insights/publications/2020/04/a-us-guide	NOUN
ihlr-28406	546	4	2024	2024	NUM
ihlr-28406	546	5	]	]	PUNCT
ihlr-28406	546	6	inventions	invention	NOUN
ihlr-28406	546	7	and	and	CCONJ
ihlr-28406	546	8	patents	patent	NOUN
ihlr-28406	546	9	for	for	ADP
ihlr-28406	546	10	treating	treat	VERB
ihlr-28406	546	11	297	297	NUM
ihlr-28406	546	12	thyroid	thyroid	NOUN
ihlr-28406	546	13	disease	disease	NOUN
ihlr-28406	546	14	rights	right	NOUN
ihlr-28406	546	15	.	.	PUNCT
ihlr-28406	547	1	153	153	NUM
ihlr-28406	547	2	the	the	DET
ihlr-28406	547	3	scope	scope	NOUN
ihlr-28406	547	4	question	question	NOUN
ihlr-28406	547	5	is	be	AUX
ihlr-28406	547	6	not	not	PART
ihlr-28406	547	7	limited	limit	VERB
ihlr-28406	547	8	to	to	ADP
ihlr-28406	547	9	validity	validity	NOUN
ihlr-28406	547	10	or	or	CCONJ
ihlr-28406	547	11	infringement	infringement	NOUN
ihlr-28406	547	12	.	.	PUNCT
ihlr-28406	548	1	154	154	NUM
ihlr-28406	548	2	rather	rather	ADV
ihlr-28406	548	3	,	,	PUNCT
ihlr-28406	548	4	it	it	PRON
ihlr-28406	548	5	refers	refer	VERB
ihlr-28406	548	6	to	to	ADP
ihlr-28406	548	7	a	a	DET
ihlr-28406	548	8	range	range	NOUN
ihlr-28406	548	9	of	of	ADP
ihlr-28406	548	10	patent	patent	NOUN
ihlr-28406	548	11	rights	right	NOUN
ihlr-28406	548	12	protecting	protect	VERB
ihlr-28406	548	13	monopoly	monopoly	NOUN
ihlr-28406	548	14	.	.	PUNCT
ihlr-28406	549	1	155	155	NUM
ihlr-28406	549	2	consider	consider	VERB
ihlr-28406	549	3	u.s	u.s	PROPN
ihlr-28406	549	4	.	.	PROPN
ihlr-28406	549	5	patent	patent	NOUN
ihlr-28406	549	6	no	no	PROPN
ihlr-28406	549	7	.	.	PROPN
ihlr-28406	549	8	9,980,933	9,980,933	NUM
ihlr-28406	549	9	,	,	PUNCT
ihlr-28406	549	10	thyroid	thyroid	NOUN
ihlr-28406	549	11	hormone	hormone	NOUN
ihlr-28406	549	12	analogs	analog	NOUN
ihlr-28406	549	13	and	and	CCONJ
ihlr-28406	549	14	methods	method	NOUN
ihlr-28406	549	15	of	of	ADP
ihlr-28406	549	16	use	use	NOUN
ihlr-28406	549	17	,	,	PUNCT
ihlr-28406	549	18	which	which	PRON
ihlr-28406	549	19	claims	claim	VERB
ihlr-28406	549	20	:	:	PUNCT
ihlr-28406	549	21	1	1	X
ihlr-28406	549	22	.	.	X
ihlr-28406	549	23	a	a	DET
ihlr-28406	549	24	method	method	NOUN
ihlr-28406	549	25	for	for	ADP
ihlr-28406	549	26	treating	treat	VERB
ihlr-28406	549	27	a	a	DET
ihlr-28406	549	28	condition	condition	NOUN
ihlr-28406	549	29	by	by	ADP
ihlr-28406	549	30	promoting	promote	VERB
ihlr-28406	549	31	angiogenesis	angiogenesis	NOUN
ihlr-28406	549	32	,	,	PUNCT
ihlr-28406	549	33	wherein	wherein	SCONJ
ihlr-28406	549	34	the	the	DET
ihlr-28406	549	35	condition	condition	NOUN
ihlr-28406	549	36	is	be	AUX
ihlr-28406	549	37	selected	select	VERB
ihlr-28406	549	38	from	from	ADP
ihlr-28406	549	39	the	the	DET
ihlr-28406	549	40	group	group	NOUN
ihlr-28406	549	41	consisting	consist	VERB
ihlr-28406	549	42	of	of	ADP
ihlr-28406	549	43	occlusive	occlusive	ADJ
ihlr-28406	549	44	vascular	vascular	ADJ
ihlr-28406	549	45	disease	disease	NOUN
ihlr-28406	549	46	,	,	PUNCT
ihlr-28406	549	47	coronary	coronary	ADJ
ihlr-28406	549	48	disease	disease	NOUN
ihlr-28406	549	49	,	,	PUNCT
ihlr-28406	549	50	erectile	erectile	ADJ
ihlr-28406	549	51	dysfunction	dysfunction	NOUN
ihlr-28406	549	52	,	,	PUNCT
ihlr-28406	549	53	myocardial	myocardial	ADJ
ihlr-28406	549	54	infarction	infarction	NOUN
ihlr-28406	549	55	,	,	PUNCT
ihlr-28406	549	56	ischemia	ischemia	NOUN
ihlr-28406	549	57	,	,	PUNCT
ihlr-28406	549	58	stroke	stroke	NOUN
ihlr-28406	549	59	,	,	PUNCT
ihlr-28406	549	60	peripheral	peripheral	ADJ
ihlr-28406	549	61	artery	artery	NOUN
ihlr-28406	549	62	vascular	vascular	ADJ
ihlr-28406	549	63	disorders	disorder	NOUN
ihlr-28406	549	64	,	,	PUNCT
ihlr-28406	549	65	wound	wound	ADJ
ihlr-28406	549	66	healing	healing	NOUN
ihlr-28406	549	67	and	and	CCONJ
ihlr-28406	549	68	burns	burn	NOUN
ihlr-28406	549	69	,	,	PUNCT
ihlr-28406	549	70	said	say	VERB
ihlr-28406	549	71	method	method	NOUN
ihlr-28406	549	72	comprising	comprise	VERB
ihlr-28406	549	73	the	the	DET
ihlr-28406	549	74	steps	step	NOUN
ihlr-28406	549	75	of	of	ADP
ihlr-28406	549	76	:	:	PUNCT
ihlr-28406	549	77	formulating	formulate	VERB
ihlr-28406	549	78	a	a	DET
ihlr-28406	549	79	polymer	polymer	NOUN
ihlr-28406	549	80	into	into	ADP
ihlr-28406	549	81	a	a	DET
ihlr-28406	549	82	nanoparticle	nanoparticle	NOUN
ihlr-28406	549	83	,	,	PUNCT
ihlr-28406	549	84	wherein	wherein	SCONJ
ihlr-28406	549	85	the	the	DET
ihlr-28406	549	86	nanoparticle	nanoparticle	NOUN
ihlr-28406	549	87	is	be	AUX
ihlr-28406	549	88	less	less	ADJ
ihlr-28406	549	89	than	than	ADP
ihlr-28406	549	90	200	200	NUM
ihlr-28406	549	91	nanometers	nanometer	NOUN
ihlr-28406	549	92	,	,	PUNCT
ihlr-28406	549	93	wherein	wherein	SCONJ
ihlr-28406	549	94	the	the	DET
ihlr-28406	549	95	polymer	polymer	NOUN
ihlr-28406	549	96	is	be	AUX
ihlr-28406	549	97	polyglycolide	polyglycolide	ADJ
ihlr-28406	549	98	,	,	PUNCT
ihlr-28406	549	99	polylactide	polylactide	ADV
ihlr-28406	549	100	,	,	PUNCT
ihlr-28406	549	101	or	or	CCONJ
ihlr-28406	549	102	a	a	DET
ihlr-28406	549	103	copolymer	copolymer	NOUN
ihlr-28406	549	104	thereof	thereof	ADV
ihlr-28406	549	105	;	;	PUNCT
ihlr-28406	549	106	conjugating	conjugate	VERB
ihlr-28406	549	107	a	a	DET
ihlr-28406	549	108	thyroid	thyroid	NOUN
ihlr-28406	549	109	hormone	hormone	NOUN
ihlr-28406	549	110	analog	analog	NOUN
ihlr-28406	549	111	to	to	ADP
ihlr-28406	549	112	the	the	DET
ihlr-28406	549	113	nanoparticle	nanoparticle	NOUN
ihlr-28406	549	114	forming	form	VERB
ihlr-28406	549	115	a	a	DET
ihlr-28406	549	116	conjugated	conjugate	VERB
ihlr-28406	549	117	thyroid	thyroid	NOUN
ihlr-28406	549	118	hormone	hormone	NOUN
ihlr-28406	549	119	analog	analog	NOUN
ihlr-28406	549	120	;	;	PUNCT
ihlr-28406	549	121	coating	coat	VERB
ihlr-28406	549	122	a	a	DET
ihlr-28406	549	123	medical	medical	ADJ
ihlr-28406	549	124	device	device	NOUN
ihlr-28406	549	125	with	with	ADP
ihlr-28406	549	126	the	the	DET
ihlr-28406	549	127	conjugated	conjugate	VERB
ihlr-28406	549	128	thyroid	thyroid	PROPN
ihlr-28406	549	129	hormone	hormone	NOUN
ihlr-28406	549	130	analog	analog	NOUN
ihlr-28406	549	131	;	;	PUNCT
ihlr-28406	549	132	administering	administer	VERB
ihlr-28406	549	133	an	an	DET
ihlr-28406	549	134	effective	effective	ADJ
ihlr-28406	549	135	amount	amount	NOUN
ihlr-28406	549	136	of	of	ADP
ihlr-28406	549	137	the	the	DET
ihlr-28406	549	138	conjugated	conjugate	VERB
ihlr-28406	549	139	thyroid	thyroid	PROPN
ihlr-28406	549	140	hormone	hormone	NOUN
ihlr-28406	549	141	analog	analog	NOUN
ihlr-28406	549	142	to	to	ADP
ihlr-28406	549	143	a	a	DET
ihlr-28406	549	144	subject	subject	NOUN
ihlr-28406	549	145	suffering	suffering	NOUN
ihlr-28406	549	146	from	from	ADP
ihlr-28406	549	147	the	the	DET
ihlr-28406	549	148	condition	condition	NOUN
ihlr-28406	549	149	by	by	ADP
ihlr-28406	549	150	inserting	insert	VERB
ihlr-28406	549	151	the	the	DET
ihlr-28406	549	152	medical	medical	ADJ
ihlr-28406	549	153	device	device	NOUN
ihlr-28406	549	154	coated	coat	VERB
ihlr-28406	549	155	with	with	ADP
ihlr-28406	549	156	the	the	DET
ihlr-28406	549	157	conjugated	conjugate	VERB
ihlr-28406	549	158	thyroid	thyroid	PROPN
ihlr-28406	549	159	hormone	hormone	NOUN
ihlr-28406	549	160	analog	analog	NOUN
ihlr-28406	549	161	into	into	ADP
ihlr-28406	549	162	the	the	DET
ihlr-28406	549	163	subject	subject	NOUN
ihlr-28406	549	164	;	;	PUNCT
ihlr-28406	549	165	initiating	initiate	VERB
ihlr-28406	549	166	non	non	ADJ
ihlr-28406	549	167	-	-	ADJ
ihlr-28406	549	168	genomic	genomic	ADJ
ihlr-28406	549	169	signal	signal	NOUN
ihlr-28406	549	170	transduction	transduction	NOUN
ihlr-28406	549	171	pathways	pathway	NOUN
ihlr-28406	549	172	at	at	ADP
ihlr-28406	549	173	an	an	DET
ihlr-28406	549	174	integrin	integrin	NOUN
ihlr-28406	549	175	𝛼𝜈𝛽3	𝛼𝜈𝛽3	PROPN
ihlr-28406	549	176	surface	surface	NOUN
ihlr-28406	549	177	receptor	receptor	NOUN
ihlr-28406	549	178	of	of	ADP
ihlr-28406	549	179	a	a	DET
ihlr-28406	549	180	cell	cell	NOUN
ihlr-28406	549	181	by	by	ADP
ihlr-28406	549	182	contacting	contact	VERB
ihlr-28406	549	183	the	the	DET
ihlr-28406	549	184	conjugated	conjugated	ADJ
ihlr-28406	549	185	thyroid	thyroid	PROPN
ihlr-28406	549	186	hormone	hormone	NOUN
ihlr-28406	549	187	analog	analog	NOUN
ihlr-28406	549	188	with	with	ADP
ihlr-28406	549	189	the	the	DET
ihlr-28406	549	190	𝛼𝜈𝛽3	𝛼𝜈𝛽3	PROPN
ihlr-28406	549	191	surface	surface	NOUN
ihlr-28406	549	192	receptor	receptor	NOUN
ihlr-28406	549	193	,	,	PUNCT
ihlr-28406	549	194	said	say	VERB
ihlr-28406	549	195	conjugated	conjugated	ADJ
ihlr-28406	549	196	thyroid	thyroid	PROPN
ihlr-28406	549	197	hormone	hormone	NOUN
ihlr-28406	549	198	analog	analog	NOUN
ihlr-28406	549	199	does	do	AUX
ihlr-28406	549	200	not	not	PART
ihlr-28406	549	201	gain	gain	VERB
ihlr-28406	549	202	entry	entry	NOUN
ihlr-28406	549	203	to	to	ADP
ihlr-28406	549	204	the	the	DET
ihlr-28406	549	205	cell	cell	NOUN
ihlr-28406	549	206	’s	’s	PART
ihlr-28406	549	207	interior.156	interior.156	NOUN
ihlr-28406	549	208	this	this	DET
ihlr-28406	549	209	claim	claim	NOUN
ihlr-28406	549	210	has	have	VERB
ihlr-28406	549	211	a	a	DET
ihlr-28406	549	212	long	long	ADJ
ihlr-28406	549	213	preamble	preamble	NOUN
ihlr-28406	549	214	,	,	PUNCT
ihlr-28406	549	215	but	but	CCONJ
ihlr-28406	549	216	the	the	DET
ihlr-28406	549	217	general	general	ADJ
ihlr-28406	549	218	rule	rule	NOUN
ihlr-28406	549	219	is	be	AUX
ihlr-28406	549	220	the	the	DET
ihlr-28406	549	221	preamble	preamble	NOUN
ihlr-28406	549	222	does	do	AUX
ihlr-28406	549	223	not	not	PART
ihlr-28406	549	224	limit	limit	VERB
ihlr-28406	549	225	claim	claim	NOUN
ihlr-28406	549	226	scope	scope	NOUN
ihlr-28406	549	227	.	.	PUNCT
ihlr-28406	550	1	however	however	ADV
ihlr-28406	550	2	,	,	PUNCT
ihlr-28406	550	3	this	this	DET
ihlr-28406	550	4	claim	claim	NOUN
ihlr-28406	550	5	is	be	AUX
ihlr-28406	550	6	limited	limit	VERB
ihlr-28406	550	7	by	by	ADP
ihlr-28406	550	8	the	the	DET
ihlr-28406	550	9	preamble	preamble	NOUN
ihlr-28406	550	10	due	due	ADP
ihlr-28406	550	11	to	to	ADP
ihlr-28406	550	12	the	the	DET
ihlr-28406	550	13	specificity	specificity	NOUN
ihlr-28406	550	14	with	with	ADP
ihlr-28406	550	15	which	which	PRON
ihlr-28406	550	16	the	the	DET
ihlr-28406	550	17	condition	condition	NOUN
ihlr-28406	550	18	is	be	AUX
ihlr-28406	550	19	described	describe	VERB
ihlr-28406	550	20	,	,	PUNCT
ihlr-28406	550	21	as	as	ADP
ihlr-28406	550	22	a	a	DET
ihlr-28406	550	23	selection	selection	NOUN
ihlr-28406	550	24	from	from	ADP
ihlr-28406	550	25	a	a	DET
ihlr-28406	550	26	group	group	NOUN
ihlr-28406	550	27	.	.	PUNCT
ihlr-28406	551	1	an	an	DET
ihlr-28406	551	2	alternative	alternative	ADJ
ihlr-28406	551	3	analysis	analysis	NOUN
ihlr-28406	551	4	may	may	AUX
ihlr-28406	551	5	reveal	reveal	VERB
ihlr-28406	551	6	,	,	PUNCT
ihlr-28406	551	7	this	this	DET
ihlr-28406	551	8	claim	claim	NOUN
ihlr-28406	551	9	contains	contain	VERB
ihlr-28406	551	10	two	two	NUM
ihlr-28406	551	11	transitional	transitional	ADJ
ihlr-28406	551	12	phrases	phrase	NOUN
ihlr-28406	551	13	,	,	PUNCT
ihlr-28406	551	14	consisting	consist	VERB
ihlr-28406	551	15	and	and	CCONJ
ihlr-28406	551	16	comprising	comprising	NOUN
ihlr-28406	551	17	.	.	PUNCT
ihlr-28406	552	1	typically	typically	ADV
ihlr-28406	552	2	,	,	PUNCT
ihlr-28406	552	3	comprising	comprise	VERB
ihlr-28406	552	4	157	157	NUM
ihlr-28406	552	5	is	be	AUX
ihlr-28406	552	6	the	the	DET
ihlr-28406	552	7	broadest	broad	ADJ
ihlr-28406	552	8	—	—	PUNCT
ihlr-28406	552	9	—	—	PUNCT
ihlr-28406	552	10	—	—	PUNCT
ihlr-28406	552	11	—	—	PUNCT
ihlr-28406	552	12	—	—	PUNCT
ihlr-28406	552	13	—	—	PUNCT
ihlr-28406	552	14	—	—	PUNCT
ihlr-28406	552	15	—	—	PUNCT
ihlr-28406	552	16	—	—	PUNCT
ihlr-28406	552	17	—	—	PUNCT
ihlr-28406	552	18	—	—	PUNCT
ihlr-28406	552	19	—	—	PUNCT
ihlr-28406	552	20	—	—	PUNCT
ihlr-28406	552	21	—	—	PUNCT
ihlr-28406	552	22	—	—	PUNCT
ihlr-28406	552	23	—	—	PUNCT
ihlr-28406	552	24	—	—	PUNCT
ihlr-28406	552	25	—	—	PUNCT
ihlr-28406	552	26	—	—	PUNCT
ihlr-28406	552	27	—	—	PUNCT
ihlr-28406	552	28	—	—	PUNCT
ihlr-28406	552	29	—	—	PUNCT
ihlr-28406	552	30	—	—	PUNCT
ihlr-28406	552	31	—	—	PUNCT
ihlr-28406	552	32	—	—	PUNCT
ihlr-28406	552	33	—	—	PUNCT
ihlr-28406	552	34	—	—	PUNCT
ihlr-28406	552	35	—	—	PUNCT
ihlr-28406	552	36	—	—	PUNCT
ihlr-28406	552	37	153	153	NUM
ihlr-28406	552	38	.	.	PUNCT
ihlr-28406	552	39	lemley	lemley	PROPN
ihlr-28406	552	40	&	&	CCONJ
ihlr-28406	552	41	mckenna	mckenna	PROPN
ihlr-28406	552	42	,	,	PUNCT
ihlr-28406	552	43	supra	supra	PROPN
ihlr-28406	552	44	note	note	VERB
ihlr-28406	552	45	146	146	NUM
ihlr-28406	552	46	,	,	PUNCT
ihlr-28406	552	47	at	at	ADP
ihlr-28406	552	48	2209	2209	NUM
ihlr-28406	552	49	(	(	PUNCT
ihlr-28406	552	50	ip	ip	DET
ihlr-28406	552	51	regimes	regime	NOUN
ihlr-28406	552	52	require	require	VERB
ihlr-28406	552	53	,	,	PUNCT
ihlr-28406	552	54	not	not	PART
ihlr-28406	552	55	just	just	ADV
ihlr-28406	552	56	similarity	similarity	NOUN
ihlr-28406	552	57	between	between	ADP
ihlr-28406	552	58	the	the	DET
ihlr-28406	552	59	defendant	defendant	NOUN
ihlr-28406	552	60	’s	’s	PART
ihlr-28406	552	61	and	and	CCONJ
ihlr-28406	552	62	plaintiff	plaintiff	VERB
ihlr-28406	552	63	’s	’s	PART
ihlr-28406	552	64	works	work	NOUN
ihlr-28406	552	65	,	,	PUNCT
ihlr-28406	552	66	but	but	CCONJ
ihlr-28406	552	67	similarity	similarity	NOUN
ihlr-28406	552	68	with	with	ADP
ihlr-28406	552	69	respect	respect	NOUN
ihlr-28406	552	70	to	to	ADP
ihlr-28406	552	71	the	the	DET
ihlr-28406	552	72	protectable	protectable	ADJ
ihlr-28406	552	73	elements	element	NOUN
ihlr-28406	552	74	.	.	PUNCT
ihlr-28406	553	1	154	154	NUM
ihlr-28406	553	2	.	.	PUNCT
ihlr-28406	553	3	lemley	lemley	PROPN
ihlr-28406	553	4	&	&	CCONJ
ihlr-28406	553	5	mckenna	mckenna	PROPN
ihlr-28406	553	6	,	,	PUNCT
ihlr-28406	553	7	supra	supra	PROPN
ihlr-28406	553	8	note	note	VERB
ihlr-28406	553	9	146	146	NUM
ihlr-28406	553	10	,	,	PUNCT
ihlr-28406	553	11	at	at	ADP
ihlr-28406	553	12	2202	2202	NUM
ihlr-28406	553	13	(	(	PUNCT
ihlr-28406	553	14	ip	ip	DET
ihlr-28406	553	15	regimes	regime	NOUN
ihlr-28406	553	16	require	require	VERB
ihlr-28406	553	17	,	,	PUNCT
ihlr-28406	553	18	not	not	PART
ihlr-28406	553	19	just	just	ADV
ihlr-28406	553	20	similarity	similarity	NOUN
ihlr-28406	553	21	between	between	ADP
ihlr-28406	553	22	the	the	DET
ihlr-28406	553	23	defendant	defendant	NOUN
ihlr-28406	553	24	’s	’s	PART
ihlr-28406	553	25	and	and	CCONJ
ihlr-28406	553	26	plaintiff	plaintiff	VERB
ihlr-28406	553	27	’s	’s	PART
ihlr-28406	553	28	works	work	NOUN
ihlr-28406	553	29	,	,	PUNCT
ihlr-28406	553	30	but	but	CCONJ
ihlr-28406	553	31	similarity	similarity	NOUN
ihlr-28406	553	32	with	with	ADP
ihlr-28406	553	33	respect	respect	NOUN
ihlr-28406	553	34	to	to	ADP
ihlr-28406	553	35	the	the	DET
ihlr-28406	553	36	protectable	protectable	ADJ
ihlr-28406	553	37	elements	element	NOUN
ihlr-28406	553	38	.	.	PUNCT
ihlr-28406	553	39	)	)	PUNCT
ihlr-28406	554	1	155	155	NUM
ihlr-28406	554	2	.	.	PUNCT
ihlr-28406	555	1	dan	dan	PROPN
ihlr-28406	555	2	l.	l.	PROPN
ihlr-28406	555	3	burk	burk	PROPN
ihlr-28406	555	4	&	&	CCONJ
ihlr-28406	555	5	mark	mark	PROPN
ihlr-28406	555	6	a.	a.	PROPN
ihlr-28406	555	7	lemley	lemley	PROPN
ihlr-28406	555	8	,	,	PUNCT
ihlr-28406	555	9	policy	policy	NOUN
ihlr-28406	555	10	levers	lever	NOUN
ihlr-28406	555	11	in	in	ADP
ihlr-28406	555	12	patent	patent	NOUN
ihlr-28406	555	13	law	law	NOUN
ihlr-28406	555	14	,	,	PUNCT
ihlr-28406	555	15	89	89	NUM
ihlr-28406	555	16	va	va	NOUN
ihlr-28406	555	17	.	.	PUNCT
ihlr-28406	556	1	l.	l.	PROPN
ihlr-28406	556	2	rev	rev	PROPN
ihlr-28406	556	3	.	.	PROPN
ihlr-28406	556	4	1575	1575	NUM
ihlr-28406	556	5	,	,	PUNCT
ihlr-28406	556	6	1617	1617	NUM
ihlr-28406	556	7	2003	2003	NUM
ihlr-28406	556	8	)	)	PUNCT
ihlr-28406	556	9	.	.	PUNCT
ihlr-28406	557	1	156	156	NUM
ihlr-28406	557	2	.	.	PUNCT
ihlr-28406	557	3	mousa	mousa	PROPN
ihlr-28406	557	4	,	,	PUNCT
ihlr-28406	557	5	et	et	PROPN
ihlr-28406	557	6	al	al	PROPN
ihlr-28406	557	7	.	.	PROPN
ihlr-28406	557	8	,	,	PUNCT
ihlr-28406	557	9	thyroid	thyroid	VERB
ihlr-28406	557	10	hormone	hormone	NOUN
ihlr-28406	557	11	analogs	analog	NOUN
ihlr-28406	557	12	and	and	CCONJ
ihlr-28406	557	13	methods	method	NOUN
ihlr-28406	557	14	of	of	ADP
ihlr-28406	557	15	use	use	NOUN
ihlr-28406	557	16	u.s	u.s	PROPN
ihlr-28406	557	17	.	.	PROPN
ihlr-28406	557	18	patent	patent	NOUN
ihlr-28406	557	19	no	no	PROPN
ihlr-28406	557	20	.	.	PROPN
ihlr-28406	557	21	9,980,933	9,980,933	NUM
ihlr-28406	557	22	,	,	PUNCT
ihlr-28406	557	23	to	to	PART
ihlr-28406	557	24	mousa	mousa	VERB
ihlr-28406	557	25	,	,	PUNCT
ihlr-28406	557	26	et	et	PROPN
ihlr-28406	557	27	al	al	PROPN
ihlr-28406	557	28	.	.	PROPN
ihlr-28406	557	29	,	,	PUNCT
ihlr-28406	557	30	(	(	PUNCT
ihlr-28406	557	31	issued	issue	VERB
ihlr-28406	557	32	may	may	PROPN
ihlr-28406	557	33	29	29	NUM
ihlr-28406	557	34	,	,	PUNCT
ihlr-28406	557	35	2018	2018	NUM
ihlr-28406	557	36	)	)	PUNCT
ihlr-28406	557	37	.	.	PUNCT
ihlr-28406	558	1	157	157	NUM
ihlr-28406	558	2	.	.	PUNCT
ihlr-28406	558	3	mars	mars	PROPN
ihlr-28406	558	4	inc	inc	PROPN
ihlr-28406	558	5	.	.	PROPN
ihlr-28406	559	1	v.	v.	PROPN
ihlr-28406	559	2	h.j	h.j	PROPN
ihlr-28406	559	3	.	.	PROPN
ihlr-28406	559	4	heinz	heinz	PROPN
ihlr-28406	559	5	co.	co.	PROPN
ihlr-28406	559	6	,	,	PUNCT
ihlr-28406	559	7	377	377	NUM
ihlr-28406	559	8	f.3d	f.3d	NUM
ihlr-28406	559	9	1369	1369	NUM
ihlr-28406	559	10	,	,	PUNCT
ihlr-28406	559	11	1376	1376	NUM
ihlr-28406	559	12	,	,	PUNCT
ihlr-28406	559	13	71	71	NUM
ihlr-28406	559	14	uspq2d	uspq2d	PROPN
ihlr-28406	559	15	1837	1837	NUM
ihlr-28406	559	16	,	,	PUNCT
ihlr-28406	559	17	1843	1843	NUM
ihlr-28406	560	1	(	(	PUNCT
ihlr-28406	560	2	fed	fed	PROPN
ihlr-28406	560	3	.	.	PUNCT
ihlr-28406	560	4	cir	cir	PROPN
ihlr-28406	560	5	.	.	PROPN
ihlr-28406	560	6	2004	2004	NUM
ihlr-28406	560	7	)	)	PUNCT
ihlr-28406	560	8	(	(	PUNCT
ihlr-28406	560	9	“	"	PUNCT
ihlr-28406	560	10	like	like	ADP
ihlr-28406	560	11	the	the	DET
ihlr-28406	560	12	term	term	NOUN
ihlr-28406	560	13	‘	'	PUNCT
ihlr-28406	560	14	comprising	comprising	NOUN
ihlr-28406	560	15	,	,	PUNCT
ihlr-28406	560	16	’	'	PUNCT
ihlr-28406	560	17	the	the	DET
ihlr-28406	560	18	terms	term	NOUN
ihlr-28406	560	19	‘	'	PUNCT
ihlr-28406	560	20	containing	contain	VERB
ihlr-28406	560	21	’	'	PUNCT
ihlr-28406	560	22	and	and	CCONJ
ihlr-28406	560	23	‘	'	PUNCT
ihlr-28406	560	24	mixture	mixture	NOUN
ihlr-28406	560	25	’	'	PUNCT
ihlr-28406	560	26	are	be	AUX
ihlr-28406	560	27	open	open	ADJ
ihlr-28406	560	28	-	-	PUNCT
ihlr-28406	560	29	ended	ended	ADJ
ihlr-28406	560	30	.	.	PUNCT
ihlr-28406	560	31	”	"	PUNCT
ihlr-28406	560	32	)	)	PUNCT
ihlr-28406	560	33	.	.	PUNCT
ihlr-28406	561	1	see	see	VERB
ihlr-28406	561	2	also	also	ADV
ihlr-28406	561	3	genentech	genentech	PROPN
ihlr-28406	561	4	,	,	PUNCT
ihlr-28406	561	5	inc	inc	PROPN
ihlr-28406	561	6	.	.	PROPN
ihlr-28406	562	1	v.	v.	PROPN
ihlr-28406	562	2	chiron	chiron	PROPN
ihlr-28406	562	3	corp	corp	PROPN
ihlr-28406	562	4	.	.	PROPN
ihlr-28406	562	5	,	,	PUNCT
ihlr-28406	562	6	112	112	NUM
ihlr-28406	562	7	f.3d	f.3d	NUM
ihlr-28406	562	8	495	495	NUM
ihlr-28406	562	9	,	,	PUNCT
ihlr-28406	562	10	501	501	NUM
ihlr-28406	562	11	,	,	PUNCT
ihlr-28406	562	12	42	42	NUM
ihlr-28406	562	13	uspq2d	uspq2d	NOUN
ihlr-28406	562	14	1608	1608	NUM
ihlr-28406	562	15	,	,	PUNCT
ihlr-28406	562	16	1613	1613	NUM
ihlr-28406	562	17	(	(	PUNCT
ihlr-28406	562	18	fed	fed	PROPN
ihlr-28406	562	19	.	.	PUNCT
ihlr-28406	562	20	cir	cir	PROPN
ihlr-28406	562	21	.	.	PROPN
ihlr-28406	562	22	1997	1997	NUM
ihlr-28406	562	23	)	)	PUNCT
ihlr-28406	563	1	(	(	PUNCT
ihlr-28406	563	2	“	"	PUNCT
ihlr-28406	563	3	comprising	comprising	NOUN
ihlr-28406	563	4	”	"	PUNCT
ihlr-28406	563	5	is	be	AUX
ihlr-28406	563	6	a	a	DET
ihlr-28406	563	7	term	term	NOUN
ihlr-28406	563	8	of	of	ADP
ihlr-28406	563	9	art	art	NOUN
ihlr-28406	563	10	used	use	VERB
ihlr-28406	563	11	in	in	ADP
ihlr-28406	563	12	claim	claim	NOUN
ihlr-28406	563	13	language	language	NOUN
ihlr-28406	563	14	which	which	PRON
ihlr-28406	563	15	means	mean	VERB
ihlr-28406	563	16	that	that	SCONJ
ihlr-28406	563	17	the	the	DET
ihlr-28406	563	18	named	name	VERB
ihlr-28406	563	19	elements	element	NOUN
ihlr-28406	563	20	are	be	AUX
ihlr-28406	563	21	essential	essential	ADJ
ihlr-28406	563	22	,	,	PUNCT
ihlr-28406	563	23	but	but	CCONJ
ihlr-28406	563	24	other	other	ADJ
ihlr-28406	563	25	elements	element	NOUN
ihlr-28406	563	26	may	may	AUX
ihlr-28406	563	27	be	be	AUX
ihlr-28406	563	28	added	add	VERB
ihlr-28406	563	29	and	and	CCONJ
ihlr-28406	563	30	still	still	ADV
ihlr-28406	563	31	form	form	VERB
ihlr-28406	563	32	a	a	DET
ihlr-28406	563	33	construct	construct	NOUN
ihlr-28406	563	34	within	within	ADP
ihlr-28406	563	35	the	the	DET
ihlr-28406	563	36	scope	scope	NOUN
ihlr-28406	563	37	of	of	ADP
ihlr-28406	563	38	the	the	DET
ihlr-28406	563	39	claim	claim	NOUN
ihlr-28406	563	40	.	.	PUNCT
ihlr-28406	563	41	)	)	PUNCT
ihlr-28406	564	1	(	(	PUNCT
ihlr-28406	564	2	comprising	comprising	NOUN
ihlr-28406	564	3	means	mean	VERB
ihlr-28406	564	4	the	the	DET
ihlr-28406	564	5	invention	invention	NOUN
ihlr-28406	564	6	includes	include	VERB
ihlr-28406	564	7	but	but	CCONJ
ihlr-28406	564	8	is	be	AUX
ihlr-28406	564	9	not	not	PART
ihlr-28406	564	10	limited	limit	VERB
ihlr-28406	564	11	to	to	ADP
ihlr-28406	564	12	the	the	DET
ihlr-28406	564	13	elements	element	NOUN
ihlr-28406	564	14	identified	identify	VERB
ihlr-28406	564	15	in	in	ADP
ihlr-28406	564	16	the	the	DET
ihlr-28406	564	17	claim	claim	NOUN
ihlr-28406	564	18	.	.	PUNCT
ihlr-28406	564	19	)	)	PUNCT
ihlr-28406	564	20	.	.	PUNCT
ihlr-28406	565	1	indiana	indiana	PROPN
ihlr-28406	565	2	health	health	PROPN
ihlr-28406	565	3	law	law	PROPN
ihlr-28406	565	4	review	review	NOUN
ihlr-28406	565	5	[	[	X
ihlr-28406	565	6	vol	vol	NOUN
ihlr-28406	565	7	.	.	PUNCT
ihlr-28406	566	1	21:277	21:277	NOUN
ihlr-28406	566	2	298	298	NUM
ihlr-28406	566	3	transitional	transitional	ADJ
ihlr-28406	566	4	phrase	phrase	NOUN
ihlr-28406	566	5	and	and	CCONJ
ihlr-28406	566	6	consisting	consist	VERB
ihlr-28406	566	7	of158	of158	NOUN
ihlr-28406	566	8	is	be	AUX
ihlr-28406	566	9	the	the	DET
ihlr-28406	566	10	narrowest	narrow	ADJ
ihlr-28406	566	11	.	.	PUNCT
ihlr-28406	567	1	however	however	ADV
ihlr-28406	567	2	,	,	PUNCT
ihlr-28406	567	3	this	this	DET
ihlr-28406	567	4	claim	claim	NOUN
ihlr-28406	567	5	is	be	AUX
ihlr-28406	567	6	unique	unique	ADJ
ihlr-28406	567	7	because	because	SCONJ
ihlr-28406	567	8	it	it	PRON
ihlr-28406	567	9	is	be	AUX
ihlr-28406	567	10	arguably	arguably	ADV
ihlr-28406	567	11	two	two	NUM
ihlr-28406	567	12	claims	claim	NOUN
ihlr-28406	567	13	.	.	PUNCT
ihlr-28406	568	1	for	for	ADP
ihlr-28406	568	2	example	example	NOUN
ihlr-28406	568	3	,	,	PUNCT
ihlr-28406	568	4	consider	consider	VERB
ihlr-28406	568	5	if	if	SCONJ
ihlr-28406	568	6	the	the	DET
ihlr-28406	568	7	claim	claim	NOUN
ihlr-28406	568	8	was	be	AUX
ihlr-28406	568	9	re	re	VERB
ihlr-28406	568	10	-	-	VERB
ihlr-28406	568	11	written	write	VERB
ihlr-28406	568	12	as	as	ADP
ihlr-28406	568	13	one	one	NUM
ihlr-28406	568	14	independent	independent	ADJ
ihlr-28406	568	15	claim	claim	NOUN
ihlr-28406	568	16	and	and	CCONJ
ihlr-28406	568	17	one	one	NUM
ihlr-28406	568	18	dependent	dependent	ADJ
ihlr-28406	568	19	claim	claim	NOUN
ihlr-28406	568	20	1	1	X
ihlr-28406	568	21	.	.	PUNCT
ihlr-28406	568	22	a	a	DET
ihlr-28406	568	23	method	method	NOUN
ihlr-28406	568	24	for	for	ADP
ihlr-28406	568	25	treating	treat	VERB
ihlr-28406	568	26	a	a	DET
ihlr-28406	568	27	condition	condition	NOUN
ihlr-28406	568	28	by	by	ADP
ihlr-28406	568	29	promoting	promote	VERB
ihlr-28406	568	30	angiogenesis	angiogenesis	NOUN
ihlr-28406	568	31	,	,	PUNCT
ihlr-28406	568	32	wherein	wherein	SCONJ
ihlr-28406	568	33	the	the	DET
ihlr-28406	568	34	condition	condition	NOUN
ihlr-28406	568	35	is	be	AUX
ihlr-28406	568	36	selected	select	VERB
ihlr-28406	568	37	from	from	ADP
ihlr-28406	568	38	the	the	DET
ihlr-28406	568	39	group	group	NOUN
ihlr-28406	568	40	consisting	consist	VERB
ihlr-28406	568	41	of	of	ADP
ihlr-28406	568	42	occlusive	occlusive	ADJ
ihlr-28406	568	43	vascular	vascular	ADJ
ihlr-28406	568	44	disease	disease	NOUN
ihlr-28406	568	45	,	,	PUNCT
ihlr-28406	568	46	coronary	coronary	ADJ
ihlr-28406	568	47	disease	disease	NOUN
ihlr-28406	568	48	,	,	PUNCT
ihlr-28406	568	49	erectile	erectile	ADJ
ihlr-28406	568	50	dysfunction	dysfunction	NOUN
ihlr-28406	568	51	,	,	PUNCT
ihlr-28406	568	52	myocardial	myocardial	ADJ
ihlr-28406	568	53	infarction	infarction	NOUN
ihlr-28406	568	54	,	,	PUNCT
ihlr-28406	568	55	ischemia	ischemia	NOUN
ihlr-28406	568	56	,	,	PUNCT
ihlr-28406	568	57	stroke	stroke	NOUN
ihlr-28406	568	58	,	,	PUNCT
ihlr-28406	568	59	peripheral	peripheral	ADJ
ihlr-28406	568	60	artery	artery	NOUN
ihlr-28406	568	61	vascular	vascular	ADJ
ihlr-28406	568	62	disorders	disorder	NOUN
ihlr-28406	568	63	,	,	PUNCT
ihlr-28406	568	64	wound	wound	ADJ
ihlr-28406	568	65	healing	healing	NOUN
ihlr-28406	568	66	and	and	CCONJ
ihlr-28406	568	67	burns	burn	NOUN
ihlr-28406	568	68	[	[	X
ihlr-28406	568	69	.	.	PUNCT
ihlr-28406	568	70	]	]	PUNCT
ihlr-28406	569	1	[	[	X
ihlr-28406	569	2	2	2	X
ihlr-28406	569	3	.	.	PUNCT
ihlr-28406	569	4	the	the	DET
ihlr-28406	569	5	method	method	NOUN
ihlr-28406	569	6	of	of	ADP
ihlr-28406	569	7	claim	claim	NOUN
ihlr-28406	569	8	1	1	NUM
ihlr-28406	569	9	,	,	PUNCT
ihlr-28406	569	10	the	the	DET
ihlr-28406	569	11	method	method	NOUN
ihlr-28406	569	12	]	]	PUNCT
ihlr-28406	569	13	comprising	comprise	VERB
ihlr-28406	569	14	the	the	DET
ihlr-28406	569	15	steps	step	NOUN
ihlr-28406	569	16	of	of	ADP
ihlr-28406	569	17	:	:	PUNCT
ihlr-28406	569	18	formulating	formulate	VERB
ihlr-28406	569	19	a	a	DET
ihlr-28406	569	20	polymer	polymer	NOUN
ihlr-28406	569	21	into	into	ADP
ihlr-28406	569	22	a	a	DET
ihlr-28406	569	23	nanoparticle	nanoparticle	NOUN
ihlr-28406	569	24	,	,	PUNCT
ihlr-28406	569	25	wherein	wherein	SCONJ
ihlr-28406	569	26	the	the	DET
ihlr-28406	569	27	nanoparticle	nanoparticle	NOUN
ihlr-28406	569	28	is	be	AUX
ihlr-28406	569	29	less	less	ADJ
ihlr-28406	569	30	than	than	ADP
ihlr-28406	569	31	200	200	NUM
ihlr-28406	569	32	nanometers	nanometer	NOUN
ihlr-28406	569	33	,	,	PUNCT
ihlr-28406	569	34	wherein	wherein	SCONJ
ihlr-28406	569	35	the	the	DET
ihlr-28406	569	36	polymer	polymer	NOUN
ihlr-28406	569	37	is	be	AUX
ihlr-28406	569	38	polyglycolide	polyglycolide	ADJ
ihlr-28406	569	39	,	,	PUNCT
ihlr-28406	569	40	polylactide	polylactide	ADV
ihlr-28406	569	41	,	,	PUNCT
ihlr-28406	569	42	or	or	CCONJ
ihlr-28406	569	43	a	a	DET
ihlr-28406	569	44	co	co	NOUN
ihlr-28406	569	45	-	-	NOUN
ihlr-28406	569	46	polymer	polymer	NOUN
ihlr-28406	569	47	thereof	thereof	ADV
ihlr-28406	569	48	;	;	PUNCT
ihlr-28406	569	49	conjugating	conjugate	VERB
ihlr-28406	569	50	a	a	DET
ihlr-28406	569	51	thyroid	thyroid	NOUN
ihlr-28406	569	52	hormone	hormone	NOUN
ihlr-28406	569	53	analog	analog	NOUN
ihlr-28406	569	54	to	to	ADP
ihlr-28406	569	55	the	the	DET
ihlr-28406	569	56	nanoparticle	nanoparticle	NOUN
ihlr-28406	569	57	forming	form	VERB
ihlr-28406	569	58	a	a	DET
ihlr-28406	569	59	conjugated	conjugate	VERB
ihlr-28406	569	60	thyroid	thyroid	NOUN
ihlr-28406	569	61	hormone	hormone	NOUN
ihlr-28406	569	62	analog	analog	NOUN
ihlr-28406	569	63	;	;	PUNCT
ihlr-28406	569	64	coating	coat	VERB
ihlr-28406	569	65	a	a	DET
ihlr-28406	569	66	medical	medical	ADJ
ihlr-28406	569	67	device	device	NOUN
ihlr-28406	569	68	with	with	ADP
ihlr-28406	569	69	the	the	DET
ihlr-28406	569	70	conjugated	conjugate	VERB
ihlr-28406	569	71	thyroid	thyroid	PROPN
ihlr-28406	569	72	hormone	hormone	NOUN
ihlr-28406	569	73	analog	analog	NOUN
ihlr-28406	569	74	;	;	PUNCT
ihlr-28406	569	75	administering	administer	VERB
ihlr-28406	569	76	an	an	DET
ihlr-28406	569	77	effective	effective	ADJ
ihlr-28406	569	78	amount	amount	NOUN
ihlr-28406	569	79	of	of	ADP
ihlr-28406	569	80	the	the	DET
ihlr-28406	569	81	conjugated	conjugate	VERB
ihlr-28406	569	82	thyroid	thyroid	PROPN
ihlr-28406	569	83	hormone	hormone	NOUN
ihlr-28406	569	84	analog	analog	NOUN
ihlr-28406	569	85	to	to	ADP
ihlr-28406	569	86	a	a	DET
ihlr-28406	569	87	subject	subject	NOUN
ihlr-28406	569	88	suffering	suffering	NOUN
ihlr-28406	569	89	from	from	ADP
ihlr-28406	569	90	the	the	DET
ihlr-28406	569	91	condition	condition	NOUN
ihlr-28406	569	92	by	by	ADP
ihlr-28406	569	93	inserting	insert	VERB
ihlr-28406	569	94	the	the	DET
ihlr-28406	569	95	medical	medical	ADJ
ihlr-28406	569	96	device	device	NOUN
ihlr-28406	569	97	coated	coat	VERB
ihlr-28406	569	98	with	with	ADP
ihlr-28406	569	99	the	the	DET
ihlr-28406	569	100	conjugated	conjugate	VERB
ihlr-28406	569	101	thyroid	thyroid	PROPN
ihlr-28406	569	102	hormone	hormone	NOUN
ihlr-28406	569	103	analog	analog	NOUN
ihlr-28406	569	104	into	into	ADP
ihlr-28406	569	105	the	the	DET
ihlr-28406	569	106	subject	subject	NOUN
ihlr-28406	569	107	;	;	PUNCT
ihlr-28406	569	108	initiating	initiate	VERB
ihlr-28406	569	109	non	non	ADJ
ihlr-28406	569	110	-	-	ADJ
ihlr-28406	569	111	genomic	genomic	ADJ
ihlr-28406	569	112	signal	signal	NOUN
ihlr-28406	569	113	transduction	transduction	NOUN
ihlr-28406	569	114	pathways	pathway	NOUN
ihlr-28406	569	115	at	at	ADP
ihlr-28406	569	116	an	an	DET
ihlr-28406	569	117	integrin	integrin	NOUN
ihlr-28406	569	118	𝛼𝜈𝛽3	𝛼𝜈𝛽3	PROPN
ihlr-28406	569	119	surface	surface	NOUN
ihlr-28406	569	120	receptor	receptor	NOUN
ihlr-28406	569	121	of	of	ADP
ihlr-28406	569	122	a	a	DET
ihlr-28406	569	123	cell	cell	NOUN
ihlr-28406	569	124	by	by	ADP
ihlr-28406	569	125	contacting	contact	VERB
ihlr-28406	569	126	the	the	DET
ihlr-28406	569	127	conjugated	conjugated	ADJ
ihlr-28406	569	128	thyroid	thyroid	PROPN
ihlr-28406	569	129	hormone	hormone	NOUN
ihlr-28406	569	130	analog	analog	NOUN
ihlr-28406	569	131	with	with	ADP
ihlr-28406	569	132	the	the	DET
ihlr-28406	569	133	𝛼𝜈𝛽3	𝛼𝜈𝛽3	PROPN
ihlr-28406	569	134	surface	surface	NOUN
ihlr-28406	569	135	receptor	receptor	NOUN
ihlr-28406	569	136	,	,	PUNCT
ihlr-28406	569	137	said	say	VERB
ihlr-28406	569	138	conjugated	conjugated	ADJ
ihlr-28406	569	139	thyroid	thyroid	PROPN
ihlr-28406	569	140	hormone	hormone	NOUN
ihlr-28406	569	141	analog	analog	NOUN
ihlr-28406	569	142	does	do	AUX
ihlr-28406	569	143	not	not	PART
ihlr-28406	569	144	gain	gain	VERB
ihlr-28406	569	145	entry	entry	NOUN
ihlr-28406	569	146	to	to	ADP
ihlr-28406	569	147	the	the	DET
ihlr-28406	569	148	cell	cell	NOUN
ihlr-28406	569	149	’s	’s	PART
ihlr-28406	569	150	interior.159	interior.159	ADJ
ihlr-28406	569	151	in	in	ADP
ihlr-28406	569	152	this	this	DET
ihlr-28406	569	153	instance	instance	NOUN
ihlr-28406	569	154	,	,	PUNCT
ihlr-28406	569	155	the	the	DET
ihlr-28406	569	156	independent	independent	ADJ
ihlr-28406	569	157	claim	claim	NOUN
ihlr-28406	569	158	would	would	AUX
ihlr-28406	569	159	have	have	VERB
ihlr-28406	569	160	a	a	DET
ihlr-28406	569	161	broader	broad	ADJ
ihlr-28406	569	162	scope	scope	NOUN
ihlr-28406	569	163	,	,	PUNCT
ihlr-28406	569	164	where	where	SCONJ
ihlr-28406	569	165	the	the	DET
ihlr-28406	569	166	dependent	dependent	ADJ
ihlr-28406	569	167	claim	claim	NOUN
ihlr-28406	569	168	has	have	VERB
ihlr-28406	569	169	a	a	DET
ihlr-28406	569	170	narrower	narrow	ADJ
ihlr-28406	569	171	scope	scope	NOUN
ihlr-28406	569	172	.	.	PUNCT
ihlr-28406	570	1	however	however	ADV
ihlr-28406	570	2	,	,	PUNCT
ihlr-28406	570	3	as	as	SCONJ
ihlr-28406	570	4	the	the	DET
ihlr-28406	570	5	claim	claim	NOUN
ihlr-28406	570	6	is	be	AUX
ihlr-28406	570	7	written	write	VERB
ihlr-28406	570	8	,	,	PUNCT
ihlr-28406	570	9	as	as	ADP
ihlr-28406	570	10	one	one	NUM
ihlr-28406	570	11	claim	claim	NOUN
ihlr-28406	570	12	,	,	PUNCT
ihlr-28406	570	13	the	the	DET
ihlr-28406	570	14	claim	claim	NOUN
ihlr-28406	570	15	is	be	AUX
ihlr-28406	570	16	exceptionally	exceptionally	ADV
ihlr-28406	570	17	narrow	narrow	ADJ
ihlr-28406	570	18	,	,	PUNCT
ihlr-28406	570	19	limited	limit	VERB
ihlr-28406	570	20	to	to	ADP
ihlr-28406	570	21	only	only	ADV
ihlr-28406	570	22	to	to	ADP
ihlr-28406	570	23	the	the	DET
ihlr-28406	570	24	exact	exact	ADJ
ihlr-28406	570	25	and	and	CCONJ
ihlr-28406	570	26	specified	specify	VERB
ihlr-28406	570	27	materials	material	NOUN
ihlr-28406	570	28	and	and	CCONJ
ihlr-28406	570	29	steps	step	NOUN
ihlr-28406	570	30	described	describe	VERB
ihlr-28406	570	31	.	.	PUNCT
ihlr-28406	571	1	indeed	indeed	ADV
ihlr-28406	571	2	,	,	PUNCT
ihlr-28406	571	3	the	the	DET
ihlr-28406	571	4	general	general	ADJ
ihlr-28406	571	5	idea	idea	NOUN
ihlr-28406	571	6	is	be	AUX
ihlr-28406	571	7	more	more	ADJ
ihlr-28406	571	8	words	word	NOUN
ihlr-28406	571	9	mean	mean	VERB
ihlr-28406	571	10	narrower	narrow	ADJ
ihlr-28406	571	11	claims	claim	NOUN
ihlr-28406	571	12	.	.	PUNCT
ihlr-28406	572	1	160	160	NUM
ihlr-28406	572	2	some	some	PRON
ihlr-28406	572	3	suggest	suggest	VERB
ihlr-28406	572	4	patent	patent	NOUN
ihlr-28406	572	5	law	law	NOUN
ihlr-28406	572	6	has	have	VERB
ihlr-28406	572	7	gaps	gap	NOUN
ihlr-28406	572	8	resulting	result	VERB
ihlr-28406	572	9	from	from	ADP
ihlr-28406	572	10	conceptual	conceptual	ADJ
ihlr-28406	572	11	separations	separation	NOUN
ihlr-28406	572	12	in	in	ADP
ihlr-28406	572	13	patentability	patentability	NOUN
ihlr-28406	572	14	,	,	PUNCT
ihlr-28406	572	15	infringement	infringement	NOUN
ihlr-28406	572	16	,	,	PUNCT
ihlr-28406	572	17	and	and	CCONJ
ihlr-28406	572	18	defenses	defense	NOUN
ihlr-28406	572	19	.	.	PUNCT
ihlr-28406	573	1	161	161	NUM
ihlr-28406	573	2	for	for	ADP
ihlr-28406	573	3	example	example	NOUN
ihlr-28406	573	4	,	,	PUNCT
ihlr-28406	573	5	a	a	DET
ihlr-28406	573	6	party	party	NOUN
ihlr-28406	573	7	may	may	AUX
ihlr-28406	573	8	successfully	successfully	ADV
ihlr-28406	573	9	argue	argue	VERB
ihlr-28406	573	10	a	a	DET
ihlr-28406	573	11	patent	patent	NOUN
ihlr-28406	573	12	claim	claim	NOUN
ihlr-28406	573	13	means	mean	VERB
ihlr-28406	573	14	one	one	NUM
ihlr-28406	573	15	thing	thing	NOUN
ihlr-28406	573	16	in	in	ADP
ihlr-28406	573	17	one	one	NUM
ihlr-28406	573	18	context	context	NOUN
ihlr-28406	573	19	,	,	PUNCT
ihlr-28406	573	20	but	but	CCONJ
ihlr-28406	574	1	something	something	PRON
ihlr-28406	574	2	totally	totally	ADV
ihlr-28406	574	3	different	different	ADJ
ihlr-28406	574	4	in	in	ADP
ihlr-28406	574	5	another	another	PRON
ihlr-28406	574	6	.	.	PUNCT
ihlr-28406	575	1	162	162	NUM
ihlr-28406	575	2	for	for	ADP
ihlr-28406	575	3	example	example	NOUN
ihlr-28406	575	4	,	,	PUNCT
ihlr-28406	575	5	one	one	PRON
ihlr-28406	575	6	may	may	AUX
ihlr-28406	575	7	argue	argue	VERB
ihlr-28406	575	8	the	the	DET
ihlr-28406	575	9	claim	claim	NOUN
ihlr-28406	575	10	scope	scope	NOUN
ihlr-28406	575	11	is	be	AUX
ihlr-28406	575	12	—	—	PUNCT
ihlr-28406	575	13	—	—	PUNCT
ihlr-28406	575	14	—	—	PUNCT
ihlr-28406	575	15	—	—	PUNCT
ihlr-28406	575	16	—	—	PUNCT
ihlr-28406	575	17	—	—	PUNCT
ihlr-28406	575	18	—	—	PUNCT
ihlr-28406	575	19	—	—	PUNCT
ihlr-28406	575	20	—	—	PUNCT
ihlr-28406	575	21	—	—	PUNCT
ihlr-28406	575	22	—	—	PUNCT
ihlr-28406	575	23	—	—	PUNCT
ihlr-28406	575	24	—	—	PUNCT
ihlr-28406	575	25	—	—	PUNCT
ihlr-28406	575	26	—	—	PUNCT
ihlr-28406	575	27	—	—	PUNCT
ihlr-28406	575	28	—	—	PUNCT
ihlr-28406	575	29	—	—	PUNCT
ihlr-28406	575	30	—	—	PUNCT
ihlr-28406	575	31	—	—	PUNCT
ihlr-28406	575	32	—	—	PUNCT
ihlr-28406	575	33	—	—	PUNCT
ihlr-28406	575	34	—	—	PUNCT
ihlr-28406	575	35	—	—	PUNCT
ihlr-28406	575	36	—	—	PUNCT
ihlr-28406	575	37	—	—	PUNCT
ihlr-28406	575	38	—	—	PUNCT
ihlr-28406	575	39	—	—	PUNCT
ihlr-28406	575	40	—	—	PUNCT
ihlr-28406	575	41	158	158	X
ihlr-28406	575	42	.	.	PUNCT
ihlr-28406	576	1	ppg	ppg	NOUN
ihlr-28406	576	2	industries	industry	NOUN
ihlr-28406	576	3	v.	v.	ADP
ihlr-28406	576	4	guardian	guardian	ADJ
ihlr-28406	576	5	industries	industry	NOUN
ihlr-28406	576	6	,	,	PUNCT
ihlr-28406	576	7	156	156	NUM
ihlr-28406	576	8	f.3d	f.3d	NUM
ihlr-28406	576	9	1351	1351	NUM
ihlr-28406	576	10	,	,	PUNCT
ihlr-28406	576	11	1354	1354	NUM
ihlr-28406	576	12	,	,	PUNCT
ihlr-28406	576	13	48	48	NUM
ihlr-28406	576	14	uspq2d	uspq2d	NOUN
ihlr-28406	576	15	1351	1351	NUM
ihlr-28406	576	16	,	,	PUNCT
ihlr-28406	576	17	135354	135354	NUM
ihlr-28406	576	18	(	(	PUNCT
ihlr-28406	576	19	fed	fed	PROPN
ihlr-28406	576	20	.	.	PUNCT
ihlr-28406	576	21	cir	cir	PROPN
ihlr-28406	576	22	.	.	PROPN
ihlr-28406	576	23	1998	1998	NUM
ihlr-28406	576	24	)	)	PUNCT
ihlr-28406	577	1	(	(	PUNCT
ihlr-28406	577	2	consisting	consist	VERB
ihlr-28406	577	3	essentially	essentially	ADV
ihlr-28406	577	4	of	of	ADP
ihlr-28406	577	5	limits	limit	NOUN
ihlr-28406	577	6	the	the	DET
ihlr-28406	577	7	scope	scope	NOUN
ihlr-28406	577	8	of	of	ADP
ihlr-28406	577	9	a	a	DET
ihlr-28406	577	10	claim	claim	NOUN
ihlr-28406	577	11	to	to	ADP
ihlr-28406	577	12	the	the	DET
ihlr-28406	577	13	specified	specified	ADJ
ihlr-28406	577	14	materials	material	NOUN
ihlr-28406	577	15	or	or	CCONJ
ihlr-28406	577	16	steps	step	NOUN
ihlr-28406	577	17	and	and	CCONJ
ihlr-28406	577	18	those	those	PRON
ihlr-28406	577	19	that	that	PRON
ihlr-28406	577	20	do	do	AUX
ihlr-28406	577	21	not	not	PART
ihlr-28406	577	22	materially	materially	ADV
ihlr-28406	577	23	affect	affect	VERB
ihlr-28406	577	24	the	the	DET
ihlr-28406	577	25	basic	basic	ADJ
ihlr-28406	577	26	and	and	CCONJ
ihlr-28406	577	27	novel	novel	ADJ
ihlr-28406	577	28	characteristics	characteristic	NOUN
ihlr-28406	577	29	of	of	ADP
ihlr-28406	577	30	the	the	DET
ihlr-28406	577	31	claimed	claim	VERB
ihlr-28406	577	32	invention	invention	NOUN
ihlr-28406	577	33	.	.	PUNCT
ihlr-28406	577	34	)	)	PUNCT
ihlr-28406	577	35	.	.	PUNCT
ihlr-28406	578	1	159	159	NUM
ihlr-28406	578	2	.	.	PUNCT
ihlr-28406	578	3	mousa	mousa	PROPN
ihlr-28406	578	4	,	,	PUNCT
ihlr-28406	578	5	et	et	PROPN
ihlr-28406	578	6	al	al	PROPN
ihlr-28406	578	7	.	.	PROPN
ihlr-28406	578	8	,	,	PUNCT
ihlr-28406	578	9	thyroid	thyroid	VERB
ihlr-28406	578	10	hormone	hormone	NOUN
ihlr-28406	578	11	analogs	analog	NOUN
ihlr-28406	578	12	and	and	CCONJ
ihlr-28406	578	13	methods	method	NOUN
ihlr-28406	578	14	of	of	ADP
ihlr-28406	578	15	use	use	NOUN
ihlr-28406	578	16	u.s	u.s	PROPN
ihlr-28406	578	17	.	.	PROPN
ihlr-28406	578	18	patent	patent	NOUN
ihlr-28406	578	19	no	no	PROPN
ihlr-28406	578	20	.	.	PROPN
ihlr-28406	578	21	9,980,933	9,980,933	NUM
ihlr-28406	578	22	,	,	PUNCT
ihlr-28406	578	23	to	to	PART
ihlr-28406	578	24	mousa	mousa	VERB
ihlr-28406	578	25	,	,	PUNCT
ihlr-28406	578	26	et	et	PROPN
ihlr-28406	578	27	al	al	PROPN
ihlr-28406	578	28	.	.	PROPN
ihlr-28406	578	29	,	,	PUNCT
ihlr-28406	578	30	(	(	PUNCT
ihlr-28406	578	31	issued	issue	VERB
ihlr-28406	578	32	may	may	PROPN
ihlr-28406	578	33	29	29	NUM
ihlr-28406	578	34	,	,	PUNCT
ihlr-28406	578	35	2018	2018	NUM
ihlr-28406	578	36	)	)	PUNCT
ihlr-28406	578	37	.	.	PUNCT
ihlr-28406	579	1	160	160	NUM
ihlr-28406	579	2	.	.	PUNCT
ihlr-28406	580	1	marco	marco	PROPN
ihlr-28406	580	2	,	,	PUNCT
ihlr-28406	580	3	et	et	PROPN
ihlr-28406	580	4	al	al	PROPN
ihlr-28406	580	5	.	.	PROPN
ihlr-28406	580	6	,	,	PUNCT
ihlr-28406	580	7	supra	supra	PROPN
ihlr-28406	580	8	note	note	VERB
ihlr-28406	580	9	114	114	NUM
ihlr-28406	580	10	(	(	PUNCT
ihlr-28406	580	11	“	"	PUNCT
ihlr-28406	580	12	further	far	ADV
ihlr-28406	580	13	,	,	PUNCT
ihlr-28406	580	14	this	this	DET
ihlr-28406	580	15	process	process	NOUN
ihlr-28406	580	16	almost	almost	ADV
ihlr-28406	580	17	always	always	ADV
ihlr-28406	580	18	involves	involve	VERB
ihlr-28406	580	19	adding	add	VERB
ihlr-28406	580	20	words	word	NOUN
ihlr-28406	580	21	to	to	ADP
ihlr-28406	580	22	the	the	DET
ihlr-28406	580	23	claim	claim	NOUN
ihlr-28406	580	24	:	:	PUNCT
ihlr-28406	580	25	modifiers	modifier	NOUN
ihlr-28406	580	26	,	,	PUNCT
ihlr-28406	580	27	qualifiers	qualifier	NOUN
ihlr-28406	580	28	,	,	PUNCT
ihlr-28406	580	29	or	or	CCONJ
ihlr-28406	580	30	other	other	ADJ
ihlr-28406	580	31	details	detail	NOUN
ihlr-28406	580	32	.	.	PUNCT
ihlr-28406	580	33	”	"	PUNCT
ihlr-28406	580	34	)	)	PUNCT
ihlr-28406	580	35	.	.	PUNCT
ihlr-28406	581	1	161	161	NUM
ihlr-28406	581	2	.	.	PUNCT
ihlr-28406	582	1	lemley	lemley	PROPN
ihlr-28406	582	2	&	&	CCONJ
ihlr-28406	582	3	mckenna	mckenna	PROPN
ihlr-28406	582	4	,	,	PUNCT
ihlr-28406	582	5	supra	supra	PROPN
ihlr-28406	582	6	note	note	VERB
ihlr-28406	582	7	146	146	NUM
ihlr-28406	582	8	,	,	PUNCT
ihlr-28406	582	9	at	at	ADP
ihlr-28406	582	10	2202	2202	NUM
ihlr-28406	582	11	(	(	PUNCT
ihlr-28406	582	12	arguing	argue	VERB
ihlr-28406	582	13	patent	patent	NOUN
ihlr-28406	582	14	owners	owner	NOUN
ihlr-28406	582	15	can	can	AUX
ihlr-28406	582	16	and	and	CCONJ
ihlr-28406	582	17	do	do	AUX
ihlr-28406	582	18	exploit	exploit	VERB
ihlr-28406	582	19	these	these	DET
ihlr-28406	582	20	gaps	gap	NOUN
ihlr-28406	582	21	with	with	ADP
ihlr-28406	582	22	some	some	DET
ihlr-28406	582	23	regularity	regularity	NOUN
ihlr-28406	582	24	.	.	PUNCT
ihlr-28406	583	1	for	for	ADP
ihlr-28406	583	2	example	example	NOUN
ihlr-28406	583	3	,	,	PUNCT
ihlr-28406	583	4	patentees	patentee	NOUN
ihlr-28406	583	5	in	in	ADP
ihlr-28406	583	6	computer	computer	NOUN
ihlr-28406	583	7	software	software	NOUN
ihlr-28406	583	8	,	,	PUNCT
ihlr-28406	583	9	have	have	AUX
ihlr-28406	583	10	sought	seek	VERB
ihlr-28406	583	11	broader	broad	ADJ
ihlr-28406	583	12	patent	patent	NOUN
ihlr-28406	583	13	claim	claim	NOUN
ihlr-28406	583	14	interpretation	interpretation	NOUN
ihlr-28406	583	15	,	,	PUNCT
ihlr-28406	583	16	to	to	ADP
ihlr-28406	583	17	the	the	DET
ihlr-28406	583	18	point	point	NOUN
ihlr-28406	583	19	where	where	SCONJ
ihlr-28406	583	20	many	many	ADJ
ihlr-28406	583	21	claims	claim	NOUN
ihlr-28406	583	22	are	be	AUX
ihlr-28406	583	23	not	not	PART
ihlr-28406	583	24	limited	limit	VERB
ihlr-28406	583	25	either	either	ADV
ihlr-28406	583	26	to	to	ADP
ihlr-28406	583	27	a	a	DET
ihlr-28406	583	28	particular	particular	ADJ
ihlr-28406	583	29	computer	computer	NOUN
ihlr-28406	583	30	algorithm	algorithm	NOUN
ihlr-28406	583	31	or	or	CCONJ
ihlr-28406	583	32	approach	approach	NOUN
ihlr-28406	583	33	or	or	CCONJ
ihlr-28406	583	34	to	to	ADP
ihlr-28406	583	35	a	a	DET
ihlr-28406	583	36	particular	particular	ADJ
ihlr-28406	583	37	hardware	hardware	NOUN
ihlr-28406	583	38	implementation	implementation	NOUN
ihlr-28406	583	39	.	.	PUNCT
ihlr-28406	583	40	)	)	PUNCT
ihlr-28406	583	41	.	.	PUNCT
ihlr-28406	584	1	162	162	NUM
ihlr-28406	584	2	.	.	PUNCT
ihlr-28406	585	1	i	i	PRON
ihlr-28406	585	2	d.	d.	PROPN
ihlr-28406	585	3	2024	2024	NUM
ihlr-28406	585	4	]	]	PUNCT
ihlr-28406	585	5	inventions	invention	NOUN
ihlr-28406	585	6	and	and	CCONJ
ihlr-28406	585	7	patents	patent	NOUN
ihlr-28406	585	8	for	for	ADP
ihlr-28406	585	9	treating	treat	VERB
ihlr-28406	585	10	299	299	NUM
ihlr-28406	585	11	thyroid	thyroid	NOUN
ihlr-28406	585	12	disease	disease	NOUN
ihlr-28406	585	13	narrow	narrow	ADJ
ihlr-28406	585	14	to	to	ADP
ihlr-28406	585	15	the	the	DET
ihlr-28406	585	16	examiner	examiner	NOUN
ihlr-28406	585	17	and	and	CCONJ
ihlr-28406	585	18	broad	broad	ADJ
ihlr-28406	585	19	to	to	ADP
ihlr-28406	585	20	the	the	DET
ihlr-28406	585	21	judge	judge	NOUN
ihlr-28406	585	22	,	,	PUNCT
ihlr-28406	585	23	knowing	know	VERB
ihlr-28406	585	24	neither	neither	CCONJ
ihlr-28406	585	25	may	may	AUX
ihlr-28406	585	26	have	have	VERB
ihlr-28406	585	27	knowledge	knowledge	NOUN
ihlr-28406	585	28	necessary	necessary	ADJ
ihlr-28406	585	29	to	to	ADP
ihlr-28406	585	30	understanding	understand	VERB
ihlr-28406	585	31	the	the	DET
ihlr-28406	585	32	underlying	underlie	VERB
ihlr-28406	585	33	invention	invention	NOUN
ihlr-28406	585	34	.	.	PUNCT
ihlr-28406	586	1	163	163	NUM
ihlr-28406	586	2	ultimately	ultimately	ADV
ihlr-28406	586	3	,	,	PUNCT
ihlr-28406	586	4	scope	scope	NOUN
ihlr-28406	586	5	is	be	AUX
ihlr-28406	586	6	a	a	DET
ihlr-28406	586	7	term	term	NOUN
ihlr-28406	586	8	of	of	ADP
ihlr-28406	586	9	art	art	NOUN
ihlr-28406	586	10	and	and	CCONJ
ihlr-28406	586	11	is	be	AUX
ihlr-28406	586	12	best	well	ADV
ihlr-28406	586	13	understood	understand	VERB
ihlr-28406	586	14	as	as	ADP
ihlr-28406	586	15	a	a	DET
ihlr-28406	586	16	continuous	continuous	ADJ
ihlr-28406	586	17	scale	scale	NOUN
ihlr-28406	586	18	.	.	PUNCT
ihlr-28406	586	19	164	164	NUM
ihlr-28406	586	20	in	in	ADP
ihlr-28406	586	21	other	other	ADJ
ihlr-28406	586	22	words	word	NOUN
ihlr-28406	586	23	,	,	PUNCT
ihlr-28406	586	24	whether	whether	SCONJ
ihlr-28406	586	25	a	a	DET
ihlr-28406	586	26	claim	claim	NOUN
ihlr-28406	586	27	is	be	AUX
ihlr-28406	586	28	broad	broad	ADJ
ihlr-28406	586	29	or	or	CCONJ
ihlr-28406	586	30	narrow	narrow	ADJ
ihlr-28406	586	31	is	be	AUX
ihlr-28406	586	32	a	a	DET
ihlr-28406	586	33	subjective	subjective	ADJ
ihlr-28406	586	34	ascription	ascription	NOUN
ihlr-28406	586	35	,	,	PUNCT
ihlr-28406	586	36	often	often	ADV
ihlr-28406	586	37	based	base	VERB
ihlr-28406	586	38	on	on	ADP
ihlr-28406	586	39	relative	relative	ADJ
ihlr-28406	586	40	comparison	comparison	NOUN
ihlr-28406	586	41	.	.	PUNCT
ihlr-28406	587	1	165	165	NUM
ihlr-28406	587	2	as	as	ADP
ihlr-28406	587	3	such	such	ADJ
ihlr-28406	587	4	,	,	PUNCT
ihlr-28406	587	5	data	datum	NOUN
ihlr-28406	587	6	is	be	AUX
ihlr-28406	587	7	a	a	DET
ihlr-28406	587	8	critical	critical	ADJ
ihlr-28406	587	9	advantage	advantage	NOUN
ihlr-28406	587	10	for	for	ADP
ihlr-28406	587	11	the	the	DET
ihlr-28406	587	12	modern	modern	ADJ
ihlr-28406	587	13	firm	firm	NOUN
ihlr-28406	587	14	because	because	SCONJ
ihlr-28406	587	15	data	datum	NOUN
ihlr-28406	587	16	defines	define	VERB
ihlr-28406	587	17	the	the	DET
ihlr-28406	587	18	targets	target	NOUN
ihlr-28406	587	19	to	to	PART
ihlr-28406	587	20	which	which	PRON
ihlr-28406	587	21	the	the	DET
ihlr-28406	587	22	claim	claim	NOUN
ihlr-28406	587	23	is	be	AUX
ihlr-28406	587	24	compared	compare	VERB
ihlr-28406	587	25	.	.	PUNCT
ihlr-28406	588	1	iii	iii	X
ihlr-28406	588	2	.	.	PUNCT
ihlr-28406	588	3	clinical	clinical	ADJ
ihlr-28406	588	4	commercialization	commercialization	NOUN
ihlr-28406	588	5	the	the	DET
ihlr-28406	588	6	hardest	hard	ADJ
ihlr-28406	588	7	part	part	NOUN
ihlr-28406	588	8	of	of	ADP
ihlr-28406	588	9	inventing	invent	VERB
ihlr-28406	588	10	new	new	ADJ
ihlr-28406	588	11	treatments	treatment	NOUN
ihlr-28406	588	12	or	or	CCONJ
ihlr-28406	588	13	biotechnologies	biotechnology	NOUN
ihlr-28406	588	14	is	be	AUX
ihlr-28406	588	15	commercialization	commercialization	NOUN
ihlr-28406	588	16	.	.	PUNCT
ihlr-28406	589	1	commercialization	commercialization	NOUN
ihlr-28406	589	2	is	be	AUX
ihlr-28406	589	3	the	the	DET
ihlr-28406	589	4	process	process	NOUN
ihlr-28406	589	5	of	of	ADP
ihlr-28406	589	6	bringing	bring	VERB
ihlr-28406	589	7	new	new	ADJ
ihlr-28406	589	8	drugs	drug	NOUN
ihlr-28406	589	9	and	and	CCONJ
ihlr-28406	589	10	biotechnologies	biotechnology	NOUN
ihlr-28406	589	11	to	to	ADP
ihlr-28406	589	12	market	market	NOUN
ihlr-28406	589	13	.	.	PUNCT
ihlr-28406	590	1	166	166	NUM
ihlr-28406	590	2	the	the	DET
ihlr-28406	590	3	commercialization	commercialization	NOUN
ihlr-28406	590	4	process	process	NOUN
ihlr-28406	590	5	can	can	AUX
ihlr-28406	590	6	take	take	VERB
ihlr-28406	590	7	over	over	ADP
ihlr-28406	590	8	ten	ten	NUM
ihlr-28406	590	9	years	year	NOUN
ihlr-28406	590	10	in	in	ADP
ihlr-28406	590	11	certain	certain	ADJ
ihlr-28406	590	12	circumstances	circumstance	NOUN
ihlr-28406	590	13	and	and	CCONJ
ihlr-28406	590	14	in	in	ADP
ihlr-28406	590	15	fact	fact	NOUN
ihlr-28406	590	16	there	there	PRON
ihlr-28406	590	17	are	be	VERB
ihlr-28406	590	18	even	even	ADV
ihlr-28406	590	19	publicly	publicly	ADV
ihlr-28406	590	20	traded	trade	VERB
ihlr-28406	590	21	pharmaceutical	pharmaceutical	ADJ
ihlr-28406	590	22	companies	company	NOUN
ihlr-28406	590	23	without	without	ADP
ihlr-28406	590	24	revenue	revenue	NOUN
ihlr-28406	590	25	that	that	PRON
ihlr-28406	590	26	have	have	AUX
ihlr-28406	590	27	completely	completely	ADV
ihlr-28406	590	28	failed	fail	VERB
ihlr-28406	590	29	to	to	PART
ihlr-28406	590	30	commercialize	commercialize	VERB
ihlr-28406	590	31	their	their	PRON
ihlr-28406	590	32	innovations	innovation	NOUN
ihlr-28406	590	33	over	over	ADP
ihlr-28406	590	34	the	the	DET
ihlr-28406	590	35	course	course	NOUN
ihlr-28406	590	36	of	of	ADP
ihlr-28406	590	37	a	a	DET
ihlr-28406	590	38	decade	decade	NOUN
ihlr-28406	590	39	.	.	PUNCT
ihlr-28406	591	1	167	167	NUM
ihlr-28406	591	2	however	however	ADV
ihlr-28406	591	3	,	,	PUNCT
ihlr-28406	591	4	given	give	VERB
ihlr-28406	591	5	the	the	DET
ihlr-28406	591	6	appropriate	appropriate	ADJ
ihlr-28406	591	7	strategy	strategy	NOUN
ihlr-28406	591	8	,	,	PUNCT
ihlr-28406	591	9	commercialization	commercialization	NOUN
ihlr-28406	591	10	may	may	AUX
ihlr-28406	591	11	happen	happen	VERB
ihlr-28406	591	12	faster	fast	ADV
ihlr-28406	591	13	.	.	PUNCT
ihlr-28406	592	1	yet	yet	ADV
ihlr-28406	592	2	,	,	PUNCT
ihlr-28406	592	3	it	it	PRON
ihlr-28406	592	4	is	be	AUX
ihlr-28406	592	5	a	a	DET
ihlr-28406	592	6	difficult	difficult	ADJ
ihlr-28406	592	7	balance	balance	NOUN
ihlr-28406	592	8	between	between	ADP
ihlr-28406	592	9	customer	customer	NOUN
ihlr-28406	592	10	safety	safety	NOUN
ihlr-28406	592	11	and	and	CCONJ
ihlr-28406	592	12	meeting	meeting	NOUN
ihlr-28406	592	13	need	need	VERB
ihlr-28406	592	14	in	in	ADP
ihlr-28406	592	15	the	the	DET
ihlr-28406	592	16	market	market	NOUN
ihlr-28406	592	17	.	.	PUNCT
ihlr-28406	593	1	a.	a.	NOUN
ihlr-28406	593	2	value	value	NOUN
ihlr-28406	593	3	probably	probably	ADV
ihlr-28406	593	4	the	the	DET
ihlr-28406	593	5	most	most	ADV
ihlr-28406	593	6	important	important	ADJ
ihlr-28406	593	7	part	part	NOUN
ihlr-28406	593	8	of	of	ADP
ihlr-28406	593	9	the	the	DET
ihlr-28406	593	10	commercialization	commercialization	NOUN
ihlr-28406	593	11	process	process	NOUN
ihlr-28406	593	12	is	be	AUX
ihlr-28406	593	13	adding	add	VERB
ihlr-28406	593	14	value	value	NOUN
ihlr-28406	593	15	.	.	PUNCT
ihlr-28406	594	1	the	the	DET
ihlr-28406	594	2	best	good	ADJ
ihlr-28406	594	3	way	way	NOUN
ihlr-28406	594	4	to	to	PART
ihlr-28406	594	5	add	add	VERB
ihlr-28406	594	6	value	value	NOUN
ihlr-28406	594	7	is	be	AUX
ihlr-28406	594	8	to	to	PART
ihlr-28406	594	9	invent	invent	VERB
ihlr-28406	594	10	solutions	solution	NOUN
ihlr-28406	594	11	to	to	ADP
ihlr-28406	594	12	problems	problem	NOUN
ihlr-28406	594	13	.	.	PUNCT
ihlr-28406	595	1	for	for	ADP
ihlr-28406	595	2	example	example	NOUN
ihlr-28406	595	3	,	,	PUNCT
ihlr-28406	595	4	in	in	ADP
ihlr-28406	595	5	the	the	DET
ihlr-28406	595	6	context	context	NOUN
ihlr-28406	595	7	of	of	ADP
ihlr-28406	595	8	thyroid	thyroid	NOUN
ihlr-28406	595	9	disease	disease	NOUN
ihlr-28406	595	10	there	there	PRON
ihlr-28406	595	11	exists	exist	VERB
ihlr-28406	595	12	a	a	DET
ihlr-28406	595	13	need	need	NOUN
ihlr-28406	595	14	for	for	SCONJ
ihlr-28406	595	15	value	value	NOUN
ihlr-28406	595	16	to	to	PART
ihlr-28406	595	17	be	be	AUX
ihlr-28406	595	18	added	add	VERB
ihlr-28406	595	19	through	through	ADP
ihlr-28406	595	20	solutions	solution	NOUN
ihlr-28406	595	21	to	to	ADP
ihlr-28406	595	22	both	both	CCONJ
ihlr-28406	595	23	general	general	ADJ
ihlr-28406	595	24	and	and	CCONJ
ihlr-28406	595	25	narrow	narrow	ADJ
ihlr-28406	595	26	forms	form	NOUN
ihlr-28406	595	27	of	of	ADP
ihlr-28406	595	28	thyroid	thyroid	NOUN
ihlr-28406	595	29	disease	disease	NOUN
ihlr-28406	595	30	.	.	PUNCT
ihlr-28406	596	1	more	more	ADV
ihlr-28406	596	2	often	often	ADV
ihlr-28406	596	3	,	,	PUNCT
ihlr-28406	596	4	in	in	ADP
ihlr-28406	596	5	the	the	DET
ihlr-28406	596	6	context	context	NOUN
ihlr-28406	596	7	of	of	ADP
ihlr-28406	596	8	patent	patent	NOUN
ihlr-28406	596	9	law	law	NOUN
ihlr-28406	596	10	,	,	PUNCT
ihlr-28406	596	11	value	value	NOUN
ihlr-28406	596	12	for	for	ADP
ihlr-28406	596	13	innovations	innovation	NOUN
ihlr-28406	596	14	is	be	AUX
ihlr-28406	596	15	calculated	calculate	VERB
ihlr-28406	596	16	when	when	SCONJ
ihlr-28406	596	17	infringement	infringement	NOUN
ihlr-28406	596	18	occurs	occur	VERB
ihlr-28406	596	19	in	in	ADP
ihlr-28406	596	20	the	the	DET
ihlr-28406	596	21	context	context	NOUN
ihlr-28406	596	22	of	of	ADP
ihlr-28406	596	23	damages	damage	NOUN
ihlr-28406	596	24	.	.	PUNCT
ihlr-28406	597	1	168	168	NUM
ihlr-28406	597	2	the	the	DET
ihlr-28406	597	3	patent	patent	NOUN
ihlr-28406	597	4	act	act	NOUN
ihlr-28406	597	5	states	state	VERB
ihlr-28406	597	6	“	"	PUNCT
ihlr-28406	597	7	[	[	X
ihlr-28406	597	8	u]pon	u]pon	ADP
ihlr-28406	597	9	finding	finding	NOUN
ihlr-28406	597	10	for	for	ADP
ihlr-28406	597	11	the	the	DET
ihlr-28406	597	12	claimant	claimant	NOUN
ihlr-28406	597	13	the	the	DET
ihlr-28406	597	14	court	court	NOUN
ihlr-28406	597	15	shall	shall	AUX
ihlr-28406	597	16	award	award	VERB
ihlr-28406	597	17	the	the	DET
ihlr-28406	597	18	claimant	claimant	ADJ
ihlr-28406	597	19	damages	damage	NOUN
ihlr-28406	597	20	adequate	adequate	ADJ
ihlr-28406	597	21	to	to	PART
ihlr-28406	597	22	compensate	compensate	VERB
ihlr-28406	597	23	for	for	ADP
ihlr-28406	597	24	the	the	DET
ihlr-28406	597	25	infringement	infringement	NOUN
ihlr-28406	597	26	,	,	PUNCT
ihlr-28406	597	27	but	but	CCONJ
ihlr-28406	597	28	in	in	ADP
ihlr-28406	597	29	no	no	DET
ihlr-28406	597	30	event	event	NOUN
ihlr-28406	597	31	less	less	ADJ
ihlr-28406	597	32	than	than	ADP
ihlr-28406	597	33	a	a	DET
ihlr-28406	597	34	reasonable	reasonable	ADJ
ihlr-28406	597	35	royalty	royalty	NOUN
ihlr-28406	597	36	.	.	PUNCT
ihlr-28406	597	37	”169	”169	PUNCT
ihlr-28406	598	1	generally	generally	ADV
ihlr-28406	598	2	,	,	PUNCT
ihlr-28406	598	3	a	a	DET
ihlr-28406	598	4	patent	patent	NOUN
ihlr-28406	598	5	infringement	infringement	NOUN
ihlr-28406	598	6	assessment	assessment	NOUN
ihlr-28406	598	7	is	be	AUX
ihlr-28406	598	8	based	base	VERB
ihlr-28406	598	9	on	on	ADP
ihlr-28406	598	10	first	first	ADV
ihlr-28406	598	11	determining	determine	VERB
ihlr-28406	598	12	the	the	DET
ihlr-28406	598	13	meaning	meaning	NOUN
ihlr-28406	598	14	in	in	ADP
ihlr-28406	598	15	each	each	DET
ihlr-28406	598	16	patent	patent	NOUN
ihlr-28406	598	17	claim	claim	NOUN
ihlr-28406	598	18	and	and	CCONJ
ihlr-28406	598	19	—	—	PUNCT
ihlr-28406	598	20	—	—	PUNCT
ihlr-28406	598	21	—	—	PUNCT
ihlr-28406	598	22	—	—	PUNCT
ihlr-28406	598	23	—	—	PUNCT
ihlr-28406	598	24	—	—	PUNCT
ihlr-28406	598	25	—	—	PUNCT
ihlr-28406	598	26	—	—	PUNCT
ihlr-28406	598	27	—	—	PUNCT
ihlr-28406	598	28	—	—	PUNCT
ihlr-28406	598	29	—	—	PUNCT
ihlr-28406	598	30	—	—	PUNCT
ihlr-28406	598	31	—	—	PUNCT
ihlr-28406	598	32	—	—	PUNCT
ihlr-28406	598	33	—	—	PUNCT
ihlr-28406	598	34	—	—	PUNCT
ihlr-28406	598	35	—	—	PUNCT
ihlr-28406	598	36	—	—	PUNCT
ihlr-28406	598	37	—	—	PUNCT
ihlr-28406	598	38	—	—	PUNCT
ihlr-28406	598	39	—	—	PUNCT
ihlr-28406	598	40	—	—	PUNCT
ihlr-28406	598	41	—	—	PUNCT
ihlr-28406	598	42	—	—	PUNCT
ihlr-28406	598	43	—	—	PUNCT
ihlr-28406	598	44	—	—	PUNCT
ihlr-28406	598	45	—	—	PUNCT
ihlr-28406	598	46	—	—	PUNCT
ihlr-28406	598	47	—	—	PUNCT
ihlr-28406	598	48	163	163	NUM
ihlr-28406	598	49	.	.	PUNCT
ihlr-28406	599	1	eileen	eileen	PROPN
ihlr-28406	599	2	m.	m.	PROPN
ihlr-28406	599	3	herlihy	herlihy	PROPN
ihlr-28406	599	4	,	,	PUNCT
ihlr-28406	599	5	the	the	DET
ihlr-28406	599	6	ripple	ripple	ADJ
ihlr-28406	599	7	effect	effect	NOUN
ihlr-28406	599	8	of	of	ADP
ihlr-28406	599	9	seventh	seventh	ADJ
ihlr-28406	599	10	amendment	amendment	NOUN
ihlr-28406	599	11	decisions	decision	NOUN
ihlr-28406	599	12	on	on	ADP
ihlr-28406	599	13	the	the	DET
ihlr-28406	599	14	development	development	NOUN
ihlr-28406	599	15	of	of	ADP
ihlr-28406	599	16	substantive	substantive	ADJ
ihlr-28406	599	17	patent	patent	NOUN
ihlr-28406	599	18	law	law	NOUN
ihlr-28406	599	19	,	,	PUNCT
ihlr-28406	599	20	27	27	NUM
ihlr-28406	599	21	santa	santa	PROPN
ihlr-28406	599	22	clara	clara	PROPN
ihlr-28406	599	23	comput	comput	PROPN
ihlr-28406	599	24	.	.	PUNCT
ihlr-28406	599	25	&	&	CCONJ
ihlr-28406	599	26	high	high	PROPN
ihlr-28406	599	27	tech	tech	PROPN
ihlr-28406	599	28	l.j	l.j	PROPN
ihlr-28406	599	29	.	.	PROPN
ihlr-28406	599	30	333	333	NUM
ihlr-28406	599	31	,	,	PUNCT
ihlr-28406	599	32	343	343	NUM
ihlr-28406	599	33	(	(	PUNCT
ihlr-28406	599	34	2011	2011	NUM
ihlr-28406	599	35	)	)	PUNCT
ihlr-28406	599	36	.	.	PUNCT
ihlr-28406	600	1	164	164	NUM
ihlr-28406	600	2	.	.	PUNCT
ihlr-28406	601	1	brian	brian	PROPN
ihlr-28406	601	2	s.	s.	PROPN
ihlr-28406	601	3	haney	haney	PROPN
ihlr-28406	601	4	,	,	PUNCT
ihlr-28406	601	5	quantum	quantum	NOUN
ihlr-28406	601	6	patents	patent	NOUN
ihlr-28406	601	7	,	,	PUNCT
ihlr-28406	601	8	27	27	NUM
ihlr-28406	601	9	b.u	b.u	PROPN
ihlr-28406	601	10	.	.	PUNCT
ihlr-28406	601	11	j.	j.	PROPN
ihlr-28406	601	12	sci	sci	PROPN
ihlr-28406	601	13	.	.	PROPN
ihlr-28406	601	14	&	&	CCONJ
ihlr-28406	601	15	tech	tech	PROPN
ihlr-28406	601	16	.	.	PUNCT
ihlr-28406	602	1	l.	l.	PROPN
ihlr-28406	602	2	41	41	NUM
ihlr-28406	602	3	,	,	PUNCT
ihlr-28406	602	4	64(2021	64(2021	NUM
ihlr-28406	602	5	)	)	PUNCT
ihlr-28406	602	6	.	.	PUNCT
ihlr-28406	603	1	165	165	NUM
ihlr-28406	603	2	.	.	PUNCT
ihlr-28406	604	1	brian	brian	PROPN
ihlr-28406	604	2	s.	s.	PROPN
ihlr-28406	604	3	haney	haney	PROPN
ihlr-28406	604	4	,	,	PUNCT
ihlr-28406	604	5	ai	ai	VERB
ihlr-28406	604	6	patents	patent	NOUN
ihlr-28406	604	7	:	:	PUNCT
ihlr-28406	604	8	a	a	DET
ihlr-28406	604	9	data	data	NOUN
ihlr-28406	604	10	driven	drive	VERB
ihlr-28406	604	11	approach	approach	NOUN
ihlr-28406	604	12	,	,	PUNCT
ihlr-28406	604	13	19	19	NUM
ihlr-28406	604	14	chi.-kent	chi.-kent	PROPN
ihlr-28406	604	15	j.	j.	PROPN
ihlr-28406	604	16	intell	intell	PROPN
ihlr-28406	604	17	.	.	PUNCT
ihlr-28406	605	1	prop	prop	NOUN
ihlr-28406	605	2	.	.	PUNCT
ihlr-28406	606	1	407	407	NUM
ihlr-28406	606	2	,	,	PUNCT
ihlr-28406	606	3	462	462	NUM
ihlr-28406	606	4	(	(	PUNCT
ihlr-28406	606	5	2020	2020	NUM
ihlr-28406	606	6	)	)	PUNCT
ihlr-28406	606	7	.	.	PUNCT
ihlr-28406	607	1	166	166	NUM
ihlr-28406	607	2	.	.	PUNCT
ihlr-28406	608	1	paul	paul	PROPN
ihlr-28406	608	2	mj	mj	PROPN
ihlr-28406	608	3	,	,	PUNCT
ihlr-28406	608	4	thangaraj	thangaraj	PROPN
ihlr-28406	608	5	h	h	NOUN
ihlr-28406	608	6	,	,	PUNCT
ihlr-28406	608	7	ma	ma	PROPN
ihlr-28406	608	8	jk	jk	PROPN
ihlr-28406	608	9	.	.	PUNCT
ihlr-28406	608	10	commercialization	commercialization	NOUN
ihlr-28406	608	11	of	of	ADP
ihlr-28406	608	12	new	new	ADJ
ihlr-28406	608	13	biotechnology	biotechnology	NOUN
ihlr-28406	608	14	:	:	PUNCT
ihlr-28406	608	15	a	a	DET
ihlr-28406	608	16	systematic	systematic	ADJ
ihlr-28406	608	17	review	review	NOUN
ihlr-28406	608	18	of	of	ADP
ihlr-28406	608	19	16	16	NUM
ihlr-28406	608	20	commercial	commercial	ADJ
ihlr-28406	608	21	case	case	NOUN
ihlr-28406	608	22	studies	study	NOUN
ihlr-28406	608	23	in	in	ADP
ihlr-28406	608	24	a	a	DET
ihlr-28406	608	25	novel	novel	ADJ
ihlr-28406	608	26	manufacturing	manufacturing	NOUN
ihlr-28406	608	27	sector	sector	NOUN
ihlr-28406	608	28	.	.	PUNCT
ihlr-28406	609	1	plant	plant	NOUN
ihlr-28406	609	2	biotechnol	biotechnol	NOUN
ihlr-28406	609	3	j.	j.	PROPN
ihlr-28406	609	4	2015	2015	NUM
ihlr-28406	609	5	oct;13(8):1209	oct;13(8):1209	PROPN
ihlr-28406	609	6	-	-	PUNCT
ihlr-28406	609	7	20	20	PROPN
ihlr-28406	609	8	.	.	PUNCT
ihlr-28406	610	1	doi	doi	NOUN
ihlr-28406	610	2	:	:	PUNCT
ihlr-28406	610	3	10.1111	10.1111	NUM
ihlr-28406	610	4	/	/	SYM
ihlr-28406	610	5	pbi.12426	pbi.12426	NUM
ihlr-28406	610	6	.	.	PUNCT
ihlr-28406	611	1	epub	epub	PROPN
ihlr-28406	611	2	2015	2015	NUM
ihlr-28406	611	3	jul	jul	PROPN
ihlr-28406	611	4	3	3	NUM
ihlr-28406	611	5	.	.	PUNCT
ihlr-28406	612	1	pmid	pmid	NOUN
ihlr-28406	612	2	:	:	PUNCT
ihlr-28406	612	3	26140440	26140440	NUM
ihlr-28406	612	4	.	.	PUNCT
ihlr-28406	613	1	167	167	NUM
ihlr-28406	613	2	.	.	PUNCT
ihlr-28406	613	3	atyr	atyr	PROPN
ihlr-28406	613	4	pharma	pharma	PROPN
ihlr-28406	613	5	inc	inc	PROPN
ihlr-28406	613	6	.	.	PROPN
ihlr-28406	613	7	,	,	PUNCT
ihlr-28406	613	8	annual	annual	ADJ
ihlr-28406	613	9	report	report	NOUN
ihlr-28406	613	10	(	(	PUNCT
ihlr-28406	613	11	form	form	NOUN
ihlr-28406	613	12	10	10	NUM
ihlr-28406	613	13	-	-	PUNCT
ihlr-28406	613	14	k	k	NOUN
ihlr-28406	613	15	)	)	PUNCT
ihlr-28406	613	16	(	(	PUNCT
ihlr-28406	613	17	mar	mar	PROPN
ihlr-28406	613	18	.	.	PROPN
ihlr-28406	613	19	14	14	NUM
ihlr-28406	613	20	,	,	PUNCT
ihlr-28406	613	21	2024	2024	NUM
ihlr-28406	613	22	)	)	PUNCT
ihlr-28406	613	23	168	168	NUM
ihlr-28406	613	24	.	.	PUNCT
ihlr-28406	614	1	jennifer	jennifer	PROPN
ihlr-28406	614	2	l.	l.	PROPN
ihlr-28406	614	3	blouin	blouin	PROPN
ihlr-28406	614	4	&	&	CCONJ
ihlr-28406	614	5	melissa	melissa	PROPN
ihlr-28406	614	6	f.	f.	PROPN
ihlr-28406	614	7	wasserman	wasserman	PROPN
ihlr-28406	614	8	,	,	PUNCT
ihlr-28406	614	9	tax	tax	NOUN
ihlr-28406	614	10	solutions	solution	NOUN
ihlr-28406	614	11	to	to	ADP
ihlr-28406	614	12	patent	patent	NOUN
ihlr-28406	614	13	damages	damage	NOUN
ihlr-28406	614	14	,	,	PUNCT
ihlr-28406	614	15	26	26	NUM
ihlr-28406	614	16	tex	tex	PROPN
ihlr-28406	614	17	.	.	PROPN
ihlr-28406	614	18	intell	intell	PROPN
ihlr-28406	614	19	.	.	PUNCT
ihlr-28406	615	1	prop	prop	PROPN
ihlr-28406	615	2	.	.	PUNCT
ihlr-28406	616	1	l.j	l.j	PROPN
ihlr-28406	616	2	.	.	PROPN
ihlr-28406	616	3	5	5	NUM
ihlr-28406	616	4	(	(	PUNCT
ihlr-28406	616	5	2018	2018	NUM
ihlr-28406	616	6	)	)	PUNCT
ihlr-28406	616	7	.	.	PUNCT
ihlr-28406	617	1	169	169	NUM
ihlr-28406	617	2	.	.	NOUN
ihlr-28406	617	3	35	35	NUM
ihlr-28406	617	4	u.s.c	u.s.c	NOUN
ihlr-28406	617	5	.	.	PUNCT
ihlr-28406	618	1	§	§	PROPN
ihlr-28406	618	2	284	284	NUM
ihlr-28406	618	3	(	(	PUNCT
ihlr-28406	618	4	2015	2015	NUM
ihlr-28406	618	5	)	)	PUNCT
ihlr-28406	618	6	.	.	PUNCT
ihlr-28406	619	1	indiana	indiana	PROPN
ihlr-28406	619	2	health	health	PROPN
ihlr-28406	619	3	law	law	PROPN
ihlr-28406	619	4	review	review	NOUN
ihlr-28406	619	5	[	[	X
ihlr-28406	619	6	vol	vol	NOUN
ihlr-28406	619	7	.	.	PUNCT
ihlr-28406	620	1	21:277	21:277	NOUN
ihlr-28406	620	2	300	300	NUM
ihlr-28406	620	3	second	second	ADJ
ihlr-28406	620	4	showing	show	VERB
ihlr-28406	620	5	the	the	DET
ihlr-28406	620	6	accused	accuse	VERB
ihlr-28406	620	7	infringement	infringement	NOUN
ihlr-28406	620	8	meets	meet	VERB
ihlr-28406	620	9	each	each	DET
ihlr-28406	620	10	claim	claim	NOUN
ihlr-28406	620	11	term	term	NOUN
ihlr-28406	620	12	.	.	PUNCT
ihlr-28406	621	1	170	170	NUM
ihlr-28406	621	2	direct	direct	ADJ
ihlr-28406	621	3	infringement	infringement	NOUN
ihlr-28406	621	4	is	be	AUX
ihlr-28406	621	5	the	the	DET
ihlr-28406	621	6	broadest	broad	ADJ
ihlr-28406	621	7	clause	clause	NOUN
ihlr-28406	621	8	conferring	confer	VERB
ihlr-28406	621	9	infringement	infringement	NOUN
ihlr-28406	621	10	liability	liability	NOUN
ihlr-28406	621	11	in	in	ADP
ihlr-28406	621	12	the	the	DET
ihlr-28406	621	13	patent	patent	NOUN
ihlr-28406	621	14	act	act	NOUN
ihlr-28406	621	15	.	.	PUNCT
ihlr-28406	622	1	171	171	NUM
ihlr-28406	622	2	in	in	ADP
ihlr-28406	622	3	other	other	ADJ
ihlr-28406	622	4	words	word	NOUN
ihlr-28406	622	5	,	,	PUNCT
ihlr-28406	622	6	35	35	NUM
ihlr-28406	622	7	u.s.c	u.s.c	NOUN
ihlr-28406	622	8	.	.	PUNCT
ihlr-28406	623	1	§	§	PROPN
ihlr-28406	623	2	271(a	271(a	PROPN
ihlr-28406	623	3	)	)	PUNCT
ihlr-28406	623	4	requires	require	VERB
ihlr-28406	623	5	the	the	DET
ihlr-28406	623	6	unauthorized	unauthorized	ADJ
ihlr-28406	623	7	use	use	NOUN
ihlr-28406	623	8	of	of	ADP
ihlr-28406	623	9	a	a	DET
ihlr-28406	623	10	patented	patented	ADJ
ihlr-28406	623	11	invention	invention	NOUN
ihlr-28406	623	12	by	by	ADP
ihlr-28406	623	13	making	make	VERB
ihlr-28406	623	14	,	,	PUNCT
ihlr-28406	623	15	using	use	VERB
ihlr-28406	623	16	,	,	PUNCT
ihlr-28406	623	17	offering	offer	VERB
ihlr-28406	623	18	for	for	ADP
ihlr-28406	623	19	sale	sale	NOUN
ihlr-28406	623	20	,	,	PUNCT
ihlr-28406	623	21	selling	selling	NOUN
ihlr-28406	623	22	,	,	PUNCT
ihlr-28406	623	23	or	or	CCONJ
ihlr-28406	623	24	importing	import	VERB
ihlr-28406	623	25	the	the	DET
ihlr-28406	623	26	invention	invention	NOUN
ihlr-28406	623	27	.	.	PUNCT
ihlr-28406	624	1	172	172	NUM
ihlr-28406	624	2	the	the	DET
ihlr-28406	624	3	act	act	NOUN
ihlr-28406	624	4	clearly	clearly	ADV
ihlr-28406	624	5	states	state	VERB
ihlr-28406	624	6	,	,	PUNCT
ihlr-28406	624	7	“	"	PUNCT
ihlr-28406	624	8	[	[	X
ihlr-28406	624	9	i]f	i]f	ADP
ihlr-28406	624	10	a	a	DET
ihlr-28406	624	11	patent	patent	NOUN
ihlr-28406	624	12	is	be	AUX
ihlr-28406	624	13	found	find	VERB
ihlr-28406	624	14	to	to	PART
ihlr-28406	624	15	be	be	AUX
ihlr-28406	624	16	valid	valid	ADJ
ihlr-28406	624	17	and	and	CCONJ
ihlr-28406	624	18	infringed	infringe	VERB
ihlr-28406	624	19	,	,	PUNCT
ihlr-28406	624	20	its	its	PRON
ihlr-28406	624	21	owner	owner	NOUN
ihlr-28406	624	22	is	be	AUX
ihlr-28406	624	23	entitled	entitle	VERB
ihlr-28406	624	24	to	to	PART
ihlr-28406	624	25	infringement	infringement	VERB
ihlr-28406	624	26	damages	damage	NOUN
ihlr-28406	624	27	.	.	PUNCT
ihlr-28406	625	1	”173	”173	NOUN
ihlr-28406	625	2	courts	court	NOUN
ihlr-28406	625	3	have	have	AUX
ihlr-28406	625	4	interpreted	interpret	VERB
ihlr-28406	625	5	the	the	DET
ihlr-28406	625	6	patent	patent	NOUN
ihlr-28406	625	7	act	act	NOUN
ihlr-28406	625	8	to	to	PART
ihlr-28406	625	9	mean	mean	VERB
ihlr-28406	625	10	that	that	SCONJ
ihlr-28406	625	11	patent	patent	NOUN
ihlr-28406	625	12	damages	damage	NOUN
ihlr-28406	625	13	come	come	VERB
ihlr-28406	625	14	in	in	ADP
ihlr-28406	625	15	two	two	NUM
ihlr-28406	625	16	primary	primary	ADJ
ihlr-28406	625	17	measures	measure	NOUN
ihlr-28406	625	18	:	:	PUNCT
ihlr-28406	625	19	lost	lose	VERB
ihlr-28406	625	20	profits	profit	NOUN
ihlr-28406	625	21	and	and	CCONJ
ihlr-28406	625	22	reasonable	reasonable	ADJ
ihlr-28406	625	23	royalties	royalty	NOUN
ihlr-28406	625	24	.	.	PUNCT
ihlr-28406	626	1	174	174	NUM
ihlr-28406	626	2	lost	lose	VERB
ihlr-28406	626	3	profits	profit	NOUN
ihlr-28406	626	4	provide	provide	VERB
ihlr-28406	626	5	the	the	DET
ihlr-28406	626	6	patentee	patentee	NOUN
ihlr-28406	626	7	with	with	ADP
ihlr-28406	626	8	the	the	DET
ihlr-28406	626	9	profits	profit	NOUN
ihlr-28406	626	10	the	the	DET
ihlr-28406	626	11	patentee	patentee	NOUN
ihlr-28406	626	12	would	would	AUX
ihlr-28406	626	13	have	have	AUX
ihlr-28406	626	14	made	make	VERB
ihlr-28406	626	15	but	but	CCONJ
ihlr-28406	626	16	for	for	ADP
ihlr-28406	626	17	the	the	DET
ihlr-28406	626	18	infringing	infringe	VERB
ihlr-28406	626	19	sales	sale	NOUN
ihlr-28406	626	20	as	as	ADP
ihlr-28406	626	21	damages	damage	NOUN
ihlr-28406	626	22	in	in	ADP
ihlr-28406	626	23	litigation	litigation	NOUN
ihlr-28406	626	24	.	.	PUNCT
ihlr-28406	627	1	175	175	NUM
ihlr-28406	627	2	“	"	PUNCT
ihlr-28406	627	3	proving	prove	VERB
ihlr-28406	627	4	lost	lose	VERB
ihlr-28406	627	5	profits	profit	NOUN
ihlr-28406	627	6	,	,	PUNCT
ihlr-28406	627	7	however	however	ADV
ihlr-28406	627	8	,	,	PUNCT
ihlr-28406	627	9	is	be	AUX
ihlr-28406	627	10	not	not	PART
ihlr-28406	627	11	an	an	DET
ihlr-28406	627	12	easy	easy	ADJ
ihlr-28406	627	13	endeavor	endeavor	NOUN
ihlr-28406	627	14	.	.	PUNCT
ihlr-28406	627	15	”176	”176	PUNCT
ihlr-28406	628	1	the	the	DET
ihlr-28406	628	2	prevailing	prevail	VERB
ihlr-28406	628	3	patentee	patentee	NOUN
ihlr-28406	628	4	must	must	AUX
ihlr-28406	628	5	prove	prove	VERB
ihlr-28406	628	6	:	:	PUNCT
ihlr-28406	628	7	(	(	PUNCT
ihlr-28406	628	8	1	1	X
ihlr-28406	628	9	)	)	PUNCT
ihlr-28406	628	10	demand	demand	NOUN
ihlr-28406	628	11	for	for	ADP
ihlr-28406	628	12	the	the	DET
ihlr-28406	628	13	patented	patented	ADJ
ihlr-28406	628	14	product	product	NOUN
ihlr-28406	628	15	,	,	PUNCT
ihlr-28406	628	16	(	(	PUNCT
ihlr-28406	628	17	2	2	X
ihlr-28406	628	18	)	)	PUNCT
ihlr-28406	628	19	a	a	DET
ihlr-28406	628	20	lack	lack	NOUN
ihlr-28406	628	21	of	of	ADP
ihlr-28406	628	22	alternatives	alternative	NOUN
ihlr-28406	628	23	for	for	ADP
ihlr-28406	628	24	the	the	DET
ihlr-28406	628	25	product	product	NOUN
ihlr-28406	628	26	,	,	PUNCT
ihlr-28406	628	27	(	(	PUNCT
ihlr-28406	628	28	3	3	X
ihlr-28406	628	29	)	)	PUNCT
ihlr-28406	628	30	the	the	DET
ihlr-28406	628	31	patentee	patentee	NOUN
ihlr-28406	628	32	’s	’s	PART
ihlr-28406	628	33	ability	ability	NOUN
ihlr-28406	628	34	to	to	PART
ihlr-28406	628	35	meet	meet	VERB
ihlr-28406	628	36	the	the	DET
ihlr-28406	628	37	additional	additional	ADJ
ihlr-28406	628	38	demand	demand	NOUN
ihlr-28406	628	39	,	,	PUNCT
ihlr-28406	628	40	and	and	CCONJ
ihlr-28406	628	41	(	(	PUNCT
ihlr-28406	628	42	4	4	X
ihlr-28406	628	43	)	)	PUNCT
ihlr-28406	628	44	the	the	DET
ihlr-28406	628	45	foreseeable	foreseeable	ADJ
ihlr-28406	628	46	profits	profit	NOUN
ihlr-28406	628	47	.	.	PUNCT
ihlr-28406	629	1	177	177	NUM
ihlr-28406	629	2	the	the	DET
ihlr-28406	629	3	second	second	ADJ
ihlr-28406	629	4	measure	measure	NOUN
ihlr-28406	629	5	for	for	ADP
ihlr-28406	629	6	damages	damage	NOUN
ihlr-28406	629	7	is	be	AUX
ihlr-28406	629	8	reasonable	reasonable	ADJ
ihlr-28406	629	9	royalties	royalty	NOUN
ihlr-28406	629	10	,	,	PUNCT
ihlr-28406	629	11	which	which	PRON
ihlr-28406	629	12	are	be	AUX
ihlr-28406	629	13	the	the	DET
ihlr-28406	629	14	dominant	dominant	ADJ
ihlr-28406	629	15	damages	damage	NOUN
ihlr-28406	629	16	determination	determination	NOUN
ihlr-28406	629	17	.	.	PUNCT
ihlr-28406	630	1	178	178	NUM
ihlr-28406	630	2	today	today	NOUN
ihlr-28406	630	3	,	,	PUNCT
ihlr-28406	630	4	over	over	ADP
ihlr-28406	630	5	80	80	NUM
ihlr-28406	630	6	%	%	NOUN
ihlr-28406	630	7	of	of	ADP
ihlr-28406	630	8	all	all	DET
ihlr-28406	630	9	patent	patent	NOUN
ihlr-28406	630	10	damage	damage	NOUN
ihlr-28406	630	11	awards	award	NOUN
ihlr-28406	630	12	are	be	AUX
ihlr-28406	630	13	reasonable	reasonable	ADJ
ihlr-28406	630	14	royalties	royalty	NOUN
ihlr-28406	630	15	.	.	PUNCT
ihlr-28406	631	1	179	179	NUM
ihlr-28406	631	2	as	as	ADP
ihlr-28406	631	3	such	such	ADJ
ihlr-28406	631	4	,	,	PUNCT
ihlr-28406	631	5	some	some	PRON
ihlr-28406	631	6	describe	describe	VERB
ihlr-28406	631	7	the	the	DET
ihlr-28406	631	8	reasonable	reasonable	ADJ
ihlr-28406	631	9	royalty	royalty	NOUN
ihlr-28406	631	10	model	model	NOUN
ihlr-28406	631	11	180	180	NUM
ihlr-28406	631	12	as	as	ADP
ihlr-28406	631	13	a	a	DET
ihlr-28406	631	14	historic	historic	ADJ
ihlr-28406	631	15	bedrock	bedrock	NOUN
ihlr-28406	631	16	technique	technique	NOUN
ihlr-28406	631	17	in	in	ADP
ihlr-28406	631	18	patent	patent	NOUN
ihlr-28406	631	19	license	license	NOUN
ihlr-28406	631	20	valuation	valuation	NOUN
ihlr-28406	631	21	.	.	PUNCT
ihlr-28406	632	1	181	181	NUM
ihlr-28406	632	2	courts	court	NOUN
ihlr-28406	632	3	typically	typically	ADV
ihlr-28406	632	4	apply	apply	VERB
ihlr-28406	632	5	a	a	DET
ihlr-28406	632	6	fifteen	fifteen	NUM
ihlr-28406	632	7	factor	factor	NOUN
ihlr-28406	632	8	analysis	analysis	NOUN
ihlr-28406	632	9	set	set	VERB
ihlr-28406	632	10	out	out	ADP
ihlr-28406	632	11	in	in	ADP
ihlr-28406	632	12	georgia	georgia	PROPN
ihlr-28406	632	13	-	-	PUNCT
ihlr-28406	632	14	pacific	pacific	PROPN
ihlr-28406	632	15	corp	corp	PROPN
ihlr-28406	632	16	.	.	PROPN
ihlr-28406	633	1	v.	v.	PROPN
ihlr-28406	633	2	united	united	PROPN
ihlr-28406	633	3	states	states	PROPN
ihlr-28406	633	4	plywood	plywood	PROPN
ihlr-28406	633	5	corp	corp	PROPN
ihlr-28406	633	6	to	to	PART
ihlr-28406	633	7	determine	determine	VERB
ihlr-28406	633	8	reasonable	reasonable	ADJ
ihlr-28406	633	9	royalty.182	royalty.182	NOUN
ihlr-28406	633	10	as	as	ADP
ihlr-28406	634	1	such	such	ADJ
ihlr-28406	634	2	,	,	PUNCT
ihlr-28406	634	3	judicial	judicial	ADJ
ihlr-28406	634	4	discretion	discretion	NOUN
ihlr-28406	634	5	determines	determine	VERB
ihlr-28406	634	6	questions	question	NOUN
ihlr-28406	634	7	relating	relate	VERB
ihlr-28406	634	8	to	to	ADP
ihlr-28406	634	9	conflicting	conflict	VERB
ihlr-28406	634	10	evidence	evidence	NOUN
ihlr-28406	634	11	for	for	ADP
ihlr-28406	634	12	—	—	PUNCT
ihlr-28406	634	13	—	—	PUNCT
ihlr-28406	634	14	—	—	PUNCT
ihlr-28406	634	15	—	—	PUNCT
ihlr-28406	634	16	—	—	PUNCT
ihlr-28406	634	17	—	—	PUNCT
ihlr-28406	634	18	—	—	PUNCT
ihlr-28406	634	19	—	—	PUNCT
ihlr-28406	634	20	—	—	PUNCT
ihlr-28406	634	21	—	—	PUNCT
ihlr-28406	634	22	—	—	PUNCT
ihlr-28406	634	23	—	—	PUNCT
ihlr-28406	634	24	—	—	PUNCT
ihlr-28406	634	25	—	—	PUNCT
ihlr-28406	634	26	—	—	PUNCT
ihlr-28406	634	27	—	—	PUNCT
ihlr-28406	634	28	—	—	PUNCT
ihlr-28406	634	29	—	—	PUNCT
ihlr-28406	634	30	—	—	PUNCT
ihlr-28406	634	31	—	—	PUNCT
ihlr-28406	634	32	—	—	PUNCT
ihlr-28406	634	33	—	—	PUNCT
ihlr-28406	634	34	—	—	PUNCT
ihlr-28406	634	35	—	—	PUNCT
ihlr-28406	634	36	—	—	PUNCT
ihlr-28406	634	37	—	—	PUNCT
ihlr-28406	634	38	—	—	PUNCT
ihlr-28406	634	39	—	—	PUNCT
ihlr-28406	634	40	—	—	PUNCT
ihlr-28406	634	41	170	170	NUM
ihlr-28406	634	42	.	.	PUNCT
ihlr-28406	634	43	christopher	christopher	PROPN
ihlr-28406	634	44	j.	j.	PROPN
ihlr-28406	634	45	white	white	PROPN
ihlr-28406	634	46	&	&	CCONJ
ihlr-28406	634	47	hamid	hamid	PROPN
ihlr-28406	634	48	r.	r.	PROPN
ihlr-28406	634	49	piroozi	piroozi	PROPN
ihlr-28406	634	50	,	,	PUNCT
ihlr-28406	634	51	drafting	draft	VERB
ihlr-28406	634	52	patent	patent	NOUN
ihlr-28406	634	53	applications	application	NOUN
ihlr-28406	634	54	covering	cover	VERB
ihlr-28406	634	55	artificial	artificial	ADJ
ihlr-28406	634	56	intelligence	intelligence	NOUN
ihlr-28406	634	57	systems	system	NOUN
ihlr-28406	634	58	,	,	PUNCT
ihlr-28406	634	59	landslide	landslide	NOUN
ihlr-28406	634	60	,	,	PUNCT
ihlr-28406	634	61	jan.-feb	jan.-feb	PROPN
ihlr-28406	634	62	.	.	PROPN
ihlr-28406	634	63	2019	2019	NUM
ihlr-28406	634	64	,	,	PUNCT
ihlr-28406	634	65	at	at	ADP
ihlr-28406	634	66	10	10	NUM
ihlr-28406	634	67	,	,	PUNCT
ihlr-28406	634	68	14	14	NUM
ihlr-28406	634	69	(	(	PUNCT
ihlr-28406	634	70	the	the	DET
ihlr-28406	634	71	u.s	u.s	PROPN
ihlr-28406	634	72	.	.	PROPN
ihlr-28406	634	73	code	code	PROPN
ihlr-28406	634	74	generally	generally	ADV
ihlr-28406	634	75	divides	divide	VERB
ihlr-28406	634	76	infringement	infringement	NOUN
ihlr-28406	634	77	in	in	ADP
ihlr-28406	634	78	to	to	ADP
ihlr-28406	634	79	two	two	NUM
ihlr-28406	634	80	categories	category	NOUN
ihlr-28406	634	81	:	:	PUNCT
ihlr-28406	634	82	direct	direct	ADJ
ihlr-28406	634	83	infringement	infringement	NOUN
ihlr-28406	634	84	and	and	CCONJ
ihlr-28406	634	85	indirect	indirect	ADJ
ihlr-28406	634	86	infringement	infringement	NOUN
ihlr-28406	634	87	.	.	PUNCT
ihlr-28406	634	88	)	)	PUNCT
ihlr-28406	634	89	.	.	PUNCT
ihlr-28406	635	1	171	171	NUM
ihlr-28406	635	2	.	.	X
ihlr-28406	635	3	35	35	NUM
ihlr-28406	635	4	u.s.c	u.s.c	NOUN
ihlr-28406	635	5	.	.	PUNCT
ihlr-28406	636	1	§	§	PROPN
ihlr-28406	636	2	271(a	271(a	PROPN
ihlr-28406	636	3	)	)	PUNCT
ihlr-28406	636	4	(	(	PUNCT
ihlr-28406	636	5	“	"	PUNCT
ihlr-28406	636	6	except	except	SCONJ
ihlr-28406	636	7	as	as	ADV
ihlr-28406	636	8	otherwise	otherwise	ADV
ihlr-28406	636	9	provided	provide	VERB
ihlr-28406	636	10	in	in	ADP
ihlr-28406	636	11	this	this	DET
ihlr-28406	636	12	title	title	NOUN
ihlr-28406	636	13	,	,	PUNCT
ihlr-28406	636	14	whoever	whoever	PRON
ihlr-28406	636	15	without	without	ADP
ihlr-28406	636	16	authority	authority	NOUN
ihlr-28406	636	17	makes	make	VERB
ihlr-28406	636	18	,	,	PUNCT
ihlr-28406	636	19	uses	use	NOUN
ihlr-28406	636	20	,	,	PUNCT
ihlr-28406	636	21	offers	offer	VERB
ihlr-28406	636	22	to	to	PART
ihlr-28406	636	23	sell	sell	VERB
ihlr-28406	636	24	,	,	PUNCT
ihlr-28406	636	25	or	or	CCONJ
ihlr-28406	636	26	sells	sell	VERB
ihlr-28406	636	27	any	any	DET
ihlr-28406	636	28	patented	patented	ADJ
ihlr-28406	636	29	invention	invention	NOUN
ihlr-28406	636	30	,	,	PUNCT
ihlr-28406	636	31	within	within	ADP
ihlr-28406	636	32	the	the	DET
ihlr-28406	636	33	united	united	PROPN
ihlr-28406	636	34	states	states	PROPN
ihlr-28406	636	35	or	or	CCONJ
ihlr-28406	636	36	imports	import	NOUN
ihlr-28406	636	37	into	into	ADP
ihlr-28406	636	38	the	the	DET
ihlr-28406	636	39	united	united	PROPN
ihlr-28406	636	40	states	states	PROPN
ihlr-28406	636	41	any	any	DET
ihlr-28406	636	42	patented	patented	ADJ
ihlr-28406	636	43	invention	invention	NOUN
ihlr-28406	636	44	during	during	ADP
ihlr-28406	636	45	the	the	DET
ihlr-28406	636	46	term	term	NOUN
ihlr-28406	636	47	of	of	ADP
ihlr-28406	636	48	the	the	DET
ihlr-28406	636	49	patent	patent	NOUN
ihlr-28406	636	50	therefor	therefor	ADV
ihlr-28406	636	51	,	,	PUNCT
ihlr-28406	636	52	infringes	infringe	VERB
ihlr-28406	636	53	the	the	DET
ihlr-28406	636	54	patent	patent	NOUN
ihlr-28406	636	55	.	.	PUNCT
ihlr-28406	636	56	”	"	PUNCT
ihlr-28406	636	57	)	)	PUNCT
ihlr-28406	636	58	.	.	PUNCT
ihlr-28406	637	1	172	172	X
ihlr-28406	637	2	.	.	PUNCT
ihlr-28406	637	3	tabrez	tabrez	PROPN
ihlr-28406	637	4	y.	y.	PROPN
ihlr-28406	637	5	ebrahim	ebrahim	PROPN
ihlr-28406	637	6	,	,	PUNCT
ihlr-28406	637	7	artificial	artificial	ADJ
ihlr-28406	637	8	intelligence	intelligence	NOUN
ihlr-28406	637	9	patent	patent	NOUN
ihlr-28406	637	10	infringement	infringement	NOUN
ihlr-28406	637	11	(	(	PUNCT
ihlr-28406	637	12	2020	2020	NUM
ihlr-28406	637	13	)	)	PUNCT
ihlr-28406	637	14	(	(	PUNCT
ihlr-28406	637	15	unpublished	unpublished	ADJ
ihlr-28406	637	16	draft	draft	NOUN
ihlr-28406	637	17	)	)	PUNCT
ihlr-28406	637	18	(	(	PUNCT
ihlr-28406	637	19	on	on	ADP
ihlr-28406	637	20	file	file	NOUN
ihlr-28406	637	21	with	with	ADP
ihlr-28406	637	22	author	author	NOUN
ihlr-28406	637	23	)	)	PUNCT
ihlr-28406	637	24	.	.	PUNCT
ihlr-28406	638	1	173	173	NUM
ihlr-28406	638	2	.	.	PUNCT
ihlr-28406	638	3	blouin	blouin	PROPN
ihlr-28406	638	4	&	&	CCONJ
ihlr-28406	638	5	wasserman	wasserman	PROPN
ihlr-28406	638	6	,	,	PUNCT
ihlr-28406	638	7	supra	supra	PROPN
ihlr-28406	638	8	note	note	PROPN
ihlr-28406	638	9	168	168	NUM
ihlr-28406	638	10	,	,	PUNCT
ihlr-28406	638	11	at	at	ADP
ihlr-28406	638	12	5	5	NUM
ihlr-28406	638	13	.	.	PUNCT
ihlr-28406	638	14	174.id	174.id	NUM
ihlr-28406	638	15	.	.	NOUN
ihlr-28406	638	16	175	175	NUM
ihlr-28406	638	17	.	.	PUNCT
ihlr-28406	639	1	i	i	PRON
ihlr-28406	639	2	d.	d.	PROPN
ihlr-28406	639	3	176	176	NUM
ihlr-28406	639	4	.	.	PUNCT
ihlr-28406	640	1	i	i	PRON
ihlr-28406	640	2	d.	d.	PROPN
ihlr-28406	640	3	at	at	ADP
ihlr-28406	640	4	6	6	NUM
ihlr-28406	640	5	.	.	NOUN
ihlr-28406	640	6	177	177	NUM
ihlr-28406	640	7	.	.	PUNCT
ihlr-28406	641	1	i	i	PRON
ihlr-28406	641	2	d.	d.	PROPN
ihlr-28406	641	3	see	see	VERB
ihlr-28406	641	4	panduit	panduit	PROPN
ihlr-28406	641	5	corp	corp	PROPN
ihlr-28406	641	6	.	.	PROPN
ihlr-28406	642	1	v.	v.	ADP
ihlr-28406	642	2	stahlin	stahlin	PROPN
ihlr-28406	642	3	bros	bros	PROPN
ihlr-28406	642	4	.	.	PROPN
ihlr-28406	642	5	fibre	fibre	PROPN
ihlr-28406	642	6	works	work	NOUN
ihlr-28406	642	7	,	,	PUNCT
ihlr-28406	643	1	575	575	NUM
ihlr-28406	643	2	f.2d	f.2d	NOUN
ihlr-28406	643	3	1152	1152	NUM
ihlr-28406	643	4	,	,	PUNCT
ihlr-28406	643	5	1156	1156	NUM
ihlr-28406	643	6	(	(	PUNCT
ihlr-28406	643	7	6th	6th	ADJ
ihlr-28406	643	8	cir	cir	NOUN
ihlr-28406	643	9	.	.	PROPN
ihlr-28406	643	10	1978	1978	NUM
ihlr-28406	643	11	)	)	PUNCT
ihlr-28406	643	12	.	.	PUNCT
ihlr-28406	644	1	178	178	NUM
ihlr-28406	644	2	.	.	PUNCT
ihlr-28406	645	1	i	i	PRON
ihlr-28406	645	2	d.	d.	PROPN
ihlr-28406	645	3	(	(	PUNCT
ihlr-28406	645	4	arguing	argue	VERB
ihlr-28406	645	5	tax	tax	NOUN
ihlr-28406	645	6	-	-	PUNCT
ihlr-28406	645	7	related	relate	VERB
ihlr-28406	645	8	transfer	transfer	NOUN
ihlr-28406	645	9	prices	price	NOUN
ihlr-28406	645	10	are	be	AUX
ihlr-28406	645	11	useful	useful	ADJ
ihlr-28406	645	12	evidence	evidence	NOUN
ihlr-28406	645	13	for	for	ADP
ihlr-28406	645	14	calculating	calculate	VERB
ihlr-28406	645	15	reasonable	reasonable	ADJ
ihlr-28406	645	16	royalty	royalty	NOUN
ihlr-28406	645	17	patent	patent	NOUN
ihlr-28406	645	18	damages	damage	NOUN
ihlr-28406	645	19	.	.	PUNCT
ihlr-28406	645	20	)	)	PUNCT
ihlr-28406	646	1	179	179	NUM
ihlr-28406	646	2	.	.	PUNCT
ihlr-28406	647	1	i	i	PRON
ihlr-28406	647	2	d.	d.	PROPN
ihlr-28406	647	3	180	180	NUM
ihlr-28406	647	4	.	.	PUNCT
ihlr-28406	647	5	mark	mark	PROPN
ihlr-28406	647	6	a.	a.	PROPN
ihlr-28406	647	7	lemley	lemley	PROPN
ihlr-28406	647	8	,	,	PUNCT
ihlr-28406	647	9	distinguishing	distinguish	VERB
ihlr-28406	647	10	lost	lose	VERB
ihlr-28406	647	11	profits	profit	NOUN
ihlr-28406	647	12	from	from	ADP
ihlr-28406	647	13	reasonable	reasonable	ADJ
ihlr-28406	647	14	royalties	royalty	NOUN
ihlr-28406	647	15	,	,	PUNCT
ihlr-28406	647	16	51	51	NUM
ihlr-28406	647	17	william	william	PROPN
ihlr-28406	647	18	&	&	CCONJ
ihlr-28406	647	19	mary	mary	PROPN
ihlr-28406	647	20	l.	l.	PROPN
ihlr-28406	647	21	rev	rev	PROPN
ihlr-28406	647	22	.	.	PROPN
ihlr-28406	647	23	655	655	NUM
ihlr-28406	647	24	,	,	PUNCT
ihlr-28406	647	25	669	669	NUM
ihlr-28406	647	26	(	(	PUNCT
ihlr-28406	647	27	2009	2009	NUM
ihlr-28406	647	28	)	)	PUNCT
ihlr-28406	647	29	.	.	PUNCT
ihlr-28406	648	1	(	(	PUNCT
ihlr-28406	648	2	under	under	ADP
ihlr-28406	648	3	a	a	DET
ihlr-28406	648	4	reasonable	reasonable	ADJ
ihlr-28406	648	5	-	-	PUNCT
ihlr-28406	648	6	royalty	royalty	NOUN
ihlr-28406	648	7	model	model	NOUN
ihlr-28406	648	8	,	,	PUNCT
ihlr-28406	648	9	patent	patent	NOUN
ihlr-28406	648	10	law	law	NOUN
ihlr-28406	648	11	aims	aim	VERB
ihlr-28406	648	12	to	to	PART
ihlr-28406	648	13	provide	provide	VERB
ihlr-28406	648	14	patentees	patentee	NOUN
ihlr-28406	648	15	with	with	ADP
ihlr-28406	648	16	payment	payment	NOUN
ihlr-28406	648	17	for	for	ADP
ihlr-28406	648	18	the	the	DET
ihlr-28406	648	19	“	"	PUNCT
ihlr-28406	648	20	rate	rate	NOUN
ihlr-28406	648	21	that	that	PRON
ihlr-28406	648	22	would	would	AUX
ihlr-28406	648	23	have	have	VERB
ihlr-28406	648	24	both	both	CCONJ
ihlr-28406	648	25	compensated	compensate	VERB
ihlr-28406	648	26	patentees	patentee	NOUN
ihlr-28406	648	27	and	and	CCONJ
ihlr-28406	648	28	allowed	allow	VERB
ihlr-28406	648	29	users	user	NOUN
ihlr-28406	648	30	of	of	ADP
ihlr-28406	648	31	the	the	DET
ihlr-28406	648	32	technology	technology	NOUN
ihlr-28406	648	33	to	to	PART
ihlr-28406	648	34	make	make	VERB
ihlr-28406	648	35	a	a	DET
ihlr-28406	648	36	reasonable	reasonable	ADJ
ihlr-28406	648	37	profit	profit	NOUN
ihlr-28406	648	38	.	.	PUNCT
ihlr-28406	648	39	”	"	PUNCT
ihlr-28406	648	40	)	)	PUNCT
ihlr-28406	648	41	.	.	PUNCT
ihlr-28406	649	1	181	181	NUM
ihlr-28406	649	2	.	.	PUNCT
ihlr-28406	649	3	amy	amy	PROPN
ihlr-28406	649	4	l.	l.	PROPN
ihlr-28406	649	5	landers	landers	PROPN
ihlr-28406	649	6	,	,	PUNCT
ihlr-28406	649	7	patent	patent	NOUN
ihlr-28406	649	8	valuation	valuation	NOUN
ihlr-28406	649	9	theory	theory	NOUN
ihlr-28406	649	10	and	and	CCONJ
ihlr-28406	649	11	the	the	DET
ihlr-28406	649	12	economics	economic	NOUN
ihlr-28406	649	13	of	of	ADP
ihlr-28406	649	14	improvement	improvement	NOUN
ihlr-28406	649	15	,	,	PUNCT
ihlr-28406	649	16	88	88	NUM
ihlr-28406	649	17	tex	tex	PROPN
ihlr-28406	649	18	.	.	PROPN
ihlr-28406	649	19	l.	l.	PROPN
ihlr-28406	649	20	rev	rev	PROPN
ihlr-28406	649	21	.	.	PROPN
ihlr-28406	649	22	163	163	NUM
ihlr-28406	649	23	,	,	PUNCT
ihlr-28406	649	24	166	166	NUM
ihlr-28406	649	25	(	(	PUNCT
ihlr-28406	649	26	2009	2009	NUM
ihlr-28406	649	27	)	)	PUNCT
ihlr-28406	649	28	.	.	PUNCT
ihlr-28406	650	1	(	(	PUNCT
ihlr-28406	650	2	patent	patent	NOUN
ihlr-28406	650	3	damages	damage	NOUN
ihlr-28406	650	4	are	be	AUX
ihlr-28406	650	5	a	a	DET
ihlr-28406	650	6	make	make	VERB
ihlr-28406	650	7	-	-	PUNCT
ihlr-28406	650	8	whole	whole	ADJ
ihlr-28406	650	9	remedy	remedy	NOUN
ihlr-28406	650	10	,	,	PUNCT
ihlr-28406	650	11	intended	intend	VERB
ihlr-28406	650	12	to	to	PART
ihlr-28406	650	13	restore	restore	VERB
ihlr-28406	650	14	the	the	DET
ihlr-28406	650	15	patentee	patentee	NOUN
ihlr-28406	650	16	to	to	ADP
ihlr-28406	650	17	the	the	DET
ihlr-28406	650	18	same	same	ADJ
ihlr-28406	650	19	position	position	NOUN
ihlr-28406	650	20	as	as	ADP
ihlr-28406	650	21	before	before	ADP
ihlr-28406	650	22	the	the	DET
ihlr-28406	650	23	infringement	infringement	NOUN
ihlr-28406	650	24	.	.	PUNCT
ihlr-28406	651	1	in	in	ADP
ihlr-28406	651	2	the	the	DET
ihlr-28406	651	3	context	context	NOUN
ihlr-28406	651	4	of	of	ADP
ihlr-28406	651	5	patent	patent	NOUN
ihlr-28406	651	6	litigation	litigation	NOUN
ihlr-28406	651	7	,	,	PUNCT
ihlr-28406	651	8	income	income	NOUN
ihlr-28406	651	9	models	model	NOUN
ihlr-28406	651	10	are	be	AUX
ihlr-28406	651	11	particularly	particularly	ADV
ihlr-28406	651	12	popular	popular	ADJ
ihlr-28406	651	13	for	for	ADP
ihlr-28406	651	14	determining	determine	VERB
ihlr-28406	651	15	damages	damage	NOUN
ihlr-28406	651	16	.	.	PUNCT
ihlr-28406	651	17	)	)	PUNCT
ihlr-28406	651	18	.	.	PUNCT
ihlr-28406	652	1	182	182	NUM
ihlr-28406	652	2	.	.	X
ihlr-28406	653	1	318	318	NUM
ihlr-28406	653	2	f.	f.	PROPN
ihlr-28406	653	3	supp	supp	PROPN
ihlr-28406	653	4	.	.	PUNCT
ihlr-28406	654	1	1116	1116	NUM
ihlr-28406	654	2	,	,	PUNCT
ihlr-28406	654	3	1120	1120	NUM
ihlr-28406	654	4	(	(	PUNCT
ihlr-28406	654	5	s.d.n.y	s.d.n.y	PROPN
ihlr-28406	654	6	.	.	NOUN
ihlr-28406	654	7	1970	1970	NUM
ihlr-28406	654	8	)	)	PUNCT
ihlr-28406	654	9	.	.	PUNCT
ihlr-28406	655	1	(	(	PUNCT
ihlr-28406	655	2	“	"	PUNCT
ihlr-28406	655	3	a	a	DET
ihlr-28406	655	4	comprehensive	comprehensive	ADJ
ihlr-28406	655	5	list	list	NOUN
ihlr-28406	655	6	of	of	ADP
ihlr-28406	655	7	evidentiary	evidentiary	ADJ
ihlr-28406	655	8	facts	fact	NOUN
ihlr-28406	655	9	relevant	relevant	ADJ
ihlr-28406	655	10	,	,	PUNCT
ihlr-28406	655	11	in	in	ADP
ihlr-28406	655	12	general	general	ADJ
ihlr-28406	655	13	,	,	PUNCT
ihlr-28406	655	14	to	to	ADP
ihlr-28406	655	15	the	the	DET
ihlr-28406	655	16	determination	determination	NOUN
ihlr-28406	655	17	of	of	ADP
ihlr-28406	655	18	the	the	DET
ihlr-28406	655	19	amount	amount	NOUN
ihlr-28406	655	20	of	of	ADP
ihlr-28406	655	21	a	a	DET
ihlr-28406	655	22	reasonable	reasonable	ADJ
ihlr-28406	655	23	royalty	royalty	NOUN
ihlr-28406	655	24	for	for	ADP
ihlr-28406	655	25	a	a	DET
ihlr-28406	655	26	patent	patent	NOUN
ihlr-28406	655	27	license	license	NOUN
ihlr-28406	655	28	may	may	AUX
ihlr-28406	655	29	be	be	AUX
ihlr-28406	655	30	drawn	draw	VERB
ihlr-28406	655	31	from	from	ADP
ihlr-28406	655	32	a	a	DET
ihlr-28406	655	33	conspectus	conspectus	NOUN
ihlr-28406	655	34	of	of	ADP
ihlr-28406	655	35	the	the	DET
ihlr-28406	655	36	leading	lead	VERB
ihlr-28406	655	37	cases	case	NOUN
ihlr-28406	655	38	.	.	PUNCT
ihlr-28406	655	39	”	"	PUNCT
ihlr-28406	655	40	)	)	PUNCT
ihlr-28406	655	41	.	.	PUNCT
ihlr-28406	656	1	2024	2024	NUM
ihlr-28406	656	2	]	]	PUNCT
ihlr-28406	656	3	inventions	invention	NOUN
ihlr-28406	656	4	and	and	CCONJ
ihlr-28406	656	5	patents	patent	NOUN
ihlr-28406	656	6	for	for	ADP
ihlr-28406	656	7	treating	treat	VERB
ihlr-28406	656	8	301	301	NUM
ihlr-28406	656	9	thyroid	thyroid	NOUN
ihlr-28406	656	10	disease	disease	NOUN
ihlr-28406	656	11	amount	amount	NOUN
ihlr-28406	656	12	.	.	PUNCT
ihlr-28406	657	1	183	183	NUM
ihlr-28406	657	2	and	and	CCONJ
ihlr-28406	657	3	,	,	PUNCT
ihlr-28406	657	4	courts	court	NOUN
ihlr-28406	657	5	inevitably	inevitably	ADV
ihlr-28406	657	6	have	have	VERB
ihlr-28406	657	7	broad	broad	ADJ
ihlr-28406	657	8	judgment	judgment	NOUN
ihlr-28406	657	9	in	in	ADP
ihlr-28406	657	10	evaluating	evaluate	VERB
ihlr-28406	657	11	the	the	DET
ihlr-28406	657	12	relevant	relevant	ADJ
ihlr-28406	657	13	patent	patent	NOUN
ihlr-28406	657	14	value	value	NOUN
ihlr-28406	657	15	factors	factor	NOUN
ihlr-28406	657	16	.	.	PUNCT
ihlr-28406	658	1	184	184	NUM
ihlr-28406	658	2	however	however	ADV
ihlr-28406	658	3	,	,	PUNCT
ihlr-28406	658	4	there	there	PRON
ihlr-28406	658	5	are	be	VERB
ihlr-28406	658	6	much	much	ADV
ihlr-28406	658	7	better	well	ADJ
ihlr-28406	658	8	ways	way	NOUN
ihlr-28406	658	9	to	to	PART
ihlr-28406	658	10	value	value	VERB
ihlr-28406	658	11	inventions	invention	NOUN
ihlr-28406	658	12	for	for	ADP
ihlr-28406	658	13	new	new	ADJ
ihlr-28406	658	14	treatments	treatment	NOUN
ihlr-28406	658	15	for	for	ADP
ihlr-28406	658	16	thyroid	thyroid	NOUN
ihlr-28406	658	17	disease	disease	NOUN
ihlr-28406	658	18	than	than	ADP
ihlr-28406	658	19	damages	damage	NOUN
ihlr-28406	658	20	.	.	PUNCT
ihlr-28406	659	1	a	a	DET
ihlr-28406	659	2	better	well	ADJ
ihlr-28406	659	3	way	way	NOUN
ihlr-28406	659	4	to	to	PART
ihlr-28406	659	5	think	think	VERB
ihlr-28406	659	6	about	about	ADP
ihlr-28406	659	7	calculating	calculate	VERB
ihlr-28406	659	8	value	value	NOUN
ihlr-28406	659	9	is	be	AUX
ihlr-28406	659	10	with	with	ADP
ihlr-28406	659	11	options	option	NOUN
ihlr-28406	659	12	pricing	pricing	NOUN
ihlr-28406	659	13	185	185	NUM
ihlr-28406	659	14	because	because	SCONJ
ihlr-28406	659	15	option	option	NOUN
ihlr-28406	659	16	valuations	valuation	NOUN
ihlr-28406	659	17	reflect	reflect	VERB
ihlr-28406	659	18	a	a	DET
ihlr-28406	659	19	more	more	ADV
ihlr-28406	659	20	diverse	diverse	ADJ
ihlr-28406	659	21	and	and	CCONJ
ihlr-28406	659	22	accurate	accurate	ADJ
ihlr-28406	659	23	economic	economic	ADJ
ihlr-28406	659	24	information	information	NOUN
ihlr-28406	659	25	source	source	NOUN
ihlr-28406	659	26	.	.	PUNCT
ihlr-28406	660	1	186	186	NUM
ihlr-28406	660	2	real	real	ADJ
ihlr-28406	660	3	options	option	NOUN
ihlr-28406	660	4	theory	theory	NOUN
ihlr-28406	660	5	can	can	AUX
ihlr-28406	660	6	be	be	AUX
ihlr-28406	660	7	used	use	VERB
ihlr-28406	660	8	to	to	PART
ihlr-28406	660	9	value	value	VERB
ihlr-28406	660	10	inventions	invention	NOUN
ihlr-28406	660	11	for	for	ADP
ihlr-28406	660	12	thyroid	thyroid	NOUN
ihlr-28406	660	13	disease	disease	NOUN
ihlr-28406	660	14	to	to	PART
ihlr-28406	660	15	account	account	VERB
ihlr-28406	660	16	the	the	DET
ihlr-28406	660	17	value	value	NOUN
ihlr-28406	660	18	patents	patent	NOUN
ihlr-28406	660	19	add	add	VERB
ihlr-28406	660	20	absent	absent	ADJ
ihlr-28406	660	21	infringement	infringement	NOUN
ihlr-28406	660	22	,	,	PUNCT
ihlr-28406	660	23	such	such	ADJ
ihlr-28406	660	24	as	as	ADP
ihlr-28406	660	25	security	security	NOUN
ihlr-28406	660	26	value	value	NOUN
ihlr-28406	660	27	on	on	ADP
ihlr-28406	660	28	corporate	corporate	ADJ
ihlr-28406	660	29	balance	balance	NOUN
ihlr-28406	660	30	sheets	sheet	NOUN
ihlr-28406	660	31	,	,	PUNCT
ihlr-28406	660	32	as	as	SCONJ
ihlr-28406	660	33	an	an	DET
ihlr-28406	660	34	intellectual	intellectual	ADJ
ihlr-28406	660	35	asset	asset	NOUN
ihlr-28406	660	36	to	to	PART
ihlr-28406	660	37	attract	attract	VERB
ihlr-28406	660	38	grant	grant	NOUN
ihlr-28406	660	39	funding	funding	NOUN
ihlr-28406	660	40	and	and	CCONJ
ihlr-28406	660	41	research	research	NOUN
ihlr-28406	660	42	revenue	revenue	NOUN
ihlr-28406	660	43	,	,	PUNCT
ihlr-28406	660	44	or	or	CCONJ
ihlr-28406	660	45	as	as	ADP
ihlr-28406	660	46	product	product	NOUN
ihlr-28406	660	47	for	for	ADP
ihlr-28406	660	48	the	the	DET
ihlr-28406	660	49	public	public	ADJ
ihlr-28406	660	50	good	good	NOUN
ihlr-28406	660	51	and	and	CCONJ
ihlr-28406	660	52	the	the	DET
ihlr-28406	660	53	associated	associated	ADJ
ihlr-28406	660	54	tax	tax	NOUN
ihlr-28406	660	55	benefits	benefit	NOUN
ihlr-28406	660	56	.	.	PUNCT
ihlr-28406	661	1	187	187	NUM
ihlr-28406	661	2	another	another	DET
ihlr-28406	661	3	option	option	NOUN
ihlr-28406	661	4	could	could	AUX
ihlr-28406	661	5	be	be	AUX
ihlr-28406	661	6	biotechnology	biotechnology	NOUN
ihlr-28406	661	7	patents	patent	NOUN
ihlr-28406	661	8	.	.	PUNCT
ihlr-28406	662	1	for	for	ADP
ihlr-28406	662	2	example	example	NOUN
ihlr-28406	662	3	,	,	PUNCT
ihlr-28406	662	4	the	the	DET
ihlr-28406	662	5	option	option	NOUN
ihlr-28406	662	6	to	to	PART
ihlr-28406	662	7	choose	choose	VERB
ihlr-28406	662	8	between	between	ADP
ihlr-28406	662	9	exclusively	exclusively	ADV
ihlr-28406	662	10	commercializing	commercialize	VERB
ihlr-28406	662	11	the	the	DET
ihlr-28406	662	12	patented	patented	ADJ
ihlr-28406	662	13	invention	invention	NOUN
ihlr-28406	662	14	or	or	CCONJ
ihlr-28406	662	15	foregoing	forego	VERB
ihlr-28406	662	16	commercialization	commercialization	NOUN
ihlr-28406	662	17	altogether	altogether	ADV
ihlr-28406	662	18	adds	add	VERB
ihlr-28406	662	19	value	value	NOUN
ihlr-28406	662	20	to	to	ADP
ihlr-28406	662	21	a	a	DET
ihlr-28406	662	22	company	company	NOUN
ihlr-28406	662	23	insofar	insofar	ADV
ihlr-28406	662	24	as	as	SCONJ
ihlr-28406	662	25	it	it	PRON
ihlr-28406	662	26	provides	provide	VERB
ihlr-28406	662	27	the	the	DET
ihlr-28406	662	28	ability	ability	NOUN
ihlr-28406	662	29	to	to	PART
ihlr-28406	662	30	shape	shape	VERB
ihlr-28406	662	31	innovation	innovation	NOUN
ihlr-28406	662	32	in	in	ADP
ihlr-28406	662	33	the	the	DET
ihlr-28406	662	34	market	market	NOUN
ihlr-28406	662	35	.	.	PUNCT
ihlr-28406	663	1	188	188	NUM
ihlr-28406	663	2	one	one	NUM
ihlr-28406	663	3	of	of	ADP
ihlr-28406	663	4	the	the	DET
ihlr-28406	663	5	first	first	ADJ
ihlr-28406	663	6	steps	step	NOUN
ihlr-28406	663	7	in	in	ADP
ihlr-28406	663	8	framing	frame	VERB
ihlr-28406	663	9	patents	patent	NOUN
ihlr-28406	663	10	as	as	SCONJ
ihlr-28406	663	11	real	real	ADJ
ihlr-28406	663	12	options	option	NOUN
ihlr-28406	663	13	is	be	AUX
ihlr-28406	663	14	to	to	PART
ihlr-28406	663	15	define	define	VERB
ihlr-28406	663	16	the	the	DET
ihlr-28406	663	17	patent	patent	NOUN
ihlr-28406	663	18	’s	’s	PART
ihlr-28406	663	19	market	market	NOUN
ihlr-28406	663	20	price.189	price.189	PROPN
ihlr-28406	663	21	the	the	DET
ihlr-28406	663	22	patent	patent	NOUN
ihlr-28406	663	23	’s	’s	PART
ihlr-28406	663	24	filing	filing	NOUN
ihlr-28406	663	25	fees	fee	NOUN
ihlr-28406	663	26	,	,	PUNCT
ihlr-28406	663	27	and	and	CCONJ
ihlr-28406	663	28	development	development	NOUN
ihlr-28406	663	29	costs	cost	NOUN
ihlr-28406	663	30	contribute	contribute	VERB
ihlr-28406	663	31	components	component	NOUN
ihlr-28406	663	32	for	for	ADP
ihlr-28406	663	33	the	the	DET
ihlr-28406	663	34	patent	patent	NOUN
ihlr-28406	663	35	—	—	PUNCT
ihlr-28406	663	36	—	—	PUNCT
ihlr-28406	663	37	—	—	PUNCT
ihlr-28406	663	38	—	—	PUNCT
ihlr-28406	663	39	—	—	PUNCT
ihlr-28406	663	40	—	—	PUNCT
ihlr-28406	663	41	—	—	PUNCT
ihlr-28406	663	42	—	—	PUNCT
ihlr-28406	663	43	—	—	PUNCT
ihlr-28406	663	44	—	—	PUNCT
ihlr-28406	663	45	—	—	PUNCT
ihlr-28406	663	46	—	—	PUNCT
ihlr-28406	663	47	—	—	PUNCT
ihlr-28406	663	48	—	—	PUNCT
ihlr-28406	663	49	—	—	PUNCT
ihlr-28406	663	50	—	—	PUNCT
ihlr-28406	663	51	—	—	PUNCT
ihlr-28406	663	52	—	—	PUNCT
ihlr-28406	663	53	—	—	PUNCT
ihlr-28406	663	54	—	—	PUNCT
ihlr-28406	663	55	—	—	PUNCT
ihlr-28406	663	56	—	—	PUNCT
ihlr-28406	663	57	—	—	PUNCT
ihlr-28406	663	58	—	—	PUNCT
ihlr-28406	663	59	—	—	PUNCT
ihlr-28406	663	60	—	—	PUNCT
ihlr-28406	663	61	—	—	PUNCT
ihlr-28406	663	62	—	—	PUNCT
ihlr-28406	663	63	—	—	PUNCT
ihlr-28406	663	64	183	183	NUM
ihlr-28406	663	65	.	.	PUNCT
ihlr-28406	664	1	general	general	PROPN
ihlr-28406	664	2	motors	motors	PROPN
ihlr-28406	664	3	corp	corp	PROPN
ihlr-28406	665	1	.	.	PROPN
ihlr-28406	665	2	v.	v.	ADP
ihlr-28406	665	3	dailey	dailey	PROPN
ihlr-28406	665	4	,	,	PUNCT
ihlr-28406	665	5	93	93	NUM
ihlr-28406	665	6	f.2d	f.2d	NOUN
ihlr-28406	665	7	938	938	NUM
ihlr-28406	665	8	,	,	PUNCT
ihlr-28406	665	9	942	942	NUM
ihlr-28406	665	10	(	(	PUNCT
ihlr-28406	665	11	6th	6th	ADJ
ihlr-28406	665	12	cir	cir	NOUN
ihlr-28406	665	13	.	.	PUNCT
ihlr-28406	665	14	1937	1937	NUM
ihlr-28406	665	15	)	)	PUNCT
ihlr-28406	665	16	.	.	PUNCT
ihlr-28406	666	1	184	184	X
ihlr-28406	666	2	.	.	PUNCT
ihlr-28406	667	1	see	see	VERB
ihlr-28406	667	2	georgia	georgia	PROPN
ihlr-28406	667	3	-	-	PUNCT
ihlr-28406	667	4	pacific	pacific	PROPN
ihlr-28406	667	5	corp	corp	PROPN
ihlr-28406	667	6	.	.	PROPN
ihlr-28406	668	1	v.	v.	PROPN
ihlr-28406	668	2	united	united	PROPN
ihlr-28406	668	3	states	states	PROPN
ihlr-28406	668	4	plywood	plywood	PROPN
ihlr-28406	668	5	corp	corp	PROPN
ihlr-28406	668	6	.	.	PROPN
ihlr-28406	668	7	,	,	PUNCT
ihlr-28406	668	8	318	318	NUM
ihlr-28406	668	9	f.	f.	PROPN
ihlr-28406	668	10	supp	supp	PROPN
ihlr-28406	668	11	.	.	PUNCT
ihlr-28406	669	1	at	at	ADP
ihlr-28406	669	2	1116	1116	NUM
ihlr-28406	669	3	.	.	PUNCT
ihlr-28406	670	1	185	185	NUM
ihlr-28406	670	2	.	.	PUNCT
ihlr-28406	671	1	real	real	ADJ
ihlr-28406	671	2	options	option	NOUN
ihlr-28406	671	3	are	be	AUX
ihlr-28406	671	4	a	a	DET
ihlr-28406	671	5	financial	financial	ADJ
ihlr-28406	671	6	derivatives	derivative	NOUN
ihlr-28406	671	7	contract	contract	NOUN
ihlr-28406	671	8	creating	create	VERB
ihlr-28406	671	9	the	the	DET
ihlr-28406	671	10	right	right	NOUN
ihlr-28406	671	11	to	to	PART
ihlr-28406	671	12	purchase	purchase	VERB
ihlr-28406	671	13	an	an	DET
ihlr-28406	671	14	underlying	underlie	VERB
ihlr-28406	671	15	asset	asset	NOUN
ihlr-28406	671	16	at	at	ADP
ihlr-28406	671	17	a	a	DET
ihlr-28406	671	18	defined	define	VERB
ihlr-28406	671	19	price	price	NOUN
ihlr-28406	671	20	.	.	PUNCT
ihlr-28406	672	1	every	every	DET
ihlr-28406	672	2	option	option	NOUN
ihlr-28406	672	3	has	have	VERB
ihlr-28406	672	4	a	a	DET
ihlr-28406	672	5	price	price	NOUN
ihlr-28406	672	6	and	and	CCONJ
ihlr-28406	672	7	the	the	DET
ihlr-28406	672	8	decisions	decision	NOUN
ihlr-28406	672	9	available	available	ADJ
ihlr-28406	672	10	to	to	ADP
ihlr-28406	672	11	a	a	DET
ihlr-28406	672	12	company	company	NOUN
ihlr-28406	672	13	can	can	AUX
ihlr-28406	672	14	be	be	AUX
ihlr-28406	672	15	characterized	characterize	VERB
ihlr-28406	672	16	as	as	ADP
ihlr-28406	672	17	real	real	ADJ
ihlr-28406	672	18	options	option	NOUN
ihlr-28406	672	19	and	and	CCONJ
ihlr-28406	672	20	defined	define	VERB
ihlr-28406	672	21	in	in	ADP
ihlr-28406	672	22	terms	term	NOUN
ihlr-28406	672	23	of	of	ADP
ihlr-28406	672	24	value	value	NOUN
ihlr-28406	672	25	by	by	ADP
ihlr-28406	672	26	elements	element	NOUN
ihlr-28406	672	27	like	like	ADP
ihlr-28406	672	28	exercise	exercise	NOUN
ihlr-28406	672	29	price	price	NOUN
ihlr-28406	672	30	or	or	CCONJ
ihlr-28406	672	31	expiration	expiration	NOUN
ihlr-28406	672	32	date	date	NOUN
ihlr-28406	672	33	.	.	PUNCT
ihlr-28406	673	1	there	there	PRON
ihlr-28406	673	2	are	be	VERB
ihlr-28406	673	3	five	five	NUM
ihlr-28406	673	4	key	key	ADJ
ihlr-28406	673	5	elements	element	NOUN
ihlr-28406	673	6	for	for	ADP
ihlr-28406	673	7	options	option	NOUN
ihlr-28406	673	8	:	:	PUNCT
ihlr-28406	673	9	(	(	PUNCT
ihlr-28406	673	10	1	1	X
ihlr-28406	673	11	)	)	PUNCT
ihlr-28406	673	12	a	a	DET
ihlr-28406	673	13	right	right	NOUN
ihlr-28406	673	14	but	but	CCONJ
ihlr-28406	673	15	not	not	PART
ihlr-28406	673	16	an	an	DET
ihlr-28406	673	17	obligation	obligation	NOUN
ihlr-28406	673	18	,	,	PUNCT
ihlr-28406	673	19	(	(	PUNCT
ihlr-28406	673	20	2	2	X
ihlr-28406	673	21	)	)	PUNCT
ihlr-28406	673	22	at	at	ADP
ihlr-28406	673	23	or	or	CCONJ
ihlr-28406	673	24	before	before	ADP
ihlr-28406	673	25	some	some	DET
ihlr-28406	673	26	specified	specify	VERB
ihlr-28406	673	27	time	time	NOUN
ihlr-28406	673	28	(	(	PUNCT
ihlr-28406	673	29	3	3	NUM
ihlr-28406	673	30	)	)	PUNCT
ihlr-28406	673	31	to	to	PART
ihlr-28406	673	32	purchase	purchase	VERB
ihlr-28406	673	33	a	a	DET
ihlr-28406	673	34	call	call	NOUN
ihlr-28406	673	35	option	option	NOUN
ihlr-28406	673	36	,	,	PUNCT
ihlr-28406	673	37	or	or	CCONJ
ihlr-28406	673	38	sell	sell	VERB
ihlr-28406	673	39	a	a	DET
ihlr-28406	673	40	put	put	NOUN
ihlr-28406	673	41	option	option	NOUN
ihlr-28406	673	42	(	(	PUNCT
ihlr-28406	673	43	4	4	NUM
ihlr-28406	673	44	)	)	PUNCT
ihlr-28406	673	45	at	at	ADP
ihlr-28406	673	46	a	a	DET
ihlr-28406	673	47	prespecified	prespecified	ADJ
ihlr-28406	673	48	price	price	NOUN
ihlr-28406	673	49	the	the	DET
ihlr-28406	673	50	exercise	exercise	NOUN
ihlr-28406	673	51	price	price	NOUN
ihlr-28406	673	52	(	(	PUNCT
ihlr-28406	673	53	5	5	NUM
ihlr-28406	673	54	)	)	PUNCT
ihlr-28406	673	55	an	an	DET
ihlr-28406	673	56	underlying	underlie	VERB
ihlr-28406	673	57	asset	asset	NOUN
ihlr-28406	673	58	whose	whose	DET
ihlr-28406	673	59	price	price	NOUN
ihlr-28406	673	60	is	be	AUX
ihlr-28406	673	61	subject	subject	ADJ
ihlr-28406	673	62	to	to	ADP
ihlr-28406	673	63	some	some	DET
ihlr-28406	673	64	form	form	NOUN
ihlr-28406	673	65	of	of	ADP
ihlr-28406	673	66	random	random	ADJ
ihlr-28406	673	67	variation	variation	NOUN
ihlr-28406	673	68	.	.	PUNCT
ihlr-28406	674	1	see	see	VERB
ihlr-28406	674	2	nikitas	nikita	NOUN
ihlr-28406	674	3	stamatopoulos	stamatopoulos	PROPN
ihlr-28406	674	4	,	,	PUNCT
ihlr-28406	674	5	et	et	PROPN
ihlr-28406	674	6	al	al	PROPN
ihlr-28406	674	7	.	.	PROPN
ihlr-28406	674	8	,	,	PUNCT
ihlr-28406	674	9	option	option	NOUN
ihlr-28406	674	10	pricing	pricing	NOUN
ihlr-28406	674	11	using	use	VERB
ihlr-28406	674	12	quantum	quantum	ADJ
ihlr-28406	674	13	computers	computer	NOUN
ihlr-28406	674	14	,	,	PUNCT
ihlr-28406	674	15	4	4	NUM
ihlr-28406	674	16	quantum	quantum	NOUN
ihlr-28406	674	17	291	291	NUM
ihlr-28406	674	18	,	,	PUNCT
ihlr-28406	674	19	291	291	NUM
ihlr-28406	674	20	(	(	PUNCT
ihlr-28406	674	21	2020	2020	NUM
ihlr-28406	674	22	)	)	PUNCT
ihlr-28406	674	23	,	,	PUNCT
ihlr-28406	674	24	https://arxiv.org/abs/1905.02666	https://arxiv.org/abs/1905.02666	NOUN
ihlr-28406	674	25	.	.	PUNCT
ihlr-28406	675	1	(	(	PUNCT
ihlr-28406	675	2	“	"	PUNCT
ihlr-28406	675	3	options	option	NOUN
ihlr-28406	675	4	are	be	AUX
ihlr-28406	675	5	financial	financial	ADJ
ihlr-28406	675	6	derivative	derivative	ADJ
ihlr-28406	675	7	contracts	contract	NOUN
ihlr-28406	675	8	that	that	PRON
ihlr-28406	675	9	give	give	VERB
ihlr-28406	675	10	the	the	DET
ihlr-28406	675	11	buyer	buyer	NOUN
ihlr-28406	675	12	the	the	DET
ihlr-28406	675	13	right	right	NOUN
ihlr-28406	675	14	,	,	PUNCT
ihlr-28406	675	15	but	but	CCONJ
ihlr-28406	675	16	not	not	PART
ihlr-28406	675	17	the	the	DET
ihlr-28406	675	18	obligation	obligation	NOUN
ihlr-28406	675	19	,	,	PUNCT
ihlr-28406	675	20	to	to	PART
ihlr-28406	675	21	buy	buy	VERB
ihlr-28406	675	22	(	(	PUNCT
ihlr-28406	675	23	call	call	NOUN
ihlr-28406	675	24	option	option	NOUN
ihlr-28406	675	25	)	)	PUNCT
ihlr-28406	675	26	or	or	CCONJ
ihlr-28406	675	27	sell	sell	VERB
ihlr-28406	675	28	(	(	PUNCT
ihlr-28406	675	29	put	put	NOUN
ihlr-28406	675	30	option	option	NOUN
ihlr-28406	675	31	)	)	PUNCT
ihlr-28406	675	32	an	an	DET
ihlr-28406	675	33	underlying	underlie	VERB
ihlr-28406	675	34	asset	asset	NOUN
ihlr-28406	675	35	at	at	ADP
ihlr-28406	675	36	an	an	DET
ihlr-28406	675	37	agreed	agree	VERB
ihlr-28406	675	38	-	-	PUNCT
ihlr-28406	675	39	upon	upon	NOUN
ihlr-28406	675	40	price	price	NOUN
ihlr-28406	675	41	(	(	PUNCT
ihlr-28406	675	42	strike	strike	NOUN
ihlr-28406	675	43	)	)	PUNCT
ihlr-28406	675	44	and	and	CCONJ
ihlr-28406	675	45	timeframe	timeframe	NOUN
ihlr-28406	675	46	.	.	PUNCT
ihlr-28406	675	47	”	"	PUNCT
ihlr-28406	675	48	)	)	PUNCT
ihlr-28406	675	49	see	see	VERB
ihlr-28406	675	50	also	also	ADV
ihlr-28406	675	51	andrew	andrew	PROPN
ihlr-28406	675	52	chin	chin	PROPN
ihlr-28406	675	53	,	,	PUNCT
ihlr-28406	675	54	teaching	teach	VERB
ihlr-28406	675	55	patents	patent	NOUN
ihlr-28406	675	56	as	as	ADP
ihlr-28406	675	57	real	real	ADJ
ihlr-28406	675	58	options	option	NOUN
ihlr-28406	675	59	,	,	PUNCT
ihlr-28406	675	60	95	95	NUM
ihlr-28406	675	61	n.c	n.c	PROPN
ihlr-28406	675	62	.	.	PROPN
ihlr-28406	675	63	l.	l.	PROPN
ihlr-28406	675	64	rev	rev	PROPN
ihlr-28406	675	65	.	.	PROPN
ihlr-28406	675	66	1433	1433	NUM
ihlr-28406	675	67	,	,	PUNCT
ihlr-28406	675	68	1441	1441	NUM
ihlr-28406	675	69	(	(	PUNCT
ihlr-28406	675	70	2017	2017	NUM
ihlr-28406	675	71	)	)	PUNCT
ihlr-28406	675	72	,	,	PUNCT
ihlr-28406	675	73	http://scholarship.law.unc.edu/nclr/vol95/iss5/4	http://scholarship.law.unc.edu/nclr/vol95/iss5/4	NOUN
ihlr-28406	675	74	.	.	PUNCT
ihlr-28406	676	1	(	(	PUNCT
ihlr-28406	676	2	“	"	PUNCT
ihlr-28406	676	3	a	a	DET
ihlr-28406	676	4	real	real	ADJ
ihlr-28406	676	5	option	option	NOUN
ihlr-28406	676	6	is	be	AUX
ihlr-28406	676	7	the	the	DET
ihlr-28406	676	8	right	right	NOUN
ihlr-28406	676	9	,	,	PUNCT
ihlr-28406	676	10	but	but	CCONJ
ihlr-28406	676	11	not	not	PART
ihlr-28406	676	12	the	the	DET
ihlr-28406	676	13	obligation	obligation	NOUN
ihlr-28406	676	14	,	,	PUNCT
ihlr-28406	676	15	to	to	PART
ihlr-28406	676	16	pay	pay	VERB
ihlr-28406	676	17	a	a	DET
ihlr-28406	676	18	predetermined	predetermine	VERB
ihlr-28406	676	19	price	price	NOUN
ihlr-28406	676	20	to	to	PART
ihlr-28406	676	21	undertake	undertake	VERB
ihlr-28406	676	22	a	a	DET
ihlr-28406	676	23	potentially	potentially	ADV
ihlr-28406	676	24	profitable	profitable	ADJ
ihlr-28406	676	25	action	action	NOUN
ihlr-28406	676	26	in	in	ADP
ihlr-28406	676	27	the	the	DET
ihlr-28406	676	28	future	future	NOUN
ihlr-28406	676	29	.	.	PUNCT
ihlr-28406	676	30	”	"	PUNCT
ihlr-28406	676	31	)	)	PUNCT
ihlr-28406	676	32	see	see	VERB
ihlr-28406	676	33	also	also	ADV
ihlr-28406	676	34	robert	robert	PROPN
ihlr-28406	676	35	pitkethly	pitkethly	ADV
ihlr-28406	676	36	,	,	PUNCT
ihlr-28406	676	37	the	the	DET
ihlr-28406	676	38	valuation	valuation	NOUN
ihlr-28406	676	39	of	of	ADP
ihlr-28406	676	40	patents	patent	NOUN
ihlr-28406	676	41	:	:	PUNCT
ihlr-28406	676	42	a	a	DET
ihlr-28406	676	43	review	review	NOUN
ihlr-28406	676	44	of	of	ADP
ihlr-28406	676	45	patent	patent	NOUN
ihlr-28406	676	46	valuation	valuation	NOUN
ihlr-28406	676	47	methods	method	NOUN
ihlr-28406	676	48	with	with	ADP
ihlr-28406	676	49	consideration	consideration	NOUN
ihlr-28406	676	50	of	of	ADP
ihlr-28406	676	51	option	option	NOUN
ihlr-28406	676	52	-	-	PUNCT
ihlr-28406	676	53	based	base	VERB
ihlr-28406	676	54	methods	method	NOUN
ihlr-28406	676	55	and	and	CCONJ
ihlr-28406	676	56	the	the	DET
ihlr-28406	676	57	potential	potential	NOUN
ihlr-28406	676	58	for	for	ADP
ihlr-28406	676	59	further	further	ADJ
ihlr-28406	676	60	research	research	NOUN
ihlr-28406	676	61	,	,	PUNCT
ihlr-28406	676	62	judge	judge	NOUN
ihlr-28406	676	63	inst	inst	PROPN
ihlr-28406	676	64	.	.	PUNCT
ihlr-28406	677	1	working	working	NOUN
ihlr-28406	677	2	paper	paper	NOUN
ihlr-28406	677	3	(	(	PUNCT
ihlr-28406	677	4	1997	1997	NUM
ihlr-28406	677	5	)	)	PUNCT
ihlr-28406	677	6	,	,	PUNCT
ihlr-28406	677	7	http://users.ox.ac.uk/~mast0140/ejwp0599.pdf	http://users.ox.ac.uk/~mast0140/ejwp0599.pdf	X
ihlr-28406	677	8	.	.	PUNCT
ihlr-28406	678	1	186	186	NUM
ihlr-28406	678	2	.	.	PUNCT
ihlr-28406	678	3	christopher	christopher	PROPN
ihlr-28406	678	4	a.	a.	PROPN
ihlr-28406	678	5	cotropia	cotropia	PROPN
ihlr-28406	678	6	,	,	PUNCT
ihlr-28406	678	7	describing	describe	VERB
ihlr-28406	678	8	patents	patent	NOUN
ihlr-28406	678	9	as	as	ADP
ihlr-28406	678	10	real	real	ADJ
ihlr-28406	678	11	options	option	NOUN
ihlr-28406	678	12	,	,	PUNCT
ihlr-28406	678	13	34	34	NUM
ihlr-28406	678	14	j.	j.	PROPN
ihlr-28406	678	15	corp	corp	PROPN
ihlr-28406	678	16	.	.	PROPN
ihlr-28406	678	17	l.	l.	PROPN
ihlr-28406	678	18	1127	1127	NUM
ihlr-28406	678	19	,	,	PUNCT
ihlr-28406	678	20	1128	1128	NUM
ihlr-28406	678	21	(	(	PUNCT
ihlr-28406	678	22	2009	2009	NUM
ihlr-28406	678	23	)	)	PUNCT
ihlr-28406	678	24	.	.	PUNCT
ihlr-28406	679	1	187	187	NUM
ihlr-28406	679	2	.	.	PUNCT
ihlr-28406	680	1	i	i	PRON
ihlr-28406	680	2	d.	d.	PROPN
ihlr-28406	680	3	at	at	ADP
ihlr-28406	680	4	1131	1131	NUM
ihlr-28406	680	5	.	.	PUNCT
ihlr-28406	681	1	188	188	NUM
ihlr-28406	681	2	.	.	PUNCT
ihlr-28406	681	3	maria	maria	PROPN
ihlr-28406	681	4	isabella	isabella	PROPN
ihlr-28406	681	5	leone	leone	PROPN
ihlr-28406	681	6	&	&	CCONJ
ihlr-28406	681	7	raffaele	raffaele	PROPN
ihlr-28406	681	8	oriani	oriani	PROPN
ihlr-28406	681	9	,	,	PUNCT
ihlr-28406	681	10	the	the	DET
ihlr-28406	681	11	option	option	NOUN
ihlr-28406	681	12	value	value	NOUN
ihlr-28406	681	13	of	of	ADP
ihlr-28406	681	14	patent	patent	NOUN
ihlr-28406	681	15	licenses	license	NOUN
ihlr-28406	681	16	,	,	PUNCT
ihlr-28406	681	17	2	2	NUM
ihlr-28406	681	18	(	(	PUNCT
ihlr-28406	681	19	2007	2007	NUM
ihlr-28406	681	20	)	)	PUNCT
ihlr-28406	681	21	,	,	PUNCT
ihlr-28406	681	22	https://www.researchgate.net/publication/252398618_the_option_value_of_patent_licenses	https://www.researchgate.net/publication/252398618_the_option_value_of_patent_license	NOUN
ihlr-28406	681	23	.	.	PUNCT
ihlr-28406	682	1	(	(	PUNCT
ihlr-28406	682	2	as	as	ADP
ihlr-28406	682	3	a	a	DET
ihlr-28406	682	4	consequence	consequence	NOUN
ihlr-28406	682	5	,	,	PUNCT
ihlr-28406	682	6	recent	recent	ADJ
ihlr-28406	682	7	attempts	attempt	NOUN
ihlr-28406	682	8	in	in	ADP
ihlr-28406	682	9	patent	patent	NOUN
ihlr-28406	682	10	valuation	valuation	NOUN
ihlr-28406	682	11	efforts	effort	NOUN
ihlr-28406	682	12	have	have	AUX
ihlr-28406	682	13	been	be	AUX
ihlr-28406	682	14	developed	develop	VERB
ihlr-28406	682	15	with	with	ADP
ihlr-28406	682	16	a	a	DET
ihlr-28406	682	17	real	real	ADJ
ihlr-28406	682	18	options	option	NOUN
ihlr-28406	682	19	framework	framework	NOUN
ihlr-28406	682	20	,	,	PUNCT
ihlr-28406	682	21	recognizing	recognize	VERB
ihlr-28406	682	22	uncertainty	uncertainty	NOUN
ihlr-28406	682	23	in	in	ADP
ihlr-28406	682	24	patent	patent	NOUN
ihlr-28406	682	25	value	value	NOUN
ihlr-28406	682	26	.	.	PUNCT
ihlr-28406	682	27	)	)	PUNCT
ihlr-28406	682	28	.	.	PUNCT
ihlr-28406	683	1	189	189	NUM
ihlr-28406	683	2	.	.	PUNCT
ihlr-28406	684	1	a	a	DET
ihlr-28406	684	2	technology	technology	NOUN
ihlr-28406	684	3	’s	’s	PART
ihlr-28406	684	4	market	market	NOUN
ihlr-28406	684	5	value	value	NOUN
ihlr-28406	684	6	is	be	AUX
ihlr-28406	684	7	connected	connect	VERB
ihlr-28406	684	8	to	to	ADP
ihlr-28406	684	9	licensing	license	VERB
ihlr-28406	684	10	revenues	revenue	NOUN
ihlr-28406	684	11	and	and	CCONJ
ihlr-28406	684	12	sales	sale	NOUN
ihlr-28406	684	13	.	.	PUNCT
ihlr-28406	685	1	importantly	importantly	ADV
ihlr-28406	685	2	,	,	PUNCT
ihlr-28406	685	3	patents	patent	NOUN
ihlr-28406	685	4	are	be	AUX
ihlr-28406	685	5	a	a	DET
ihlr-28406	685	6	valuable	valuable	ADJ
ihlr-28406	685	7	asset	asset	NOUN
ihlr-28406	685	8	class	class	NOUN
ihlr-28406	685	9	in	in	ADP
ihlr-28406	685	10	information	information	NOUN
ihlr-28406	685	11	and	and	CCONJ
ihlr-28406	685	12	knowledge	knowledge	NOUN
ihlr-28406	685	13	economies	economy	NOUN
ihlr-28406	685	14	.	.	PUNCT
ihlr-28406	686	1	this	this	PRON
ihlr-28406	686	2	is	be	AUX
ihlr-28406	686	3	especially	especially	ADV
ihlr-28406	686	4	true	true	ADJ
ihlr-28406	686	5	for	for	ADP
ihlr-28406	686	6	high	high	ADJ
ihlr-28406	686	7	-	-	PUNCT
ihlr-28406	686	8	technology	technology	NOUN
ihlr-28406	686	9	and	and	CCONJ
ihlr-28406	686	10	pharmaceutical	pharmaceutical	NOUN
ihlr-28406	686	11	companies	company	NOUN
ihlr-28406	686	12	working	work	VERB
ihlr-28406	686	13	in	in	ADP
ihlr-28406	686	14	the	the	DET
ihlr-28406	686	15	synthetic	synthetic	ADJ
ihlr-28406	686	16	life	life	NOUN
ihlr-28406	686	17	space	space	NOUN
ihlr-28406	686	18	.	.	PUNCT
ihlr-28406	687	1	see	see	VERB
ihlr-28406	687	2	stefania	stefania	PROPN
ihlr-28406	687	3	fusco	fusco	PROPN
ihlr-28406	687	4	,	,	PUNCT
ihlr-28406	687	5	the	the	DET
ihlr-28406	687	6	patentability	patentability	NOUN
ihlr-28406	687	7	of	of	ADP
ihlr-28406	687	8	financial	financial	ADJ
ihlr-28406	687	9	methods	method	NOUN
ihlr-28406	687	10	:	:	PUNCT
ihlr-28406	687	11	the	the	DET
ihlr-28406	687	12	market	market	NOUN
ihlr-28406	687	13	participants	participant	NOUN
ihlr-28406	687	14	’	'	PUNCT
ihlr-28406	687	15	perspectives	perspective	NOUN
ihlr-28406	687	16	,	,	PUNCT
ihlr-28406	687	17	45	45	NUM
ihlr-28406	687	18	loy	loy	PROPN
ihlr-28406	687	19	.	.	PUNCT
ihlr-28406	688	1	l.a	l.a	PROPN
ihlr-28406	688	2	.	.	PROPN
ihlr-28406	688	3	l.	l.	PROPN
ihlr-28406	688	4	rev	rev	PROPN
ihlr-28406	688	5	.	.	PROPN
ihlr-28406	688	6	1	1	NUM
ihlr-28406	688	7	(	(	PUNCT
ihlr-28406	688	8	2011	2011	NUM
ihlr-28406	688	9	)	)	PUNCT
ihlr-28406	688	10	,	,	PUNCT
ihlr-28406	688	11	https://ssrn.com/abstract=1800853	https://ssrn.com/abstract=1800853	PROPN
ihlr-28406	688	12	.	.	PUNCT
ihlr-28406	689	1	(	(	PUNCT
ihlr-28406	689	2	discussing	discuss	VERB
ihlr-28406	689	3	the	the	DET
ihlr-28406	689	4	patent	patent	NOUN
ihlr-28406	689	5	and	and	CCONJ
ihlr-28406	689	6	innovation	innovation	NOUN
ihlr-28406	689	7	in	in	ADP
ihlr-28406	689	8	the	the	DET
ihlr-28406	689	9	financial	financial	ADJ
ihlr-28406	689	10	industry	industry	NOUN
ihlr-28406	689	11	with	with	ADP
ihlr-28406	689	12	data	datum	NOUN
ihlr-28406	689	13	analytics	analytic	NOUN
ihlr-28406	689	14	compiled	compile	VERB
ihlr-28406	689	15	through	through	ADP
ihlr-28406	689	16	market	market	NOUN
ihlr-28406	689	17	surveys	survey	NOUN
ihlr-28406	689	18	and	and	CCONJ
ihlr-28406	689	19	interviews	interview	NOUN
ihlr-28406	689	20	.	.	PUNCT
ihlr-28406	689	21	)	)	PUNCT
ihlr-28406	690	1	see	see	AUX
ihlr-28406	690	2	also	also	ADV
ihlr-28406	690	3	ted	te	VERB
ihlr-28406	690	4	hagelin	hagelin	PROPN
ihlr-28406	690	5	,	,	PUNCT
ihlr-28406	690	6	a	a	DET
ihlr-28406	690	7	new	new	ADJ
ihlr-28406	690	8	method	method	NOUN
ihlr-28406	690	9	to	to	PART
ihlr-28406	690	10	value	value	VERB
ihlr-28406	690	11	intellectual	intellectual	ADJ
ihlr-28406	690	12	property	property	NOUN
ihlr-28406	690	13	,	,	PUNCT
ihlr-28406	690	14	30	30	NUM
ihlr-28406	690	15	aipla	aipla	ADJ
ihlr-28406	690	16	q.	q.	PROPN
ihlr-28406	690	17	j.	j.	PROPN
ihlr-28406	690	18	353	353	PROPN
ihlr-28406	690	19	,	,	PUNCT
ihlr-28406	690	20	362	362	NUM
ihlr-28406	690	21	(	(	PUNCT
ihlr-28406	690	22	2002	2002	NUM
ihlr-28406	690	23	)	)	PUNCT
ihlr-28406	690	24	.	.	PUNCT
ihlr-28406	691	1	https://ssrn.com/abstract=1800853	https://ssrn.com/abstract=1800853	PROPN
ihlr-28406	691	2	https://www.researchgate.net/publication/252398618_the_option_value_of_patent_licenses	https://www.researchgate.net/publication/252398618_the_option_value_of_patent_license	VERB
ihlr-28406	691	3	http://users.ox.ac.uk/~mast0140/ejwp0599.pdf	http://users.ox.ac.uk/~mast0140/ejwp0599.pdf	PROPN
ihlr-28406	691	4	http://scholarship.law.unc.edu/nclr/vol95/iss5/4	http://scholarship.law.unc.edu/nclr/vol95/iss5/4	PROPN
ihlr-28406	691	5	https://arxiv.org/abs/1905.02666	https://arxiv.org/abs/1905.02666	PROPN
ihlr-28406	691	6	indiana	indiana	PROPN
ihlr-28406	691	7	health	health	PROPN
ihlr-28406	691	8	law	law	PROPN
ihlr-28406	691	9	review	review	NOUN
ihlr-28406	692	1	[	[	X
ihlr-28406	692	2	vol	vol	NOUN
ihlr-28406	692	3	.	.	PUNCT
ihlr-28406	693	1	21:277	21:277	NOUN
ihlr-28406	693	2	302	302	NUM
ihlr-28406	693	3	option	option	NOUN
ihlr-28406	693	4	price	price	NOUN
ihlr-28406	693	5	.	.	PUNCT
ihlr-28406	694	1	190	190	NUM
ihlr-28406	694	2	as	as	ADP
ihlr-28406	694	3	such	such	ADJ
ihlr-28406	694	4	,	,	PUNCT
ihlr-28406	694	5	for	for	ADP
ihlr-28406	694	6	thyroid	thyroid	NOUN
ihlr-28406	694	7	patents	patent	NOUN
ihlr-28406	694	8	,	,	PUNCT
ihlr-28406	694	9	options	option	NOUN
ihlr-28406	694	10	pricing	pricing	NOUN
ihlr-28406	694	11	may	may	AUX
ihlr-28406	694	12	be	be	AUX
ihlr-28406	694	13	valuable	valuable	ADJ
ihlr-28406	694	14	due	due	ADP
ihlr-28406	694	15	to	to	ADP
ihlr-28406	694	16	the	the	DET
ihlr-28406	694	17	need	need	NOUN
ihlr-28406	694	18	for	for	ADP
ihlr-28406	694	19	narrow	narrow	ADJ
ihlr-28406	694	20	and	and	CCONJ
ihlr-28406	694	21	specialized	specialized	ADJ
ihlr-28406	694	22	skillsets	skillset	NOUN
ihlr-28406	694	23	in	in	ADP
ihlr-28406	694	24	drafting	drafting	NOUN
ihlr-28406	694	25	.	.	PUNCT
ihlr-28406	695	1	options	option	NOUN
ihlr-28406	695	2	pricing	pricing	NOUN
ihlr-28406	695	3	models	model	NOUN
ihlr-28406	695	4	also	also	ADV
ihlr-28406	695	5	account	account	VERB
ihlr-28406	695	6	for	for	ADP
ihlr-28406	695	7	costs	cost	NOUN
ihlr-28406	695	8	,	,	PUNCT
ihlr-28406	695	9	191	191	NUM
ihlr-28406	695	10	profits,192	profits,192	NOUN
ihlr-28406	695	11	and	and	CCONJ
ihlr-28406	695	12	royalties	royalty	NOUN
ihlr-28406	695	13	.	.	PUNCT
ihlr-28406	696	1	193	193	NUM
ihlr-28406	696	2	for	for	ADP
ihlr-28406	696	3	example	example	NOUN
ihlr-28406	696	4	,	,	PUNCT
ihlr-28406	696	5	the	the	DET
ihlr-28406	696	6	option	option	NOUN
ihlr-28406	696	7	price	price	NOUN
ihlr-28406	696	8	in	in	ADP
ihlr-28406	696	9	a	a	DET
ihlr-28406	696	10	licensing	licensing	NOUN
ihlr-28406	696	11	contract	contract	NOUN
ihlr-28406	696	12	for	for	ADP
ihlr-28406	696	13	a	a	DET
ihlr-28406	696	14	new	new	ADJ
ihlr-28406	696	15	treatment	treatment	NOUN
ihlr-28406	696	16	to	to	ADP
ihlr-28406	696	17	hyperthyroidism	hyperthyroidism	NOUN
ihlr-28406	696	18	would	would	AUX
ihlr-28406	696	19	include	include	VERB
ihlr-28406	696	20	the	the	DET
ihlr-28406	696	21	licensee	licensee	NOUN
ihlr-28406	696	22	’s	’s	PART
ihlr-28406	696	23	initial	initial	ADJ
ihlr-28406	696	24	fee	fee	NOUN
ihlr-28406	696	25	to	to	PART
ihlr-28406	696	26	acquire	acquire	VERB
ihlr-28406	696	27	the	the	DET
ihlr-28406	696	28	right	right	NOUN
ihlr-28406	696	29	to	to	PART
ihlr-28406	696	30	develop	develop	VERB
ihlr-28406	696	31	,	,	PUNCT
ihlr-28406	696	32	future	future	ADJ
ihlr-28406	696	33	payments	payment	NOUN
ihlr-28406	696	34	resulting	result	VERB
ihlr-28406	696	35	from	from	ADP
ihlr-28406	696	36	market	market	NOUN
ihlr-28406	696	37	exclusivity	exclusivity	NOUN
ihlr-28406	696	38	,	,	PUNCT
ihlr-28406	696	39	and	and	CCONJ
ihlr-28406	696	40	the	the	DET
ihlr-28406	696	41	cost	cost	NOUN
ihlr-28406	696	42	to	to	PART
ihlr-28406	696	43	commercialize	commercialize	VERB
ihlr-28406	696	44	the	the	DET
ihlr-28406	696	45	underlying	underlie	VERB
ihlr-28406	696	46	technology.194	technology.194	PROPN
ihlr-28406	696	47	patent	patent	NOUN
ihlr-28406	696	48	valuation	valuation	NOUN
ihlr-28406	696	49	methods	method	NOUN
ihlr-28406	696	50	are	be	AUX
ihlr-28406	696	51	a	a	DET
ihlr-28406	696	52	starting	starting	NOUN
ihlr-28406	696	53	point	point	NOUN
ihlr-28406	696	54	towards	towards	ADP
ihlr-28406	696	55	better	well	ADJ
ihlr-28406	696	56	ip	ip	PRON
ihlr-28406	696	57	strategy	strategy	NOUN
ihlr-28406	696	58	.	.	PUNCT
ihlr-28406	697	1	195	195	NUM
ihlr-28406	697	2	this	this	DET
ihlr-28406	697	3	paper	paper	NOUN
ihlr-28406	697	4	seeks	seek	VERB
ihlr-28406	697	5	to	to	PART
ihlr-28406	697	6	advance	advance	VERB
ihlr-28406	697	7	the	the	DET
ihlr-28406	697	8	literature	literature	NOUN
ihlr-28406	697	9	toward	toward	ADP
ihlr-28406	697	10	a	a	DET
ihlr-28406	697	11	concrete	concrete	ADJ
ihlr-28406	697	12	framework	framework	NOUN
ihlr-28406	697	13	for	for	ADP
ihlr-28406	697	14	thyroid	thyroid	NOUN
ihlr-28406	697	15	patent	patent	NOUN
ihlr-28406	697	16	valuation	valuation	NOUN
ihlr-28406	697	17	by	by	ADP
ihlr-28406	697	18	defining	define	VERB
ihlr-28406	697	19	patent	patent	NOUN
ihlr-28406	697	20	value	value	NOUN
ihlr-28406	697	21	metrics	metric	NOUN
ihlr-28406	697	22	with	with	ADP
ihlr-28406	697	23	reference	reference	NOUN
ihlr-28406	697	24	to	to	ADP
ihlr-28406	697	25	the	the	DET
ihlr-28406	697	26	state	state	NOUN
ihlr-28406	697	27	-	-	PUNCT
ihlr-28406	697	28	of	of	ADP
ihlr-28406	697	29	-	-	PUNCT
ihlr-28406	697	30	the	the	DET
ihlr-28406	697	31	-	-	PUNCT
ihlr-28406	697	32	art	art	NOUN
ihlr-28406	697	33	.	.	PUNCT
ihlr-28406	698	1	one	one	NUM
ihlr-28406	698	2	problem	problem	NOUN
ihlr-28406	698	3	that	that	PRON
ihlr-28406	698	4	persists	persist	VERB
ihlr-28406	698	5	is	be	AUX
ihlr-28406	698	6	how	how	SCONJ
ihlr-28406	698	7	to	to	PART
ihlr-28406	698	8	use	use	VERB
ihlr-28406	698	9	this	this	DET
ihlr-28406	698	10	information	information	NOUN
ihlr-28406	698	11	to	to	PART
ihlr-28406	698	12	make	make	VERB
ihlr-28406	698	13	better	well	ADJ
ihlr-28406	698	14	patent	patent	NOUN
ihlr-28406	698	15	strategy	strategy	NOUN
ihlr-28406	698	16	decisions	decision	NOUN
ihlr-28406	698	17	.	.	PUNCT
ihlr-28406	699	1	integrating	integrate	VERB
ihlr-28406	699	2	factors	factor	NOUN
ihlr-28406	699	3	correlating	correlate	VERB
ihlr-28406	699	4	with	with	ADP
ihlr-28406	699	5	patent	patent	NOUN
ihlr-28406	699	6	value	value	NOUN
ihlr-28406	699	7	with	with	ADP
ihlr-28406	699	8	an	an	DET
ihlr-28406	699	9	expert	expert	NOUN
ihlr-28406	699	10	system	system	NOUN
ihlr-28406	699	11	provides	provide	VERB
ihlr-28406	699	12	a	a	DET
ihlr-28406	699	13	solution	solution	NOUN
ihlr-28406	699	14	formalizing	formalize	VERB
ihlr-28406	699	15	the	the	DET
ihlr-28406	699	16	decision	decision	NOUN
ihlr-28406	699	17	process	process	NOUN
ihlr-28406	699	18	.	.	PUNCT
ihlr-28406	700	1	moreover	moreover	ADV
ihlr-28406	700	2	,	,	PUNCT
ihlr-28406	700	3	the	the	DET
ihlr-28406	700	4	value	value	NOUN
ihlr-28406	700	5	of	of	ADP
ihlr-28406	700	6	new	new	ADJ
ihlr-28406	700	7	thyroid	thyroid	NOUN
ihlr-28406	700	8	inventions	invention	NOUN
ihlr-28406	700	9	,	,	PUNCT
ihlr-28406	700	10	and	and	CCONJ
ihlr-28406	700	11	their	their	PRON
ihlr-28406	700	12	associate	associate	ADJ
ihlr-28406	700	13	patents	patent	NOUN
ihlr-28406	700	14	are	be	AUX
ihlr-28406	700	15	largely	largely	ADV
ihlr-28406	700	16	tied	tie	VERB
ihlr-28406	700	17	to	to	ADP
ihlr-28406	700	18	the	the	DET
ihlr-28406	700	19	progress	progress	NOUN
ihlr-28406	700	20	through	through	ADP
ihlr-28406	700	21	clinical	clinical	ADJ
ihlr-28406	700	22	trials	trial	NOUN
ihlr-28406	700	23	made	make	VERB
ihlr-28406	700	24	by	by	ADP
ihlr-28406	700	25	the	the	DET
ihlr-28406	700	26	inventor	inventor	NOUN
ihlr-28406	700	27	.	.	PUNCT
ihlr-28406	701	1	b.	b.	PROPN
ihlr-28406	701	2	fda	fda	PROPN
ihlr-28406	701	3	trials	trial	NOUN
ihlr-28406	701	4	clinical	clinical	ADJ
ihlr-28406	701	5	trials	trial	NOUN
ihlr-28406	701	6	are	be	AUX
ihlr-28406	701	7	prospective	prospective	ADJ
ihlr-28406	701	8	,	,	PUNCT
ihlr-28406	701	9	organized	organized	ADJ
ihlr-28406	701	10	,	,	PUNCT
ihlr-28406	701	11	systematic	systematic	ADJ
ihlr-28406	701	12	exposures	exposure	NOUN
ihlr-28406	701	13	of	of	ADP
ihlr-28406	701	14	patients	patient	NOUN
ihlr-28406	701	15	to	to	ADP
ihlr-28406	701	16	an	an	DET
ihlr-28406	701	17	intervention	intervention	NOUN
ihlr-28406	701	18	of	of	ADP
ihlr-28406	701	19	some	some	DET
ihlr-28406	701	20	kind	kind	NOUN
ihlr-28406	701	21	.	.	PUNCT
ihlr-28406	702	1	196	196	NUM
ihlr-28406	702	2	despite	despite	SCONJ
ihlr-28406	702	3	widespread	widespread	ADJ
ihlr-28406	702	4	fraud	fraud	NOUN
ihlr-28406	702	5	and	and	CCONJ
ihlr-28406	702	6	corruption	corruption	NOUN
ihlr-28406	702	7	,	,	PUNCT
ihlr-28406	702	8	the	the	DET
ihlr-28406	702	9	united	united	PROPN
ihlr-28406	702	10	states	states	PROPN
ihlr-28406	702	11	food	food	PROPN
ihlr-28406	702	12	and	and	CCONJ
ihlr-28406	702	13	drug	drug	NOUN
ihlr-28406	702	14	administration	administration	NOUN
ihlr-28406	702	15	has	have	AUX
ihlr-28406	702	16	evolved	evolve	VERB
ihlr-28406	702	17	as	as	ADP
ihlr-28406	702	18	one	one	NUM
ihlr-28406	702	19	of	of	ADP
ihlr-28406	702	20	the	the	DET
ihlr-28406	702	21	world	world	NOUN
ihlr-28406	702	22	’s	’s	PART
ihlr-28406	702	23	—	—	PUNCT
ihlr-28406	702	24	—	—	PUNCT
ihlr-28406	702	25	—	—	PUNCT
ihlr-28406	702	26	—	—	PUNCT
ihlr-28406	702	27	—	—	PUNCT
ihlr-28406	702	28	—	—	PUNCT
ihlr-28406	702	29	—	—	PUNCT
ihlr-28406	702	30	—	—	PUNCT
ihlr-28406	702	31	—	—	PUNCT
ihlr-28406	702	32	—	—	PUNCT
ihlr-28406	702	33	—	—	PUNCT
ihlr-28406	702	34	—	—	PUNCT
ihlr-28406	702	35	—	—	PUNCT
ihlr-28406	702	36	—	—	PUNCT
ihlr-28406	702	37	—	—	PUNCT
ihlr-28406	702	38	—	—	PUNCT
ihlr-28406	702	39	—	—	PUNCT
ihlr-28406	702	40	—	—	PUNCT
ihlr-28406	702	41	—	—	PUNCT
ihlr-28406	702	42	—	—	PUNCT
ihlr-28406	702	43	—	—	PUNCT
ihlr-28406	702	44	—	—	PUNCT
ihlr-28406	702	45	—	—	PUNCT
ihlr-28406	702	46	—	—	PUNCT
ihlr-28406	702	47	—	—	PUNCT
ihlr-28406	702	48	—	—	PUNCT
ihlr-28406	702	49	—	—	PUNCT
ihlr-28406	702	50	—	—	PUNCT
ihlr-28406	702	51	—	—	PUNCT
ihlr-28406	702	52	190	190	NUM
ihlr-28406	702	53	.	.	PUNCT
ihlr-28406	702	54	united	united	PROPN
ihlr-28406	702	55	states	states	PROPN
ihlr-28406	702	56	patent	patent	PROPN
ihlr-28406	702	57	and	and	CCONJ
ihlr-28406	702	58	trademark	trademark	NOUN
ihlr-28406	702	59	office	office	NOUN
ihlr-28406	702	60	,	,	PUNCT
ihlr-28406	702	61	uspto	uspto	PROPN
ihlr-28406	702	62	fee	fee	NOUN
ihlr-28406	702	63	schedule	schedule	NOUN
ihlr-28406	702	64	(	(	PUNCT
ihlr-28406	702	65	2020	2020	NUM
ihlr-28406	702	66	)	)	PUNCT
ihlr-28406	702	67	,	,	PUNCT
ihlr-28406	703	1	https://www.uspto.gov/learning-and-resources/fees-and-payment/uspto-fee-schedule	https://www.uspto.gov/learning-and-resources/fees-and-payment/uspto-fee-schedule	PROPN
ihlr-28406	703	2	.	.	X
ihlr-28406	703	3	see	see	VERB
ihlr-28406	703	4	also	also	ADV
ihlr-28406	703	5	leahy	leahy	PROPN
ihlr-28406	703	6	-	-	PUNCT
ihlr-28406	703	7	smith	smith	PROPN
ihlr-28406	703	8	america	america	PROPN
ihlr-28406	703	9	invents	invents	PROPN
ihlr-28406	703	10	act	act	VERB
ihlr-28406	703	11	of	of	ADP
ihlr-28406	703	12	2011	2011	NUM
ihlr-28406	703	13	,	,	PUNCT
ihlr-28406	703	14	pub	pub	NOUN
ihlr-28406	703	15	.	.	PUNCT
ihlr-28406	704	1	l.	l.	PROPN
ihlr-28406	704	2	no	no	INTJ
ihlr-28406	704	3	.	.	PROPN
ihlr-28406	705	1	112	112	NUM
ihlr-28406	705	2	-	-	SYM
ihlr-28406	705	3	29	29	NUM
ihlr-28406	705	4	,	,	PUNCT
ihlr-28406	705	5	125	125	NUM
ihlr-28406	705	6	stat	stat	NOUN
ihlr-28406	705	7	.	.	PUNCT
ihlr-28406	706	1	284	284	NUM
ihlr-28406	706	2	-	-	SYM
ihlr-28406	706	3	341	341	NUM
ihlr-28406	706	4	.	.	PUNCT
ihlr-28406	707	1	(	(	PUNCT
ihlr-28406	707	2	see	see	VERB
ihlr-28406	707	3	section	section	NOUN
ihlr-28406	707	4	11	11	NUM
ihlr-28406	707	5	fees	fee	NOUN
ihlr-28406	707	6	for	for	ADP
ihlr-28406	707	7	patent	patent	NOUN
ihlr-28406	707	8	services	service	NOUN
ihlr-28406	707	9	,	,	PUNCT
ihlr-28406	707	10	which	which	PRON
ihlr-28406	707	11	de	de	X
ihlr-28406	707	12	facto	facto	X
ihlr-28406	707	13	prevents	prevent	VERB
ihlr-28406	707	14	inventors	inventor	NOUN
ihlr-28406	707	15	living	live	VERB
ihlr-28406	707	16	in	in	ADP
ihlr-28406	707	17	poverty	poverty	NOUN
ihlr-28406	707	18	from	from	ADP
ihlr-28406	707	19	being	be	AUX
ihlr-28406	707	20	able	able	ADJ
ihlr-28406	707	21	to	to	PART
ihlr-28406	707	22	patent	patent	VERB
ihlr-28406	707	23	or	or	CCONJ
ihlr-28406	707	24	protect	protect	VERB
ihlr-28406	707	25	their	their	PRON
ihlr-28406	707	26	inventions	invention	NOUN
ihlr-28406	707	27	.	.	PUNCT
ihlr-28406	707	28	)	)	PUNCT
ihlr-28406	708	1	191	191	NUM
ihlr-28406	708	2	.	.	PUNCT
ihlr-28406	709	1	cotropia	cotropia	PROPN
ihlr-28406	709	2	,	,	PUNCT
ihlr-28406	709	3	supra	supra	PROPN
ihlr-28406	709	4	note	note	NOUN
ihlr-28406	709	5	186	186	NUM
ihlr-28406	709	6	,	,	PUNCT
ihlr-28406	709	7	at	at	ADP
ihlr-28406	709	8	1135	1135	NUM
ihlr-28406	709	9	.	.	PUNCT
ihlr-28406	710	1	192	192	NUM
ihlr-28406	710	2	.	.	PUNCT
ihlr-28406	711	1	leone	leone	PROPN
ihlr-28406	711	2	&	&	CCONJ
ihlr-28406	711	3	oriani	oriani	PROPN
ihlr-28406	711	4	,	,	PUNCT
ihlr-28406	711	5	supra	supra	PROPN
ihlr-28406	711	6	note	note	NOUN
ihlr-28406	711	7	188	188	NUM
ihlr-28406	711	8	,	,	PUNCT
ihlr-28406	711	9	at	at	ADP
ihlr-28406	711	10	5	5	NUM
ihlr-28406	711	11	(	(	PUNCT
ihlr-28406	711	12	and	and	CCONJ
ihlr-28406	711	13	,	,	PUNCT
ihlr-28406	711	14	the	the	DET
ihlr-28406	711	15	net	net	ADJ
ihlr-28406	711	16	present	present	ADJ
ihlr-28406	711	17	value	value	NOUN
ihlr-28406	711	18	for	for	ADP
ihlr-28406	711	19	a	a	DET
ihlr-28406	711	20	patent	patent	NOUN
ihlr-28406	711	21	license	license	NOUN
ihlr-28406	711	22	is	be	AUX
ihlr-28406	711	23	subject	subject	ADJ
ihlr-28406	711	24	to	to	ADP
ihlr-28406	711	25	volatility	volatility	NOUN
ihlr-28406	711	26	stemming	stem	VERB
ihlr-28406	711	27	from	from	ADP
ihlr-28406	711	28	different	different	ADJ
ihlr-28406	711	29	sources	source	NOUN
ihlr-28406	711	30	of	of	ADP
ihlr-28406	711	31	uncertainty	uncertainty	NOUN
ihlr-28406	711	32	.	.	PUNCT
ihlr-28406	712	1	thus	thus	ADV
ihlr-28406	712	2	,	,	PUNCT
ihlr-28406	712	3	licensing	licensing	NOUN
ihlr-28406	712	4	contracts	contract	NOUN
ihlr-28406	712	5	provide	provide	VERB
ihlr-28406	712	6	the	the	DET
ihlr-28406	712	7	licensee	licensee	NOUN
ihlr-28406	712	8	with	with	ADP
ihlr-28406	712	9	the	the	DET
ihlr-28406	712	10	opportunity	opportunity	NOUN
ihlr-28406	712	11	to	to	PART
ihlr-28406	712	12	acquire	acquire	VERB
ihlr-28406	712	13	the	the	DET
ihlr-28406	712	14	cash	cash	NOUN
ihlr-28406	712	15	flows	flow	NOUN
ihlr-28406	712	16	from	from	ADP
ihlr-28406	712	17	the	the	DET
ihlr-28406	712	18	commercialization	commercialization	NOUN
ihlr-28406	712	19	of	of	ADP
ihlr-28406	712	20	the	the	DET
ihlr-28406	712	21	patented	patented	ADJ
ihlr-28406	712	22	technology	technology	NOUN
ihlr-28406	712	23	.	.	PUNCT
ihlr-28406	712	24	)	)	PUNCT
ihlr-28406	712	25	.	.	PUNCT
ihlr-28406	713	1	193	193	NUM
ihlr-28406	713	2	.	.	PUNCT
ihlr-28406	714	1	andrew	andrew	PROPN
ihlr-28406	714	2	chin	chin	PROPN
ihlr-28406	714	3	,	,	PUNCT
ihlr-28406	714	4	supra	supra	PROPN
ihlr-28406	714	5	note	note	PROPN
ihlr-28406	714	6	184	184	NUM
ihlr-28406	714	7	,	,	PUNCT
ihlr-28406	714	8	at	at	ADP
ihlr-28406	714	9	1438	1438	NUM
ihlr-28406	714	10	.	.	PUNCT
ihlr-28406	715	1	(	(	PUNCT
ihlr-28406	715	2	most	most	ADJ
ihlr-28406	715	3	research	research	NOUN
ihlr-28406	715	4	focuses	focus	VERB
ihlr-28406	715	5	on	on	ADP
ihlr-28406	715	6	the	the	DET
ihlr-28406	715	7	black	black	ADJ
ihlr-28406	715	8	-	-	PUNCT
ihlr-28406	715	9	scholesmerton	scholesmerton	PROPN
ihlr-28406	715	10	model	model	NOUN
ihlr-28406	715	11	for	for	ADP
ihlr-28406	715	12	options	option	NOUN
ihlr-28406	715	13	pricing	pricing	NOUN
ihlr-28406	715	14	.	.	PUNCT
ihlr-28406	716	1	the	the	DET
ihlr-28406	716	2	black	black	ADJ
ihlr-28406	716	3	-	-	PUNCT
ihlr-28406	716	4	scholes	schole	NOUN
ihlr-28406	716	5	-	-	PUNCT
ihlr-28406	716	6	merton	merton	NOUN
ihlr-28406	716	7	model	model	NOUN
ihlr-28406	716	8	is	be	AUX
ihlr-28406	716	9	based	base	VERB
ihlr-28406	716	10	on	on	ADP
ihlr-28406	716	11	simplifying	simplify	VERB
ihlr-28406	716	12	assumptions	assumption	NOUN
ihlr-28406	716	13	about	about	ADP
ihlr-28406	716	14	the	the	DET
ihlr-28406	716	15	statistical	statistical	ADJ
ihlr-28406	716	16	movement	movement	NOUN
ihlr-28406	716	17	of	of	ADP
ihlr-28406	716	18	stock	stock	NOUN
ihlr-28406	716	19	prices	price	NOUN
ihlr-28406	716	20	and	and	CCONJ
ihlr-28406	716	21	market	market	NOUN
ihlr-28406	716	22	efficiency	efficiency	NOUN
ihlr-28406	716	23	)	)	PUNCT
ihlr-28406	716	24	.	.	PUNCT
ihlr-28406	717	1	[	[	X
ihlr-28406	717	2	https://perma.cc/2pnb-9ukv	https://perma.cc/2pnb-9ukv	X
ihlr-28406	717	3	]	]	X
ihlr-28406	717	4	194	194	NUM
ihlr-28406	717	5	.	.	PUNCT
ihlr-28406	718	1	leone	leone	PROPN
ihlr-28406	718	2	&	&	CCONJ
ihlr-28406	718	3	oriana	oriana	PROPN
ihlr-28406	718	4	,	,	PUNCT
ihlr-28406	718	5	supra	supra	PROPN
ihlr-28406	718	6	note	note	PROPN
ihlr-28406	718	7	188	188	NUM
ihlr-28406	718	8	,	,	PUNCT
ihlr-28406	718	9	at	at	ADP
ihlr-28406	718	10	5	5	NUM
ihlr-28406	718	11	.	.	NOUN
ihlr-28406	718	12	195	195	NUM
ihlr-28406	718	13	.	.	PUNCT
ihlr-28406	719	1	robert	robert	PROPN
ihlr-28406	719	2	pitkethly	pitkethly	ADV
ihlr-28406	719	3	,	,	PUNCT
ihlr-28406	719	4	the	the	DET
ihlr-28406	719	5	value	value	NOUN
ihlr-28406	719	6	of	of	ADP
ihlr-28406	719	7	patents	patent	NOUN
ihlr-28406	719	8	,	,	PUNCT
ihlr-28406	719	9	wp	wp	PROPN
ihlr-28406	719	10	21/97	21/97	NUM
ihlr-28406	719	11	judge	judge	NOUN
ihlr-28406	719	12	institute	institute	PROPN
ihlr-28406	719	13	working	working	PROPN
ihlr-28406	719	14	paper	paper	PROPN
ihlr-28406	719	15	1	1	NUM
ihlr-28406	719	16	,	,	PUNCT
ihlr-28406	719	17	1	1	NUM
ihlr-28406	719	18	(	(	PUNCT
ihlr-28406	719	19	1997	1997	NUM
ihlr-28406	719	20	)	)	PUNCT
ihlr-28406	719	21	,	,	PUNCT
ihlr-28406	719	22	https://users.ox.ac.uk/~mast0140/ejwp0599.pdf	https://users.ox.ac.uk/~mast0140/ejwp0599.pdf	PROPN
ihlr-28406	719	23	.	.	PUNCT
ihlr-28406	720	1	[	[	X
ihlr-28406	720	2	https://perma.cc/h4wl-bjwe	https://perma.cc/h4wl-bjwe	X
ihlr-28406	720	3	]	]	X
ihlr-28406	720	4	see	see	VERB
ihlr-28406	720	5	also	also	ADV
ihlr-28406	720	6	fusco	fusco	PROPN
ihlr-28406	720	7	,	,	PUNCT
ihlr-28406	720	8	supra	supra	PROPN
ihlr-28406	720	9	note	note	NOUN
ihlr-28406	720	10	189	189	NUM
ihlr-28406	720	11	,	,	PUNCT
ihlr-28406	720	12	at	at	ADP
ihlr-28406	720	13	4	4	NUM
ihlr-28406	720	14	.	.	PUNCT
ihlr-28406	721	1	(	(	PUNCT
ihlr-28406	721	2	discussing	discuss	VERB
ihlr-28406	721	3	the	the	DET
ihlr-28406	721	4	patent	patent	NOUN
ihlr-28406	721	5	and	and	CCONJ
ihlr-28406	721	6	innovation	innovation	NOUN
ihlr-28406	721	7	in	in	ADP
ihlr-28406	721	8	the	the	DET
ihlr-28406	721	9	financial	financial	ADJ
ihlr-28406	721	10	industry	industry	NOUN
ihlr-28406	721	11	with	with	ADP
ihlr-28406	721	12	data	datum	NOUN
ihlr-28406	721	13	analytics	analytic	NOUN
ihlr-28406	721	14	compiled	compile	VERB
ihlr-28406	721	15	through	through	ADP
ihlr-28406	721	16	market	market	NOUN
ihlr-28406	721	17	surveys	survey	NOUN
ihlr-28406	721	18	and	and	CCONJ
ihlr-28406	721	19	interviews	interview	NOUN
ihlr-28406	721	20	.	.	PUNCT
ihlr-28406	721	21	)	)	PUNCT
ihlr-28406	722	1	see	see	VERB
ihlr-28406	722	2	also	also	ADV
ihlr-28406	722	3	stefania	stefania	PROPN
ihlr-28406	722	4	fusco	fusco	PROPN
ihlr-28406	722	5	,	,	PUNCT
ihlr-28406	722	6	et	et	PROPN
ihlr-28406	722	7	al	al	PROPN
ihlr-28406	722	8	.	.	PROPN
ihlr-28406	722	9	,	,	PUNCT
ihlr-28406	722	10	monetization	monetization	NOUN
ihlr-28406	722	11	strategies	strategy	NOUN
ihlr-28406	722	12	of	of	ADP
ihlr-28406	722	13	university	university	NOUN
ihlr-28406	722	14	patents	patent	NOUN
ihlr-28406	722	15	through	through	ADP
ihlr-28406	722	16	paes	paes	PROPN
ihlr-28406	722	17	:	:	PUNCT
ihlr-28406	722	18	an	an	DET
ihlr-28406	722	19	analysis	analysis	NOUN
ihlr-28406	722	20	of	of	ADP
ihlr-28406	722	21	us	us	PROPN
ihlr-28406	722	22	patent	patent	NOUN
ihlr-28406	722	23	transfers	transfer	NOUN
ihlr-28406	722	24	,	,	PUNCT
ihlr-28406	722	25	issi	issi	PROPN
ihlr-28406	722	26	conference	conference	NOUN
ihlr-28406	722	27	proceedings	proceeding	NOUN
ihlr-28406	722	28	(	(	PUNCT
ihlr-28406	722	29	forthcoming	forthcome	VERB
ihlr-28406	722	30	2019	2019	NUM
ihlr-28406	722	31	)	)	PUNCT
ihlr-28406	722	32	,	,	PUNCT
ihlr-28406	722	33	https://papers.ssrn.com/sol3/	https://papers.ssrn.com/sol3/	X
ihlr-28406	722	34	papers.cfm?abstract_id=3410086	papers.cfm?abstract_id=3410086	NUM
ihlr-28406	722	35	.	.	PUNCT
ihlr-28406	723	1	[	[	X
ihlr-28406	723	2	https://perma.cc/9sjr-xafl	https://perma.cc/9sjr-xafl	X
ihlr-28406	723	3	]	]	X
ihlr-28406	723	4	196	196	NUM
ihlr-28406	723	5	.	.	PUNCT
ihlr-28406	724	1	suzanne	suzanne	PROPN
ihlr-28406	724	2	white	white	PROPN
ihlr-28406	724	3	junod	junod	PROPN
ihlr-28406	724	4	,	,	PUNCT
ihlr-28406	724	5	fda	fda	PROPN
ihlr-28406	724	6	and	and	CCONJ
ihlr-28406	724	7	clinical	clinical	ADJ
ihlr-28406	724	8	drug	drug	NOUN
ihlr-28406	724	9	trials	trial	NOUN
ihlr-28406	724	10	:	:	PUNCT
ihlr-28406	724	11	a	a	DET
ihlr-28406	724	12	short	short	ADJ
ihlr-28406	724	13	history	history	NOUN
ihlr-28406	724	14	,	,	PUNCT
ihlr-28406	724	15	fda	fda	PROPN
ihlr-28406	724	16	1	1	NUM
ihlr-28406	724	17	.	.	NOUN
ihlr-28406	724	18	1	1	NUM
ihlr-28406	724	19	(	(	PUNCT
ihlr-28406	724	20	2008	2008	NUM
ihlr-28406	724	21	)	)	PUNCT
ihlr-28406	724	22	,	,	PUNCT
ihlr-28406	724	23	https://www.fda.gov/media/110437/download	https://www.fda.gov/media/110437/download	X
ihlr-28406	725	1	[	[	X
ihlr-28406	725	2	https://perma.cc/677n-68rk	https://perma.cc/677n-68rk	X
ihlr-28406	725	3	]	]	X
ihlr-28406	725	4	(	(	PUNCT
ihlr-28406	725	5	based	base	VERB
ihlr-28406	725	6	largely	largely	ADV
ihlr-28406	725	7	on	on	ADP
ihlr-28406	725	8	observations	observation	NOUN
ihlr-28406	725	9	and	and	CCONJ
ihlr-28406	725	10	tested	test	VERB
ihlr-28406	725	11	through	through	ADP
ihlr-28406	725	12	time	time	NOUN
ihlr-28406	725	13	by	by	ADP
ihlr-28406	725	14	trial	trial	NOUN
ihlr-28406	725	15	and	and	CCONJ
ihlr-28406	725	16	error	error	NOUN
ihlr-28406	725	17	,	,	PUNCT
ihlr-28406	725	18	ancient	ancient	ADJ
ihlr-28406	725	19	medicine	medicine	NOUN
ihlr-28406	725	20	such	such	ADJ
ihlr-28406	725	21	as	as	ADP
ihlr-28406	725	22	that	that	PRON
ihlr-28406	725	23	practiced	practice	VERB
ihlr-28406	725	24	by	by	ADP
ihlr-28406	725	25	the	the	DET
ihlr-28406	725	26	egyptians	egyptians	PROPN
ihlr-28406	725	27	,	,	PUNCT
ihlr-28406	725	28	babylonians	babylonians	PROPN
ihlr-28406	725	29	,	,	PUNCT
ihlr-28406	725	30	and	and	CCONJ
ihlr-28406	725	31	hebrews	hebrew	NOUN
ihlr-28406	725	32	was	be	AUX
ihlr-28406	725	33	closely	closely	ADV
ihlr-28406	725	34	allied	ally	VERB
ihlr-28406	725	35	with	with	ADP
ihlr-28406	725	36	religion	religion	NOUN
ihlr-28406	725	37	)	)	PUNCT
ihlr-28406	725	38	.	.	PUNCT
ihlr-28406	726	1	https://perma.cc/677n-68rk	https://perma.cc/677n-68rk	PROPN
ihlr-28406	726	2	https://www.fda.gov/media/110437/download	https://www.fda.gov/media/110437/download	VERB
ihlr-28406	726	3	https://perma.cc/9sjr-xafl	https://perma.cc/9sjr-xafl	PROPN
ihlr-28406	726	4	https://papers.ssrn.com/sol3	https://papers.ssrn.com/sol3	PROPN
ihlr-28406	726	5	https://perma.cc/h4wl-bjwe	https://perma.cc/h4wl-bjwe	PROPN
ihlr-28406	726	6	https://users.ox.ac.uk/~mast0140/ejwp0599.pdf	https://users.ox.ac.uk/~mast0140/ejwp0599.pdf	PROPN
ihlr-28406	726	7	https://perma.cc/2pnb-9ukv	https://perma.cc/2pnb-9ukv	PROPN
ihlr-28406	726	8	https://www.uspto.gov/learning-and-resources/fees-and-payment/uspto-fee-schedule	https://www.uspto.gov/learning-and-resources/fees-and-payment/uspto-fee-schedule	PROPN
ihlr-28406	726	9	2024	2024	NUM
ihlr-28406	726	10	]	]	PUNCT
ihlr-28406	726	11	inventions	invention	NOUN
ihlr-28406	726	12	and	and	CCONJ
ihlr-28406	726	13	patents	patent	NOUN
ihlr-28406	726	14	for	for	ADP
ihlr-28406	726	15	treating	treat	VERB
ihlr-28406	726	16	303	303	NUM
ihlr-28406	726	17	thyroid	thyroid	NOUN
ihlr-28406	726	18	disease	disease	NOUN
ihlr-28406	726	19	institutional	institutional	ADJ
ihlr-28406	726	20	authorities	authority	NOUN
ihlr-28406	726	21	for	for	ADP
ihlr-28406	726	22	conducting	conduct	VERB
ihlr-28406	726	23	and	and	CCONJ
ihlr-28406	726	24	evaluating	evaluate	VERB
ihlr-28406	726	25	controlled	control	VERB
ihlr-28406	726	26	clinical	clinical	ADJ
ihlr-28406	726	27	drug	drug	NOUN
ihlr-28406	726	28	trials	trial	NOUN
ihlr-28406	726	29	.	.	PUNCT
ihlr-28406	727	1	197	197	NUM
ihlr-28406	727	2	significant	significant	ADJ
ihlr-28406	727	3	statutory	statutory	ADJ
ihlr-28406	727	4	barriers	barrier	NOUN
ihlr-28406	727	5	stifle	stifle	VERB
ihlr-28406	727	6	the	the	DET
ihlr-28406	727	7	process	process	NOUN
ihlr-28406	727	8	by	by	ADP
ihlr-28406	727	9	which	which	PRON
ihlr-28406	727	10	new	new	ADJ
ihlr-28406	727	11	drugs	drug	NOUN
ihlr-28406	727	12	and	and	CCONJ
ihlr-28406	727	13	biotechnologies	biotechnology	NOUN
ihlr-28406	727	14	migrate	migrate	VERB
ihlr-28406	727	15	to	to	ADP
ihlr-28406	727	16	market	market	NOUN
ihlr-28406	727	17	.	.	PUNCT
ihlr-28406	728	1	as	as	ADP
ihlr-28406	728	2	a	a	DET
ihlr-28406	728	3	result	result	NOUN
ihlr-28406	728	4	,	,	PUNCT
ihlr-28406	728	5	the	the	DET
ihlr-28406	728	6	public	public	NOUN
ihlr-28406	728	7	loses	lose	VERB
ihlr-28406	728	8	out	out	ADP
ihlr-28406	728	9	on	on	ADP
ihlr-28406	728	10	medical	medical	ADJ
ihlr-28406	728	11	advancements	advancement	NOUN
ihlr-28406	728	12	and	and	CCONJ
ihlr-28406	728	13	inventions	invention	NOUN
ihlr-28406	728	14	,	,	PUNCT
ihlr-28406	728	15	which	which	PRON
ihlr-28406	728	16	would	would	AUX
ihlr-28406	728	17	otherwise	otherwise	ADV
ihlr-28406	728	18	save	save	VERB
ihlr-28406	728	19	lives	life	NOUN
ihlr-28406	728	20	and	and	CCONJ
ihlr-28406	728	21	improve	improve	VERB
ihlr-28406	728	22	the	the	DET
ihlr-28406	728	23	public	public	ADJ
ihlr-28406	728	24	quality	quality	NOUN
ihlr-28406	728	25	of	of	ADP
ihlr-28406	728	26	life	life	NOUN
ihlr-28406	728	27	.	.	PUNCT
ihlr-28406	729	1	the	the	DET
ihlr-28406	729	2	fda	fda	PROPN
ihlr-28406	729	3	plays	play	VERB
ihlr-28406	729	4	an	an	DET
ihlr-28406	729	5	essential	essential	ADJ
ihlr-28406	729	6	role	role	NOUN
ihlr-28406	729	7	in	in	ADP
ihlr-28406	729	8	the	the	DET
ihlr-28406	729	9	process	process	NOUN
ihlr-28406	729	10	by	by	ADP
ihlr-28406	729	11	which	which	PRON
ihlr-28406	729	12	new	new	ADJ
ihlr-28406	729	13	drugs	drug	NOUN
ihlr-28406	729	14	and	and	CCONJ
ihlr-28406	729	15	biotechnologies	biotechnology	NOUN
ihlr-28406	729	16	come	come	VERB
ihlr-28406	729	17	to	to	ADP
ihlr-28406	729	18	market	market	NOUN
ihlr-28406	729	19	.	.	PUNCT
ihlr-28406	730	1	198	198	NUM
ihlr-28406	730	2	however	however	ADV
ihlr-28406	730	3	,	,	PUNCT
ihlr-28406	730	4	more	more	ADV
ihlr-28406	730	5	essential	essential	ADJ
ihlr-28406	730	6	is	be	AUX
ihlr-28406	730	7	that	that	SCONJ
ihlr-28406	730	8	the	the	DET
ihlr-28406	730	9	public	public	ADJ
ihlr-28406	730	10	and	and	CCONJ
ihlr-28406	730	11	private	private	ADJ
ihlr-28406	730	12	interests	interest	NOUN
ihlr-28406	730	13	are	be	AUX
ihlr-28406	730	14	aligned	align	VERB
ihlr-28406	730	15	through	through	ADP
ihlr-28406	730	16	a	a	DET
ihlr-28406	730	17	transparent	transparent	ADJ
ihlr-28406	730	18	,	,	PUNCT
ihlr-28406	730	19	lucid	lucid	ADJ
ihlr-28406	730	20	,	,	PUNCT
ihlr-28406	730	21	and	and	CCONJ
ihlr-28406	730	22	accessible	accessible	ADJ
ihlr-28406	730	23	incentive	incentive	NOUN
ihlr-28406	730	24	structure	structure	NOUN
ihlr-28406	730	25	embedded	embed	VERB
ihlr-28406	730	26	in	in	ADP
ihlr-28406	730	27	the	the	DET
ihlr-28406	730	28	regulatory	regulatory	ADJ
ihlr-28406	730	29	climate	climate	NOUN
ihlr-28406	730	30	.	.	PUNCT
ihlr-28406	731	1	there	there	PRON
ihlr-28406	731	2	are	be	VERB
ihlr-28406	731	3	many	many	ADJ
ihlr-28406	731	4	interests	interest	NOUN
ihlr-28406	731	5	at	at	ADP
ihlr-28406	731	6	play	play	NOUN
ihlr-28406	731	7	in	in	ADP
ihlr-28406	731	8	designing	design	VERB
ihlr-28406	731	9	incentives	incentive	NOUN
ihlr-28406	731	10	to	to	PART
ihlr-28406	731	11	promote	promote	VERB
ihlr-28406	731	12	and	and	CCONJ
ihlr-28406	731	13	foster	foster	ADJ
ihlr-28406	731	14	innovation	innovation	NOUN
ihlr-28406	731	15	and	and	CCONJ
ihlr-28406	731	16	progress	progress	NOUN
ihlr-28406	731	17	.	.	PUNCT
ihlr-28406	732	1	199	199	NUM
ihlr-28406	732	2	as	as	ADP
ihlr-28406	732	3	such	such	ADJ
ihlr-28406	732	4	,	,	PUNCT
ihlr-28406	732	5	structuring	structuring	NOUN
ihlr-28406	732	6	incentives	incentive	NOUN
ihlr-28406	732	7	for	for	ADP
ihlr-28406	732	8	firms	firm	NOUN
ihlr-28406	732	9	,	,	PUNCT
ihlr-28406	732	10	the	the	DET
ihlr-28406	732	11	public	public	NOUN
ihlr-28406	732	12	,	,	PUNCT
ihlr-28406	732	13	and	and	CCONJ
ihlr-28406	732	14	the	the	DET
ihlr-28406	732	15	fda	fda	PROPN
ihlr-28406	732	16	is	be	AUX
ihlr-28406	732	17	crucial	crucial	ADJ
ihlr-28406	732	18	to	to	ADP
ihlr-28406	732	19	creating	create	VERB
ihlr-28406	732	20	an	an	DET
ihlr-28406	732	21	optimal	optimal	ADJ
ihlr-28406	732	22	regulatory	regulatory	ADJ
ihlr-28406	732	23	framework	framework	NOUN
ihlr-28406	732	24	.	.	PUNCT
ihlr-28406	733	1	to	to	PART
ihlr-28406	733	2	bring	bring	VERB
ihlr-28406	733	3	any	any	DET
ihlr-28406	733	4	new	new	ADJ
ihlr-28406	733	5	drug	drug	NOUN
ihlr-28406	733	6	or	or	CCONJ
ihlr-28406	733	7	device	device	NOUN
ihlr-28406	733	8	relating	relate	VERB
ihlr-28406	733	9	to	to	ADP
ihlr-28406	733	10	the	the	DET
ihlr-28406	733	11	human	human	ADJ
ihlr-28406	733	12	thyroid	thyroid	NOUN
ihlr-28406	733	13	to	to	PART
ihlr-28406	733	14	market	market	VERB
ihlr-28406	733	15	you	you	PRON
ihlr-28406	733	16	need	need	VERB
ihlr-28406	733	17	to	to	PART
ihlr-28406	733	18	get	get	VERB
ihlr-28406	733	19	fda	fda	PROPN
ihlr-28406	733	20	clearance	clearance	NOUN
ihlr-28406	733	21	.	.	PUNCT
ihlr-28406	734	1	the	the	DET
ihlr-28406	734	2	fda	fda	PROPN
ihlr-28406	734	3	approval	approval	PROPN
ihlr-28406	734	4	path	path	NOUN
ihlr-28406	734	5	depends	depend	VERB
ihlr-28406	734	6	on	on	ADP
ihlr-28406	734	7	the	the	DET
ihlr-28406	734	8	risk	risk	NOUN
ihlr-28406	734	9	of	of	ADP
ihlr-28406	734	10	the	the	DET
ihlr-28406	734	11	device	device	NOUN
ihlr-28406	734	12	.	.	PUNCT
ihlr-28406	735	1	in	in	ADP
ihlr-28406	735	2	some	some	DET
ihlr-28406	735	3	circumstances	circumstance	NOUN
ihlr-28406	735	4	,	,	PUNCT
ihlr-28406	735	5	a	a	DET
ihlr-28406	735	6	device	device	NOUN
ihlr-28406	735	7	may	may	AUX
ihlr-28406	735	8	be	be	AUX
ihlr-28406	735	9	able	able	ADJ
ihlr-28406	735	10	to	to	PART
ihlr-28406	735	11	be	be	AUX
ihlr-28406	735	12	fast	fast	ADV
ihlr-28406	735	13	tracked	track	VERB
ihlr-28406	735	14	to	to	ADP
ihlr-28406	735	15	approval	approval	NOUN
ihlr-28406	735	16	if	if	SCONJ
ihlr-28406	735	17	there	there	PRON
ihlr-28406	735	18	is	be	VERB
ihlr-28406	735	19	a	a	DET
ihlr-28406	735	20	predicate	predicate	ADJ
ihlr-28406	735	21	device	device	NOUN
ihlr-28406	735	22	.	.	PUNCT
ihlr-28406	736	1	for	for	ADP
ihlr-28406	736	2	the	the	DET
ihlr-28406	736	3	predicate	predicate	ADJ
ihlr-28406	736	4	device	device	NOUN
ihlr-28406	736	5	to	to	PART
ihlr-28406	736	6	be	be	AUX
ihlr-28406	736	7	successful	successful	ADJ
ihlr-28406	736	8	,	,	PUNCT
ihlr-28406	736	9	the	the	DET
ihlr-28406	736	10	device	device	NOUN
ihlr-28406	736	11	needs	need	VERB
ihlr-28406	736	12	to	to	PART
ihlr-28406	736	13	be	be	AUX
ihlr-28406	736	14	very	very	ADV
ihlr-28406	736	15	similar	similar	ADJ
ihlr-28406	736	16	.	.	PUNCT
ihlr-28406	737	1	there	there	PRON
ihlr-28406	737	2	will	will	AUX
ihlr-28406	737	3	be	be	AUX
ihlr-28406	737	4	a	a	DET
ihlr-28406	737	5	comparison	comparison	NOUN
ihlr-28406	737	6	of	of	ADP
ihlr-28406	737	7	both	both	DET
ihlr-28406	737	8	mechanics	mechanic	NOUN
ihlr-28406	737	9	and	and	CCONJ
ihlr-28406	737	10	disease	disease	NOUN
ihlr-28406	737	11	for	for	ADP
ihlr-28406	737	12	which	which	PRON
ihlr-28406	737	13	the	the	DET
ihlr-28406	737	14	device	device	NOUN
ihlr-28406	737	15	is	be	AUX
ihlr-28406	737	16	manufactured	manufacture	VERB
ihlr-28406	737	17	.	.	PUNCT
ihlr-28406	738	1	devices	device	NOUN
ihlr-28406	738	2	are	be	AUX
ihlr-28406	738	3	regulated	regulate	VERB
ihlr-28406	738	4	by	by	ADP
ihlr-28406	738	5	algorithm	algorithm	NOUN
ihlr-28406	738	6	and	and	CCONJ
ihlr-28406	738	7	there	there	PRON
ihlr-28406	738	8	is	be	VERB
ihlr-28406	738	9	guidance	guidance	NOUN
ihlr-28406	738	10	around	around	ADP
ihlr-28406	738	11	software	software	NOUN
ihlr-28406	738	12	as	as	ADP
ihlr-28406	738	13	a	a	DET
ihlr-28406	738	14	medical	medical	ADJ
ihlr-28406	738	15	device	device	NOUN
ihlr-28406	738	16	.	.	PUNCT
ihlr-28406	739	1	another	another	DET
ihlr-28406	739	2	issue	issue	NOUN
ihlr-28406	739	3	that	that	PRON
ihlr-28406	739	4	may	may	AUX
ihlr-28406	739	5	arrive	arrive	VERB
ihlr-28406	739	6	relates	relate	VERB
ihlr-28406	739	7	to	to	ADP
ihlr-28406	739	8	software	software	NOUN
ihlr-28406	739	9	as	as	ADP
ihlr-28406	739	10	a	a	DET
ihlr-28406	739	11	medical	medical	ADJ
ihlr-28406	739	12	device	device	NOUN
ihlr-28406	739	13	.	.	PUNCT
ihlr-28406	740	1	200	200	NUM
ihlr-28406	740	2	for	for	ADP
ihlr-28406	740	3	purposes	purpose	NOUN
ihlr-28406	740	4	of	of	ADP
ihlr-28406	740	5	fda	fda	PROPN
ihlr-28406	740	6	trials	trial	NOUN
ihlr-28406	740	7	there	there	PRON
ihlr-28406	740	8	are	be	VERB
ihlr-28406	740	9	three	three	NUM
ihlr-28406	740	10	categories	category	NOUN
ihlr-28406	740	11	of	of	ADP
ihlr-28406	740	12	medical	medical	ADJ
ihlr-28406	740	13	devices	device	NOUN
ihlr-28406	740	14	.	.	PUNCT
ihlr-28406	741	1	201	201	NUM
ihlr-28406	741	2	the	the	DET
ihlr-28406	741	3	first	first	ADJ
ihlr-28406	741	4	category	category	NOUN
ihlr-28406	741	5	is	be	AUX
ihlr-28406	741	6	category	category	NOUN
ihlr-28406	741	7	1	1	NUM
ihlr-28406	741	8	,	,	PUNCT
ihlr-28406	741	9	which	which	PRON
ihlr-28406	741	10	requires	require	VERB
ihlr-28406	741	11	full	full	ADJ
ihlr-28406	741	12	clinical	clinical	ADJ
ihlr-28406	741	13	trials	trial	NOUN
ihlr-28406	741	14	and	and	CCONJ
ihlr-28406	741	15	poses	pose	VERB
ihlr-28406	741	16	the	the	DET
ihlr-28406	741	17	most	most	ADV
ihlr-28406	741	18	severe	severe	ADJ
ihlr-28406	741	19	risk	risk	NOUN
ihlr-28406	741	20	to	to	ADP
ihlr-28406	741	21	life	life	NOUN
ihlr-28406	741	22	.	.	PUNCT
ihlr-28406	742	1	the	the	DET
ihlr-28406	742	2	second	second	ADJ
ihlr-28406	742	3	category	category	NOUN
ihlr-28406	742	4	is	be	AUX
ihlr-28406	742	5	category	category	NOUN
ihlr-28406	742	6	2	2	NUM
ihlr-28406	742	7	,	,	PUNCT
ihlr-28406	742	8	which	which	PRON
ihlr-28406	742	9	includes	include	VERB
ihlr-28406	742	10	an	an	DET
ihlr-28406	742	11	accelerated	accelerated	ADJ
ihlr-28406	742	12	approval	approval	NOUN
ihlr-28406	742	13	path	path	NOUN
ihlr-28406	742	14	and	and	CCONJ
ihlr-28406	742	15	has	have	VERB
ihlr-28406	742	16	milder	mild	ADJ
ihlr-28406	742	17	risk	risk	NOUN
ihlr-28406	742	18	and	and	CCONJ
ihlr-28406	742	19	lacks	lack	VERB
ihlr-28406	742	20	any	any	DET
ihlr-28406	742	21	potentially	potentially	ADV
ihlr-28406	742	22	lethal	lethal	ADJ
ihlr-28406	742	23	risk	risk	NOUN
ihlr-28406	742	24	.	.	PUNCT
ihlr-28406	743	1	the	the	DET
ihlr-28406	743	2	third	third	ADJ
ihlr-28406	743	3	category	category	NOUN
ihlr-28406	743	4	is	be	AUX
ihlr-28406	743	5	category	category	NOUN
ihlr-28406	743	6	3	3	NUM
ihlr-28406	743	7	,	,	PUNCT
ihlr-28406	743	8	where	where	SCONJ
ihlr-28406	743	9	devices	device	NOUN
ihlr-28406	743	10	carry	carry	VERB
ihlr-28406	743	11	the	the	DET
ihlr-28406	743	12	least	least	ADJ
ihlr-28406	743	13	risk	risk	NOUN
ihlr-28406	743	14	and	and	CCONJ
ihlr-28406	743	15	require	require	VERB
ihlr-28406	743	16	no	no	DET
ihlr-28406	743	17	clinical	clinical	ADJ
ihlr-28406	743	18	trials	trial	NOUN
ihlr-28406	743	19	for	for	ADP
ihlr-28406	743	20	approval	approval	NOUN
ihlr-28406	743	21	.	.	PUNCT
ihlr-28406	744	1	still	still	ADV
ihlr-28406	744	2	there	there	PRON
ihlr-28406	744	3	may	may	AUX
ihlr-28406	744	4	be	be	AUX
ihlr-28406	744	5	better	well	ADJ
ihlr-28406	744	6	opportunities	opportunity	NOUN
ihlr-28406	744	7	for	for	ADP
ihlr-28406	744	8	innovation	innovation	NOUN
ihlr-28406	744	9	outside	outside	ADP
ihlr-28406	744	10	the	the	DET
ihlr-28406	744	11	united	united	PROPN
ihlr-28406	744	12	states	states	PROPN
ihlr-28406	744	13	where	where	SCONJ
ihlr-28406	744	14	there	there	PRON
ihlr-28406	744	15	exits	exit	VERB
ihlr-28406	744	16	great	great	ADJ
ihlr-28406	744	17	opportunity	opportunity	NOUN
ihlr-28406	744	18	to	to	PART
ihlr-28406	744	19	solve	solve	VERB
ihlr-28406	744	20	real	real	ADJ
ihlr-28406	744	21	problems	problem	NOUN
ihlr-28406	744	22	relating	relate	VERB
ihlr-28406	744	23	to	to	PART
ihlr-28406	744	24	thyroid	thyroid	NOUN
ihlr-28406	744	25	disease	disease	NOUN
ihlr-28406	744	26	.	.	PUNCT
ihlr-28406	745	1	c.	c.	PROPN
ihlr-28406	745	2	innovation	innovation	NOUN
ihlr-28406	745	3	there	there	PRON
ihlr-28406	745	4	is	be	VERB
ihlr-28406	745	5	opportunity	opportunity	NOUN
ihlr-28406	745	6	for	for	ADP
ihlr-28406	745	7	innovation	innovation	NOUN
ihlr-28406	745	8	relating	relate	VERB
ihlr-28406	745	9	to	to	PART
ihlr-28406	745	10	thyroid	thyroid	NOUN
ihlr-28406	745	11	disease	disease	NOUN
ihlr-28406	745	12	.	.	PUNCT
ihlr-28406	746	1	in	in	ADP
ihlr-28406	746	2	fact	fact	NOUN
ihlr-28406	746	3	,	,	PUNCT
ihlr-28406	746	4	—	—	PUNCT
ihlr-28406	746	5	—	—	PUNCT
ihlr-28406	746	6	—	—	PUNCT
ihlr-28406	746	7	—	—	PUNCT
ihlr-28406	746	8	—	—	PUNCT
ihlr-28406	746	9	—	—	PUNCT
ihlr-28406	746	10	—	—	PUNCT
ihlr-28406	746	11	—	—	PUNCT
ihlr-28406	746	12	—	—	PUNCT
ihlr-28406	746	13	—	—	PUNCT
ihlr-28406	746	14	—	—	PUNCT
ihlr-28406	746	15	—	—	PUNCT
ihlr-28406	746	16	—	—	PUNCT
ihlr-28406	746	17	—	—	PUNCT
ihlr-28406	746	18	—	—	PUNCT
ihlr-28406	746	19	—	—	PUNCT
ihlr-28406	746	20	—	—	PUNCT
ihlr-28406	746	21	—	—	PUNCT
ihlr-28406	746	22	—	—	PUNCT
ihlr-28406	746	23	—	—	PUNCT
ihlr-28406	746	24	—	—	PUNCT
ihlr-28406	746	25	—	—	PUNCT
ihlr-28406	746	26	—	—	PUNCT
ihlr-28406	746	27	—	—	PUNCT
ihlr-28406	746	28	—	—	PUNCT
ihlr-28406	746	29	—	—	PUNCT
ihlr-28406	746	30	—	—	PUNCT
ihlr-28406	746	31	—	—	PUNCT
ihlr-28406	746	32	—	—	PUNCT
ihlr-28406	746	33	197	197	NUM
ihlr-28406	746	34	.	.	PUNCT
ihlr-28406	747	1	i	i	PRON
ihlr-28406	747	2	d.	d.	PROPN
ihlr-28406	747	3	198	198	NUM
ihlr-28406	747	4	.	.	PUNCT
ihlr-28406	748	1	patricia	patricia	PROPN
ihlr-28406	748	2	j.	j.	PROPN
ihlr-28406	748	3	zettler	zettler	PROPN
ihlr-28406	748	4	,	,	PUNCT
ihlr-28406	748	5	et	et	PROPN
ihlr-28406	748	6	al	al	PROPN
ihlr-28406	748	7	.	.	PROPN
ihlr-28406	748	8	,	,	PUNCT
ihlr-28406	748	9	implementing	implement	VERB
ihlr-28406	748	10	a	a	DET
ihlr-28406	748	11	public	public	ADJ
ihlr-28406	748	12	health	health	NOUN
ihlr-28406	748	13	perspective	perspective	NOUN
ihlr-28406	748	14	in	in	ADP
ihlr-28406	748	15	fda	fda	PROPN
ihlr-28406	748	16	drug	drug	PROPN
ihlr-28406	748	17	regulation	regulation	NOUN
ihlr-28406	748	18	,	,	PUNCT
ihlr-28406	748	19	73	73	NUM
ihlr-28406	748	20	food	food	NOUN
ihlr-28406	748	21	&	&	CCONJ
ihlr-28406	748	22	drug	drug	PROPN
ihlr-28406	748	23	law	law	PROPN
ihlr-28406	748	24	j.	j.	PROPN
ihlr-28406	748	25	,	,	PUNCT
ihlr-28406	748	26	221	221	NUM
ihlr-28406	748	27	,	,	PUNCT
ihlr-28406	748	28	222	222	NUM
ihlr-28406	748	29	(	(	PUNCT
ihlr-28406	748	30	2018	2018	NUM
ihlr-28406	748	31	)	)	PUNCT
ihlr-28406	748	32	.	.	PUNCT
ihlr-28406	749	1	(	(	PUNCT
ihlr-28406	749	2	“	"	PUNCT
ihlr-28406	749	3	fda	fda	PROPN
ihlr-28406	749	4	,	,	PUNCT
ihlr-28406	749	5	through	through	ADP
ihlr-28406	749	6	its	its	PRON
ihlr-28406	749	7	authority	authority	NOUN
ihlr-28406	749	8	over	over	ADP
ihlr-28406	749	9	the	the	DET
ihlr-28406	749	10	drug	drug	NOUN
ihlr-28406	749	11	market	market	NOUN
ihlr-28406	749	12	,	,	PUNCT
ihlr-28406	749	13	undoubtedly	undoubtedly	ADV
ihlr-28406	749	14	has	have	VERB
ihlr-28406	749	15	an	an	DET
ihlr-28406	749	16	important	important	ADJ
ihlr-28406	749	17	role	role	NOUN
ihlr-28406	749	18	to	to	PART
ihlr-28406	749	19	play	play	VERB
ihlr-28406	749	20	in	in	ADP
ihlr-28406	749	21	this	this	DET
ihlr-28406	749	22	landscape	landscape	NOUN
ihlr-28406	749	23	.	.	PUNCT
ihlr-28406	749	24	”	"	PUNCT
ihlr-28406	749	25	)	)	PUNCT
ihlr-28406	749	26	see	see	VERB
ihlr-28406	749	27	also	also	ADV
ihlr-28406	749	28	junod	junod	PROPN
ihlr-28406	749	29	,	,	PUNCT
ihlr-28406	749	30	supra	supra	PROPN
ihlr-28406	749	31	note	note	PROPN
ihlr-28406	749	32	196	196	NUM
ihlr-28406	749	33	,	,	PUNCT
ihlr-28406	749	34	at	at	ADP
ihlr-28406	749	35	1	1	NUM
ihlr-28406	749	36	(	(	PUNCT
ihlr-28406	749	37	“	"	PUNCT
ihlr-28406	749	38	the	the	DET
ihlr-28406	749	39	fda	fda	PROPN
ihlr-28406	749	40	is	be	AUX
ihlr-28406	749	41	a	a	DET
ihlr-28406	749	42	prominent	prominent	ADJ
ihlr-28406	749	43	institutional	institutional	ADJ
ihlr-28406	749	44	authority	authority	NOUN
ihlr-28406	749	45	for	for	ADP
ihlr-28406	749	46	conducting	conduct	VERB
ihlr-28406	749	47	and	and	CCONJ
ihlr-28406	749	48	evaluating	evaluate	VERB
ihlr-28406	749	49	clinical	clinical	ADJ
ihlr-28406	749	50	drug	drug	NOUN
ihlr-28406	749	51	trials	trial	NOUN
ihlr-28406	749	52	.	.	PUNCT
ihlr-28406	749	53	”	"	PUNCT
ihlr-28406	749	54	)	)	PUNCT
ihlr-28406	749	55	.	.	PUNCT
ihlr-28406	750	1	199	199	NUM
ihlr-28406	750	2	.	.	PUNCT
ihlr-28406	751	1	see	see	VERB
ihlr-28406	751	2	:	:	PUNCT
ihlr-28406	751	3	fda	fda	PROPN
ihlr-28406	751	4	new	new	ADJ
ihlr-28406	751	5	drug	drug	NOUN
ihlr-28406	751	6	approval	approval	NOUN
ihlr-28406	751	7	,	,	PUNCT
ihlr-28406	751	8	constitutional	constitutional	ADJ
ihlr-28406	751	9	rights	right	NOUN
ihlr-28406	751	10	,	,	PUNCT
ihlr-28406	751	11	and	and	CCONJ
ihlr-28406	751	12	the	the	DET
ihlr-28406	751	13	public	public	NOUN
ihlr-28406	751	14	’s	’s	PART
ihlr-28406	751	15	health	health	NOUN
ihlr-28406	751	16	,	,	PUNCT
ihlr-28406	751	17	37	37	NUM
ihlr-28406	751	18	j.	j.	NOUN
ihlr-28406	751	19	of	of	ADP
ihlr-28406	751	20	law	law	PROPN
ihlr-28406	751	21	,	,	PUNCT
ihlr-28406	751	22	med	med	PROPN
ihlr-28406	751	23	.	.	PROPN
ihlr-28406	751	24	&	&	CCONJ
ihlr-28406	751	25	ethics	ethic	NOUN
ihlr-28406	751	26	2	2	NUM
ihlr-28406	751	27	,	,	PUNCT
ihlr-28406	751	28	7	7	NUM
ihlr-28406	751	29	(	(	PUNCT
ihlr-28406	751	30	2009	2009	NUM
ihlr-28406	751	31	)	)	PUNCT
ihlr-28406	751	32	.	.	PUNCT
ihlr-28406	752	1	200	200	NUM
ihlr-28406	752	2	.	.	PUNCT
ihlr-28406	752	3	software	software	NOUN
ihlr-28406	752	4	as	as	ADP
ihlr-28406	752	5	a	a	DET
ihlr-28406	752	6	medical	medical	ADJ
ihlr-28406	752	7	device	device	NOUN
ihlr-28406	752	8	(	(	PUNCT
ihlr-28406	752	9	samd	samd	ADJ
ihlr-28406	752	10	)	)	PUNCT
ihlr-28406	752	11	,	,	PUNCT
ihlr-28406	752	12	fda(dec	fda(dec	PROPN
ihlr-28406	752	13	.	.	PUNCT
ihlr-28406	752	14	04,2018	04,2018	PROPN
ihlr-28406	752	15	)	)	PUNCT
ihlr-28406	752	16	,	,	PUNCT
ihlr-28406	752	17	https://www.fda.gov/	https://www.fda.gov/	PROPN
ihlr-28406	752	18	medical	medical	ADJ
ihlr-28406	752	19	-	-	PUNCT
ihlr-28406	752	20	devices	device	NOUN
ihlr-28406	752	21	/	/	SYM
ihlr-28406	752	22	digital	digital	ADJ
ihlr-28406	752	23	-	-	PUNCT
ihlr-28406	752	24	health	health	NOUN
ihlr-28406	752	25	-	-	PUNCT
ihlr-28406	752	26	center	center	NOUN
ihlr-28406	752	27	-	-	PUNCT
ihlr-28406	752	28	excellence	excellence	NOUN
ihlr-28406	752	29	/	/	SYM
ihlr-28406	752	30	software	software	NOUN
ihlr-28406	752	31	-	-	PUNCT
ihlr-28406	752	32	medical	medical	ADJ
ihlr-28406	752	33	-	-	PUNCT
ihlr-28406	752	34	device	device	NOUN
ihlr-28406	752	35	-	-	PUNCT
ihlr-28406	752	36	samd	samd	NOUN
ihlr-28406	752	37	.	.	PUNCT
ihlr-28406	753	1	[	[	X
ihlr-28406	753	2	https://perma	https://perma	X
ihlr-28406	753	3	.	.	PUNCT
ihlr-28406	753	4	cc/9h5y	cc/9h5y	NOUN
ihlr-28406	753	5	-	-	PUNCT
ihlr-28406	753	6	yy2e	yy2e	ADJ
ihlr-28406	753	7	]	]	X
ihlr-28406	753	8	201	201	NUM
ihlr-28406	753	9	.	.	PUNCT
ihlr-28406	754	1	how	how	SCONJ
ihlr-28406	754	2	to	to	PART
ihlr-28406	754	3	find	find	VERB
ihlr-28406	754	4	and	and	CCONJ
ihlr-28406	754	5	effectively	effectively	ADV
ihlr-28406	754	6	use	use	VERB
ihlr-28406	754	7	predicate	predicate	NOUN
ihlr-28406	754	8	devices	device	NOUN
ihlr-28406	754	9	,	,	PUNCT
ihlr-28406	754	10	fda	fda	PROPN
ihlr-28406	754	11	,	,	PUNCT
ihlr-28406	754	12	(	(	PUNCT
ihlr-28406	754	13	sept	sept	PROPN
ihlr-28406	754	14	.	.	PROPN
ihlr-28406	754	15	4	4	NUM
ihlr-28406	754	16	,	,	PUNCT
ihlr-28406	754	17	2018	2018	NUM
ihlr-28406	754	18	)	)	PUNCT
ihlr-28406	754	19	,	,	PUNCT
ihlr-28406	754	20	https://www.fda.gov/medical-devices/premarket-notification-510k/how-find-and-effectivelyuse-predicate-devices	https://www.fda.gov/medical-devices/premarket-notification-510k/how-find-and-effectivelyuse-predicate-device	NOUN
ihlr-28406	754	21	.	.	PUNCT
ihlr-28406	755	1	[	[	X
ihlr-28406	755	2	https://perma.cc/9uts-lxce	https://perma.cc/9uts-lxce	X
ihlr-28406	755	3	]	]	X
ihlr-28406	755	4	https://perma.cc/9uts-lxce	https://perma.cc/9uts-lxce	X
ihlr-28406	756	1	https://www.fda.gov/medical-devices/premarket-notification-510k/how-find-and-effectively	https://www.fda.gov/medical-devices/premarket-notification-510k/how-find-and-effectively	ADV
ihlr-28406	756	2	https://perma	https://perma	X
ihlr-28406	756	3	https://www.fda.gov	https://www.fda.gov	PROPN
ihlr-28406	756	4	indiana	indiana	PROPN
ihlr-28406	756	5	health	health	PROPN
ihlr-28406	756	6	law	law	PROPN
ihlr-28406	756	7	review	review	NOUN
ihlr-28406	757	1	[	[	X
ihlr-28406	757	2	vol	vol	NOUN
ihlr-28406	757	3	.	.	PUNCT
ihlr-28406	758	1	21:277	21:277	NOUN
ihlr-28406	758	2	304	304	NUM
ihlr-28406	758	3	treatments	treatment	NOUN
ihlr-28406	758	4	for	for	ADP
ihlr-28406	758	5	thyroid	thyroid	NOUN
ihlr-28406	758	6	disease	disease	NOUN
ihlr-28406	758	7	have	have	AUX
ihlr-28406	758	8	not	not	PART
ihlr-28406	758	9	improved	improve	VERB
ihlr-28406	758	10	in	in	ADP
ihlr-28406	758	11	over	over	ADP
ihlr-28406	758	12	five	five	NUM
ihlr-28406	758	13	decades	decade	NOUN
ihlr-28406	758	14	since	since	SCONJ
ihlr-28406	758	15	screening	screen	VERB
ihlr-28406	758	16	for	for	ADP
ihlr-28406	758	17	hypothyroidism	hypothyroidism	NOUN
ihlr-28406	758	18	using	use	VERB
ihlr-28406	758	19	antibodies	antibody	NOUN
ihlr-28406	758	20	was	be	AUX
ihlr-28406	758	21	originally	originally	ADV
ihlr-28406	758	22	first	first	ADV
ihlr-28406	758	23	introduced	introduce	VERB
ihlr-28406	758	24	.	.	PUNCT
ihlr-28406	759	1	202	202	NUM
ihlr-28406	759	2	inventing	inventing	NOUN
ihlr-28406	759	3	is	be	AUX
ihlr-28406	759	4	the	the	DET
ihlr-28406	759	5	only	only	ADJ
ihlr-28406	759	6	way	way	NOUN
ihlr-28406	759	7	to	to	PART
ihlr-28406	759	8	innovate	innovate	VERB
ihlr-28406	759	9	;	;	PUNCT
ihlr-28406	759	10	it	it	PRON
ihlr-28406	759	11	’s	’	VERB
ihlr-28406	759	12	a	a	DET
ihlr-28406	759	13	process	process	NOUN
ihlr-28406	759	14	by	by	ADP
ihlr-28406	759	15	which	which	PRON
ihlr-28406	759	16	problems	problem	NOUN
ihlr-28406	759	17	are	be	AUX
ihlr-28406	759	18	solved	solve	VERB
ihlr-28406	759	19	anew	anew	ADV
ihlr-28406	759	20	.	.	PUNCT
ihlr-28406	760	1	inventions	invention	NOUN
ihlr-28406	760	2	are	be	AUX
ihlr-28406	760	3	new	new	ADJ
ihlr-28406	760	4	and	and	CCONJ
ihlr-28406	760	5	useful	useful	ADJ
ihlr-28406	760	6	machines	machine	NOUN
ihlr-28406	760	7	or	or	CCONJ
ihlr-28406	760	8	processes	process	NOUN
ihlr-28406	760	9	.	.	PUNCT
ihlr-28406	761	1	203	203	NUM
ihlr-28406	761	2	inventing	invent	VERB
ihlr-28406	761	3	new	new	ADJ
ihlr-28406	761	4	drugs	drug	NOUN
ihlr-28406	761	5	and	and	CCONJ
ihlr-28406	761	6	biotechnologies	biotechnology	NOUN
ihlr-28406	761	7	for	for	ADP
ihlr-28406	761	8	solving	solve	VERB
ihlr-28406	761	9	problems	problem	NOUN
ihlr-28406	761	10	and	and	CCONJ
ihlr-28406	761	11	curing	cure	VERB
ihlr-28406	761	12	conditions	condition	NOUN
ihlr-28406	761	13	relating	relate	VERB
ihlr-28406	761	14	to	to	PART
ihlr-28406	761	15	thyroid	thyroid	NOUN
ihlr-28406	761	16	disease	disease	NOUN
ihlr-28406	761	17	is	be	AUX
ihlr-28406	761	18	easy	easy	ADJ
ihlr-28406	761	19	.	.	PUNCT
ihlr-28406	762	1	the	the	DET
ihlr-28406	762	2	hard	hard	ADJ
ihlr-28406	762	3	part	part	NOUN
ihlr-28406	762	4	,	,	PUNCT
ihlr-28406	762	5	bringing	bring	VERB
ihlr-28406	762	6	inventions	invention	NOUN
ihlr-28406	762	7	to	to	ADP
ihlr-28406	762	8	life	life	NOUN
ihlr-28406	762	9	,	,	PUNCT
ihlr-28406	762	10	is	be	AUX
ihlr-28406	762	11	an	an	DET
ihlr-28406	762	12	extremely	extremely	ADV
ihlr-28406	762	13	long	long	ADJ
ihlr-28406	762	14	,	,	PUNCT
ihlr-28406	762	15	meticulous	meticulous	ADJ
ihlr-28406	762	16	,	,	PUNCT
ihlr-28406	762	17	and	and	CCONJ
ihlr-28406	762	18	daunting	daunt	VERB
ihlr-28406	762	19	challenge	challenge	NOUN
ihlr-28406	762	20	.	.	PUNCT
ihlr-28406	763	1	it	it	PRON
ihlr-28406	763	2	’s	’	VERB
ihlr-28406	763	3	important	important	ADJ
ihlr-28406	763	4	to	to	PART
ihlr-28406	763	5	study	study	VERB
ihlr-28406	763	6	history	history	NOUN
ihlr-28406	763	7	to	to	PART
ihlr-28406	763	8	move	move	VERB
ihlr-28406	763	9	forward	forward	ADV
ihlr-28406	763	10	.	.	PUNCT
ihlr-28406	764	1	generally	generally	ADV
ihlr-28406	764	2	,	,	PUNCT
ihlr-28406	764	3	inventions	invention	NOUN
ihlr-28406	764	4	are	be	AUX
ihlr-28406	764	5	as	as	ADV
ihlr-28406	764	6	good	good	ADJ
ihlr-28406	764	7	as	as	ADP
ihlr-28406	764	8	the	the	DET
ihlr-28406	764	9	history	history	NOUN
ihlr-28406	764	10	they	they	PRON
ihlr-28406	764	11	erase	erase	VERB
ihlr-28406	764	12	.	.	PUNCT
ihlr-28406	765	1	for	for	ADP
ihlr-28406	765	2	inventions	invention	NOUN
ihlr-28406	765	3	relating	relate	VERB
ihlr-28406	765	4	to	to	PART
ihlr-28406	765	5	thyroid	thyroid	NOUN
ihlr-28406	765	6	disease	disease	NOUN
ihlr-28406	765	7	,	,	PUNCT
ihlr-28406	765	8	it	it	PRON
ihlr-28406	765	9	’s	’	VERB
ihlr-28406	765	10	possible	possible	ADJ
ihlr-28406	765	11	to	to	PART
ihlr-28406	765	12	overwrite	overwrite	VERB
ihlr-28406	765	13	roughly	roughly	ADV
ihlr-28406	765	14	fifty	fifty	NUM
ihlr-28406	765	15	years	year	NOUN
ihlr-28406	765	16	of	of	ADP
ihlr-28406	765	17	history	history	NOUN
ihlr-28406	765	18	because	because	SCONJ
ihlr-28406	765	19	treatments	treatment	NOUN
ihlr-28406	765	20	have	have	AUX
ihlr-28406	765	21	not	not	PART
ihlr-28406	765	22	changed	change	VERB
ihlr-28406	765	23	much	much	ADJ
ihlr-28406	765	24	since.204	since.204	NOUN
ihlr-28406	765	25	according	accord	VERB
ihlr-28406	765	26	to	to	ADP
ihlr-28406	765	27	dr	dr	PROPN
ihlr-28406	765	28	.	.	PROPN
ihlr-28406	765	29	elizabeth	elizabeth	PROPN
ihlr-28406	765	30	mcanich	mcanich	PROPN
ihlr-28406	765	31	,	,	PUNCT
ihlr-28406	765	32	the	the	DET
ihlr-28406	765	33	world	world	NOUN
ihlr-28406	765	34	’s	’s	PART
ihlr-28406	765	35	leading	lead	VERB
ihlr-28406	765	36	expert	expert	NOUN
ihlr-28406	765	37	on	on	ADP
ihlr-28406	765	38	thyroid	thyroid	NOUN
ihlr-28406	765	39	disease	disease	NOUN
ihlr-28406	765	40	and	and	CCONJ
ihlr-28406	765	41	a	a	DET
ihlr-28406	765	42	current	current	ADJ
ihlr-28406	765	43	professor	professor	NOUN
ihlr-28406	765	44	at	at	ADP
ihlr-28406	765	45	stanford	stanford	PROPN
ihlr-28406	765	46	medical	medical	PROPN
ihlr-28406	765	47	school	school	PROPN
ihlr-28406	765	48	,	,	PUNCT
ihlr-28406	765	49	“	"	PUNCT
ihlr-28406	765	50	two	two	NUM
ihlr-28406	765	51	major	major	ADJ
ihlr-28406	765	52	developments	development	NOUN
ihlr-28406	765	53	in	in	ADP
ihlr-28406	765	54	the	the	DET
ihlr-28406	765	55	1970s	1970	NOUN
ihlr-28406	765	56	led	lead	VERB
ihlr-28406	765	57	to	to	ADP
ihlr-28406	765	58	a	a	DET
ihlr-28406	765	59	transition	transition	NOUN
ihlr-28406	765	60	in	in	ADP
ihlr-28406	765	61	clinical	clinical	ADJ
ihlr-28406	765	62	practice	practice	NOUN
ihlr-28406	765	63	:	:	PUNCT
ihlr-28406	765	64	1	1	X
ihlr-28406	765	65	)	)	PUNCT
ihlr-28406	765	66	the	the	DET
ihlr-28406	765	67	development	development	NOUN
ihlr-28406	765	68	of	of	ADP
ihlr-28406	765	69	the	the	DET
ihlr-28406	765	70	serum	serum	NOUN
ihlr-28406	765	71	tsh	tsh	NOUN
ihlr-28406	765	72	radioimmunoassay	radioimmunoassay	PROPN
ihlr-28406	765	73	led	lead	VERB
ihlr-28406	765	74	to	to	ADP
ihlr-28406	765	75	the	the	DET
ihlr-28406	765	76	discovery	discovery	NOUN
ihlr-28406	765	77	that	that	SCONJ
ihlr-28406	765	78	many	many	ADJ
ihlr-28406	765	79	patients	patient	NOUN
ihlr-28406	765	80	were	be	AUX
ihlr-28406	765	81	overtreated	overtreate	VERB
ihlr-28406	765	82	,	,	PUNCT
ihlr-28406	765	83	resulting	result	VERB
ihlr-28406	765	84	in	in	ADP
ihlr-28406	765	85	a	a	DET
ihlr-28406	765	86	dramatic	dramatic	ADJ
ihlr-28406	765	87	reduction	reduction	NOUN
ihlr-28406	765	88	in	in	ADP
ihlr-28406	765	89	thyroid	thyroid	NOUN
ihlr-28406	765	90	hormone	hormone	NOUN
ihlr-28406	765	91	replacement	replacement	NOUN
ihlr-28406	765	92	dosage	dosage	NOUN
ihlr-28406	765	93	,	,	PUNCT
ihlr-28406	765	94	and	and	CCONJ
ihlr-28406	765	95	2	2	X
ihlr-28406	765	96	)	)	PUNCT
ihlr-28406	765	97	the	the	DET
ihlr-28406	765	98	identification	identification	NOUN
ihlr-28406	765	99	of	of	ADP
ihlr-28406	765	100	peripheral	peripheral	ADJ
ihlr-28406	765	101	deiodinase	deiodinase	NOUN
ihlr-28406	765	102	-	-	PUNCT
ihlr-28406	765	103	mediated	mediate	VERB
ihlr-28406	765	104	t4	t4	PROPN
ihlr-28406	765	105	-	-	PUNCT
ihlr-28406	765	106	to	to	ADP
ihlr-28406	765	107	-	-	PUNCT
ihlr-28406	765	108	t3	t3	NOUN
ihlr-28406	765	109	conversion	conversion	NOUN
ihlr-28406	765	110	provided	provide	VERB
ihlr-28406	765	111	a	a	DET
ihlr-28406	765	112	physiologic	physiologic	ADJ
ihlr-28406	765	113	means	mean	NOUN
ihlr-28406	765	114	to	to	PART
ihlr-28406	765	115	justify	justify	VERB
ihlr-28406	765	116	l	l	NOUN
ihlr-28406	765	117	-	-	NOUN
ihlr-28406	765	118	thyroxine	thyroxine	NOUN
ihlr-28406	765	119	monotherapy	monotherapy	NOUN
ihlr-28406	765	120	.	.	PUNCT
ihlr-28406	765	121	”205	”205	PUNCT
ihlr-28406	766	1	an	an	DET
ihlr-28406	766	2	important	important	ADJ
ihlr-28406	766	3	evolution	evolution	NOUN
ihlr-28406	766	4	for	for	ADP
ihlr-28406	766	5	the	the	DET
ihlr-28406	766	6	future	future	NOUN
ihlr-28406	766	7	of	of	ADP
ihlr-28406	766	8	thyroid	thyroid	NOUN
ihlr-28406	766	9	hormone	hormone	NOUN
ihlr-28406	766	10	treatment	treatment	NOUN
ihlr-28406	766	11	will	will	AUX
ihlr-28406	766	12	likely	likely	ADV
ihlr-28406	766	13	be	be	AUX
ihlr-28406	766	14	the	the	DET
ihlr-28406	766	15	use	use	NOUN
ihlr-28406	766	16	of	of	ADP
ihlr-28406	766	17	combination	combination	NOUN
ihlr-28406	766	18	therapy	therapy	NOUN
ihlr-28406	766	19	.	.	PUNCT
ihlr-28406	767	1	indeed	indeed	ADV
ihlr-28406	767	2	,	,	PUNCT
ihlr-28406	767	3	providing	provide	VERB
ihlr-28406	767	4	new	new	ADJ
ihlr-28406	767	5	mechanisms	mechanism	NOUN
ihlr-28406	767	6	for	for	ADP
ihlr-28406	767	7	the	the	DET
ihlr-28406	767	8	treatment	treatment	NOUN
ihlr-28406	767	9	of	of	ADP
ihlr-28406	767	10	thyroid	thyroid	NOUN
ihlr-28406	767	11	that	that	SCONJ
ihlr-28406	767	12	more	more	ADV
ihlr-28406	767	13	closely	closely	ADV
ihlr-28406	767	14	model	model	VERB
ihlr-28406	767	15	the	the	DET
ihlr-28406	767	16	biological	biological	ADJ
ihlr-28406	767	17	synthesis	synthesis	NOUN
ihlr-28406	767	18	of	of	ADP
ihlr-28406	767	19	thyroid	thyroid	NOUN
ihlr-28406	767	20	hormone	hormone	NOUN
ihlr-28406	767	21	offer	offer	VERB
ihlr-28406	767	22	the	the	DET
ihlr-28406	767	23	opportunity	opportunity	NOUN
ihlr-28406	767	24	for	for	ADP
ihlr-28406	767	25	improved	improved	ADJ
ihlr-28406	767	26	treatment	treatment	NOUN
ihlr-28406	767	27	options	option	NOUN
ihlr-28406	767	28	and	and	CCONJ
ihlr-28406	767	29	maintaining	maintain	VERB
ihlr-28406	767	30	patient	patient	ADJ
ihlr-28406	767	31	metabolic	metabolic	NOUN
ihlr-28406	767	32	homeostasis	homeostasis	NOUN
ihlr-28406	767	33	.	.	PUNCT
ihlr-28406	767	34	206	206	NUM
ihlr-28406	767	35	still	still	ADV
ihlr-28406	767	36	patients	patient	NOUN
ihlr-28406	767	37	are	be	AUX
ihlr-28406	767	38	only	only	ADV
ihlr-28406	767	39	treated	treat	VERB
ihlr-28406	767	40	with	with	ADP
ihlr-28406	767	41	lt4	lt4	PROPN
ihlr-28406	767	42	.	.	PUNCT
ihlr-28406	768	1	but	but	CCONJ
ihlr-28406	768	2	a	a	DET
ihlr-28406	768	3	common	common	ADJ
ihlr-28406	768	4	problem	problem	NOUN
ihlr-28406	768	5	with	with	ADP
ihlr-28406	768	6	symptom	symptom	NOUN
ihlr-28406	768	7	-	-	PUNCT
ihlr-28406	768	8	based	base	VERB
ihlr-28406	768	9	diagnostics	diagnostic	NOUN
ihlr-28406	768	10	is	be	AUX
ihlr-28406	768	11	that	that	SCONJ
ihlr-28406	768	12	there	there	PRON
ihlr-28406	768	13	is	be	VERB
ihlr-28406	768	14	no	no	DET
ihlr-28406	768	15	method	method	NOUN
ihlr-28406	768	16	for	for	ADP
ihlr-28406	768	17	identifying	identify	VERB
ihlr-28406	768	18	the	the	DET
ihlr-28406	768	19	root	root	NOUN
ihlr-28406	768	20	cause	cause	NOUN
ihlr-28406	768	21	of	of	ADP
ihlr-28406	768	22	symptoms	symptom	NOUN
ihlr-28406	768	23	and	and	CCONJ
ihlr-28406	768	24	therefore	therefore	ADV
ihlr-28406	768	25	,	,	PUNCT
ihlr-28406	768	26	it	it	PRON
ihlr-28406	768	27	is	be	AUX
ihlr-28406	768	28	likely	likely	ADJ
ihlr-28406	768	29	that	that	SCONJ
ihlr-28406	768	30	many	many	ADJ
ihlr-28406	768	31	peripheral	peripheral	ADJ
ihlr-28406	768	32	problems	problem	NOUN
ihlr-28406	768	33	relating	relate	VERB
ihlr-28406	768	34	to	to	ADP
ihlr-28406	768	35	unstable	unstable	ADJ
ihlr-28406	768	36	metabolic	metabolic	NOUN
ihlr-28406	768	37	control	control	NOUN
ihlr-28406	768	38	stemming	stem	VERB
ihlr-28406	768	39	from	from	ADP
ihlr-28406	768	40	thyroid	thyroid	NOUN
ihlr-28406	768	41	disease	disease	NOUN
ihlr-28406	768	42	go	go	VERB
ihlr-28406	768	43	unnoticed	unnoticed	ADJ
ihlr-28406	768	44	.	.	PUNCT
ihlr-28406	769	1	the	the	DET
ihlr-28406	769	2	secret	secret	NOUN
ihlr-28406	769	3	to	to	ADP
ihlr-28406	769	4	inventing	invent	VERB
ihlr-28406	769	5	any	any	DET
ihlr-28406	769	6	new	new	ADJ
ihlr-28406	769	7	cure	cure	NOUN
ihlr-28406	769	8	or	or	CCONJ
ihlr-28406	769	9	treatment	treatment	NOUN
ihlr-28406	769	10	has	have	VERB
ihlr-28406	769	11	three	three	NUM
ihlr-28406	769	12	steps	step	NOUN
ihlr-28406	769	13	.	.	PUNCT
ihlr-28406	770	1	first	first	ADV
ihlr-28406	770	2	,	,	PUNCT
ihlr-28406	770	3	write	write	VERB
ihlr-28406	770	4	down	down	ADP
ihlr-28406	770	5	the	the	DET
ihlr-28406	770	6	problem	problem	NOUN
ihlr-28406	770	7	.	.	PUNCT
ihlr-28406	771	1	second	second	ADJ
ihlr-28406	771	2	,	,	PUNCT
ihlr-28406	771	3	study	study	VERB
ihlr-28406	771	4	and	and	CCONJ
ihlr-28406	771	5	think	think	VERB
ihlr-28406	771	6	about	about	ADP
ihlr-28406	771	7	the	the	DET
ihlr-28406	771	8	problem	problem	NOUN
ihlr-28406	771	9	.	.	PUNCT
ihlr-28406	772	1	third	third	ADV
ihlr-28406	772	2	,	,	PUNCT
ihlr-28406	772	3	write	write	VERB
ihlr-28406	772	4	down	down	ADP
ihlr-28406	772	5	the	the	DET
ihlr-28406	772	6	solution	solution	NOUN
ihlr-28406	772	7	in	in	ADP
ihlr-28406	772	8	patentable	patentable	ADJ
ihlr-28406	772	9	form	form	NOUN
ihlr-28406	772	10	.	.	PUNCT
ihlr-28406	773	1	thus	thus	ADV
ihlr-28406	773	2	,	,	PUNCT
ihlr-28406	773	3	the	the	DET
ihlr-28406	773	4	process	process	NOUN
ihlr-28406	773	5	for	for	ADP
ihlr-28406	773	6	inventing	invent	VERB
ihlr-28406	773	7	new	new	ADJ
ihlr-28406	773	8	treatments	treatment	NOUN
ihlr-28406	773	9	for	for	ADP
ihlr-28406	773	10	thyroid	thyroid	NOUN
ihlr-28406	773	11	disease	disease	NOUN
ihlr-28406	773	12	is	be	AUX
ihlr-28406	773	13	relatively	relatively	ADV
ihlr-28406	773	14	straightforward	straightforward	ADJ
ihlr-28406	773	15	,	,	PUNCT
ihlr-28406	773	16	insofar	insofar	ADV
ihlr-28406	773	17	as	as	SCONJ
ihlr-28406	773	18	the	the	DET
ihlr-28406	773	19	process	process	NOUN
ihlr-28406	773	20	simply	simply	ADV
ihlr-28406	773	21	requires	require	VERB
ihlr-28406	773	22	the	the	DET
ihlr-28406	773	23	identification	identification	NOUN
ihlr-28406	773	24	of	of	ADP
ihlr-28406	773	25	existing	exist	VERB
ihlr-28406	773	26	problems	problem	NOUN
ihlr-28406	773	27	,	,	PUNCT
ihlr-28406	773	28	which	which	PRON
ihlr-28406	773	29	are	be	AUX
ihlr-28406	773	30	abundant	abundant	ADJ
ihlr-28406	773	31	,	,	PUNCT
ihlr-28406	773	32	and	and	CCONJ
ihlr-28406	773	33	the	the	DET
ihlr-28406	773	34	focus	focus	NOUN
ihlr-28406	773	35	to	to	PART
ihlr-28406	773	36	generate	generate	VERB
ihlr-28406	773	37	a	a	DET
ihlr-28406	773	38	solution	solution	NOUN
ihlr-28406	773	39	.	.	PUNCT
ihlr-28406	774	1	however	however	ADV
ihlr-28406	774	2	,	,	PUNCT
ihlr-28406	774	3	large	large	ADJ
ihlr-28406	774	4	institutional	institutional	ADJ
ihlr-28406	774	5	barriers	barrier	NOUN
ihlr-28406	774	6	still	still	ADV
ihlr-28406	774	7	loom	loom	VERB
ihlr-28406	774	8	to	to	PART
ihlr-28406	774	9	slow	slow	VERB
ihlr-28406	774	10	innovation	innovation	NOUN
ihlr-28406	774	11	and	and	CCONJ
ihlr-28406	774	12	progress	progress	VERB
ihlr-28406	774	13	more	more	ADV
ihlr-28406	774	14	generally	generally	ADV
ihlr-28406	774	15	.	.	PUNCT
ihlr-28406	775	1	—	—	PUNCT
ihlr-28406	775	2	—	—	PUNCT
ihlr-28406	775	3	—	—	PUNCT
ihlr-28406	775	4	—	—	PUNCT
ihlr-28406	775	5	—	—	PUNCT
ihlr-28406	775	6	—	—	PUNCT
ihlr-28406	775	7	—	—	PUNCT
ihlr-28406	775	8	—	—	PUNCT
ihlr-28406	775	9	—	—	PUNCT
ihlr-28406	775	10	—	—	PUNCT
ihlr-28406	775	11	—	—	PUNCT
ihlr-28406	775	12	—	—	PUNCT
ihlr-28406	775	13	—	—	PUNCT
ihlr-28406	775	14	—	—	PUNCT
ihlr-28406	775	15	—	—	PUNCT
ihlr-28406	775	16	—	—	PUNCT
ihlr-28406	775	17	—	—	PUNCT
ihlr-28406	775	18	—	—	PUNCT
ihlr-28406	775	19	—	—	PUNCT
ihlr-28406	775	20	—	—	PUNCT
ihlr-28406	775	21	—	—	PUNCT
ihlr-28406	775	22	—	—	PUNCT
ihlr-28406	775	23	—	—	PUNCT
ihlr-28406	775	24	—	—	PUNCT
ihlr-28406	775	25	—	—	PUNCT
ihlr-28406	775	26	—	—	PUNCT
ihlr-28406	775	27	—	—	PUNCT
ihlr-28406	775	28	—	—	PUNCT
ihlr-28406	775	29	—	—	PUNCT
ihlr-28406	775	30	202	202	NUM
ihlr-28406	775	31	.	.	PUNCT
ihlr-28406	776	1	elizabeth	elizabeth	PROPN
ihlr-28406	776	2	a.	a.	PROPN
ihlr-28406	776	3	mcaninch	mcaninch	PROPN
ihlr-28406	776	4	,	,	PUNCT
ihlr-28406	776	5	and	and	CCONJ
ihlr-28406	776	6	antonio	antonio	PROPN
ihlr-28406	776	7	c.	c.	PROPN
ihlr-28406	776	8	bianco	bianco	PROPN
ihlr-28406	776	9	,	,	PUNCT
ihlr-28406	776	10	the	the	DET
ihlr-28406	776	11	history	history	NOUN
ihlr-28406	776	12	and	and	CCONJ
ihlr-28406	776	13	future	future	NOUN
ihlr-28406	776	14	of	of	ADP
ihlr-28406	776	15	treatment	treatment	NOUN
ihlr-28406	776	16	of	of	ADP
ihlr-28406	776	17	hypothyroidism	hypothyroidism	NOUN
ihlr-28406	776	18	,	,	PUNCT
ihlr-28406	776	19	164	164	NUM
ihlr-28406	776	20	annals	annal	VERB
ihlr-28406	776	21	internal	internal	ADJ
ihlr-28406	776	22	med	med	PROPN
ihlr-28406	776	23	.	.	PUNCT
ihlr-28406	777	1	50	50	NUM
ihlr-28406	777	2	,	,	PUNCT
ihlr-28406	777	3	82	82	NUM
ihlr-28406	777	4	(	(	PUNCT
ihlr-28406	777	5	2016	2016	NUM
ihlr-28406	777	6	)	)	PUNCT
ihlr-28406	777	7	203	203	NUM
ihlr-28406	777	8	.	.	PUNCT
ihlr-28406	777	9	35	35	NUM
ihlr-28406	777	10	u.s.c	u.s.c	NOUN
ihlr-28406	777	11	.	.	PUNCT
ihlr-28406	778	1	§	§	PROPN
ihlr-28406	778	2	101	101	NUM
ihlr-28406	778	3	.	.	PUNCT
ihlr-28406	778	4	204	204	NUM
ihlr-28406	778	5	.	.	PUNCT
ihlr-28406	779	1	mcaninch	mcaninch	ADJ
ihlr-28406	779	2	,	,	PUNCT
ihlr-28406	779	3	supra	supra	PROPN
ihlr-28406	779	4	note	note	NOUN
ihlr-28406	779	5	202	202	NUM
ihlr-28406	779	6	,	,	PUNCT
ihlr-28406	779	7	at	at	ADP
ihlr-28406	779	8	80	80	NUM
ihlr-28406	779	9	.	.	PUNCT
ihlr-28406	779	10	.	.	PUNCT
ihlr-28406	780	1	205	205	NUM
ihlr-28406	780	2	.	.	PUNCT
ihlr-28406	781	1	i	i	PRON
ihlr-28406	781	2	d.	d.	PROPN
ihlr-28406	781	3	at	at	ADP
ihlr-28406	781	4	50	50	NUM
ihlr-28406	781	5	.	.	PUNCT
ihlr-28406	781	6	206	206	NUM
ihlr-28406	781	7	.	.	PUNCT
ihlr-28406	782	1	gomes	gome	NOUN
ihlr-28406	782	2	-	-	PUNCT
ihlr-28406	782	3	lima	lima	PROPN
ihlr-28406	782	4	,	,	PUNCT
ihlr-28406	782	5	supra	supra	PROPN
ihlr-28406	782	6	note	note	NOUN
ihlr-28406	782	7	108	108	NUM
ihlr-28406	782	8	,	,	PUNCT
ihlr-28406	782	9	at	at	ADP
ihlr-28406	782	10	3	3	NUM
ihlr-28406	782	11	.	.	NOUN
ihlr-28406	782	12	2024	2024	NUM
ihlr-28406	782	13	]	]	PUNCT
ihlr-28406	782	14	inventions	invention	NOUN
ihlr-28406	782	15	and	and	CCONJ
ihlr-28406	782	16	patents	patent	NOUN
ihlr-28406	782	17	for	for	ADP
ihlr-28406	782	18	treating	treat	VERB
ihlr-28406	782	19	305	305	NUM
ihlr-28406	782	20	thyroid	thyroid	NOUN
ihlr-28406	782	21	disease	disease	NOUN
ihlr-28406	782	22	iv	iv	X
ihlr-28406	782	23	.	.	PUNCT
ihlr-28406	782	24	conclusion	conclusion	NOUN
ihlr-28406	782	25	this	this	DET
ihlr-28406	782	26	paper	paper	NOUN
ihlr-28406	782	27	proceeds	proceed	NOUN
ihlr-28406	782	28	in	in	ADP
ihlr-28406	782	29	three	three	NUM
ihlr-28406	782	30	parts	part	NOUN
ihlr-28406	782	31	.	.	PUNCT
ihlr-28406	783	1	part	part	NOUN
ihlr-28406	783	2	i	i	PRON
ihlr-28406	783	3	explored	explore	VERB
ihlr-28406	783	4	thyroid	thyroid	NOUN
ihlr-28406	783	5	disease	disease	NOUN
ihlr-28406	783	6	,	,	PUNCT
ihlr-28406	783	7	including	include	VERB
ihlr-28406	783	8	diagnostics	diagnostic	NOUN
ihlr-28406	783	9	,	,	PUNCT
ihlr-28406	783	10	hypothyroidism	hypothyroidism	NOUN
ihlr-28406	783	11	,	,	PUNCT
ihlr-28406	783	12	and	and	CCONJ
ihlr-28406	783	13	hyperthyroidism	hyperthyroidism	NOUN
ihlr-28406	783	14	.	.	PUNCT
ihlr-28406	784	1	part	part	NOUN
ihlr-28406	784	2	ii	ii	PROPN
ihlr-28406	784	3	empirically	empirically	ADV
ihlr-28406	784	4	investigated	investigate	VERB
ihlr-28406	784	5	inventions	invention	NOUN
ihlr-28406	784	6	for	for	SCONJ
ihlr-28406	784	7	treatments	treatment	NOUN
ihlr-28406	784	8	to	to	PART
ihlr-28406	784	9	thyroid	thyroid	VERB
ihlr-28406	784	10	disease	disease	NOUN
ihlr-28406	784	11	through	through	ADP
ihlr-28406	784	12	the	the	DET
ihlr-28406	784	13	lens	lens	NOUN
ihlr-28406	784	14	of	of	ADP
ihlr-28406	784	15	the	the	DET
ihlr-28406	784	16	patent	patent	NOUN
ihlr-28406	784	17	system	system	NOUN
ihlr-28406	784	18	.	.	PUNCT
ihlr-28406	785	1	part	part	NOUN
ihlr-28406	785	2	iii	iii	NUM
ihlr-28406	785	3	consolidated	consolidated	ADJ
ihlr-28406	785	4	considerations	consideration	NOUN
ihlr-28406	785	5	for	for	ADP
ihlr-28406	785	6	commercialization	commercialization	NOUN
ihlr-28406	785	7	of	of	ADP
ihlr-28406	785	8	inventions	invention	NOUN
ihlr-28406	785	9	for	for	ADP
ihlr-28406	785	10	treating	treat	VERB
ihlr-28406	785	11	thyroid	thyroid	NOUN
ihlr-28406	785	12	disease	disease	NOUN
ihlr-28406	785	13	.	.	PUNCT
ihlr-28406	786	1	as	as	SCONJ
ihlr-28406	786	2	evolution	evolution	NOUN
ihlr-28406	786	3	207	207	NUM
ihlr-28406	786	4	continues	continue	VERB
ihlr-28406	786	5	,	,	PUNCT
ihlr-28406	786	6	the	the	DET
ihlr-28406	786	7	future	future	NOUN
ihlr-28406	786	8	will	will	AUX
ihlr-28406	786	9	likely	likely	ADV
ihlr-28406	786	10	be	be	AUX
ihlr-28406	786	11	defined	define	VERB
ihlr-28406	786	12	by	by	ADP
ihlr-28406	786	13	human	human	ADJ
ihlr-28406	786	14	-	-	PUNCT
ihlr-28406	786	15	machine	machine	NOUN
ihlr-28406	786	16	symbiosis	symbiosis	NOUN
ihlr-28406	786	17	.	.	PUNCT
ihlr-28406	787	1	in	in	ADP
ihlr-28406	787	2	turn	turn	NOUN
ihlr-28406	787	3	,	,	PUNCT
ihlr-28406	787	4	the	the	DET
ihlr-28406	787	5	process	process	NOUN
ihlr-28406	787	6	of	of	ADP
ihlr-28406	787	7	integration	integration	NOUN
ihlr-28406	787	8	with	with	ADP
ihlr-28406	787	9	the	the	DET
ihlr-28406	787	10	next	next	ADJ
ihlr-28406	787	11	generation	generation	NOUN
ihlr-28406	787	12	of	of	ADP
ihlr-28406	787	13	humans	human	NOUN
ihlr-28406	787	14	will	will	AUX
ihlr-28406	787	15	likely	likely	ADV
ihlr-28406	787	16	lead	lead	VERB
ihlr-28406	787	17	to	to	ADP
ihlr-28406	787	18	a	a	DET
ihlr-28406	787	19	complete	complete	ADJ
ihlr-28406	787	20	cure	cure	NOUN
ihlr-28406	787	21	for	for	ADP
ihlr-28406	787	22	human	human	ADJ
ihlr-28406	787	23	thyroid	thyroid	NOUN
ihlr-28406	787	24	disease	disease	NOUN
ihlr-28406	787	25	,	,	PUNCT
ihlr-28406	787	26	it	it	PRON
ihlr-28406	787	27	’s	’	VERB
ihlr-28406	787	28	only	only	ADV
ihlr-28406	787	29	a	a	DET
ihlr-28406	787	30	matter	matter	NOUN
ihlr-28406	787	31	of	of	ADP
ihlr-28406	787	32	time	time	NOUN
ihlr-28406	787	33	.	.	PUNCT
ihlr-28406	788	1	in	in	ADP
ihlr-28406	788	2	the	the	DET
ihlr-28406	788	3	words	word	NOUN
ihlr-28406	788	4	of	of	ADP
ihlr-28406	788	5	jonas	jonas	PROPN
ihlr-28406	788	6	sulk	sulk	PROPN
ihlr-28406	788	7	,	,	PUNCT
ihlr-28406	788	8	“	"	PUNCT
ihlr-28406	788	9	there	there	PRON
ihlr-28406	788	10	is	be	VERB
ihlr-28406	788	11	hope	hope	NOUN
ihlr-28406	788	12	in	in	ADP
ihlr-28406	788	13	dreams	dream	NOUN
ihlr-28406	788	14	,	,	PUNCT
ihlr-28406	788	15	imagination	imagination	NOUN
ihlr-28406	788	16	,	,	PUNCT
ihlr-28406	788	17	and	and	CCONJ
ihlr-28406	788	18	in	in	ADP
ihlr-28406	788	19	the	the	DET
ihlr-28406	788	20	courage	courage	NOUN
ihlr-28406	788	21	of	of	ADP
ihlr-28406	788	22	those	those	PRON
ihlr-28406	788	23	who	who	PRON
ihlr-28406	788	24	wish	wish	VERB
ihlr-28406	788	25	to	to	PART
ihlr-28406	788	26	make	make	VERB
ihlr-28406	788	27	those	those	DET
ihlr-28406	788	28	dreams	dream	NOUN
ihlr-28406	788	29	a	a	DET
ihlr-28406	788	30	reality	reality	NOUN
ihlr-28406	788	31	.	.	PUNCT
ihlr-28406	788	32	”	"	PUNCT
ihlr-28406	789	1	—	—	PUNCT
ihlr-28406	789	2	—	—	PUNCT
ihlr-28406	789	3	—	—	PUNCT
ihlr-28406	789	4	—	—	PUNCT
ihlr-28406	789	5	—	—	PUNCT
ihlr-28406	789	6	—	—	PUNCT
ihlr-28406	789	7	—	—	PUNCT
ihlr-28406	789	8	—	—	PUNCT
ihlr-28406	789	9	—	—	PUNCT
ihlr-28406	789	10	—	—	PUNCT
ihlr-28406	789	11	—	—	PUNCT
ihlr-28406	789	12	—	—	PUNCT
ihlr-28406	789	13	—	—	PUNCT
ihlr-28406	789	14	—	—	PUNCT
ihlr-28406	789	15	—	—	PUNCT
ihlr-28406	789	16	—	—	PUNCT
ihlr-28406	789	17	—	—	PUNCT
ihlr-28406	789	18	—	—	PUNCT
ihlr-28406	789	19	—	—	PUNCT
ihlr-28406	789	20	—	—	PUNCT
ihlr-28406	789	21	—	—	PUNCT
ihlr-28406	789	22	—	—	PUNCT
ihlr-28406	789	23	—	—	PUNCT
ihlr-28406	789	24	—	—	PUNCT
ihlr-28406	789	25	—	—	PUNCT
ihlr-28406	789	26	—	—	PUNCT
ihlr-28406	789	27	—	—	PUNCT
ihlr-28406	789	28	—	—	PUNCT
ihlr-28406	789	29	—	—	PUNCT
ihlr-28406	789	30	207	207	NUM
ihlr-28406	789	31	.	.	PUNCT
ihlr-28406	790	1	charles	charles	PROPN
ihlr-28406	790	2	darwin	darwin	PROPN
ihlr-28406	790	3	,	,	PUNCT
ihlr-28406	790	4	on	on	ADP
ihlr-28406	790	5	the	the	DET
ihlr-28406	790	6	origin	origin	NOUN
ihlr-28406	790	7	of	of	ADP
ihlr-28406	790	8	species	specie	NOUN
ihlr-28406	790	9	by	by	ADP
ihlr-28406	790	10	means	mean	NOUN
ihlr-28406	790	11	of	of	ADP
ihlr-28406	790	12	natural	natural	ADJ
ihlr-28406	790	13	selection	selection	NOUN
ihlr-28406	790	14	,	,	PUNCT
ihlr-28406	790	15	or	or	CCONJ
ihlr-28406	790	16	the	the	DET
ihlr-28406	790	17	preservation	preservation	NOUN
ihlr-28406	790	18	of	of	ADP
ihlr-28406	790	19	favored	favor	VERB
ihlr-28406	790	20	races	race	NOUN
ihlr-28406	790	21	in	in	ADP
ihlr-28406	790	22	the	the	DET
ihlr-28406	790	23	struggle	struggle	NOUN
ihlr-28406	790	24	for	for	ADP
ihlr-28406	790	25	life	life	NOUN
ihlr-28406	790	26	14	14	NUM
ihlr-28406	790	27	(	(	PUNCT
ihlr-28406	790	28	london	london	PROPN
ihlr-28406	790	29	,	,	PUNCT
ihlr-28406	790	30	john	john	PROPN
ihlr-28406	790	31	murray	murray	PROPN
ihlr-28406	790	32	1859	1859	NUM
ihlr-28406	790	33	)	)	PUNCT
ihlr-28406	790	34	.	.	PUNCT
ihlr-28406	791	1	(	(	PUNCT
ihlr-28406	791	2	when	when	SCONJ
ihlr-28406	791	3	we	we	PRON
ihlr-28406	791	4	look	look	VERB
ihlr-28406	791	5	to	to	ADP
ihlr-28406	791	6	the	the	DET
ihlr-28406	791	7	individuals	individual	NOUN
ihlr-28406	791	8	of	of	ADP
ihlr-28406	791	9	the	the	DET
ihlr-28406	791	10	same	same	ADJ
ihlr-28406	791	11	variety	variety	NOUN
ihlr-28406	791	12	of	of	ADP
ihlr-28406	791	13	our	our	PRON
ihlr-28406	791	14	ancestors	ancestor	NOUN
ihlr-28406	791	15	,	,	PUNCT
ihlr-28406	791	16	one	one	NUM
ihlr-28406	791	17	of	of	ADP
ihlr-28406	791	18	the	the	DET
ihlr-28406	791	19	most	most	ADV
ihlr-28406	791	20	striking	striking	ADJ
ihlr-28406	791	21	points	point	NOUN
ihlr-28406	791	22	is	be	AUX
ihlr-28406	791	23	they	they	PRON
ihlr-28406	791	24	generally	generally	ADV
ihlr-28406	791	25	differ	differ	VERB
ihlr-28406	791	26	much	much	ADV
ihlr-28406	791	27	more	more	ADJ
ihlr-28406	791	28	from	from	ADP
ihlr-28406	791	29	each	each	DET
ihlr-28406	791	30	other	other	ADJ
ihlr-28406	791	31	,	,	PUNCT
ihlr-28406	791	32	than	than	SCONJ
ihlr-28406	791	33	do	do	VERB
ihlr-28406	791	34	the	the	DET
ihlr-28406	791	35	individuals	individual	NOUN
ihlr-28406	791	36	of	of	ADP
ihlr-28406	791	37	any	any	DET
ihlr-28406	791	38	one	one	NUM
ihlr-28406	791	39	species	specie	NOUN
ihlr-28406	791	40	or	or	CCONJ
ihlr-28406	791	41	variety	variety	NOUN
ihlr-28406	791	42	in	in	ADP
ihlr-28406	791	43	a	a	DET
ihlr-28406	791	44	state	state	NOUN
ihlr-28406	791	45	of	of	ADP
ihlr-28406	791	46	nature	nature	NOUN
ihlr-28406	791	47	.	.	PUNCT
ihlr-28406	791	48	)	)	PUNCT
ihlr-28406	792	1	indiana	indiana	PROPN
ihlr-28406	792	2	health	health	PROPN
ihlr-28406	792	3	law	law	PROPN
ihlr-28406	792	4	review	review	NOUN
ihlr-28406	792	5	[	[	X
ihlr-28406	792	6	vol	vol	NOUN
ihlr-28406	792	7	.	.	PUNCT
ihlr-28406	793	1	21:277	21:277	NOUN
ihlr-28406	793	2	306	306	NUM
ihlr-28406	793	3	v.	v.	ADP
ihlr-28406	793	4	appendices	appendix	NOUN
ihlr-28406	793	5	appendix	appendix	VERB
ihlr-28406	793	6	a.	a.	NOUN
ihlr-28406	793	7	hypothalamic	hypothalamic	ADJ
ihlr-28406	793	8	-	-	PUNCT
ihlr-28406	793	9	pituitary	pituitary	ADJ
ihlr-28406	793	10	-	-	PUNCT
ihlr-28406	793	11	thyroid	thyroid	NOUN
ihlr-28406	793	12	axis	axis	NOUN
ihlr-28406	793	13	model	model	NOUN
ihlr-28406	793	14	2024	2024	NUM
ihlr-28406	793	15	]	]	PUNCT
ihlr-28406	793	16	inventions	invention	NOUN
ihlr-28406	793	17	and	and	CCONJ
ihlr-28406	793	18	patents	patent	NOUN
ihlr-28406	793	19	for	for	ADP
ihlr-28406	793	20	treating	treat	VERB
ihlr-28406	793	21	307	307	NUM
ihlr-28406	793	22	thyroid	thyroid	NOUN
ihlr-28406	793	23	disease	disease	NOUN
ihlr-28406	793	24	appendix	appendix	VERB
ihlr-28406	793	25	b.	b.	PROPN
ihlr-28406	793	26	hypothalamic	hypothalamic	ADJ
ihlr-28406	793	27	-	-	PUNCT
ihlr-28406	793	28	pituitary	pituitary	ADJ
ihlr-28406	793	29	-	-	PUNCT
ihlr-28406	793	30	thyroid	thyroid	NOUN
ihlr-28406	793	31	axis	axis	NOUN
ihlr-28406	793	32	description	description	NOUN
ihlr-28406	793	33	indiana	indiana	PROPN
ihlr-28406	793	34	health	health	PROPN
ihlr-28406	793	35	law	law	PROPN
ihlr-28406	793	36	review	review	NOUN
ihlr-28406	793	37	[	[	X
ihlr-28406	793	38	vol	vol	NOUN
ihlr-28406	793	39	.	.	PUNCT
ihlr-28406	794	1	21:277	21:277	NOUN
ihlr-28406	794	2	308	308	NUM
ihlr-28406	794	3	appendix	appendix	PROPN
ihlr-28406	794	4	c.	c.	PROPN
ihlr-28406	794	5	levothyroxine	levothyroxine	PROPN
ihlr-28406	794	6	tablet	tablet	PROPN
ihlr-28406	794	7	information	information	PROPN
ihlr-28406	794	8	2024	2024	NUM
ihlr-28406	794	9	]	]	PUNCT
ihlr-28406	794	10	inventions	invention	NOUN
ihlr-28406	794	11	and	and	CCONJ
ihlr-28406	794	12	patents	patent	NOUN
ihlr-28406	794	13	for	for	ADP
ihlr-28406	794	14	treating	treat	VERB
ihlr-28406	794	15	309	309	NUM
ihlr-28406	794	16	thyroid	thyroid	NOUN
ihlr-28406	794	17	disease	disease	NOUN
ihlr-28406	794	18	appendix	appendix	VERB
ihlr-28406	794	19	d.	d.	PROPN
ihlr-28406	794	20	symptoms	symptom	NOUN
ihlr-28406	794	21	for	for	ADP
ihlr-28406	794	22	thyroid	thyroid	NOUN
ihlr-28406	794	23	disease	disease	NOUN
ihlr-28406	794	24	hypothyroidism208	hypothyroidism208	PROPN
ihlr-28406	794	25	hyperthyroidism209	hyperthyroidism209	PROPN
ihlr-28406	794	26	1	1	NUM
ihlr-28406	794	27	.	.	PUNCT
ihlr-28406	794	28	weight	weight	NOUN
ihlr-28406	794	29	gain	gain	NOUN
ihlr-28406	794	30	.	.	PUNCT
ihlr-28406	795	1	2	2	X
ihlr-28406	795	2	.	.	X
ihlr-28406	795	3	depression	depression	NOUN
ihlr-28406	795	4	.	.	PUNCT
ihlr-28406	796	1	3	3	X
ihlr-28406	796	2	.	.	X
ihlr-28406	796	3	slow	slow	ADJ
ihlr-28406	796	4	movements	movement	NOUN
ihlr-28406	796	5	and	and	CCONJ
ihlr-28406	796	6	thoughts	thought	NOUN
ihlr-28406	796	7	.	.	PUNCT
ihlr-28406	797	1	4	4	X
ihlr-28406	797	2	.	.	X
ihlr-28406	797	3	muscle	muscle	NOUN
ihlr-28406	797	4	aches	ache	NOUN
ihlr-28406	797	5	and	and	CCONJ
ihlr-28406	797	6	weakness	weakness	NOUN
ihlr-28406	797	7	.	.	PUNCT
ihlr-28406	798	1	5	5	X
ihlr-28406	798	2	.	.	X
ihlr-28406	798	3	muscle	muscle	NOUN
ihlr-28406	798	4	cramps	cramp	NOUN
ihlr-28406	798	5	.	.	PUNCT
ihlr-28406	799	1	6	6	NUM
ihlr-28406	799	2	.	.	NOUN
ihlr-28406	799	3	dry	dry	ADJ
ihlr-28406	799	4	and	and	CCONJ
ihlr-28406	799	5	scaly	scaly	NOUN
ihlr-28406	799	6	skin	skin	NOUN
ihlr-28406	799	7	.	.	PUNCT
ihlr-28406	800	1	7	7	X
ihlr-28406	800	2	.	.	X
ihlr-28406	800	3	brittle	brittle	ADJ
ihlr-28406	800	4	hair	hair	NOUN
ihlr-28406	800	5	and	and	CCONJ
ihlr-28406	800	6	nails	nail	NOUN
ihlr-28406	800	7	.	.	PUNCT
ihlr-28406	801	1	8	8	NUM
ihlr-28406	801	2	.	.	PUNCT
ihlr-28406	801	3	loss	loss	NOUN
ihlr-28406	801	4	of	of	ADP
ihlr-28406	801	5	libido	libido	NOUN
ihlr-28406	801	6	.	.	PUNCT
ihlr-28406	802	1	9	9	X
ihlr-28406	802	2	.	.	X
ihlr-28406	802	3	pain	pain	NOUN
ihlr-28406	802	4	,	,	PUNCT
ihlr-28406	802	5	numbness	numbness	NOUN
ihlr-28406	802	6	,	,	PUNCT
ihlr-28406	802	7	and	and	CCONJ
ihlr-28406	802	8	a	a	DET
ihlr-28406	802	9	tingling	tingle	VERB
ihlr-28406	802	10	sensation	sensation	NOUN
ihlr-28406	802	11	.	.	PUNCT
ihlr-28406	803	1	10	10	NUM
ihlr-28406	803	2	.	.	X
ihlr-28406	803	3	tiredness	tiredness	NOUN
ihlr-28406	803	4	.	.	PUNCT
ihlr-28406	804	1	11	11	NUM
ihlr-28406	804	2	.	.	PUNCT
ihlr-28406	805	1	more	more	ADJ
ihlr-28406	805	2	sensitivity	sensitivity	NOUN
ihlr-28406	805	3	to	to	PART
ihlr-28406	805	4	cold	cold	VERB
ihlr-28406	805	5	.	.	PUNCT
ihlr-28406	806	1	12	12	NUM
ihlr-28406	806	2	.	.	PUNCT
ihlr-28406	807	1	constipation	constipation	NOUN
ihlr-28406	807	2	.	.	PUNCT
ihlr-28406	808	1	13	13	NUM
ihlr-28406	808	2	.	.	X
ihlr-28406	808	3	dry	dry	ADJ
ihlr-28406	808	4	skin	skin	NOUN
ihlr-28406	808	5	.	.	PUNCT
ihlr-28406	809	1	14	14	NUM
ihlr-28406	809	2	.	.	PUNCT
ihlr-28406	810	1	puffy	puffy	ADJ
ihlr-28406	810	2	face	face	NOUN
ihlr-28406	810	3	.	.	PUNCT
ihlr-28406	811	1	15	15	X
ihlr-28406	811	2	.	.	PUNCT
ihlr-28406	811	3	hoarse	hoarse	ADJ
ihlr-28406	811	4	voice	voice	NOUN
ihlr-28406	811	5	.	.	PUNCT
ihlr-28406	812	1	16	16	NUM
ihlr-28406	812	2	.	.	PUNCT
ihlr-28406	813	1	coarse	coarse	ADJ
ihlr-28406	813	2	hair	hair	NOUN
ihlr-28406	813	3	and	and	CCONJ
ihlr-28406	813	4	skin	skin	NOUN
ihlr-28406	813	5	.	.	PUNCT
ihlr-28406	814	1	17	17	NUM
ihlr-28406	814	2	.	.	X
ihlr-28406	814	3	muscle	muscle	NOUN
ihlr-28406	814	4	weakness	weakness	NOUN
ihlr-28406	814	5	.	.	PUNCT
ihlr-28406	815	1	18	18	NUM
ihlr-28406	815	2	.	.	X
ihlr-28406	815	3	muscle	muscle	NOUN
ihlr-28406	815	4	aches	ache	NOUN
ihlr-28406	815	5	,	,	PUNCT
ihlr-28406	815	6	tenderness	tenderness	NOUN
ihlr-28406	815	7	,	,	PUNCT
ihlr-28406	815	8	and	and	CCONJ
ihlr-28406	815	9	stiffness	stiffness	NOUN
ihlr-28406	815	10	.	.	PUNCT
ihlr-28406	816	1	19	19	NUM
ihlr-28406	816	2	.	.	PUNCT
ihlr-28406	816	3	unusually	unusually	ADV
ihlr-28406	816	4	heavy	heavy	ADJ
ihlr-28406	816	5	menstrual	menstrual	ADJ
ihlr-28406	816	6	cycles	cycle	NOUN
ihlr-28406	816	7	.	.	PUNCT
ihlr-28406	817	1	20	20	NUM
ihlr-28406	817	2	.	.	X
ihlr-28406	817	3	thinning	thin	VERB
ihlr-28406	817	4	hair	hair	NOUN
ihlr-28406	817	5	.	.	PUNCT
ihlr-28406	818	1	21	21	NUM
ihlr-28406	818	2	.	.	NUM
ihlr-28406	818	3	slowed	slow	VERB
ihlr-28406	818	4	heart	heart	NOUN
ihlr-28406	818	5	rate	rate	NOUN
ihlr-28406	818	6	,	,	PUNCT
ihlr-28406	818	7	also	also	ADV
ihlr-28406	818	8	called	call	VERB
ihlr-28406	818	9	bradycardia	bradycardia	NOUN
ihlr-28406	818	10	.	.	PUNCT
ihlr-28406	819	1	22	22	NUM
ihlr-28406	819	2	.	.	PUNCT
ihlr-28406	819	3	depression	depression	NOUN
ihlr-28406	819	4	.	.	PUNCT
ihlr-28406	820	1	23	23	NUM
ihlr-28406	820	2	.	.	PUNCT
ihlr-28406	821	1	memory	memory	NOUN
ihlr-28406	821	2	problems	problem	NOUN
ihlr-28406	821	3	.	.	PUNCT
ihlr-28406	822	1	24	24	NUM
ihlr-28406	822	2	.	.	PUNCT
ihlr-28406	823	1	feeding	feeding	NOUN
ihlr-28406	823	2	problems	problem	NOUN
ihlr-28406	823	3	.	.	PUNCT
ihlr-28406	824	1	25	25	NUM
ihlr-28406	824	2	.	.	PUNCT
ihlr-28406	824	3	poor	poor	ADJ
ihlr-28406	824	4	growth	growth	NOUN
ihlr-28406	824	5	.	.	PUNCT
ihlr-28406	825	1	26	26	NUM
ihlr-28406	825	2	.	.	PUNCT
ihlr-28406	825	3	poor	poor	ADJ
ihlr-28406	825	4	weight	weight	NOUN
ihlr-28406	825	5	gain	gain	NOUN
ihlr-28406	825	6	.	.	PUNCT
ihlr-28406	826	1	27	27	NUM
ihlr-28406	826	2	.	.	PUNCT
ihlr-28406	826	3	jaundice	jaundice	NOUN
ihlr-28406	826	4	.	.	PUNCT
ihlr-28406	827	1	1	1	X
ihlr-28406	827	2	.	.	X
ihlr-28406	827	3	losing	lose	VERB
ihlr-28406	827	4	weight	weight	NOUN
ihlr-28406	827	5	without	without	ADP
ihlr-28406	827	6	trying	try	VERB
ihlr-28406	827	7	.	.	PUNCT
ihlr-28406	828	1	2	2	X
ihlr-28406	828	2	.	.	X
ihlr-28406	828	3	tachycardia	tachycardia	NOUN
ihlr-28406	828	4	.	.	PUNCT
ihlr-28406	829	1	3	3	X
ihlr-28406	829	2	.	.	X
ihlr-28406	829	3	arrhythmia	arrhythmia	NOUN
ihlr-28406	829	4	.	.	PUNCT
ihlr-28406	830	1	4	4	X
ihlr-28406	830	2	.	.	X
ihlr-28406	830	3	pounding	pound	VERB
ihlr-28406	830	4	of	of	ADP
ihlr-28406	830	5	the	the	DET
ihlr-28406	830	6	heart	heart	NOUN
ihlr-28406	830	7	,	,	PUNCT
ihlr-28406	830	8	sometimes	sometimes	ADV
ihlr-28406	830	9	called	call	VERB
ihlr-28406	830	10	heart	heart	NOUN
ihlr-28406	830	11	palpitations	palpitation	NOUN
ihlr-28406	830	12	.	.	PUNCT
ihlr-28406	831	1	5	5	X
ihlr-28406	831	2	.	.	NUM
ihlr-28406	831	3	increased	increase	VERB
ihlr-28406	831	4	hunger	hunger	NOUN
ihlr-28406	831	5	.	.	PUNCT
ihlr-28406	832	1	6	6	X
ihlr-28406	832	2	.	.	X
ihlr-28406	832	3	nervousness	nervousness	NOUN
ihlr-28406	832	4	,	,	PUNCT
ihlr-28406	832	5	anxiety	anxiety	NOUN
ihlr-28406	832	6	,	,	PUNCT
ihlr-28406	832	7	and	and	CCONJ
ihlr-28406	832	8	irritability	irritability	NOUN
ihlr-28406	832	9	.	.	PUNCT
ihlr-28406	833	1	7	7	X
ihlr-28406	833	2	.	.	X
ihlr-28406	833	3	tremor	tremor	NOUN
ihlr-28406	833	4	.	.	PUNCT
ihlr-28406	834	1	8	8	X
ihlr-28406	834	2	.	.	X
ihlr-28406	834	3	sweating	sweating	NOUN
ihlr-28406	834	4	.	.	PUNCT
ihlr-28406	835	1	9	9	X
ihlr-28406	835	2	.	.	X
ihlr-28406	835	3	changes	change	NOUN
ihlr-28406	835	4	in	in	ADP
ihlr-28406	835	5	menstrual	menstrual	ADJ
ihlr-28406	835	6	cycles	cycle	NOUN
ihlr-28406	835	7	.	.	PUNCT
ihlr-28406	836	1	10	10	NUM
ihlr-28406	836	2	.	.	NUM
ihlr-28406	836	3	increased	increase	VERB
ihlr-28406	836	4	sensitivity	sensitivity	NOUN
ihlr-28406	836	5	to	to	PART
ihlr-28406	836	6	heat	heat	VERB
ihlr-28406	836	7	.	.	PUNCT
ihlr-28406	837	1	11	11	NUM
ihlr-28406	837	2	.	.	PUNCT
ihlr-28406	838	1	changes	change	NOUN
ihlr-28406	838	2	in	in	ADP
ihlr-28406	838	3	bowel	bowel	NOUN
ihlr-28406	838	4	patterns	pattern	NOUN
ihlr-28406	838	5	.	.	PUNCT
ihlr-28406	839	1	12	12	NUM
ihlr-28406	839	2	.	.	X
ihlr-28406	839	3	swelling	swell	VERB
ihlr-28406	839	4	at	at	ADP
ihlr-28406	839	5	the	the	DET
ihlr-28406	839	6	base	base	NOUN
ihlr-28406	839	7	of	of	ADP
ihlr-28406	839	8	the	the	DET
ihlr-28406	839	9	neck	neck	NOUN
ihlr-28406	839	10	.	.	PUNCT
ihlr-28406	840	1	13	13	NUM
ihlr-28406	840	2	.	.	PUNCT
ihlr-28406	840	3	tiredness	tiredness	NOUN
ihlr-28406	840	4	.	.	PUNCT
ihlr-28406	841	1	14	14	NUM
ihlr-28406	841	2	.	.	PUNCT
ihlr-28406	841	3	muscle	muscle	NOUN
ihlr-28406	841	4	weakness	weakness	NOUN
ihlr-28406	841	5	.	.	PUNCT
ihlr-28406	842	1	15	15	X
ihlr-28406	842	2	.	.	PUNCT
ihlr-28406	842	3	sleep	sleep	NOUN
ihlr-28406	842	4	problems	problem	NOUN
ihlr-28406	842	5	.	.	PUNCT
ihlr-28406	843	1	16	16	NUM
ihlr-28406	843	2	.	.	PUNCT
ihlr-28406	844	1	warm	warm	ADJ
ihlr-28406	844	2	,	,	PUNCT
ihlr-28406	844	3	moist	moist	ADJ
ihlr-28406	844	4	skin	skin	NOUN
ihlr-28406	844	5	.	.	PUNCT
ihlr-28406	845	1	17	17	NUM
ihlr-28406	845	2	.	.	X
ihlr-28406	845	3	thinning	thin	VERB
ihlr-28406	845	4	skin	skin	NOUN
ihlr-28406	845	5	.	.	PUNCT
ihlr-28406	846	1	18	18	NUM
ihlr-28406	846	2	.	.	X
ihlr-28406	847	1	fine	fine	ADJ
ihlr-28406	847	2	,	,	PUNCT
ihlr-28406	847	3	brittle	brittle	ADJ
ihlr-28406	847	4	hair	hair	NOUN
ihlr-28406	847	5	.	.	PUNCT
ihlr-28406	848	1	19	19	NUM
ihlr-28406	848	2	.	.	X
ihlr-28406	848	3	nervousness	nervousness	NOUN
ihlr-28406	848	4	,	,	PUNCT
ihlr-28406	848	5	anxiety	anxiety	NOUN
ihlr-28406	848	6	,	,	PUNCT
ihlr-28406	848	7	and	and	CCONJ
ihlr-28406	848	8	irritability	irritability	NOUN
ihlr-28406	848	9	20	20	NUM
ihlr-28406	848	10	.	.	PUNCT
ihlr-28406	849	1	hyperactivity	hyperactivity	NOUN
ihlr-28406	849	2	.	.	PUNCT
ihlr-28406	850	1	21	21	NUM
ihlr-28406	850	2	.	.	PUNCT
ihlr-28406	851	1	mood	mood	NOUN
ihlr-28406	851	2	swings	swing	NOUN
ihlr-28406	851	3	22	22	NUM
ihlr-28406	851	4	.	.	PUNCT
ihlr-28406	852	1	difficulty	difficulty	NOUN
ihlr-28406	852	2	sleeping	sleep	VERB
ihlr-28406	852	3	23	23	NUM
ihlr-28406	852	4	.	.	PUNCT
ihlr-28406	853	1	feeling	feel	VERB
ihlr-28406	853	2	tired	tired	ADJ
ihlr-28406	853	3	all	all	DET
ihlr-28406	853	4	the	the	DET
ihlr-28406	853	5	time	time	NOUN
ihlr-28406	853	6	24	24	NUM
ihlr-28406	853	7	.	.	PUNCT
ihlr-28406	854	1	sensitivity	sensitivity	NOUN
ihlr-28406	854	2	to	to	PART
ihlr-28406	854	3	heat	heat	VERB
ihlr-28406	854	4	.	.	PUNCT
ihlr-28406	855	1	—	—	PUNCT
ihlr-28406	855	2	—	—	PUNCT
ihlr-28406	855	3	—	—	PUNCT
ihlr-28406	855	4	—	—	PUNCT
ihlr-28406	855	5	—	—	PUNCT
ihlr-28406	855	6	—	—	PUNCT
ihlr-28406	855	7	—	—	PUNCT
ihlr-28406	855	8	—	—	PUNCT
ihlr-28406	855	9	—	—	PUNCT
ihlr-28406	855	10	—	—	PUNCT
ihlr-28406	855	11	—	—	PUNCT
ihlr-28406	855	12	—	—	PUNCT
ihlr-28406	855	13	—	—	PUNCT
ihlr-28406	855	14	—	—	PUNCT
ihlr-28406	855	15	—	—	PUNCT
ihlr-28406	855	16	—	—	PUNCT
ihlr-28406	855	17	—	—	PUNCT
ihlr-28406	855	18	—	—	PUNCT
ihlr-28406	855	19	—	—	PUNCT
ihlr-28406	855	20	—	—	PUNCT
ihlr-28406	855	21	—	—	PUNCT
ihlr-28406	855	22	—	—	PUNCT
ihlr-28406	855	23	—	—	PUNCT
ihlr-28406	855	24	—	—	PUNCT
ihlr-28406	855	25	—	—	PUNCT
ihlr-28406	855	26	—	—	PUNCT
ihlr-28406	855	27	—	—	PUNCT
ihlr-28406	855	28	—	—	PUNCT
ihlr-28406	855	29	—	—	PUNCT
ihlr-28406	855	30	208	208	NUM
ihlr-28406	855	31	.	.	X
ihlr-28406	856	1	nhs	nhs	NOUN
ihlr-28406	856	2	,	,	PUNCT
ihlr-28406	856	3	symptoms	symptom	NOUN
ihlr-28406	856	4	-	-	PUNCT
ihlr-28406	856	5	underactive	underactive	ADJ
ihlr-28406	856	6	thyroid	thyroid	NOUN
ihlr-28406	856	7	(	(	PUNCT
ihlr-28406	856	8	hypothyroidism	hypothyroidism	NOUN
ihlr-28406	856	9	)	)	PUNCT
ihlr-28406	856	10	(	(	PUNCT
ihlr-28406	856	11	2022	2022	NUM
ihlr-28406	856	12	)	)	PUNCT
ihlr-28406	856	13	,	,	PUNCT
ihlr-28406	856	14	https://www.nhs.uk/conditions/underactive-thyroid-hypothyroidism/symptoms/.	https://www.nhs.uk/conditions/underactive-thyroid-hypothyroidism/symptoms/.	PRON
ihlr-28406	856	15	see	see	VERB
ihlr-28406	856	16	also	also	ADV
ihlr-28406	856	17	mayo	mayo	NOUN
ihlr-28406	856	18	clinic	clinic	PROPN
ihlr-28406	856	19	,	,	PUNCT
ihlr-28406	856	20	hypothyroidism	hypothyroidism	NOUN
ihlr-28406	856	21	(	(	PUNCT
ihlr-28406	856	22	underactive	underactive	ADJ
ihlr-28406	856	23	thyroid	thyroid	NOUN
ihlr-28406	856	24	)	)	PUNCT
ihlr-28406	856	25	(	(	PUNCT
ihlr-28406	856	26	2022	2022	NUM
ihlr-28406	856	27	)	)	PUNCT
ihlr-28406	856	28	,	,	PUNCT
ihlr-28406	856	29	https://www.mayoclinic.org/diseasesconditions/hypothyroidism/symptoms-causes/syc-20350284	https://www.mayoclinic.org/diseasesconditions/hypothyroidism/symptoms-causes/syc-20350284	NOUN
ihlr-28406	856	30	.	.	PUNCT
ihlr-28406	857	1	209	209	NUM
ihlr-28406	857	2	.	.	PUNCT
ihlr-28406	858	1	may	may	AUX
ihlr-28406	858	2	clinic	clinic	VERB
ihlr-28406	858	3	,	,	PUNCT
ihlr-28406	858	4	hyperthyroidism	hyperthyroidism	NOUN
ihlr-28406	858	5	(	(	PUNCT
ihlr-28406	858	6	overactive	overactive	ADJ
ihlr-28406	858	7	thyroid	thyroid	NOUN
ihlr-28406	858	8	)	)	PUNCT
ihlr-28406	858	9	(	(	PUNCT
ihlr-28406	858	10	2022	2022	NUM
ihlr-28406	858	11	)	)	PUNCT
ihlr-28406	858	12	.	.	PUNCT
ihlr-28406	859	1	see	see	AUX
ihlr-28406	859	2	also	also	ADV
ihlr-28406	859	3	symptomsoveractive	symptomsoveractive	ADJ
ihlr-28406	859	4	thyroid	thyroid	NOUN
ihlr-28406	859	5	(	(	PUNCT
ihlr-28406	859	6	hyperthyroidism	hyperthyroidism	NOUN
ihlr-28406	859	7	)	)	PUNCT
ihlr-28406	859	8	(	(	PUNCT
ihlr-28406	859	9	2022	2022	NUM
ihlr-28406	859	10	)	)	PUNCT
ihlr-28406	859	11	,	,	PUNCT
ihlr-28406	860	1	https://www.nhs.uk/conditions/overactive-thyroidhyperthyroidism/symptoms/.	https://www.nhs.uk/conditions/overactive-thyroidhyperthyroidism/symptoms/.	PROPN
ihlr-28406	860	2	https://www.nhs.uk/conditions/overactive-thyroid	https://www.nhs.uk/conditions/overactive-thyroid	PROPN
ihlr-28406	860	3	https://www.mayoclinic.org/diseases	https://www.mayoclinic.org/diseases	X
ihlr-28406	860	4	https://www.nhs.uk/conditions/underactive-thyroid-hypothyroidism/symptoms	https://www.nhs.uk/conditions/underactive-thyroid-hypothyroidism/symptom	NOUN
ihlr-28406	860	5	indiana	indiana	PROPN
ihlr-28406	860	6	health	health	PROPN
ihlr-28406	860	7	law	law	PROPN
ihlr-28406	860	8	review	review	NOUN
ihlr-28406	861	1	[	[	X
ihlr-28406	861	2	vol	vol	NOUN
ihlr-28406	861	3	.	.	PUNCT
ihlr-28406	862	1	21:277	21:277	NOUN
ihlr-28406	862	2	310	310	NUM
ihlr-28406	862	3	28	28	NUM
ihlr-28406	862	4	.	.	PUNCT
ihlr-28406	863	1	constipation	constipation	NOUN
ihlr-28406	863	2	.	.	PUNCT
ihlr-28406	864	1	29	29	NUM
ihlr-28406	864	2	.	.	PUNCT
ihlr-28406	864	3	poor	poor	ADJ
ihlr-28406	864	4	muscle	muscle	NOUN
ihlr-28406	864	5	tone	tone	NOUN
ihlr-28406	864	6	.	.	PUNCT
ihlr-28406	865	1	30	30	NUM
ihlr-28406	865	2	.	.	PUNCT
ihlr-28406	866	1	dry	dry	ADJ
ihlr-28406	866	2	skin	skin	NOUN
ihlr-28406	866	3	.	.	PUNCT
ihlr-28406	867	1	31	31	NUM
ihlr-28406	867	2	.	.	PUNCT
ihlr-28406	867	3	hoarse	hoarse	ADJ
ihlr-28406	867	4	crying	crying	NOUN
ihlr-28406	867	5	.	.	PUNCT
ihlr-28406	868	1	32	32	NUM
ihlr-28406	868	2	.	.	PUNCT
ihlr-28406	868	3	enlarged	enlarge	VERB
ihlr-28406	868	4	tongue	tongue	NOUN
ihlr-28406	868	5	.	.	PUNCT
ihlr-28406	869	1	33	33	NUM
ihlr-28406	869	2	.	.	PUNCT
ihlr-28406	870	1	umbilical	umbilical	ADJ
ihlr-28406	870	2	hernia	hernia	NOUN
ihlr-28406	870	3	.	.	PUNCT
ihlr-28406	871	1	34	34	NUM
ihlr-28406	871	2	.	.	PUNCT
ihlr-28406	872	1	poor	poor	ADJ
ihlr-28406	872	2	growth	growth	NOUN
ihlr-28406	872	3	that	that	PRON
ihlr-28406	872	4	leads	lead	VERB
ihlr-28406	872	5	to	to	ADP
ihlr-28406	872	6	short	short	ADJ
ihlr-28406	872	7	stature	stature	NOUN
ihlr-28406	872	8	.	.	PUNCT
ihlr-28406	873	1	35	35	NUM
ihlr-28406	873	2	.	.	NUM
ihlr-28406	873	3	delayed	delay	VERB
ihlr-28406	873	4	development	development	NOUN
ihlr-28406	873	5	of	of	ADP
ihlr-28406	873	6	permanent	permanent	ADJ
ihlr-28406	873	7	teeth	tooth	NOUN
ihlr-28406	873	8	.	.	PUNCT
ihlr-28406	874	1	36	36	NUM
ihlr-28406	874	2	.	.	PUNCT
ihlr-28406	874	3	delayed	delay	VERB
ihlr-28406	874	4	puberty	puberty	NOUN
ihlr-28406	874	5	.	.	PUNCT
ihlr-28406	875	1	37	37	NUM
ihlr-28406	875	2	.	.	PUNCT
ihlr-28406	876	1	poor	poor	ADJ
ihlr-28406	876	2	mental	mental	ADJ
ihlr-28406	876	3	development	development	NOUN
ihlr-28406	876	4	.	.	PUNCT
ihlr-28406	877	1	25	25	NUM
ihlr-28406	877	2	.	.	X
ihlr-28406	877	3	muscle	muscle	NOUN
ihlr-28406	877	4	weakness	weakness	NOUN
ihlr-28406	877	5	26	26	NUM
ihlr-28406	877	6	.	.	PUNCT
ihlr-28406	878	1	diarrhea	diarrhea	PROPN
ihlr-28406	878	2	.	.	PUNCT
ihlr-28406	879	1	27	27	NUM
ihlr-28406	879	2	.	.	PUNCT
ihlr-28406	880	1	needing	need	VERB
ihlr-28406	880	2	to	to	PART
ihlr-28406	880	3	pee	pee	VERB
ihlr-28406	880	4	more	more	ADV
ihlr-28406	880	5	than	than	ADP
ihlr-28406	880	6	usual	usual	ADJ
ihlr-28406	880	7	.	.	PUNCT
ihlr-28406	881	1	28	28	NUM
ihlr-28406	881	2	.	.	PUNCT
ihlr-28406	882	1	persistent	persistent	ADJ
ihlr-28406	882	2	thirst	thirst	NOUN
ihlr-28406	882	3	.	.	PUNCT
ihlr-28406	883	1	29	29	NUM
ihlr-28406	883	2	.	.	X
ihlr-28406	883	3	itchiness	itchiness	NOUN
ihlr-28406	883	4	.	.	PUNCT
ihlr-28406	884	1	30	30	NUM
ihlr-28406	884	2	.	.	PUNCT
ihlr-28406	885	1	loss	loss	NOUN
ihlr-28406	885	2	of	of	ADP
ihlr-28406	885	3	interest	interest	NOUN
ihlr-28406	885	4	in	in	ADP
ihlr-28406	885	5	sex	sex	NOUN
ihlr-28406	885	6	.	.	PUNCT
ihlr-28406	886	1	structure	structure	NOUN
ihlr-28406	886	2	bookmarks	bookmark	NOUN
ihlr-28406	886	3	inventions	invention	NOUN
ihlr-28406	886	4	and	and	CCONJ
ihlr-28406	886	5	patents	patent	NOUN
ihlr-28406	886	6	for	for	ADP
ihlr-28406	886	7	treating	treat	VERB